data_2rvq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rvq _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.02 142.76 48.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.884 0.754 . . . . 0.0 112.862 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.28 68.79 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.281 1.041 . . . . 0.0 113.513 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.98 -24.98 76.15 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.445 1.021 . . . . 0.0 114.982 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.22 -55.82 37.96 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.355 1.578 . . . . 0.0 114.36 -174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.83 -34.41 95.65 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.357 2.038 . . . . 0.0 113.068 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.69 -51.02 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.155 0.888 . . . . 0.0 110.91 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -66.78 -42.28 86.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.589 0.756 . . . . 0.0 110.118 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 69.7 mt -63.32 -35.16 79.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.932 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.21 93.21 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.508 1.504 . . . . 0.0 112.077 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.39 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.92 0.488 . . . . 0.0 111.864 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -51.57 -53.86 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.512 1.125 . . . . 0.0 111.393 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 mt -53.11 -49.1 67.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.718 1.607 . . . . 0.0 112.104 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -48.04 -51.63 23.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.49 1.041 . . . . 0.0 111.985 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -69.45 -31.99 70.65 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.53 -23.3 57.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 1.5 p -119.22 5.12 11.24 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.598 1.544 . . . . 0.0 114.867 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.65 73.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.165 1.348 . . . . 0.0 112.718 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -70.1 -32.96 71.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.8 -54.14 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.012 0.925 . . . . 0.0 109.667 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.92 -46.48 81.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.51 1.524 . . . . 0.0 112.551 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -54.71 -56.78 15.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.586 0.754 . . . . 0.0 111.514 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.43 -38.07 71.4 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.0 99.45 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.334 -0.854 . . . . 0.0 111.802 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.97 94.99 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.506 -0.746 . . . . 0.0 113.596 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -58.8 -49.89 76.01 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.848 1.324 . . . . 0.0 110.603 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.78 80.96 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.63 0.772 . . . . 0.0 112.509 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.1 75.36 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.817 0.847 . . . . 0.0 112.606 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -56.82 -50.95 70.84 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.436 1.094 . . . . 0.0 112.289 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -55.51 -42.01 73.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.613 1.165 . . . . 0.0 113.075 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.79 10.68 17.62 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.625 1.17 . . . . 0.0 113.089 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 53.63 33.32 16.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.392 2.277 . . . . 0.0 114.777 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -89.29 146.51 24.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.23 1.412 . . . . 0.0 112.386 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.6 p -77.91 -30.63 50.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.881 1.272 . . . . 0.0 112.967 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -131.24 151.76 51.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.126 1.37 . . . . 0.0 112.603 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.7 mt -67.46 129.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 0.0 109.928 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 pt -122.71 167.1 15.16 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.429 1.892 . . . . 0.0 111.265 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -54.55 -34.5 82.73 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.344 2.696 . . . . 0.0 114.952 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.03 -36.75 75.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.988 0.915 . . . . 0.0 113.252 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -63.23 -38.69 92.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.551 -0.718 . . . . 0.0 111.982 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.21 -46.27 71.05 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.502 0.721 . . . . 0.0 111.761 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -50.65 -46.64 58.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.725 0.81 . . . . 0.0 111.746 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.83 -62.31 1.73 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.944 0.898 . . . . 0.0 112.173 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.99 69.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.755 1.222 . . . . 0.0 113.074 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -56.87 -61.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.857 0.863 . . . . 0.0 110.741 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.0 -32.69 74.11 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -86.79 -8.59 57.21 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -129.3 118.1 21.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 112.407 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.78 -26.81 67.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.822 -1.173 . . . . 0.0 114.067 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -70.98 -31.36 67.89 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 111.489 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.75 -36.94 67.81 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 111.493 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.54 -29.38 66.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.406 1.003 . . . . 0.0 112.771 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -77.11 -46.0 25.01 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.417 1.008 . . . . 0.0 112.417 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 mt -57.18 -45.1 83.98 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.083 0.953 . . . . 0.0 112.877 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 123.763 0.825 . . . . 0.0 111.992 178.045 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.25 96.06 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.12 140.37 97.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.33 0.652 . . . . 0.0 110.789 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -58.66 149.52 76.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.44 2.093 . . . . 0.0 111.15 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.15 109.26 1.06 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.783 -0.573 . . . . 0.0 109.929 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.31 131.45 46.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.921 0.889 . . . . 0.0 110.387 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -63.34 155.57 28.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.275 0.63 . . . . 0.0 110.813 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.84 121.05 10.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.296 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -58.46 136.7 57.56 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.406 0.682 . . . . 0.0 111.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.8 100.39 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.102 0.561 . . . . 0.0 111.309 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 N--CA 1.469 0.492 0 C-N-CA 124.546 1.138 . . . . 0.0 111.409 174.477 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.92 -41.47 74.58 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.14 -58.34 8.34 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 0.0 112.223 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 51.6 t -71.97 -35.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.962 -0.461 . . . . 0.0 111.372 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 tp -50.15 -57.54 7.49 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.679 169.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.77 -34.21 77.65 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -63.72 -50.16 70.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.509 0.724 . . . . 0.0 112.546 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.37 -44.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.921 0.889 . . . . 0.0 111.966 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.41 66.05 61.02 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.52 1.928 . . . . 0.0 111.445 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -55.99 -25.88 56.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.016 3.144 . . . . 0.0 114.18 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.3 -14.21 59.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.521 2.328 . . . . 0.0 114.2 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -121.17 126.21 49.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.527 1.131 . . . . 0.0 111.741 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.68 -164.75 40.54 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.071 0.843 . . . . 0.0 113.667 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.9 tt -143.79 149.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.99 -1.3 . . . . 0.0 111.73 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -80.69 156.07 26.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -56.65 -39.25 73.37 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.243 -0.91 . . . . 0.0 112.128 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.98 -55.82 29.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.189 1.396 . . . . 0.0 111.57 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.95 -42.08 97.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.469 0.708 . . . . 0.0 112.558 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 53.9 ttp -54.59 -53.55 53.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.846 0.859 . . . . 0.0 111.681 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.4 85.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.786 0.708 . . . . 0.0 113.069 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.84 -48.33 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.161 0.984 . . . . 0.0 111.113 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 65.1 mtt -57.5 -41.64 81.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.984 1.265 . . . . 0.0 112.615 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.86 -52.06 67.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.432 0.56 . . . . 0.0 110.727 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 72.8 m -54.92 -47.57 74.23 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.12 0.873 . . . . 0.0 112.794 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -54.54 -46.89 73.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 112.02 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -44.1 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.513 0.597 . . . . 0.0 111.739 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.06 -41.98 84.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.356 0.98 . . . . 0.0 111.933 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -60.0 -31.14 69.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 tp -90.9 -34.1 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 111.707 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.13 -42.05 89.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.61 1.164 . . . . 0.0 112.46 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -56.82 -44.38 81.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.371 1.068 . . . . 0.0 111.925 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -64.93 -44.87 88.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.053 0.941 . . . . 0.0 111.76 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.52 -49.4 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.707 1.203 . . . . 0.0 110.986 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.37 81.96 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 112.359 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.87 -46.11 90.86 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.268 0.937 . . . . 0.0 113.594 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.6 -41.89 87.75 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.379 -1.071 . . . . 0.0 112.856 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.47 94.36 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.156 0.889 . . . . 0.0 111.53 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -57.69 -49.76 75.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.418 1.087 . . . . 0.0 111.928 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.74 -49.86 67.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.471 1.109 . . . . 0.0 112.039 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.9 -48.22 78.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.685 0.794 . . . . 0.0 111.733 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -44.97 73.92 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.766 0.712 . . . . 0.0 112.473 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -57.6 -52.21 66.37 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.898 . . . . 0.0 112.387 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -62.43 -32.75 73.65 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -81.16 4.8 18.83 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.908 1.283 . . . . 0.0 113.627 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 56.86 31.9 20.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.968 2.107 . . . . 0.0 114.275 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -101.08 140.97 34.64 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.6 1.56 . . . . 0.0 112.074 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 61.0 p -79.68 -19.63 48.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.844 1.258 . . . . 0.0 113.086 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 63.7 p -114.73 148.91 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.87 2.068 . . . . 0.0 111.651 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.75 129.32 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.202 1.001 . . . . 0.0 110.014 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 6.1 p -83.37 162.42 21.06 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.016 0.912 . . . . 0.0 113.31 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -65.78 -10.29 36.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 0.0 114.295 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.44 -40.97 8.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.17 1.388 . . . . 0.0 112.187 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.53 -39.97 74.3 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.118 0.967 . . . . 0.0 112.663 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -57.81 -41.32 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -61.86 -49.5 75.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.229 0.922 . . . . 0.0 110.376 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 45.2 m -60.81 -46.86 88.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.397 1.079 . . . . 0.0 111.833 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.2 -46.93 65.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.445 1.098 . . . . 0.0 112.525 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.5 -51.23 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.605 0.762 . . . . 0.0 111.008 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -53.96 -45.78 71.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.114 0.966 . . . . 0.0 112.598 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.92 -36.77 72.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.875 1.27 . . . . 0.0 112.962 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.81 -22.41 25.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.551 1.14 . . . . 0.0 113.787 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 124.736 1.214 . . . . 0.0 112.108 -172.743 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.59 -179.22 27.29 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.947 0.784 . . . . 0.0 113.48 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.46 -50.04 23.7 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.578 -0.954 . . . . 0.0 111.997 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.76 -26.69 55.76 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.71 1.148 . . . . 0.0 115.458 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.78 -52.33 73.13 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.77 -37.1 89.0 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.59 2.194 . . . . 0.0 112.914 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.77 -40.97 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.755 0.822 . . . . 0.0 110.827 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.69 -45.12 87.98 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.373 -0.83 . . . . 0.0 112.547 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.01 -40.45 89.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.647 1.112 . . . . 0.0 111.827 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.38 90.45 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.346 -0.846 . . . . 0.0 111.334 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.88 -18.64 57.44 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.52 -59.43 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.322 -0.861 . . . . 0.0 110.733 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.67 -21.27 64.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.299 1.04 . . . . 0.0 112.869 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -37.7 -49.3 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.594 1.958 . . . . 0.0 112.917 159.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -61.18 -50.24 73.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.917 0.78 . . . . 0.0 112.5 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.34 -48.4 81.77 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.621 . . . . 0.0 111.348 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 71.8 m -60.98 -41.18 95.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.665 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.04 83.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.323 0.965 . . . . 0.0 112.086 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -56.5 -46.44 80.5 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.048 0.84 . . . . 0.0 112.561 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 86.5 mt -57.66 -57.76 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.698 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.01 -30.81 69.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.3 -55.22 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.909 1.231 . . . . 0.0 111.192 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.21 -36.68 84.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.647 -0.658 . . . . 0.0 112.102 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.57 96.83 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.477 -0.765 . . . . 0.0 112.433 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.38 -40.03 95.53 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.179 0.895 . . . . 0.0 113.175 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -64.2 -44.56 91.57 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.726 -0.867 . . . . 0.0 111.271 172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -42.98 87.84 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.287 0.949 . . . . 0.0 112.435 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.43 79.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.717 0.807 . . . . 0.0 112.281 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -55.86 -48.14 76.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.386 1.074 . . . . 0.0 112.164 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.77 -39.34 77.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.174 0.989 . . . . 0.0 113.519 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.79 2.97 27.6 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 57.22 32.54 21.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.502 1.921 . . . . 0.0 113.811 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.97 146.27 28.59 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.817 1.647 . . . . 0.0 112.332 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -100.48 9.58 42.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.696 1.598 . . . . 0.0 113.492 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.51 136.22 44.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.831 -1.168 . . . . 0.0 111.304 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.72 131.09 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.029 0.932 . . . . 0.0 109.732 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.87 165.93 14.12 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 125.936 1.694 . . . . 0.0 111.807 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -46.13 -44.47 19.4 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.26 3.306 . . . . 0.0 115.586 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.776 0.83 . . . . 0.0 112.702 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.38 -44.5 95.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.848 0.859 . . . . 0.0 112.16 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.24 -42.07 96.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.92 0.888 . . . . 0.0 111.804 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.865 0.866 . . . . 0.0 111.788 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.03 -46.94 72.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.662 1.185 . . . . 0.0 112.064 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.96 -47.54 64.73 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 94.1 mt -65.46 -55.46 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.35 0.66 . . . . 0.0 110.944 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -54.95 -37.84 66.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.603 1.161 . . . . 0.0 113.506 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.87 0.43 54.96 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -125.02 127.16 46.55 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.752 1.16 . . . . 0.0 112.943 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -57.11 -51.35 69.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.021 0.929 . . . . 0.0 112.918 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -66.24 -34.12 77.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 112.2 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.28 -41.04 73.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.293 0.637 . . . . 0.0 112.575 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -58.88 -40.06 83.24 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.463 1.483 . . . . 0.0 111.88 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.69 -3.18 1.38 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.32 1.448 . . . . 0.0 114.879 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -76.15 -73.32 0.28 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.76 1.164 . . . . 0.0 110.147 167.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 123.715 0.806 . . . . 0.0 112.873 -173.339 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.21 114.0 6.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.061 1.344 . . . . 0.0 110.929 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 37.3 tp -64.61 127.9 92.91 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.143 0.977 . . . . 0.0 110.531 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.35 119.72 7.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.747 2.298 . . . . 0.0 112.09 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.05 138.05 40.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.047 0.939 . . . . 0.0 111.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.68 140.19 58.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.851 0.861 . . . . 0.0 111.496 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -73.33 150.95 41.48 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.068 0.947 . . . . 0.0 112.089 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -90.92 139.14 31.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 111.824 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -81.09 124.78 29.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.43 0.692 . . . . 0.0 110.827 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -108.97 6.37 25.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.73 1.212 . . . . 0.0 113.058 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 124.848 1.259 . . . . 0.0 112.274 172.613 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -62.31 -29.95 70.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.541 0.736 . . . . 0.0 112.573 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.04 -50.04 72.23 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.337 0.971 . . . . 0.0 111.568 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -52.47 -52.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 119.524 1.056 . . . . 0.0 110.202 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.94 -52.59 64.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.89 0.876 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.38 -35.02 73.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.779 1.232 . . . . 0.0 114.001 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.5 -42.03 59.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.272 0.942 . . . . 0.0 112.812 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -87.09 -61.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.318 1.047 . . . . 0.0 112.231 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -137.23 91.43 14.57 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.683 1.593 . . . . 0.0 110.57 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -56.36 -29.24 76.26 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.814 3.009 . . . . 0.0 115.173 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -84.35 -1.78 56.02 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.479 1.912 . . . . 0.0 113.951 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -111.28 137.63 48.77 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.259 1.424 . . . . 0.0 111.848 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.84 14.18 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.954 1.74 . . . . 0.0 113.233 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.64 141.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 110.207 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -73.99 155.79 38.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.653 -0.655 . . . . 0.0 112.72 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p -57.32 -37.24 72.21 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.288 -0.882 . . . . 0.0 112.005 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.34 -47.48 85.71 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.948 1.299 . . . . 0.0 111.998 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.32 94.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.832 0.853 . . . . 0.0 112.933 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.76 -39.09 87.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.473 1.033 . . . . 0.0 111.896 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -44.46 76.9 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.247 0.927 . . . . 0.0 113.167 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -68.58 -35.1 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.315 1.058 . . . . 0.0 112.531 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 38.3 tpp -57.95 -41.14 82.21 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.65 -1.282 . . . . 0.0 111.284 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -65.83 -35.34 80.41 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.045 -1.034 . . . . 0.0 112.216 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 47.7 m -58.55 -39.4 80.14 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.27 -1.519 . . . . 0.0 112.19 167.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.94 -33.51 76.2 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.628 -1.295 . . . . 0.0 113.134 172.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . 0.444 ' HA ' ' CD2' ' D' ' 70' ' ' PHE . 47.0 t -57.96 -52.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.45 1.023 . . . . 0.0 110.935 165.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -64.92 -32.46 74.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.856 0.863 . . . . 0.0 113.249 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.1 -63.82 1.22 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.219 1.408 . . . . 0.0 113.505 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 81.2 mt -68.15 -51.8 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.155 0.982 . . . . 0.0 111.196 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' D' ' 66' ' ' VAL . 9.1 m-30 -66.85 -35.98 81.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.547 -0.721 . . . . 0.0 111.051 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.12 -47.64 84.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.171 0.988 . . . . 0.0 112.62 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.28 -46.69 85.57 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.133 -0.98 . . . . 0.0 112.113 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.01 -44.15 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 118.762 0.71 . . . . 0.0 111.368 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.48 84.55 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.302 0.956 . . . . 0.0 112.392 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.17 -47.15 91.12 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.429 1.014 . . . . 0.0 113.547 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -64.83 -45.17 87.3 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.478 -1.013 . . . . 0.0 112.607 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.25 83.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.215 173.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -60.17 -53.12 61.5 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.254 1.022 . . . . 0.0 111.639 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -57.37 -42.06 81.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.33 -0.857 . . . . 0.0 112.811 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.86 -46.0 90.68 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.692 1.197 . . . . 0.0 112.012 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.98 96.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.91 0.884 . . . . 0.0 112.427 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -60.91 -40.66 94.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.387 1.075 . . . . 0.0 112.839 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -57.6 -37.96 74.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.615 0.766 . . . . 0.0 112.135 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -86.43 15.7 5.2 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.204 1.402 . . . . 0.0 113.737 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 52.25 28.05 5.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.466 2.306 . . . . 0.0 115.121 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -71.76 156.71 39.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.429 1.091 . . . . 0.0 112.805 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 63.7 p -80.52 -29.44 37.22 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.713 1.205 . . . . 0.0 113.068 165.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 5.7 t -141.96 168.73 19.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.578 1.551 . . . . 0.0 113.048 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.18 107.05 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 19.2 p -88.75 169.28 11.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.332 1.053 . . . . 0.0 112.277 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 46.3 p -52.99 -36.95 60.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.209 -0.932 . . . . 0.0 112.946 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.43 -42.9 67.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.683 1.193 . . . . 0.0 112.267 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -61.8 -42.56 99.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.476 0.58 . . . . 0.0 111.736 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.94 -50.58 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.613 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -49.12 -53.69 19.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.829 1.195 . . . . 0.0 111.296 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 55.9 m -59.77 -43.26 94.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.616 -0.677 . . . . 0.0 111.968 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.68 75.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.461 1.028 . . . . 0.0 112.324 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -35.33 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.549 -1.345 . . . . 0.0 112.415 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.04 -21.47 64.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.777 1.171 . . . . 0.0 113.388 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.82 -43.14 22.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.357 1.063 . . . . 0.0 111.93 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.82 -25.99 66.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 127.033 2.133 . . . . 0.0 110.813 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.68 152.25 42.42 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.003 0.811 . . . . 0.0 112.731 171.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.24 -31.84 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.305 -1.115 . . . . 0.0 113.46 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.45 -22.35 77.71 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.659 1.123 . . . . 0.0 115.27 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.31 -54.2 58.26 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 119.653 1.727 . . . . 0.0 113.672 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -56.74 -31.4 87.87 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.022 1.815 . . . . 0.0 113.761 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.4 -46.78 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.821 1.191 . . . . 0.0 111.109 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -67.76 -38.75 83.84 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.18 -0.95 . . . . 0.0 113.096 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.66 -42.6 97.33 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.684 -1.26 . . . . 0.0 111.349 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.57 71.51 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.295 -0.878 . . . . 0.0 112.736 169.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.49 75.99 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 120.239 1.381 . . . . 0.0 113.498 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.99 -47.56 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.882 -1.136 . . . . 0.0 109.731 168.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.22 -39.43 86.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.689 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -52.85 -47.24 67.9 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.704 1.593 . . . . 0.0 112.595 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -57.91 -43.77 86.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.675 -0.64 . . . . 0.0 111.925 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.2 -34.4 70.83 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.969 -1.082 . . . . 0.0 112.877 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 88.7 m -53.65 -49.54 67.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.904 1.281 . . . . 0.0 110.071 164.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.38 82.91 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.196 0.907 . . . . 0.0 112.941 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.32 -43.26 91.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.751 1.16 . . . . 0.0 113.389 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.27 -43.62 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.781 -1.2 . . . . 0.0 110.137 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.06 -30.53 71.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.023 0.929 . . . . 0.0 113.331 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -63.59 -49.13 74.55 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.004 1.275 . . . . 0.0 111.384 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.06 -46.69 82.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.752 0.821 . . . . 0.0 111.253 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.95 78.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.969 0.908 . . . . 0.0 113.138 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -45.78 95.18 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.995 1.283 . . . . 0.0 112.765 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.89 -43.92 97.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.331 1.066 . . . . 0.0 111.423 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.47 75.99 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.573 -0.705 . . . . 0.0 112.845 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -45.63 82.43 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.158 -0.964 . . . . 0.0 112.336 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.25 -42.76 73.88 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.213 1.405 . . . . 0.0 112.982 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -57.16 -22.97 44.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -106.65 4.81 28.29 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.677 1.591 . . . . 0.0 112.838 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.18 31.73 14.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.965 2.106 . . . . 0.0 114.191 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.24 156.22 17.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.19 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.4 p -114.51 15.87 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.494 1.918 . . . . 0.0 112.961 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -133.61 129.43 36.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.098 1.359 . . . . 0.0 110.745 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -73.99 124.35 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 109.837 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 pt -126.0 169.94 10.56 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.788 1.635 . . . . 0.0 111.053 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.66 -34.34 83.23 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.191 2.594 . . . . 0.0 114.703 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.14 -24.57 67.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -81.79 -38.27 25.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.108 0.963 . . . . 0.0 111.865 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.73 0.696 . . . . 0.0 112.555 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -57.09 -57.75 11.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.166 -0.959 . . . . 0.0 111.159 166.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.01 -43.55 91.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.941 0.896 . . . . 0.0 112.72 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.43 45.11 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 15.5 mt -113.96 -63.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.884 1.274 . . . . 0.0 110.278 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.97 -27.87 69.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -99.94 0.78 41.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.763 1.225 . . . . 0.0 113.018 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.65 114.15 26.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.435 1.016 . . . . 0.0 110.417 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -49.61 -43.52 46.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.461 1.504 . . . . 0.0 113.093 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.788 0.835 . . . . 0.0 112.157 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.89 -17.63 61.5 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.21 -0.9 . . . . 0.0 112.484 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.39 -34.69 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.286 1.403 . . . . 0.0 112.591 165.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.54 -30.24 65.67 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.121 -0.987 . . . . 0.0 112.882 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 66.9 tp -92.7 -52.27 4.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 CA--C 1.548 0.899 0 C-N-CA 126.32 1.848 . . . . 0.0 110.534 -169.242 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 62.6 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -66.2 110.77 3.13 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.644 . . . . 0.0 109.366 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.07 123.33 83.66 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.563 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.68 138.73 71.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.763 2.309 . . . . 0.0 111.676 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.62 113.93 2.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.516 0.726 . . . . 0.0 109.466 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.7 117.64 15.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.627 0.771 . . . . 0.0 110.502 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 86.8 m -107.25 108.22 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.756 1.222 . . . . 0.0 108.354 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -65.93 127.33 31.64 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.149 0.58 . . . . 0.0 110.858 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 18.4 p -71.27 138.18 49.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.861 0.865 . . . . 0.0 113.063 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.42 -29.35 47.09 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.977 0.911 . . . . 0.0 112.333 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.009 1.323 . . . . 0.0 111.43 171.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -67.32 -41.85 84.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.189 -0.945 . . . . 0.0 112.165 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -54.7 -37.75 66.19 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.063 0.847 . . . . 0.0 112.43 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.03 -48.79 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.464 0.706 . . . . 0.0 111.896 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 34.4 tp -50.67 -42.95 57.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.634 1.106 . . . . 0.0 112.72 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.51 -24.78 22.07 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -72.2 -32.0 66.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.314 1.045 . . . . 0.0 112.662 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.83 -41.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.7 1.2 . . . . 0.0 113.536 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -135.45 70.73 67.03 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.47 1.508 . . . . 0.0 110.692 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -58.06 -23.09 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.611 2.874 . . . . 0.0 113.974 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -77.46 -6.51 53.75 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.656 1.982 . . . . 0.0 113.963 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 98.8 m -115.37 129.77 56.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.271 1.428 . . . . 0.0 111.34 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.09 175.15 41.2 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.974 1.273 . . . . 0.0 113.423 172.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.83 140.65 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.167 -1.196 . . . . 0.0 110.923 171.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 34.4 p -73.2 154.5 40.24 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 38.6 p -54.68 -44.02 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.025 0.93 . . . . 0.0 112.291 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.82 -46.9 87.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.792 1.237 . . . . 0.0 112.155 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.28 89.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.354 0.661 . . . . 0.0 112.263 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 74.8 mtm -60.78 -40.89 94.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.08 -1.012 . . . . 0.0 112.449 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.18 -42.17 97.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.665 1.126 . . . . 0.0 113.899 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.01 -51.84 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.25 1.02 . . . . 0.0 110.073 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 46.3 mtp -61.29 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -50.66 -50.62 54.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.501 1.5 . . . . 0.0 112.339 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -59.37 -55.8 30.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.634 0.774 . . . . 0.0 111.519 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -61.71 -43.89 97.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.61 -51.18 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.391 0.996 . . . . 0.0 110.908 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -62.02 -40.92 97.33 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.739 0.7 . . . . 0.0 111.569 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -56.54 -28.89 61.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.8 mt -49.75 -57.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.36 1.437 . . . . 0.0 109.917 172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.8 -52.91 38.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 0.0 111.335 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -54.73 -35.49 63.75 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.79 -53.19 5.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.352 1.061 . . . . 0.0 112.1 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.76 -58.58 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 120.263 1.392 . . . . 0.0 111.386 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.41 62.93 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.481 -0.762 . . . . 0.0 112.106 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.0 -47.91 88.71 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 118.9 0.773 . . . . 0.0 113.164 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.16 -39.86 93.55 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.197 -1.179 . . . . 0.0 112.214 172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.57 78.79 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.045 -1.034 . . . . 0.0 112.222 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -60.63 -50.6 72.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.063 0.945 . . . . 0.0 111.271 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -51.09 -48.99 61.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.11 0.868 . . . . 0.0 111.946 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.01 -48.67 75.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.577 0.751 . . . . 0.0 111.773 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.73 73.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.741 0.816 . . . . 0.0 112.916 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -58.48 -52.18 66.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.432 1.015 . . . . 0.0 111.467 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -60.95 -35.07 75.78 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -82.57 5.41 21.01 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.817 1.247 . . . . 0.0 113.769 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 56.19 34.3 23.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.998 2.119 . . . . 0.0 114.328 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -101.13 142.71 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.725 1.61 . . . . 0.0 112.626 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 48.4 p -83.73 -22.27 32.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.467 1.507 . . . . 0.0 113.498 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 40.1 m -126.22 128.98 48.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.508 1.523 . . . . 0.0 111.41 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.92 130.62 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.17 1.388 . . . . 0.0 110.737 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.1 p -84.33 160.19 20.74 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 41.3 p -55.34 -38.8 69.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.068 -1.02 . . . . 0.0 112.433 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.32 -43.59 90.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.686 1.194 . . . . 0.0 112.287 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -62.11 -41.86 98.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.498 0.719 . . . . 0.0 112.305 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.64 -54.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.517 0.599 . . . . 0.0 109.864 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -55.31 -42.1 73.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.246 0.93 . . . . 0.0 112.818 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 89.4 m -62.34 -50.31 72.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.397 1.079 . . . . 0.0 111.707 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.28 84.32 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.561 1.073 . . . . 0.0 112.691 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.49 -56.05 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.504 1.122 . . . . 0.0 110.264 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -57.44 -41.91 81.39 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.789 1.177 . . . . 0.0 113.405 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.54 -45.37 91.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 112.418 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -89.54 -23.36 22.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.552 1.032 0 C-N-CA 127.139 2.176 . . . . 0.0 110.813 176.144 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.82 -165.18 10.28 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.502 1.525 . . . . 0.0 111.022 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.99 -30.21 24.06 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.44 -36.25 88.45 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.468 1.033 . . . . 0.0 115.361 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.74 -55.81 21.26 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.475 1.137 . . . . 0.0 113.943 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.04 -33.69 49.82 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 112.876 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.26 -37.71 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 120.569 1.531 . . . . 0.0 113.027 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -53.71 -53.58 50.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.972 0.805 . . . . 0.0 111.017 168.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.76 -50.9 69.17 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.401 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.66 61.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.904 1.229 . . . . 0.0 113.289 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.22 -46.03 65.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.133 0.973 . . . . 0.0 112.211 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.27 -56.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.4 1.08 . . . . 0.0 111.784 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.43 -46.63 82.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.336 1.455 . . . . 0.0 113.029 -172.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -58.27 -46.43 86.03 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.513 1.051 . . . . 0.0 110.762 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -62.64 -51.93 65.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.391 0.676 . . . . 0.0 112.555 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.2 -42.04 89.96 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.235 -0.915 . . . . 0.0 111.995 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -53.64 -51.8 61.95 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.095 . . . . 0.0 110.776 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.81 95.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.756 0.822 . . . . 0.0 113.167 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -60.68 -47.73 84.93 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.467 1.03 . . . . 0.0 112.864 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.1 -50.58 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.45 0.7 . . . . 0.0 109.951 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.63 -37.84 79.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.186 0.994 . . . . 0.0 113.207 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.93 -55.4 29.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.55 1.068 . . . . 0.0 111.615 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.51 -47.15 82.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.687 1.195 . . . . 0.0 111.707 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.47 92.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 0.0 112.453 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.98 98.04 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.321 -0.862 . . . . 0.0 113.202 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.35 -44.67 96.79 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.803 1.301 . . . . 0.0 110.937 172.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.29 89.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.411 -0.805 . . . . 0.0 112.668 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.35 89.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.173 -0.954 . . . . 0.0 112.547 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -57.59 -47.06 83.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.044 0.937 . . . . 0.0 112.024 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.22 -41.67 79.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -86.31 10.12 15.8 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 53.76 30.12 10.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.791 2.036 . . . . 0.0 114.564 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.2 144.99 28.59 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.194 1.398 . . . . 0.0 112.165 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -76.92 -26.21 53.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.698 1.199 . . . . 0.0 112.764 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -128.99 151.66 49.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.433 1.493 . . . . 0.0 112.531 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.4 131.13 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.602 1.161 . . . . 0.0 110.264 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.82 149.62 36.34 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.57 1.948 . . . . 0.0 109.544 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -48.32 -40.55 35.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.713 2.942 . . . . 0.0 114.964 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -60.19 -38.86 84.55 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.284 1.034 . . . . 0.0 113.062 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -61.91 -42.23 98.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.669 0.788 . . . . 0.0 112.175 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.77 -46.08 89.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 111.936 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.68 -50.47 72.03 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.808 0.843 . . . . 0.0 111.82 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 84.3 mt -57.08 -50.6 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.421 -0.8 . . . . 0.0 111.871 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.11 64.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.161 0.984 . . . . 0.0 112.84 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 tt -68.65 -35.76 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 118.479 0.581 . . . . 0.0 112.533 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.362 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -66.06 -37.84 86.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.781 0.832 . . . . 0.0 112.304 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.01 115.81 18.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.021 0.928 . . . . 0.0 112.669 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.73 -39.39 84.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.238 -0.914 . . . . 0.0 113.449 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -67.31 -39.35 85.88 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.158 -0.964 . . . . 0.0 111.766 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.28 -36.38 83.92 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.432 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.14 -37.16 84.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.81 1.641 . . . . 0.0 112.739 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.53 -39.1 91.4 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.343 -0.848 . . . . 0.0 112.224 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.54 -53.79 8.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 113.622 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 111.444 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.03 131.77 47.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.892 1.277 . . . . 0.0 111.723 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.17 -34.95 0.58 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -57.65 129.23 32.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.723 2.282 . . . . 0.0 112.562 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -67.95 113.64 5.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.069 0.947 . . . . 0.0 111.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.31 -26.02 23.62 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.345 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 41.5 m -70.46 106.9 3.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 109.961 171.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -140.79 154.4 46.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.391 1.077 . . . . 0.0 113.067 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 53.0 m -67.76 147.86 52.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.844 0.858 . . . . 0.0 111.58 167.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -57.94 -46.69 84.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.44 0.696 . . . . 0.0 112.188 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 124.098 0.959 . . . . 0.0 110.218 167.804 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.35 -45.09 92.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.698 1.199 . . . . 0.0 112.274 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.79 -35.36 80.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.144 0.978 . . . . 0.0 112.248 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.46 -50.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.476 0.58 . . . . 0.0 110.59 171.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.11 -38.21 82.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.406 -0.809 . . . . 0.0 112.776 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -51.62 -34.94 39.79 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.219 1.408 . . . . 0.0 113.379 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.67 -14.24 60.72 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.9 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.798 1.639 . . . . 0.0 111.36 -170.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.81 73.11 79.19 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.559 1.944 . . . . 0.0 110.073 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.26 -23.92 64.84 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.756 2.971 . . . . 0.0 114.743 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -79.17 -3.48 45.79 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.997 1.719 . . . . 0.0 113.894 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 43.2 m -119.42 140.06 51.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.842 1.657 . . . . 0.0 111.007 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.11 -166.22 25.82 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.533 1.063 . . . . 0.0 113.968 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.98 137.06 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.963 -1.316 . . . . 0.0 110.237 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.33 147.12 41.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.025 0.93 . . . . 0.0 112.777 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.9 p -56.96 -34.62 68.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.009 0.923 . . . . 0.0 112.756 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -75.67 -44.09 44.18 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.404 1.082 . . . . 0.0 111.762 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.2 -37.42 72.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.871 0.868 . . . . 0.0 113.3 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 64.5 ttp -52.43 -50.77 61.91 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.268 -0.895 . . . . 0.0 111.712 167.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.7 95.52 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.872 1.225 . . . . 0.0 114.066 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.63 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.379 1.09 . . . . 0.0 110.878 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 92.6 mmm -60.81 -40.03 91.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.363 0.983 . . . . 0.0 112.443 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.64 -47.96 82.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.831 0.741 . . . . 0.0 111.781 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -56.27 -53.29 59.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.333 1.053 . . . . 0.0 111.996 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -53.17 -55.1 26.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.674 1.19 . . . . 0.0 112.218 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.46 -51.0 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.184 0.994 . . . . 0.0 110.83 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -60.61 -38.77 85.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.822 0.737 . . . . 0.0 112.378 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -64.83 -52.09 58.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.251 0.932 . . . . 0.0 113.257 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.02 -31.45 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.167 0.894 . . . . 0.0 113.103 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -47.6 -51.33 21.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.123 1.369 . . . . 0.0 111.781 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -59.51 -44.87 93.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.379 0.672 . . . . 0.0 112.017 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -67.01 -52.34 43.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.171 0.588 . . . . 0.0 111.523 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.35 -42.93 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.161 0.984 . . . . 0.0 111.278 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.34 91.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.78 0.832 . . . . 0.0 112.095 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.97 -51.03 59.86 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.786 0.708 . . . . 0.0 113.226 169.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -56.4 -40.72 75.11 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.002 -1.293 . . . . 0.0 112.633 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.89 -47.61 51.96 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.298 1.039 . . . . 0.0 112.62 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -77.55 -39.8 44.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.75 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -50.35 -50.39 51.34 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.745 1.157 . . . . 0.0 111.274 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.59 -44.02 97.78 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.732 1.213 . . . . 0.0 112.747 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.55 88.25 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.337 -0.852 . . . . 0.0 112.063 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -63.16 -38.25 90.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.8 1.24 . . . . 0.0 113.142 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -59.6 -34.11 72.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.662 1.119 . . . . 0.0 111.728 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -83.71 11.95 6.61 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.419 1.487 . . . . 0.0 113.257 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 59.46 28.57 17.98 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.696 2.398 . . . . 0.0 115.197 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.88 139.35 53.31 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.526 1.531 . . . . 0.0 112.815 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 35.6 p -86.97 -31.81 20.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.272 1.429 . . . . 0.0 113.591 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -87.48 147.69 25.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.655 1.582 . . . . 0.0 111.741 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 56.9 mt -104.78 120.92 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 0.0 108.353 168.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -100.38 161.89 13.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.068 0.947 . . . . 0.0 113.118 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 53.0 p -66.84 -23.68 66.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.429 1.092 . . . . 0.0 113.669 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.72 -42.83 21.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.644 1.178 . . . . 0.0 112.189 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -54.82 -28.7 51.47 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.991 1.317 . . . . 0.0 114.035 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.76 -32.83 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.79 0.836 . . . . 0.0 112.449 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -54.96 -33.98 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.432 1.093 . . . . 0.0 112.811 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 51.7 m -99.53 -46.65 5.39 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.639 1.176 . . . . 0.0 111.406 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.5 74.89 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.925 -1.109 . . . . 0.0 113.019 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.8 -36.79 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.646 -1.284 . . . . 0.0 111.135 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.53 -36.65 84.9 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.441 1.096 . . . . 0.0 113.055 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.35 -42.65 87.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.179 0.592 . . . . 0.0 112.007 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.66 -54.11 15.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 125.187 1.395 . . . . 0.0 110.832 -170.392 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.6 179.91 52.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.02 1.295 . . . . 0.0 114.094 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.15 57.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.15 96.93 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 121.331 -0.856 . . . . 0.0 114.286 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.66 10.95 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.71 -33.51 76.64 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.375 2.05 . . . . 0.0 113.388 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -49.28 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.746 1.157 . . . . 0.0 111.176 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -64.21 -34.87 79.09 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.571 -0.706 . . . . 0.0 112.586 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.91 -44.3 81.12 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.382 -0.823 . . . . 0.0 112.278 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.14 78.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.624 1.102 . . . . 0.0 112.519 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.79 -21.44 19.35 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -91.53 -54.16 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.322 1.449 . . . . 0.0 111.281 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.4 mt -50.17 -45.54 53.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.953 1.701 . . . . 0.0 113.391 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -48.13 -53.44 16.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.408 1.083 . . . . 0.0 112.172 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 -41.35 80.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.039 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.95 -49.55 75.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.993 0.815 . . . . 0.0 111.48 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -57.56 -48.64 78.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.127 0.971 . . . . 0.0 111.53 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.18 62.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.143 1.377 . . . . 0.0 113.432 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.95 -34.34 67.93 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 -34.48 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 118.77 0.714 . . . . 0.0 110.833 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.29 -44.3 88.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.912 0.778 . . . . 0.0 111.68 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.96 -53.06 61.96 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.533 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.65 -36.75 79.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.694 0.797 . . . . 0.0 112.323 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -38.39 79.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.463 1.028 . . . . 0.0 112.657 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.6 -45.56 93.08 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.619 0.645 . . . . 0.0 112.581 168.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.55 -42.18 95.85 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.482 -1.011 . . . . 0.0 111.842 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.38 -45.31 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.48 1.037 . . . . 0.0 111.625 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.7 86.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.758 0.823 . . . . 0.0 112.094 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -57.33 -48.61 78.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.855 1.262 . . . . 0.0 112.678 173.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -58.52 -39.44 80.13 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.524 1.129 . . . . 0.0 113.259 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.57 4.67 31.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.565 1.146 . . . . 0.0 112.968 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 53.09 36.88 23.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.423 2.289 . . . . 0.0 114.177 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.09 149.67 22.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.72 1.608 . . . . 0.0 112.513 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 33.1 p -85.46 -28.86 24.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.214 1.406 . . . . 0.0 113.345 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -119.36 140.24 50.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.32 1.848 . . . . 0.0 111.153 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.29 121.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 109.129 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.51 162.8 20.61 Favored Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 124.315 1.046 . . . . 0.0 111.671 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.38 -35.73 85.28 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.971 2.447 . . . . 0.0 114.091 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -64.3 -43.74 93.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.582 1.083 . . . . 0.0 111.692 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.75 -41.94 98.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.683 0.793 . . . . 0.0 111.424 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -64.06 -44.75 91.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 0.0 112.636 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.83 -51.22 70.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.049 -1.032 . . . . 0.0 111.044 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.06 -41.83 48.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.916 1.286 . . . . 0.0 113.362 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.27 -45.99 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.843 0.747 . . . . 0.0 112.966 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -71.13 -19.46 62.43 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.16 -28.56 64.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.814 1.246 . . . . 0.0 113.492 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -129.63 123.07 30.36 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.598 1.09 . . . . 0.0 112.637 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -61.77 -47.33 85.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.118 0.967 . . . . 0.0 113.059 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -60.67 -53.46 57.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.868 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -49.74 -47.13 50.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.633 1.106 . . . . 0.0 111.753 171.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -61.32 -30.1 70.29 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.704 -1.248 . . . . 0.0 114.151 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.64 -49.66 7.83 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.396 1.078 . . . . 0.0 112.362 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.09 -44.2 87.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.609 2.364 . . . . 0.0 113.409 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tp . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.215 -173.073 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.95 123.16 22.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.593 0.757 . . . . 0.0 110.369 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.04 144.2 29.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.295 1.038 . . . . 0.0 111.258 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -59.57 140.16 92.53 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.175 2.583 . . . . 0.0 112.345 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.29 146.36 51.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.28 1.032 . . . . 0.0 112.012 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.03 136.37 53.73 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.617 0.767 . . . . 0.0 110.529 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p -119.94 161.4 20.94 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.97 119.71 10.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 171.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.7 p -68.74 157.08 37.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 113.051 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -57.35 129.0 39.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.238 0.615 . . . . 0.0 110.833 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 123.747 0.819 . . . . 0.0 112.462 -172.21 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -56.91 -52.83 63.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.889 1.276 . . . . 0.0 112.556 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.93 -50.84 69.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.956 0.902 . . . . 0.0 111.345 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 83.2 t -57.03 -46.4 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.84 0.856 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.57 -50.8 62.25 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.341 1.056 . . . . 0.0 112.085 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.41 -43.77 79.68 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.267 1.027 . . . . 0.0 112.299 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -66.15 -47.74 73.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.37 -30.04 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -121.55 90.36 47.92 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.201 1.4 . . . . 0.0 110.226 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.79 -26.26 72.74 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.626 2.884 . . . . 0.0 114.491 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.25 -12.64 61.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.218 1.807 . . . . 0.0 113.62 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -103.12 117.5 34.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 110.097 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.56 -169.68 15.64 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.855 1.217 . . . . 0.0 112.937 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.94 151.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -70.01 143.87 52.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.835 0.854 . . . . 0.0 112.461 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 34.8 p -58.37 -40.29 81.89 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.012 0.925 . . . . 0.0 112.196 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.82 -43.64 98.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.94 0.896 . . . . 0.0 111.702 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.49 81.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.185 0.594 . . . . 0.0 112.566 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.2 mmm -65.92 -41.83 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.965 -1.084 . . . . 0.0 112.98 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.41 -41.96 88.67 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.298 0.953 . . . . 0.0 113.041 170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -61.12 -49.78 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.791 1.637 . . . . 0.0 111.008 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mmm -56.03 -40.49 73.55 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.668 1.122 . . . . 0.0 112.933 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -64.65 -42.5 95.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.812 -1.18 . . . . 0.0 111.726 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -55.61 -46.85 77.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.603 0.761 . . . . 0.0 111.241 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -56.79 -52.7 64.01 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.677 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.46 -41.33 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.87 1.214 . . . . 0.0 112.384 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -66.05 -54.52 24.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.072 0.851 . . . . 0.0 112.057 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.7 -50.8 71.1 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 11.9 pt -62.58 -36.48 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.368 1.067 . . . . 0.0 112.489 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -66.94 -23.52 65.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.323 1.049 . . . . 0.0 112.33 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -81.22 -47.83 12.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.59 0.756 . . . . 0.0 110.944 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -54.98 -42.94 73.07 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 13.7 tt -59.63 -34.0 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.767 0.712 . . . . 0.0 112.552 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.43 88.21 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.301 0.955 . . . . 0.0 111.797 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.82 94.48 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.995 0.807 . . . . 0.0 113.371 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -70.95 -40.4 72.04 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.076 -1.25 . . . . 0.0 112.741 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.91 72.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.914 -1.116 . . . . 0.0 111.576 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -62.43 -47.4 84.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.363 1.065 . . . . 0.0 112.123 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -54.28 -46.84 72.82 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.0 -1.062 . . . . 0.0 112.403 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.88 -41.73 98.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 0.0 112.304 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.43 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.922 0.889 . . . . 0.0 112.257 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -60.8 -42.37 97.46 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.501 1.12 . . . . 0.0 112.594 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -57.62 -33.37 68.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.211 0.914 . . . . 0.0 112.302 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -90.01 7.84 35.54 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.473 1.509 . . . . 0.0 113.326 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.25 31.1 13.53 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.526 2.33 . . . . 0.0 114.876 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -91.39 143.25 26.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.93 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 40.2 p -90.11 -37.56 14.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.363 1.465 . . . . 0.0 113.213 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 72.9 p -106.22 -179.45 3.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.534 1.933 . . . . 0.0 111.515 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mt -125.22 125.25 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.998 1.319 . . . . 0.0 109.358 171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -101.77 164.22 11.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.263 1.025 . . . . 0.0 113.084 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 45.8 p -57.33 -43.22 83.18 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.211 -0.931 . . . . 0.0 112.565 170.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.19 -37.03 84.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.209 1.004 . . . . 0.0 112.836 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.91 -39.43 90.58 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.577 0.751 . . . . 0.0 111.952 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.32 -43.12 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 169.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -54.82 -45.33 74.41 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.455 1.025 . . . . 0.0 112.587 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 42.2 p -70.48 -38.27 74.36 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.411 1.005 . . . . 0.0 112.174 171.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -24.63 63.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 117.59 -1.195 . . . . 0.0 114.164 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -46.62 -50.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 121.204 1.82 . . . . 0.0 111.612 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.45 -28.06 64.73 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.33 -39.33 54.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.538 1.135 . . . . 0.0 111.772 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -84.57 -20.31 31.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.016 1.726 . . . . 0.0 112.906 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 63.3 tp . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 126.412 1.885 . . . . 0.0 109.976 169.467 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.61 162.01 41.08 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.653 1.121 . . . . 0.0 112.585 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -36.96 63.63 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.99 -24.41 74.46 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.287 0.946 . . . . 0.0 115.26 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -58.75 17.03 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.805 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.89 -38.52 92.61 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.478 2.119 . . . . 0.0 113.219 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.78 -53.95 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.033 0.933 . . . . 0.0 110.954 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -57.17 -50.09 73.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.777 0.831 . . . . 0.0 112.286 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.66 -45.59 85.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.316 1.046 . . . . 0.0 111.617 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.12 96.22 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.254 0.934 . . . . 0.0 112.97 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.89 75.19 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.257 -0.902 . . . . 0.0 112.656 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.43 -41.85 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.54 -0.725 . . . . 0.0 111.541 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.8 -52.75 38.05 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.355 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -59.53 -42.87 93.3 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.236 1.38 . . . . 0.0 113.108 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -53.98 -47.87 70.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.585 0.754 . . . . 0.0 112.626 171.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.92 -45.04 75.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.828 0.851 . . . . 0.0 112.392 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -54.94 -40.04 69.52 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.543 1.537 . . . . 0.0 112.285 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.7 -47.21 70.72 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.914 1.234 . . . . 0.0 112.269 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -63.42 -46.62 85.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.606 0.762 . . . . 0.0 112.403 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -51.52 -55.39 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.771 0.714 . . . . 0.0 110.369 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.49 -46.31 83.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.438 0.695 . . . . 0.0 112.154 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.42 -51.49 64.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.724 0.693 . . . . 0.0 111.913 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.3 -33.24 72.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.604 0.762 . . . . 0.0 112.765 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.67 90.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.62 1.1 . . . . 0.0 112.094 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.68 -46.09 89.68 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 122.084 -0.385 . . . . 0.0 112.655 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -61.33 -45.17 95.56 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.956 -0.732 . . . . 0.0 111.473 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.45 81.96 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.995 0.918 . . . . 0.0 112.723 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.25 86.72 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.607 -0.683 . . . . 0.0 112.375 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -59.08 -39.5 82.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -60.03 -31.68 70.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -89.99 3.84 51.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.06 0.944 . . . . 0.0 113.503 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 56.46 33.03 21.8 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.904 2.081 . . . . 0.0 113.711 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.21 147.7 26.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.623 1.569 . . . . 0.0 112.553 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.4 p -98.02 2.02 48.4 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.974 1.71 . . . . 0.0 113.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -126.27 120.09 29.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.676 1.591 . . . . 0.0 110.709 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.29 123.77 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.493 1.517 . . . . 0.0 109.056 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.17 167.21 9.38 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.074 1.75 . . . . 0.0 111.309 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -48.32 -40.31 35.66 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.4 -36.27 75.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.974 0.909 . . . . 0.0 113.213 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -65.56 -39.66 91.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.264 0.938 . . . . 0.0 112.429 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.01 -44.34 85.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.149 0.58 . . . . 0.0 111.229 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -57.19 -49.91 74.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.448 -0.783 . . . . 0.0 112.035 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 64.8 mt -56.56 -46.55 80.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.081 0.952 . . . . 0.0 111.766 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.4 76.91 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.44 -0.787 . . . . 0.0 112.893 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.06 -45.82 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.472 1.109 . . . . 0.0 110.985 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.79 -24.9 64.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.959 1.304 . . . . 0.0 114.512 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -88.78 -34.97 16.91 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.344 1.058 . . . . 0.0 112.181 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.42 117.41 7.9 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.13 0.877 . . . . 0.0 112.489 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.44 -37.12 74.76 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.181 0.993 . . . . 0.0 113.079 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -64.93 -43.87 91.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.432 1.014 . . . . 0.0 111.865 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.91 -32.77 69.81 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.857 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.59 -39.6 94.24 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.218 1.372 . . . . 0.0 112.061 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.22 -41.97 96.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 112.231 171.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 29.7 tp -75.23 -49.26 19.91 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 125.609 1.564 . . . . 0.0 110.295 -175.469 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.844 0.831 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.6 122.35 14.49 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 0.0 111.053 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.37 138.74 81.16 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.182 0.593 . . . . 0.0 111.22 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -61.15 150.41 84.57 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.788 2.326 . . . . 0.0 111.61 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.14 108.24 2.6 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.75 -0.594 . . . . 0.0 110.423 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.79 151.26 45.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.655 1.182 . . . . 0.0 111.262 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -57.67 122.76 13.56 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.022 0.929 . . . . 0.0 110.731 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -62.68 133.35 54.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.406 0.682 . . . . 0.0 111.3 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -77.83 108.54 11.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.913 -0.492 . . . . 0.0 110.787 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.36 -0.26 57.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.539 1.135 . . . . 0.0 112.877 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 125.105 1.362 . . . . 0.0 111.692 175.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -58.52 -54.4 47.5 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 111.292 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.66 -36.84 79.72 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.627 1.171 . . . . 0.0 112.835 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 81.5 t -55.47 -56.61 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.701 0.8 . . . . 0.0 110.605 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.71 -25.34 59.07 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -52.35 -37.66 56.66 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.991 1.268 . . . . 0.0 112.147 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.56 -47.03 23.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.761 0.825 . . . . 0.0 112.728 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.41 -47.38 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.024 0.93 . . . . 0.0 112.285 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -127.34 82.64 67.83 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.812 2.045 . . . . 0.0 110.4 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -57.67 -24.9 65.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.488 2.792 . . . . 0.0 115.533 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -86.3 -7.9 58.14 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.929 2.092 . . . . 0.0 114.097 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -126.19 122.66 36.25 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.48 1.036 . . . . 0.0 112.539 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.8 178.66 26.11 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.384 1.469 . . . . 0.0 113.704 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.56 134.26 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.662 1.585 . . . . 0.0 109.541 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 23.5 p -70.46 160.7 31.91 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -55.06 -42.89 73.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.174 0.99 . . . . 0.0 112.22 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.82 -44.09 91.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.932 1.293 . . . . 0.0 112.149 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.44 92.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 112.43 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.4 mtm -58.15 -44.94 88.14 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.203 -0.936 . . . . 0.0 111.676 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.93 -49.13 63.5 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.773 1.178 . . . . 0.0 114.651 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.65 -22.32 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.732 1.266 . . . . 0.0 113.833 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.55 -35.75 61.08 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.504 -1.373 . . . . 0.0 112.125 170.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -55.76 -40.3 72.39 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 78.7 p -79.03 -37.14 39.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.072 -1.017 . . . . 0.0 112.339 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -58.25 -40.03 80.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.339 0.972 . . . . 0.0 112.858 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.22 -54.39 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.504 1.121 . . . . 0.0 111.287 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.65 -44.38 93.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.716 0.807 . . . . 0.0 111.536 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -58.3 -49.8 75.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.032 0.833 . . . . 0.0 112.944 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.19 -51.24 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.542 1.137 . . . . 0.0 110.732 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.41 -52.43 59.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.807 0.843 . . . . 0.0 111.892 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -53.06 -48.89 67.34 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.442 1.097 . . . . 0.0 112.519 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.21 -50.41 65.98 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 44.1 mt -63.24 -48.28 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.092 0.86 . . . . 0.0 110.491 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.93 90.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.81 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.26 -51.0 58.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.464 1.03 . . . . 0.0 112.95 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -61.62 -45.7 92.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.55 1.175 . . . . 0.0 112.591 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.68 77.84 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.061 -1.025 . . . . 0.0 112.361 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -61.58 -47.79 83.87 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.357 1.063 . . . . 0.0 111.799 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -57.76 -36.06 71.61 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.841 1.256 . . . . 0.0 112.802 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.16 -41.78 85.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.122 0.874 . . . . 0.0 112.375 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.24 86.28 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.951 -1.093 . . . . 0.0 112.483 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -63.5 -41.94 98.51 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.508 1.123 . . . . 0.0 112.74 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -59.16 -38.45 79.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.99 8.32 3.28 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.252 1.421 . . . . 0.0 113.879 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 53.46 29.68 9.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.82 2.448 . . . . 0.0 115.23 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -81.56 158.82 24.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.153 0.981 . . . . 0.0 112.868 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 65.3 p -112.85 -10.29 13.58 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.978 1.711 . . . . 0.0 113.496 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 53.0 m -134.23 135.01 42.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.582 1.953 . . . . 0.0 109.461 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.46 112.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 108.822 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 55.2 p -96.87 170.42 9.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.216 1.406 . . . . 0.0 111.903 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 37.1 p -53.16 -37.2 61.67 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.929 0.891 . . . . 0.0 112.71 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.71 -44.99 69.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.722 1.209 . . . . 0.0 112.422 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.37 -42.3 91.31 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.612 0.642 . . . . 0.0 111.89 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 69.5 mt -58.17 -53.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.608 0.763 . . . . 0.0 110.356 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -50.7 -46.46 58.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.809 1.186 . . . . 0.0 112.405 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 98.8 m -61.74 -49.4 76.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.773 0.829 . . . . 0.0 112.115 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.04 81.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.992 0.917 . . . . 0.0 112.686 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -51.49 -51.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.617 1.167 . . . . 0.0 110.993 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.58 -44.25 97.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.921 0.888 . . . . 0.0 112.699 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.32 -36.26 83.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.211 1.004 . . . . 0.0 113.26 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.24 -30.42 48.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.0 1.32 . . . . 0.0 113.061 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 125.755 1.622 . . . . 0.0 111.911 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.31 50.4 1.0 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.069 1.795 . . . . 0.0 115.628 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.1 -15.24 21.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.38 79.69 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.975 -1.078 . . . . 0.0 113.702 165.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.36 -59.23 11.67 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 118.642 1.221 . . . . 0.0 112.58 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.71 -31.34 60.38 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.244 1.963 . . . . 0.0 114.383 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.18 -48.79 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.739 1.154 . . . . 0.0 112.059 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -61.08 -38.37 86.01 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.101 -0.999 . . . . 0.0 111.99 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.37 -30.06 70.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.978 -1.076 . . . . 0.0 112.729 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.15 92.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.696 1.135 . . . . 0.0 111.998 168.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.61 90.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.21 -49.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.906 -1.122 . . . . 0.0 112.015 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.6 -35.58 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.595 1.158 . . . . 0.0 112.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.3 -50.0 51.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -76.71 -38.25 54.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.572 0.749 . . . . 0.0 112.921 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.72 -45.17 86.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.317 0.508 . . . . 0.0 111.346 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -77.5 -28.42 52.11 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.66 -46.15 77.58 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.267 0.94 . . . . 0.0 112.545 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.76 -42.19 96.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.963 0.801 . . . . 0.0 112.61 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.09 -55.02 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.518 0.727 . . . . 0.0 110.259 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.84 -32.79 73.56 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.18 -52.36 62.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.695 1.198 . . . . 0.0 111.612 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.73 -36.1 83.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.692 -0.63 . . . . 0.0 112.017 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.13 90.91 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.619 -0.675 . . . . 0.0 111.939 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.05 -46.11 85.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.166 0.889 . . . . 0.0 113.681 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -60.95 -46.13 91.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.155 0.977 . . . . 0.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.44 82.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.607 -0.683 . . . . 0.0 112.305 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.97 88.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.284 1.034 . . . . 0.0 112.629 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -54.48 -50.63 67.3 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.755 1.222 . . . . 0.0 111.86 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -58.68 -38.76 78.91 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -87.72 6.33 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.591 1.156 . . . . 0.0 113.267 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 52.88 34.88 17.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.107 2.163 . . . . 0.0 114.275 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 148.99 21.81 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.506 1.522 . . . . 0.0 112.805 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.0 p -90.58 -28.71 18.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.311 1.445 . . . . 0.0 113.074 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -122.75 138.54 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.302 1.441 . . . . 0.0 111.765 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.72 130.19 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.892 1.277 . . . . 0.0 110.849 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.19 164.39 20.43 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 125.743 1.617 . . . . 0.0 111.481 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.01 -38.3 48.9 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.692 2.928 . . . . 0.0 114.923 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.47 -40.55 87.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.736 0.814 . . . . 0.0 113.036 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -62.21 -41.81 98.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.018 0.826 . . . . 0.0 111.812 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.23 -45.68 87.12 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.84 0.856 . . . . 0.0 111.476 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -58.13 -48.69 79.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.007 0.923 . . . . 0.0 112.024 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.27 -46.77 82.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.76 0.824 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.13 -52.17 59.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.89 0.768 . . . . 0.0 112.622 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 24.6 pt -71.16 -24.99 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -74.36 -43.38 56.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.273 1.429 . . . . 0.0 112.46 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -73.81 -21.34 60.18 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -120.57 115.0 22.56 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.113 0.965 . . . . 0.0 111.382 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.05 -37.33 64.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.666 1.186 . . . . 0.0 112.873 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -60.5 -30.52 69.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 112.757 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.39 -38.17 35.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.946 0.898 . . . . 0.0 111.497 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.07 -32.12 70.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.617 0.767 . . . . 0.0 112.87 172.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.27 -42.23 96.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.54 1.136 . . . . 0.0 113.2 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -51.97 66.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.766 0.826 . . . . 0.0 112.052 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 113.388 -172.846 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 136.48 39.02 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.039 1.336 . . . . 0.0 110.148 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.12 150.31 97.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.422 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.09 128.82 31.8 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.982 2.455 . . . . 0.0 112.995 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.36 143.84 56.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.589 0.756 . . . . 0.0 110.556 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.32 114.31 3.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.28 0.632 . . . . 0.0 110.089 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.25 156.07 39.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.35 1.06 . . . . 0.0 111.967 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.81 113.96 4.16 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 170.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 30.0 p -67.2 143.63 56.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.694 0.798 . . . . 0.0 112.311 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.69 141.23 57.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.181 0.593 . . . . 0.0 110.852 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.274 0.559 . . . . 0.0 110.909 -178.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -62.22 -38.38 88.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.66 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.59 -53.18 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.814 0.845 . . . . 0.0 111.64 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.35 -43.0 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.53 1.132 . . . . 0.0 111.982 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -52.85 -49.96 64.72 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.429 1.013 . . . . 0.0 111.697 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.98 -37.62 77.24 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.044 0.838 . . . . 0.0 113.013 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -75.8 -46.17 32.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.1 0.96 . . . . 0.0 113.38 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.39 -36.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.951 1.3 . . . . 0.0 111.831 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -120.79 68.08 15.45 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.294 1.838 . . . . 0.0 111.547 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.24 -38.82 3.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.152 2.568 . . . . 0.0 112.968 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.81 -42.9 7.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.772 1.229 . . . . 0.0 112.852 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -69.6 172.98 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.41 1.884 . . . . 0.0 112.822 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.72 -163.23 10.32 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 124.529 1.062 . . . . 0.0 113.938 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.13 152.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.305 1.442 . . . . 0.0 110.627 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 51.4 p -81.24 154.82 26.42 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.207 0.912 . . . . 0.0 112.842 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 47.9 p -56.69 -40.13 75.03 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.215 -0.928 . . . . 0.0 112.011 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.48 -50.22 74.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.955 1.302 . . . . 0.0 111.849 172.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.55 98.12 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.678 0.791 . . . . 0.0 112.989 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.9 -43.58 86.24 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.094 -1.003 . . . . 0.0 111.454 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.08 -48.64 66.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.503 1.049 . . . . 0.0 113.544 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.92 -47.23 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.138 0.975 . . . . 0.0 111.393 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.26 -39.58 83.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.451 1.023 . . . . 0.0 112.887 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -63.99 -46.44 84.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.173 -0.955 . . . . 0.0 111.183 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 57.7 m -55.4 -46.79 76.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.258 0.936 . . . . 0.0 112.373 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -53.94 -53.86 46.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.735 0.814 . . . . 0.0 111.179 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 82.7 t -57.11 -49.0 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.485 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -52.16 -50.77 61.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 120.186 1.357 . . . . 0.0 111.752 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.26 -51.43 66.22 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.59 -45.33 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.379 1.072 . . . . 0.0 111.342 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -55.03 -51.51 66.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.07 1.348 . . . . 0.0 112.369 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.98 -42.02 97.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.165 0.986 . . . . 0.0 112.003 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -60.68 -51.72 68.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.051 0.94 . . . . 0.0 112.305 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 pt -69.52 -26.36 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.88 67.67 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.349 0.977 . . . . 0.0 112.395 169.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.24 86.05 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.166 0.412 . . . . 0.0 112.394 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.5 -43.19 86.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.254 -1.144 . . . . 0.0 112.046 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.72 -42.69 75.69 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.878 1.217 . . . . 0.0 113.129 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 81.5 p -70.03 -44.23 69.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.945 0.793 . . . . 0.0 112.332 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -55.69 -42.16 74.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.653 1.115 . . . . 0.0 113.339 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -57.01 -35.03 68.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.683 1.193 . . . . 0.0 112.389 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.72 -45.58 64.65 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.316 -0.865 . . . . 0.0 112.052 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -59.04 -39.16 81.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.951 1.3 . . . . 0.0 113.616 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -56.55 -29.83 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.13 1.372 . . . . 0.0 112.813 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -99.2 13.86 31.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.812 1.645 . . . . 0.0 112.232 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.62 29.22 6.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.631 2.372 . . . . 0.0 114.464 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -73.36 139.82 46.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.52 1.128 . . . . 0.0 111.336 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 59.6 p -76.61 -32.81 58.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.719 1.208 . . . . 0.0 113.787 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -136.93 -167.94 2.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.505 1.922 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.29 113.09 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.83 1.252 . . . . 0.0 110.482 168.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 30.4 p -85.7 168.87 13.98 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.125 1.37 . . . . 0.0 113.647 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 34.9 p -50.06 -44.72 51.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.23 1.412 . . . . 0.0 113.497 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.04 -42.2 69.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.084 0.953 . . . . 0.0 112.007 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.74 -29.86 71.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.1 -48.84 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.091 -1.006 . . . . 0.0 110.956 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -38.49 83.19 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.331 -0.856 . . . . 0.0 111.406 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 32.6 m -58.43 -48.09 81.82 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.442 -0.786 . . . . 0.0 111.974 169.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.14 -44.65 83.59 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.945 -1.097 . . . . 0.0 112.243 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.41 -49.95 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.844 0.858 . . . . 0.0 111.959 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -72.02 -14.16 61.8 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.19 -29.33 21.83 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.328 1.051 . . . . 0.0 112.121 170.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.2 -47.4 24.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 112.784 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.545 0.778 0 C-N-CA 124.549 1.14 . . . . 0.0 112.166 -176.828 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.31 151.62 34.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.686 1.136 . . . . 0.0 113.367 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.86 60.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.24 -9.21 86.83 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.05 31.54 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.533 1.667 . . . . 0.0 114.984 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.86 -35.86 81.04 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.62 2.88 . . . . 0.0 114.738 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.71 -44.82 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.018 0.927 . . . . 0.0 110.547 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -65.02 -49.29 70.76 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.51 -38.08 86.43 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.092 -1.005 . . . . 0.0 111.703 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.48 87.58 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.515 -0.74 . . . . 0.0 112.298 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.32 82.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.215 0.916 . . . . 0.0 112.103 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.3 -49.67 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.551 -0.718 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.86 -33.14 75.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -62.07 -29.37 70.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.98 -6.92 50.31 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.322 -1.486 . . . . 0.0 113.917 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.47 -43.76 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.457 1.103 . . . . 0.0 111.268 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 57.9 p -62.56 -19.53 63.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.701 0.801 . . . . 0.0 112.736 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.73 -40.53 40.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.958 1.303 . . . . 0.0 113.666 166.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.95 -45.35 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.667 1.121 . . . . 0.0 111.578 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.24 -41.25 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.118 0.967 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.41 -45.16 85.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.81 1.244 . . . . 0.0 113.17 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -61.26 -44.53 97.08 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.463 1.029 . . . . 0.0 112.034 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.16 -41.26 87.96 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.81 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.19 75.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.108 -0.995 . . . . 0.0 112.528 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.18 -44.14 93.29 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.355 0.978 . . . . 0.0 112.914 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.703 -0.881 . . . . 0.0 111.254 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.18 88.26 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.281 -0.887 . . . . 0.0 112.979 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.16 78.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.055 1.342 . . . . 0.0 112.145 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -54.0 -47.7 71.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.584 1.153 . . . . 0.0 112.508 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -57.97 -34.56 70.08 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.03 4.21 45.98 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.821 1.248 . . . . 0.0 113.444 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.14 32.04 19.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.824 2.05 . . . . 0.0 114.324 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.89 154.05 21.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.933 1.693 . . . . 0.0 113.018 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -115.36 15.68 16.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.474 1.91 . . . . 0.0 113.082 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -130.69 126.85 37.57 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.191 1.397 . . . . 0.0 110.4 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.09 124.27 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.921 0.888 . . . . 0.0 109.766 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.86 164.92 24.08 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.724 1.61 . . . . 0.0 110.879 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -50.16 -34.94 41.01 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.564 2.843 . . . . 0.0 114.915 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.51 -35.57 79.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.889 0.876 . . . . 0.0 113.362 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.63 -39.42 77.18 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.924 -1.11 . . . . 0.0 112.026 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.89 -39.84 91.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.455 0.702 . . . . 0.0 111.229 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.22 -51.74 66.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.336 1.054 . . . . 0.0 111.052 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.09 -39.87 79.69 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.188 0.904 . . . . 0.0 112.811 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.21 70.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.585 0.754 . . . . 0.0 112.493 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.08 -30.53 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -48.82 -35.86 15.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.276 1.83 . . . . 0.0 113.643 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.36 -12.29 61.48 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -130.71 130.34 43.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.009 1.323 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.05 -48.34 82.2 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.128 -0.983 . . . . 0.0 113.24 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.42 -45.99 88.41 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.481 -0.762 . . . . 0.0 112.044 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.8 -36.87 85.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.072 0.851 . . . . 0.0 112.438 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -60.92 -46.39 90.86 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.994 1.27 . . . . 0.0 111.753 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.41 -32.83 74.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 113.388 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.25 -47.89 54.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.488 1.515 . . . . 0.0 112.037 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.772 0.796 . . . . 0.0 110.368 175.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 63.7 tp -99.35 114.58 27.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 109.888 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.58 149.67 98.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.992 170.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.07 118.38 5.16 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.973 2.449 . . . . 0.0 112.344 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.55 132.4 48.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.69 0.796 . . . . 0.0 111.078 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.08 135.42 57.51 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 162.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 38.9 m -62.93 111.74 2.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.279 0.491 . . . . 0.0 110.129 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.31 98.39 6.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.538 0.735 . . . . 0.0 110.021 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -56.15 133.95 52.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.465 0.706 . . . . 0.0 110.126 170.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -61.43 111.1 1.65 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.995 0.518 . . . . 0.0 110.944 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.236 0.384 0 C-N-CA 123.568 0.747 . . . . 0.0 111.396 -174.745 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.01 -42.29 99.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.597 . . . . 0.0 112.519 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -55.07 -37.19 66.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.014 1.325 . . . . 0.0 113.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.23 -57.01 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.873 1.269 . . . . 0.0 111.2 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.58 -37.36 27.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.644 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -46.94 -43.31 18.95 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.844 1.202 . . . . 0.0 112.239 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.89 -50.92 8.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.065 . . . . 0.0 113.08 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.29 -43.71 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 118.837 0.744 . . . . 0.0 112.912 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -126.4 69.06 68.31 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.06 1.744 . . . . 0.0 110.449 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -58.14 -21.42 51.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.798 2.998 . . . . 0.0 114.015 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.19 -10.37 59.4 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.678 1.991 . . . . 0.0 113.991 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -111.45 120.34 41.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.064 1.346 . . . . 0.0 111.948 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.47 168.46 42.15 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.436 1.493 . . . . 0.0 113.923 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 56.9 mt -133.59 132.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.322 1.449 . . . . 0.0 108.694 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 31.0 p -73.94 156.33 37.73 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 51.2 p -55.66 -38.19 69.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.3 -0.875 . . . . 0.0 112.293 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.99 -44.66 84.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.66 1.184 . . . . 0.0 112.452 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.73 88.28 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.917 0.887 . . . . 0.0 111.906 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.3 mtm -59.36 -46.13 89.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.747 -0.595 . . . . 0.0 111.073 171.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.67 58.38 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.961 1.267 . . . . 0.0 114.81 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.04 -35.63 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.202 1.501 . . . . 0.0 111.977 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 78.1 mtm -62.83 -36.64 83.85 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.297 -0.877 . . . . 0.0 112.841 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.37 -46.05 91.8 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 110.527 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -53.89 -47.46 71.11 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.491 0.716 . . . . 0.0 111.973 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -52.03 -37.59 54.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.01 -51.15 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.559 1.527 . . . . 0.0 111.137 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.99 -45.1 95.1 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.179 0.592 . . . . 0.0 111.583 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -56.37 -47.84 78.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.1 -45.84 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.178 0.899 . . . . 0.0 110.02 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.49 -50.75 67.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.943 0.792 . . . . 0.0 111.948 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.56 -44.87 95.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.039 0.936 . . . . 0.0 112.72 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -60.19 -49.72 76.52 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.79 0.723 . . . . 0.0 111.866 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.25 -51.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.163 0.985 . . . . 0.0 110.785 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.46 72.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.111 0.964 . . . . 0.0 112.343 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.82 50.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.517 1.055 . . . . 0.0 113.685 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.28 -45.21 94.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.217 1.009 . . . . 0.0 112.38 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.62 80.7 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.948 0.795 . . . . 0.0 111.796 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 68.4 m -58.27 -52.43 65.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.556 0.742 . . . . 0.0 112.252 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -59.13 -37.9 78.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.971 0.908 . . . . 0.0 113.241 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.22 -42.97 87.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 112.096 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.98 88.5 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.801 0.728 . . . . 0.0 111.972 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -59.38 -45.4 91.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 112.532 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -56.89 -43.04 80.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.671 1.188 . . . . 0.0 112.359 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -79.56 6.7 9.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.446 1.099 . . . . 0.0 113.943 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 54.0 43.18 31.16 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.153 2.181 . . . . 0.0 114.114 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.09 152.02 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.087 1.355 . . . . 0.0 112.434 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 33.1 p -77.88 -45.39 24.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 111.706 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 28.2 m -61.56 117.05 5.25 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.996 1.318 . . . . 0.0 111.746 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -74.17 129.11 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.347 1.459 . . . . 0.0 108.959 163.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -96.41 159.7 14.8 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 38.6 p -57.4 -39.24 75.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.944 0.898 . . . . 0.0 112.387 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.31 -42.23 96.45 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.673 1.189 . . . . 0.0 112.391 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.506 -0.746 . . . . 0.0 111.839 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.56 -42.83 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.38 -0.825 . . . . 0.0 111.12 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.31 -39.15 82.16 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.806 -1.184 . . . . 0.0 112.236 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 81.6 m -64.82 -45.11 87.59 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.918 -1.114 . . . . 0.0 111.964 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.33 -44.14 75.62 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.824 1.193 . . . . 0.0 111.799 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.47 -55.0 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.402 1.081 . . . . 0.0 111.353 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -52.97 -47.27 68.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 120.081 1.31 . . . . 0.0 112.333 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.98 -51.58 67.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.746 1.218 . . . . 0.0 112.577 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.38 -31.15 23.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -170.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 126.401 1.88 . . . . 0.0 111.097 -170.623 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.8 156.35 53.23 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.817 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.78 64.37 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.42 83.9 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.023 1.297 . . . . 0.0 115.895 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.14 82.16 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.686 1.743 . . . . 0.0 115.399 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.19 -39.48 90.13 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.649 2.232 . . . . 0.0 112.922 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.83 -48.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.057 1.343 . . . . 0.0 110.688 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -62.53 -44.4 96.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.76 -53.97 44.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.801 0.84 . . . . 0.0 110.802 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.26 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -53.81 53.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.759 0.823 . . . . 0.0 111.785 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.53 -40.45 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.079 0.952 . . . . 0.0 112.694 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.22 -18.51 58.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.032 1.333 . . . . 0.0 113.739 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -100.47 -29.94 12.1 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.002 1.321 . . . . 0.0 112.927 173.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -55.74 -54.99 37.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.532 1.133 . . . . 0.0 112.943 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -38.02 66.56 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.643 -0.661 . . . . 0.0 112.346 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 38.0 p -64.61 -29.51 70.52 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.567 -0.708 . . . . 0.0 112.846 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.9 65.32 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.701 0.8 . . . . 0.0 112.791 167.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -78.51 -41.63 31.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.56 -0.712 . . . . 0.0 112.379 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -53.97 -50.7 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.226 0.61 . . . . 0.0 110.561 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.73 -33.32 70.71 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.86 -53.0 63.17 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.989 0.813 . . . . 0.0 111.199 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.689 0.796 . . . . 0.0 112.159 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.77 84.59 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.104 -0.997 . . . . 0.0 112.909 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.14 -42.33 93.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.053 0.835 . . . . 0.0 112.659 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.46 -44.41 82.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.023 0.911 . . . . 0.0 111.927 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.59 82.05 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.371 0.987 . . . . 0.0 112.018 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.96 79.56 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.204 1.002 . . . . 0.0 112.58 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.88 -48.59 69.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.32 -32.93 67.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -91.84 6.12 47.34 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.029 1.332 . . . . 0.0 112.629 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.26 32.8 16.86 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.307 2.243 . . . . 0.0 114.252 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -99.68 152.18 20.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.295 1.438 . . . . 0.0 113.041 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -102.02 -6.66 23.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.655 1.582 . . . . 0.0 113.881 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -128.11 129.95 47.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.666 1.587 . . . . 0.0 110.877 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.16 124.69 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.465 1.506 . . . . 0.0 109.721 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.6 pt -117.18 168.16 9.52 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 125.912 1.685 . . . . 0.0 111.34 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.67 -37.07 63.45 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.385 2.723 . . . . 0.0 115.294 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.72 -38.57 88.36 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.314 -0.866 . . . . 0.0 112.797 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -65.59 -39.64 91.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.4 -0.812 . . . . 0.0 112.034 172.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.49 -44.85 93.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.593 0.757 . . . . 0.0 112.045 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.28 -50.13 73.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.898 0.879 . . . . 0.0 111.692 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.7 mt -58.07 -45.33 87.29 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.712 0.805 . . . . 0.0 112.349 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.37 -51.86 61.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.161 0.984 . . . . 0.0 112.129 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.26 -39.97 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -55.28 -42.87 74.16 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.957 -1.089 . . . . 0.0 112.385 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -86.16 -8.08 58.1 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -129.19 116.92 19.92 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.653 1.115 . . . . 0.0 112.409 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -67.53 -35.4 79.01 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -64.92 -42.08 95.02 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.194 0.906 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -51.87 -48.5 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.156 168.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -67.6 -14.62 63.1 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -84.34 -40.65 17.65 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.502 1.046 . . . . 0.0 111.324 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.95 -53.28 11.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.983 1.313 . . . . 0.0 112.019 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 127.109 2.163 . . . . 0.0 107.957 174.081 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.1 t . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.32 111.23 12.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.522 0.729 . . . . 0.0 110.423 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.59 144.43 45.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.953 . . . . 0.0 111.02 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -59.14 148.64 84.79 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.786 2.324 . . . . 0.0 111.729 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.26 70.31 4.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.192 0.997 . . . . 0.0 111.341 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.7 135.76 56.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.179 1.392 . . . . 0.0 110.964 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 31.2 p -69.2 154.04 42.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.855 0.862 . . . . 0.0 112.137 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.7 128.93 39.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.331 1.052 . . . . 0.0 111.707 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 55.9 p -84.88 -9.07 58.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -122.49 142.77 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.236 1.414 . . . . 0.0 111.813 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.6 t60 . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 124.724 1.21 . . . . 0.0 113.125 178.412 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 119.73 -0.176 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.1 -42.68 88.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.824 0.85 . . . . 0.0 112.622 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.08 -45.93 86.31 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.382 -0.824 . . . . 0.0 112.33 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.69 -45.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.469 0.708 . . . . 0.0 110.814 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -53.46 -47.85 69.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.422 1.01 . . . . 0.0 112.73 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -53.35 -41.09 65.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 0.0 112.884 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -76.37 -41.23 48.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.378 1.071 . . . . 0.0 112.821 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.37 -55.36 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.207 1.403 . . . . 0.0 112.732 -168.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -149.52 71.04 9.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.574 1.15 . . . . 0.0 111.47 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.03 -20.28 67.47 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.368 2.712 . . . . 0.0 114.666 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.73 -25.62 68.28 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -119.74 126.12 50.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.9 1.28 . . . . 0.0 109.591 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.98 -172.22 25.93 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.06 0.838 . . . . 0.0 113.489 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -140.18 155.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.948 -1.325 . . . . 0.0 111.689 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 42.0 p -89.35 157.04 18.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.683 0.793 . . . . 0.0 113.039 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.969 . . . . 0.0 112.402 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.07 -48.52 81.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.24 1.016 . . . . 0.0 111.373 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.4 94.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 112.73 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.6 mtp -55.11 -46.22 75.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.023 0.829 . . . . 0.0 111.316 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.76 -46.44 67.36 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.313 0.959 . . . . 0.0 114.245 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.07 -45.5 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 118.086 0.943 . . . . 0.0 111.41 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 85.4 mtp -60.37 -36.23 77.58 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.084 -1.01 . . . . 0.0 113.205 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -60.06 -41.3 92.08 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.92 0.782 . . . . 0.0 110.966 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 50.8 m -60.27 -50.17 74.71 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.302 -0.873 . . . . 0.0 112.13 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -52.03 -47.04 65.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.661 0.784 . . . . 0.0 112.683 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.82 -27.34 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.47 -34.18 72.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.378 0.99 . . . . 0.0 111.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.25 -48.01 71.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.83 -42.01 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 119.493 1.042 . . . . 0.0 111.004 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -56.93 -42.74 80.57 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.392 0.996 . . . . 0.0 111.655 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.29 -41.76 98.78 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -62.64 -45.91 90.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.454 1.025 . . . . 0.0 112.726 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.67 -53.49 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.973 0.909 . . . . 0.0 110.538 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.0 87.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.752 0.821 . . . . 0.0 112.368 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.44 59.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.647 1.118 . . . . 0.0 113.69 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -64.11 -41.04 97.4 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.345 -1.091 . . . . 0.0 111.95 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.78 94.9 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.095 -1.003 . . . . 0.0 112.149 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.6 t -60.78 -46.96 88.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.73 1.212 . . . . 0.0 111.726 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -57.37 -46.01 83.81 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.146 -0.971 . . . . 0.0 112.285 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.78 -45.33 86.13 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.508 0.723 . . . . 0.0 111.863 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.84 80.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.811 0.732 . . . . 0.0 112.22 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -58.29 -49.68 76.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.354 0.979 . . . . 0.0 112.256 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -56.53 -38.37 71.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.88 0.764 . . . . 0.0 112.504 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.64 2.8 31.63 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.931 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.45 35.08 22.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.11 2.164 . . . . 0.0 114.343 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -104.33 145.44 30.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.374 1.87 . . . . 0.0 112.249 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 27.2 p -84.32 -51.88 6.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.152 1.381 . . . . 0.0 111.487 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 60.0 m -82.05 127.35 33.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.042 1.337 . . . . 0.0 111.618 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.09 133.89 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.682 1.193 . . . . 0.0 110.971 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 9.4 p -90.93 160.7 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -50.53 -45.77 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 112.666 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.76 -44.96 88.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.199 1.0 . . . . 0.0 111.63 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -59.14 -40.59 85.97 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.625 0.77 . . . . 0.0 112.272 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.73 -52.83 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.066 0.848 . . . . 0.0 110.969 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -57.65 -42.28 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.954 0.797 . . . . 0.0 112.575 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 92.3 m -64.26 -46.27 84.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.153 0.981 . . . . 0.0 111.247 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.4 81.31 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.139 1.336 . . . . 0.0 113.183 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.8 -51.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.873 0.869 . . . . 0.0 110.664 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.39 -27.69 67.3 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 77.1 mt -64.46 -37.79 88.77 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.451 1.023 . . . . 0.0 111.93 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 50.4 mt -79.37 -29.66 42.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.551 1.01 0 C-N-CA 126.331 1.852 . . . . 0.0 111.39 179.329 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.464 0.649 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.22 147.05 43.68 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.247 0.927 . . . . 0.0 112.983 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.29 -58.95 2.96 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.753 0.821 . . . . 0.0 113.059 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.86 88.4 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.11 -59.61 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 119.483 1.642 . . . . 0.0 113.938 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.03 -33.64 98.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.539 2.159 . . . . 0.0 113.058 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.76 -42.67 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.21 1.368 . . . . 0.0 111.584 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -77.22 -38.87 50.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.869 -1.144 . . . . 0.0 113.602 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.91 -43.62 73.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.92 1.236 . . . . 0.0 110.581 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.92 91.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.943 0.897 . . . . 0.0 112.787 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.78 -42.94 76.28 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.293 1.406 . . . . 0.0 112.667 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -60.14 -53.39 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.574 0.625 . . . . 0.0 111.39 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.11 -21.59 65.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -48.85 -49.06 41.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.644 1.111 . . . . 0.0 112.062 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -64.03 -29.56 70.7 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -73.59 -51.42 16.95 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.983 0.913 . . . . 0.0 111.659 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 67.8 p -70.88 -21.42 62.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.972 -1.08 . . . . 0.0 113.372 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.55 94.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.244 1.018 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -38.63 91.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.242 0.928 . . . . 0.0 111.768 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mt -56.47 -52.66 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 118.809 0.731 . . . . 0.0 110.148 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.39 -30.04 70.81 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.21 -53.85 42.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.805 1.184 . . . . 0.0 111.165 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.62 -41.51 99.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.856 0.863 . . . . 0.0 111.995 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.38 87.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.317 1.047 . . . . 0.0 111.858 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.75 97.73 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.766 1.175 . . . . 0.0 112.935 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.18 -44.36 95.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.435 1.117 . . . . 0.0 111.253 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.226 -0.921 . . . . 0.0 112.462 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.22 82.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.402 1.081 . . . . 0.0 112.011 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.68 -50.33 63.49 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 0.0 112.21 171.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -58.16 -36.0 72.38 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -87.05 3.34 46.46 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.797 1.239 . . . . 0.0 113.441 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 92.3 mttt 55.64 32.91 20.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.844 2.058 . . . . 0.0 114.257 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.6 152.79 22.01 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.907 1.683 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 30.4 p -109.41 12.17 24.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.014 1.726 . . . . 0.0 112.905 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -133.54 126.65 31.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.472 -1.393 . . . . 0.0 111.268 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.6 127.52 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.027 0.931 . . . . 0.0 109.19 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.04 167.13 13.83 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.987 1.715 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -44.49 -42.71 14.16 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.241 3.294 . . . . 0.0 115.465 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.87 -40.69 93.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.749 0.82 . . . . 0.0 112.887 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -65.66 -41.56 92.38 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.621 0.768 . . . . 0.0 111.904 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.57 -43.9 95.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.41 0.684 . . . . 0.0 111.618 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -56.69 -50.29 72.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.426 1.09 . . . . 0.0 111.713 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.79 -46.85 81.29 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.736 0.698 . . . . 0.0 111.978 173.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.79 62.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.596 0.758 . . . . 0.0 112.593 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 pt -68.34 -30.84 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -65.78 -41.89 91.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.774 1.229 . . . . 0.0 112.388 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -79.57 -7.55 58.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -171.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -124.1 122.0 36.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.952 1.251 . . . . 0.0 111.361 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -53.33 -41.61 65.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.42 1.088 . . . . 0.0 112.516 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -64.08 -29.49 70.63 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.286 -0.883 . . . . 0.0 113.358 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.57 -43.83 30.52 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.607 -0.683 . . . . 0.0 111.306 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -53.93 -45.55 71.27 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.91 0.884 . . . . 0.0 112.261 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.39 -26.5 53.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.086 1.354 . . . . 0.0 113.915 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -91.12 -97.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.088 1.355 . . . . 0.0 110.276 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 CA--C 1.541 0.614 0 CA-C-N 119.852 1.205 . . . . 0.0 110.617 175.322 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -71.76 106.39 4.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.138 0.575 . . . . 0.0 109.593 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.59 140.43 97.51 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.135 0.574 . . . . 0.0 110.98 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -59.29 144.84 99.26 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.607 2.205 . . . . 0.0 111.407 172.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.72 124.21 17.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.301 0.64 . . . . 0.0 110.062 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.45 119.69 7.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.976 0.91 . . . . 0.0 110.004 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -57.14 123.03 13.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.215 1.006 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.17 111.51 5.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 23.4 t -123.13 118.34 27.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.148 1.379 . . . . 0.0 109.73 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -84.57 128.65 34.71 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.689 0.795 . . . . 0.0 110.786 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 123.702 0.801 . . . . 0.0 111.728 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -45.79 -34.68 3.84 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.746 1.618 . . . . 0.0 113.046 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -50.23 -33.93 21.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.497 -1.377 . . . . 0.0 114.086 171.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.5 -50.71 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.456 1.025 . . . . 0.0 110.454 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -51.87 66.76 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.876 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -51.0 -40.45 58.15 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -80.55 -50.29 10.21 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 113.179 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.44 -47.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.738 0.815 . . . . 0.0 111.937 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -131.24 84.9 55.53 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.598 1.559 . . . . 0.0 110.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.4 -31.26 76.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.571 2.847 . . . . 0.0 115.161 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -70.13 -19.51 63.22 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -94.59 133.16 38.53 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.855 1.262 . . . . 0.0 112.048 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.34 -172.49 13.22 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.731 1.158 . . . . 0.0 114.691 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -121.96 162.21 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.616 1.566 . . . . 0.0 110.284 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -89.45 163.58 15.2 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.958 168.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -55.84 -41.22 73.96 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.169 0.988 . . . . 0.0 111.845 168.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.43 -41.15 93.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.308 1.043 . . . . 0.0 112.176 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.32 92.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.763 0.825 . . . . 0.0 112.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 56.6 tpp -52.9 -48.26 67.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.005 168.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.55 -45.39 77.23 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.497 1.046 . . . . 0.0 114.729 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.72 -42.55 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.49 1.145 . . . . 0.0 112.011 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.73 -41.0 94.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.936 -1.102 . . . . 0.0 111.46 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -60.79 -47.3 86.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.848 0.859 . . . . 0.0 112.083 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 81.0 p -64.81 -39.63 93.91 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.572 1.533 . . . . 0.0 112.775 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -51.82 -55.83 17.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.93 1.292 . . . . 0.0 111.908 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.35 -31.2 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -60.94 -44.07 97.76 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.058 0.845 . . . . 0.0 112.04 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.49 -42.22 87.09 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.727 -0.608 . . . . 0.0 111.987 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.99 -43.28 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.34 -0.85 . . . . 0.0 111.466 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.36 -44.56 76.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.418 1.463 . . . . 0.0 112.501 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.717 0.69 . . . . 0.0 111.743 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -61.68 -43.76 98.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.775 0.83 . . . . 0.0 112.881 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -52.95 -52.8 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.555 1.142 . . . . 0.0 110.132 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.36 90.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.28 -50.85 61.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.892 0.758 . . . . 0.0 113.235 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -64.17 -41.45 97.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.604 -0.939 . . . . 0.0 112.156 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.15 94.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.419 1.009 . . . . 0.0 112.007 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -57.8 -53.77 54.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.291 1.036 . . . . 0.0 111.866 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -51.88 -54.75 25.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.169 0.987 . . . . 0.0 112.025 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.62 -44.51 89.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.297 1.039 . . . . 0.0 112.705 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.39 79.35 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.967 0.803 . . . . 0.0 112.138 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -63.14 -45.33 92.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.776 0.83 . . . . 0.0 112.594 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -60.62 -35.94 77.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.076 0.95 . . . . 0.0 112.45 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -86.18 15.49 5.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.613 1.565 . . . . 0.0 113.215 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 55.3 29.04 12.2 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.547 2.339 . . . . 0.0 115.075 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -81.77 152.92 26.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.489 1.116 . . . . 0.0 112.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 53.9 p -71.13 -35.6 71.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.834 1.253 . . . . 0.0 112.824 170.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 7.2 t -143.73 167.39 22.4 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.39 1.476 . . . . 0.0 112.806 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 84.1 mt -71.45 138.19 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.51 1.524 . . . . 0.0 110.457 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 16.7 p -112.51 166.16 11.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.511 1.125 . . . . 0.0 111.814 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 31.7 p -51.56 -41.66 61.29 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.403 1.081 . . . . 0.0 112.67 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.51 -45.76 89.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.3 1.04 . . . . 0.0 111.932 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.87 -40.68 96.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.323 0.51 . . . . 0.0 112.276 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.5 -51.78 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.685 0.794 . . . . 0.0 110.963 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -53.2 -48.63 67.95 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.68 1.127 . . . . 0.0 111.852 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 77.1 m -60.49 -46.28 90.67 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.187 0.903 . . . . 0.0 112.16 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.29 72.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.475 1.034 . . . . 0.0 112.753 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -60.31 -50.92 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.005 0.922 . . . . 0.0 110.583 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -58.42 -39.52 80.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.493 1.117 . . . . 0.0 113.748 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 72.4 mt -58.08 -44.2 87.42 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.721 0.691 . . . . 0.0 112.212 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.11 -37.76 64.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.226 1.01 . . . . 0.0 112.139 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 mt . . . . . 0 CA--C 1.553 1.091 0 C-N-CA 126.565 1.946 . . . . 0.0 111.059 -171.681 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.19 135.56 47.59 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.146 3.231 . . . . 0.0 113.491 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -74.32 156.87 50.47 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.875 1.226 . . . . 0.0 113.693 171.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 99.8 mmm -68.68 138.38 54.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.74 0.816 . . . . 0.0 111.867 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 40.1 p -80.96 143.45 32.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.427 1.091 . . . . 0.0 113.412 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.41 151.61 52.33 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.353 0.978 . . . . 0.0 112.964 170.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.49 136.18 57.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.039 0.936 . . . . 0.0 111.686 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.52 -28.1 73.54 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.221 0.915 . . . . 0.0 114.712 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.82 137.07 58.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.968 1.307 . . . . 0.0 112.244 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -92.75 168.19 11.37 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.805 1.242 . . . . 0.0 112.139 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.16 -152.76 48.89 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.181 0.896 . . . . 0.0 113.43 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.43 5.3 35.32 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 124.759 1.171 . . . . 0.0 115.95 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -77.12 150.12 35.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.427 1.491 . . . . 0.0 111.776 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.18 132.18 46.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.147 0.579 . . . . 0.0 110.978 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.62 138.54 55.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.575 0.75 . . . . 0.0 111.354 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.01 133.92 51.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.525 0.73 . . . . 0.0 111.86 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.16 145.8 54.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.936 0.894 . . . . 0.0 111.489 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.97 137.59 58.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.347 0.659 . . . . 0.0 111.706 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 135.39 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.745 0.818 . . . . 0.0 111.779 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 33.4 p -73.12 156.99 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.369 1.067 . . . . 0.0 112.265 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -60.81 146.2 47.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 51.8 p -74.41 -37.37 63.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.576 1.15 . . . . 0.0 112.923 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -58.18 129.31 41.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 112.134 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.82 144.48 49.11 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.645 1.178 . . . . 0.0 112.102 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 118.22 10.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.67 0.788 . . . . 0.0 112.173 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.8 165.01 54.04 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.651 1.119 . . . . 0.0 113.66 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.59 151.99 32.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.923 0.889 . . . . 0.0 111.488 171.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -79.5 117.72 20.71 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.764 -0.585 . . . . 0.0 110.098 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.61 147.58 34.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.504 1.122 . . . . 0.0 110.403 170.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.23 -27.2 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.438 2.092 . . . . 0.0 114.32 -167.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.94 -32.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 120.629 -1.295 . . . . 0.0 113.244 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.87 -30.32 74.87 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.348 0.975 . . . . 0.0 114.046 170.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -79.41 -37.87 36.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.33 1.052 . . . . 0.0 111.714 170.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.84 -39.97 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.529 1.059 . . . . 0.0 111.265 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -50.57 -48.2 57.63 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.321 0.964 . . . . 0.0 112.394 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.7 -38.65 87.16 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.037 0.935 . . . . 0.0 112.953 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.24 -42.53 91.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.66 1.118 . . . . 0.0 111.992 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.9 -44.63 94.13 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.438 0.695 . . . . 0.0 111.707 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -61.13 -45.85 92.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.103 0.961 . . . . 0.0 112.764 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -58.73 -42.21 88.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.209 1.403 . . . . 0.0 112.444 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.98 -20.91 54.84 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 124.837 1.208 . . . . 0.0 114.464 170.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.83 39.69 30.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.094 2.158 . . . . 0.0 113.51 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -62.88 -36.67 84.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.863 0.865 . . . . 0.0 112.527 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -151.84 178.75 9.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.726 1.211 . . . . 0.0 112.682 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -61.58 -39.09 89.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.552 1.141 . . . . 0.0 113.651 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -139.67 146.84 40.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.541 1.536 . . . . 0.0 110.982 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.77 118.87 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.02 142.76 48.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.884 0.754 . . . . 0.0 112.862 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.28 68.79 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.281 1.041 . . . . 0.0 113.513 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.98 -24.98 76.15 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.445 1.021 . . . . 0.0 114.982 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.22 -55.82 37.96 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.355 1.578 . . . . 0.0 114.36 -174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.83 -34.41 95.65 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.357 2.038 . . . . 0.0 113.068 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.69 -51.02 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.155 0.888 . . . . 0.0 110.91 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -66.78 -42.28 86.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.589 0.756 . . . . 0.0 110.118 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 69.7 mt -63.32 -35.16 79.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.932 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.21 93.21 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.508 1.504 . . . . 0.0 112.077 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.39 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.92 0.488 . . . . 0.0 111.864 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -51.57 -53.86 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.512 1.125 . . . . 0.0 111.393 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 mt -53.11 -49.1 67.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.718 1.607 . . . . 0.0 112.104 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -48.04 -51.63 23.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.49 1.041 . . . . 0.0 111.985 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -69.45 -31.99 70.65 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.53 -23.3 57.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 1.5 p -119.22 5.12 11.24 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.598 1.544 . . . . 0.0 114.867 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.65 73.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.165 1.348 . . . . 0.0 112.718 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -70.1 -32.96 71.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.8 -54.14 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.012 0.925 . . . . 0.0 109.667 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.92 -46.48 81.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.51 1.524 . . . . 0.0 112.551 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -54.71 -56.78 15.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.586 0.754 . . . . 0.0 111.514 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.43 -38.07 71.4 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.0 99.45 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.334 -0.854 . . . . 0.0 111.802 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.97 94.99 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.506 -0.746 . . . . 0.0 113.596 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -58.8 -49.89 76.01 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.848 1.324 . . . . 0.0 110.603 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.78 80.96 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.63 0.772 . . . . 0.0 112.509 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.1 75.36 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.817 0.847 . . . . 0.0 112.606 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -56.82 -50.95 70.84 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.436 1.094 . . . . 0.0 112.289 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -55.51 -42.01 73.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.613 1.165 . . . . 0.0 113.075 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.79 10.68 17.62 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.625 1.17 . . . . 0.0 113.089 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 53.63 33.32 16.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.392 2.277 . . . . 0.0 114.777 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -89.29 146.51 24.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.23 1.412 . . . . 0.0 112.386 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.6 p -77.91 -30.63 50.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.881 1.272 . . . . 0.0 112.967 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -131.24 151.76 51.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.126 1.37 . . . . 0.0 112.603 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.7 mt -67.46 129.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 0.0 109.928 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 pt -122.71 167.1 15.16 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.429 1.892 . . . . 0.0 111.265 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -54.55 -34.5 82.73 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.344 2.696 . . . . 0.0 114.952 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.03 -36.75 75.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.988 0.915 . . . . 0.0 113.252 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -63.23 -38.69 92.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.551 -0.718 . . . . 0.0 111.982 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.21 -46.27 71.05 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.502 0.721 . . . . 0.0 111.761 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -50.65 -46.64 58.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.725 0.81 . . . . 0.0 111.746 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.83 -62.31 1.73 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.944 0.898 . . . . 0.0 112.173 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.99 69.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.755 1.222 . . . . 0.0 113.074 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -56.87 -61.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.857 0.863 . . . . 0.0 110.741 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.0 -32.69 74.11 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -86.79 -8.59 57.21 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -129.3 118.1 21.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 112.407 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.78 -26.81 67.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.822 -1.173 . . . . 0.0 114.067 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -70.98 -31.36 67.89 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 111.489 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.75 -36.94 67.81 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 111.493 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.54 -29.38 66.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.406 1.003 . . . . 0.0 112.771 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -77.11 -46.0 25.01 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.417 1.008 . . . . 0.0 112.417 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 mt -57.18 -45.1 83.98 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.083 0.953 . . . . 0.0 112.877 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -83.6 122.19 28.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.763 0.825 . . . . 0.0 111.992 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.35 -127.81 44.45 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.686 0.66 . . . . 0.0 114.407 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -62.91 123.95 19.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.357 1.063 . . . . 0.0 111.953 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.89 123.75 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.351 1.061 . . . . 0.0 109.937 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.393 0.677 . . . . 0.0 111.806 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.44 124.3 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 121.582 -0.699 . . . . 0.0 109.65 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.32 72.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.65 0.78 . . . . 0.0 113.065 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -78.06 158.36 29.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.115 0.966 . . . . 0.0 112.57 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.56 77.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.057 0.837 . . . . 0.0 114.855 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 141.9 48.19 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.871 1.224 . . . . 0.0 113.065 172.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 52.4 t -68.47 123.71 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.047 0.939 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.48 144.36 42.99 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.242 1.017 . . . . 0.0 111.347 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.75 -34.98 17.24 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.113 2.542 . . . . 0.0 113.354 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -71.14 133.49 46.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.87 0.868 . . . . 0.0 110.525 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.33 117.76 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.799 0.839 . . . . 0.0 109.71 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -80.79 148.07 30.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.935 0.894 . . . . 0.0 111.244 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.17 132.09 51.63 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.864 -0.522 . . . . 0.0 111.272 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.0 120.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.25 96.06 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.12 140.37 97.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.33 0.652 . . . . 0.0 110.789 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -58.66 149.52 76.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.44 2.093 . . . . 0.0 111.15 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.15 109.26 1.06 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.783 -0.573 . . . . 0.0 109.929 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.31 131.45 46.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.921 0.889 . . . . 0.0 110.387 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -63.34 155.57 28.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.275 0.63 . . . . 0.0 110.813 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.84 121.05 10.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.296 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -58.46 136.7 57.56 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.406 0.682 . . . . 0.0 111.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.8 100.39 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.102 0.561 . . . . 0.0 111.309 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -62.62 152.66 34.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.546 1.138 . . . . 0.0 111.409 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.97 116.44 2.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.08 0.952 . . . . 0.0 111.037 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.91 140.52 57.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.738 0.815 . . . . 0.0 111.861 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.48 112.34 5.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.703 0.801 . . . . 0.0 111.047 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.32 178.64 37.71 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.862 1.22 . . . . 0.0 114.422 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.485 1.514 . . . . 0.0 111.951 174.684 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.888 0 CA-C-O 119.877 -0.401 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -60.85 -23.98 78.1 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.838 3.692 . . . . 0.0 114.904 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -63.77 -20.1 63.77 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.327 0.965 . . . . 0.0 115.234 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.3 mmm -79.56 141.76 56.84 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 118.559 1.18 . . . . 0.0 112.108 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.24 144.04 94.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.103 2.536 . . . . 0.0 112.175 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -72.45 124.26 90.57 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 121.581 -0.699 . . . . 0.0 110.211 170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -63.5 147.02 93.43 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.169 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.79 115.43 5.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.388 0.675 . . . . 0.0 111.633 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.66 143.96 27.36 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.942 1.297 . . . . 0.0 111.315 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 54.5 p -66.81 156.78 34.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.815 0.846 . . . . 0.0 112.207 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.2 131.45 84.12 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.718 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.17 128.55 30.98 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.067 2.512 . . . . 0.0 113.342 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.12 131.05 94.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.243 0.617 . . . . 0.0 111.257 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.6 137.69 65.65 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.054 2.503 . . . . 0.0 112.016 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.68 131.75 51.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.584 0.753 . . . . 0.0 110.726 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.4 134.17 54.03 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.575 0.75 . . . . 0.0 110.883 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 140.11 48.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.668 0.652 . . . . 0.0 112.253 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 69.4 p -60.63 152.51 26.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.453 0.701 . . . . 0.0 112.354 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.67 103.81 1.17 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.556 0.742 . . . . 0.0 110.173 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.69 130.48 44.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 110.429 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 124.1 21.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.124 0.57 . . . . 0.0 110.989 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.4 t -79.42 108.24 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 56.1 p -76.79 166.34 23.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 0.0 112.687 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 108.44 2.22 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 124.14 19.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.59 0.756 . . . . 0.0 110.927 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.28 142.13 47.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.172 0.589 . . . . 0.0 110.351 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.92 105.3 4.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.606 -0.684 . . . . 0.0 111.163 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -101.35 -1.36 33.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.627 1.571 . . . . 0.0 113.158 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.09 139.24 42.66 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.305 1.042 . . . . 0.0 111.578 167.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.33 16.19 62.29 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -63.66 138.17 58.39 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.628 1.214 . . . . 0.0 113.151 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -96.87 -26.79 14.96 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.867 1.267 . . . . 0.0 113.273 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -99.27 88.36 3.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.722 1.609 . . . . 0.0 110.598 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -137.76 154.65 49.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.848 1.659 . . . . 0.0 112.238 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.28 -16.48 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.652 1.181 . . . . 0.0 113.692 170.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -63.76 122.27 16.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.563 0.745 . . . . 0.0 111.104 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.41 150.56 46.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.113 0.965 . . . . 0.0 110.142 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.3 118.54 2.49 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.588 0.755 . . . . 0.0 110.192 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -62.54 110.73 1.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.215 1.006 . . . . 0.0 110.727 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 15.3 t -154.92 -179.74 8.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.333 1.853 . . . . 0.0 109.662 -172.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -62.14 -17.81 59.02 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -42.2 -33.31 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.639 1.976 . . . . 0.0 114.185 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -41.69 -54.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.234 1.814 . . . . 0.0 111.705 169.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -90.56 -25.15 20.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.46 -58.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.096 0.959 . . . . 0.0 110.412 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.92 -41.47 74.58 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.14 -58.34 8.34 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 0.0 112.223 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 51.6 t -71.97 -35.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.962 -0.461 . . . . 0.0 111.372 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 tp -50.15 -57.54 7.49 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.679 169.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.77 -34.21 77.65 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -63.72 -50.16 70.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.509 0.724 . . . . 0.0 112.546 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.37 -44.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.921 0.889 . . . . 0.0 111.966 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.41 66.05 61.02 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.52 1.928 . . . . 0.0 111.445 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -55.99 -25.88 56.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.016 3.144 . . . . 0.0 114.18 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.3 -14.21 59.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.521 2.328 . . . . 0.0 114.2 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -121.17 126.21 49.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.527 1.131 . . . . 0.0 111.741 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.68 -164.75 40.54 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.071 0.843 . . . . 0.0 113.667 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.9 tt -143.79 149.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.99 -1.3 . . . . 0.0 111.73 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -80.69 156.07 26.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -56.65 -39.25 73.37 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.243 -0.91 . . . . 0.0 112.128 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.98 -55.82 29.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.189 1.396 . . . . 0.0 111.57 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.95 -42.08 97.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.469 0.708 . . . . 0.0 112.558 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 53.9 ttp -54.59 -53.55 53.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.846 0.859 . . . . 0.0 111.681 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.4 85.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.786 0.708 . . . . 0.0 113.069 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.84 -48.33 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.161 0.984 . . . . 0.0 111.113 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 65.1 mtt -57.5 -41.64 81.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.984 1.265 . . . . 0.0 112.615 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.86 -52.06 67.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.432 0.56 . . . . 0.0 110.727 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 72.8 m -54.92 -47.57 74.23 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.12 0.873 . . . . 0.0 112.794 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -54.54 -46.89 73.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 112.02 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -44.1 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.513 0.597 . . . . 0.0 111.739 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.06 -41.98 84.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.356 0.98 . . . . 0.0 111.933 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -60.0 -31.14 69.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 tp -90.9 -34.1 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 111.707 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.13 -42.05 89.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.61 1.164 . . . . 0.0 112.46 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -56.82 -44.38 81.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.371 1.068 . . . . 0.0 111.925 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -64.93 -44.87 88.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.053 0.941 . . . . 0.0 111.76 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.52 -49.4 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.707 1.203 . . . . 0.0 110.986 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.37 81.96 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 112.359 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.87 -46.11 90.86 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.268 0.937 . . . . 0.0 113.594 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.6 -41.89 87.75 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.379 -1.071 . . . . 0.0 112.856 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.47 94.36 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.156 0.889 . . . . 0.0 111.53 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -57.69 -49.76 75.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.418 1.087 . . . . 0.0 111.928 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.74 -49.86 67.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.471 1.109 . . . . 0.0 112.039 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.9 -48.22 78.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.685 0.794 . . . . 0.0 111.733 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -44.97 73.92 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.766 0.712 . . . . 0.0 112.473 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -57.6 -52.21 66.37 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.898 . . . . 0.0 112.387 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -62.43 -32.75 73.65 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -81.16 4.8 18.83 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.908 1.283 . . . . 0.0 113.627 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 56.86 31.9 20.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.968 2.107 . . . . 0.0 114.275 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -101.08 140.97 34.64 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.6 1.56 . . . . 0.0 112.074 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 61.0 p -79.68 -19.63 48.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.844 1.258 . . . . 0.0 113.086 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 63.7 p -114.73 148.91 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.87 2.068 . . . . 0.0 111.651 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.75 129.32 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.202 1.001 . . . . 0.0 110.014 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 6.1 p -83.37 162.42 21.06 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.016 0.912 . . . . 0.0 113.31 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -65.78 -10.29 36.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 0.0 114.295 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.44 -40.97 8.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.17 1.388 . . . . 0.0 112.187 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.53 -39.97 74.3 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.118 0.967 . . . . 0.0 112.663 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -57.81 -41.32 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -61.86 -49.5 75.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.229 0.922 . . . . 0.0 110.376 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 45.2 m -60.81 -46.86 88.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.397 1.079 . . . . 0.0 111.833 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.2 -46.93 65.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.445 1.098 . . . . 0.0 112.525 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.5 -51.23 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.605 0.762 . . . . 0.0 111.008 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -53.96 -45.78 71.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.114 0.966 . . . . 0.0 112.598 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.92 -36.77 72.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.875 1.27 . . . . 0.0 112.962 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.81 -22.41 25.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.551 1.14 . . . . 0.0 113.787 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 24.5 mt -115.69 78.56 6.97 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.736 1.214 . . . . 0.0 112.108 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -61.87 157.35 43.71 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.818 2.345 . . . . 0.0 113.412 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 -137.8 49.34 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.862 1.22 . . . . 0.0 114.53 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.76 -21.2 66.71 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.65 -41.39 85.96 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.435 -0.791 . . . . 0.0 112.061 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.82 73.39 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.118 0.872 . . . . 0.0 113.244 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.6 -44.14 80.84 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.45 1.023 . . . . 0.0 110.963 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -66.04 -71.07 0.21 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.701 0.8 . . . . 0.0 112.251 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.28 69.16 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -166.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.44 -57.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.327 1.051 . . . . 0.0 111.459 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 10.8 t -66.26 -58.56 5.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.075 1.307 . . . . 0.0 111.645 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.47 -30.11 69.74 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.242 -0.911 . . . . 0.0 112.3 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.5 -48.8 59.54 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.119 0.866 . . . . 0.0 113.917 168.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -66.91 -39.51 87.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 111.854 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.21 -40.96 87.44 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.291 0.95 . . . . 0.0 112.199 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.66 -23.48 67.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 99.6 t -48.47 -41.59 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 120.147 1.34 . . . . 0.0 111.865 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 38.0 m -52.37 -39.46 60.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.77 1.228 . . . . 0.0 112.946 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.0 -47.82 76.12 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.091 -1.006 . . . . 0.0 111.059 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -61.92 -32.24 72.62 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 60.3 p -81.35 -39.3 25.3 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.418 1.008 . . . . 0.0 112.827 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 42.4 m -69.39 -51.64 34.64 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.43 142.24 33.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.97 0.908 . . . . 0.0 112.224 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 82.2 tttt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 124.176 0.991 . . . . 0.0 112.044 177.434 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.37 149.33 91.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.989 3.126 . . . . 0.0 113.076 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -61.24 137.34 47.76 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.777 0.703 . . . . 0.0 112.307 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.6 mmm -59.82 137.64 58.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.47 0.708 . . . . 0.0 111.738 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p -91.14 160.54 15.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.964 1.306 . . . . 0.0 112.815 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.99 -123.99 27.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.683 0.658 . . . . 0.0 112.385 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.96 144.16 57.47 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.92 0.86 . . . . 0.0 112.159 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.86 3.9 75.32 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.753 1.168 . . . . 0.0 115.643 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.82 117.42 16.64 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.055 1.427 . . . . 0.0 110.969 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.67 124.93 23.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.09 0.556 . . . . 0.0 110.697 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.1 11.64 52.31 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 124.33 0.967 . . . . 0.0 115.179 -171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.0 154.93 53.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.052 1.31 . . . . 0.0 114.14 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.51 118.78 6.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.258 1.023 . . . . 0.0 110.587 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.05 136.49 57.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.359 0.664 . . . . 0.0 110.949 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -58.8 129.94 44.52 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.31 0.644 . . . . 0.0 111.278 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 56.43 1.98 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.155 1.382 . . . . 0.0 112.066 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -54.28 133.48 44.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.168 1.387 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.02 136.4 57.94 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.036 0.534 . . . . 0.0 111.092 172.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.74 102.0 2.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.499 0.719 . . . . 0.0 109.988 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 39.3 p -69.75 148.78 48.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.298 1.039 . . . . 0.0 112.009 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.98 139.45 55.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.387 0.675 . . . . 0.0 111.248 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 61.5 p -71.18 -25.64 62.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.361 1.064 . . . . 0.0 113.423 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -55.52 125.97 23.24 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.951 1.3 . . . . 0.0 112.038 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.09 142.06 36.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.494 1.117 . . . . 0.0 111.545 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.93 -27.61 66.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.317 0.647 . . . . 0.0 112.653 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.03 -141.5 47.41 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.87 1.224 . . . . 0.0 112.993 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.42 97.81 8.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.53 0.732 . . . . 0.0 111.059 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -103.15 141.62 35.55 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.184 1.394 . . . . 0.0 110.182 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.0 74.87 80.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.152 0.981 . . . . 0.0 112.157 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -65.99 165.46 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.649 2.233 . . . . 0.0 111.784 165.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.0 -21.35 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.271 -1.518 . . . . 0.0 113.047 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.76 -43.68 91.86 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.207 0.912 . . . . 0.0 112.92 161.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -71.09 -37.85 72.41 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.518 -0.989 . . . . 0.0 112.259 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 37.0 t -55.94 -44.89 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.495 1.043 . . . . 0.0 110.529 168.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -63.03 -38.3 90.62 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.671 -1.268 . . . . 0.0 112.411 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.02 -41.52 99.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.156 0.982 . . . . 0.0 113.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.73 -43.34 99.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.859 0.864 . . . . 0.0 111.575 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.55 -42.08 98.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 112.509 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -54.33 -55.77 25.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.066 1.346 . . . . 0.0 111.153 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.89 -37.0 84.97 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.01 0.924 . . . . 0.0 113.062 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.99 8.42 23.22 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.053 2.263 . . . . 0.0 116.493 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.9 24.86 14.86 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.489 1.916 . . . . 0.0 115.387 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.6 -32.34 18.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.391 1.076 . . . . 0.0 112.894 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t -124.57 137.87 54.36 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.039 1.336 . . . . 0.0 110.757 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -80.17 -40.11 27.95 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.167 -0.958 . . . . 0.0 112.349 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -137.23 165.25 26.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.518 1.527 . . . . 0.0 111.505 173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.41 105.88 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.453 1.501 . . . . 0.0 108.491 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.59 -179.22 27.29 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.947 0.784 . . . . 0.0 113.48 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.46 -50.04 23.7 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.578 -0.954 . . . . 0.0 111.997 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.76 -26.69 55.76 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.71 1.148 . . . . 0.0 115.458 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.78 -52.33 73.13 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.77 -37.1 89.0 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.59 2.194 . . . . 0.0 112.914 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.77 -40.97 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.755 0.822 . . . . 0.0 110.827 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.69 -45.12 87.98 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.373 -0.83 . . . . 0.0 112.547 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.01 -40.45 89.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.647 1.112 . . . . 0.0 111.827 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.38 90.45 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.346 -0.846 . . . . 0.0 111.334 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.88 -18.64 57.44 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.52 -59.43 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.322 -0.861 . . . . 0.0 110.733 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.67 -21.27 64.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.299 1.04 . . . . 0.0 112.869 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -37.7 -49.3 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.594 1.958 . . . . 0.0 112.917 159.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -61.18 -50.24 73.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.917 0.78 . . . . 0.0 112.5 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.34 -48.4 81.77 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.621 . . . . 0.0 111.348 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 71.8 m -60.98 -41.18 95.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.665 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.04 83.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.323 0.965 . . . . 0.0 112.086 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -56.5 -46.44 80.5 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.048 0.84 . . . . 0.0 112.561 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 86.5 mt -57.66 -57.76 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.698 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.01 -30.81 69.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.3 -55.22 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.909 1.231 . . . . 0.0 111.192 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.21 -36.68 84.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.647 -0.658 . . . . 0.0 112.102 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.57 96.83 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.477 -0.765 . . . . 0.0 112.433 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.38 -40.03 95.53 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.179 0.895 . . . . 0.0 113.175 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -64.2 -44.56 91.57 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.726 -0.867 . . . . 0.0 111.271 172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -42.98 87.84 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.287 0.949 . . . . 0.0 112.435 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.43 79.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.717 0.807 . . . . 0.0 112.281 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -55.86 -48.14 76.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.386 1.074 . . . . 0.0 112.164 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.77 -39.34 77.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.174 0.989 . . . . 0.0 113.519 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.79 2.97 27.6 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 57.22 32.54 21.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.502 1.921 . . . . 0.0 113.811 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.97 146.27 28.59 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.817 1.647 . . . . 0.0 112.332 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -100.48 9.58 42.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.696 1.598 . . . . 0.0 113.492 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.51 136.22 44.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.831 -1.168 . . . . 0.0 111.304 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.72 131.09 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.029 0.932 . . . . 0.0 109.732 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.87 165.93 14.12 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 125.936 1.694 . . . . 0.0 111.807 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -46.13 -44.47 19.4 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.26 3.306 . . . . 0.0 115.586 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.776 0.83 . . . . 0.0 112.702 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.38 -44.5 95.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.848 0.859 . . . . 0.0 112.16 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.24 -42.07 96.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.92 0.888 . . . . 0.0 111.804 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.865 0.866 . . . . 0.0 111.788 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.03 -46.94 72.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.662 1.185 . . . . 0.0 112.064 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.96 -47.54 64.73 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 94.1 mt -65.46 -55.46 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.35 0.66 . . . . 0.0 110.944 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -54.95 -37.84 66.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.603 1.161 . . . . 0.0 113.506 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.87 0.43 54.96 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -125.02 127.16 46.55 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.752 1.16 . . . . 0.0 112.943 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -57.11 -51.35 69.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.021 0.929 . . . . 0.0 112.918 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -66.24 -34.12 77.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 112.2 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.28 -41.04 73.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.293 0.637 . . . . 0.0 112.575 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -58.88 -40.06 83.24 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.463 1.483 . . . . 0.0 111.88 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.69 -3.18 1.38 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.32 1.448 . . . . 0.0 114.879 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -76.15 -73.32 0.28 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.76 1.164 . . . . 0.0 110.147 167.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.35 -20.39 51.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.715 0.806 . . . . 0.0 112.873 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.24 -21.75 54.26 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 124.418 1.009 . . . . 0.0 114.66 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -87.99 2.42 51.79 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 66.4 t -77.42 109.21 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.169 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -79.64 114.0 18.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 109.734 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -79.39 118.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.775 0.83 . . . . 0.0 109.032 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 139.19 58.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.599 0.76 . . . . 0.0 111.686 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -64.71 117.4 7.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.484 0.714 . . . . 0.0 111.393 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.11 131.83 39.35 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.93 0.776 . . . . 0.0 112.145 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.17 171.46 39.49 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.204 0.907 . . . . 0.0 113.506 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 81.9 t -61.79 123.23 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.704 0.802 . . . . 0.0 110.241 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.72 157.26 49.47 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.598 1.159 . . . . 0.0 111.714 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.71 125.07 17.56 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.102 2.535 . . . . 0.0 112.852 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.7 140.32 42.4 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.463 0.705 . . . . 0.0 110.765 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.29 124.39 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.006 0.923 . . . . 0.0 110.237 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -97.79 154.89 17.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.859 1.264 . . . . 0.0 111.257 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.54 113.2 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.29 0.636 . . . . 0.0 111.879 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.66 -18.52 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.099 0.96 . . . . 0.0 113.132 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.21 114.0 6.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.061 1.344 . . . . 0.0 110.929 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 37.3 tp -64.61 127.9 92.91 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.143 0.977 . . . . 0.0 110.531 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.35 119.72 7.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.747 2.298 . . . . 0.0 112.09 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.05 138.05 40.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.047 0.939 . . . . 0.0 111.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.68 140.19 58.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.851 0.861 . . . . 0.0 111.496 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -73.33 150.95 41.48 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.068 0.947 . . . . 0.0 112.089 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -90.92 139.14 31.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 111.824 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -81.09 124.78 29.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.43 0.692 . . . . 0.0 110.827 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -108.97 6.37 25.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.73 1.212 . . . . 0.0 113.058 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -66.91 -31.5 72.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.848 1.259 . . . . 0.0 112.274 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.56 156.77 16.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.905 1.682 . . . . 0.0 111.791 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.68 -36.74 83.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.095 0.958 . . . . 0.0 113.363 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -66.76 124.34 22.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 111.769 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.66 24.88 21.46 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 125.448 1.499 . . . . 0.0 115.437 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 125.761 1.624 . . . . 0.0 112.418 -176.636 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 CA-C-O 118.753 -1.026 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -65.84 166.9 18.92 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.152 3.235 . . . . 0.0 113.86 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 64.91 -155.81 48.04 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.833 1.206 . . . . 0.0 113.866 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 99.8 mmm -104.97 140.17 20.81 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.572 1.149 . . . . 0.0 111.457 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -61.86 139.12 78.12 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.877 2.385 . . . . 0.0 111.533 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -69.67 135.46 88.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.561 -0.712 . . . . 0.0 111.216 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.58 117.92 4.94 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.098 2.532 . . . . 0.0 111.57 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.7 123.84 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.641 0.776 . . . . 0.0 111.13 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.44 135.24 55.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.36 0.664 . . . . 0.0 110.492 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 51.3 p -63.53 151.36 41.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.247 0.619 . . . . 0.0 111.645 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.73 132.7 89.04 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.734 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -58.65 139.01 88.96 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.736 2.29 . . . . 0.0 111.248 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 133.88 83.0 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.122 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -59.95 152.1 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.857 2.371 . . . . 0.0 111.538 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.44 105.61 1.21 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 110.479 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -78.57 144.88 35.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.182 0.993 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.46 62.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.126 0.87 . . . . 0.0 114.888 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -68.98 132.74 47.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 111.705 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.93 145.66 54.34 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.199 1.0 . . . . 0.0 110.652 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.94 117.88 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.468 0.707 . . . . 0.0 110.443 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 141.82 58.01 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.379 0.672 . . . . 0.0 111.67 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.93 109.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 36.4 m -71.42 102.8 2.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.744 0.818 . . . . 0.0 110.194 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.8 144.43 56.31 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.254 1.022 . . . . 0.0 111.29 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.6 120.63 10.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.397 0.679 . . . . 0.0 111.303 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.62 144.13 26.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.158 0.983 . . . . 0.0 111.521 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -67.19 136.33 54.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.388 0.675 . . . . 0.0 111.026 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -74.18 -26.27 60.19 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.898 0.879 . . . . 0.0 112.555 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.25 129.1 40.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.249 1.02 . . . . 0.0 112.009 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.71 -179.79 28.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.021 0.82 . . . . 0.0 113.756 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.49 141.32 43.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.831 . . . . 0.0 111.179 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.22 125.18 21.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.092 0.957 . . . . 0.0 110.32 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.85 95.51 3.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.584 0.754 . . . . 0.0 110.654 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.62 136.59 57.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.352 1.061 . . . . 0.0 109.959 168.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -67.29 126.42 29.2 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.056 0.542 . . . . 0.0 110.353 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 47.7 p -65.76 151.16 47.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.607 0.763 . . . . 0.0 111.404 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -64.73 119.14 10.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.419 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -87.77 150.43 23.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.729 1.212 . . . . 0.0 111.064 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -83.12 146.23 28.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.502 0.721 . . . . 0.0 110.629 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 2.5 p -150.95 161.09 43.38 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -153.61 -179.1 7.48 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.079 -1.013 . . . . 0.0 113.709 -122.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 96.9 p -71.9 -27.7 63.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 121.15 1.795 . . . . 0.0 114.092 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.56 -45.47 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 121.348 -0.845 . . . . 0.0 109.867 160.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -98.96 34.16 2.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.801 2.04 . . . . 0.0 114.378 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.7 -48.43 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.069 -1.645 . . . . 0.0 110.711 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -62.31 -29.95 70.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.541 0.736 . . . . 0.0 112.573 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.04 -50.04 72.23 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.337 0.971 . . . . 0.0 111.568 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -52.47 -52.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 119.524 1.056 . . . . 0.0 110.202 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.94 -52.59 64.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.89 0.876 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.38 -35.02 73.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.779 1.232 . . . . 0.0 114.001 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.5 -42.03 59.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.272 0.942 . . . . 0.0 112.812 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -87.09 -61.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.318 1.047 . . . . 0.0 112.231 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -137.23 91.43 14.57 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.683 1.593 . . . . 0.0 110.57 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -56.36 -29.24 76.26 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.814 3.009 . . . . 0.0 115.173 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -84.35 -1.78 56.02 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.479 1.912 . . . . 0.0 113.951 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -111.28 137.63 48.77 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.259 1.424 . . . . 0.0 111.848 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.84 14.18 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.954 1.74 . . . . 0.0 113.233 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.64 141.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 110.207 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -73.99 155.79 38.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.653 -0.655 . . . . 0.0 112.72 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p -57.32 -37.24 72.21 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.288 -0.882 . . . . 0.0 112.005 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.34 -47.48 85.71 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.948 1.299 . . . . 0.0 111.998 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.32 94.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.832 0.853 . . . . 0.0 112.933 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.76 -39.09 87.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.473 1.033 . . . . 0.0 111.896 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -44.46 76.9 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.247 0.927 . . . . 0.0 113.167 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -68.58 -35.1 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.315 1.058 . . . . 0.0 112.531 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 38.3 tpp -57.95 -41.14 82.21 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.65 -1.282 . . . . 0.0 111.284 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -65.83 -35.34 80.41 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.045 -1.034 . . . . 0.0 112.216 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 47.7 m -58.55 -39.4 80.14 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.27 -1.519 . . . . 0.0 112.19 167.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.94 -33.51 76.2 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.628 -1.295 . . . . 0.0 113.134 172.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . 0.444 ' HA ' ' CD2' ' D' ' 70' ' ' PHE . 47.0 t -57.96 -52.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.45 1.023 . . . . 0.0 110.935 165.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -64.92 -32.46 74.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.856 0.863 . . . . 0.0 113.249 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.1 -63.82 1.22 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.219 1.408 . . . . 0.0 113.505 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 81.2 mt -68.15 -51.8 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.155 0.982 . . . . 0.0 111.196 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' D' ' 66' ' ' VAL . 9.1 m-30 -66.85 -35.98 81.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.547 -0.721 . . . . 0.0 111.051 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.12 -47.64 84.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.171 0.988 . . . . 0.0 112.62 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.28 -46.69 85.57 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.133 -0.98 . . . . 0.0 112.113 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.01 -44.15 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 118.762 0.71 . . . . 0.0 111.368 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.48 84.55 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.302 0.956 . . . . 0.0 112.392 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.17 -47.15 91.12 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.429 1.014 . . . . 0.0 113.547 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -64.83 -45.17 87.3 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.478 -1.013 . . . . 0.0 112.607 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.25 83.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.215 173.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -60.17 -53.12 61.5 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.254 1.022 . . . . 0.0 111.639 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -57.37 -42.06 81.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.33 -0.857 . . . . 0.0 112.811 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.86 -46.0 90.68 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.692 1.197 . . . . 0.0 112.012 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.98 96.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.91 0.884 . . . . 0.0 112.427 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -60.91 -40.66 94.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.387 1.075 . . . . 0.0 112.839 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -57.6 -37.96 74.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.615 0.766 . . . . 0.0 112.135 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -86.43 15.7 5.2 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.204 1.402 . . . . 0.0 113.737 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 52.25 28.05 5.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.466 2.306 . . . . 0.0 115.121 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -71.76 156.71 39.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.429 1.091 . . . . 0.0 112.805 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 63.7 p -80.52 -29.44 37.22 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.713 1.205 . . . . 0.0 113.068 165.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 5.7 t -141.96 168.73 19.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.578 1.551 . . . . 0.0 113.048 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.18 107.05 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 19.2 p -88.75 169.28 11.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.332 1.053 . . . . 0.0 112.277 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 46.3 p -52.99 -36.95 60.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.209 -0.932 . . . . 0.0 112.946 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.43 -42.9 67.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.683 1.193 . . . . 0.0 112.267 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -61.8 -42.56 99.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.476 0.58 . . . . 0.0 111.736 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.94 -50.58 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.613 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -49.12 -53.69 19.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.829 1.195 . . . . 0.0 111.296 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 55.9 m -59.77 -43.26 94.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.616 -0.677 . . . . 0.0 111.968 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.68 75.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.461 1.028 . . . . 0.0 112.324 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -35.33 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.549 -1.345 . . . . 0.0 112.415 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.04 -21.47 64.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.777 1.171 . . . . 0.0 113.388 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.82 -43.14 22.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.357 1.063 . . . . 0.0 111.93 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.82 -25.99 66.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 83.6 mt -121.18 90.95 47.81 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.033 2.133 . . . . 0.0 110.813 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -66.79 -27.63 44.08 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.717 2.945 . . . . 0.0 115.327 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.72 129.25 44.28 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.294 0.949 . . . . 0.0 113.57 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -61.64 -38.0 86.08 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.147 -1.207 . . . . 0.0 113.298 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.76 -39.1 93.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.646 0.778 . . . . 0.0 111.84 173.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.37 77.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.729 0.812 . . . . 0.0 111.721 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.17 -45.5 75.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.072 -1.018 . . . . 0.0 112.096 171.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.11 -48.77 77.81 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 112.149 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.62 71.18 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -65.42 -43.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.093 -1.005 . . . . 0.0 112.076 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.3 m -61.48 -39.43 90.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.386 0.994 . . . . 0.0 112.597 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.83 -34.77 76.55 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.063 -1.023 . . . . 0.0 111.727 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.91 70.38 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.189 1.376 . . . . 0.0 114.324 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 8.1 m -60.56 -35.02 75.04 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.601 1.201 . . . . 0.0 112.047 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -71.53 -44.34 64.79 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.461 -0.774 . . . . 0.0 111.247 169.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.97 74.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.41 1.084 . . . . 0.0 112.981 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.02 -39.29 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.751 1.16 . . . . 0.0 112.767 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 85.6 m -60.42 -43.55 96.64 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.701 0.682 . . . . 0.0 111.612 170.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.88 -44.61 91.18 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.315 0.961 . . . . 0.0 112.074 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -57.99 -40.14 79.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.554 0.742 . . . . 0.0 112.536 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -80.74 -33.88 34.8 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 54.4 p -78.5 -19.52 52.84 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.35 139.96 18.22 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 0.0 113.609 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.255 1.347 0 C-N-CA 125.627 1.571 . . . . 0.0 112.806 -179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.66 148.05 46.54 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.376 3.384 . . . . 0.0 114.731 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 79.27 -9.9 38.22 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.216 1.389 . . . . 0.0 115.828 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.6 mmm -88.58 147.08 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.013 1.407 . . . . 0.0 111.185 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 12.7 t -76.21 118.01 18.5 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.448 0.699 . . . . 0.0 112.348 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.43 153.58 51.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.078 1.323 . . . . 0.0 114.039 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.41 132.27 50.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.33 1.052 . . . . 0.0 111.907 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.32 155.87 50.92 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.63 1.109 . . . . 0.0 113.68 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.1 -39.63 90.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.151 0.981 . . . . 0.0 112.437 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -67.41 117.84 9.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.489 1.115 . . . . 0.0 110.772 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.33 -162.05 15.71 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.464 1.03 . . . . 0.0 114.224 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.99 -153.32 3.56 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.436 1.017 . . . . 0.0 113.642 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.23 122.2 11.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.768 1.227 . . . . 0.0 111.022 172.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 133.32 50.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.381 0.672 . . . . 0.0 110.835 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -72.73 101.03 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 0.0 110.833 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.44 143.71 56.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.586 0.754 . . . . 0.0 110.774 167.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.46 117.28 5.07 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 0.0 110.048 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.92 140.9 56.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.567 0.747 . . . . 0.0 111.243 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.14 110.42 1.21 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 110.839 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 40.3 p -72.27 153.47 41.52 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.544 1.137 . . . . 0.0 111.224 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -66.02 113.83 4.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.673 -0.642 . . . . 0.0 110.299 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 51.0 p -72.61 -34.69 67.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.618 1.167 . . . . 0.0 112.807 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.4 131.31 50.6 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 111.668 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -60.91 133.34 56.0 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.934 1.294 . . . . 0.0 112.097 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.82 57.0 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.955 0.902 . . . . 0.0 112.737 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 -167.16 36.16 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.314 0.959 . . . . 0.0 113.604 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.75 139.42 53.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.396 1.078 . . . . 0.0 112.631 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -106.81 137.5 44.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 110.542 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.12 157.74 73.19 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.024 1.33 . . . . 0.0 112.005 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -54.37 -34.96 82.9 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.795 2.997 . . . . 0.0 114.61 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.0 m -54.64 -30.89 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.66 -24.93 60.44 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.544 1.545 . . . . 0.0 114.747 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -96.77 -42.8 7.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.57 1.548 . . . . 0.0 111.557 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.38 -42.66 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.019 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.07 -37.13 78.96 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.693 1.588 . . . . 0.0 112.953 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.08 -45.89 75.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.46 1.104 . . . . 0.0 111.597 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.32 -40.76 82.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.051 0.941 . . . . 0.0 112.374 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.06 -42.63 98.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.838 0.855 . . . . 0.0 112.266 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -61.86 -51.61 67.5 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.049 -1.032 . . . . 0.0 111.411 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -55.07 -42.4 72.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.921 1.288 . . . . 0.0 112.669 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.48 6.13 8.98 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.116 1.817 . . . . 0.0 116.179 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 57.88 30.33 18.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.601 1.961 . . . . 0.0 114.728 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -68.13 -49.45 61.01 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.257 -0.902 . . . . 0.0 111.028 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 90.8 p -145.24 159.19 43.39 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 163.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -52.09 -45.29 64.76 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.206 1.802 . . . . 0.0 113.03 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -137.14 131.52 32.71 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.62 1.568 . . . . 0.0 110.222 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.42 121.91 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.983 1.313 . . . . 0.0 109.547 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.68 152.25 42.42 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.003 0.811 . . . . 0.0 112.731 171.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.24 -31.84 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.305 -1.115 . . . . 0.0 113.46 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.45 -22.35 77.71 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.659 1.123 . . . . 0.0 115.27 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.31 -54.2 58.26 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 119.653 1.727 . . . . 0.0 113.672 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -56.74 -31.4 87.87 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.022 1.815 . . . . 0.0 113.761 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.4 -46.78 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.821 1.191 . . . . 0.0 111.109 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -67.76 -38.75 83.84 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.18 -0.95 . . . . 0.0 113.096 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.66 -42.6 97.33 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.684 -1.26 . . . . 0.0 111.349 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.57 71.51 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.295 -0.878 . . . . 0.0 112.736 169.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.49 75.99 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 120.239 1.381 . . . . 0.0 113.498 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.99 -47.56 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.882 -1.136 . . . . 0.0 109.731 168.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.22 -39.43 86.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.689 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -52.85 -47.24 67.9 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.704 1.593 . . . . 0.0 112.595 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -57.91 -43.77 86.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.675 -0.64 . . . . 0.0 111.925 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.2 -34.4 70.83 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.969 -1.082 . . . . 0.0 112.877 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 88.7 m -53.65 -49.54 67.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.904 1.281 . . . . 0.0 110.071 164.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.38 82.91 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.196 0.907 . . . . 0.0 112.941 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.32 -43.26 91.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.751 1.16 . . . . 0.0 113.389 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.27 -43.62 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.781 -1.2 . . . . 0.0 110.137 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.06 -30.53 71.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.023 0.929 . . . . 0.0 113.331 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -63.59 -49.13 74.55 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.004 1.275 . . . . 0.0 111.384 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.06 -46.69 82.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.752 0.821 . . . . 0.0 111.253 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.95 78.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.969 0.908 . . . . 0.0 113.138 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -45.78 95.18 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.995 1.283 . . . . 0.0 112.765 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.89 -43.92 97.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.331 1.066 . . . . 0.0 111.423 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.47 75.99 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.573 -0.705 . . . . 0.0 112.845 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -45.63 82.43 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.158 -0.964 . . . . 0.0 112.336 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.25 -42.76 73.88 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.213 1.405 . . . . 0.0 112.982 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -57.16 -22.97 44.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -106.65 4.81 28.29 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.677 1.591 . . . . 0.0 112.838 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.18 31.73 14.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.965 2.106 . . . . 0.0 114.191 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.24 156.22 17.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.19 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.4 p -114.51 15.87 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.494 1.918 . . . . 0.0 112.961 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -133.61 129.43 36.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.098 1.359 . . . . 0.0 110.745 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -73.99 124.35 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 109.837 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 pt -126.0 169.94 10.56 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.788 1.635 . . . . 0.0 111.053 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.66 -34.34 83.23 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.191 2.594 . . . . 0.0 114.703 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.14 -24.57 67.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -81.79 -38.27 25.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.108 0.963 . . . . 0.0 111.865 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.73 0.696 . . . . 0.0 112.555 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -57.09 -57.75 11.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.166 -0.959 . . . . 0.0 111.159 166.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.01 -43.55 91.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.941 0.896 . . . . 0.0 112.72 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.43 45.11 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 15.5 mt -113.96 -63.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.884 1.274 . . . . 0.0 110.278 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.97 -27.87 69.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -99.94 0.78 41.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.763 1.225 . . . . 0.0 113.018 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.65 114.15 26.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.435 1.016 . . . . 0.0 110.417 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -49.61 -43.52 46.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.461 1.504 . . . . 0.0 113.093 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.788 0.835 . . . . 0.0 112.157 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.89 -17.63 61.5 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.21 -0.9 . . . . 0.0 112.484 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.39 -34.69 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.286 1.403 . . . . 0.0 112.591 165.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.54 -30.24 65.67 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.121 -0.987 . . . . 0.0 112.882 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 66.9 tp -92.7 -52.27 4.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 33.0 mt -114.5 -161.02 0.75 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.32 1.848 . . . . 0.0 110.534 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.39 -122.79 29.29 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.187 -0.945 . . . . 0.0 112.225 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -109.41 118.58 37.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.609 1.163 . . . . 0.0 109.065 162.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.68 127.04 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.572 0.749 . . . . 0.0 110.085 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 26.8 m -65.76 110.06 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.64 0.776 . . . . 0.0 110.838 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.08 116.68 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.32 5.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.333 0.653 . . . . 0.0 111.001 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.56 142.47 50.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.813 0.845 . . . . 0.0 111.445 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.52 105.17 0.9 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.338 0.97 . . . . 0.0 113.398 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.75 43.79 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.713 1.149 . . . . 0.0 112.505 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.75 106.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.971 0.908 . . . . 0.0 110.061 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.09 147.61 88.33 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.192 0.997 . . . . 0.0 111.001 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -61.35 117.0 3.77 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.636 2.224 . . . . 0.0 110.737 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.54 130.61 40.44 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.752 -0.592 . . . . 0.0 111.097 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 80.2 mt -77.98 124.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.0 113.22 4.83 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.043 -0.411 . . . . 0.0 109.966 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.09 128.08 34.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.276 0.63 . . . . 0.0 110.81 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.68 116.31 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -66.2 110.77 3.13 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.644 . . . . 0.0 109.366 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.07 123.33 83.66 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.563 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.68 138.73 71.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.763 2.309 . . . . 0.0 111.676 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.62 113.93 2.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.516 0.726 . . . . 0.0 109.466 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.7 117.64 15.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.627 0.771 . . . . 0.0 110.502 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 86.8 m -107.25 108.22 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.756 1.222 . . . . 0.0 108.354 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -65.93 127.33 31.64 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.149 0.58 . . . . 0.0 110.858 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 18.4 p -71.27 138.18 49.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.861 0.865 . . . . 0.0 113.063 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.42 -29.35 47.09 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.977 0.911 . . . . 0.0 112.333 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -64.97 130.98 45.37 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.009 1.323 . . . . 0.0 111.43 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.21 148.89 48.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.239 1.016 . . . . 0.0 113.057 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.16 143.66 48.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.084 0.953 . . . . 0.0 112.724 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 122.32 15.94 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.621 1.168 . . . . 0.0 112.182 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.85 135.39 30.41 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.469 1.033 . . . . 0.0 112.902 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.908 1.283 . . . . 0.0 112.172 176.162 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -59.64 139.26 88.09 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.093 3.195 . . . . 0.0 113.088 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -64.58 147.9 51.05 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.981 0.801 . . . . 0.0 112.487 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.08 145.49 84.95 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.708 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -55.61 139.88 83.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.241 2.627 . . . . 0.0 113.393 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -56.38 130.95 76.11 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.244 1.018 . . . . 0.0 111.799 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.77 156.39 66.15 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.2 56.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.476 1.111 . . . . 0.0 113.9 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.74 -20.12 61.94 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.407 1.483 . . . . 0.0 114.2 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -72.26 144.2 48.49 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.173 0.989 . . . . 0.0 112.183 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.34 98.25 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 123.564 0.745 . . . . 0.0 112.675 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.01 -16.49 32.29 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.549 2.833 . . . . 0.0 114.054 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.23 140.41 78.65 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.592 1.157 . . . . 0.0 113.084 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -63.77 145.98 91.47 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.651 2.901 . . . . 0.0 113.166 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.29 148.1 45.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 0.0 111.748 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.56 143.91 54.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.307 1.043 . . . . 0.0 112.424 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.64 -20.23 79.5 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.518 1.056 . . . . 0.0 114.75 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -70.99 158.36 36.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.373 1.469 . . . . 0.0 113.818 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.52 143.69 55.54 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.477 1.111 . . . . 0.0 111.589 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 137.65 58.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.795 0.838 . . . . 0.0 111.42 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.91 144.17 56.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.314 0.645 . . . . 0.0 111.643 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.47 117.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.262 0.625 . . . . 0.0 109.459 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -72.7 139.95 47.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.904 0.882 . . . . 0.0 112.178 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -80.81 138.8 36.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.051 0.941 . . . . 0.0 110.908 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 131.94 47.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.022 0.529 . . . . 0.0 110.684 170.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -65.47 120.99 13.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.31 131.28 46.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.046 0.938 . . . . 0.0 110.971 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.73 133.7 55.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.265 1.026 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.37 145.49 52.88 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.169 1.388 . . . . 0.0 112.899 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.29 -133.28 3.82 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.542 1.067 . . . . 0.0 111.81 172.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.48 -40.34 82.44 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.615 0.766 . . . . 0.0 111.355 166.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.14 160.1 24.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.777 2.031 . . . . 0.0 111.256 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.13 156.72 16.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.505 1.522 . . . . 0.0 112.143 173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -80.96 72.07 7.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.208 1.403 . . . . 0.0 111.637 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.25 -38.74 84.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.483 1.513 . . . . 0.0 113.027 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 8.4 t -121.63 162.19 21.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.352 1.461 . . . . 0.0 111.913 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -66.21 150.79 48.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.537 1.535 . . . . 0.0 113.163 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -111.13 12.71 21.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.09 1.756 . . . . 0.0 112.983 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -76.38 -23.65 54.11 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.178 1.391 . . . . 0.0 112.891 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 16.2 p -71.55 148.02 47.1 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.952 1.701 . . . . 0.0 113.933 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.97 -28.39 64.42 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.3 1.04 . . . . 0.0 113.502 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 77.5 p -43.44 -39.46 3.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.842 2.057 . . . . 0.0 114.767 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.62 -26.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.991 1.717 . . . . 0.0 114.281 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -51.8 -37.09 50.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.454 1.101 . . . . 0.0 112.874 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.54 -40.85 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 120.902 -1.124 . . . . 0.0 111.254 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -67.32 -41.85 84.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.189 -0.945 . . . . 0.0 112.165 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -54.7 -37.75 66.19 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.063 0.847 . . . . 0.0 112.43 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.03 -48.79 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.464 0.706 . . . . 0.0 111.896 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 34.4 tp -50.67 -42.95 57.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.634 1.106 . . . . 0.0 112.72 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.51 -24.78 22.07 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -72.2 -32.0 66.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.314 1.045 . . . . 0.0 112.662 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.83 -41.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.7 1.2 . . . . 0.0 113.536 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -135.45 70.73 67.03 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.47 1.508 . . . . 0.0 110.692 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -58.06 -23.09 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.611 2.874 . . . . 0.0 113.974 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -77.46 -6.51 53.75 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.656 1.982 . . . . 0.0 113.963 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 98.8 m -115.37 129.77 56.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.271 1.428 . . . . 0.0 111.34 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.09 175.15 41.2 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.974 1.273 . . . . 0.0 113.423 172.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.83 140.65 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.167 -1.196 . . . . 0.0 110.923 171.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 34.4 p -73.2 154.5 40.24 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 38.6 p -54.68 -44.02 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.025 0.93 . . . . 0.0 112.291 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.82 -46.9 87.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.792 1.237 . . . . 0.0 112.155 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.28 89.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.354 0.661 . . . . 0.0 112.263 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 74.8 mtm -60.78 -40.89 94.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.08 -1.012 . . . . 0.0 112.449 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.18 -42.17 97.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.665 1.126 . . . . 0.0 113.899 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.01 -51.84 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.25 1.02 . . . . 0.0 110.073 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 46.3 mtp -61.29 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -50.66 -50.62 54.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.501 1.5 . . . . 0.0 112.339 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -59.37 -55.8 30.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.634 0.774 . . . . 0.0 111.519 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -61.71 -43.89 97.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.61 -51.18 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.391 0.996 . . . . 0.0 110.908 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -62.02 -40.92 97.33 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.739 0.7 . . . . 0.0 111.569 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -56.54 -28.89 61.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.8 mt -49.75 -57.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.36 1.437 . . . . 0.0 109.917 172.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.8 -52.91 38.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 0.0 111.335 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -54.73 -35.49 63.75 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.79 -53.19 5.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.352 1.061 . . . . 0.0 112.1 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.76 -58.58 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 120.263 1.392 . . . . 0.0 111.386 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.41 62.93 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.481 -0.762 . . . . 0.0 112.106 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.0 -47.91 88.71 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 118.9 0.773 . . . . 0.0 113.164 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.16 -39.86 93.55 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.197 -1.179 . . . . 0.0 112.214 172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.57 78.79 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.045 -1.034 . . . . 0.0 112.222 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -60.63 -50.6 72.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.063 0.945 . . . . 0.0 111.271 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -51.09 -48.99 61.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.11 0.868 . . . . 0.0 111.946 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.01 -48.67 75.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.577 0.751 . . . . 0.0 111.773 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.73 73.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.741 0.816 . . . . 0.0 112.916 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -58.48 -52.18 66.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.432 1.015 . . . . 0.0 111.467 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -60.95 -35.07 75.78 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -82.57 5.41 21.01 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.817 1.247 . . . . 0.0 113.769 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 56.19 34.3 23.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.998 2.119 . . . . 0.0 114.328 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -101.13 142.71 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.725 1.61 . . . . 0.0 112.626 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 48.4 p -83.73 -22.27 32.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.467 1.507 . . . . 0.0 113.498 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 40.1 m -126.22 128.98 48.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.508 1.523 . . . . 0.0 111.41 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.92 130.62 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.17 1.388 . . . . 0.0 110.737 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.1 p -84.33 160.19 20.74 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 41.3 p -55.34 -38.8 69.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.068 -1.02 . . . . 0.0 112.433 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.32 -43.59 90.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.686 1.194 . . . . 0.0 112.287 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -62.11 -41.86 98.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.498 0.719 . . . . 0.0 112.305 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.64 -54.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.517 0.599 . . . . 0.0 109.864 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -55.31 -42.1 73.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.246 0.93 . . . . 0.0 112.818 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 89.4 m -62.34 -50.31 72.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.397 1.079 . . . . 0.0 111.707 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.28 84.32 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.561 1.073 . . . . 0.0 112.691 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.49 -56.05 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.504 1.122 . . . . 0.0 110.264 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -57.44 -41.91 81.39 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.789 1.177 . . . . 0.0 113.405 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.54 -45.37 91.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 112.418 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -89.54 -23.36 22.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.07 80.15 73.22 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 127.139 2.176 . . . . 0.0 110.813 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -62.55 -25.11 75.5 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.887 2.391 . . . . 0.0 115.368 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.03 135.49 22.92 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.061 1.791 . . . . 0.0 114.796 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -56.13 -49.66 73.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.174 1.39 . . . . 0.0 113.149 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 tp -55.57 -47.51 76.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.974 0.91 . . . . 0.0 111.925 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.74 -47.7 58.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 112.406 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -60.93 -42.49 98.28 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.239 0.927 . . . . 0.0 111.76 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -57.0 -47.77 80.05 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.407 1.083 . . . . 0.0 111.905 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.73 72.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.833 0.742 . . . . 0.0 112.474 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.63 -52.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 72.0 m -56.61 -44.45 81.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.21 -48.86 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.233 0.924 . . . . 0.0 111.624 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.9 -46.19 69.07 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.73 0.681 . . . . 0.0 112.841 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.6 m -60.66 -57.63 11.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.08 0.952 . . . . 0.0 111.515 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.66 -42.51 75.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.964 1.306 . . . . 0.0 113.118 -177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -52.44 64.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.63 0.772 . . . . 0.0 111.481 172.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.35 -31.88 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 31.0 m -56.68 -27.15 58.23 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.318 1.417 . . . . 0.0 112.851 171.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -83.17 -5.21 59.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -111.42 -30.43 7.4 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 113.015 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p -56.18 -21.92 25.88 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 50.7 p -67.19 -19.76 65.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.697 1.599 . . . . 0.0 114.535 172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.18 179.35 7.69 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.978 1.311 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.975 1.71 . . . . 0.0 112.031 -177.79 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.044 0 CA-C-O 118.668 -1.073 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -59.13 129.45 31.75 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.398 2.732 . . . . 0.0 113.19 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 72.39 4.5 60.66 Favored Glycine 0 CA--C 1.539 1.594 0 N-CA-C 116.204 1.241 . . . . 0.0 116.204 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 13.9 tpt -85.85 115.98 23.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.513 1.657 . . . . 0.0 110.551 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p -85.62 163.12 18.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.532 1.133 . . . . 0.0 113.36 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.67 169.81 41.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.354 0.978 . . . . 0.0 113.915 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.22 -40.61 36.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.596 1.158 . . . . 0.0 112.01 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.54 -178.05 19.6 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.637 1.113 . . . . 0.0 113.514 164.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.88 135.44 55.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.43 1.092 . . . . 0.0 111.861 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -72.25 138.91 47.8 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.845 0.858 . . . . 0.0 111.406 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.2 146.2 20.51 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.047 0.832 . . . . 0.0 112.19 -167.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.78 -23.86 2.44 Favored Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.272 1.415 . . . . 0.0 115.445 -172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.09 134.61 48.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.885 1.274 . . . . 0.0 111.378 170.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.49 134.62 46.66 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.039 0.935 . . . . 0.0 111.853 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -79.14 127.58 32.2 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.547 0.739 . . . . 0.0 110.963 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.89 128.66 37.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.552 0.741 . . . . 0.0 111.594 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.06 143.24 47.52 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.913 0.885 . . . . 0.0 110.895 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.98 126.86 29.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.33 0.652 . . . . 0.0 111.5 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.02 136.82 55.87 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.82 0.848 . . . . 0.0 111.197 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 39.0 p -70.09 150.89 46.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.724 0.81 . . . . 0.0 111.596 171.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -65.04 137.06 57.46 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.631 -0.668 . . . . 0.0 111.179 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 21.0 t -63.1 136.94 58.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 111.535 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.0 t -66.63 116.56 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.139 0.576 . . . . 0.0 110.502 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.87 131.24 48.11 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.892 0.877 . . . . 0.0 111.025 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 131.6 51.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.593 0.757 . . . . 0.0 111.987 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 122.42 29.7 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.028 0.823 . . . . 0.0 112.153 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.57 148.48 30.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.706 0.802 . . . . 0.0 112.455 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -89.19 143.99 26.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.019 0.928 . . . . 0.0 110.139 163.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.85 70.83 29.05 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.82 0.848 . . . . 0.0 112.889 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.95 -43.51 57.49 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.829 2.352 . . . . 0.0 112.844 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.34 -47.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.666 1.186 . . . . 0.0 111.098 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.77 80.4 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.319 0.962 . . . . 0.0 113.79 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -65.68 -38.23 88.7 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.088 -1.242 . . . . 0.0 112.434 173.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.05 -40.85 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 118.815 0.734 . . . . 0.0 111.566 170.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -56.24 -52.1 65.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.653 1.115 . . . . 0.0 111.295 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -55.33 -49.49 72.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.505 1.122 . . . . 0.0 112.359 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -50.31 -52.82 33.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.589 1.155 . . . . 0.0 111.832 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.85 -41.02 92.23 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.655 0.782 . . . . 0.0 112.712 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -61.61 -52.28 65.02 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.398 1.479 . . . . 0.0 111.81 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.58 -41.26 80.76 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.961 1.305 . . . . 0.0 112.58 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.64 -8.72 57.27 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.677 1.132 . . . . 0.0 115.825 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 53.23 31.82 12.3 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 113.884 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -67.57 -31.86 72.22 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.2 t -131.05 164.38 25.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.538 1.135 . . . . 0.0 112.716 170.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -74.28 -39.0 63.25 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.239 1.015 . . . . 0.0 111.677 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -133.25 119.7 20.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.793 1.237 . . . . 0.0 110.429 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.12 119.46 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.617 1.567 . . . . 0.0 109.159 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.82 -165.18 10.28 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.502 1.525 . . . . 0.0 111.022 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.99 -30.21 24.06 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.44 -36.25 88.45 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.468 1.033 . . . . 0.0 115.361 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.74 -55.81 21.26 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.475 1.137 . . . . 0.0 113.943 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.04 -33.69 49.82 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 112.876 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.26 -37.71 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 120.569 1.531 . . . . 0.0 113.027 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -53.71 -53.58 50.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.972 0.805 . . . . 0.0 111.017 168.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.76 -50.9 69.17 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.401 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.66 61.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.904 1.229 . . . . 0.0 113.289 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.22 -46.03 65.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.133 0.973 . . . . 0.0 112.211 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.27 -56.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.4 1.08 . . . . 0.0 111.784 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.43 -46.63 82.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.336 1.455 . . . . 0.0 113.029 -172.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -58.27 -46.43 86.03 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.513 1.051 . . . . 0.0 110.762 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -62.64 -51.93 65.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.391 0.676 . . . . 0.0 112.555 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.2 -42.04 89.96 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.235 -0.915 . . . . 0.0 111.995 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -53.64 -51.8 61.95 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.095 . . . . 0.0 110.776 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.81 95.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.756 0.822 . . . . 0.0 113.167 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -60.68 -47.73 84.93 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.467 1.03 . . . . 0.0 112.864 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.1 -50.58 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.45 0.7 . . . . 0.0 109.951 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.63 -37.84 79.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.186 0.994 . . . . 0.0 113.207 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.93 -55.4 29.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.55 1.068 . . . . 0.0 111.615 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.51 -47.15 82.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.687 1.195 . . . . 0.0 111.707 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.47 92.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 0.0 112.453 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.98 98.04 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.321 -0.862 . . . . 0.0 113.202 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.35 -44.67 96.79 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.803 1.301 . . . . 0.0 110.937 172.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.29 89.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.411 -0.805 . . . . 0.0 112.668 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.35 89.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.173 -0.954 . . . . 0.0 112.547 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -57.59 -47.06 83.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.044 0.937 . . . . 0.0 112.024 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.22 -41.67 79.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -86.31 10.12 15.8 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 53.76 30.12 10.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.791 2.036 . . . . 0.0 114.564 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.2 144.99 28.59 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.194 1.398 . . . . 0.0 112.165 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -76.92 -26.21 53.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.698 1.199 . . . . 0.0 112.764 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -128.99 151.66 49.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.433 1.493 . . . . 0.0 112.531 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.4 131.13 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.602 1.161 . . . . 0.0 110.264 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.82 149.62 36.34 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.57 1.948 . . . . 0.0 109.544 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -48.32 -40.55 35.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.713 2.942 . . . . 0.0 114.964 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -60.19 -38.86 84.55 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.284 1.034 . . . . 0.0 113.062 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -61.91 -42.23 98.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.669 0.788 . . . . 0.0 112.175 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 84.6 mt -62.77 -46.08 89.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 111.936 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.68 -50.47 72.03 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.808 0.843 . . . . 0.0 111.82 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 84.3 mt -57.08 -50.6 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.421 -0.8 . . . . 0.0 111.871 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.11 64.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.161 0.984 . . . . 0.0 112.84 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 tt -68.65 -35.76 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 118.479 0.581 . . . . 0.0 112.533 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.362 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -66.06 -37.84 86.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.781 0.832 . . . . 0.0 112.304 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.01 115.81 18.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.021 0.928 . . . . 0.0 112.669 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.73 -39.39 84.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.238 -0.914 . . . . 0.0 113.449 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -67.31 -39.35 85.88 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.158 -0.964 . . . . 0.0 111.766 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.28 -36.38 83.92 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.432 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.14 -37.16 84.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.81 1.641 . . . . 0.0 112.739 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.53 -39.1 91.4 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.343 -0.848 . . . . 0.0 112.224 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.54 -53.79 8.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 113.622 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.98 119.18 34.97 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 111.444 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.31 144.65 32.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.364 0.983 . . . . 0.0 112.614 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -78.03 155.09 30.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.129 0.972 . . . . 0.0 112.319 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.92 130.31 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.322 1.049 . . . . 0.0 110.371 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 30.4 m -65.33 114.49 4.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 0.0 110.607 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -79.64 123.78 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.802 0.841 . . . . 0.0 109.172 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.5 88.14 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.719 0.808 . . . . 0.0 112.605 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -63.26 126.5 27.61 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.257 1.023 . . . . 0.0 111.031 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.04 122.95 30.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.582 0.61 . . . . 0.0 112.8 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.77 -138.41 2.18 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.694 1.14 . . . . 0.0 112.608 171.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.45 127.67 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.843 -0.798 . . . . 0.0 109.62 167.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -58.43 119.96 40.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.315 1.046 . . . . 0.0 110.893 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -63.77 152.06 82.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.935 2.423 . . . . 0.0 112.526 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -62.46 149.09 43.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.005 172.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.81 115.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.601 0.76 . . . . 0.0 109.361 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -76.32 156.45 33.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.01 0.924 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.84 143.14 52.03 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.89 -12.64 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.03 131.77 47.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.892 1.277 . . . . 0.0 111.723 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.17 -34.95 0.58 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -57.65 129.23 32.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.723 2.282 . . . . 0.0 112.562 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -67.95 113.64 5.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.069 0.947 . . . . 0.0 111.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.31 -26.02 23.62 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.345 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 41.5 m -70.46 106.9 3.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 109.961 171.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -140.79 154.4 46.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.391 1.077 . . . . 0.0 113.067 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 53.0 m -67.76 147.86 52.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.844 0.858 . . . . 0.0 111.58 167.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -57.94 -46.69 84.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.44 0.696 . . . . 0.0 112.188 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.39 130.27 34.72 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.098 0.959 . . . . 0.0 110.218 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.86 131.04 37.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.636 . . . . 0.0 111.068 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.48 135.0 48.28 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.251 0.62 . . . . 0.0 110.89 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -73.46 107.27 5.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.805 0.842 . . . . 0.0 111.479 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.55 167.69 54.26 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.718 1.152 . . . . 0.0 113.566 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 124.785 1.234 . . . . 0.0 112.341 173.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 CA-C-O 119.22 -0.766 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -59.48 133.2 50.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.585 2.857 . . . . 0.0 112.36 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 68.59 9.43 58.62 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.714 1.149 . . . . 0.0 115.961 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 96.4 mmm -101.4 152.5 38.0 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.263 1.425 . . . . 0.0 111.034 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -57.3 144.8 90.11 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.241 . . . . 0.0 111.842 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -63.16 127.99 91.72 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 121.674 -0.642 . . . . 0.0 110.822 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -62.49 158.11 42.82 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.191 2.594 . . . . 0.0 112.815 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.05 120.21 12.75 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.722 -0.611 . . . . 0.0 111.272 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.69 155.71 20.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.848 1.659 . . . . 0.0 111.397 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -27.32 62.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.374 1.07 . . . . 0.0 113.499 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.4 133.68 88.39 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.282 1.033 . . . . 0.0 112.108 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.46 149.94 89.13 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.216 2.611 . . . . 0.0 112.394 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.19 96.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 119.022 -0.513 . . . . 0.0 110.926 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -61.43 142.95 97.1 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.9 2.4 . . . . 0.0 111.779 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.27 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.098 0.559 . . . . 0.0 110.213 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.47 126.45 25.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.963 0.905 . . . . 0.0 111.032 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.57 130.12 50.52 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.005 0.812 . . . . 0.0 112.045 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -61.35 142.31 57.0 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 112.347 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.56 132.89 54.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.58 0.752 . . . . 0.0 110.863 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.46 134.25 56.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.664 0.786 . . . . 0.0 110.377 172.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 129.46 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.871 0.468 . . . . 0.0 110.71 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.42 91.82 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -62.34 119.3 8.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.971 0.908 . . . . 0.0 109.386 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 114.76 4.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.612 0.765 . . . . 0.0 110.563 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.85 123.26 18.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.729 0.812 . . . . 0.0 111.289 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -86.81 140.04 30.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.84 133.88 54.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.121 0.569 . . . . 0.0 110.82 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.13 156.29 22.03 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.681 1.193 . . . . 0.0 112.183 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -57.29 127.79 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.141 0.496 . . . . 0.0 111.432 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.57 -2.95 70.36 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.1 -44.68 53.06 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.772 1.786 . . . . 0.0 111.566 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.65 143.8 45.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.607 1.163 . . . . 0.0 111.642 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -64.14 132.71 51.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.688 0.795 . . . . 0.0 109.919 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -71.6 102.68 2.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.208 1.003 . . . . 0.0 110.485 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -125.38 71.33 1.2 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.975 1.71 . . . . 0.0 111.202 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -62.6 132.24 51.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.602 0.761 . . . . 0.0 111.598 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -137.63 -166.98 2.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.913 1.685 . . . . 0.0 110.371 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.031 0.933 . . . . 0.0 111.927 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.01 121.87 11.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.769 1.628 . . . . 0.0 111.062 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -135.19 -104.83 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.558 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -70.73 -10.88 60.43 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.773 -1.204 . . . . 0.0 113.358 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -57.67 -38.53 75.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.206 1.802 . . . . 0.0 113.918 162.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -59.78 -44.23 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.283 1.033 . . . . 0.0 110.394 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -105.35 29.11 6.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.531 1.532 . . . . 0.0 112.882 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.55 -34.8 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.35 -45.09 92.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.698 1.199 . . . . 0.0 112.274 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.79 -35.36 80.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.144 0.978 . . . . 0.0 112.248 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.46 -50.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.476 0.58 . . . . 0.0 110.59 171.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.11 -38.21 82.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.406 -0.809 . . . . 0.0 112.776 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -51.62 -34.94 39.79 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.219 1.408 . . . . 0.0 113.379 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.67 -14.24 60.72 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.9 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.798 1.639 . . . . 0.0 111.36 -170.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.81 73.11 79.19 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.559 1.944 . . . . 0.0 110.073 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.26 -23.92 64.84 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.756 2.971 . . . . 0.0 114.743 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -79.17 -3.48 45.79 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.997 1.719 . . . . 0.0 113.894 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 43.2 m -119.42 140.06 51.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.842 1.657 . . . . 0.0 111.007 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.11 -166.22 25.82 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.533 1.063 . . . . 0.0 113.968 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.98 137.06 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.963 -1.316 . . . . 0.0 110.237 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.33 147.12 41.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.025 0.93 . . . . 0.0 112.777 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.9 p -56.96 -34.62 68.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.009 0.923 . . . . 0.0 112.756 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -75.67 -44.09 44.18 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.404 1.082 . . . . 0.0 111.762 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.2 -37.42 72.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.871 0.868 . . . . 0.0 113.3 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 64.5 ttp -52.43 -50.77 61.91 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.268 -0.895 . . . . 0.0 111.712 167.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.7 95.52 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.872 1.225 . . . . 0.0 114.066 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.63 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.379 1.09 . . . . 0.0 110.878 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 92.6 mmm -60.81 -40.03 91.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.363 0.983 . . . . 0.0 112.443 175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.64 -47.96 82.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.831 0.741 . . . . 0.0 111.781 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -56.27 -53.29 59.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.333 1.053 . . . . 0.0 111.996 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -53.17 -55.1 26.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.674 1.19 . . . . 0.0 112.218 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.46 -51.0 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.184 0.994 . . . . 0.0 110.83 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -60.61 -38.77 85.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.822 0.737 . . . . 0.0 112.378 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -64.83 -52.09 58.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.251 0.932 . . . . 0.0 113.257 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.02 -31.45 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.167 0.894 . . . . 0.0 113.103 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -47.6 -51.33 21.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.123 1.369 . . . . 0.0 111.781 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -59.51 -44.87 93.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.379 0.672 . . . . 0.0 112.017 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -67.01 -52.34 43.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.171 0.588 . . . . 0.0 111.523 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.35 -42.93 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.161 0.984 . . . . 0.0 111.278 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.34 91.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.78 0.832 . . . . 0.0 112.095 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.97 -51.03 59.86 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.786 0.708 . . . . 0.0 113.226 169.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -56.4 -40.72 75.11 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.002 -1.293 . . . . 0.0 112.633 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.89 -47.61 51.96 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.298 1.039 . . . . 0.0 112.62 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -77.55 -39.8 44.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.75 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -50.35 -50.39 51.34 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.745 1.157 . . . . 0.0 111.274 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.59 -44.02 97.78 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.732 1.213 . . . . 0.0 112.747 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.55 88.25 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.337 -0.852 . . . . 0.0 112.063 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -63.16 -38.25 90.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.8 1.24 . . . . 0.0 113.142 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -59.6 -34.11 72.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.662 1.119 . . . . 0.0 111.728 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -83.71 11.95 6.61 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.419 1.487 . . . . 0.0 113.257 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 59.46 28.57 17.98 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.696 2.398 . . . . 0.0 115.197 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.88 139.35 53.31 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.526 1.531 . . . . 0.0 112.815 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 35.6 p -86.97 -31.81 20.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.272 1.429 . . . . 0.0 113.591 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -87.48 147.69 25.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.655 1.582 . . . . 0.0 111.741 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 56.9 mt -104.78 120.92 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 0.0 108.353 168.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -100.38 161.89 13.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.068 0.947 . . . . 0.0 113.118 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 53.0 p -66.84 -23.68 66.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.429 1.092 . . . . 0.0 113.669 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.72 -42.83 21.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.644 1.178 . . . . 0.0 112.189 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -54.82 -28.7 51.47 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.991 1.317 . . . . 0.0 114.035 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.76 -32.83 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.79 0.836 . . . . 0.0 112.449 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -54.96 -33.98 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.432 1.093 . . . . 0.0 112.811 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 51.7 m -99.53 -46.65 5.39 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.639 1.176 . . . . 0.0 111.406 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.5 74.89 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.925 -1.109 . . . . 0.0 113.019 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.8 -36.79 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.646 -1.284 . . . . 0.0 111.135 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.53 -36.65 84.9 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.441 1.096 . . . . 0.0 113.055 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.35 -42.65 87.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.179 0.592 . . . . 0.0 112.007 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.66 -54.11 15.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -104.3 111.59 65.22 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.187 1.395 . . . . 0.0 110.832 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.05 152.88 76.19 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.339 2.693 . . . . 0.0 113.68 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.37 -140.53 45.19 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.846 1.212 . . . . 0.0 114.824 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.5 -14.04 61.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -52.35 -48.49 65.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.731 0.812 . . . . 0.0 110.999 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.79 72.88 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -46.31 -52.25 13.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.589 1.156 . . . . 0.0 110.826 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -68.34 -49.31 61.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.756 1.222 . . . . 0.0 113.004 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.13 -44.9 71.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.392 -0.817 . . . . 0.0 112.972 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 86.8 t -69.61 -47.08 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.588 1.155 . . . . 0.0 111.677 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 64.7 p -66.84 -26.74 67.06 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -76.75 -42.58 40.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.602 0.761 . . . . 0.0 111.831 165.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.48 -23.28 34.53 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.997 1.76 . . . . 0.0 116.079 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 73.0 p -56.31 -38.98 72.03 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.973 1.887 . . . . 0.0 112.418 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.79 -43.57 95.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.274 1.03 . . . . 0.0 111.338 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.56 91.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.061 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -52.18 -52.45 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 120.029 1.286 . . . . 0.0 110.703 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 46.7 m -54.75 -47.55 73.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.402 0.681 . . . . 0.0 112.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.79 -48.86 76.97 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.032 0.833 . . . . 0.0 112.337 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -66.48 -31.01 71.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.9 p -81.83 -32.17 31.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.7 1.136 . . . . 0.0 113.691 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 56.6 p -79.45 -30.3 42.12 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.469 1.031 . . . . 0.0 113.721 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.78 136.86 39.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.164 . . . . 0.0 112.564 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.253 1.263 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.931 -179.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.88 133.46 50.88 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.435 2.757 . . . . 0.0 113.379 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -81.05 -173.96 48.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.922 . . . . 0.0 113.244 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.5 mmm -59.55 -30.8 68.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.25 1.02 . . . . 0.0 113.433 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p -91.51 -1.85 57.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.007 1.723 . . . . 0.0 114.386 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.36 8.55 66.39 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.031 1.3 . . . . 0.0 115.769 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -89.6 24.33 2.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.354 1.461 . . . . 0.0 114.712 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.36 15.92 61.96 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.86 133.19 51.37 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.711 1.256 . . . . 0.0 112.857 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -73.7 150.76 41.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.295 1.038 . . . . 0.0 111.063 166.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.73 -138.28 37.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.987 0.804 . . . . 0.0 113.15 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.17 24.38 65.19 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 123.939 0.78 . . . . 0.0 114.256 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -53.01 126.58 21.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.614 1.965 . . . . 0.0 112.408 -174.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.28 132.99 50.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.821 0.849 . . . . 0.0 111.971 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -76.02 147.34 38.82 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.303 1.041 . . . . 0.0 111.952 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.18 134.59 52.02 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 111.495 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.79 136.81 53.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.768 0.827 . . . . 0.0 111.319 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.2 140.23 58.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.055 0.542 . . . . 0.0 110.975 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.67 115.42 6.48 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.39 0.676 . . . . 0.0 111.14 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 36.4 p -81.76 -32.14 31.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.805 1.242 . . . . 0.0 112.752 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.45 133.31 49.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.838 1.255 . . . . 0.0 112.984 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 89.0 p -137.52 171.79 13.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.537 1.935 . . . . 0.0 110.505 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 117.28 6.17 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.298 -0.876 . . . . 0.0 110.85 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -65.49 141.61 58.42 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.091 0.956 . . . . 0.0 112.111 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.3 119.98 12.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.948 0.899 . . . . 0.0 112.098 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.07 142.95 48.16 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.169 0.89 . . . . 0.0 111.888 171.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.02 128.62 37.03 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.669 0.788 . . . . 0.0 111.806 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -106.94 34.64 3.35 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.388 1.475 . . . . 0.0 112.021 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -123.24 174.47 3.47 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.276 2.23 . . . . 0.0 109.995 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -54.18 -36.12 84.69 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.154 2.569 . . . . 0.0 113.96 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -60.32 -22.92 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 125.2 1.4 . . . . 0.0 114.426 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.09 91.7 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.615 1.102 . . . . 0.0 114.125 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -58.59 -49.83 76.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.853 0.827 . . . . 0.0 110.928 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -58.14 -49.0 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.115 0.966 . . . . 0.0 111.105 174.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -54.77 -49.57 70.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.309 1.444 . . . . 0.0 112.812 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.73 -49.03 76.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.506 1.122 . . . . 0.0 111.991 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.02 -37.69 88.46 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.93 . . . . 0.0 112.859 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.23 -45.88 86.92 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.631 0.772 . . . . 0.0 112.233 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -66.84 -47.64 71.34 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.313 0.645 . . . . 0.0 112.123 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.9 -48.71 64.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.91 1.684 . . . . 0.0 112.493 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.16 -4.34 59.35 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.969 1.271 . . . . 0.0 115.977 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.52 38.81 28.98 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.199 1.8 . . . . 0.0 113.975 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -69.06 -23.88 64.1 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 97.0 p -148.69 168.7 22.18 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.644 1.578 . . . . 0.0 111.846 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -61.47 -46.06 91.62 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.845 0.858 . . . . 0.0 112.284 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -139.37 138.02 36.23 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.97 1.708 . . . . 0.0 110.848 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.37 115.75 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 0.0 109.665 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.6 179.91 52.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.02 1.295 . . . . 0.0 114.094 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.15 57.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.15 96.93 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 121.331 -0.856 . . . . 0.0 114.286 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.66 10.95 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.71 -33.51 76.64 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.375 2.05 . . . . 0.0 113.388 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -49.28 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.746 1.157 . . . . 0.0 111.176 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -64.21 -34.87 79.09 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.571 -0.706 . . . . 0.0 112.586 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.91 -44.3 81.12 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.382 -0.823 . . . . 0.0 112.278 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.14 78.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.624 1.102 . . . . 0.0 112.519 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.79 -21.44 19.35 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -91.53 -54.16 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.322 1.449 . . . . 0.0 111.281 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.4 mt -50.17 -45.54 53.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.953 1.701 . . . . 0.0 113.391 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -48.13 -53.44 16.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.408 1.083 . . . . 0.0 112.172 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 -41.35 80.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.039 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.95 -49.55 75.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.993 0.815 . . . . 0.0 111.48 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -57.56 -48.64 78.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.127 0.971 . . . . 0.0 111.53 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.18 62.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.143 1.377 . . . . 0.0 113.432 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.95 -34.34 67.93 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 -34.48 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 118.77 0.714 . . . . 0.0 110.833 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.29 -44.3 88.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.912 0.778 . . . . 0.0 111.68 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.96 -53.06 61.96 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.533 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.65 -36.75 79.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.694 0.797 . . . . 0.0 112.323 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -38.39 79.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.463 1.028 . . . . 0.0 112.657 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.6 -45.56 93.08 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.619 0.645 . . . . 0.0 112.581 168.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.55 -42.18 95.85 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.482 -1.011 . . . . 0.0 111.842 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.38 -45.31 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.48 1.037 . . . . 0.0 111.625 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.7 86.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.758 0.823 . . . . 0.0 112.094 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -57.33 -48.61 78.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.855 1.262 . . . . 0.0 112.678 173.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -58.52 -39.44 80.13 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.524 1.129 . . . . 0.0 113.259 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.57 4.67 31.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.565 1.146 . . . . 0.0 112.968 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 53.09 36.88 23.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.423 2.289 . . . . 0.0 114.177 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.09 149.67 22.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.72 1.608 . . . . 0.0 112.513 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 33.1 p -85.46 -28.86 24.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.214 1.406 . . . . 0.0 113.345 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -119.36 140.24 50.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.32 1.848 . . . . 0.0 111.153 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.29 121.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 109.129 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.51 162.8 20.61 Favored Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 124.315 1.046 . . . . 0.0 111.671 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.38 -35.73 85.28 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.971 2.447 . . . . 0.0 114.091 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -64.3 -43.74 93.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.582 1.083 . . . . 0.0 111.692 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.75 -41.94 98.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.683 0.793 . . . . 0.0 111.424 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -64.06 -44.75 91.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 0.0 112.636 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.83 -51.22 70.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.049 -1.032 . . . . 0.0 111.044 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.06 -41.83 48.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.916 1.286 . . . . 0.0 113.362 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.27 -45.99 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.843 0.747 . . . . 0.0 112.966 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -71.13 -19.46 62.43 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.16 -28.56 64.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.814 1.246 . . . . 0.0 113.492 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -129.63 123.07 30.36 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.598 1.09 . . . . 0.0 112.637 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -61.77 -47.33 85.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.118 0.967 . . . . 0.0 113.059 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -60.67 -53.46 57.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.868 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -49.74 -47.13 50.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.633 1.106 . . . . 0.0 111.753 171.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -61.32 -30.1 70.29 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.704 -1.248 . . . . 0.0 114.151 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.64 -49.66 7.83 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.396 1.078 . . . . 0.0 112.362 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.09 -44.2 87.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.609 2.364 . . . . 0.0 113.409 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tp -119.48 -65.37 1.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.215 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.04 -174.94 19.78 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mmt-85 -146.3 179.77 7.29 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.737 2.815 . . . . 0.0 109.981 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.45 145.33 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.841 0.856 . . . . 0.0 111.555 158.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -89.08 108.1 19.41 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 49.0 mm -84.12 113.66 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.877 . . . . 0.0 109.729 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.15 43.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.806 . . . . 0.0 111.842 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -93.32 146.81 23.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.456 1.102 . . . . 0.0 111.605 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.59 0.21 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.573 1.082 . . . . 0.0 113.595 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.05 -153.79 50.27 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.108 1.337 . . . . 0.0 113.755 -172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.78 125.0 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.018 1.327 . . . . 0.0 109.932 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.91 144.97 40.1 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 111.121 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -59.85 137.19 74.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.848 2.365 . . . . 0.0 111.958 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.45 137.34 57.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.217 0.607 . . . . 0.0 110.239 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 72.2 mt -71.01 117.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.21 0.604 . . . . 0.0 109.562 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -105.02 130.55 53.2 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 109.942 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.29 132.23 49.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.177 0.591 . . . . 0.0 111.449 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.0 103.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.95 123.16 22.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.593 0.757 . . . . 0.0 110.369 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.04 144.2 29.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.295 1.038 . . . . 0.0 111.258 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -59.57 140.16 92.53 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.175 2.583 . . . . 0.0 112.345 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.29 146.36 51.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.28 1.032 . . . . 0.0 112.012 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.03 136.37 53.73 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.617 0.767 . . . . 0.0 110.529 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p -119.94 161.4 20.94 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.97 119.71 10.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 171.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.7 p -68.74 157.08 37.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 113.051 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -57.35 129.0 39.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.238 0.615 . . . . 0.0 110.833 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -60.04 117.93 5.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.747 0.819 . . . . 0.0 112.462 -172.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.85 119.99 11.69 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.277 1.031 . . . . 0.0 110.621 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.07 148.21 44.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.72 0.808 . . . . 0.0 112.628 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.02 137.3 53.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.069 0.947 . . . . 0.0 111.612 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 149.39 3.18 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.717 1.151 . . . . 0.0 113.924 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.028 1.731 . . . . 0.0 111.783 -176.351 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 CA-C-O 118.824 -0.987 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.1 -6.8 11.2 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.071 3.18 . . . . 0.0 114.344 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 75.62 6.32 80.89 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.134 1.349 . . . . 0.0 115.331 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 97.5 mmm -68.7 149.01 98.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.606 1.162 . . . . 0.0 111.916 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -33.83 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.078 2.519 . . . . 0.0 113.129 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -68.88 149.26 97.92 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.004 0.922 . . . . 0.0 112.19 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.23 124.9 17.39 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.233 2.622 . . . . 0.0 112.295 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.82 131.89 45.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.248 0.619 . . . . 0.0 112.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.31 151.45 46.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.136 0.974 . . . . 0.0 111.512 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -64.75 113.64 3.92 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.206 0.603 . . . . 0.0 111.155 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.86 152.17 51.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.489 1.516 . . . . 0.0 111.917 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -61.26 153.28 66.38 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.178 2.585 . . . . 0.0 112.408 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.55 145.91 96.96 Favored Pre-proline 0 CA--C 1.553 1.075 0 O-C-N 121.778 -0.576 . . . . 0.0 111.777 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.73 140.68 96.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.013 2.475 . . . . 0.0 113.087 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.27 123.14 15.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.695 0.798 . . . . 0.0 110.983 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 54.33 20.92 2.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.675 1.99 . . . . 0.0 114.834 -171.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.4 -157.49 15.34 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.116 1.341 . . . . 0.0 113.576 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 22.1 t -67.56 126.62 29.9 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.7 . . . . 0.0 111.442 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.46 126.11 34.18 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.738 1.215 . . . . 0.0 111.313 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.22 -32.36 66.43 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.602 1.161 . . . . 0.0 113.309 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 -14.5 62.84 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.43 117.34 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.906 1.282 . . . . 0.0 110.229 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -124.99 103.6 8.11 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.971 1.308 . . . . 0.0 109.184 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 39.83 64.35 0.89 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.805 2.042 . . . . 0.0 113.33 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 137.53 31.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.647 0.779 . . . . 0.0 111.526 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.56 115.52 3.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.504 0.722 . . . . 0.0 111.015 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.05 132.52 50.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.927 0.891 . . . . 0.0 110.28 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.92 114.24 5.58 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.883 0.873 . . . . 0.0 110.02 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -73.67 143.09 46.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.978 0.511 . . . . 0.0 111.771 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.84 11.14 62.55 Favored Glycine 0 CA--C 1.541 1.68 0 N-CA-C 115.285 0.874 . . . . 0.0 115.285 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.59 128.04 35.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.009 1.324 . . . . 0.0 110.855 172.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.37 131.93 45.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.974 0.91 . . . . 0.0 110.737 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -61.51 125.05 22.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.918 0.887 . . . . 0.0 109.877 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.11 132.12 52.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.66 136.42 58.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.624 0.77 . . . . 0.0 110.637 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 12.6 t -70.22 120.93 16.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.511 0.325 . . . . 0.0 110.137 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -125.06 132.06 53.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.465 1.506 . . . . 0.0 110.296 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.1 106.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.389 2.675 . . . . 0.0 114.233 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -85.13 138.15 32.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.067 0.947 . . . . 0.0 109.62 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -146.74 143.06 28.42 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -162.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 47.72 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 135.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -51.55 -17.97 0.98 Allowed 'General case' 0 N--CA 1.48 1.057 0 O-C-N 119.817 -1.802 . . . . 0.0 114.741 163.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.96 -52.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.85 1.26 . . . . 0.0 111.028 170.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -83.34 -27.98 29.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.832 0.853 . . . . 0.0 113.045 -169.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 18.8 m -46.61 -43.56 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.812 1.187 . . . . 0.0 112.341 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -56.91 -52.83 63.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.889 1.276 . . . . 0.0 112.556 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.93 -50.84 69.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.956 0.902 . . . . 0.0 111.345 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 83.2 t -57.03 -46.4 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.84 0.856 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.57 -50.8 62.25 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.341 1.056 . . . . 0.0 112.085 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.41 -43.77 79.68 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.267 1.027 . . . . 0.0 112.299 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -66.15 -47.74 73.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.37 -30.04 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -121.55 90.36 47.92 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.201 1.4 . . . . 0.0 110.226 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.79 -26.26 72.74 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.626 2.884 . . . . 0.0 114.491 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.25 -12.64 61.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.218 1.807 . . . . 0.0 113.62 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -103.12 117.5 34.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 110.097 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.56 -169.68 15.64 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.855 1.217 . . . . 0.0 112.937 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.94 151.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -70.01 143.87 52.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.835 0.854 . . . . 0.0 112.461 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 34.8 p -58.37 -40.29 81.89 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.012 0.925 . . . . 0.0 112.196 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.82 -43.64 98.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.94 0.896 . . . . 0.0 111.702 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.49 81.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.185 0.594 . . . . 0.0 112.566 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.2 mmm -65.92 -41.83 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.965 -1.084 . . . . 0.0 112.98 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.41 -41.96 88.67 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.298 0.953 . . . . 0.0 113.041 170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -61.12 -49.78 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.791 1.637 . . . . 0.0 111.008 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mmm -56.03 -40.49 73.55 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.668 1.122 . . . . 0.0 112.933 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -64.65 -42.5 95.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.812 -1.18 . . . . 0.0 111.726 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -55.61 -46.85 77.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.603 0.761 . . . . 0.0 111.241 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -56.79 -52.7 64.01 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.677 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.46 -41.33 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.87 1.214 . . . . 0.0 112.384 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -66.05 -54.52 24.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.072 0.851 . . . . 0.0 112.057 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.7 -50.8 71.1 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 11.9 pt -62.58 -36.48 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.368 1.067 . . . . 0.0 112.489 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 10.7 m-30 -66.94 -23.52 65.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.323 1.049 . . . . 0.0 112.33 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -81.22 -47.83 12.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.59 0.756 . . . . 0.0 110.944 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -54.98 -42.94 73.07 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 13.7 tt -59.63 -34.0 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.767 0.712 . . . . 0.0 112.552 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.43 88.21 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.301 0.955 . . . . 0.0 111.797 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.82 94.48 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.995 0.807 . . . . 0.0 113.371 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -70.95 -40.4 72.04 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.076 -1.25 . . . . 0.0 112.741 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.91 72.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.914 -1.116 . . . . 0.0 111.576 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -62.43 -47.4 84.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.363 1.065 . . . . 0.0 112.123 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -54.28 -46.84 72.82 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.0 -1.062 . . . . 0.0 112.403 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.88 -41.73 98.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 0.0 112.304 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.43 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.922 0.889 . . . . 0.0 112.257 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -60.8 -42.37 97.46 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.501 1.12 . . . . 0.0 112.594 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -57.62 -33.37 68.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.211 0.914 . . . . 0.0 112.302 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -90.01 7.84 35.54 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.473 1.509 . . . . 0.0 113.326 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.25 31.1 13.53 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.526 2.33 . . . . 0.0 114.876 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -91.39 143.25 26.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.93 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 40.2 p -90.11 -37.56 14.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.363 1.465 . . . . 0.0 113.213 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 72.9 p -106.22 -179.45 3.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.534 1.933 . . . . 0.0 111.515 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mt -125.22 125.25 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.998 1.319 . . . . 0.0 109.358 171.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -101.77 164.22 11.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.263 1.025 . . . . 0.0 113.084 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 45.8 p -57.33 -43.22 83.18 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.211 -0.931 . . . . 0.0 112.565 170.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.19 -37.03 84.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.209 1.004 . . . . 0.0 112.836 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.91 -39.43 90.58 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.577 0.751 . . . . 0.0 111.952 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.32 -43.12 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 169.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -54.82 -45.33 74.41 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.455 1.025 . . . . 0.0 112.587 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 42.2 p -70.48 -38.27 74.36 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.411 1.005 . . . . 0.0 112.174 171.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -24.63 63.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 117.59 -1.195 . . . . 0.0 114.164 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -46.62 -50.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 121.204 1.82 . . . . 0.0 111.612 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.45 -28.06 64.73 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.33 -39.33 54.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.538 1.135 . . . . 0.0 111.772 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -84.57 -20.31 31.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.016 1.726 . . . . 0.0 112.906 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 63.3 tp -144.08 100.8 4.91 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 126.412 1.885 . . . . 0.0 109.976 169.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.75 143.51 95.18 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.046 2.498 . . . . 0.0 112.714 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.01 89.62 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.433 0.54 . . . . 0.0 113.348 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -65.29 -39.11 92.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.739 -0.859 . . . . 0.0 112.286 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 46.2 tp -66.2 -43.72 85.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.663 0.785 . . . . 0.0 111.401 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.72 68.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.39 0.676 . . . . 0.0 111.84 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -57.47 -45.82 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.267 1.027 . . . . 0.0 112.448 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -56.64 -54.26 48.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 0.0 111.604 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.99 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.374 1.07 . . . . 0.0 113.135 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.2 -68.15 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.801 0.84 . . . . 0.0 110.942 171.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.5 m -71.36 -40.82 70.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -163.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -68.35 -37.29 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.026 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.91 95.6 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.638 0.637 . . . . 0.0 113.368 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.2 m -54.74 -53.62 52.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.508 1.123 . . . . 0.0 111.391 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -54.91 -47.51 74.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.929 0.892 . . . . 0.0 111.988 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.35 88.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 0.0 112.677 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.65 -48.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.646 1.112 . . . . 0.0 111.432 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 39.8 m -54.14 -44.12 71.13 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.78 1.173 . . . . 0.0 112.167 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.67 -48.52 81.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.161 0.984 . . . . 0.0 111.906 173.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -58.85 -44.75 91.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.485 1.114 . . . . 0.0 112.885 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -1.19 54.35 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 11.5 t -56.28 138.3 50.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.115 1.366 . . . . 0.0 113.59 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.14 149.06 47.96 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.273 1.029 . . . . 0.0 112.842 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.054 1.342 . . . . 0.0 112.45 177.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 CA-C-O 119.573 -0.571 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.95 141.34 89.09 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.942 3.094 . . . . 0.0 113.551 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -70.3 173.41 39.78 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.757 1.17 . . . . 0.0 113.964 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.7 mmm -62.61 143.43 57.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.604 0.762 . . . . 0.0 112.324 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p -79.54 170.12 17.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.982 1.313 . . . . 0.0 113.649 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.01 -177.39 45.23 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.702 1.144 . . . . 0.0 114.505 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 54.41 20.42 2.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.9 2.08 . . . . 0.0 115.252 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.9 171.62 41.6 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.167 1.365 . . . . 0.0 113.975 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.64 124.49 18.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.592 1.157 . . . . 0.0 111.221 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -71.63 129.97 40.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.888 0.875 . . . . 0.0 111.486 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.82 145.85 47.66 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.795 1.188 . . . . 0.0 114.009 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.42 -135.67 49.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.539 1.066 . . . . 0.0 112.939 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -76.9 115.36 16.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.656 0.782 . . . . 0.0 110.259 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.05 157.29 35.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.609 0.763 . . . . 0.0 112.629 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 103.38 2.57 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 123.63 18.18 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.29 147.34 52.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.704 0.802 . . . . 0.0 111.409 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.76 134.34 56.94 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.389 0.676 . . . . 0.0 111.573 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.83 137.36 58.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.728 0.811 . . . . 0.0 111.395 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 27.1 p -66.38 149.86 49.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.836 0.854 . . . . 0.0 111.995 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.65 142.22 58.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.157 0.583 . . . . 0.0 110.447 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t -60.03 127.35 31.46 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.9 0.48 . . . . 0.0 110.869 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -62.33 125.87 25.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.372 0.669 . . . . 0.0 111.308 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.11 126.83 29.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.757 0.823 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.33 122.52 15.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.402 0.681 . . . . 0.0 111.875 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.41 173.19 25.61 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.08 0.848 . . . . 0.0 112.969 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 64.1 tp -54.34 123.4 12.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.503 0.721 . . . . 0.0 110.812 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -77.84 145.43 36.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.341 0.657 . . . . 0.0 111.731 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.71 148.96 60.87 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.943 1.297 . . . . 0.0 110.657 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.44 -42.95 63.0 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.157 2.571 . . . . 0.0 113.707 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.89 -41.08 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.814 0.846 . . . . 0.0 111.257 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.12 97.13 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.583 1.087 . . . . 0.0 113.85 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.6 -45.06 95.68 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.233 -1.157 . . . . 0.0 111.42 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.05 -47.9 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.677 0.791 . . . . 0.0 111.336 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -47.56 -47.82 28.15 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 119.806 1.185 . . . . 0.0 112.336 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.15 -51.32 68.34 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.411 1.085 . . . . 0.0 112.504 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -54.69 -44.02 73.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 112.831 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.44 -44.84 89.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.189 0.995 . . . . 0.0 112.11 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -64.9 -48.96 72.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.966 0.906 . . . . 0.0 112.199 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -57.59 -43.82 84.9 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.273 1.429 . . . . 0.0 112.551 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.59 -13.56 65.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.267 1.413 . . . . 0.0 115.302 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.66 40.05 31.64 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.464 1.906 . . . . 0.0 113.288 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -70.6 -32.61 70.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.2 p -131.33 165.36 23.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.432 1.493 . . . . 0.0 111.737 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -56.08 -47.1 78.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.534 1.134 . . . . 0.0 112.907 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -139.58 154.15 47.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.958 1.703 . . . . 0.0 109.994 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 t -116.55 109.16 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.063 0.945 . . . . 0.0 108.877 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.61 162.01 41.08 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.653 1.121 . . . . 0.0 112.585 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -36.96 63.63 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.99 -24.41 74.46 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.287 0.946 . . . . 0.0 115.26 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -58.75 17.03 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.805 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.89 -38.52 92.61 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.478 2.119 . . . . 0.0 113.219 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.78 -53.95 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.033 0.933 . . . . 0.0 110.954 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -57.17 -50.09 73.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.777 0.831 . . . . 0.0 112.286 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.66 -45.59 85.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.316 1.046 . . . . 0.0 111.617 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.12 96.22 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.254 0.934 . . . . 0.0 112.97 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.89 75.19 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.257 -0.902 . . . . 0.0 112.656 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.43 -41.85 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.54 -0.725 . . . . 0.0 111.541 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.8 -52.75 38.05 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.355 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -59.53 -42.87 93.3 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.236 1.38 . . . . 0.0 113.108 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -53.98 -47.87 70.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.585 0.754 . . . . 0.0 112.626 171.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.92 -45.04 75.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.828 0.851 . . . . 0.0 112.392 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -54.94 -40.04 69.52 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.543 1.537 . . . . 0.0 112.285 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.7 -47.21 70.72 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.914 1.234 . . . . 0.0 112.269 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -63.42 -46.62 85.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.606 0.762 . . . . 0.0 112.403 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -51.52 -55.39 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.771 0.714 . . . . 0.0 110.369 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.49 -46.31 83.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.438 0.695 . . . . 0.0 112.154 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.42 -51.49 64.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.724 0.693 . . . . 0.0 111.913 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.3 -33.24 72.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.604 0.762 . . . . 0.0 112.765 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.67 90.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.62 1.1 . . . . 0.0 112.094 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.68 -46.09 89.68 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 122.084 -0.385 . . . . 0.0 112.655 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -61.33 -45.17 95.56 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.956 -0.732 . . . . 0.0 111.473 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.45 81.96 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.995 0.918 . . . . 0.0 112.723 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.25 86.72 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.607 -0.683 . . . . 0.0 112.375 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -59.08 -39.5 82.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -60.03 -31.68 70.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -89.99 3.84 51.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.06 0.944 . . . . 0.0 113.503 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 56.46 33.03 21.8 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.904 2.081 . . . . 0.0 113.711 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.21 147.7 26.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.623 1.569 . . . . 0.0 112.553 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.4 p -98.02 2.02 48.4 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.974 1.71 . . . . 0.0 113.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -126.27 120.09 29.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.676 1.591 . . . . 0.0 110.709 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.29 123.77 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.493 1.517 . . . . 0.0 109.056 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.17 167.21 9.38 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.074 1.75 . . . . 0.0 111.309 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -48.32 -40.31 35.66 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.4 -36.27 75.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.974 0.909 . . . . 0.0 113.213 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -65.56 -39.66 91.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.264 0.938 . . . . 0.0 112.429 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.01 -44.34 85.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.149 0.58 . . . . 0.0 111.229 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -57.19 -49.91 74.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.448 -0.783 . . . . 0.0 112.035 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 64.8 mt -56.56 -46.55 80.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.081 0.952 . . . . 0.0 111.766 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.4 76.91 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.44 -0.787 . . . . 0.0 112.893 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.06 -45.82 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.472 1.109 . . . . 0.0 110.985 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.79 -24.9 64.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.959 1.304 . . . . 0.0 114.512 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -88.78 -34.97 16.91 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.344 1.058 . . . . 0.0 112.181 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.42 117.41 7.9 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.13 0.877 . . . . 0.0 112.489 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.44 -37.12 74.76 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.181 0.993 . . . . 0.0 113.079 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -64.93 -43.87 91.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.432 1.014 . . . . 0.0 111.865 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.91 -32.77 69.81 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.857 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.59 -39.6 94.24 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.218 1.372 . . . . 0.0 112.061 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.22 -41.97 96.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 112.231 171.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 29.7 tp -75.23 -49.26 19.91 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.99 102.74 14.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.609 1.564 . . . . 0.0 110.295 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.34 152.18 49.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.446 0.546 . . . . 0.0 112.725 162.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.0 -35.74 79.42 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.588 -0.948 . . . . 0.0 112.617 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.81 131.95 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.052 1.341 . . . . 0.0 110.606 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 28.4 p -105.15 -23.2 12.95 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.091 1.356 . . . . 0.0 113.92 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.58 104.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 108.873 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.98 137.92 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.594 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -92.61 138.72 31.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.116 0.966 . . . . 0.0 111.608 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.47 -156.28 31.11 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.361 0.981 . . . . 0.0 113.922 -170.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.3 156.75 53.55 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.504 1.05 . . . . 0.0 113.578 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 39.7 t -67.97 128.8 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.718 -0.872 . . . . 0.0 110.346 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 98.2 mt -123.78 147.46 53.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.564 1.546 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -56.99 134.68 66.13 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.362 2.708 . . . . 0.0 112.917 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -73.08 -44.36 60.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.738 0.815 . . . . 0.0 111.932 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 34.3 mm -63.17 131.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.039 0.935 . . . . 0.0 110.234 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -94.38 142.91 26.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.28 1.032 . . . . 0.0 111.6 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.71 147.17 53.62 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.41 0.684 . . . . 0.0 112.277 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 22.3 t 60.83 119.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 127.119 2.168 . . . . 0.0 112.713 -165.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.6 122.35 14.49 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 0.0 111.053 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.37 138.74 81.16 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.182 0.593 . . . . 0.0 111.22 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -61.15 150.41 84.57 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.788 2.326 . . . . 0.0 111.61 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.14 108.24 2.6 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.75 -0.594 . . . . 0.0 110.423 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.79 151.26 45.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.655 1.182 . . . . 0.0 111.262 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -57.67 122.76 13.56 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.022 0.929 . . . . 0.0 110.731 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -62.68 133.35 54.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.406 0.682 . . . . 0.0 111.3 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -77.83 108.54 11.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.913 -0.492 . . . . 0.0 110.787 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.36 -0.26 57.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.539 1.135 . . . . 0.0 112.877 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -73.68 142.05 46.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.105 1.362 . . . . 0.0 111.692 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.25 127.3 32.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.57 0.748 . . . . 0.0 110.593 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.74 147.31 53.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.701 0.8 . . . . 0.0 112.681 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.15 114.49 5.31 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.326 1.05 . . . . 0.0 111.903 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.16 147.48 44.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.934 1.254 . . . . 0.0 113.429 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 124.74 1.216 . . . . 0.0 112.226 173.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 CA-C-O 119.205 -0.775 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.33 -32.01 16.98 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.679 2.92 . . . . 0.0 113.762 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -60.83 123.42 32.69 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.37 0.986 . . . . 0.0 112.803 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.5 141.43 82.85 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.553 0.741 . . . . 0.0 112.065 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.41 148.94 92.48 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.104 2.536 . . . . 0.0 112.071 172.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -65.33 124.7 87.77 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.603 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -61.96 130.14 29.89 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.758 2.305 . . . . 0.0 110.999 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.7 117.58 6.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.51 0.724 . . . . 0.0 112.233 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.3 135.72 57.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.307 1.043 . . . . 0.0 110.544 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -58.85 122.83 14.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.242 0.617 . . . . 0.0 111.152 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 139.77 84.75 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.06 0.544 . . . . 0.0 112.174 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -59.74 131.52 40.39 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.82 2.346 . . . . 0.0 111.317 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.18 132.07 94.97 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.947 -0.549 . . . . 0.0 110.999 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.1 129.53 26.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.958 2.439 . . . . 0.0 112.058 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.73 125.28 24.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.911 0.884 . . . . 0.0 110.401 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -72.34 113.22 9.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.79 -178.5 30.42 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.355 0.978 . . . . 0.0 113.528 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 57.3 p -65.77 -32.02 73.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.05 0.94 . . . . 0.0 112.913 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.13 125.36 23.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.473 1.509 . . . . 0.0 111.324 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.0 157.64 37.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.878 1.271 . . . . 0.0 112.582 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.75 -34.39 75.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.778 0.831 . . . . 0.0 112.565 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.31 113.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.156 1.382 . . . . 0.0 109.232 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -106.06 172.15 6.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.932 1.693 . . . . 0.0 110.745 171.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.81 113.94 2.77 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 117.91 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.696 0.798 . . . . 0.0 110.687 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -68.31 143.63 55.12 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 110.511 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.4 110.54 1.69 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.0 110.178 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.66 145.59 55.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.329 1.052 . . . . 0.0 111.323 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -63.82 129.44 40.1 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.548 0.339 . . . . 0.0 111.271 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 135.63 51.72 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.11 125.46 10.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.68 1.192 . . . . 0.0 111.084 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.73 117.51 4.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.391 1.076 . . . . 0.0 111.145 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.36 125.85 30.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.167 0.987 . . . . 0.0 110.35 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -114.12 153.12 30.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.293 1.837 . . . . 0.0 109.754 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -61.06 115.52 3.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.417 0.687 . . . . 0.0 110.353 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 15.4 t -70.61 130.43 41.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 0.0 111.482 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.44 142.24 52.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.637 0.775 . . . . 0.0 111.223 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.66 -8.76 59.42 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.99 100.59 0.22 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.825 1.65 . . . . 0.0 111.686 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -150.68 -160.8 1.22 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.705 1.602 . . . . 0.0 110.165 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -72.98 36.77 0.08 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.592 1.957 . . . . 0.0 112.469 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.8 p -124.97 -14.24 6.68 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.98 1.712 . . . . 0.0 115.249 -154.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.1 -55.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.221 0.919 . . . . 0.0 111.411 -169.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -56.21 -22.89 32.13 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 m -51.38 -32.86 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.996 1.319 . . . . 0.0 112.986 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -58.52 -54.4 47.5 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 111.292 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.66 -36.84 79.72 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.627 1.171 . . . . 0.0 112.835 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 81.5 t -55.47 -56.61 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.701 0.8 . . . . 0.0 110.605 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.71 -25.34 59.07 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -52.35 -37.66 56.66 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.991 1.268 . . . . 0.0 112.147 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.56 -47.03 23.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.761 0.825 . . . . 0.0 112.728 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.41 -47.38 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.024 0.93 . . . . 0.0 112.285 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -127.34 82.64 67.83 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.812 2.045 . . . . 0.0 110.4 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -57.67 -24.9 65.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.488 2.792 . . . . 0.0 115.533 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -86.3 -7.9 58.14 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.929 2.092 . . . . 0.0 114.097 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -126.19 122.66 36.25 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.48 1.036 . . . . 0.0 112.539 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.8 178.66 26.11 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.384 1.469 . . . . 0.0 113.704 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.56 134.26 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.662 1.585 . . . . 0.0 109.541 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 23.5 p -70.46 160.7 31.91 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -55.06 -42.89 73.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.174 0.99 . . . . 0.0 112.22 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.82 -44.09 91.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.932 1.293 . . . . 0.0 112.149 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.44 92.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 112.43 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.4 mtm -58.15 -44.94 88.14 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.203 -0.936 . . . . 0.0 111.676 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.93 -49.13 63.5 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.773 1.178 . . . . 0.0 114.651 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.65 -22.32 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.732 1.266 . . . . 0.0 113.833 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.55 -35.75 61.08 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.504 -1.373 . . . . 0.0 112.125 170.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -55.76 -40.3 72.39 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 78.7 p -79.03 -37.14 39.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.072 -1.017 . . . . 0.0 112.339 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -58.25 -40.03 80.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.339 0.972 . . . . 0.0 112.858 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.22 -54.39 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.504 1.121 . . . . 0.0 111.287 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.65 -44.38 93.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.716 0.807 . . . . 0.0 111.536 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -58.3 -49.8 75.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.032 0.833 . . . . 0.0 112.944 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.19 -51.24 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.542 1.137 . . . . 0.0 110.732 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.41 -52.43 59.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.807 0.843 . . . . 0.0 111.892 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -53.06 -48.89 67.34 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.442 1.097 . . . . 0.0 112.519 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.21 -50.41 65.98 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 44.1 mt -63.24 -48.28 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.092 0.86 . . . . 0.0 110.491 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.93 90.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.81 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.26 -51.0 58.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.464 1.03 . . . . 0.0 112.95 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -61.62 -45.7 92.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.55 1.175 . . . . 0.0 112.591 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.68 77.84 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.061 -1.025 . . . . 0.0 112.361 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -61.58 -47.79 83.87 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.357 1.063 . . . . 0.0 111.799 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -57.76 -36.06 71.61 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.841 1.256 . . . . 0.0 112.802 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.16 -41.78 85.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.122 0.874 . . . . 0.0 112.375 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.24 86.28 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.951 -1.093 . . . . 0.0 112.483 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -63.5 -41.94 98.51 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.508 1.123 . . . . 0.0 112.74 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -59.16 -38.45 79.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.99 8.32 3.28 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.252 1.421 . . . . 0.0 113.879 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 53.46 29.68 9.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.82 2.448 . . . . 0.0 115.23 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -81.56 158.82 24.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.153 0.981 . . . . 0.0 112.868 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 65.3 p -112.85 -10.29 13.58 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.978 1.711 . . . . 0.0 113.496 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 53.0 m -134.23 135.01 42.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.582 1.953 . . . . 0.0 109.461 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.46 112.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 108.822 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 55.2 p -96.87 170.42 9.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.216 1.406 . . . . 0.0 111.903 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 37.1 p -53.16 -37.2 61.67 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.929 0.891 . . . . 0.0 112.71 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.71 -44.99 69.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.722 1.209 . . . . 0.0 112.422 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.37 -42.3 91.31 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.612 0.642 . . . . 0.0 111.89 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 69.5 mt -58.17 -53.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.608 0.763 . . . . 0.0 110.356 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -50.7 -46.46 58.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.809 1.186 . . . . 0.0 112.405 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 98.8 m -61.74 -49.4 76.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.773 0.829 . . . . 0.0 112.115 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.04 81.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.992 0.917 . . . . 0.0 112.686 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -51.49 -51.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.617 1.167 . . . . 0.0 110.993 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.58 -44.25 97.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.921 0.888 . . . . 0.0 112.699 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.32 -36.26 83.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.211 1.004 . . . . 0.0 113.26 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.24 -30.42 48.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.0 1.32 . . . . 0.0 113.061 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 68.0 mt -120.88 63.79 11.53 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.755 1.622 . . . . 0.0 111.911 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.4 -39.34 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.915 2.41 . . . . 0.0 112.491 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.97 129.63 18.55 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.655 1.121 . . . . 0.0 113.081 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -59.88 -37.87 80.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.585 0.754 . . . . 0.0 112.399 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.0 tp -52.55 -52.85 52.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.346 1.058 . . . . 0.0 111.818 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.6 -47.51 81.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.749 0.82 . . . . 0.0 111.649 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.78 -55.11 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.448 1.099 . . . . 0.0 112.016 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -60.47 -46.54 89.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.645 1.178 . . . . 0.0 112.105 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.82 76.72 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.15 -39.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.034 -1.041 . . . . 0.0 112.267 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 67.4 m -59.47 -42.01 91.06 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.466 1.485 . . . . 0.0 112.47 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -61.8 -34.33 75.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.032 -1.043 . . . . 0.0 111.766 168.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.3 -44.24 84.51 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.798 1.189 . . . . 0.0 113.678 165.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -57.42 -46.58 83.38 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.687 1.743 . . . . 0.0 111.44 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.05 -42.84 95.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.266 0.627 . . . . 0.0 111.945 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.12 82.77 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.831 0.853 . . . . 0.0 112.425 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 94.4 t -57.96 -51.96 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.208 0.913 . . . . 0.0 111.57 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 69.2 p -74.09 -16.45 61.02 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -91.2 -49.2 6.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.668 1.587 . . . . 0.0 112.92 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -106.26 -50.96 3.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.392 1.077 . . . . 0.0 112.779 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -63.66 -51.26 65.91 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.032 0.833 . . . . 0.0 113.234 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 97.7 p -75.96 -11.41 59.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.47 143.61 54.95 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.994 0.917 . . . . 0.0 112.7 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.416 1.487 . . . . 0.0 112.509 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 CA-C-O 119.172 -0.794 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.5 140.87 71.29 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.977 3.118 . . . . 0.0 113.079 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -69.83 172.39 39.99 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.364 0.983 . . . . 0.0 114.009 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 97.0 mmm -69.21 157.67 36.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 112.16 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 17.8 t -84.97 123.03 30.05 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.711 0.805 . . . . 0.0 111.838 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.67 137.58 37.03 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.504 1.05 . . . . 0.0 113.097 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -50.98 141.5 13.58 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.475 1.51 . . . . 0.0 114.905 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.68 -175.17 30.8 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.794 1.188 . . . . 0.0 113.782 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.87 -59.49 5.36 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.309 1.444 . . . . 0.0 112.769 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -151.47 138.68 19.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.325 1.45 . . . . 0.0 110.801 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.16 -142.85 38.45 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.25 0.929 . . . . 0.0 113.863 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.66 153.37 9.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.657 1.122 . . . . 0.0 114.011 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.71 125.24 23.66 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.901 0.88 . . . . 0.0 111.671 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.1 130.13 42.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.673 0.789 . . . . 0.0 111.257 172.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -64.22 120.13 11.55 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.674 -0.641 . . . . 0.0 109.455 169.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.19 128.91 38.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.643 . . . . 0.0 111.333 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.7 143.28 54.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.501 0.72 . . . . 0.0 110.652 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.14 118.44 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.98 0.512 . . . . 0.0 110.677 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.66 133.12 55.78 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.695 0.798 . . . . 0.0 110.656 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 38.2 p -62.07 150.47 38.2 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.205 0.602 . . . . 0.0 110.936 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -58.23 121.56 11.04 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.654 -0.654 . . . . 0.0 109.765 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 22.2 t -58.82 126.8 29.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.268 0.627 . . . . 0.0 110.864 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -61.5 122.48 15.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.122 0.569 . . . . 0.0 110.904 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.16 134.66 57.26 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.453 0.701 . . . . 0.0 111.122 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.68 3.01 17.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 113.918 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.26 -160.91 50.68 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.771 1.177 . . . . 0.0 112.631 -166.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.51 -44.39 67.71 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.264 -0.55 . . . . 0.0 112.123 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 106.53 0.57 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.748 0.819 . . . . 0.0 111.896 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -154.67 130.69 5.51 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.584 1.154 . . . . 0.0 111.28 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.55 125.24 13.54 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.769 2.312 . . . . 0.0 113.91 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 t -58.49 -35.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.867 1.267 . . . . 0.0 112.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.1 -26.3 63.3 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.065 0.84 . . . . 0.0 114.281 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -81.64 -44.65 16.89 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.736 1.268 . . . . 0.0 111.42 168.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -50.27 -50.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.213 0.915 . . . . 0.0 111.1 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -64.59 -43.18 94.65 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.406 -0.809 . . . . 0.0 112.699 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -59.64 -41.77 91.26 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.803 0.729 . . . . 0.0 112.402 171.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.71 -41.2 92.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.269 1.028 . . . . 0.0 112.814 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.17 -44.46 83.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.13 0.877 . . . . 0.0 111.441 172.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -61.81 -54.41 42.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.659 0.784 . . . . 0.0 112.319 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.5 -50.73 59.34 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.923 1.689 . . . . 0.0 112.565 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.24 -0.05 64.98 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.332 1.444 . . . . 0.0 115.596 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 65.6 t30 52.17 41.66 30.26 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.291 1.836 . . . . 0.0 113.549 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -71.8 -28.01 63.31 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 113.424 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.9 t -141.0 153.08 45.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.785 1.234 . . . . 0.0 111.841 170.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -66.77 -29.16 69.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.246 1.019 . . . . 0.0 112.585 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -134.84 120.31 19.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.59 1.556 . . . . 0.0 110.516 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.78 122.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.173 1.389 . . . . 0.0 108.236 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.31 50.4 1.0 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.069 1.795 . . . . 0.0 115.628 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.1 -15.24 21.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.38 79.69 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.975 -1.078 . . . . 0.0 113.702 165.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.36 -59.23 11.67 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 118.642 1.221 . . . . 0.0 112.58 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.71 -31.34 60.38 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.244 1.963 . . . . 0.0 114.383 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.18 -48.79 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.739 1.154 . . . . 0.0 112.059 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -61.08 -38.37 86.01 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.101 -0.999 . . . . 0.0 111.99 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.37 -30.06 70.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.978 -1.076 . . . . 0.0 112.729 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.15 92.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.696 1.135 . . . . 0.0 111.998 168.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.61 90.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.21 -49.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.906 -1.122 . . . . 0.0 112.015 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.6 -35.58 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.595 1.158 . . . . 0.0 112.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.3 -50.0 51.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -76.71 -38.25 54.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.572 0.749 . . . . 0.0 112.921 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.72 -45.17 86.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.317 0.508 . . . . 0.0 111.346 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -77.5 -28.42 52.11 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.66 -46.15 77.58 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.267 0.94 . . . . 0.0 112.545 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.76 -42.19 96.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.963 0.801 . . . . 0.0 112.61 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.09 -55.02 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.518 0.727 . . . . 0.0 110.259 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.84 -32.79 73.56 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.18 -52.36 62.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.695 1.198 . . . . 0.0 111.612 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.73 -36.1 83.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.692 -0.63 . . . . 0.0 112.017 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.13 90.91 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.619 -0.675 . . . . 0.0 111.939 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.05 -46.11 85.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.166 0.889 . . . . 0.0 113.681 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -60.95 -46.13 91.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.155 0.977 . . . . 0.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.44 82.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.607 -0.683 . . . . 0.0 112.305 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.97 88.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.284 1.034 . . . . 0.0 112.629 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -54.48 -50.63 67.3 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.755 1.222 . . . . 0.0 111.86 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -58.68 -38.76 78.91 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -87.72 6.33 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.591 1.156 . . . . 0.0 113.267 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 52.88 34.88 17.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.107 2.163 . . . . 0.0 114.275 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 148.99 21.81 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.506 1.522 . . . . 0.0 112.805 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.0 p -90.58 -28.71 18.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.311 1.445 . . . . 0.0 113.074 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -122.75 138.54 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.302 1.441 . . . . 0.0 111.765 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.72 130.19 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.892 1.277 . . . . 0.0 110.849 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.19 164.39 20.43 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 125.743 1.617 . . . . 0.0 111.481 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.01 -38.3 48.9 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.692 2.928 . . . . 0.0 114.923 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.47 -40.55 87.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.736 0.814 . . . . 0.0 113.036 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -62.21 -41.81 98.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.018 0.826 . . . . 0.0 111.812 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.23 -45.68 87.12 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.84 0.856 . . . . 0.0 111.476 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -58.13 -48.69 79.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.007 0.923 . . . . 0.0 112.024 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.27 -46.77 82.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.76 0.824 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.13 -52.17 59.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.89 0.768 . . . . 0.0 112.622 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 24.6 pt -71.16 -24.99 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -74.36 -43.38 56.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.273 1.429 . . . . 0.0 112.46 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -73.81 -21.34 60.18 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -120.57 115.0 22.56 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.113 0.965 . . . . 0.0 111.382 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.05 -37.33 64.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.666 1.186 . . . . 0.0 112.873 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -60.5 -30.52 69.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 112.757 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.39 -38.17 35.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.946 0.898 . . . . 0.0 111.497 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.07 -32.12 70.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.617 0.767 . . . . 0.0 112.87 172.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.27 -42.23 96.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.54 1.136 . . . . 0.0 113.2 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -51.97 66.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.766 0.826 . . . . 0.0 112.052 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.75 169.43 10.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 113.388 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.48 143.34 43.97 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.602 -0.686 . . . . 0.0 112.829 169.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.89 160.24 12.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.449 0.7 . . . . 0.0 111.054 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.99 117.47 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.34 0.656 . . . . 0.0 110.524 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 36.2 p -88.07 162.23 16.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.358 1.463 . . . . 0.0 112.147 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 tt -61.11 139.41 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 111.988 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.9 133.66 55.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.64 0.776 . . . . 0.0 112.523 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -139.64 159.9 41.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.66 1.584 . . . . 0.0 111.907 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.34 -153.77 15.18 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.59 0.614 . . . . 0.0 114.428 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.41 -168.63 25.81 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.873 1.225 . . . . 0.0 113.874 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.69 112.92 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.747 0.819 . . . . 0.0 109.298 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.24 141.34 73.86 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.551 0.74 . . . . 0.0 111.314 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.41 139.3 76.03 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.334 2.689 . . . . 0.0 112.305 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -100.8 98.81 9.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.19 0.996 . . . . 0.0 109.987 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 73.2 mt -72.75 119.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.751 0.82 . . . . 0.0 109.448 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -96.02 150.14 20.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.467 1.107 . . . . 0.0 111.108 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.45 141.49 57.64 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.792 0.437 . . . . 0.0 111.135 169.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.88 98.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 136.48 39.02 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.039 1.336 . . . . 0.0 110.148 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.12 150.31 97.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.422 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.09 128.82 31.8 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.982 2.455 . . . . 0.0 112.995 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.36 143.84 56.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.589 0.756 . . . . 0.0 110.556 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.32 114.31 3.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.28 0.632 . . . . 0.0 110.089 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.25 156.07 39.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.35 1.06 . . . . 0.0 111.967 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.81 113.96 4.16 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 170.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 30.0 p -67.2 143.63 56.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.694 0.798 . . . . 0.0 112.311 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.69 141.23 57.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.181 0.593 . . . . 0.0 110.852 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -74.59 97.33 3.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.274 0.559 . . . . 0.0 110.909 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -112.21 142.77 44.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.204 1.801 . . . . 0.0 110.563 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.72 56.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.425 0.69 . . . . 0.0 112.348 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.23 11.2 31.06 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.245 1.418 . . . . 0.0 113.334 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.95 9.88 63.85 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.263 1.411 . . . . 0.0 114.877 -169.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.252 1.213 0 C-N-CA 127.1 2.16 . . . . 0.0 111.385 179.326 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.92 -42.59 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.376 2.718 . . . . 0.0 112.424 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -83.87 -148.14 8.43 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.762 1.172 . . . . 0.0 112.386 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -71.14 128.17 90.71 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.715 -0.874 . . . . 0.0 110.958 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.04 145.33 73.21 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.247 2.631 . . . . 0.0 112.617 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -73.1 127.88 88.65 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.105 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -63.02 143.98 91.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.973 2.449 . . . . 0.0 112.468 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.95 92.79 3.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.598 0.759 . . . . 0.0 111.01 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.33 -39.97 62.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.44 1.096 . . . . 0.0 111.646 175.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 60.9 p -70.09 161.39 30.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.689 1.596 . . . . 0.0 112.923 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.55 131.5 45.32 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.186 0.994 . . . . 0.0 113.499 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -66.93 146.25 77.02 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.358 2.705 . . . . 0.0 112.462 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.64 95.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.751 -0.593 . . . . 0.0 111.202 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -62.85 147.76 94.24 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.966 2.444 . . . . 0.0 112.182 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.24 149.95 47.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.125 0.97 . . . . 0.0 112.09 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.61 135.96 57.83 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.069 0.548 . . . . 0.0 110.871 170.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.97 63.06 Favored Glycine 0 CA--C 1.54 1.614 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -173.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -67.91 129.36 39.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.405 1.603 . . . . 0.0 111.645 174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.63 147.56 33.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.431 1.092 . . . . 0.0 111.911 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 91.6 mttt 54.77 27.69 9.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.331 1.852 . . . . 0.0 114.502 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 140.21 58.65 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.154 0.982 . . . . 0.0 112.874 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.94 -46.53 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.014 0.926 . . . . 0.0 111.24 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 36.7 p -116.02 172.0 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.282 1.833 . . . . 0.0 111.961 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -80.18 148.48 30.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.019 0.927 . . . . 0.0 111.416 170.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.7 130.15 45.09 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.618 0.767 . . . . 0.0 111.83 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.549 1.14 . . . . 0.0 110.849 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.74 144.01 51.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.823 0.849 . . . . 0.0 111.945 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.89 143.36 31.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.303 1.441 . . . . 0.0 111.21 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 p30 -140.24 162.71 34.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.615 1.566 . . . . 0.0 112.512 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 -160.62 6.74 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.092 0.853 . . . . 0.0 113.232 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.08 48.87 1.03 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.74 1.216 . . . . 0.0 111.849 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.06 62.73 2.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.116 2.167 . . . . 0.0 111.353 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.81 112.04 1.88 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.445 0.698 . . . . 0.0 109.96 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.2 137.99 51.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.514 1.126 . . . . 0.0 111.155 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.49 138.17 58.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.365 0.666 . . . . 0.0 110.257 169.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 38.0 p -64.1 145.47 55.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.954 0.502 . . . . 0.0 111.199 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -68.79 120.79 15.28 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.566 -0.709 . . . . 0.0 110.949 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -96.08 92.01 6.23 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 0.0 109.929 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -110.6 5.08 20.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.869 1.268 . . . . 0.0 113.103 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 37.0 p -60.6 145.98 46.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.956 0.902 . . . . 0.0 112.302 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . 0.302 48.7 m-85 -68.16 134.35 50.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.79 1.281 . . . . 0.0 111.869 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -179.7 -48.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 -155.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 pt -48.15 -38.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.835 1.654 . . . . 0.0 113.903 169.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -66.27 -46.93 75.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.755 0.822 . . . . 0.0 112.026 174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.38 -46.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 118.677 0.671 . . . . 0.0 110.491 170.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -62.22 -38.38 88.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.66 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.59 -53.18 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.814 0.845 . . . . 0.0 111.64 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.35 -43.0 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.53 1.132 . . . . 0.0 111.982 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -52.85 -49.96 64.72 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.429 1.013 . . . . 0.0 111.697 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.98 -37.62 77.24 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.044 0.838 . . . . 0.0 113.013 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -75.8 -46.17 32.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.1 0.96 . . . . 0.0 113.38 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.39 -36.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.951 1.3 . . . . 0.0 111.831 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -120.79 68.08 15.45 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.294 1.838 . . . . 0.0 111.547 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.24 -38.82 3.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.152 2.568 . . . . 0.0 112.968 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.81 -42.9 7.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.772 1.229 . . . . 0.0 112.852 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -69.6 172.98 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.41 1.884 . . . . 0.0 112.822 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.72 -163.23 10.32 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 124.529 1.062 . . . . 0.0 113.938 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.13 152.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.305 1.442 . . . . 0.0 110.627 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 51.4 p -81.24 154.82 26.42 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.207 0.912 . . . . 0.0 112.842 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 47.9 p -56.69 -40.13 75.03 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.215 -0.928 . . . . 0.0 112.011 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.48 -50.22 74.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.955 1.302 . . . . 0.0 111.849 172.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.55 98.12 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.678 0.791 . . . . 0.0 112.989 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.9 -43.58 86.24 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.094 -1.003 . . . . 0.0 111.454 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.08 -48.64 66.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.503 1.049 . . . . 0.0 113.544 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.92 -47.23 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.138 0.975 . . . . 0.0 111.393 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.26 -39.58 83.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.451 1.023 . . . . 0.0 112.887 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -63.99 -46.44 84.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.173 -0.955 . . . . 0.0 111.183 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 57.7 m -55.4 -46.79 76.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.258 0.936 . . . . 0.0 112.373 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -53.94 -53.86 46.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.735 0.814 . . . . 0.0 111.179 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 82.7 t -57.11 -49.0 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.485 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -52.16 -50.77 61.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 120.186 1.357 . . . . 0.0 111.752 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.26 -51.43 66.22 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.59 -45.33 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.379 1.072 . . . . 0.0 111.342 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -55.03 -51.51 66.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.07 1.348 . . . . 0.0 112.369 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.98 -42.02 97.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.165 0.986 . . . . 0.0 112.003 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -60.68 -51.72 68.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.051 0.94 . . . . 0.0 112.305 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 pt -69.52 -26.36 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.88 67.67 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.349 0.977 . . . . 0.0 112.395 169.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.24 86.05 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.166 0.412 . . . . 0.0 112.394 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.5 -43.19 86.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.254 -1.144 . . . . 0.0 112.046 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.72 -42.69 75.69 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.878 1.217 . . . . 0.0 113.129 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 81.5 p -70.03 -44.23 69.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.945 0.793 . . . . 0.0 112.332 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -55.69 -42.16 74.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.653 1.115 . . . . 0.0 113.339 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -57.01 -35.03 68.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.683 1.193 . . . . 0.0 112.389 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.72 -45.58 64.65 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.316 -0.865 . . . . 0.0 112.052 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -59.04 -39.16 81.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.951 1.3 . . . . 0.0 113.616 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -56.55 -29.83 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.13 1.372 . . . . 0.0 112.813 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -99.2 13.86 31.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.812 1.645 . . . . 0.0 112.232 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.62 29.22 6.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.631 2.372 . . . . 0.0 114.464 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -73.36 139.82 46.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.52 1.128 . . . . 0.0 111.336 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 59.6 p -76.61 -32.81 58.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.719 1.208 . . . . 0.0 113.787 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -136.93 -167.94 2.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.505 1.922 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.29 113.09 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.83 1.252 . . . . 0.0 110.482 168.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 30.4 p -85.7 168.87 13.98 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.125 1.37 . . . . 0.0 113.647 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 34.9 p -50.06 -44.72 51.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.23 1.412 . . . . 0.0 113.497 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.04 -42.2 69.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.084 0.953 . . . . 0.0 112.007 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.74 -29.86 71.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.1 -48.84 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.091 -1.006 . . . . 0.0 110.956 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -38.49 83.19 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.331 -0.856 . . . . 0.0 111.406 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 32.6 m -58.43 -48.09 81.82 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.442 -0.786 . . . . 0.0 111.974 169.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.14 -44.65 83.59 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.945 -1.097 . . . . 0.0 112.243 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.41 -49.95 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.844 0.858 . . . . 0.0 111.959 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -72.02 -14.16 61.8 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.19 -29.33 21.83 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.328 1.051 . . . . 0.0 112.121 170.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.2 -47.4 24.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 112.784 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 79.8 mt -106.1 130.32 23.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.549 1.14 . . . . 0.0 112.166 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.56 159.78 22.21 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.639 2.892 . . . . 0.0 113.299 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.94 -139.17 41.01 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.961 1.267 . . . . 0.0 114.858 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -66.67 -26.39 67.02 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.32 -33.46 63.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.265 1.026 . . . . 0.0 112.25 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.75 4.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.314 1.046 . . . . 0.0 112.318 169.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.03 -45.36 90.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.611 1.164 . . . . 0.0 111.338 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -54.17 -55.37 28.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.009 0.924 . . . . 0.0 111.751 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.37 83.4 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -56.4 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.625 1.102 . . . . 0.0 110.757 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -56.44 -49.07 75.65 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.605 1.093 . . . . 0.0 112.905 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -61.87 -43.48 98.77 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.439 -0.788 . . . . 0.0 112.145 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.73 97.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.544 1.069 . . . . 0.0 113.736 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -58.09 -50.2 74.28 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.244 1.018 . . . . 0.0 110.919 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -59.26 -44.58 92.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.148 0.579 . . . . 0.0 112.166 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.31 75.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.051 0.941 . . . . 0.0 112.184 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.74 -54.93 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.946 0.794 . . . . 0.0 110.565 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 97.5 m -52.92 -51.46 61.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.74 0.816 . . . . 0.0 112.375 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -58.18 -43.74 87.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.467 1.107 . . . . 0.0 112.635 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -71.67 -34.68 69.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.387 0.675 . . . . 0.0 112.748 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.5 p -78.99 -32.56 45.25 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.497 1.044 . . . . 0.0 113.5 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 54.5 p -76.36 -14.85 60.06 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.37 135.81 38.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.051 1.34 . . . . 0.0 113.014 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.213 1.405 . . . . 0.0 112.969 -177.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.61 -25.46 50.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.626 3.551 . . . . 0.0 116.968 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -63.91 -18.61 62.33 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 124.386 0.993 . . . . 0.0 115.56 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 99.2 mmm -81.31 161.7 23.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.764 1.226 . . . . 0.0 112.765 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t -65.21 159.01 24.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.807 0.843 . . . . 0.0 112.909 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.77 -146.41 49.41 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.776 1.179 . . . . 0.0 113.318 -170.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.59 143.51 38.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.179 0.992 . . . . 0.0 112.692 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.88 -169.71 15.36 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.851 1.215 . . . . 0.0 114.212 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.06 127.87 34.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.673 1.189 . . . . 0.0 111.49 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -105.47 144.97 31.5 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.94 1.296 . . . . 0.0 111.677 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.25 148.09 51.17 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.094 0.854 . . . . 0.0 113.309 171.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.27 153.25 31.88 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.091 0.853 . . . . 0.0 113.063 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.87 125.1 11.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 111.705 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 128.44 35.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.735 0.814 . . . . 0.0 111.39 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -66.41 131.69 46.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.73 0.812 . . . . 0.0 111.295 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 136.42 55.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.497 0.719 . . . . 0.0 111.652 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.91 133.75 51.55 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.635 0.774 . . . . 0.0 111.293 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.43 139.45 57.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.474 0.71 . . . . 0.0 111.714 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.18 109.55 8.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.948 0.899 . . . . 0.0 111.268 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 41.6 m -61.57 123.43 17.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.526 1.131 . . . . 0.0 111.933 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 49.92 33.37 6.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.666 1.986 . . . . 0.0 114.834 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 16.1 t -59.88 122.62 14.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 112.747 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 47.0 p -92.76 143.95 25.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.938 1.695 . . . . 0.0 111.284 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.59 118.95 12.27 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.535 -0.728 . . . . 0.0 110.971 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.25 140.38 50.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.976 0.91 . . . . 0.0 112.319 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.46 -168.14 24.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.099 1.333 . . . . 0.0 113.788 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 88.4 mt -95.42 -2.05 49.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 113.887 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -102.37 152.52 21.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.195 1.398 . . . . 0.0 112.7 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -123.64 70.14 46.14 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.519 1.128 . . . . 0.0 111.225 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -61.39 156.56 45.63 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.392 2.061 . . . . 0.0 110.991 169.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.47 -32.33 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.379 -0.826 . . . . 0.0 112.651 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.59 -35.03 88.39 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.37 0.986 . . . . 0.0 115.039 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.08 -45.18 86.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.515 1.158 . . . . 0.0 110.228 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.18 -36.09 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.833 0.853 . . . . 0.0 111.749 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -56.97 -37.43 71.6 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.26 1.391 . . . . 0.0 112.556 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.44 -46.02 81.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.735 1.152 . . . . 0.0 112.496 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.78 -41.01 85.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.545 0.738 . . . . 0.0 111.966 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.75 -37.51 82.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.447 1.499 . . . . 0.0 112.737 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -60.41 -39.3 86.88 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.674 1.189 . . . . 0.0 112.338 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.41 -40.05 74.03 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.296 0.953 . . . . 0.0 111.943 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.23 7.61 29.32 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.825 1.679 . . . . 0.0 115.82 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 53.06 26.71 5.04 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.807 2.043 . . . . 0.0 115.018 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.49 -50.74 40.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 113.605 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -120.36 145.34 47.24 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.2 1.0 . . . . 0.0 111.65 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -71.26 -27.09 63.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.458 1.103 . . . . 0.0 112.485 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -139.67 130.69 26.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.936 1.694 . . . . 0.0 111.346 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.36 97.82 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.691 1.196 . . . . 0.0 109.277 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.31 151.62 34.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.686 1.136 . . . . 0.0 113.367 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.86 60.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.24 -9.21 86.83 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.05 31.54 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.533 1.667 . . . . 0.0 114.984 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.86 -35.86 81.04 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.62 2.88 . . . . 0.0 114.738 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.71 -44.82 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.018 0.927 . . . . 0.0 110.547 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -65.02 -49.29 70.76 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.51 -38.08 86.43 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.092 -1.005 . . . . 0.0 111.703 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.48 87.58 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.515 -0.74 . . . . 0.0 112.298 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.32 82.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.215 0.916 . . . . 0.0 112.103 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.3 -49.67 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.551 -0.718 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.86 -33.14 75.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -62.07 -29.37 70.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.98 -6.92 50.31 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.322 -1.486 . . . . 0.0 113.917 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.47 -43.76 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.457 1.103 . . . . 0.0 111.268 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 57.9 p -62.56 -19.53 63.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.701 0.801 . . . . 0.0 112.736 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.73 -40.53 40.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.958 1.303 . . . . 0.0 113.666 166.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.95 -45.35 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.667 1.121 . . . . 0.0 111.578 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.24 -41.25 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.118 0.967 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.41 -45.16 85.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.81 1.244 . . . . 0.0 113.17 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -61.26 -44.53 97.08 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.463 1.029 . . . . 0.0 112.034 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.16 -41.26 87.96 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.81 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.19 75.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.108 -0.995 . . . . 0.0 112.528 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.18 -44.14 93.29 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.355 0.978 . . . . 0.0 112.914 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.703 -0.881 . . . . 0.0 111.254 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.18 88.26 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.281 -0.887 . . . . 0.0 112.979 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.16 78.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.055 1.342 . . . . 0.0 112.145 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -54.0 -47.7 71.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.584 1.153 . . . . 0.0 112.508 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -57.97 -34.56 70.08 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.03 4.21 45.98 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.821 1.248 . . . . 0.0 113.444 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.14 32.04 19.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.824 2.05 . . . . 0.0 114.324 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.89 154.05 21.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.933 1.693 . . . . 0.0 113.018 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -115.36 15.68 16.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.474 1.91 . . . . 0.0 113.082 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -130.69 126.85 37.57 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.191 1.397 . . . . 0.0 110.4 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.09 124.27 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.921 0.888 . . . . 0.0 109.766 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.86 164.92 24.08 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.724 1.61 . . . . 0.0 110.879 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -50.16 -34.94 41.01 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.564 2.843 . . . . 0.0 114.915 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.51 -35.57 79.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.889 0.876 . . . . 0.0 113.362 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.63 -39.42 77.18 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.924 -1.11 . . . . 0.0 112.026 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.89 -39.84 91.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.455 0.702 . . . . 0.0 111.229 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.22 -51.74 66.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.336 1.054 . . . . 0.0 111.052 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.09 -39.87 79.69 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.188 0.904 . . . . 0.0 112.811 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.21 70.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.585 0.754 . . . . 0.0 112.493 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.08 -30.53 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -48.82 -35.86 15.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.276 1.83 . . . . 0.0 113.643 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.36 -12.29 61.48 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -130.71 130.34 43.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.009 1.323 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.05 -48.34 82.2 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.128 -0.983 . . . . 0.0 113.24 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.42 -45.99 88.41 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.481 -0.762 . . . . 0.0 112.044 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.8 -36.87 85.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.072 0.851 . . . . 0.0 112.438 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -60.92 -46.39 90.86 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.994 1.27 . . . . 0.0 111.753 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.41 -32.83 74.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 113.388 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.25 -47.89 54.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.488 1.515 . . . . 0.0 112.037 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 tt -68.29 105.3 2.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.772 0.796 . . . . 0.0 110.368 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.37 -156.39 7.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.745 1.64 . . . . 0.0 111.104 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -97.89 144.75 27.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.177 0.991 . . . . 0.0 110.742 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.8 119.65 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.578 0.751 . . . . 0.0 109.807 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 59.0 p -120.41 156.76 30.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.652 1.581 . . . . 0.0 111.288 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 85.8 mt -71.5 116.28 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.22 128.41 36.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.555 0.742 . . . . 0.0 111.886 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.08 5.44 42.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.598 1.159 . . . . 0.0 113.163 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.52 -149.11 8.81 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.152 1.358 . . . . 0.0 113.82 171.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.2 -150.36 40.65 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.652 1.12 . . . . 0.0 113.795 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.52 127.17 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.788 0.835 . . . . 0.0 109.903 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.14 156.1 37.38 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.144 1.377 . . . . 0.0 111.602 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 132.17 49.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.194 2.596 . . . . 0.0 112.519 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -72.46 122.33 21.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.897 -0.502 . . . . 0.0 110.433 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 99.0 mt -67.13 -41.35 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.515 1.126 . . . . 0.0 111.496 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -110.12 151.79 26.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.964 1.306 . . . . 0.0 112.017 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.6 144.3 57.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.216 0.606 . . . . 0.0 111.543 168.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.9 t -71.14 116.77 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.194 0.598 . . . . 0.0 110.125 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 63.7 tp -99.35 114.58 27.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 109.888 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.58 149.67 98.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.992 170.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.07 118.38 5.16 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.973 2.449 . . . . 0.0 112.344 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.55 132.4 48.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.69 0.796 . . . . 0.0 111.078 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.08 135.42 57.51 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 162.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 38.9 m -62.93 111.74 2.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.279 0.491 . . . . 0.0 110.129 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.31 98.39 6.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.538 0.735 . . . . 0.0 110.021 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -56.15 133.95 52.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.465 0.706 . . . . 0.0 110.126 170.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -61.43 111.1 1.65 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.995 0.518 . . . . 0.0 110.944 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -75.51 126.96 32.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.568 0.747 . . . . 0.0 111.396 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.12 122.9 13.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.148 0.979 . . . . 0.0 110.338 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.7 137.57 57.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.442 0.697 . . . . 0.0 112.491 -175.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.97 -19.85 60.53 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.26 1.024 . . . . 0.0 113.695 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.81 29.84 74.01 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.358 0.98 . . . . 0.0 113.64 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.817 2.047 . . . . 0.0 111.695 -177.309 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.85 133.92 53.84 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.921 3.081 . . . . 0.0 113.759 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -65.99 152.98 51.86 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.342 0.972 . . . . 0.0 113.301 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 99.4 mmm -60.03 144.13 87.09 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.988 -0.713 . . . . 0.0 111.769 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -57.29 134.81 66.36 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.149 2.566 . . . . 0.0 113.575 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.97 147.89 84.13 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.335 0.654 . . . . 0.0 111.633 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -57.74 134.91 65.97 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.858 2.372 . . . . 0.0 113.509 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.26 55.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.37 0.668 . . . . 0.0 111.964 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.06 114.75 11.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.02 0.928 . . . . 0.0 110.798 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.2 p -143.5 166.19 25.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.378 1.471 . . . . 0.0 112.76 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.04 139.63 93.03 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.359 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.19 123.1 13.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.128 2.552 . . . . 0.0 113.021 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.69 152.63 68.86 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.923 1.689 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -57.64 128.02 27.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.786 2.324 . . . . 0.0 111.832 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.81 -120.48 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.317 1.447 . . . . 0.0 110.496 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.19 160.2 14.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.743 1.617 . . . . 0.0 111.736 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.47 -171.4 42.07 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.399 1.476 . . . . 0.0 111.802 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 66.7 p -51.92 -31.54 28.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.973 1.309 . . . . 0.0 114.187 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -52.47 -26.34 12.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.907 1.683 . . . . 0.0 114.184 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -58.75 -25.93 63.49 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 119.608 1.094 . . . . 0.0 113.838 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.45 -10.76 59.74 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.647 1.179 . . . . 0.0 114.145 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.47 105.65 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.105 0.962 . . . . 0.0 110.024 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 126.23 29.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.968 0.907 . . . . 0.0 110.025 172.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.3 122.45 16.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.42 0.688 . . . . 0.0 110.852 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 136.14 57.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.712 0.805 . . . . 0.0 112.327 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -88.67 -10.13 49.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.988 0.915 . . . . 0.0 113.249 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.49 141.24 55.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.961 1.304 . . . . 0.0 111.084 168.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.78 129.61 41.83 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.015 0.926 . . . . 0.0 111.061 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.75 127.72 33.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.092 0.557 . . . . 0.0 112.392 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 -159.26 5.73 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.916 0.769 . . . . 0.0 113.314 168.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.92 -29.95 70.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.057 0.943 . . . . 0.0 113.245 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 60.87 152.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.347 2.659 . . . . 0.0 113.55 -167.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.97 146.1 37.69 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.689 0.796 . . . . 0.0 110.906 170.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.04 122.01 12.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 0.0 111.527 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.29 141.36 50.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 111.347 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -71.22 157.76 37.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.122 0.969 . . . . 0.0 112.546 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.9 126.38 27.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.791 . . . . 0.0 110.532 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.08 154.41 42.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.309 1.044 . . . . 0.0 112.808 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -86.63 72.17 10.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 110.073 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 53.1 m -62.8 -36.93 84.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.009 0.923 . . . . 0.0 111.404 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.43 -154.85 0.47 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.959 1.703 . . . . 0.0 108.291 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t 68.14 -35.97 0.3 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.965 1.711 . . . . 0.0 114.769 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 44.4 mm -35.37 -45.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 128.68 2.792 . . . . 0.0 113.357 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -103.07 -34.65 8.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.844 1.257 . . . . 0.0 112.844 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 51.3 t -47.17 -51.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 119.751 1.16 . . . . 0.0 111.719 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.01 -42.29 99.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.597 . . . . 0.0 112.519 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -55.07 -37.19 66.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.014 1.325 . . . . 0.0 113.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.23 -57.01 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.873 1.269 . . . . 0.0 111.2 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.58 -37.36 27.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.644 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -46.94 -43.31 18.95 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.844 1.202 . . . . 0.0 112.239 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.89 -50.92 8.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.065 . . . . 0.0 113.08 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.29 -43.71 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 118.837 0.744 . . . . 0.0 112.912 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -126.4 69.06 68.31 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.06 1.744 . . . . 0.0 110.449 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -58.14 -21.42 51.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.798 2.998 . . . . 0.0 114.015 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.19 -10.37 59.4 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.678 1.991 . . . . 0.0 113.991 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -111.45 120.34 41.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.064 1.346 . . . . 0.0 111.948 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.47 168.46 42.15 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.436 1.493 . . . . 0.0 113.923 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 56.9 mt -133.59 132.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.322 1.449 . . . . 0.0 108.694 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 31.0 p -73.94 156.33 37.73 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 51.2 p -55.66 -38.19 69.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.3 -0.875 . . . . 0.0 112.293 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.99 -44.66 84.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.66 1.184 . . . . 0.0 112.452 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.73 88.28 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.917 0.887 . . . . 0.0 111.906 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.3 mtm -59.36 -46.13 89.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.747 -0.595 . . . . 0.0 111.073 171.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.67 58.38 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.961 1.267 . . . . 0.0 114.81 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.04 -35.63 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.202 1.501 . . . . 0.0 111.977 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 78.1 mtm -62.83 -36.64 83.85 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.297 -0.877 . . . . 0.0 112.841 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.37 -46.05 91.8 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 110.527 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -53.89 -47.46 71.11 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.491 0.716 . . . . 0.0 111.973 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -52.03 -37.59 54.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.01 -51.15 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.559 1.527 . . . . 0.0 111.137 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.99 -45.1 95.1 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.179 0.592 . . . . 0.0 111.583 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -56.37 -47.84 78.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.1 -45.84 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.178 0.899 . . . . 0.0 110.02 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.49 -50.75 67.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.943 0.792 . . . . 0.0 111.948 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.56 -44.87 95.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.039 0.936 . . . . 0.0 112.72 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -60.19 -49.72 76.52 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.79 0.723 . . . . 0.0 111.866 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.25 -51.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.163 0.985 . . . . 0.0 110.785 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.46 72.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.111 0.964 . . . . 0.0 112.343 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.82 50.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.517 1.055 . . . . 0.0 113.685 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.28 -45.21 94.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.217 1.009 . . . . 0.0 112.38 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.62 80.7 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.948 0.795 . . . . 0.0 111.796 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 68.4 m -58.27 -52.43 65.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.556 0.742 . . . . 0.0 112.252 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -59.13 -37.9 78.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.971 0.908 . . . . 0.0 113.241 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.22 -42.97 87.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 112.096 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.98 88.5 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.801 0.728 . . . . 0.0 111.972 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -59.38 -45.4 91.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 112.532 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -56.89 -43.04 80.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.671 1.188 . . . . 0.0 112.359 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -79.56 6.7 9.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.446 1.099 . . . . 0.0 113.943 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 54.0 43.18 31.16 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.153 2.181 . . . . 0.0 114.114 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.09 152.02 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.087 1.355 . . . . 0.0 112.434 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 33.1 p -77.88 -45.39 24.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 111.706 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 28.2 m -61.56 117.05 5.25 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.996 1.318 . . . . 0.0 111.746 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -74.17 129.11 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.347 1.459 . . . . 0.0 108.959 163.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -96.41 159.7 14.8 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 38.6 p -57.4 -39.24 75.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.944 0.898 . . . . 0.0 112.387 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.31 -42.23 96.45 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.673 1.189 . . . . 0.0 112.391 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.506 -0.746 . . . . 0.0 111.839 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.56 -42.83 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.38 -0.825 . . . . 0.0 111.12 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.31 -39.15 82.16 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.806 -1.184 . . . . 0.0 112.236 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 81.6 m -64.82 -45.11 87.59 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.918 -1.114 . . . . 0.0 111.964 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.33 -44.14 75.62 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.824 1.193 . . . . 0.0 111.799 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.47 -55.0 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.402 1.081 . . . . 0.0 111.353 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -52.97 -47.27 68.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 120.081 1.31 . . . . 0.0 112.333 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.98 -51.58 67.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.746 1.218 . . . . 0.0 112.577 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.38 -31.15 23.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -170.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 42.5 mt -124.36 57.92 15.24 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 126.401 1.88 . . . . 0.0 111.097 -170.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.58 -26.88 61.56 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.299 2.666 . . . . 0.0 113.621 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.86 133.37 52.43 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.831 1.205 . . . . 0.0 113.209 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.61 -50.43 73.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.421 1.089 . . . . 0.0 112.844 -172.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 tt -58.47 -53.28 60.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.63 0.772 . . . . 0.0 110.154 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.71 63.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.067 0.849 . . . . 0.0 112.724 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.44 -51.83 57.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.54 1.136 . . . . 0.0 112.017 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -64.04 -43.03 96.79 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.366 0.666 . . . . 0.0 112.271 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.16 72.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 114.041 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.52 -43.08 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.495 1.498 . . . . 0.0 112.381 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -58.67 -52.04 67.37 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.712 1.142 . . . . 0.0 112.928 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.83 -31.64 72.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.66 0.784 . . . . 0.0 111.488 170.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.4 -41.2 79.6 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.925 1.25 . . . . 0.0 114.321 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 66.6 m -55.09 -43.64 74.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.313 1.557 . . . . 0.0 111.374 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -64.8 -42.52 94.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.947 0.899 . . . . 0.0 111.423 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.38 -46.39 80.1 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 112.313 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -52.59 -49.88 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.167 0.894 . . . . 0.0 110.823 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 34.7 m -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.133 0.879 . . . . 0.0 112.402 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.36 -20.23 64.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.416 1.087 . . . . 0.0 113.892 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -90.8 -45.6 8.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.862 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 77.6 p -63.68 -26.45 68.67 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.438 1.017 . . . . 0.0 113.414 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 85.8 p -70.55 -14.63 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.92 147.02 54.01 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.142 0.883 . . . . 0.0 112.59 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.957 1.303 . . . . 0.0 112.636 -178.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.45 -20.19 31.89 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.205 3.27 . . . . 0.0 114.824 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 81.37 162.92 30.0 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.546 1.069 . . . . 0.0 113.362 -171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 52.7 ttm -62.09 126.79 28.56 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.121 0.969 . . . . 0.0 111.774 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p -77.43 -44.73 28.1 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.566 1.147 . . . . 0.0 112.573 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.69 173.33 21.97 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.687 1.137 . . . . 0.0 113.508 165.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.91 127.78 33.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.97 0.908 . . . . 0.0 111.432 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.28 130.99 51.81 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.536 1.065 . . . . 0.0 113.165 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.57 146.69 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.436 1.095 . . . . 0.0 112.36 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -74.63 -22.97 58.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.3 5.74 67.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.884 1.23 . . . . 0.0 115.264 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.8 -174.87 30.61 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.062 1.315 . . . . 0.0 114.183 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.1 144.48 57.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.656 1.182 . . . . 0.0 112.16 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.69 54.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.557 0.743 . . . . 0.0 111.567 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.99 141.47 54.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.782 0.833 . . . . 0.0 111.673 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.86 136.96 56.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.621 0.768 . . . . 0.0 112.241 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.77 143.65 55.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.078 0.951 . . . . 0.0 111.53 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.77 124.05 21.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.282 0.633 . . . . 0.0 110.927 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 135.89 55.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.836 0.854 . . . . 0.0 111.513 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -70.46 149.74 46.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.072 0.949 . . . . 0.0 112.134 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.97 141.52 52.98 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.529 0.732 . . . . 0.0 111.305 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 62.0 p -78.46 -20.48 50.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 113.546 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 60.7 p -67.28 160.8 26.34 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.354 1.461 . . . . 0.0 113.258 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -56.65 122.45 12.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.856 1.262 . . . . 0.0 112.093 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.15 142.25 43.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.013 0.925 . . . . 0.0 111.661 171.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.97 -178.16 48.18 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 123.639 0.637 . . . . 0.0 114.412 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 mt -78.72 161.57 26.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.011 1.324 . . . . 0.0 112.554 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -81.22 89.19 6.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 109.939 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.8 154.59 80.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.843 0.857 . . . . 0.0 111.169 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.23 147.54 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.026 2.484 . . . . 0.0 111.791 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 t 64.09 -25.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 126.615 1.966 . . . . 0.0 115.172 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 -41.37 70.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 120.768 1.622 . . . . 0.0 113.853 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.74 -39.85 94.33 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.164 -1.198 . . . . 0.0 112.435 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.05 -43.38 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.278 0.631 . . . . 0.0 110.243 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.28 -42.15 98.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.48 -47.62 83.47 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.324 -0.86 . . . . 0.0 111.958 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.15 -40.11 96.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.092 0.957 . . . . 0.0 112.695 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.73 -47.32 82.78 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.629 1.572 . . . . 0.0 111.114 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -66.08 -43.5 87.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.064 0.946 . . . . 0.0 113.311 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.77 -43.91 63.17 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.937 1.295 . . . . 0.0 111.832 172.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.58 0.16 14.76 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.591 1.567 . . . . 0.0 116.447 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 50.71 39.07 20.96 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.472 1.909 . . . . 0.0 113.207 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -53.07 -49.81 65.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.7 t -126.12 150.46 48.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.955 1.302 . . . . 0.0 111.502 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -81.18 -16.86 51.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.286 1.035 . . . . 0.0 113.077 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -136.52 124.4 22.69 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.628 1.571 . . . . 0.0 110.838 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.96 109.35 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.737 1.215 . . . . 0.0 109.964 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.8 156.35 53.23 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.817 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.78 64.37 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.42 83.9 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.023 1.297 . . . . 0.0 115.895 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.14 82.16 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.686 1.743 . . . . 0.0 115.399 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.19 -39.48 90.13 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.649 2.232 . . . . 0.0 112.922 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.83 -48.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.057 1.343 . . . . 0.0 110.688 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -62.53 -44.4 96.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.76 -53.97 44.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.801 0.84 . . . . 0.0 110.802 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.26 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -53.81 53.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.759 0.823 . . . . 0.0 111.785 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.53 -40.45 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.079 0.952 . . . . 0.0 112.694 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.22 -18.51 58.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.032 1.333 . . . . 0.0 113.739 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -100.47 -29.94 12.1 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.002 1.321 . . . . 0.0 112.927 173.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -55.74 -54.99 37.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.532 1.133 . . . . 0.0 112.943 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -38.02 66.56 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.643 -0.661 . . . . 0.0 112.346 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 38.0 p -64.61 -29.51 70.52 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.567 -0.708 . . . . 0.0 112.846 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.9 65.32 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.701 0.8 . . . . 0.0 112.791 167.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -78.51 -41.63 31.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.56 -0.712 . . . . 0.0 112.379 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -53.97 -50.7 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.226 0.61 . . . . 0.0 110.561 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.73 -33.32 70.71 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.86 -53.0 63.17 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.989 0.813 . . . . 0.0 111.199 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.689 0.796 . . . . 0.0 112.159 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.77 84.59 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.104 -0.997 . . . . 0.0 112.909 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.14 -42.33 93.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.053 0.835 . . . . 0.0 112.659 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.46 -44.41 82.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.023 0.911 . . . . 0.0 111.927 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.59 82.05 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.371 0.987 . . . . 0.0 112.018 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.96 79.56 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.204 1.002 . . . . 0.0 112.58 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.88 -48.59 69.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.32 -32.93 67.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -91.84 6.12 47.34 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.029 1.332 . . . . 0.0 112.629 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.26 32.8 16.86 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.307 2.243 . . . . 0.0 114.252 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -99.68 152.18 20.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.295 1.438 . . . . 0.0 113.041 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -102.02 -6.66 23.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.655 1.582 . . . . 0.0 113.881 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -128.11 129.95 47.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.666 1.587 . . . . 0.0 110.877 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.16 124.69 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.465 1.506 . . . . 0.0 109.721 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.6 pt -117.18 168.16 9.52 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 125.912 1.685 . . . . 0.0 111.34 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.67 -37.07 63.45 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.385 2.723 . . . . 0.0 115.294 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.72 -38.57 88.36 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.314 -0.866 . . . . 0.0 112.797 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -65.59 -39.64 91.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.4 -0.812 . . . . 0.0 112.034 172.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.49 -44.85 93.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.593 0.757 . . . . 0.0 112.045 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.28 -50.13 73.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.898 0.879 . . . . 0.0 111.692 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.7 mt -58.07 -45.33 87.29 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.712 0.805 . . . . 0.0 112.349 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.37 -51.86 61.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.161 0.984 . . . . 0.0 112.129 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.26 -39.97 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -55.28 -42.87 74.16 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.957 -1.089 . . . . 0.0 112.385 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -86.16 -8.08 58.1 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -129.19 116.92 19.92 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.653 1.115 . . . . 0.0 112.409 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -67.53 -35.4 79.01 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -64.92 -42.08 95.02 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.194 0.906 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -51.87 -48.5 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.156 168.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -67.6 -14.62 63.1 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -84.34 -40.65 17.65 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.502 1.046 . . . . 0.0 111.324 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.95 -53.28 11.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.983 1.313 . . . . 0.0 112.019 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.11 94.71 9.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.109 2.163 . . . . 0.0 107.957 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 43.94 0.59 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-O 119.24 -0.756 . . . . 0.0 114.463 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -124.58 7.33 8.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.087 1.355 . . . . 0.0 113.694 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.12 125.97 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.97 1.308 . . . . 0.0 108.85 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 27.3 m -61.92 125.83 25.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.701 0.801 . . . . 0.0 111.457 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 79.4 mt -79.27 118.24 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.771 0.829 . . . . 0.0 109.464 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.56 148.08 33.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.111 0.964 . . . . 0.0 112.659 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -77.56 160.24 28.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.86 . . . . 0.0 112.54 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.19 82.92 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.446 1.022 . . . . 0.0 115.135 -172.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.74 163.77 32.14 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.743 1.163 . . . . 0.0 113.634 169.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.53 147.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.919 0.887 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.79 151.33 96.88 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.048 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.84 128.97 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.878 2.386 . . . . 0.0 112.567 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.97 138.0 55.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.151 0.58 . . . . 0.0 110.423 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 65.9 mt -75.6 114.7 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -119.26 146.98 44.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 110.378 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.7 137.68 58.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.731 0.412 . . . . 0.0 110.697 167.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.1 t -71.1 107.18 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.32 111.23 12.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.522 0.729 . . . . 0.0 110.423 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.59 144.43 45.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.953 . . . . 0.0 111.02 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -59.14 148.64 84.79 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.786 2.324 . . . . 0.0 111.729 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.26 70.31 4.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.192 0.997 . . . . 0.0 111.341 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.7 135.76 56.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.179 1.392 . . . . 0.0 110.964 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 31.2 p -69.2 154.04 42.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.855 0.862 . . . . 0.0 112.137 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.7 128.93 39.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.331 1.052 . . . . 0.0 111.707 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 55.9 p -84.88 -9.07 58.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -122.49 142.77 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.236 1.414 . . . . 0.0 111.813 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -55.51 -38.94 69.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.724 1.21 . . . . 0.0 113.125 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.14 -30.35 66.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.579 1.151 . . . . 0.0 113.554 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.43 60.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.145 0.978 . . . . 0.0 112.532 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.98 123.93 15.13 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.316 1.046 . . . . 0.0 111.815 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.66 150.93 51.85 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.497 1.046 . . . . 0.0 113.552 173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.656 1.183 . . . . 0.0 112.179 173.684 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.888 0 CA-C-O 118.648 -1.085 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -65.62 168.27 15.28 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.887 3.058 . . . . 0.0 112.98 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.88 -2.16 51.11 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.93 1.252 . . . . 0.0 115.528 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 27.8 ptm -134.16 154.84 80.3 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 110.25 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.29 137.54 82.12 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.796 2.33 . . . . 0.0 112.515 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -67.43 157.82 84.33 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.791 0.836 . . . . 0.0 111.631 172.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -56.5 -32.4 89.38 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.899 2.4 . . . . 0.0 114.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.67 58.8 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -90.49 118.9 30.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.138 1.375 . . . . 0.0 110.441 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 35.3 p -67.8 149.93 49.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.065 0.946 . . . . 0.0 112.522 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 148.25 91.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.564 172.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.31 124.8 16.94 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.201 2.601 . . . . 0.0 113.089 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.25 138.71 94.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.407 0.683 . . . . 0.0 112.291 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.59 137.36 63.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.213 2.609 . . . . 0.0 112.223 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -112.22 153.12 27.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.749 1.619 . . . . 0.0 111.265 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -63.28 133.79 54.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.076 0.95 . . . . 0.0 111.687 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.69 -165.59 28.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.635 1.588 . . . . 0.0 112.582 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 18.9 t -72.33 129.94 39.58 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.394 0.677 . . . . 0.0 111.77 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.5 125.19 25.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.49 1.116 . . . . 0.0 111.22 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.57 136.58 56.55 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.046 0.939 . . . . 0.0 111.368 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.16 140.78 58.81 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.157 0.583 . . . . 0.0 111.536 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.99 114.7 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.233 0.613 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 29.1 p -75.52 144.65 41.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.181 0.993 . . . . 0.0 112.698 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.59 148.51 23.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.036 1.334 . . . . 0.0 110.528 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 112.16 1.78 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.657 0.783 . . . . 0.0 112.017 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -81.68 165.27 21.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.608 1.163 . . . . 0.0 111.797 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.58 123.09 16.35 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.66 -0.65 . . . . 0.0 109.578 163.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.6 122.15 12.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.847 1.259 . . . . 0.0 111.835 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.84 143.38 45.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.7 0.8 . . . . 0.0 112.051 170.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.97 9.52 59.97 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.5 126.26 26.71 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.845 1.322 . . . . 0.0 110.918 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -138.48 124.57 20.18 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.385 1.474 . . . . 0.0 110.516 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.11 -44.53 79.72 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.228 1.011 . . . . 0.0 112.244 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.12 108.38 4.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.415 1.086 . . . . 0.0 109.968 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.14 127.65 32.38 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.865 0.866 . . . . 0.0 110.639 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 52.3 p -67.82 156.71 36.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.789 0.835 . . . . 0.0 111.737 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -60.32 119.96 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.617 -0.677 . . . . 0.0 110.094 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.92 130.29 45.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.938 0.895 . . . . 0.0 110.543 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -60.4 123.84 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.335 1.054 . . . . 0.0 111.62 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -85.93 16.25 4.3 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.13 179.5 1.17 Allowed 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.261 -0.899 . . . . 0.0 112.378 165.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t 67.75 -29.49 0.15 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.491 1.916 . . . . 0.0 114.932 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.7 -26.25 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.59 1.956 . . . . 0.0 114.343 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -55.15 -34.21 63.59 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.199 -0.938 . . . . 0.0 112.154 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t -56.18 -48.23 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.916 0.886 . . . . 0.0 110.8 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.1 -42.68 88.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.824 0.85 . . . . 0.0 112.622 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.08 -45.93 86.31 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.382 -0.824 . . . . 0.0 112.33 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.69 -45.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.469 0.708 . . . . 0.0 110.814 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -53.46 -47.85 69.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.422 1.01 . . . . 0.0 112.73 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -53.35 -41.09 65.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 0.0 112.884 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -76.37 -41.23 48.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.378 1.071 . . . . 0.0 112.821 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.37 -55.36 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.207 1.403 . . . . 0.0 112.732 -168.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -149.52 71.04 9.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.574 1.15 . . . . 0.0 111.47 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.03 -20.28 67.47 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.368 2.712 . . . . 0.0 114.666 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.73 -25.62 68.28 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -119.74 126.12 50.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.9 1.28 . . . . 0.0 109.591 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.98 -172.22 25.93 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.06 0.838 . . . . 0.0 113.489 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -140.18 155.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.948 -1.325 . . . . 0.0 111.689 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 42.0 p -89.35 157.04 18.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.683 0.793 . . . . 0.0 113.039 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.969 . . . . 0.0 112.402 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.07 -48.52 81.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.24 1.016 . . . . 0.0 111.373 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.4 94.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 112.73 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.6 mtp -55.11 -46.22 75.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.023 0.829 . . . . 0.0 111.316 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.76 -46.44 67.36 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.313 0.959 . . . . 0.0 114.245 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.07 -45.5 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 118.086 0.943 . . . . 0.0 111.41 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 85.4 mtp -60.37 -36.23 77.58 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.084 -1.01 . . . . 0.0 113.205 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -60.06 -41.3 92.08 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.92 0.782 . . . . 0.0 110.966 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 50.8 m -60.27 -50.17 74.71 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.302 -0.873 . . . . 0.0 112.13 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -52.03 -47.04 65.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.661 0.784 . . . . 0.0 112.683 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.82 -27.34 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.47 -34.18 72.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.378 0.99 . . . . 0.0 111.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.25 -48.01 71.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.83 -42.01 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 119.493 1.042 . . . . 0.0 111.004 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -56.93 -42.74 80.57 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.392 0.996 . . . . 0.0 111.655 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.29 -41.76 98.78 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -62.64 -45.91 90.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.454 1.025 . . . . 0.0 112.726 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.67 -53.49 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.973 0.909 . . . . 0.0 110.538 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.0 87.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.752 0.821 . . . . 0.0 112.368 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.44 59.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.647 1.118 . . . . 0.0 113.69 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -64.11 -41.04 97.4 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.345 -1.091 . . . . 0.0 111.95 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.78 94.9 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.095 -1.003 . . . . 0.0 112.149 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.6 t -60.78 -46.96 88.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.73 1.212 . . . . 0.0 111.726 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -57.37 -46.01 83.81 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.146 -0.971 . . . . 0.0 112.285 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.78 -45.33 86.13 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.508 0.723 . . . . 0.0 111.863 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.84 80.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.811 0.732 . . . . 0.0 112.22 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -58.29 -49.68 76.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.354 0.979 . . . . 0.0 112.256 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -56.53 -38.37 71.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.88 0.764 . . . . 0.0 112.504 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.64 2.8 31.63 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.931 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.45 35.08 22.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.11 2.164 . . . . 0.0 114.343 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -104.33 145.44 30.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.374 1.87 . . . . 0.0 112.249 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 27.2 p -84.32 -51.88 6.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.152 1.381 . . . . 0.0 111.487 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 60.0 m -82.05 127.35 33.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.042 1.337 . . . . 0.0 111.618 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.09 133.89 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.682 1.193 . . . . 0.0 110.971 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 9.4 p -90.93 160.7 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -50.53 -45.77 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 112.666 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.76 -44.96 88.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.199 1.0 . . . . 0.0 111.63 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -59.14 -40.59 85.97 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.625 0.77 . . . . 0.0 112.272 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.73 -52.83 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.066 0.848 . . . . 0.0 110.969 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -57.65 -42.28 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.954 0.797 . . . . 0.0 112.575 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 92.3 m -64.26 -46.27 84.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.153 0.981 . . . . 0.0 111.247 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.4 81.31 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.139 1.336 . . . . 0.0 113.183 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.8 -51.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.873 0.869 . . . . 0.0 110.664 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.39 -27.69 67.3 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 77.1 mt -64.46 -37.79 88.77 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.451 1.023 . . . . 0.0 111.93 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 50.4 mt -79.37 -29.66 42.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.14 68.19 3.44 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.331 1.852 . . . . 0.0 111.39 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.62 -26.65 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.298 2.665 . . . . 0.0 114.716 -172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 138.54 47.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.618 1.104 . . . . 0.0 113.7 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -49.69 -55.09 15.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.826 1.25 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.06 -37.87 84.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.362 0.665 . . . . 0.0 112.472 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.94 80.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.46 0.704 . . . . 0.0 111.668 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -55.61 -49.24 73.32 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.198 0.999 . . . . 0.0 111.57 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -55.94 -57.36 12.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.37 76.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.469 1.108 . . . . 0.0 112.975 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.63 -32.27 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.499 -0.75 . . . . 0.0 112.688 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -67.98 -40.42 83.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.429 0.691 . . . . 0.0 112.237 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.4 -36.6 76.12 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.105 -0.997 . . . . 0.0 111.47 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -43.97 90.33 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.336 0.969 . . . . 0.0 113.965 168.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -58.03 -50.62 72.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.786 1.293 . . . . 0.0 110.98 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.05 -44.81 75.07 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.216 0.606 . . . . 0.0 111.789 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.91 65.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.798 0.839 . . . . 0.0 112.641 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.72 -34.68 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 119.709 1.14 . . . . 0.0 113.352 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 96.4 m -62.79 -37.37 86.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 119.082 0.855 . . . . 0.0 112.196 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.17 -43.6 91.21 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.996 -1.065 . . . . 0.0 111.853 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -58.88 -32.52 69.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -78.74 -7.67 57.99 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t -65.83 130.65 44.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.262 0.937 . . . . 0.0 112.122 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.77 140.85 30.12 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.262 1.025 . . . . 0.0 112.266 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.94 1.296 . . . . 0.0 112.343 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.932 0 CA-C-O 118.946 -0.919 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -56.67 131.43 45.57 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.068 3.179 . . . . 0.0 114.052 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -78.58 -171.99 40.26 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.564 1.078 . . . . 0.0 113.986 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.3 137.54 57.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.557 0.743 . . . . 0.0 111.734 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 34.8 p -71.06 149.02 46.95 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.986 0.914 . . . . 0.0 112.788 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.99 -149.17 19.77 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.197 0.903 . . . . 0.0 112.877 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.48 78.13 7.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.736 1.214 . . . . 0.0 110.69 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.43 10.18 74.61 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 125.155 1.36 . . . . 0.0 115.141 -169.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.24 120.44 32.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -122.51 109.14 13.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.638 1.575 . . . . 0.0 109.381 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.52 49.61 68.31 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.386 0.517 . . . . 0.0 112.266 -167.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.07 -173.08 48.9 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.697 1.141 . . . . 0.0 113.009 -163.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -71.35 120.44 16.93 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.31 -1.112 . . . . 0.0 110.282 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.92 132.81 50.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.434 0.694 . . . . 0.0 111.36 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -62.08 128.86 38.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.941 0.896 . . . . 0.0 110.859 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.41 120.32 12.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.356 0.662 . . . . 0.0 110.871 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.85 0.86 . . . . 0.0 111.232 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 122.63 16.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.25 0.62 . . . . 0.0 110.846 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.88 135.33 55.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.691 0.796 . . . . 0.0 111.274 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.3 p -67.82 161.78 25.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.033 0.933 . . . . 0.0 111.647 171.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.04 106.52 0.85 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.664 0.786 . . . . 0.0 110.731 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 65.8 p -82.76 -26.15 32.14 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.947 1.299 . . . . 0.0 113.35 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 28.3 t -59.78 119.57 7.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.148 0.979 . . . . 0.0 110.854 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -71.05 120.49 16.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.249 1.02 . . . . 0.0 110.987 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 144.18 56.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 112.483 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 179.39 29.29 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.979 1.276 . . . . 0.0 112.984 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.62 139.07 51.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.551 0.74 . . . . 0.0 112.041 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -89.98 139.44 30.6 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.784 0.834 . . . . 0.0 110.202 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -123.69 153.59 66.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.539 1.136 . . . . 0.0 111.155 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.79 -41.0 56.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.026 3.15 . . . . 0.0 114.416 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.27 -33.44 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.122 0.969 . . . . 0.0 113.275 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.73 89.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 113.36 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.85 -50.01 70.55 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.359 1.08 . . . . 0.0 111.921 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.37 -36.35 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 O-C-N 121.899 -0.501 . . . . 0.0 112.263 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -56.85 -53.25 60.01 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.831 1.252 . . . . 0.0 112.119 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -61.52 -42.12 98.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.593 1.157 . . . . 0.0 113.066 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.45 -47.84 78.29 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.871 0.76 . . . . 0.0 111.943 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 56.3 tp -62.06 -47.08 86.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.141 0.882 . . . . 0.0 112.054 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -54.74 -50.14 69.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.533 1.133 . . . . 0.0 112.652 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.79 -36.97 73.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.645 1.178 . . . . 0.0 112.693 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.36 76.49 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.581 1.086 . . . . 0.0 113.941 171.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.0 t30 54.88 35.61 24.76 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.194 1.798 . . . . 0.0 113.512 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.13 -25.91 61.91 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 61.0 p -127.7 161.95 27.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.005 1.722 . . . . 0.0 112.601 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.29 -46.31 87.33 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.11 0.964 . . . . 0.0 112.849 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -114.07 130.79 56.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.863 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.91 97.36 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.5 1.12 . . . . 0.0 109.706 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.22 147.05 43.68 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.247 0.927 . . . . 0.0 112.983 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.29 -58.95 2.96 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.753 0.821 . . . . 0.0 113.059 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.86 88.4 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.11 -59.61 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 119.483 1.642 . . . . 0.0 113.938 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.03 -33.64 98.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.539 2.159 . . . . 0.0 113.058 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.76 -42.67 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.21 1.368 . . . . 0.0 111.584 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -77.22 -38.87 50.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.869 -1.144 . . . . 0.0 113.602 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.91 -43.62 73.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.92 1.236 . . . . 0.0 110.581 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.443 ' HB2' ' H ' ' D' ' 37' ' ' TYR . . . -62.51 -38.92 91.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.943 0.897 . . . . 0.0 112.787 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.656 ' HA ' ' H ' ' D' ' 36' ' ' SER . . . -55.78 -42.94 76.28 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.293 1.406 . . . . 0.0 112.667 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -60.14 -53.39 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.574 0.625 . . . . 0.0 111.39 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.11 -21.59 65.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -48.85 -49.06 41.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.644 1.111 . . . . 0.0 112.062 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -64.03 -29.56 70.7 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -73.59 -51.42 16.95 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.983 0.913 . . . . 0.0 111.659 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 67.8 p -70.88 -21.42 62.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.972 -1.08 . . . . 0.0 113.372 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.55 94.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.244 1.018 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -38.63 91.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.242 0.928 . . . . 0.0 111.768 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mt -56.47 -52.66 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 118.809 0.731 . . . . 0.0 110.148 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.39 -30.04 70.81 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.21 -53.85 42.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.805 1.184 . . . . 0.0 111.165 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.62 -41.51 99.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.856 0.863 . . . . 0.0 111.995 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.38 87.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.317 1.047 . . . . 0.0 111.858 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.75 97.73 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.766 1.175 . . . . 0.0 112.935 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.18 -44.36 95.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.435 1.117 . . . . 0.0 111.253 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.226 -0.921 . . . . 0.0 112.462 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.22 82.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.402 1.081 . . . . 0.0 112.011 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.68 -50.33 63.49 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 0.0 112.21 171.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -58.16 -36.0 72.38 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -87.05 3.34 46.46 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.797 1.239 . . . . 0.0 113.441 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 92.3 mttt 55.64 32.91 20.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.844 2.058 . . . . 0.0 114.257 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.6 152.79 22.01 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.907 1.683 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 30.4 p -109.41 12.17 24.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.014 1.726 . . . . 0.0 112.905 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -133.54 126.65 31.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.472 -1.393 . . . . 0.0 111.268 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.6 127.52 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.027 0.931 . . . . 0.0 109.19 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.04 167.13 13.83 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.987 1.715 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -44.49 -42.71 14.16 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.241 3.294 . . . . 0.0 115.465 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.87 -40.69 93.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.749 0.82 . . . . 0.0 112.887 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -65.66 -41.56 92.38 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.621 0.768 . . . . 0.0 111.904 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.57 -43.9 95.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.41 0.684 . . . . 0.0 111.618 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -56.69 -50.29 72.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.426 1.09 . . . . 0.0 111.713 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.79 -46.85 81.29 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.736 0.698 . . . . 0.0 111.978 173.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.79 62.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.596 0.758 . . . . 0.0 112.593 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 pt -68.34 -30.84 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -65.78 -41.89 91.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.774 1.229 . . . . 0.0 112.388 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -79.57 -7.55 58.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -171.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -124.1 122.0 36.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.952 1.251 . . . . 0.0 111.361 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -53.33 -41.61 65.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.42 1.088 . . . . 0.0 112.516 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -64.08 -29.49 70.63 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.286 -0.883 . . . . 0.0 113.358 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.57 -43.83 30.52 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.607 -0.683 . . . . 0.0 111.306 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -53.93 -45.55 71.27 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.91 0.884 . . . . 0.0 112.261 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.39 -26.5 53.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.086 1.354 . . . . 0.0 113.915 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -91.12 -97.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.088 1.355 . . . . 0.0 110.276 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.13 112.63 7.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.852 1.205 . . . . 0.0 110.617 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.71 -29.73 3.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.991 1.281 . . . . 0.0 113.258 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -66.65 -46.52 75.49 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.088 0.955 . . . . 0.0 111.669 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.93 131.02 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.45 1.1 . . . . 0.0 110.07 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 41.9 m -71.64 109.47 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.548 0.739 . . . . 0.0 109.703 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.3 119.68 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.256 0.622 . . . . 0.0 109.723 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.54 69.42 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.634 0.774 . . . . 0.0 112.589 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -71.3 158.51 36.24 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.222 1.009 . . . . 0.0 112.591 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.81 1.32 61.92 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.332 0.968 . . . . 0.0 115.277 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.83 -179.0 19.31 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.484 1.142 . . . . 0.0 113.323 165.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.57 110.19 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.675 -0.897 . . . . 0.0 110.248 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.93 150.88 92.9 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.826 0.85 . . . . 0.0 111.132 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.47 135.14 67.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.118 2.545 . . . . 0.0 113.168 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.79 91.54 5.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.85 0.86 . . . . 0.0 111.288 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 43.2 pt -62.03 143.31 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.855 0.862 . . . . 0.0 112.939 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -93.26 -20.28 20.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.958 0.903 . . . . 0.0 112.56 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.63 159.02 19.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 0.0 111.967 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.59 122.22 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.594 -0.691 . . . . 0.0 110.016 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -71.76 106.39 4.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.138 0.575 . . . . 0.0 109.593 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.59 140.43 97.51 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.135 0.574 . . . . 0.0 110.98 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -59.29 144.84 99.26 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.607 2.205 . . . . 0.0 111.407 172.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.72 124.21 17.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.301 0.64 . . . . 0.0 110.062 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.45 119.69 7.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.976 0.91 . . . . 0.0 110.004 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -57.14 123.03 13.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.215 1.006 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.17 111.51 5.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 23.4 t -123.13 118.34 27.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.148 1.379 . . . . 0.0 109.73 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -84.57 128.65 34.71 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.689 0.795 . . . . 0.0 110.786 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -74.71 134.82 41.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.702 0.801 . . . . 0.0 111.728 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -99.4 146.49 26.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.024 1.33 . . . . 0.0 111.144 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.04 140.84 58.91 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.418 0.687 . . . . 0.0 111.821 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.87 128.19 34.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.047 0.939 . . . . 0.0 111.409 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.88 132.15 46.3 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.303 0.954 . . . . 0.0 112.835 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 125.532 1.533 . . . . 0.0 112.764 178.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.846 0 CA-C-O 119.901 -0.388 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.76 -1.13 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.235 3.29 . . . . 0.0 114.944 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.18 13.57 81.16 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.356 0.979 . . . . 0.0 114.968 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.8 mmm -89.97 158.16 44.86 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.469 1.508 . . . . 0.0 111.49 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.48 124.24 15.4 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.06 2.507 . . . . 0.0 112.074 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -80.21 125.68 80.89 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.85 0.86 . . . . 0.0 110.985 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.69 -35.65 98.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.121 2.547 . . . . 0.0 114.646 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.42 -11.13 59.92 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.65 120.11 26.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 110.78 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 49.3 p -74.3 -41.29 61.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.454 1.101 . . . . 0.0 112.886 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.45 144.51 97.63 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.233 1.013 . . . . 0.0 112.362 173.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -60.24 150.21 81.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.137 2.558 . . . . 0.0 112.36 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.3 149.99 93.6 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.015 0.526 . . . . 0.0 112.053 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.92 134.12 60.37 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.07 2.514 . . . . 0.0 113.554 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.55 106.7 14.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.976 0.91 . . . . 0.0 109.995 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -104.67 16.53 25.86 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.693 1.597 . . . . 0.0 113.43 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.2 12.74 69.37 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.005 1.288 . . . . 0.0 114.863 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 40.1 p -74.47 155.06 38.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.42 1.488 . . . . 0.0 112.949 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.66 134.57 47.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.885 0.874 . . . . 0.0 110.969 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.68 143.7 57.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.943 0.897 . . . . 0.0 111.427 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.05 138.89 58.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.261 0.624 . . . . 0.0 111.558 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.81 115.39 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.316 0.646 . . . . 0.0 109.543 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -73.92 157.76 35.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.592 1.157 . . . . 0.0 112.641 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.75 119.5 7.24 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.179 0.992 . . . . 0.0 111.125 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.54 119.78 9.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.505 0.722 . . . . 0.0 110.706 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -73.67 142.08 46.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.522 0.729 . . . . 0.0 111.502 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.92 142.32 58.35 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.633 0.773 . . . . 0.0 111.429 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.98 145.17 53.8 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.973 0.909 . . . . 0.0 111.111 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.02 124.29 22.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.92 0.39 . . . . 0.0 111.735 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.69 160.12 37.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.714 0.674 . . . . 0.0 112.32 166.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.63 109.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.808 0.843 . . . . 0.0 110.829 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.73 148.85 41.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.573 1.149 . . . . 0.0 110.279 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -62.14 102.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.413 0.685 . . . . 0.0 110.695 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.57 140.8 51.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.572 1.149 . . . . 0.0 109.371 171.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -67.53 107.32 2.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.204 0.602 . . . . 0.0 110.771 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 27.8 t -78.69 -49.54 12.96 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.565 0.746 . . . . 0.0 110.795 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -80.65 109.92 15.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.001 1.32 . . . . 0.0 110.437 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.47 133.13 51.28 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 110.025 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -137.25 132.34 33.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' SER . . . . . 0.656 ' H ' ' HA ' ' C' ' 53' ' ' ALA 0.371 5.0 m 78.88 142.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 131.417 3.887 . . . . 0.0 119.809 168.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' TYR . . . . . 0.443 ' H ' ' HB2' ' C' ' 52' ' ' ALA . 0.0 OUTLIER -92.58 -9.15 42.17 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 119.126 3.01 . . . . 0.0 119.126 -137.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 38.3 t -163.19 -60.42 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -170.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -46.37 -51.46 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 127.109 2.164 . . . . 0.0 111.97 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.36 -41.39 10.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 p -51.31 -27.43 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 120.928 1.695 . . . . 0.0 114.627 -171.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -45.79 -34.68 3.84 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.746 1.618 . . . . 0.0 113.046 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -50.23 -33.93 21.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.497 -1.377 . . . . 0.0 114.086 171.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.5 -50.71 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.456 1.025 . . . . 0.0 110.454 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -51.87 66.76 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.876 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -51.0 -40.45 58.15 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -80.55 -50.29 10.21 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 113.179 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.44 -47.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.738 0.815 . . . . 0.0 111.937 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -131.24 84.9 55.53 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.598 1.559 . . . . 0.0 110.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.4 -31.26 76.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.571 2.847 . . . . 0.0 115.161 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -70.13 -19.51 63.22 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -94.59 133.16 38.53 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.855 1.262 . . . . 0.0 112.048 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.34 -172.49 13.22 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.731 1.158 . . . . 0.0 114.691 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -121.96 162.21 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.616 1.566 . . . . 0.0 110.284 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -89.45 163.58 15.2 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.958 168.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -55.84 -41.22 73.96 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.169 0.988 . . . . 0.0 111.845 168.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.43 -41.15 93.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.308 1.043 . . . . 0.0 112.176 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.32 92.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.763 0.825 . . . . 0.0 112.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 56.6 tpp -52.9 -48.26 67.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.005 168.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.55 -45.39 77.23 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.497 1.046 . . . . 0.0 114.729 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.72 -42.55 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.49 1.145 . . . . 0.0 112.011 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.73 -41.0 94.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.936 -1.102 . . . . 0.0 111.46 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -60.79 -47.3 86.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.848 0.859 . . . . 0.0 112.083 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 81.0 p -64.81 -39.63 93.91 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.572 1.533 . . . . 0.0 112.775 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -51.82 -55.83 17.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.93 1.292 . . . . 0.0 111.908 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.35 -31.2 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -60.94 -44.07 97.76 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.058 0.845 . . . . 0.0 112.04 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.49 -42.22 87.09 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.727 -0.608 . . . . 0.0 111.987 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.99 -43.28 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.34 -0.85 . . . . 0.0 111.466 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.36 -44.56 76.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.418 1.463 . . . . 0.0 112.501 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.717 0.69 . . . . 0.0 111.743 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -61.68 -43.76 98.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.775 0.83 . . . . 0.0 112.881 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -52.95 -52.8 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.555 1.142 . . . . 0.0 110.132 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.36 90.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.28 -50.85 61.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.892 0.758 . . . . 0.0 113.235 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -64.17 -41.45 97.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.604 -0.939 . . . . 0.0 112.156 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.15 94.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.419 1.009 . . . . 0.0 112.007 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -57.8 -53.77 54.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.291 1.036 . . . . 0.0 111.866 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -51.88 -54.75 25.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.169 0.987 . . . . 0.0 112.025 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.62 -44.51 89.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.297 1.039 . . . . 0.0 112.705 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.39 79.35 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.967 0.803 . . . . 0.0 112.138 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -63.14 -45.33 92.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.776 0.83 . . . . 0.0 112.594 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -60.62 -35.94 77.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.076 0.95 . . . . 0.0 112.45 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -86.18 15.49 5.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.613 1.565 . . . . 0.0 113.215 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 55.3 29.04 12.2 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.547 2.339 . . . . 0.0 115.075 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -81.77 152.92 26.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.489 1.116 . . . . 0.0 112.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 53.9 p -71.13 -35.6 71.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.834 1.253 . . . . 0.0 112.824 170.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 7.2 t -143.73 167.39 22.4 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.39 1.476 . . . . 0.0 112.806 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 84.1 mt -71.45 138.19 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.51 1.524 . . . . 0.0 110.457 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 16.7 p -112.51 166.16 11.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.511 1.125 . . . . 0.0 111.814 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 31.7 p -51.56 -41.66 61.29 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.403 1.081 . . . . 0.0 112.67 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.51 -45.76 89.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.3 1.04 . . . . 0.0 111.932 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.87 -40.68 96.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.323 0.51 . . . . 0.0 112.276 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.5 -51.78 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.685 0.794 . . . . 0.0 110.963 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -53.2 -48.63 67.95 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.68 1.127 . . . . 0.0 111.852 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 77.1 m -60.49 -46.28 90.67 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.187 0.903 . . . . 0.0 112.16 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.29 72.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.475 1.034 . . . . 0.0 112.753 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -60.31 -50.92 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.005 0.922 . . . . 0.0 110.583 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -58.42 -39.52 80.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.493 1.117 . . . . 0.0 113.748 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 72.4 mt -58.08 -44.2 87.42 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.721 0.691 . . . . 0.0 112.212 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.11 -37.76 64.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.226 1.01 . . . . 0.0 112.139 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.34 80.04 20.71 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 126.565 1.946 . . . . 0.0 111.059 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -77.09 178.47 7.6 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 124.395 3.397 . . . . 0.0 114.359 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.45 41.35 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.102 1.334 . . . . 0.0 114.113 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.73 -34.74 69.83 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.24 -1.153 . . . . 0.0 112.021 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 45.2 mt -64.0 -28.86 70.1 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.441 -0.787 . . . . 0.0 112.328 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.13 69.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.467 1.03 . . . . 0.0 111.957 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.09 -44.81 91.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.21 1.004 . . . . 0.0 110.919 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -60.42 -48.72 80.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.911 0.484 . . . . 0.0 112.032 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.45 66.35 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.78 -49.35 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 118.539 0.609 . . . . 0.0 111.628 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -61.82 -57.23 12.63 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -63.99 -44.17 93.49 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.381 -0.825 . . . . 0.0 111.428 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.54 -35.36 66.36 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.631 -0.668 . . . . 0.0 113.457 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -71.75 -45.03 62.99 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.571 1.185 . . . . 0.0 111.769 172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -53.68 -38.79 64.56 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.923 1.238 . . . . 0.0 112.967 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.5 -54.9 30.5 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.365 0.666 . . . . 0.0 112.238 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.72 -43.92 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.447 1.099 . . . . 0.0 111.283 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 44.0 m -52.26 -47.53 65.76 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.396 0.998 . . . . 0.0 112.201 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -65.92 -15.94 63.42 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -90.25 -41.28 11.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.089 0.955 . . . . 0.0 112.541 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -70.09 -25.53 63.56 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.139 -0.975 . . . . 0.0 113.098 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 59.6 p -82.59 -8.49 59.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 171.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.02 165.15 22.44 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.982 0.913 . . . . 0.0 113.324 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.347 1.459 . . . . 0.0 113.175 179.13 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.02 142.76 48.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.884 0.754 . . . . 0.0 112.862 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.28 68.79 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.281 1.041 . . . . 0.0 113.513 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.98 -24.98 76.15 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.445 1.021 . . . . 0.0 114.982 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.22 -55.82 37.96 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.355 1.578 . . . . 0.0 114.36 -174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.83 -34.41 95.65 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.357 2.038 . . . . 0.0 113.068 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.69 -51.02 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.155 0.888 . . . . 0.0 110.91 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -66.78 -42.28 86.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.589 0.756 . . . . 0.0 110.118 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 69.7 mt -63.32 -35.16 79.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.932 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.21 93.21 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.508 1.504 . . . . 0.0 112.077 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.39 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.92 0.488 . . . . 0.0 111.864 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -51.57 -53.86 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.512 1.125 . . . . 0.0 111.393 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 mt -53.11 -49.1 67.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.718 1.607 . . . . 0.0 112.104 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -48.04 -51.63 23.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.49 1.041 . . . . 0.0 111.985 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -69.45 -31.99 70.65 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.53 -23.3 57.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 1.5 p -119.22 5.12 11.24 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.598 1.544 . . . . 0.0 114.867 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.65 73.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.165 1.348 . . . . 0.0 112.718 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -70.1 -32.96 71.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.8 -54.14 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.012 0.925 . . . . 0.0 109.667 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.92 -46.48 81.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.51 1.524 . . . . 0.0 112.551 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -54.71 -56.78 15.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.586 0.754 . . . . 0.0 111.514 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.43 -38.07 71.4 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.0 99.45 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.334 -0.854 . . . . 0.0 111.802 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.97 94.99 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.506 -0.746 . . . . 0.0 113.596 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -58.8 -49.89 76.01 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.848 1.324 . . . . 0.0 110.603 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.78 80.96 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.63 0.772 . . . . 0.0 112.509 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.1 75.36 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.817 0.847 . . . . 0.0 112.606 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -56.82 -50.95 70.84 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.436 1.094 . . . . 0.0 112.289 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -55.51 -42.01 73.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.613 1.165 . . . . 0.0 113.075 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.79 10.68 17.62 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.625 1.17 . . . . 0.0 113.089 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 53.63 33.32 16.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.392 2.277 . . . . 0.0 114.777 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -89.29 146.51 24.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.23 1.412 . . . . 0.0 112.386 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.6 p -77.91 -30.63 50.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.881 1.272 . . . . 0.0 112.967 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -131.24 151.76 51.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.126 1.37 . . . . 0.0 112.603 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.7 mt -67.46 129.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 0.0 109.928 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 pt -122.71 167.1 15.16 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.429 1.892 . . . . 0.0 111.265 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -54.55 -34.5 82.73 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.344 2.696 . . . . 0.0 114.952 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.03 -36.75 75.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.988 0.915 . . . . 0.0 113.252 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -63.23 -38.69 92.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.551 -0.718 . . . . 0.0 111.982 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.21 -46.27 71.05 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.502 0.721 . . . . 0.0 111.761 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -50.65 -46.64 58.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.725 0.81 . . . . 0.0 111.746 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.83 -62.31 1.73 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.944 0.898 . . . . 0.0 112.173 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.99 69.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.755 1.222 . . . . 0.0 113.074 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -56.87 -61.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.857 0.863 . . . . 0.0 110.741 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.0 -32.69 74.11 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -86.79 -8.59 57.21 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -129.3 118.1 21.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 112.407 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.78 -26.81 67.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.822 -1.173 . . . . 0.0 114.067 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -70.98 -31.36 67.89 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 111.489 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.75 -36.94 67.81 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 111.493 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.54 -29.38 66.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.406 1.003 . . . . 0.0 112.771 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -77.11 -46.0 25.01 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.417 1.008 . . . . 0.0 112.417 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 mt -57.18 -45.1 83.98 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.083 0.953 . . . . 0.0 112.877 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 123.763 0.825 . . . . 0.0 111.992 178.045 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.25 96.06 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.12 140.37 97.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.33 0.652 . . . . 0.0 110.789 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -58.66 149.52 76.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.44 2.093 . . . . 0.0 111.15 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.15 109.26 1.06 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.783 -0.573 . . . . 0.0 109.929 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.31 131.45 46.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.921 0.889 . . . . 0.0 110.387 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -63.34 155.57 28.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.275 0.63 . . . . 0.0 110.813 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.84 121.05 10.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.296 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -58.46 136.7 57.56 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.406 0.682 . . . . 0.0 111.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.8 100.39 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.102 0.561 . . . . 0.0 111.309 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 N--CA 1.469 0.492 0 C-N-CA 124.546 1.138 . . . . 0.0 111.409 174.477 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.92 -41.47 74.58 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.14 -58.34 8.34 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 0.0 112.223 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 51.6 t -71.97 -35.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.962 -0.461 . . . . 0.0 111.372 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 tp -50.15 -57.54 7.49 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.679 169.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.77 -34.21 77.65 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -63.72 -50.16 70.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.509 0.724 . . . . 0.0 112.546 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.37 -44.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.921 0.889 . . . . 0.0 111.966 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.41 66.05 61.02 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.52 1.928 . . . . 0.0 111.445 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -55.99 -25.88 56.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.016 3.144 . . . . 0.0 114.18 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.3 -14.21 59.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.521 2.328 . . . . 0.0 114.2 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -121.17 126.21 49.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.527 1.131 . . . . 0.0 111.741 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.68 -164.75 40.54 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.071 0.843 . . . . 0.0 113.667 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.9 tt -143.79 149.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.99 -1.3 . . . . 0.0 111.73 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -80.69 156.07 26.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -56.65 -39.25 73.37 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.243 -0.91 . . . . 0.0 112.128 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.98 -55.82 29.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.189 1.396 . . . . 0.0 111.57 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.95 -42.08 97.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.469 0.708 . . . . 0.0 112.558 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 53.9 ttp -54.59 -53.55 53.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.846 0.859 . . . . 0.0 111.681 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.4 85.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.786 0.708 . . . . 0.0 113.069 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.84 -48.33 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.161 0.984 . . . . 0.0 111.113 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 65.1 mtt -57.5 -41.64 81.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.984 1.265 . . . . 0.0 112.615 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.86 -52.06 67.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.432 0.56 . . . . 0.0 110.727 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 72.8 m -54.92 -47.57 74.23 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.12 0.873 . . . . 0.0 112.794 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -54.54 -46.89 73.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 112.02 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -44.1 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.513 0.597 . . . . 0.0 111.739 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.06 -41.98 84.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.356 0.98 . . . . 0.0 111.933 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -60.0 -31.14 69.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 tp -90.9 -34.1 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 111.707 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.13 -42.05 89.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.61 1.164 . . . . 0.0 112.46 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -56.82 -44.38 81.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.371 1.068 . . . . 0.0 111.925 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -64.93 -44.87 88.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.053 0.941 . . . . 0.0 111.76 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.52 -49.4 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.707 1.203 . . . . 0.0 110.986 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.37 81.96 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 112.359 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.87 -46.11 90.86 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.268 0.937 . . . . 0.0 113.594 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.6 -41.89 87.75 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.379 -1.071 . . . . 0.0 112.856 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.47 94.36 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.156 0.889 . . . . 0.0 111.53 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -57.69 -49.76 75.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.418 1.087 . . . . 0.0 111.928 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.74 -49.86 67.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.471 1.109 . . . . 0.0 112.039 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.9 -48.22 78.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.685 0.794 . . . . 0.0 111.733 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -44.97 73.92 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.766 0.712 . . . . 0.0 112.473 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -57.6 -52.21 66.37 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.898 . . . . 0.0 112.387 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -62.43 -32.75 73.65 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -81.16 4.8 18.83 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.908 1.283 . . . . 0.0 113.627 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 56.86 31.9 20.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.968 2.107 . . . . 0.0 114.275 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -101.08 140.97 34.64 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.6 1.56 . . . . 0.0 112.074 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 61.0 p -79.68 -19.63 48.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.844 1.258 . . . . 0.0 113.086 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 63.7 p -114.73 148.91 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.87 2.068 . . . . 0.0 111.651 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.75 129.32 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.202 1.001 . . . . 0.0 110.014 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 6.1 p -83.37 162.42 21.06 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.016 0.912 . . . . 0.0 113.31 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -65.78 -10.29 36.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 0.0 114.295 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.44 -40.97 8.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.17 1.388 . . . . 0.0 112.187 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.53 -39.97 74.3 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.118 0.967 . . . . 0.0 112.663 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -57.81 -41.32 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -61.86 -49.5 75.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.229 0.922 . . . . 0.0 110.376 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 45.2 m -60.81 -46.86 88.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.397 1.079 . . . . 0.0 111.833 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.2 -46.93 65.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.445 1.098 . . . . 0.0 112.525 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.5 -51.23 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.605 0.762 . . . . 0.0 111.008 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -53.96 -45.78 71.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.114 0.966 . . . . 0.0 112.598 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.92 -36.77 72.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.875 1.27 . . . . 0.0 112.962 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.81 -22.41 25.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.551 1.14 . . . . 0.0 113.787 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 124.736 1.214 . . . . 0.0 112.108 -172.743 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.59 -179.22 27.29 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.947 0.784 . . . . 0.0 113.48 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.46 -50.04 23.7 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.578 -0.954 . . . . 0.0 111.997 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.76 -26.69 55.76 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.71 1.148 . . . . 0.0 115.458 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.78 -52.33 73.13 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.77 -37.1 89.0 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.59 2.194 . . . . 0.0 112.914 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.77 -40.97 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.755 0.822 . . . . 0.0 110.827 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.69 -45.12 87.98 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.373 -0.83 . . . . 0.0 112.547 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.01 -40.45 89.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.647 1.112 . . . . 0.0 111.827 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.38 90.45 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.346 -0.846 . . . . 0.0 111.334 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.88 -18.64 57.44 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.52 -59.43 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.322 -0.861 . . . . 0.0 110.733 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.67 -21.27 64.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.299 1.04 . . . . 0.0 112.869 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -37.7 -49.3 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.594 1.958 . . . . 0.0 112.917 159.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -61.18 -50.24 73.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.917 0.78 . . . . 0.0 112.5 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.34 -48.4 81.77 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.621 . . . . 0.0 111.348 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 71.8 m -60.98 -41.18 95.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.665 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.04 83.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.323 0.965 . . . . 0.0 112.086 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -56.5 -46.44 80.5 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.048 0.84 . . . . 0.0 112.561 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 86.5 mt -57.66 -57.76 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.698 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.01 -30.81 69.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.3 -55.22 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.909 1.231 . . . . 0.0 111.192 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.21 -36.68 84.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.647 -0.658 . . . . 0.0 112.102 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.57 96.83 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.477 -0.765 . . . . 0.0 112.433 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.38 -40.03 95.53 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.179 0.895 . . . . 0.0 113.175 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -64.2 -44.56 91.57 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.726 -0.867 . . . . 0.0 111.271 172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -42.98 87.84 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.287 0.949 . . . . 0.0 112.435 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.43 79.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.717 0.807 . . . . 0.0 112.281 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -55.86 -48.14 76.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.386 1.074 . . . . 0.0 112.164 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.77 -39.34 77.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.174 0.989 . . . . 0.0 113.519 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.79 2.97 27.6 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 57.22 32.54 21.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.502 1.921 . . . . 0.0 113.811 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.97 146.27 28.59 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.817 1.647 . . . . 0.0 112.332 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -100.48 9.58 42.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.696 1.598 . . . . 0.0 113.492 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.51 136.22 44.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.831 -1.168 . . . . 0.0 111.304 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.72 131.09 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.029 0.932 . . . . 0.0 109.732 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.87 165.93 14.12 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 125.936 1.694 . . . . 0.0 111.807 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -46.13 -44.47 19.4 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.26 3.306 . . . . 0.0 115.586 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.776 0.83 . . . . 0.0 112.702 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.38 -44.5 95.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.848 0.859 . . . . 0.0 112.16 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.24 -42.07 96.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.92 0.888 . . . . 0.0 111.804 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.865 0.866 . . . . 0.0 111.788 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.03 -46.94 72.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.662 1.185 . . . . 0.0 112.064 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.96 -47.54 64.73 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 94.1 mt -65.46 -55.46 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.35 0.66 . . . . 0.0 110.944 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -54.95 -37.84 66.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.603 1.161 . . . . 0.0 113.506 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.87 0.43 54.96 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -125.02 127.16 46.55 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.752 1.16 . . . . 0.0 112.943 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -57.11 -51.35 69.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.021 0.929 . . . . 0.0 112.918 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -66.24 -34.12 77.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 112.2 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.28 -41.04 73.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.293 0.637 . . . . 0.0 112.575 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -58.88 -40.06 83.24 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.463 1.483 . . . . 0.0 111.88 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.69 -3.18 1.38 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.32 1.448 . . . . 0.0 114.879 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -76.15 -73.32 0.28 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.76 1.164 . . . . 0.0 110.147 167.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 123.715 0.806 . . . . 0.0 112.873 -173.339 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.21 114.0 6.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.061 1.344 . . . . 0.0 110.929 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 37.3 tp -64.61 127.9 92.91 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.143 0.977 . . . . 0.0 110.531 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.35 119.72 7.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.747 2.298 . . . . 0.0 112.09 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.05 138.05 40.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.047 0.939 . . . . 0.0 111.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.68 140.19 58.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.851 0.861 . . . . 0.0 111.496 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -73.33 150.95 41.48 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.068 0.947 . . . . 0.0 112.089 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -90.92 139.14 31.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 111.824 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -81.09 124.78 29.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.43 0.692 . . . . 0.0 110.827 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -108.97 6.37 25.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.73 1.212 . . . . 0.0 113.058 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 124.848 1.259 . . . . 0.0 112.274 172.613 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -62.31 -29.95 70.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.541 0.736 . . . . 0.0 112.573 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.04 -50.04 72.23 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.337 0.971 . . . . 0.0 111.568 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -52.47 -52.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 119.524 1.056 . . . . 0.0 110.202 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.94 -52.59 64.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.89 0.876 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.38 -35.02 73.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.779 1.232 . . . . 0.0 114.001 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.5 -42.03 59.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.272 0.942 . . . . 0.0 112.812 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -87.09 -61.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.318 1.047 . . . . 0.0 112.231 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -137.23 91.43 14.57 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.683 1.593 . . . . 0.0 110.57 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -56.36 -29.24 76.26 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.814 3.009 . . . . 0.0 115.173 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -84.35 -1.78 56.02 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.479 1.912 . . . . 0.0 113.951 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -111.28 137.63 48.77 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.259 1.424 . . . . 0.0 111.848 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.84 14.18 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.954 1.74 . . . . 0.0 113.233 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.64 141.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 110.207 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -73.99 155.79 38.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.653 -0.655 . . . . 0.0 112.72 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p -57.32 -37.24 72.21 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.288 -0.882 . . . . 0.0 112.005 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.34 -47.48 85.71 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.948 1.299 . . . . 0.0 111.998 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.32 94.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.832 0.853 . . . . 0.0 112.933 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.76 -39.09 87.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.473 1.033 . . . . 0.0 111.896 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -44.46 76.9 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.247 0.927 . . . . 0.0 113.167 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -68.58 -35.1 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.315 1.058 . . . . 0.0 112.531 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 38.3 tpp -57.95 -41.14 82.21 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.65 -1.282 . . . . 0.0 111.284 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -65.83 -35.34 80.41 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.045 -1.034 . . . . 0.0 112.216 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 47.7 m -58.55 -39.4 80.14 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.27 -1.519 . . . . 0.0 112.19 167.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.94 -33.51 76.2 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.628 -1.295 . . . . 0.0 113.134 172.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' VAL . . . . . 0.463 ' HA ' ' CD2' ' D' ' 70' ' ' PHE . 47.0 t -57.96 -52.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.45 1.023 . . . . 0.0 110.935 165.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -64.92 -32.46 74.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.856 0.863 . . . . 0.0 113.249 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.1 -63.82 1.22 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.219 1.408 . . . . 0.0 113.505 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 81.2 mt -68.15 -51.8 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.155 0.982 . . . . 0.0 111.196 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' D' ' 66' ' ' VAL . 9.1 m-30 -66.85 -35.98 81.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.547 -0.721 . . . . 0.0 111.051 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.12 -47.64 84.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.171 0.988 . . . . 0.0 112.62 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.28 -46.69 85.57 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.133 -0.98 . . . . 0.0 112.113 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.01 -44.15 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 118.762 0.71 . . . . 0.0 111.368 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.48 84.55 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.302 0.956 . . . . 0.0 112.392 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.17 -47.15 91.12 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.429 1.014 . . . . 0.0 113.547 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -64.83 -45.17 87.3 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.478 -1.013 . . . . 0.0 112.607 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.25 83.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.215 173.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -60.17 -53.12 61.5 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.254 1.022 . . . . 0.0 111.639 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -57.37 -42.06 81.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.33 -0.857 . . . . 0.0 112.811 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.86 -46.0 90.68 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.692 1.197 . . . . 0.0 112.012 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.98 96.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.91 0.884 . . . . 0.0 112.427 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -60.91 -40.66 94.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.387 1.075 . . . . 0.0 112.839 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -57.6 -37.96 74.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.615 0.766 . . . . 0.0 112.135 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -86.43 15.7 5.2 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.204 1.402 . . . . 0.0 113.737 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 52.25 28.05 5.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.466 2.306 . . . . 0.0 115.121 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -71.76 156.71 39.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.429 1.091 . . . . 0.0 112.805 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 63.7 p -80.52 -29.44 37.22 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.713 1.205 . . . . 0.0 113.068 165.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 5.7 t -141.96 168.73 19.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.578 1.551 . . . . 0.0 113.048 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.18 107.05 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 19.2 p -88.75 169.28 11.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.332 1.053 . . . . 0.0 112.277 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 46.3 p -52.99 -36.95 60.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.209 -0.932 . . . . 0.0 112.946 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.43 -42.9 67.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.683 1.193 . . . . 0.0 112.267 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -61.8 -42.56 99.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.476 0.58 . . . . 0.0 111.736 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.94 -50.58 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.613 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -49.12 -53.69 19.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.829 1.195 . . . . 0.0 111.296 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 55.9 m -59.77 -43.26 94.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.616 -0.677 . . . . 0.0 111.968 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.68 75.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.461 1.028 . . . . 0.0 112.324 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -35.33 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.549 -1.345 . . . . 0.0 112.415 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.04 -21.47 64.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.777 1.171 . . . . 0.0 113.388 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.82 -43.14 22.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.357 1.063 . . . . 0.0 111.93 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.82 -25.99 66.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 127.033 2.133 . . . . 0.0 110.813 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.68 152.25 42.42 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.003 0.811 . . . . 0.0 112.731 171.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.24 -31.84 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.305 -1.115 . . . . 0.0 113.46 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.45 -22.35 77.71 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.659 1.123 . . . . 0.0 115.27 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.31 -54.2 58.26 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 119.653 1.727 . . . . 0.0 113.672 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -56.74 -31.4 87.87 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.022 1.815 . . . . 0.0 113.761 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.4 -46.78 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.821 1.191 . . . . 0.0 111.109 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -67.76 -38.75 83.84 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.18 -0.95 . . . . 0.0 113.096 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.66 -42.6 97.33 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.684 -1.26 . . . . 0.0 111.349 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.57 71.51 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.295 -0.878 . . . . 0.0 112.736 169.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.49 75.99 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 120.239 1.381 . . . . 0.0 113.498 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.99 -47.56 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.882 -1.136 . . . . 0.0 109.731 168.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.22 -39.43 86.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.689 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -52.85 -47.24 67.9 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.704 1.593 . . . . 0.0 112.595 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -57.91 -43.77 86.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.675 -0.64 . . . . 0.0 111.925 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.2 -34.4 70.83 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.969 -1.082 . . . . 0.0 112.877 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 88.7 m -53.65 -49.54 67.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.904 1.281 . . . . 0.0 110.071 164.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.38 82.91 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.196 0.907 . . . . 0.0 112.941 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.32 -43.26 91.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.751 1.16 . . . . 0.0 113.389 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.27 -43.62 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.781 -1.2 . . . . 0.0 110.137 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.06 -30.53 71.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.023 0.929 . . . . 0.0 113.331 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -63.59 -49.13 74.55 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.004 1.275 . . . . 0.0 111.384 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.06 -46.69 82.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.752 0.821 . . . . 0.0 111.253 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.95 78.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.969 0.908 . . . . 0.0 113.138 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -45.78 95.18 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.995 1.283 . . . . 0.0 112.765 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.89 -43.92 97.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.331 1.066 . . . . 0.0 111.423 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.47 75.99 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.573 -0.705 . . . . 0.0 112.845 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -45.63 82.43 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.158 -0.964 . . . . 0.0 112.336 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.25 -42.76 73.88 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.213 1.405 . . . . 0.0 112.982 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -57.16 -22.97 44.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -106.65 4.81 28.29 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.677 1.591 . . . . 0.0 112.838 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.18 31.73 14.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.965 2.106 . . . . 0.0 114.191 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.24 156.22 17.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.19 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.4 p -114.51 15.87 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.494 1.918 . . . . 0.0 112.961 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -133.61 129.43 36.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.098 1.359 . . . . 0.0 110.745 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -73.99 124.35 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 109.837 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 pt -126.0 169.94 10.56 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.788 1.635 . . . . 0.0 111.053 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.66 -34.34 83.23 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.191 2.594 . . . . 0.0 114.703 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.14 -24.57 67.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -81.79 -38.27 25.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.108 0.963 . . . . 0.0 111.865 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.73 0.696 . . . . 0.0 112.555 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -57.09 -57.75 11.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.166 -0.959 . . . . 0.0 111.159 166.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.01 -43.55 91.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.941 0.896 . . . . 0.0 112.72 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.43 45.11 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 15.5 mt -113.96 -63.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.884 1.274 . . . . 0.0 110.278 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.97 -27.87 69.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -99.94 0.78 41.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.763 1.225 . . . . 0.0 113.018 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.65 114.15 26.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.435 1.016 . . . . 0.0 110.417 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -49.61 -43.52 46.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.461 1.504 . . . . 0.0 113.093 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.788 0.835 . . . . 0.0 112.157 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.89 -17.63 61.5 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.21 -0.9 . . . . 0.0 112.484 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.39 -34.69 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.286 1.403 . . . . 0.0 112.591 165.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.54 -30.24 65.67 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.121 -0.987 . . . . 0.0 112.882 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 66.9 tp -92.7 -52.27 4.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 CA--C 1.548 0.899 0 C-N-CA 126.32 1.848 . . . . 0.0 110.534 -169.242 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 62.6 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -66.2 110.77 3.13 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.644 . . . . 0.0 109.366 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.07 123.33 83.66 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.563 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.68 138.73 71.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.763 2.309 . . . . 0.0 111.676 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.62 113.93 2.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.516 0.726 . . . . 0.0 109.466 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.7 117.64 15.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.627 0.771 . . . . 0.0 110.502 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 86.8 m -107.25 108.22 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.756 1.222 . . . . 0.0 108.354 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -65.93 127.33 31.64 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.149 0.58 . . . . 0.0 110.858 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 18.4 p -71.27 138.18 49.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.861 0.865 . . . . 0.0 113.063 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.42 -29.35 47.09 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.977 0.911 . . . . 0.0 112.333 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.009 1.323 . . . . 0.0 111.43 171.991 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -67.32 -41.85 84.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.189 -0.945 . . . . 0.0 112.165 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -54.7 -37.75 66.19 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.063 0.847 . . . . 0.0 112.43 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.03 -48.79 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.464 0.706 . . . . 0.0 111.896 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 34.4 tp -50.67 -42.95 57.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.634 1.106 . . . . 0.0 112.72 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.51 -24.78 22.07 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -72.2 -32.0 66.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.314 1.045 . . . . 0.0 112.662 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.83 -41.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.7 1.2 . . . . 0.0 113.536 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -135.45 70.73 67.03 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.47 1.508 . . . . 0.0 110.692 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -58.06 -23.09 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.611 2.874 . . . . 0.0 113.974 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -77.46 -6.51 53.75 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.656 1.982 . . . . 0.0 113.963 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 98.8 m -115.37 129.77 56.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.271 1.428 . . . . 0.0 111.34 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.09 175.15 41.2 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.974 1.273 . . . . 0.0 113.423 172.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.83 140.65 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.167 -1.196 . . . . 0.0 110.923 171.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 34.4 p -73.2 154.5 40.24 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 38.6 p -54.68 -44.02 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.025 0.93 . . . . 0.0 112.291 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.82 -46.9 87.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.792 1.237 . . . . 0.0 112.155 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.28 89.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.354 0.661 . . . . 0.0 112.263 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 74.8 mtm -60.78 -40.89 94.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.08 -1.012 . . . . 0.0 112.449 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.18 -42.17 97.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.665 1.126 . . . . 0.0 113.899 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.01 -51.84 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.25 1.02 . . . . 0.0 110.073 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 46.3 mtp -61.29 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -50.66 -50.62 54.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.501 1.5 . . . . 0.0 112.339 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -59.37 -55.8 30.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.634 0.774 . . . . 0.0 111.519 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -61.71 -43.89 97.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.61 -51.18 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.391 0.996 . . . . 0.0 110.908 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -62.02 -40.92 97.33 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.739 0.7 . . . . 0.0 111.569 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -56.54 -28.89 61.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.8 mt -49.75 -57.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.36 1.437 . . . . 0.0 109.917 172.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.8 -52.91 38.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 0.0 111.335 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -54.73 -35.49 63.75 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.79 -53.19 5.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.352 1.061 . . . . 0.0 112.1 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.76 -58.58 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 120.263 1.392 . . . . 0.0 111.386 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.41 62.93 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.481 -0.762 . . . . 0.0 112.106 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.0 -47.91 88.71 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 118.9 0.773 . . . . 0.0 113.164 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.16 -39.86 93.55 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.197 -1.179 . . . . 0.0 112.214 172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.57 78.79 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.045 -1.034 . . . . 0.0 112.222 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -60.63 -50.6 72.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.063 0.945 . . . . 0.0 111.271 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -51.09 -48.99 61.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.11 0.868 . . . . 0.0 111.946 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.01 -48.67 75.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.577 0.751 . . . . 0.0 111.773 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.73 73.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.741 0.816 . . . . 0.0 112.916 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -58.48 -52.18 66.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.432 1.015 . . . . 0.0 111.467 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -60.95 -35.07 75.78 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -82.57 5.41 21.01 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.817 1.247 . . . . 0.0 113.769 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 56.19 34.3 23.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.998 2.119 . . . . 0.0 114.328 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -101.13 142.71 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.725 1.61 . . . . 0.0 112.626 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 48.4 p -83.73 -22.27 32.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.467 1.507 . . . . 0.0 113.498 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 40.1 m -126.22 128.98 48.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.508 1.523 . . . . 0.0 111.41 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.92 130.62 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.17 1.388 . . . . 0.0 110.737 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.1 p -84.33 160.19 20.74 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 41.3 p -55.34 -38.8 69.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.068 -1.02 . . . . 0.0 112.433 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.32 -43.59 90.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.686 1.194 . . . . 0.0 112.287 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -62.11 -41.86 98.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.498 0.719 . . . . 0.0 112.305 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.64 -54.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.517 0.599 . . . . 0.0 109.864 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -55.31 -42.1 73.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.246 0.93 . . . . 0.0 112.818 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 89.4 m -62.34 -50.31 72.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.397 1.079 . . . . 0.0 111.707 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.28 84.32 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.561 1.073 . . . . 0.0 112.691 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.49 -56.05 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.504 1.122 . . . . 0.0 110.264 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -57.44 -41.91 81.39 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.789 1.177 . . . . 0.0 113.405 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.54 -45.37 91.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 112.418 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -89.54 -23.36 22.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.552 1.032 0 C-N-CA 127.139 2.176 . . . . 0.0 110.813 176.144 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.82 -165.18 10.28 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.502 1.525 . . . . 0.0 111.022 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.99 -30.21 24.06 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.44 -36.25 88.45 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.468 1.033 . . . . 0.0 115.361 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.74 -55.81 21.26 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.475 1.137 . . . . 0.0 113.943 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.04 -33.69 49.82 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 112.876 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.26 -37.71 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 120.569 1.531 . . . . 0.0 113.027 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -53.71 -53.58 50.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.972 0.805 . . . . 0.0 111.017 168.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.76 -50.9 69.17 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.401 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.66 61.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.904 1.229 . . . . 0.0 113.289 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.22 -46.03 65.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.133 0.973 . . . . 0.0 112.211 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.27 -56.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.4 1.08 . . . . 0.0 111.784 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.43 -46.63 82.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.336 1.455 . . . . 0.0 113.029 -172.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -58.27 -46.43 86.03 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.513 1.051 . . . . 0.0 110.762 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -62.64 -51.93 65.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.391 0.676 . . . . 0.0 112.555 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.2 -42.04 89.96 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.235 -0.915 . . . . 0.0 111.995 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -53.64 -51.8 61.95 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.095 . . . . 0.0 110.776 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.81 95.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.756 0.822 . . . . 0.0 113.167 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -60.68 -47.73 84.93 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.467 1.03 . . . . 0.0 112.864 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.1 -50.58 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.45 0.7 . . . . 0.0 109.951 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.63 -37.84 79.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.186 0.994 . . . . 0.0 113.207 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.93 -55.4 29.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.55 1.068 . . . . 0.0 111.615 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.51 -47.15 82.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.687 1.195 . . . . 0.0 111.707 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.47 92.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 0.0 112.453 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.98 98.04 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.321 -0.862 . . . . 0.0 113.202 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.35 -44.67 96.79 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.803 1.301 . . . . 0.0 110.937 172.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.29 89.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.411 -0.805 . . . . 0.0 112.668 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.35 89.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.173 -0.954 . . . . 0.0 112.547 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -57.59 -47.06 83.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.044 0.937 . . . . 0.0 112.024 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.22 -41.67 79.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -86.31 10.12 15.8 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 53.76 30.12 10.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.791 2.036 . . . . 0.0 114.564 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.2 144.99 28.59 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.194 1.398 . . . . 0.0 112.165 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -76.92 -26.21 53.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.698 1.199 . . . . 0.0 112.764 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -128.99 151.66 49.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.433 1.493 . . . . 0.0 112.531 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.4 131.13 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.602 1.161 . . . . 0.0 110.264 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.82 149.62 36.34 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.57 1.948 . . . . 0.0 109.544 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -48.32 -40.55 35.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.713 2.942 . . . . 0.0 114.964 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -60.19 -38.86 84.55 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.284 1.034 . . . . 0.0 113.062 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -61.91 -42.23 98.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.669 0.788 . . . . 0.0 112.175 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' D' ' 62' ' ' MET . 84.6 mt -62.77 -46.08 89.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 111.936 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.68 -50.47 72.03 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.808 0.843 . . . . 0.0 111.82 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 84.3 mt -57.08 -50.6 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.421 -0.8 . . . . 0.0 111.871 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.11 64.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.161 0.984 . . . . 0.0 112.84 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 tt -68.65 -35.76 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 118.479 0.581 . . . . 0.0 112.533 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.362 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -66.06 -37.84 86.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.781 0.832 . . . . 0.0 112.304 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.01 115.81 18.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.021 0.928 . . . . 0.0 112.669 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.73 -39.39 84.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.238 -0.914 . . . . 0.0 113.449 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -67.31 -39.35 85.88 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.158 -0.964 . . . . 0.0 111.766 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.28 -36.38 83.92 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.432 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.14 -37.16 84.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.81 1.641 . . . . 0.0 112.739 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.53 -39.1 91.4 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.343 -0.848 . . . . 0.0 112.224 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.54 -53.79 8.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 113.622 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 111.444 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.03 131.77 47.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.892 1.277 . . . . 0.0 111.723 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.17 -34.95 0.58 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -57.65 129.23 32.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.723 2.282 . . . . 0.0 112.562 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -67.95 113.64 5.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.069 0.947 . . . . 0.0 111.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.31 -26.02 23.62 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.345 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 41.5 m -70.46 106.9 3.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 109.961 171.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -140.79 154.4 46.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.391 1.077 . . . . 0.0 113.067 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 53.0 m -67.76 147.86 52.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.844 0.858 . . . . 0.0 111.58 167.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -57.94 -46.69 84.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.44 0.696 . . . . 0.0 112.188 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 124.098 0.959 . . . . 0.0 110.218 167.804 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.35 -45.09 92.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.698 1.199 . . . . 0.0 112.274 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.79 -35.36 80.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.144 0.978 . . . . 0.0 112.248 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.46 -50.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.476 0.58 . . . . 0.0 110.59 171.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.11 -38.21 82.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.406 -0.809 . . . . 0.0 112.776 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -51.62 -34.94 39.79 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.219 1.408 . . . . 0.0 113.379 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.67 -14.24 60.72 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.9 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.798 1.639 . . . . 0.0 111.36 -170.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.81 73.11 79.19 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.559 1.944 . . . . 0.0 110.073 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.26 -23.92 64.84 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.756 2.971 . . . . 0.0 114.743 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -79.17 -3.48 45.79 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.997 1.719 . . . . 0.0 113.894 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 43.2 m -119.42 140.06 51.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.842 1.657 . . . . 0.0 111.007 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.11 -166.22 25.82 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.533 1.063 . . . . 0.0 113.968 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.98 137.06 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.963 -1.316 . . . . 0.0 110.237 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.33 147.12 41.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.025 0.93 . . . . 0.0 112.777 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.9 p -56.96 -34.62 68.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.009 0.923 . . . . 0.0 112.756 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -75.67 -44.09 44.18 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.404 1.082 . . . . 0.0 111.762 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.2 -37.42 72.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.871 0.868 . . . . 0.0 113.3 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 64.5 ttp -52.43 -50.77 61.91 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.268 -0.895 . . . . 0.0 111.712 167.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.7 95.52 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.872 1.225 . . . . 0.0 114.066 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.63 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.379 1.09 . . . . 0.0 110.878 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' MET . . . . . 0.401 ' SD ' HD22 ' C' ' 83' ' ' LEU . 92.6 mmm -60.81 -40.03 91.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.363 0.983 . . . . 0.0 112.443 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.64 -47.96 82.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.831 0.741 . . . . 0.0 111.781 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -56.27 -53.29 59.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.333 1.053 . . . . 0.0 111.996 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -53.17 -55.1 26.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.674 1.19 . . . . 0.0 112.218 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.46 -51.0 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.184 0.994 . . . . 0.0 110.83 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -60.61 -38.77 85.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.822 0.737 . . . . 0.0 112.378 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -64.83 -52.09 58.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.251 0.932 . . . . 0.0 113.257 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.02 -31.45 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.167 0.894 . . . . 0.0 113.103 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -47.6 -51.33 21.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.123 1.369 . . . . 0.0 111.781 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -59.51 -44.87 93.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.379 0.672 . . . . 0.0 112.017 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -67.01 -52.34 43.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.171 0.588 . . . . 0.0 111.523 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.35 -42.93 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.161 0.984 . . . . 0.0 111.278 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.34 91.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.78 0.832 . . . . 0.0 112.095 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.97 -51.03 59.86 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.786 0.708 . . . . 0.0 113.226 169.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -56.4 -40.72 75.11 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.002 -1.293 . . . . 0.0 112.633 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.89 -47.61 51.96 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.298 1.039 . . . . 0.0 112.62 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -77.55 -39.8 44.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.75 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -50.35 -50.39 51.34 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.745 1.157 . . . . 0.0 111.274 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.59 -44.02 97.78 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.732 1.213 . . . . 0.0 112.747 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.55 88.25 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.337 -0.852 . . . . 0.0 112.063 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -63.16 -38.25 90.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.8 1.24 . . . . 0.0 113.142 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -59.6 -34.11 72.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.662 1.119 . . . . 0.0 111.728 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -83.71 11.95 6.61 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.419 1.487 . . . . 0.0 113.257 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 59.46 28.57 17.98 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.696 2.398 . . . . 0.0 115.197 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.88 139.35 53.31 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.526 1.531 . . . . 0.0 112.815 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 35.6 p -86.97 -31.81 20.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.272 1.429 . . . . 0.0 113.591 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -87.48 147.69 25.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.655 1.582 . . . . 0.0 111.741 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 56.9 mt -104.78 120.92 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 0.0 108.353 168.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -100.38 161.89 13.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.068 0.947 . . . . 0.0 113.118 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 53.0 p -66.84 -23.68 66.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.429 1.092 . . . . 0.0 113.669 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.72 -42.83 21.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.644 1.178 . . . . 0.0 112.189 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -54.82 -28.7 51.47 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.991 1.317 . . . . 0.0 114.035 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.76 -32.83 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.79 0.836 . . . . 0.0 112.449 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -54.96 -33.98 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.432 1.093 . . . . 0.0 112.811 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 51.7 m -99.53 -46.65 5.39 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.639 1.176 . . . . 0.0 111.406 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.5 74.89 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.925 -1.109 . . . . 0.0 113.019 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.8 -36.79 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.646 -1.284 . . . . 0.0 111.135 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.53 -36.65 84.9 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.441 1.096 . . . . 0.0 113.055 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.35 -42.65 87.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.179 0.592 . . . . 0.0 112.007 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.66 -54.11 15.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 125.187 1.395 . . . . 0.0 110.832 -170.392 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.6 179.91 52.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.02 1.295 . . . . 0.0 114.094 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.15 57.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.15 96.93 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 121.331 -0.856 . . . . 0.0 114.286 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.66 10.95 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.71 -33.51 76.64 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.375 2.05 . . . . 0.0 113.388 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -49.28 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.746 1.157 . . . . 0.0 111.176 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -64.21 -34.87 79.09 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.571 -0.706 . . . . 0.0 112.586 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.91 -44.3 81.12 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.382 -0.823 . . . . 0.0 112.278 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.14 78.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.624 1.102 . . . . 0.0 112.519 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.79 -21.44 19.35 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -91.53 -54.16 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.322 1.449 . . . . 0.0 111.281 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' D' ' 70' ' ' PHE . 39.4 mt -50.17 -45.54 53.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.953 1.701 . . . . 0.0 113.391 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -48.13 -53.44 16.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.408 1.083 . . . . 0.0 112.172 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 -41.35 80.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.039 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.95 -49.55 75.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.993 0.815 . . . . 0.0 111.48 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -57.56 -48.64 78.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.127 0.971 . . . . 0.0 111.53 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.18 62.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.143 1.377 . . . . 0.0 113.432 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.95 -34.34 67.93 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 -34.48 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 118.77 0.714 . . . . 0.0 110.833 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.29 -44.3 88.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.912 0.778 . . . . 0.0 111.68 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.96 -53.06 61.96 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.533 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.65 -36.75 79.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.694 0.797 . . . . 0.0 112.323 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -38.39 79.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.463 1.028 . . . . 0.0 112.657 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.6 -45.56 93.08 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.619 0.645 . . . . 0.0 112.581 168.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.55 -42.18 95.85 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.482 -1.011 . . . . 0.0 111.842 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.38 -45.31 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.48 1.037 . . . . 0.0 111.625 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.7 86.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.758 0.823 . . . . 0.0 112.094 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -57.33 -48.61 78.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.855 1.262 . . . . 0.0 112.678 173.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -58.52 -39.44 80.13 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.524 1.129 . . . . 0.0 113.259 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.57 4.67 31.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.565 1.146 . . . . 0.0 112.968 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 53.09 36.88 23.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.423 2.289 . . . . 0.0 114.177 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.09 149.67 22.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.72 1.608 . . . . 0.0 112.513 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 33.1 p -85.46 -28.86 24.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.214 1.406 . . . . 0.0 113.345 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -119.36 140.24 50.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.32 1.848 . . . . 0.0 111.153 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.29 121.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 109.129 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.51 162.8 20.61 Favored Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 124.315 1.046 . . . . 0.0 111.671 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.38 -35.73 85.28 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.971 2.447 . . . . 0.0 114.091 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -64.3 -43.74 93.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.582 1.083 . . . . 0.0 111.692 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.75 -41.94 98.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.683 0.793 . . . . 0.0 111.424 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -64.06 -44.75 91.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 0.0 112.636 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.83 -51.22 70.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.049 -1.032 . . . . 0.0 111.044 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.06 -41.83 48.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.916 1.286 . . . . 0.0 113.362 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.27 -45.99 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.843 0.747 . . . . 0.0 112.966 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -71.13 -19.46 62.43 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.16 -28.56 64.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.814 1.246 . . . . 0.0 113.492 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -129.63 123.07 30.36 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.598 1.09 . . . . 0.0 112.637 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -61.77 -47.33 85.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.118 0.967 . . . . 0.0 113.059 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -60.67 -53.46 57.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.868 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -49.74 -47.13 50.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.633 1.106 . . . . 0.0 111.753 171.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -61.32 -30.1 70.29 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.704 -1.248 . . . . 0.0 114.151 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.64 -49.66 7.83 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.396 1.078 . . . . 0.0 112.362 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.09 -44.2 87.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.609 2.364 . . . . 0.0 113.409 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tp . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.215 -173.073 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.95 123.16 22.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.593 0.757 . . . . 0.0 110.369 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.04 144.2 29.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.295 1.038 . . . . 0.0 111.258 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -59.57 140.16 92.53 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.175 2.583 . . . . 0.0 112.345 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.29 146.36 51.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.28 1.032 . . . . 0.0 112.012 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.03 136.37 53.73 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.617 0.767 . . . . 0.0 110.529 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p -119.94 161.4 20.94 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.97 119.71 10.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 171.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.7 p -68.74 157.08 37.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 113.051 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -57.35 129.0 39.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.238 0.615 . . . . 0.0 110.833 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 123.747 0.819 . . . . 0.0 112.462 -172.21 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -56.91 -52.83 63.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.889 1.276 . . . . 0.0 112.556 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.93 -50.84 69.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.956 0.902 . . . . 0.0 111.345 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 83.2 t -57.03 -46.4 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.84 0.856 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.57 -50.8 62.25 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.341 1.056 . . . . 0.0 112.085 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.41 -43.77 79.68 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.267 1.027 . . . . 0.0 112.299 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -66.15 -47.74 73.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.37 -30.04 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -121.55 90.36 47.92 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.201 1.4 . . . . 0.0 110.226 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.79 -26.26 72.74 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.626 2.884 . . . . 0.0 114.491 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.25 -12.64 61.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.218 1.807 . . . . 0.0 113.62 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -103.12 117.5 34.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 110.097 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.56 -169.68 15.64 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.855 1.217 . . . . 0.0 112.937 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.94 151.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -70.01 143.87 52.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.835 0.854 . . . . 0.0 112.461 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 34.8 p -58.37 -40.29 81.89 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.012 0.925 . . . . 0.0 112.196 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.82 -43.64 98.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.94 0.896 . . . . 0.0 111.702 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.49 81.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.185 0.594 . . . . 0.0 112.566 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.2 mmm -65.92 -41.83 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.965 -1.084 . . . . 0.0 112.98 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.41 -41.96 88.67 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.298 0.953 . . . . 0.0 113.041 170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -61.12 -49.78 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.791 1.637 . . . . 0.0 111.008 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mmm -56.03 -40.49 73.55 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.668 1.122 . . . . 0.0 112.933 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -64.65 -42.5 95.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.812 -1.18 . . . . 0.0 111.726 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -55.61 -46.85 77.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.603 0.761 . . . . 0.0 111.241 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -56.79 -52.7 64.01 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.677 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.46 -41.33 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.87 1.214 . . . . 0.0 112.384 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -66.05 -54.52 24.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.072 0.851 . . . . 0.0 112.057 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.7 -50.8 71.1 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 11.9 pt -62.58 -36.48 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.368 1.067 . . . . 0.0 112.489 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' PHE . . . . . 0.559 ' CD1' HD13 ' C' ' 55' ' ' LEU . 10.7 m-30 -66.94 -23.52 65.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.323 1.049 . . . . 0.0 112.33 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -81.22 -47.83 12.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.59 0.756 . . . . 0.0 110.944 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -54.98 -42.94 73.07 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 13.7 tt -59.63 -34.0 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.767 0.712 . . . . 0.0 112.552 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.43 88.21 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.301 0.955 . . . . 0.0 111.797 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.82 94.48 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.995 0.807 . . . . 0.0 113.371 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -70.95 -40.4 72.04 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.076 -1.25 . . . . 0.0 112.741 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.91 72.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.914 -1.116 . . . . 0.0 111.576 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -62.43 -47.4 84.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.363 1.065 . . . . 0.0 112.123 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -54.28 -46.84 72.82 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.0 -1.062 . . . . 0.0 112.403 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.88 -41.73 98.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 0.0 112.304 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.43 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.922 0.889 . . . . 0.0 112.257 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -60.8 -42.37 97.46 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.501 1.12 . . . . 0.0 112.594 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -57.62 -33.37 68.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.211 0.914 . . . . 0.0 112.302 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -90.01 7.84 35.54 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.473 1.509 . . . . 0.0 113.326 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.25 31.1 13.53 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.526 2.33 . . . . 0.0 114.876 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -91.39 143.25 26.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.93 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 40.2 p -90.11 -37.56 14.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.363 1.465 . . . . 0.0 113.213 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 72.9 p -106.22 -179.45 3.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.534 1.933 . . . . 0.0 111.515 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mt -125.22 125.25 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.998 1.319 . . . . 0.0 109.358 171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -101.77 164.22 11.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.263 1.025 . . . . 0.0 113.084 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 45.8 p -57.33 -43.22 83.18 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.211 -0.931 . . . . 0.0 112.565 170.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.19 -37.03 84.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.209 1.004 . . . . 0.0 112.836 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.91 -39.43 90.58 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.577 0.751 . . . . 0.0 111.952 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.32 -43.12 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 169.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -54.82 -45.33 74.41 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.455 1.025 . . . . 0.0 112.587 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 42.2 p -70.48 -38.27 74.36 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.411 1.005 . . . . 0.0 112.174 171.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -24.63 63.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 117.59 -1.195 . . . . 0.0 114.164 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -46.62 -50.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 121.204 1.82 . . . . 0.0 111.612 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.45 -28.06 64.73 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.33 -39.33 54.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.538 1.135 . . . . 0.0 111.772 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -84.57 -20.31 31.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.016 1.726 . . . . 0.0 112.906 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 63.3 tp . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 126.412 1.885 . . . . 0.0 109.976 169.467 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.61 162.01 41.08 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.653 1.121 . . . . 0.0 112.585 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -36.96 63.63 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.99 -24.41 74.46 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.287 0.946 . . . . 0.0 115.26 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -58.75 17.03 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.805 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.89 -38.52 92.61 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.478 2.119 . . . . 0.0 113.219 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.78 -53.95 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.033 0.933 . . . . 0.0 110.954 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -57.17 -50.09 73.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.777 0.831 . . . . 0.0 112.286 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.66 -45.59 85.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.316 1.046 . . . . 0.0 111.617 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.12 96.22 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.254 0.934 . . . . 0.0 112.97 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.89 75.19 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.257 -0.902 . . . . 0.0 112.656 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.43 -41.85 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.54 -0.725 . . . . 0.0 111.541 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.8 -52.75 38.05 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.355 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -59.53 -42.87 93.3 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.236 1.38 . . . . 0.0 113.108 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -53.98 -47.87 70.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.585 0.754 . . . . 0.0 112.626 171.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.92 -45.04 75.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.828 0.851 . . . . 0.0 112.392 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -54.94 -40.04 69.52 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.543 1.537 . . . . 0.0 112.285 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.7 -47.21 70.72 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.914 1.234 . . . . 0.0 112.269 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -63.42 -46.62 85.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.606 0.762 . . . . 0.0 112.403 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -51.52 -55.39 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.771 0.714 . . . . 0.0 110.369 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.49 -46.31 83.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.438 0.695 . . . . 0.0 112.154 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.42 -51.49 64.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.724 0.693 . . . . 0.0 111.913 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.3 -33.24 72.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.604 0.762 . . . . 0.0 112.765 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.67 90.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.62 1.1 . . . . 0.0 112.094 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.68 -46.09 89.68 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 122.084 -0.385 . . . . 0.0 112.655 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -61.33 -45.17 95.56 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.956 -0.732 . . . . 0.0 111.473 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.45 81.96 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.995 0.918 . . . . 0.0 112.723 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.25 86.72 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.607 -0.683 . . . . 0.0 112.375 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -59.08 -39.5 82.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -60.03 -31.68 70.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -89.99 3.84 51.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.06 0.944 . . . . 0.0 113.503 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 56.46 33.03 21.8 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.904 2.081 . . . . 0.0 113.711 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.21 147.7 26.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.623 1.569 . . . . 0.0 112.553 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.4 p -98.02 2.02 48.4 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.974 1.71 . . . . 0.0 113.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -126.27 120.09 29.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.676 1.591 . . . . 0.0 110.709 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.29 123.77 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.493 1.517 . . . . 0.0 109.056 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.17 167.21 9.38 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.074 1.75 . . . . 0.0 111.309 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -48.32 -40.31 35.66 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.4 -36.27 75.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.974 0.909 . . . . 0.0 113.213 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -65.56 -39.66 91.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.264 0.938 . . . . 0.0 112.429 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.01 -44.34 85.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.149 0.58 . . . . 0.0 111.229 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -57.19 -49.91 74.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.448 -0.783 . . . . 0.0 112.035 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 64.8 mt -56.56 -46.55 80.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.081 0.952 . . . . 0.0 111.766 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.4 76.91 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.44 -0.787 . . . . 0.0 112.893 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.06 -45.82 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.472 1.109 . . . . 0.0 110.985 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.79 -24.9 64.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.959 1.304 . . . . 0.0 114.512 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -88.78 -34.97 16.91 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.344 1.058 . . . . 0.0 112.181 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.42 117.41 7.9 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.13 0.877 . . . . 0.0 112.489 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.44 -37.12 74.76 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.181 0.993 . . . . 0.0 113.079 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -64.93 -43.87 91.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.432 1.014 . . . . 0.0 111.865 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.91 -32.77 69.81 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.857 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.59 -39.6 94.24 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.218 1.372 . . . . 0.0 112.061 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.22 -41.97 96.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 112.231 171.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 29.7 tp -75.23 -49.26 19.91 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 125.609 1.564 . . . . 0.0 110.295 -175.469 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.844 0.831 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.6 122.35 14.49 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 0.0 111.053 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.37 138.74 81.16 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.182 0.593 . . . . 0.0 111.22 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -61.15 150.41 84.57 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.788 2.326 . . . . 0.0 111.61 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.14 108.24 2.6 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.75 -0.594 . . . . 0.0 110.423 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.79 151.26 45.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.655 1.182 . . . . 0.0 111.262 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -57.67 122.76 13.56 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.022 0.929 . . . . 0.0 110.731 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -62.68 133.35 54.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.406 0.682 . . . . 0.0 111.3 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -77.83 108.54 11.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.913 -0.492 . . . . 0.0 110.787 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.36 -0.26 57.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.539 1.135 . . . . 0.0 112.877 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 125.105 1.362 . . . . 0.0 111.692 175.669 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -58.52 -54.4 47.5 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 111.292 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.66 -36.84 79.72 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.627 1.171 . . . . 0.0 112.835 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 81.5 t -55.47 -56.61 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.701 0.8 . . . . 0.0 110.605 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.71 -25.34 59.07 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -52.35 -37.66 56.66 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.991 1.268 . . . . 0.0 112.147 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.56 -47.03 23.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.761 0.825 . . . . 0.0 112.728 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.41 -47.38 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.024 0.93 . . . . 0.0 112.285 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -127.34 82.64 67.83 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.812 2.045 . . . . 0.0 110.4 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -57.67 -24.9 65.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.488 2.792 . . . . 0.0 115.533 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -86.3 -7.9 58.14 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.929 2.092 . . . . 0.0 114.097 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -126.19 122.66 36.25 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.48 1.036 . . . . 0.0 112.539 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.8 178.66 26.11 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.384 1.469 . . . . 0.0 113.704 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.56 134.26 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.662 1.585 . . . . 0.0 109.541 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 23.5 p -70.46 160.7 31.91 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -55.06 -42.89 73.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.174 0.99 . . . . 0.0 112.22 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.82 -44.09 91.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.932 1.293 . . . . 0.0 112.149 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.44 92.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 112.43 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.4 mtm -58.15 -44.94 88.14 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.203 -0.936 . . . . 0.0 111.676 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.93 -49.13 63.5 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.773 1.178 . . . . 0.0 114.651 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.65 -22.32 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.732 1.266 . . . . 0.0 113.833 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.55 -35.75 61.08 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.504 -1.373 . . . . 0.0 112.125 170.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -55.76 -40.3 72.39 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 78.7 p -79.03 -37.14 39.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.072 -1.017 . . . . 0.0 112.339 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -58.25 -40.03 80.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.339 0.972 . . . . 0.0 112.858 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.22 -54.39 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.504 1.121 . . . . 0.0 111.287 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.65 -44.38 93.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.716 0.807 . . . . 0.0 111.536 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -58.3 -49.8 75.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.032 0.833 . . . . 0.0 112.944 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.19 -51.24 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.542 1.137 . . . . 0.0 110.732 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.41 -52.43 59.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.807 0.843 . . . . 0.0 111.892 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -53.06 -48.89 67.34 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.442 1.097 . . . . 0.0 112.519 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.21 -50.41 65.98 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 44.1 mt -63.24 -48.28 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.092 0.86 . . . . 0.0 110.491 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.93 90.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.81 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.26 -51.0 58.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.464 1.03 . . . . 0.0 112.95 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -61.62 -45.7 92.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.55 1.175 . . . . 0.0 112.591 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.68 77.84 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.061 -1.025 . . . . 0.0 112.361 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -61.58 -47.79 83.87 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.357 1.063 . . . . 0.0 111.799 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -57.76 -36.06 71.61 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.841 1.256 . . . . 0.0 112.802 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.16 -41.78 85.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.122 0.874 . . . . 0.0 112.375 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.24 86.28 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.951 -1.093 . . . . 0.0 112.483 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -63.5 -41.94 98.51 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.508 1.123 . . . . 0.0 112.74 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -59.16 -38.45 79.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.99 8.32 3.28 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.252 1.421 . . . . 0.0 113.879 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 53.46 29.68 9.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.82 2.448 . . . . 0.0 115.23 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -81.56 158.82 24.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.153 0.981 . . . . 0.0 112.868 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 65.3 p -112.85 -10.29 13.58 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.978 1.711 . . . . 0.0 113.496 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 53.0 m -134.23 135.01 42.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.582 1.953 . . . . 0.0 109.461 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.46 112.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 108.822 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 55.2 p -96.87 170.42 9.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.216 1.406 . . . . 0.0 111.903 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 37.1 p -53.16 -37.2 61.67 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.929 0.891 . . . . 0.0 112.71 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.71 -44.99 69.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.722 1.209 . . . . 0.0 112.422 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.37 -42.3 91.31 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.612 0.642 . . . . 0.0 111.89 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 69.5 mt -58.17 -53.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.608 0.763 . . . . 0.0 110.356 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -50.7 -46.46 58.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.809 1.186 . . . . 0.0 112.405 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 98.8 m -61.74 -49.4 76.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.773 0.829 . . . . 0.0 112.115 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.04 81.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.992 0.917 . . . . 0.0 112.686 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -51.49 -51.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.617 1.167 . . . . 0.0 110.993 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.58 -44.25 97.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.921 0.888 . . . . 0.0 112.699 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.32 -36.26 83.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.211 1.004 . . . . 0.0 113.26 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.24 -30.42 48.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.0 1.32 . . . . 0.0 113.061 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 125.755 1.622 . . . . 0.0 111.911 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.31 50.4 1.0 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.069 1.795 . . . . 0.0 115.628 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.1 -15.24 21.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.38 79.69 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.975 -1.078 . . . . 0.0 113.702 165.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.36 -59.23 11.67 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 118.642 1.221 . . . . 0.0 112.58 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.71 -31.34 60.38 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.244 1.963 . . . . 0.0 114.383 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.18 -48.79 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.739 1.154 . . . . 0.0 112.059 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -61.08 -38.37 86.01 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.101 -0.999 . . . . 0.0 111.99 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.37 -30.06 70.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.978 -1.076 . . . . 0.0 112.729 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.15 92.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.696 1.135 . . . . 0.0 111.998 168.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.61 90.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.21 -49.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.906 -1.122 . . . . 0.0 112.015 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.6 -35.58 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.595 1.158 . . . . 0.0 112.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.3 -50.0 51.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -76.71 -38.25 54.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.572 0.749 . . . . 0.0 112.921 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.72 -45.17 86.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.317 0.508 . . . . 0.0 111.346 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -77.5 -28.42 52.11 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.66 -46.15 77.58 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.267 0.94 . . . . 0.0 112.545 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.76 -42.19 96.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.963 0.801 . . . . 0.0 112.61 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.09 -55.02 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.518 0.727 . . . . 0.0 110.259 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.84 -32.79 73.56 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.18 -52.36 62.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.695 1.198 . . . . 0.0 111.612 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.73 -36.1 83.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.692 -0.63 . . . . 0.0 112.017 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.13 90.91 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.619 -0.675 . . . . 0.0 111.939 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.05 -46.11 85.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.166 0.889 . . . . 0.0 113.681 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -60.95 -46.13 91.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.155 0.977 . . . . 0.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.44 82.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.607 -0.683 . . . . 0.0 112.305 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.97 88.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.284 1.034 . . . . 0.0 112.629 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -54.48 -50.63 67.3 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.755 1.222 . . . . 0.0 111.86 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -58.68 -38.76 78.91 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -87.72 6.33 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.591 1.156 . . . . 0.0 113.267 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 52.88 34.88 17.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.107 2.163 . . . . 0.0 114.275 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 148.99 21.81 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.506 1.522 . . . . 0.0 112.805 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.0 p -90.58 -28.71 18.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.311 1.445 . . . . 0.0 113.074 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -122.75 138.54 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.302 1.441 . . . . 0.0 111.765 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.72 130.19 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.892 1.277 . . . . 0.0 110.849 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.19 164.39 20.43 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 125.743 1.617 . . . . 0.0 111.481 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.01 -38.3 48.9 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.692 2.928 . . . . 0.0 114.923 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.47 -40.55 87.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.736 0.814 . . . . 0.0 113.036 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -62.21 -41.81 98.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.018 0.826 . . . . 0.0 111.812 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.23 -45.68 87.12 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.84 0.856 . . . . 0.0 111.476 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -58.13 -48.69 79.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.007 0.923 . . . . 0.0 112.024 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.27 -46.77 82.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.76 0.824 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.13 -52.17 59.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.89 0.768 . . . . 0.0 112.622 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 24.6 pt -71.16 -24.99 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -74.36 -43.38 56.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.273 1.429 . . . . 0.0 112.46 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -73.81 -21.34 60.18 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -120.57 115.0 22.56 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.113 0.965 . . . . 0.0 111.382 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.05 -37.33 64.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.666 1.186 . . . . 0.0 112.873 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -60.5 -30.52 69.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 112.757 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.39 -38.17 35.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.946 0.898 . . . . 0.0 111.497 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.07 -32.12 70.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.617 0.767 . . . . 0.0 112.87 172.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.27 -42.23 96.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.54 1.136 . . . . 0.0 113.2 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -51.97 66.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.766 0.826 . . . . 0.0 112.052 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 113.388 -172.846 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 136.48 39.02 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.039 1.336 . . . . 0.0 110.148 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.12 150.31 97.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.422 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.09 128.82 31.8 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.982 2.455 . . . . 0.0 112.995 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.36 143.84 56.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.589 0.756 . . . . 0.0 110.556 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.32 114.31 3.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.28 0.632 . . . . 0.0 110.089 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.25 156.07 39.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.35 1.06 . . . . 0.0 111.967 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.81 113.96 4.16 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 170.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 30.0 p -67.2 143.63 56.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.694 0.798 . . . . 0.0 112.311 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.69 141.23 57.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.181 0.593 . . . . 0.0 110.852 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.274 0.559 . . . . 0.0 110.909 -178.855 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -62.22 -38.38 88.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.66 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.59 -53.18 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.814 0.845 . . . . 0.0 111.64 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.35 -43.0 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.53 1.132 . . . . 0.0 111.982 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -52.85 -49.96 64.72 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.429 1.013 . . . . 0.0 111.697 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.98 -37.62 77.24 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.044 0.838 . . . . 0.0 113.013 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -75.8 -46.17 32.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.1 0.96 . . . . 0.0 113.38 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.39 -36.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.951 1.3 . . . . 0.0 111.831 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -120.79 68.08 15.45 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.294 1.838 . . . . 0.0 111.547 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.24 -38.82 3.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.152 2.568 . . . . 0.0 112.968 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.81 -42.9 7.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.772 1.229 . . . . 0.0 112.852 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -69.6 172.98 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.41 1.884 . . . . 0.0 112.822 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.72 -163.23 10.32 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 124.529 1.062 . . . . 0.0 113.938 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.13 152.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.305 1.442 . . . . 0.0 110.627 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 51.4 p -81.24 154.82 26.42 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.207 0.912 . . . . 0.0 112.842 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 47.9 p -56.69 -40.13 75.03 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.215 -0.928 . . . . 0.0 112.011 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.48 -50.22 74.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.955 1.302 . . . . 0.0 111.849 172.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.55 98.12 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.678 0.791 . . . . 0.0 112.989 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.9 -43.58 86.24 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.094 -1.003 . . . . 0.0 111.454 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.08 -48.64 66.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.503 1.049 . . . . 0.0 113.544 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.92 -47.23 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.138 0.975 . . . . 0.0 111.393 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.26 -39.58 83.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.451 1.023 . . . . 0.0 112.887 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -63.99 -46.44 84.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.173 -0.955 . . . . 0.0 111.183 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 57.7 m -55.4 -46.79 76.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.258 0.936 . . . . 0.0 112.373 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -53.94 -53.86 46.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.735 0.814 . . . . 0.0 111.179 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 82.7 t -57.11 -49.0 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.485 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -52.16 -50.77 61.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 120.186 1.357 . . . . 0.0 111.752 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.26 -51.43 66.22 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.59 -45.33 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.379 1.072 . . . . 0.0 111.342 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -55.03 -51.51 66.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.07 1.348 . . . . 0.0 112.369 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.98 -42.02 97.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.165 0.986 . . . . 0.0 112.003 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -60.68 -51.72 68.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.051 0.94 . . . . 0.0 112.305 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 pt -69.52 -26.36 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.88 67.67 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.349 0.977 . . . . 0.0 112.395 169.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.24 86.05 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.166 0.412 . . . . 0.0 112.394 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.5 -43.19 86.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.254 -1.144 . . . . 0.0 112.046 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.72 -42.69 75.69 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.878 1.217 . . . . 0.0 113.129 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 81.5 p -70.03 -44.23 69.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.945 0.793 . . . . 0.0 112.332 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -55.69 -42.16 74.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.653 1.115 . . . . 0.0 113.339 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -57.01 -35.03 68.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.683 1.193 . . . . 0.0 112.389 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.72 -45.58 64.65 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.316 -0.865 . . . . 0.0 112.052 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -59.04 -39.16 81.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.951 1.3 . . . . 0.0 113.616 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -56.55 -29.83 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.13 1.372 . . . . 0.0 112.813 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -99.2 13.86 31.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.812 1.645 . . . . 0.0 112.232 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.62 29.22 6.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.631 2.372 . . . . 0.0 114.464 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -73.36 139.82 46.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.52 1.128 . . . . 0.0 111.336 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 59.6 p -76.61 -32.81 58.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.719 1.208 . . . . 0.0 113.787 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -136.93 -167.94 2.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.505 1.922 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.29 113.09 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.83 1.252 . . . . 0.0 110.482 168.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 30.4 p -85.7 168.87 13.98 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.125 1.37 . . . . 0.0 113.647 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 34.9 p -50.06 -44.72 51.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.23 1.412 . . . . 0.0 113.497 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.04 -42.2 69.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.084 0.953 . . . . 0.0 112.007 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.74 -29.86 71.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.1 -48.84 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.091 -1.006 . . . . 0.0 110.956 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -38.49 83.19 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.331 -0.856 . . . . 0.0 111.406 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 32.6 m -58.43 -48.09 81.82 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.442 -0.786 . . . . 0.0 111.974 169.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.14 -44.65 83.59 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.945 -1.097 . . . . 0.0 112.243 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.41 -49.95 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.844 0.858 . . . . 0.0 111.959 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -72.02 -14.16 61.8 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.19 -29.33 21.83 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.328 1.051 . . . . 0.0 112.121 170.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.2 -47.4 24.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 112.784 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.545 0.778 0 C-N-CA 124.549 1.14 . . . . 0.0 112.166 -176.828 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.31 151.62 34.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.686 1.136 . . . . 0.0 113.367 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.86 60.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.24 -9.21 86.83 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.05 31.54 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.533 1.667 . . . . 0.0 114.984 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.86 -35.86 81.04 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.62 2.88 . . . . 0.0 114.738 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.71 -44.82 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.018 0.927 . . . . 0.0 110.547 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -65.02 -49.29 70.76 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.51 -38.08 86.43 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.092 -1.005 . . . . 0.0 111.703 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.48 87.58 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.515 -0.74 . . . . 0.0 112.298 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.32 82.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.215 0.916 . . . . 0.0 112.103 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.3 -49.67 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.551 -0.718 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.86 -33.14 75.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -62.07 -29.37 70.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.98 -6.92 50.31 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.322 -1.486 . . . . 0.0 113.917 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.47 -43.76 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.457 1.103 . . . . 0.0 111.268 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 57.9 p -62.56 -19.53 63.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.701 0.801 . . . . 0.0 112.736 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.73 -40.53 40.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.958 1.303 . . . . 0.0 113.666 166.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.95 -45.35 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.667 1.121 . . . . 0.0 111.578 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.24 -41.25 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.118 0.967 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.41 -45.16 85.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.81 1.244 . . . . 0.0 113.17 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -61.26 -44.53 97.08 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.463 1.029 . . . . 0.0 112.034 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.16 -41.26 87.96 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.81 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.19 75.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.108 -0.995 . . . . 0.0 112.528 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.18 -44.14 93.29 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.355 0.978 . . . . 0.0 112.914 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.703 -0.881 . . . . 0.0 111.254 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.18 88.26 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.281 -0.887 . . . . 0.0 112.979 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.16 78.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.055 1.342 . . . . 0.0 112.145 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -54.0 -47.7 71.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.584 1.153 . . . . 0.0 112.508 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -57.97 -34.56 70.08 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.03 4.21 45.98 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.821 1.248 . . . . 0.0 113.444 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.14 32.04 19.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.824 2.05 . . . . 0.0 114.324 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.89 154.05 21.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.933 1.693 . . . . 0.0 113.018 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -115.36 15.68 16.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.474 1.91 . . . . 0.0 113.082 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -130.69 126.85 37.57 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.191 1.397 . . . . 0.0 110.4 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.09 124.27 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.921 0.888 . . . . 0.0 109.766 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.86 164.92 24.08 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.724 1.61 . . . . 0.0 110.879 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -50.16 -34.94 41.01 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.564 2.843 . . . . 0.0 114.915 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.51 -35.57 79.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.889 0.876 . . . . 0.0 113.362 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.63 -39.42 77.18 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.924 -1.11 . . . . 0.0 112.026 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.89 -39.84 91.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.455 0.702 . . . . 0.0 111.229 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.22 -51.74 66.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.336 1.054 . . . . 0.0 111.052 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.09 -39.87 79.69 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.188 0.904 . . . . 0.0 112.811 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.21 70.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.585 0.754 . . . . 0.0 112.493 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.08 -30.53 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -48.82 -35.86 15.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.276 1.83 . . . . 0.0 113.643 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.36 -12.29 61.48 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -130.71 130.34 43.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.009 1.323 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.05 -48.34 82.2 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.128 -0.983 . . . . 0.0 113.24 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.42 -45.99 88.41 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.481 -0.762 . . . . 0.0 112.044 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.8 -36.87 85.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.072 0.851 . . . . 0.0 112.438 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -60.92 -46.39 90.86 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.994 1.27 . . . . 0.0 111.753 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.41 -32.83 74.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 113.388 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.25 -47.89 54.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.488 1.515 . . . . 0.0 112.037 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.772 0.796 . . . . 0.0 110.368 175.831 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 63.7 tp -99.35 114.58 27.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 109.888 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.58 149.67 98.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.992 170.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.07 118.38 5.16 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.973 2.449 . . . . 0.0 112.344 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.55 132.4 48.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.69 0.796 . . . . 0.0 111.078 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.08 135.42 57.51 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 162.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 38.9 m -62.93 111.74 2.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.279 0.491 . . . . 0.0 110.129 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.31 98.39 6.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.538 0.735 . . . . 0.0 110.021 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -56.15 133.95 52.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.465 0.706 . . . . 0.0 110.126 170.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -61.43 111.1 1.65 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.995 0.518 . . . . 0.0 110.944 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.236 0.384 0 C-N-CA 123.568 0.747 . . . . 0.0 111.396 -174.745 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.01 -42.29 99.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.597 . . . . 0.0 112.519 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -55.07 -37.19 66.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.014 1.325 . . . . 0.0 113.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.23 -57.01 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.873 1.269 . . . . 0.0 111.2 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.58 -37.36 27.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.644 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -46.94 -43.31 18.95 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.844 1.202 . . . . 0.0 112.239 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.89 -50.92 8.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.065 . . . . 0.0 113.08 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.29 -43.71 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 118.837 0.744 . . . . 0.0 112.912 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -126.4 69.06 68.31 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.06 1.744 . . . . 0.0 110.449 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -58.14 -21.42 51.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.798 2.998 . . . . 0.0 114.015 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.19 -10.37 59.4 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.678 1.991 . . . . 0.0 113.991 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -111.45 120.34 41.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.064 1.346 . . . . 0.0 111.948 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.47 168.46 42.15 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.436 1.493 . . . . 0.0 113.923 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 56.9 mt -133.59 132.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.322 1.449 . . . . 0.0 108.694 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 31.0 p -73.94 156.33 37.73 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 51.2 p -55.66 -38.19 69.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.3 -0.875 . . . . 0.0 112.293 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.99 -44.66 84.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.66 1.184 . . . . 0.0 112.452 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.73 88.28 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.917 0.887 . . . . 0.0 111.906 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.3 mtm -59.36 -46.13 89.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.747 -0.595 . . . . 0.0 111.073 171.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.67 58.38 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.961 1.267 . . . . 0.0 114.81 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.04 -35.63 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.202 1.501 . . . . 0.0 111.977 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 78.1 mtm -62.83 -36.64 83.85 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.297 -0.877 . . . . 0.0 112.841 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.37 -46.05 91.8 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 110.527 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -53.89 -47.46 71.11 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.491 0.716 . . . . 0.0 111.973 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -52.03 -37.59 54.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.01 -51.15 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.559 1.527 . . . . 0.0 111.137 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.99 -45.1 95.1 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.179 0.592 . . . . 0.0 111.583 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -56.37 -47.84 78.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.1 -45.84 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.178 0.899 . . . . 0.0 110.02 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.49 -50.75 67.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.943 0.792 . . . . 0.0 111.948 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.56 -44.87 95.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.039 0.936 . . . . 0.0 112.72 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -60.19 -49.72 76.52 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.79 0.723 . . . . 0.0 111.866 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.25 -51.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.163 0.985 . . . . 0.0 110.785 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.46 72.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.111 0.964 . . . . 0.0 112.343 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.82 50.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.517 1.055 . . . . 0.0 113.685 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.28 -45.21 94.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.217 1.009 . . . . 0.0 112.38 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.62 80.7 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.948 0.795 . . . . 0.0 111.796 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 68.4 m -58.27 -52.43 65.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.556 0.742 . . . . 0.0 112.252 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -59.13 -37.9 78.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.971 0.908 . . . . 0.0 113.241 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.22 -42.97 87.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 112.096 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.98 88.5 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.801 0.728 . . . . 0.0 111.972 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -59.38 -45.4 91.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 112.532 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -56.89 -43.04 80.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.671 1.188 . . . . 0.0 112.359 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -79.56 6.7 9.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.446 1.099 . . . . 0.0 113.943 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 54.0 43.18 31.16 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.153 2.181 . . . . 0.0 114.114 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.09 152.02 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.087 1.355 . . . . 0.0 112.434 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 33.1 p -77.88 -45.39 24.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 111.706 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 28.2 m -61.56 117.05 5.25 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.996 1.318 . . . . 0.0 111.746 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -74.17 129.11 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.347 1.459 . . . . 0.0 108.959 163.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -96.41 159.7 14.8 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 38.6 p -57.4 -39.24 75.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.944 0.898 . . . . 0.0 112.387 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.31 -42.23 96.45 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.673 1.189 . . . . 0.0 112.391 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.506 -0.746 . . . . 0.0 111.839 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.56 -42.83 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.38 -0.825 . . . . 0.0 111.12 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.31 -39.15 82.16 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.806 -1.184 . . . . 0.0 112.236 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 81.6 m -64.82 -45.11 87.59 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.918 -1.114 . . . . 0.0 111.964 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.33 -44.14 75.62 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.824 1.193 . . . . 0.0 111.799 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.47 -55.0 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.402 1.081 . . . . 0.0 111.353 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -52.97 -47.27 68.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 120.081 1.31 . . . . 0.0 112.333 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.98 -51.58 67.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.746 1.218 . . . . 0.0 112.577 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.38 -31.15 23.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -170.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 126.401 1.88 . . . . 0.0 111.097 -170.623 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.8 156.35 53.23 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.817 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.78 64.37 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.42 83.9 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.023 1.297 . . . . 0.0 115.895 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.14 82.16 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.686 1.743 . . . . 0.0 115.399 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.19 -39.48 90.13 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.649 2.232 . . . . 0.0 112.922 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.83 -48.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.057 1.343 . . . . 0.0 110.688 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -62.53 -44.4 96.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.76 -53.97 44.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.801 0.84 . . . . 0.0 110.802 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.26 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -53.81 53.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.759 0.823 . . . . 0.0 111.785 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.53 -40.45 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.079 0.952 . . . . 0.0 112.694 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.22 -18.51 58.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.032 1.333 . . . . 0.0 113.739 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -100.47 -29.94 12.1 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.002 1.321 . . . . 0.0 112.927 173.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -55.74 -54.99 37.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.532 1.133 . . . . 0.0 112.943 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -38.02 66.56 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.643 -0.661 . . . . 0.0 112.346 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 38.0 p -64.61 -29.51 70.52 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.567 -0.708 . . . . 0.0 112.846 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.9 65.32 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.701 0.8 . . . . 0.0 112.791 167.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -78.51 -41.63 31.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.56 -0.712 . . . . 0.0 112.379 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -53.97 -50.7 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.226 0.61 . . . . 0.0 110.561 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.73 -33.32 70.71 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.86 -53.0 63.17 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.989 0.813 . . . . 0.0 111.199 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.689 0.796 . . . . 0.0 112.159 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.77 84.59 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.104 -0.997 . . . . 0.0 112.909 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.14 -42.33 93.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.053 0.835 . . . . 0.0 112.659 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.46 -44.41 82.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.023 0.911 . . . . 0.0 111.927 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.59 82.05 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.371 0.987 . . . . 0.0 112.018 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.96 79.56 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.204 1.002 . . . . 0.0 112.58 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.88 -48.59 69.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.32 -32.93 67.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -91.84 6.12 47.34 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.029 1.332 . . . . 0.0 112.629 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.26 32.8 16.86 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.307 2.243 . . . . 0.0 114.252 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -99.68 152.18 20.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.295 1.438 . . . . 0.0 113.041 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -102.02 -6.66 23.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.655 1.582 . . . . 0.0 113.881 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -128.11 129.95 47.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.666 1.587 . . . . 0.0 110.877 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.16 124.69 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.465 1.506 . . . . 0.0 109.721 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.6 pt -117.18 168.16 9.52 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 125.912 1.685 . . . . 0.0 111.34 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.67 -37.07 63.45 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.385 2.723 . . . . 0.0 115.294 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.72 -38.57 88.36 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.314 -0.866 . . . . 0.0 112.797 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -65.59 -39.64 91.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.4 -0.812 . . . . 0.0 112.034 172.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.49 -44.85 93.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.593 0.757 . . . . 0.0 112.045 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.28 -50.13 73.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.898 0.879 . . . . 0.0 111.692 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.7 mt -58.07 -45.33 87.29 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.712 0.805 . . . . 0.0 112.349 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.37 -51.86 61.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.161 0.984 . . . . 0.0 112.129 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.26 -39.97 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -55.28 -42.87 74.16 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.957 -1.089 . . . . 0.0 112.385 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -86.16 -8.08 58.1 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -129.19 116.92 19.92 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.653 1.115 . . . . 0.0 112.409 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -67.53 -35.4 79.01 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -64.92 -42.08 95.02 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.194 0.906 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -51.87 -48.5 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.156 168.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -67.6 -14.62 63.1 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -84.34 -40.65 17.65 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.502 1.046 . . . . 0.0 111.324 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.95 -53.28 11.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.983 1.313 . . . . 0.0 112.019 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 127.109 2.163 . . . . 0.0 107.957 174.081 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.1 t . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.32 111.23 12.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.522 0.729 . . . . 0.0 110.423 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.59 144.43 45.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.953 . . . . 0.0 111.02 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -59.14 148.64 84.79 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.786 2.324 . . . . 0.0 111.729 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.26 70.31 4.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.192 0.997 . . . . 0.0 111.341 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.7 135.76 56.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.179 1.392 . . . . 0.0 110.964 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 31.2 p -69.2 154.04 42.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.855 0.862 . . . . 0.0 112.137 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.7 128.93 39.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.331 1.052 . . . . 0.0 111.707 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 55.9 p -84.88 -9.07 58.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -122.49 142.77 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.236 1.414 . . . . 0.0 111.813 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.6 t60 . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 124.724 1.21 . . . . 0.0 113.125 178.412 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 119.73 -0.176 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.1 -42.68 88.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.824 0.85 . . . . 0.0 112.622 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.08 -45.93 86.31 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.382 -0.824 . . . . 0.0 112.33 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.69 -45.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.469 0.708 . . . . 0.0 110.814 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -53.46 -47.85 69.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.422 1.01 . . . . 0.0 112.73 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -53.35 -41.09 65.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 0.0 112.884 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -76.37 -41.23 48.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.378 1.071 . . . . 0.0 112.821 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.37 -55.36 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.207 1.403 . . . . 0.0 112.732 -168.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -149.52 71.04 9.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.574 1.15 . . . . 0.0 111.47 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.03 -20.28 67.47 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.368 2.712 . . . . 0.0 114.666 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.73 -25.62 68.28 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -119.74 126.12 50.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.9 1.28 . . . . 0.0 109.591 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.98 -172.22 25.93 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.06 0.838 . . . . 0.0 113.489 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -140.18 155.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.948 -1.325 . . . . 0.0 111.689 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 42.0 p -89.35 157.04 18.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.683 0.793 . . . . 0.0 113.039 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.969 . . . . 0.0 112.402 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.07 -48.52 81.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.24 1.016 . . . . 0.0 111.373 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.4 94.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 112.73 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.6 mtp -55.11 -46.22 75.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.023 0.829 . . . . 0.0 111.316 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.76 -46.44 67.36 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.313 0.959 . . . . 0.0 114.245 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.07 -45.5 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 118.086 0.943 . . . . 0.0 111.41 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 85.4 mtp -60.37 -36.23 77.58 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.084 -1.01 . . . . 0.0 113.205 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -60.06 -41.3 92.08 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.92 0.782 . . . . 0.0 110.966 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 50.8 m -60.27 -50.17 74.71 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.302 -0.873 . . . . 0.0 112.13 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -52.03 -47.04 65.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.661 0.784 . . . . 0.0 112.683 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.82 -27.34 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.47 -34.18 72.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.378 0.99 . . . . 0.0 111.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.25 -48.01 71.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.83 -42.01 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 119.493 1.042 . . . . 0.0 111.004 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -56.93 -42.74 80.57 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.392 0.996 . . . . 0.0 111.655 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.29 -41.76 98.78 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -62.64 -45.91 90.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.454 1.025 . . . . 0.0 112.726 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.67 -53.49 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.973 0.909 . . . . 0.0 110.538 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.0 87.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.752 0.821 . . . . 0.0 112.368 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.44 59.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.647 1.118 . . . . 0.0 113.69 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -64.11 -41.04 97.4 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.345 -1.091 . . . . 0.0 111.95 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.78 94.9 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.095 -1.003 . . . . 0.0 112.149 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.6 t -60.78 -46.96 88.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.73 1.212 . . . . 0.0 111.726 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -57.37 -46.01 83.81 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.146 -0.971 . . . . 0.0 112.285 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.78 -45.33 86.13 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.508 0.723 . . . . 0.0 111.863 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.84 80.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.811 0.732 . . . . 0.0 112.22 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -58.29 -49.68 76.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.354 0.979 . . . . 0.0 112.256 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -56.53 -38.37 71.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.88 0.764 . . . . 0.0 112.504 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.64 2.8 31.63 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.931 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.45 35.08 22.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.11 2.164 . . . . 0.0 114.343 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -104.33 145.44 30.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.374 1.87 . . . . 0.0 112.249 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 27.2 p -84.32 -51.88 6.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.152 1.381 . . . . 0.0 111.487 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 60.0 m -82.05 127.35 33.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.042 1.337 . . . . 0.0 111.618 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.09 133.89 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.682 1.193 . . . . 0.0 110.971 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 9.4 p -90.93 160.7 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -50.53 -45.77 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 112.666 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.76 -44.96 88.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.199 1.0 . . . . 0.0 111.63 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -59.14 -40.59 85.97 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.625 0.77 . . . . 0.0 112.272 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.73 -52.83 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.066 0.848 . . . . 0.0 110.969 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -57.65 -42.28 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.954 0.797 . . . . 0.0 112.575 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 92.3 m -64.26 -46.27 84.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.153 0.981 . . . . 0.0 111.247 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.4 81.31 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.139 1.336 . . . . 0.0 113.183 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.8 -51.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.873 0.869 . . . . 0.0 110.664 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.39 -27.69 67.3 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 77.1 mt -64.46 -37.79 88.77 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.451 1.023 . . . . 0.0 111.93 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 50.4 mt -79.37 -29.66 42.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.551 1.01 0 C-N-CA 126.331 1.852 . . . . 0.0 111.39 179.329 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.464 0.649 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.22 147.05 43.68 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.247 0.927 . . . . 0.0 112.983 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.29 -58.95 2.96 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.753 0.821 . . . . 0.0 113.059 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.86 88.4 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.11 -59.61 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 119.483 1.642 . . . . 0.0 113.938 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.03 -33.64 98.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.539 2.159 . . . . 0.0 113.058 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.76 -42.67 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.21 1.368 . . . . 0.0 111.584 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -77.22 -38.87 50.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.869 -1.144 . . . . 0.0 113.602 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.91 -43.62 73.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.92 1.236 . . . . 0.0 110.581 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.92 91.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.943 0.897 . . . . 0.0 112.787 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.78 -42.94 76.28 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.293 1.406 . . . . 0.0 112.667 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -60.14 -53.39 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.574 0.625 . . . . 0.0 111.39 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.11 -21.59 65.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -48.85 -49.06 41.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.644 1.111 . . . . 0.0 112.062 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -64.03 -29.56 70.7 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -73.59 -51.42 16.95 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.983 0.913 . . . . 0.0 111.659 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 67.8 p -70.88 -21.42 62.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.972 -1.08 . . . . 0.0 113.372 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.55 94.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.244 1.018 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -38.63 91.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.242 0.928 . . . . 0.0 111.768 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mt -56.47 -52.66 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 118.809 0.731 . . . . 0.0 110.148 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.39 -30.04 70.81 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.21 -53.85 42.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.805 1.184 . . . . 0.0 111.165 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.62 -41.51 99.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.856 0.863 . . . . 0.0 111.995 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.38 87.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.317 1.047 . . . . 0.0 111.858 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.75 97.73 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.766 1.175 . . . . 0.0 112.935 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.18 -44.36 95.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.435 1.117 . . . . 0.0 111.253 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.226 -0.921 . . . . 0.0 112.462 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.22 82.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.402 1.081 . . . . 0.0 112.011 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.68 -50.33 63.49 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 0.0 112.21 171.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -58.16 -36.0 72.38 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -87.05 3.34 46.46 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.797 1.239 . . . . 0.0 113.441 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 92.3 mttt 55.64 32.91 20.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.844 2.058 . . . . 0.0 114.257 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.6 152.79 22.01 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.907 1.683 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 30.4 p -109.41 12.17 24.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.014 1.726 . . . . 0.0 112.905 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -133.54 126.65 31.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.472 -1.393 . . . . 0.0 111.268 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.6 127.52 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.027 0.931 . . . . 0.0 109.19 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.04 167.13 13.83 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.987 1.715 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -44.49 -42.71 14.16 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.241 3.294 . . . . 0.0 115.465 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.87 -40.69 93.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.749 0.82 . . . . 0.0 112.887 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -65.66 -41.56 92.38 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.621 0.768 . . . . 0.0 111.904 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.57 -43.9 95.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.41 0.684 . . . . 0.0 111.618 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -56.69 -50.29 72.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.426 1.09 . . . . 0.0 111.713 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.79 -46.85 81.29 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.736 0.698 . . . . 0.0 111.978 173.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.79 62.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.596 0.758 . . . . 0.0 112.593 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 pt -68.34 -30.84 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -65.78 -41.89 91.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.774 1.229 . . . . 0.0 112.388 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -79.57 -7.55 58.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -171.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -124.1 122.0 36.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.952 1.251 . . . . 0.0 111.361 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -53.33 -41.61 65.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.42 1.088 . . . . 0.0 112.516 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -64.08 -29.49 70.63 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.286 -0.883 . . . . 0.0 113.358 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.57 -43.83 30.52 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.607 -0.683 . . . . 0.0 111.306 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -53.93 -45.55 71.27 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.91 0.884 . . . . 0.0 112.261 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.39 -26.5 53.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.086 1.354 . . . . 0.0 113.915 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -91.12 -97.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.088 1.355 . . . . 0.0 110.276 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 CA--C 1.541 0.614 0 CA-C-N 119.852 1.205 . . . . 0.0 110.617 175.322 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -71.76 106.39 4.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.138 0.575 . . . . 0.0 109.593 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.59 140.43 97.51 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.135 0.574 . . . . 0.0 110.98 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -59.29 144.84 99.26 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.607 2.205 . . . . 0.0 111.407 172.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.72 124.21 17.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.301 0.64 . . . . 0.0 110.062 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.45 119.69 7.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.976 0.91 . . . . 0.0 110.004 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -57.14 123.03 13.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.215 1.006 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.17 111.51 5.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 23.4 t -123.13 118.34 27.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.148 1.379 . . . . 0.0 109.73 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -84.57 128.65 34.71 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.689 0.795 . . . . 0.0 110.786 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 123.702 0.801 . . . . 0.0 111.728 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -45.79 -34.68 3.84 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.746 1.618 . . . . 0.0 113.046 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -50.23 -33.93 21.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.497 -1.377 . . . . 0.0 114.086 171.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.5 -50.71 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.456 1.025 . . . . 0.0 110.454 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -51.87 66.76 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.876 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -51.0 -40.45 58.15 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -80.55 -50.29 10.21 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 113.179 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.44 -47.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.738 0.815 . . . . 0.0 111.937 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -131.24 84.9 55.53 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.598 1.559 . . . . 0.0 110.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.4 -31.26 76.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.571 2.847 . . . . 0.0 115.161 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -70.13 -19.51 63.22 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -94.59 133.16 38.53 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.855 1.262 . . . . 0.0 112.048 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.34 -172.49 13.22 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.731 1.158 . . . . 0.0 114.691 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -121.96 162.21 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.616 1.566 . . . . 0.0 110.284 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -89.45 163.58 15.2 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.958 168.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -55.84 -41.22 73.96 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.169 0.988 . . . . 0.0 111.845 168.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.43 -41.15 93.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.308 1.043 . . . . 0.0 112.176 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.32 92.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.763 0.825 . . . . 0.0 112.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 56.6 tpp -52.9 -48.26 67.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.005 168.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.55 -45.39 77.23 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.497 1.046 . . . . 0.0 114.729 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.72 -42.55 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.49 1.145 . . . . 0.0 112.011 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.73 -41.0 94.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.936 -1.102 . . . . 0.0 111.46 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -60.79 -47.3 86.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.848 0.859 . . . . 0.0 112.083 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 81.0 p -64.81 -39.63 93.91 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.572 1.533 . . . . 0.0 112.775 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -51.82 -55.83 17.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.93 1.292 . . . . 0.0 111.908 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.35 -31.2 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -60.94 -44.07 97.76 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.058 0.845 . . . . 0.0 112.04 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.49 -42.22 87.09 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.727 -0.608 . . . . 0.0 111.987 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.99 -43.28 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.34 -0.85 . . . . 0.0 111.466 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.36 -44.56 76.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.418 1.463 . . . . 0.0 112.501 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.717 0.69 . . . . 0.0 111.743 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -61.68 -43.76 98.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.775 0.83 . . . . 0.0 112.881 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -52.95 -52.8 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.555 1.142 . . . . 0.0 110.132 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.36 90.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.28 -50.85 61.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.892 0.758 . . . . 0.0 113.235 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -64.17 -41.45 97.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.604 -0.939 . . . . 0.0 112.156 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.15 94.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.419 1.009 . . . . 0.0 112.007 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -57.8 -53.77 54.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.291 1.036 . . . . 0.0 111.866 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -51.88 -54.75 25.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.169 0.987 . . . . 0.0 112.025 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.62 -44.51 89.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.297 1.039 . . . . 0.0 112.705 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.39 79.35 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.967 0.803 . . . . 0.0 112.138 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -63.14 -45.33 92.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.776 0.83 . . . . 0.0 112.594 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -60.62 -35.94 77.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.076 0.95 . . . . 0.0 112.45 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -86.18 15.49 5.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.613 1.565 . . . . 0.0 113.215 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 55.3 29.04 12.2 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.547 2.339 . . . . 0.0 115.075 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -81.77 152.92 26.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.489 1.116 . . . . 0.0 112.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 53.9 p -71.13 -35.6 71.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.834 1.253 . . . . 0.0 112.824 170.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 7.2 t -143.73 167.39 22.4 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.39 1.476 . . . . 0.0 112.806 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 84.1 mt -71.45 138.19 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.51 1.524 . . . . 0.0 110.457 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 16.7 p -112.51 166.16 11.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.511 1.125 . . . . 0.0 111.814 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 31.7 p -51.56 -41.66 61.29 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.403 1.081 . . . . 0.0 112.67 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.51 -45.76 89.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.3 1.04 . . . . 0.0 111.932 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.87 -40.68 96.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.323 0.51 . . . . 0.0 112.276 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.5 -51.78 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.685 0.794 . . . . 0.0 110.963 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -53.2 -48.63 67.95 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.68 1.127 . . . . 0.0 111.852 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 77.1 m -60.49 -46.28 90.67 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.187 0.903 . . . . 0.0 112.16 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.29 72.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.475 1.034 . . . . 0.0 112.753 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -60.31 -50.92 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.005 0.922 . . . . 0.0 110.583 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -58.42 -39.52 80.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.493 1.117 . . . . 0.0 113.748 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 72.4 mt -58.08 -44.2 87.42 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.721 0.691 . . . . 0.0 112.212 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.11 -37.76 64.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.226 1.01 . . . . 0.0 112.139 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 mt . . . . . 0 CA--C 1.553 1.091 0 C-N-CA 126.565 1.946 . . . . 0.0 111.059 -171.681 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.19 135.56 47.59 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.146 3.231 . . . . 0.0 113.491 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -74.32 156.87 50.47 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.875 1.226 . . . . 0.0 113.693 171.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 99.8 mmm -68.68 138.38 54.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.74 0.816 . . . . 0.0 111.867 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 40.1 p -80.96 143.45 32.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.427 1.091 . . . . 0.0 113.412 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.41 151.61 52.33 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.353 0.978 . . . . 0.0 112.964 170.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.49 136.18 57.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.039 0.936 . . . . 0.0 111.686 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.52 -28.1 73.54 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.221 0.915 . . . . 0.0 114.712 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.82 137.07 58.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.968 1.307 . . . . 0.0 112.244 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -92.75 168.19 11.37 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.805 1.242 . . . . 0.0 112.139 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.16 -152.76 48.89 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.181 0.896 . . . . 0.0 113.43 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.43 5.3 35.32 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 124.759 1.171 . . . . 0.0 115.95 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -77.12 150.12 35.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.427 1.491 . . . . 0.0 111.776 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.18 132.18 46.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.147 0.579 . . . . 0.0 110.978 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.62 138.54 55.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.575 0.75 . . . . 0.0 111.354 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.01 133.92 51.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.525 0.73 . . . . 0.0 111.86 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.16 145.8 54.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.936 0.894 . . . . 0.0 111.489 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.97 137.59 58.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.347 0.659 . . . . 0.0 111.706 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 135.39 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.745 0.818 . . . . 0.0 111.779 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 33.4 p -73.12 156.99 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.369 1.067 . . . . 0.0 112.265 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -60.81 146.2 47.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 51.8 p -74.41 -37.37 63.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.576 1.15 . . . . 0.0 112.923 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -58.18 129.31 41.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 112.134 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.82 144.48 49.11 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.645 1.178 . . . . 0.0 112.102 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 118.22 10.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.67 0.788 . . . . 0.0 112.173 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.8 165.01 54.04 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.651 1.119 . . . . 0.0 113.66 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.59 151.99 32.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.923 0.889 . . . . 0.0 111.488 171.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -79.5 117.72 20.71 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.764 -0.585 . . . . 0.0 110.098 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.61 147.58 34.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.504 1.122 . . . . 0.0 110.403 170.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.23 -27.2 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.438 2.092 . . . . 0.0 114.32 -167.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.94 -32.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 120.629 -1.295 . . . . 0.0 113.244 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.87 -30.32 74.87 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.348 0.975 . . . . 0.0 114.046 170.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -79.41 -37.87 36.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.33 1.052 . . . . 0.0 111.714 170.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.84 -39.97 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.529 1.059 . . . . 0.0 111.265 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -50.57 -48.2 57.63 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.321 0.964 . . . . 0.0 112.394 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.7 -38.65 87.16 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.037 0.935 . . . . 0.0 112.953 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.24 -42.53 91.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.66 1.118 . . . . 0.0 111.992 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.9 -44.63 94.13 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.438 0.695 . . . . 0.0 111.707 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -61.13 -45.85 92.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.103 0.961 . . . . 0.0 112.764 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -58.73 -42.21 88.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.209 1.403 . . . . 0.0 112.444 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.98 -20.91 54.84 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 124.837 1.208 . . . . 0.0 114.464 170.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.83 39.69 30.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.094 2.158 . . . . 0.0 113.51 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -62.88 -36.67 84.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.863 0.865 . . . . 0.0 112.527 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -151.84 178.75 9.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.726 1.211 . . . . 0.0 112.682 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -61.58 -39.09 89.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.552 1.141 . . . . 0.0 113.651 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -139.67 146.84 40.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.541 1.536 . . . . 0.0 110.982 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.77 118.87 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.02 142.76 48.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.884 0.754 . . . . 0.0 112.862 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.28 68.79 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.281 1.041 . . . . 0.0 113.513 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.98 -24.98 76.15 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.445 1.021 . . . . 0.0 114.982 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.22 -55.82 37.96 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.355 1.578 . . . . 0.0 114.36 -174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.83 -34.41 95.65 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.357 2.038 . . . . 0.0 113.068 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.69 -51.02 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.155 0.888 . . . . 0.0 110.91 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -66.78 -42.28 86.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.589 0.756 . . . . 0.0 110.118 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 69.7 mt -63.32 -35.16 79.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.932 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.21 93.21 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.508 1.504 . . . . 0.0 112.077 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.39 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.92 0.488 . . . . 0.0 111.864 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -51.57 -53.86 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.512 1.125 . . . . 0.0 111.393 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 mt -53.11 -49.1 67.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.718 1.607 . . . . 0.0 112.104 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -48.04 -51.63 23.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.49 1.041 . . . . 0.0 111.985 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -69.45 -31.99 70.65 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.53 -23.3 57.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 1.5 p -119.22 5.12 11.24 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.598 1.544 . . . . 0.0 114.867 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.65 73.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.165 1.348 . . . . 0.0 112.718 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -70.1 -32.96 71.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.8 -54.14 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.012 0.925 . . . . 0.0 109.667 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.92 -46.48 81.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.51 1.524 . . . . 0.0 112.551 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -54.71 -56.78 15.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.586 0.754 . . . . 0.0 111.514 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.43 -38.07 71.4 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.0 99.45 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.334 -0.854 . . . . 0.0 111.802 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.97 94.99 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.506 -0.746 . . . . 0.0 113.596 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -58.8 -49.89 76.01 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.848 1.324 . . . . 0.0 110.603 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.78 80.96 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.63 0.772 . . . . 0.0 112.509 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.1 75.36 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.817 0.847 . . . . 0.0 112.606 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -56.82 -50.95 70.84 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.436 1.094 . . . . 0.0 112.289 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -55.51 -42.01 73.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.613 1.165 . . . . 0.0 113.075 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.79 10.68 17.62 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.625 1.17 . . . . 0.0 113.089 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 53.63 33.32 16.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.392 2.277 . . . . 0.0 114.777 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -89.29 146.51 24.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.23 1.412 . . . . 0.0 112.386 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.6 p -77.91 -30.63 50.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.881 1.272 . . . . 0.0 112.967 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -131.24 151.76 51.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.126 1.37 . . . . 0.0 112.603 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.7 mt -67.46 129.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 0.0 109.928 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 pt -122.71 167.1 15.16 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.429 1.892 . . . . 0.0 111.265 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -54.55 -34.5 82.73 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.344 2.696 . . . . 0.0 114.952 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.03 -36.75 75.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.988 0.915 . . . . 0.0 113.252 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -63.23 -38.69 92.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.551 -0.718 . . . . 0.0 111.982 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.21 -46.27 71.05 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.502 0.721 . . . . 0.0 111.761 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -50.65 -46.64 58.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.725 0.81 . . . . 0.0 111.746 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.83 -62.31 1.73 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.944 0.898 . . . . 0.0 112.173 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.99 69.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.755 1.222 . . . . 0.0 113.074 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -56.87 -61.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.857 0.863 . . . . 0.0 110.741 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.0 -32.69 74.11 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -86.79 -8.59 57.21 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -129.3 118.1 21.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 112.407 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.78 -26.81 67.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.822 -1.173 . . . . 0.0 114.067 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -70.98 -31.36 67.89 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 111.489 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.75 -36.94 67.81 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 111.493 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.54 -29.38 66.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.406 1.003 . . . . 0.0 112.771 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -77.11 -46.0 25.01 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.417 1.008 . . . . 0.0 112.417 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 mt -57.18 -45.1 83.98 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.083 0.953 . . . . 0.0 112.877 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -83.6 122.19 28.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.763 0.825 . . . . 0.0 111.992 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.35 -127.81 44.45 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.686 0.66 . . . . 0.0 114.407 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -62.91 123.95 19.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.357 1.063 . . . . 0.0 111.953 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.89 123.75 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.351 1.061 . . . . 0.0 109.937 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.393 0.677 . . . . 0.0 111.806 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.44 124.3 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 121.582 -0.699 . . . . 0.0 109.65 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.32 72.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.65 0.78 . . . . 0.0 113.065 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -78.06 158.36 29.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.115 0.966 . . . . 0.0 112.57 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.56 77.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.057 0.837 . . . . 0.0 114.855 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 141.9 48.19 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.871 1.224 . . . . 0.0 113.065 172.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 52.4 t -68.47 123.71 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.047 0.939 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.48 144.36 42.99 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.242 1.017 . . . . 0.0 111.347 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.75 -34.98 17.24 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.113 2.542 . . . . 0.0 113.354 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -71.14 133.49 46.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.87 0.868 . . . . 0.0 110.525 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.33 117.76 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.799 0.839 . . . . 0.0 109.71 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -80.79 148.07 30.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.935 0.894 . . . . 0.0 111.244 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.17 132.09 51.63 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.864 -0.522 . . . . 0.0 111.272 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.0 120.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.25 96.06 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.12 140.37 97.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.33 0.652 . . . . 0.0 110.789 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -58.66 149.52 76.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.44 2.093 . . . . 0.0 111.15 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.15 109.26 1.06 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.783 -0.573 . . . . 0.0 109.929 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.31 131.45 46.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.921 0.889 . . . . 0.0 110.387 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -63.34 155.57 28.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.275 0.63 . . . . 0.0 110.813 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.84 121.05 10.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.296 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -58.46 136.7 57.56 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.406 0.682 . . . . 0.0 111.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.8 100.39 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.102 0.561 . . . . 0.0 111.309 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -62.62 152.66 34.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.546 1.138 . . . . 0.0 111.409 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.97 116.44 2.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.08 0.952 . . . . 0.0 111.037 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.91 140.52 57.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.738 0.815 . . . . 0.0 111.861 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.48 112.34 5.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.703 0.801 . . . . 0.0 111.047 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.32 178.64 37.71 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.862 1.22 . . . . 0.0 114.422 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.485 1.514 . . . . 0.0 111.951 174.684 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.888 0 CA-C-O 119.877 -0.401 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -60.85 -23.98 78.1 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.838 3.692 . . . . 0.0 114.904 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -63.77 -20.1 63.77 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.327 0.965 . . . . 0.0 115.234 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.3 mmm -79.56 141.76 56.84 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 118.559 1.18 . . . . 0.0 112.108 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.24 144.04 94.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.103 2.536 . . . . 0.0 112.175 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -72.45 124.26 90.57 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 121.581 -0.699 . . . . 0.0 110.211 170.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -63.5 147.02 93.43 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.169 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.79 115.43 5.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.388 0.675 . . . . 0.0 111.633 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.66 143.96 27.36 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.942 1.297 . . . . 0.0 111.315 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 54.5 p -66.81 156.78 34.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.815 0.846 . . . . 0.0 112.207 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.2 131.45 84.12 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.718 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.17 128.55 30.98 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.067 2.512 . . . . 0.0 113.342 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.12 131.05 94.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.243 0.617 . . . . 0.0 111.257 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.6 137.69 65.65 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.054 2.503 . . . . 0.0 112.016 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.68 131.75 51.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.584 0.753 . . . . 0.0 110.726 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.4 134.17 54.03 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.575 0.75 . . . . 0.0 110.883 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 140.11 48.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.668 0.652 . . . . 0.0 112.253 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 69.4 p -60.63 152.51 26.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.453 0.701 . . . . 0.0 112.354 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.67 103.81 1.17 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.556 0.742 . . . . 0.0 110.173 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.69 130.48 44.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 110.429 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 124.1 21.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.124 0.57 . . . . 0.0 110.989 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.4 t -79.42 108.24 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 56.1 p -76.79 166.34 23.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 0.0 112.687 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 108.44 2.22 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 124.14 19.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.59 0.756 . . . . 0.0 110.927 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.28 142.13 47.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.172 0.589 . . . . 0.0 110.351 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.92 105.3 4.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.606 -0.684 . . . . 0.0 111.163 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -101.35 -1.36 33.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.627 1.571 . . . . 0.0 113.158 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.09 139.24 42.66 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.305 1.042 . . . . 0.0 111.578 167.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.33 16.19 62.29 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -63.66 138.17 58.39 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.628 1.214 . . . . 0.0 113.151 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -96.87 -26.79 14.96 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.867 1.267 . . . . 0.0 113.273 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -99.27 88.36 3.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.722 1.609 . . . . 0.0 110.598 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -137.76 154.65 49.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.848 1.659 . . . . 0.0 112.238 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.28 -16.48 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.652 1.181 . . . . 0.0 113.692 170.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -63.76 122.27 16.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.563 0.745 . . . . 0.0 111.104 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.41 150.56 46.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.113 0.965 . . . . 0.0 110.142 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.3 118.54 2.49 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.588 0.755 . . . . 0.0 110.192 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -62.54 110.73 1.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.215 1.006 . . . . 0.0 110.727 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 15.3 t -154.92 -179.74 8.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.333 1.853 . . . . 0.0 109.662 -172.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -62.14 -17.81 59.02 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -42.2 -33.31 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.639 1.976 . . . . 0.0 114.185 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -41.69 -54.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.234 1.814 . . . . 0.0 111.705 169.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -90.56 -25.15 20.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.46 -58.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.096 0.959 . . . . 0.0 110.412 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.92 -41.47 74.58 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.14 -58.34 8.34 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 0.0 112.223 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 51.6 t -71.97 -35.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.962 -0.461 . . . . 0.0 111.372 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 tp -50.15 -57.54 7.49 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.679 169.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.77 -34.21 77.65 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -63.72 -50.16 70.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.509 0.724 . . . . 0.0 112.546 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.37 -44.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.921 0.889 . . . . 0.0 111.966 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.41 66.05 61.02 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.52 1.928 . . . . 0.0 111.445 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -55.99 -25.88 56.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.016 3.144 . . . . 0.0 114.18 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.3 -14.21 59.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.521 2.328 . . . . 0.0 114.2 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -121.17 126.21 49.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.527 1.131 . . . . 0.0 111.741 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.68 -164.75 40.54 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.071 0.843 . . . . 0.0 113.667 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.9 tt -143.79 149.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.99 -1.3 . . . . 0.0 111.73 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -80.69 156.07 26.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -56.65 -39.25 73.37 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.243 -0.91 . . . . 0.0 112.128 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.98 -55.82 29.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.189 1.396 . . . . 0.0 111.57 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.95 -42.08 97.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.469 0.708 . . . . 0.0 112.558 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 53.9 ttp -54.59 -53.55 53.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.846 0.859 . . . . 0.0 111.681 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.4 85.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.786 0.708 . . . . 0.0 113.069 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.84 -48.33 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.161 0.984 . . . . 0.0 111.113 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 65.1 mtt -57.5 -41.64 81.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.984 1.265 . . . . 0.0 112.615 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.86 -52.06 67.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.432 0.56 . . . . 0.0 110.727 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 72.8 m -54.92 -47.57 74.23 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.12 0.873 . . . . 0.0 112.794 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -54.54 -46.89 73.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 112.02 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -44.1 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.513 0.597 . . . . 0.0 111.739 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.06 -41.98 84.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.356 0.98 . . . . 0.0 111.933 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -60.0 -31.14 69.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 tp -90.9 -34.1 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 111.707 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.13 -42.05 89.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.61 1.164 . . . . 0.0 112.46 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -56.82 -44.38 81.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.371 1.068 . . . . 0.0 111.925 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -64.93 -44.87 88.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.053 0.941 . . . . 0.0 111.76 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.52 -49.4 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.707 1.203 . . . . 0.0 110.986 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.37 81.96 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 112.359 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.87 -46.11 90.86 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.268 0.937 . . . . 0.0 113.594 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.6 -41.89 87.75 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.379 -1.071 . . . . 0.0 112.856 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.47 94.36 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.156 0.889 . . . . 0.0 111.53 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -57.69 -49.76 75.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.418 1.087 . . . . 0.0 111.928 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.74 -49.86 67.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.471 1.109 . . . . 0.0 112.039 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.9 -48.22 78.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.685 0.794 . . . . 0.0 111.733 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -44.97 73.92 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.766 0.712 . . . . 0.0 112.473 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -57.6 -52.21 66.37 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.898 . . . . 0.0 112.387 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -62.43 -32.75 73.65 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -81.16 4.8 18.83 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.908 1.283 . . . . 0.0 113.627 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 56.86 31.9 20.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.968 2.107 . . . . 0.0 114.275 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -101.08 140.97 34.64 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.6 1.56 . . . . 0.0 112.074 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 61.0 p -79.68 -19.63 48.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.844 1.258 . . . . 0.0 113.086 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 63.7 p -114.73 148.91 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.87 2.068 . . . . 0.0 111.651 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.75 129.32 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.202 1.001 . . . . 0.0 110.014 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 6.1 p -83.37 162.42 21.06 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.016 0.912 . . . . 0.0 113.31 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -65.78 -10.29 36.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 0.0 114.295 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.44 -40.97 8.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.17 1.388 . . . . 0.0 112.187 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.53 -39.97 74.3 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.118 0.967 . . . . 0.0 112.663 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -57.81 -41.32 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -61.86 -49.5 75.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.229 0.922 . . . . 0.0 110.376 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 45.2 m -60.81 -46.86 88.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.397 1.079 . . . . 0.0 111.833 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.2 -46.93 65.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.445 1.098 . . . . 0.0 112.525 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.5 -51.23 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.605 0.762 . . . . 0.0 111.008 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -53.96 -45.78 71.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.114 0.966 . . . . 0.0 112.598 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.92 -36.77 72.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.875 1.27 . . . . 0.0 112.962 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.81 -22.41 25.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.551 1.14 . . . . 0.0 113.787 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 24.5 mt -115.69 78.56 6.97 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.736 1.214 . . . . 0.0 112.108 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -61.87 157.35 43.71 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.818 2.345 . . . . 0.0 113.412 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 -137.8 49.34 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.862 1.22 . . . . 0.0 114.53 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.76 -21.2 66.71 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.65 -41.39 85.96 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.435 -0.791 . . . . 0.0 112.061 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.82 73.39 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.118 0.872 . . . . 0.0 113.244 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.6 -44.14 80.84 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.45 1.023 . . . . 0.0 110.963 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -66.04 -71.07 0.21 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.701 0.8 . . . . 0.0 112.251 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.28 69.16 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -166.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.44 -57.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.327 1.051 . . . . 0.0 111.459 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 10.8 t -66.26 -58.56 5.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.075 1.307 . . . . 0.0 111.645 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.47 -30.11 69.74 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.242 -0.911 . . . . 0.0 112.3 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.5 -48.8 59.54 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.119 0.866 . . . . 0.0 113.917 168.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -66.91 -39.51 87.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 111.854 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.21 -40.96 87.44 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.291 0.95 . . . . 0.0 112.199 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.66 -23.48 67.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 99.6 t -48.47 -41.59 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 120.147 1.34 . . . . 0.0 111.865 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 38.0 m -52.37 -39.46 60.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.77 1.228 . . . . 0.0 112.946 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.0 -47.82 76.12 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.091 -1.006 . . . . 0.0 111.059 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -61.92 -32.24 72.62 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 60.3 p -81.35 -39.3 25.3 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.418 1.008 . . . . 0.0 112.827 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 42.4 m -69.39 -51.64 34.64 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.43 142.24 33.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.97 0.908 . . . . 0.0 112.224 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 82.2 tttt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 124.176 0.991 . . . . 0.0 112.044 177.434 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.37 149.33 91.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.989 3.126 . . . . 0.0 113.076 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -61.24 137.34 47.76 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.777 0.703 . . . . 0.0 112.307 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.6 mmm -59.82 137.64 58.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.47 0.708 . . . . 0.0 111.738 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p -91.14 160.54 15.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.964 1.306 . . . . 0.0 112.815 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.99 -123.99 27.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.683 0.658 . . . . 0.0 112.385 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.96 144.16 57.47 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.92 0.86 . . . . 0.0 112.159 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.86 3.9 75.32 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.753 1.168 . . . . 0.0 115.643 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.82 117.42 16.64 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.055 1.427 . . . . 0.0 110.969 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.67 124.93 23.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.09 0.556 . . . . 0.0 110.697 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.1 11.64 52.31 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 124.33 0.967 . . . . 0.0 115.179 -171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.0 154.93 53.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.052 1.31 . . . . 0.0 114.14 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.51 118.78 6.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.258 1.023 . . . . 0.0 110.587 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.05 136.49 57.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.359 0.664 . . . . 0.0 110.949 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -58.8 129.94 44.52 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.31 0.644 . . . . 0.0 111.278 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 56.43 1.98 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.155 1.382 . . . . 0.0 112.066 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -54.28 133.48 44.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.168 1.387 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.02 136.4 57.94 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.036 0.534 . . . . 0.0 111.092 172.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.74 102.0 2.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.499 0.719 . . . . 0.0 109.988 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 39.3 p -69.75 148.78 48.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.298 1.039 . . . . 0.0 112.009 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.98 139.45 55.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.387 0.675 . . . . 0.0 111.248 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 61.5 p -71.18 -25.64 62.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.361 1.064 . . . . 0.0 113.423 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -55.52 125.97 23.24 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.951 1.3 . . . . 0.0 112.038 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.09 142.06 36.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.494 1.117 . . . . 0.0 111.545 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.93 -27.61 66.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.317 0.647 . . . . 0.0 112.653 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.03 -141.5 47.41 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.87 1.224 . . . . 0.0 112.993 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.42 97.81 8.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.53 0.732 . . . . 0.0 111.059 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -103.15 141.62 35.55 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.184 1.394 . . . . 0.0 110.182 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.0 74.87 80.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.152 0.981 . . . . 0.0 112.157 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -65.99 165.46 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.649 2.233 . . . . 0.0 111.784 165.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.0 -21.35 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.271 -1.518 . . . . 0.0 113.047 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.76 -43.68 91.86 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.207 0.912 . . . . 0.0 112.92 161.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -71.09 -37.85 72.41 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.518 -0.989 . . . . 0.0 112.259 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 37.0 t -55.94 -44.89 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.495 1.043 . . . . 0.0 110.529 168.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -63.03 -38.3 90.62 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.671 -1.268 . . . . 0.0 112.411 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.02 -41.52 99.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.156 0.982 . . . . 0.0 113.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.73 -43.34 99.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.859 0.864 . . . . 0.0 111.575 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.55 -42.08 98.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 112.509 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -54.33 -55.77 25.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.066 1.346 . . . . 0.0 111.153 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.89 -37.0 84.97 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.01 0.924 . . . . 0.0 113.062 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.99 8.42 23.22 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.053 2.263 . . . . 0.0 116.493 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.9 24.86 14.86 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.489 1.916 . . . . 0.0 115.387 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.6 -32.34 18.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.391 1.076 . . . . 0.0 112.894 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t -124.57 137.87 54.36 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.039 1.336 . . . . 0.0 110.757 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -80.17 -40.11 27.95 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.167 -0.958 . . . . 0.0 112.349 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -137.23 165.25 26.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.518 1.527 . . . . 0.0 111.505 173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.41 105.88 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.453 1.501 . . . . 0.0 108.491 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.59 -179.22 27.29 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.947 0.784 . . . . 0.0 113.48 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.46 -50.04 23.7 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.578 -0.954 . . . . 0.0 111.997 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.76 -26.69 55.76 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.71 1.148 . . . . 0.0 115.458 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.78 -52.33 73.13 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.77 -37.1 89.0 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.59 2.194 . . . . 0.0 112.914 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.77 -40.97 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.755 0.822 . . . . 0.0 110.827 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.69 -45.12 87.98 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.373 -0.83 . . . . 0.0 112.547 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.01 -40.45 89.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.647 1.112 . . . . 0.0 111.827 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.38 90.45 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.346 -0.846 . . . . 0.0 111.334 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.88 -18.64 57.44 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.52 -59.43 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.322 -0.861 . . . . 0.0 110.733 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.67 -21.27 64.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.299 1.04 . . . . 0.0 112.869 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -37.7 -49.3 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.594 1.958 . . . . 0.0 112.917 159.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -61.18 -50.24 73.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.917 0.78 . . . . 0.0 112.5 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.34 -48.4 81.77 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.621 . . . . 0.0 111.348 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 71.8 m -60.98 -41.18 95.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.665 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.04 83.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.323 0.965 . . . . 0.0 112.086 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -56.5 -46.44 80.5 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.048 0.84 . . . . 0.0 112.561 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 86.5 mt -57.66 -57.76 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.698 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.01 -30.81 69.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.3 -55.22 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.909 1.231 . . . . 0.0 111.192 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.21 -36.68 84.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.647 -0.658 . . . . 0.0 112.102 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.57 96.83 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.477 -0.765 . . . . 0.0 112.433 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.38 -40.03 95.53 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.179 0.895 . . . . 0.0 113.175 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -64.2 -44.56 91.57 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.726 -0.867 . . . . 0.0 111.271 172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -42.98 87.84 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.287 0.949 . . . . 0.0 112.435 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.43 79.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.717 0.807 . . . . 0.0 112.281 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -55.86 -48.14 76.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.386 1.074 . . . . 0.0 112.164 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.77 -39.34 77.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.174 0.989 . . . . 0.0 113.519 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.79 2.97 27.6 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 57.22 32.54 21.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.502 1.921 . . . . 0.0 113.811 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.97 146.27 28.59 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.817 1.647 . . . . 0.0 112.332 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -100.48 9.58 42.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.696 1.598 . . . . 0.0 113.492 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.51 136.22 44.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.831 -1.168 . . . . 0.0 111.304 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.72 131.09 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.029 0.932 . . . . 0.0 109.732 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.87 165.93 14.12 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 125.936 1.694 . . . . 0.0 111.807 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -46.13 -44.47 19.4 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.26 3.306 . . . . 0.0 115.586 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.776 0.83 . . . . 0.0 112.702 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.38 -44.5 95.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.848 0.859 . . . . 0.0 112.16 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.24 -42.07 96.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.92 0.888 . . . . 0.0 111.804 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.865 0.866 . . . . 0.0 111.788 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.03 -46.94 72.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.662 1.185 . . . . 0.0 112.064 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.96 -47.54 64.73 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 94.1 mt -65.46 -55.46 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.35 0.66 . . . . 0.0 110.944 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -54.95 -37.84 66.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.603 1.161 . . . . 0.0 113.506 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.87 0.43 54.96 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -125.02 127.16 46.55 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.752 1.16 . . . . 0.0 112.943 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -57.11 -51.35 69.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.021 0.929 . . . . 0.0 112.918 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -66.24 -34.12 77.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 112.2 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.28 -41.04 73.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.293 0.637 . . . . 0.0 112.575 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -58.88 -40.06 83.24 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.463 1.483 . . . . 0.0 111.88 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.69 -3.18 1.38 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.32 1.448 . . . . 0.0 114.879 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -76.15 -73.32 0.28 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.76 1.164 . . . . 0.0 110.147 167.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.35 -20.39 51.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.715 0.806 . . . . 0.0 112.873 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.24 -21.75 54.26 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 124.418 1.009 . . . . 0.0 114.66 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -87.99 2.42 51.79 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 66.4 t -77.42 109.21 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.169 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -79.64 114.0 18.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 109.734 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -79.39 118.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.775 0.83 . . . . 0.0 109.032 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 139.19 58.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.599 0.76 . . . . 0.0 111.686 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -64.71 117.4 7.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.484 0.714 . . . . 0.0 111.393 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.11 131.83 39.35 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.93 0.776 . . . . 0.0 112.145 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.17 171.46 39.49 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.204 0.907 . . . . 0.0 113.506 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 81.9 t -61.79 123.23 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.704 0.802 . . . . 0.0 110.241 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.72 157.26 49.47 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.598 1.159 . . . . 0.0 111.714 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.71 125.07 17.56 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.102 2.535 . . . . 0.0 112.852 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.7 140.32 42.4 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.463 0.705 . . . . 0.0 110.765 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.29 124.39 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.006 0.923 . . . . 0.0 110.237 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -97.79 154.89 17.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.859 1.264 . . . . 0.0 111.257 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.54 113.2 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.29 0.636 . . . . 0.0 111.879 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.66 -18.52 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.099 0.96 . . . . 0.0 113.132 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.21 114.0 6.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.061 1.344 . . . . 0.0 110.929 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 37.3 tp -64.61 127.9 92.91 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.143 0.977 . . . . 0.0 110.531 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.35 119.72 7.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.747 2.298 . . . . 0.0 112.09 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.05 138.05 40.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.047 0.939 . . . . 0.0 111.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.68 140.19 58.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.851 0.861 . . . . 0.0 111.496 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -73.33 150.95 41.48 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.068 0.947 . . . . 0.0 112.089 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -90.92 139.14 31.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 111.824 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -81.09 124.78 29.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.43 0.692 . . . . 0.0 110.827 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -108.97 6.37 25.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.73 1.212 . . . . 0.0 113.058 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -66.91 -31.5 72.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.848 1.259 . . . . 0.0 112.274 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.56 156.77 16.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.905 1.682 . . . . 0.0 111.791 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.68 -36.74 83.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.095 0.958 . . . . 0.0 113.363 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -66.76 124.34 22.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 111.769 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.66 24.88 21.46 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 125.448 1.499 . . . . 0.0 115.437 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 125.761 1.624 . . . . 0.0 112.418 -176.636 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 CA-C-O 118.753 -1.026 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -65.84 166.9 18.92 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.152 3.235 . . . . 0.0 113.86 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 64.91 -155.81 48.04 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.833 1.206 . . . . 0.0 113.866 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 99.8 mmm -104.97 140.17 20.81 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.572 1.149 . . . . 0.0 111.457 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -61.86 139.12 78.12 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.877 2.385 . . . . 0.0 111.533 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -69.67 135.46 88.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.561 -0.712 . . . . 0.0 111.216 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.58 117.92 4.94 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.098 2.532 . . . . 0.0 111.57 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.7 123.84 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.641 0.776 . . . . 0.0 111.13 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.44 135.24 55.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.36 0.664 . . . . 0.0 110.492 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 51.3 p -63.53 151.36 41.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.247 0.619 . . . . 0.0 111.645 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.73 132.7 89.04 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.734 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -58.65 139.01 88.96 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.736 2.29 . . . . 0.0 111.248 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 133.88 83.0 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.122 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -59.95 152.1 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.857 2.371 . . . . 0.0 111.538 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.44 105.61 1.21 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 110.479 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -78.57 144.88 35.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.182 0.993 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.46 62.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.126 0.87 . . . . 0.0 114.888 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -68.98 132.74 47.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 111.705 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.93 145.66 54.34 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.199 1.0 . . . . 0.0 110.652 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.94 117.88 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.468 0.707 . . . . 0.0 110.443 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 141.82 58.01 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.379 0.672 . . . . 0.0 111.67 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.93 109.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 36.4 m -71.42 102.8 2.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.744 0.818 . . . . 0.0 110.194 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.8 144.43 56.31 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.254 1.022 . . . . 0.0 111.29 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.6 120.63 10.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.397 0.679 . . . . 0.0 111.303 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.62 144.13 26.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.158 0.983 . . . . 0.0 111.521 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -67.19 136.33 54.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.388 0.675 . . . . 0.0 111.026 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -74.18 -26.27 60.19 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.898 0.879 . . . . 0.0 112.555 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.25 129.1 40.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.249 1.02 . . . . 0.0 112.009 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.71 -179.79 28.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.021 0.82 . . . . 0.0 113.756 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.49 141.32 43.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.831 . . . . 0.0 111.179 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.22 125.18 21.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.092 0.957 . . . . 0.0 110.32 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.85 95.51 3.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.584 0.754 . . . . 0.0 110.654 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.62 136.59 57.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.352 1.061 . . . . 0.0 109.959 168.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -67.29 126.42 29.2 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.056 0.542 . . . . 0.0 110.353 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 47.7 p -65.76 151.16 47.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.607 0.763 . . . . 0.0 111.404 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -64.73 119.14 10.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.419 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -87.77 150.43 23.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.729 1.212 . . . . 0.0 111.064 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -83.12 146.23 28.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.502 0.721 . . . . 0.0 110.629 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 2.5 p -150.95 161.09 43.38 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -153.61 -179.1 7.48 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.079 -1.013 . . . . 0.0 113.709 -122.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 96.9 p -71.9 -27.7 63.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 121.15 1.795 . . . . 0.0 114.092 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.56 -45.47 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 121.348 -0.845 . . . . 0.0 109.867 160.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -98.96 34.16 2.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.801 2.04 . . . . 0.0 114.378 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.7 -48.43 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.069 -1.645 . . . . 0.0 110.711 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -62.31 -29.95 70.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.541 0.736 . . . . 0.0 112.573 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.04 -50.04 72.23 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.337 0.971 . . . . 0.0 111.568 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -52.47 -52.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 119.524 1.056 . . . . 0.0 110.202 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.94 -52.59 64.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.89 0.876 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.38 -35.02 73.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.779 1.232 . . . . 0.0 114.001 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.5 -42.03 59.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.272 0.942 . . . . 0.0 112.812 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -87.09 -61.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.318 1.047 . . . . 0.0 112.231 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -137.23 91.43 14.57 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.683 1.593 . . . . 0.0 110.57 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -56.36 -29.24 76.26 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.814 3.009 . . . . 0.0 115.173 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -84.35 -1.78 56.02 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.479 1.912 . . . . 0.0 113.951 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -111.28 137.63 48.77 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.259 1.424 . . . . 0.0 111.848 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.84 14.18 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.954 1.74 . . . . 0.0 113.233 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.64 141.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 110.207 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -73.99 155.79 38.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.653 -0.655 . . . . 0.0 112.72 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p -57.32 -37.24 72.21 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.288 -0.882 . . . . 0.0 112.005 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.34 -47.48 85.71 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.948 1.299 . . . . 0.0 111.998 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.32 94.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.832 0.853 . . . . 0.0 112.933 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.76 -39.09 87.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.473 1.033 . . . . 0.0 111.896 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -44.46 76.9 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.247 0.927 . . . . 0.0 113.167 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -68.58 -35.1 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.315 1.058 . . . . 0.0 112.531 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 38.3 tpp -57.95 -41.14 82.21 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.65 -1.282 . . . . 0.0 111.284 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -65.83 -35.34 80.41 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.045 -1.034 . . . . 0.0 112.216 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 47.7 m -58.55 -39.4 80.14 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.27 -1.519 . . . . 0.0 112.19 167.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.94 -33.51 76.2 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.628 -1.295 . . . . 0.0 113.134 172.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' VAL . . . . . 0.463 ' HA ' ' CD2' ' D' ' 70' ' ' PHE . 47.0 t -57.96 -52.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.45 1.023 . . . . 0.0 110.935 165.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -64.92 -32.46 74.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.856 0.863 . . . . 0.0 113.249 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.1 -63.82 1.22 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.219 1.408 . . . . 0.0 113.505 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 81.2 mt -68.15 -51.8 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.155 0.982 . . . . 0.0 111.196 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' D' ' 66' ' ' VAL . 9.1 m-30 -66.85 -35.98 81.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.547 -0.721 . . . . 0.0 111.051 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.12 -47.64 84.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.171 0.988 . . . . 0.0 112.62 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.28 -46.69 85.57 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.133 -0.98 . . . . 0.0 112.113 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.01 -44.15 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 118.762 0.71 . . . . 0.0 111.368 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.48 84.55 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.302 0.956 . . . . 0.0 112.392 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.17 -47.15 91.12 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.429 1.014 . . . . 0.0 113.547 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -64.83 -45.17 87.3 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.478 -1.013 . . . . 0.0 112.607 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.25 83.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.215 173.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -60.17 -53.12 61.5 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.254 1.022 . . . . 0.0 111.639 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -57.37 -42.06 81.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.33 -0.857 . . . . 0.0 112.811 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.86 -46.0 90.68 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.692 1.197 . . . . 0.0 112.012 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.98 96.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.91 0.884 . . . . 0.0 112.427 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -60.91 -40.66 94.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.387 1.075 . . . . 0.0 112.839 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -57.6 -37.96 74.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.615 0.766 . . . . 0.0 112.135 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -86.43 15.7 5.2 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.204 1.402 . . . . 0.0 113.737 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 52.25 28.05 5.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.466 2.306 . . . . 0.0 115.121 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -71.76 156.71 39.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.429 1.091 . . . . 0.0 112.805 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 63.7 p -80.52 -29.44 37.22 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.713 1.205 . . . . 0.0 113.068 165.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 5.7 t -141.96 168.73 19.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.578 1.551 . . . . 0.0 113.048 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.18 107.05 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 19.2 p -88.75 169.28 11.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.332 1.053 . . . . 0.0 112.277 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 46.3 p -52.99 -36.95 60.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.209 -0.932 . . . . 0.0 112.946 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.43 -42.9 67.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.683 1.193 . . . . 0.0 112.267 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -61.8 -42.56 99.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.476 0.58 . . . . 0.0 111.736 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.94 -50.58 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.613 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -49.12 -53.69 19.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.829 1.195 . . . . 0.0 111.296 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 55.9 m -59.77 -43.26 94.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.616 -0.677 . . . . 0.0 111.968 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.68 75.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.461 1.028 . . . . 0.0 112.324 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -35.33 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.549 -1.345 . . . . 0.0 112.415 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.04 -21.47 64.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.777 1.171 . . . . 0.0 113.388 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.82 -43.14 22.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.357 1.063 . . . . 0.0 111.93 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.82 -25.99 66.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 83.6 mt -121.18 90.95 47.81 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.033 2.133 . . . . 0.0 110.813 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -66.79 -27.63 44.08 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.717 2.945 . . . . 0.0 115.327 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.72 129.25 44.28 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.294 0.949 . . . . 0.0 113.57 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -61.64 -38.0 86.08 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.147 -1.207 . . . . 0.0 113.298 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.76 -39.1 93.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.646 0.778 . . . . 0.0 111.84 173.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.37 77.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.729 0.812 . . . . 0.0 111.721 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.17 -45.5 75.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.072 -1.018 . . . . 0.0 112.096 171.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.11 -48.77 77.81 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 112.149 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.62 71.18 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -65.42 -43.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.093 -1.005 . . . . 0.0 112.076 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.3 m -61.48 -39.43 90.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.386 0.994 . . . . 0.0 112.597 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.83 -34.77 76.55 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.063 -1.023 . . . . 0.0 111.727 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.91 70.38 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.189 1.376 . . . . 0.0 114.324 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 8.1 m -60.56 -35.02 75.04 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.601 1.201 . . . . 0.0 112.047 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -71.53 -44.34 64.79 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.461 -0.774 . . . . 0.0 111.247 169.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.97 74.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.41 1.084 . . . . 0.0 112.981 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.02 -39.29 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.751 1.16 . . . . 0.0 112.767 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 85.6 m -60.42 -43.55 96.64 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.701 0.682 . . . . 0.0 111.612 170.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.88 -44.61 91.18 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.315 0.961 . . . . 0.0 112.074 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -57.99 -40.14 79.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.554 0.742 . . . . 0.0 112.536 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -80.74 -33.88 34.8 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 54.4 p -78.5 -19.52 52.84 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.35 139.96 18.22 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 0.0 113.609 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.255 1.347 0 C-N-CA 125.627 1.571 . . . . 0.0 112.806 -179.887 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.66 148.05 46.54 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.376 3.384 . . . . 0.0 114.731 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 79.27 -9.9 38.22 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.216 1.389 . . . . 0.0 115.828 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.6 mmm -88.58 147.08 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.013 1.407 . . . . 0.0 111.185 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 12.7 t -76.21 118.01 18.5 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.448 0.699 . . . . 0.0 112.348 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.43 153.58 51.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.078 1.323 . . . . 0.0 114.039 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.41 132.27 50.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.33 1.052 . . . . 0.0 111.907 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.32 155.87 50.92 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.63 1.109 . . . . 0.0 113.68 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.1 -39.63 90.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.151 0.981 . . . . 0.0 112.437 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -67.41 117.84 9.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.489 1.115 . . . . 0.0 110.772 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.33 -162.05 15.71 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.464 1.03 . . . . 0.0 114.224 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.99 -153.32 3.56 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.436 1.017 . . . . 0.0 113.642 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.23 122.2 11.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.768 1.227 . . . . 0.0 111.022 172.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 133.32 50.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.381 0.672 . . . . 0.0 110.835 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -72.73 101.03 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 0.0 110.833 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.44 143.71 56.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.586 0.754 . . . . 0.0 110.774 167.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.46 117.28 5.07 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 0.0 110.048 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.92 140.9 56.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.567 0.747 . . . . 0.0 111.243 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.14 110.42 1.21 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 110.839 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 40.3 p -72.27 153.47 41.52 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.544 1.137 . . . . 0.0 111.224 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -66.02 113.83 4.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.673 -0.642 . . . . 0.0 110.299 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 51.0 p -72.61 -34.69 67.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.618 1.167 . . . . 0.0 112.807 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.4 131.31 50.6 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 111.668 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -60.91 133.34 56.0 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.934 1.294 . . . . 0.0 112.097 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.82 57.0 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.955 0.902 . . . . 0.0 112.737 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 -167.16 36.16 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.314 0.959 . . . . 0.0 113.604 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.75 139.42 53.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.396 1.078 . . . . 0.0 112.631 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -106.81 137.5 44.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 110.542 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.12 157.74 73.19 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.024 1.33 . . . . 0.0 112.005 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -54.37 -34.96 82.9 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.795 2.997 . . . . 0.0 114.61 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.0 m -54.64 -30.89 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.66 -24.93 60.44 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.544 1.545 . . . . 0.0 114.747 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -96.77 -42.8 7.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.57 1.548 . . . . 0.0 111.557 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.38 -42.66 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.019 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.07 -37.13 78.96 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.693 1.588 . . . . 0.0 112.953 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.08 -45.89 75.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.46 1.104 . . . . 0.0 111.597 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.32 -40.76 82.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.051 0.941 . . . . 0.0 112.374 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.06 -42.63 98.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.838 0.855 . . . . 0.0 112.266 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -61.86 -51.61 67.5 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.049 -1.032 . . . . 0.0 111.411 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -55.07 -42.4 72.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.921 1.288 . . . . 0.0 112.669 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.48 6.13 8.98 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.116 1.817 . . . . 0.0 116.179 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 57.88 30.33 18.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.601 1.961 . . . . 0.0 114.728 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -68.13 -49.45 61.01 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.257 -0.902 . . . . 0.0 111.028 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 90.8 p -145.24 159.19 43.39 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 163.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -52.09 -45.29 64.76 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.206 1.802 . . . . 0.0 113.03 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -137.14 131.52 32.71 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.62 1.568 . . . . 0.0 110.222 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.42 121.91 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.983 1.313 . . . . 0.0 109.547 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.68 152.25 42.42 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.003 0.811 . . . . 0.0 112.731 171.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.24 -31.84 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.305 -1.115 . . . . 0.0 113.46 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.45 -22.35 77.71 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.659 1.123 . . . . 0.0 115.27 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.31 -54.2 58.26 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 119.653 1.727 . . . . 0.0 113.672 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -56.74 -31.4 87.87 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.022 1.815 . . . . 0.0 113.761 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.4 -46.78 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.821 1.191 . . . . 0.0 111.109 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -67.76 -38.75 83.84 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.18 -0.95 . . . . 0.0 113.096 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.66 -42.6 97.33 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.684 -1.26 . . . . 0.0 111.349 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.57 71.51 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.295 -0.878 . . . . 0.0 112.736 169.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.49 75.99 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 120.239 1.381 . . . . 0.0 113.498 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.99 -47.56 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.882 -1.136 . . . . 0.0 109.731 168.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.22 -39.43 86.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.689 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -52.85 -47.24 67.9 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.704 1.593 . . . . 0.0 112.595 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -57.91 -43.77 86.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.675 -0.64 . . . . 0.0 111.925 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.2 -34.4 70.83 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.969 -1.082 . . . . 0.0 112.877 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 88.7 m -53.65 -49.54 67.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.904 1.281 . . . . 0.0 110.071 164.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.38 82.91 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.196 0.907 . . . . 0.0 112.941 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.32 -43.26 91.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.751 1.16 . . . . 0.0 113.389 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.27 -43.62 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.781 -1.2 . . . . 0.0 110.137 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.06 -30.53 71.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.023 0.929 . . . . 0.0 113.331 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -63.59 -49.13 74.55 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.004 1.275 . . . . 0.0 111.384 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.06 -46.69 82.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.752 0.821 . . . . 0.0 111.253 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.95 78.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.969 0.908 . . . . 0.0 113.138 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -45.78 95.18 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.995 1.283 . . . . 0.0 112.765 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.89 -43.92 97.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.331 1.066 . . . . 0.0 111.423 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.47 75.99 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.573 -0.705 . . . . 0.0 112.845 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -45.63 82.43 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.158 -0.964 . . . . 0.0 112.336 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.25 -42.76 73.88 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.213 1.405 . . . . 0.0 112.982 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -57.16 -22.97 44.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -106.65 4.81 28.29 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.677 1.591 . . . . 0.0 112.838 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.18 31.73 14.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.965 2.106 . . . . 0.0 114.191 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.24 156.22 17.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.19 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.4 p -114.51 15.87 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.494 1.918 . . . . 0.0 112.961 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -133.61 129.43 36.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.098 1.359 . . . . 0.0 110.745 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -73.99 124.35 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 109.837 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 pt -126.0 169.94 10.56 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.788 1.635 . . . . 0.0 111.053 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.66 -34.34 83.23 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.191 2.594 . . . . 0.0 114.703 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.14 -24.57 67.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -81.79 -38.27 25.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.108 0.963 . . . . 0.0 111.865 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.73 0.696 . . . . 0.0 112.555 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -57.09 -57.75 11.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.166 -0.959 . . . . 0.0 111.159 166.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.01 -43.55 91.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.941 0.896 . . . . 0.0 112.72 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.43 45.11 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 15.5 mt -113.96 -63.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.884 1.274 . . . . 0.0 110.278 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.97 -27.87 69.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -99.94 0.78 41.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.763 1.225 . . . . 0.0 113.018 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.65 114.15 26.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.435 1.016 . . . . 0.0 110.417 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -49.61 -43.52 46.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.461 1.504 . . . . 0.0 113.093 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.788 0.835 . . . . 0.0 112.157 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.89 -17.63 61.5 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.21 -0.9 . . . . 0.0 112.484 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.39 -34.69 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.286 1.403 . . . . 0.0 112.591 165.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.54 -30.24 65.67 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.121 -0.987 . . . . 0.0 112.882 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 66.9 tp -92.7 -52.27 4.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 33.0 mt -114.5 -161.02 0.75 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.32 1.848 . . . . 0.0 110.534 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.39 -122.79 29.29 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.187 -0.945 . . . . 0.0 112.225 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -109.41 118.58 37.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.609 1.163 . . . . 0.0 109.065 162.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.68 127.04 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.572 0.749 . . . . 0.0 110.085 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 26.8 m -65.76 110.06 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.64 0.776 . . . . 0.0 110.838 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.08 116.68 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.32 5.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.333 0.653 . . . . 0.0 111.001 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.56 142.47 50.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.813 0.845 . . . . 0.0 111.445 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.52 105.17 0.9 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.338 0.97 . . . . 0.0 113.398 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.75 43.79 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.713 1.149 . . . . 0.0 112.505 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.75 106.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.971 0.908 . . . . 0.0 110.061 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.09 147.61 88.33 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.192 0.997 . . . . 0.0 111.001 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -61.35 117.0 3.77 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.636 2.224 . . . . 0.0 110.737 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.54 130.61 40.44 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.752 -0.592 . . . . 0.0 111.097 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 80.2 mt -77.98 124.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.0 113.22 4.83 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.043 -0.411 . . . . 0.0 109.966 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.09 128.08 34.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.276 0.63 . . . . 0.0 110.81 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.68 116.31 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -66.2 110.77 3.13 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.644 . . . . 0.0 109.366 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.07 123.33 83.66 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.563 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.68 138.73 71.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.763 2.309 . . . . 0.0 111.676 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.62 113.93 2.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.516 0.726 . . . . 0.0 109.466 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.7 117.64 15.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.627 0.771 . . . . 0.0 110.502 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 86.8 m -107.25 108.22 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.756 1.222 . . . . 0.0 108.354 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -65.93 127.33 31.64 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.149 0.58 . . . . 0.0 110.858 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 18.4 p -71.27 138.18 49.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.861 0.865 . . . . 0.0 113.063 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.42 -29.35 47.09 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.977 0.911 . . . . 0.0 112.333 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -64.97 130.98 45.37 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.009 1.323 . . . . 0.0 111.43 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.21 148.89 48.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.239 1.016 . . . . 0.0 113.057 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.16 143.66 48.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.084 0.953 . . . . 0.0 112.724 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 122.32 15.94 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.621 1.168 . . . . 0.0 112.182 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.85 135.39 30.41 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.469 1.033 . . . . 0.0 112.902 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.908 1.283 . . . . 0.0 112.172 176.162 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -59.64 139.26 88.09 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.093 3.195 . . . . 0.0 113.088 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -64.58 147.9 51.05 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.981 0.801 . . . . 0.0 112.487 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.08 145.49 84.95 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.708 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -55.61 139.88 83.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.241 2.627 . . . . 0.0 113.393 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -56.38 130.95 76.11 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.244 1.018 . . . . 0.0 111.799 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.77 156.39 66.15 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.2 56.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.476 1.111 . . . . 0.0 113.9 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.74 -20.12 61.94 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.407 1.483 . . . . 0.0 114.2 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -72.26 144.2 48.49 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.173 0.989 . . . . 0.0 112.183 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.34 98.25 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 123.564 0.745 . . . . 0.0 112.675 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.01 -16.49 32.29 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.549 2.833 . . . . 0.0 114.054 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.23 140.41 78.65 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.592 1.157 . . . . 0.0 113.084 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -63.77 145.98 91.47 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.651 2.901 . . . . 0.0 113.166 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.29 148.1 45.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 0.0 111.748 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.56 143.91 54.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.307 1.043 . . . . 0.0 112.424 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.64 -20.23 79.5 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.518 1.056 . . . . 0.0 114.75 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -70.99 158.36 36.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.373 1.469 . . . . 0.0 113.818 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.52 143.69 55.54 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.477 1.111 . . . . 0.0 111.589 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 137.65 58.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.795 0.838 . . . . 0.0 111.42 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.91 144.17 56.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.314 0.645 . . . . 0.0 111.643 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.47 117.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.262 0.625 . . . . 0.0 109.459 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -72.7 139.95 47.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.904 0.882 . . . . 0.0 112.178 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -80.81 138.8 36.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.051 0.941 . . . . 0.0 110.908 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 131.94 47.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.022 0.529 . . . . 0.0 110.684 170.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -65.47 120.99 13.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.31 131.28 46.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.046 0.938 . . . . 0.0 110.971 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.73 133.7 55.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.265 1.026 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.37 145.49 52.88 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.169 1.388 . . . . 0.0 112.899 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.29 -133.28 3.82 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.542 1.067 . . . . 0.0 111.81 172.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.48 -40.34 82.44 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.615 0.766 . . . . 0.0 111.355 166.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.14 160.1 24.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.777 2.031 . . . . 0.0 111.256 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.13 156.72 16.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.505 1.522 . . . . 0.0 112.143 173.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -80.96 72.07 7.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.208 1.403 . . . . 0.0 111.637 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.25 -38.74 84.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.483 1.513 . . . . 0.0 113.027 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 8.4 t -121.63 162.19 21.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.352 1.461 . . . . 0.0 111.913 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -66.21 150.79 48.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.537 1.535 . . . . 0.0 113.163 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -111.13 12.71 21.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.09 1.756 . . . . 0.0 112.983 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -76.38 -23.65 54.11 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.178 1.391 . . . . 0.0 112.891 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 16.2 p -71.55 148.02 47.1 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.952 1.701 . . . . 0.0 113.933 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.97 -28.39 64.42 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.3 1.04 . . . . 0.0 113.502 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 77.5 p -43.44 -39.46 3.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.842 2.057 . . . . 0.0 114.767 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.62 -26.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.991 1.717 . . . . 0.0 114.281 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -51.8 -37.09 50.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.454 1.101 . . . . 0.0 112.874 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.54 -40.85 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 120.902 -1.124 . . . . 0.0 111.254 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -67.32 -41.85 84.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.189 -0.945 . . . . 0.0 112.165 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -54.7 -37.75 66.19 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.063 0.847 . . . . 0.0 112.43 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.03 -48.79 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.464 0.706 . . . . 0.0 111.896 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 34.4 tp -50.67 -42.95 57.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.634 1.106 . . . . 0.0 112.72 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.51 -24.78 22.07 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -72.2 -32.0 66.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.314 1.045 . . . . 0.0 112.662 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.83 -41.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.7 1.2 . . . . 0.0 113.536 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -135.45 70.73 67.03 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.47 1.508 . . . . 0.0 110.692 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -58.06 -23.09 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.611 2.874 . . . . 0.0 113.974 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -77.46 -6.51 53.75 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.656 1.982 . . . . 0.0 113.963 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 98.8 m -115.37 129.77 56.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.271 1.428 . . . . 0.0 111.34 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.09 175.15 41.2 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.974 1.273 . . . . 0.0 113.423 172.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.83 140.65 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.167 -1.196 . . . . 0.0 110.923 171.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 34.4 p -73.2 154.5 40.24 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 38.6 p -54.68 -44.02 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.025 0.93 . . . . 0.0 112.291 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.82 -46.9 87.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.792 1.237 . . . . 0.0 112.155 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.28 89.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.354 0.661 . . . . 0.0 112.263 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 74.8 mtm -60.78 -40.89 94.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.08 -1.012 . . . . 0.0 112.449 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.18 -42.17 97.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.665 1.126 . . . . 0.0 113.899 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.01 -51.84 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.25 1.02 . . . . 0.0 110.073 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 46.3 mtp -61.29 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -50.66 -50.62 54.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.501 1.5 . . . . 0.0 112.339 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -59.37 -55.8 30.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.634 0.774 . . . . 0.0 111.519 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -61.71 -43.89 97.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.61 -51.18 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.391 0.996 . . . . 0.0 110.908 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -62.02 -40.92 97.33 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.739 0.7 . . . . 0.0 111.569 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -56.54 -28.89 61.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.8 mt -49.75 -57.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.36 1.437 . . . . 0.0 109.917 172.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.8 -52.91 38.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 0.0 111.335 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -54.73 -35.49 63.75 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.79 -53.19 5.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.352 1.061 . . . . 0.0 112.1 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.76 -58.58 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 120.263 1.392 . . . . 0.0 111.386 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.41 62.93 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.481 -0.762 . . . . 0.0 112.106 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.0 -47.91 88.71 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 118.9 0.773 . . . . 0.0 113.164 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.16 -39.86 93.55 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.197 -1.179 . . . . 0.0 112.214 172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.57 78.79 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.045 -1.034 . . . . 0.0 112.222 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -60.63 -50.6 72.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.063 0.945 . . . . 0.0 111.271 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -51.09 -48.99 61.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.11 0.868 . . . . 0.0 111.946 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.01 -48.67 75.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.577 0.751 . . . . 0.0 111.773 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.73 73.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.741 0.816 . . . . 0.0 112.916 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -58.48 -52.18 66.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.432 1.015 . . . . 0.0 111.467 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -60.95 -35.07 75.78 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -82.57 5.41 21.01 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.817 1.247 . . . . 0.0 113.769 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 56.19 34.3 23.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.998 2.119 . . . . 0.0 114.328 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -101.13 142.71 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.725 1.61 . . . . 0.0 112.626 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 48.4 p -83.73 -22.27 32.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.467 1.507 . . . . 0.0 113.498 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 40.1 m -126.22 128.98 48.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.508 1.523 . . . . 0.0 111.41 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.92 130.62 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.17 1.388 . . . . 0.0 110.737 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.1 p -84.33 160.19 20.74 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 41.3 p -55.34 -38.8 69.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.068 -1.02 . . . . 0.0 112.433 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.32 -43.59 90.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.686 1.194 . . . . 0.0 112.287 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -62.11 -41.86 98.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.498 0.719 . . . . 0.0 112.305 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.64 -54.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.517 0.599 . . . . 0.0 109.864 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -55.31 -42.1 73.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.246 0.93 . . . . 0.0 112.818 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 89.4 m -62.34 -50.31 72.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.397 1.079 . . . . 0.0 111.707 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.28 84.32 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.561 1.073 . . . . 0.0 112.691 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.49 -56.05 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.504 1.122 . . . . 0.0 110.264 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -57.44 -41.91 81.39 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.789 1.177 . . . . 0.0 113.405 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.54 -45.37 91.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 112.418 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -89.54 -23.36 22.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.07 80.15 73.22 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 127.139 2.176 . . . . 0.0 110.813 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -62.55 -25.11 75.5 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.887 2.391 . . . . 0.0 115.368 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.03 135.49 22.92 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.061 1.791 . . . . 0.0 114.796 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -56.13 -49.66 73.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.174 1.39 . . . . 0.0 113.149 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 tp -55.57 -47.51 76.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.974 0.91 . . . . 0.0 111.925 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.74 -47.7 58.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 112.406 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -60.93 -42.49 98.28 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.239 0.927 . . . . 0.0 111.76 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -57.0 -47.77 80.05 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.407 1.083 . . . . 0.0 111.905 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.73 72.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.833 0.742 . . . . 0.0 112.474 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.63 -52.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 72.0 m -56.61 -44.45 81.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.21 -48.86 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.233 0.924 . . . . 0.0 111.624 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.9 -46.19 69.07 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.73 0.681 . . . . 0.0 112.841 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.6 m -60.66 -57.63 11.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.08 0.952 . . . . 0.0 111.515 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.66 -42.51 75.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.964 1.306 . . . . 0.0 113.118 -177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -52.44 64.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.63 0.772 . . . . 0.0 111.481 172.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.35 -31.88 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 31.0 m -56.68 -27.15 58.23 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.318 1.417 . . . . 0.0 112.851 171.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -83.17 -5.21 59.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -111.42 -30.43 7.4 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 113.015 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p -56.18 -21.92 25.88 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 50.7 p -67.19 -19.76 65.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.697 1.599 . . . . 0.0 114.535 172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.18 179.35 7.69 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.978 1.311 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.975 1.71 . . . . 0.0 112.031 -177.79 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.044 0 CA-C-O 118.668 -1.073 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -59.13 129.45 31.75 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.398 2.732 . . . . 0.0 113.19 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 72.39 4.5 60.66 Favored Glycine 0 CA--C 1.539 1.594 0 N-CA-C 116.204 1.241 . . . . 0.0 116.204 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 13.9 tpt -85.85 115.98 23.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.513 1.657 . . . . 0.0 110.551 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p -85.62 163.12 18.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.532 1.133 . . . . 0.0 113.36 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.67 169.81 41.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.354 0.978 . . . . 0.0 113.915 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.22 -40.61 36.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.596 1.158 . . . . 0.0 112.01 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.54 -178.05 19.6 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.637 1.113 . . . . 0.0 113.514 164.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.88 135.44 55.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.43 1.092 . . . . 0.0 111.861 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -72.25 138.91 47.8 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.845 0.858 . . . . 0.0 111.406 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.2 146.2 20.51 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.047 0.832 . . . . 0.0 112.19 -167.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.78 -23.86 2.44 Favored Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.272 1.415 . . . . 0.0 115.445 -172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.09 134.61 48.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.885 1.274 . . . . 0.0 111.378 170.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.49 134.62 46.66 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.039 0.935 . . . . 0.0 111.853 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -79.14 127.58 32.2 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.547 0.739 . . . . 0.0 110.963 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.89 128.66 37.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.552 0.741 . . . . 0.0 111.594 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.06 143.24 47.52 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.913 0.885 . . . . 0.0 110.895 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.98 126.86 29.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.33 0.652 . . . . 0.0 111.5 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.02 136.82 55.87 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.82 0.848 . . . . 0.0 111.197 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 39.0 p -70.09 150.89 46.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.724 0.81 . . . . 0.0 111.596 171.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -65.04 137.06 57.46 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.631 -0.668 . . . . 0.0 111.179 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 21.0 t -63.1 136.94 58.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 111.535 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.0 t -66.63 116.56 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.139 0.576 . . . . 0.0 110.502 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.87 131.24 48.11 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.892 0.877 . . . . 0.0 111.025 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 131.6 51.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.593 0.757 . . . . 0.0 111.987 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 122.42 29.7 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.028 0.823 . . . . 0.0 112.153 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.57 148.48 30.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.706 0.802 . . . . 0.0 112.455 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -89.19 143.99 26.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.019 0.928 . . . . 0.0 110.139 163.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.85 70.83 29.05 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.82 0.848 . . . . 0.0 112.889 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.95 -43.51 57.49 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.829 2.352 . . . . 0.0 112.844 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.34 -47.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.666 1.186 . . . . 0.0 111.098 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.77 80.4 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.319 0.962 . . . . 0.0 113.79 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -65.68 -38.23 88.7 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.088 -1.242 . . . . 0.0 112.434 173.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.05 -40.85 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 118.815 0.734 . . . . 0.0 111.566 170.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -56.24 -52.1 65.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.653 1.115 . . . . 0.0 111.295 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -55.33 -49.49 72.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.505 1.122 . . . . 0.0 112.359 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -50.31 -52.82 33.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.589 1.155 . . . . 0.0 111.832 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.85 -41.02 92.23 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.655 0.782 . . . . 0.0 112.712 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -61.61 -52.28 65.02 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.398 1.479 . . . . 0.0 111.81 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.58 -41.26 80.76 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.961 1.305 . . . . 0.0 112.58 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.64 -8.72 57.27 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.677 1.132 . . . . 0.0 115.825 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 53.23 31.82 12.3 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 113.884 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -67.57 -31.86 72.22 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.2 t -131.05 164.38 25.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.538 1.135 . . . . 0.0 112.716 170.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -74.28 -39.0 63.25 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.239 1.015 . . . . 0.0 111.677 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -133.25 119.7 20.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.793 1.237 . . . . 0.0 110.429 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.12 119.46 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.617 1.567 . . . . 0.0 109.159 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.82 -165.18 10.28 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.502 1.525 . . . . 0.0 111.022 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.99 -30.21 24.06 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.44 -36.25 88.45 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.468 1.033 . . . . 0.0 115.361 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.74 -55.81 21.26 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.475 1.137 . . . . 0.0 113.943 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.04 -33.69 49.82 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 112.876 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.26 -37.71 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 120.569 1.531 . . . . 0.0 113.027 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -53.71 -53.58 50.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.972 0.805 . . . . 0.0 111.017 168.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.76 -50.9 69.17 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.401 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.66 61.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.904 1.229 . . . . 0.0 113.289 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.22 -46.03 65.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.133 0.973 . . . . 0.0 112.211 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.27 -56.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.4 1.08 . . . . 0.0 111.784 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.43 -46.63 82.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.336 1.455 . . . . 0.0 113.029 -172.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -58.27 -46.43 86.03 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.513 1.051 . . . . 0.0 110.762 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -62.64 -51.93 65.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.391 0.676 . . . . 0.0 112.555 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.2 -42.04 89.96 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.235 -0.915 . . . . 0.0 111.995 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -53.64 -51.8 61.95 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.095 . . . . 0.0 110.776 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.81 95.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.756 0.822 . . . . 0.0 113.167 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -60.68 -47.73 84.93 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.467 1.03 . . . . 0.0 112.864 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.1 -50.58 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.45 0.7 . . . . 0.0 109.951 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.63 -37.84 79.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.186 0.994 . . . . 0.0 113.207 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.93 -55.4 29.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.55 1.068 . . . . 0.0 111.615 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.51 -47.15 82.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.687 1.195 . . . . 0.0 111.707 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.47 92.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 0.0 112.453 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.98 98.04 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.321 -0.862 . . . . 0.0 113.202 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.35 -44.67 96.79 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.803 1.301 . . . . 0.0 110.937 172.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.29 89.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.411 -0.805 . . . . 0.0 112.668 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.35 89.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.173 -0.954 . . . . 0.0 112.547 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -57.59 -47.06 83.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.044 0.937 . . . . 0.0 112.024 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.22 -41.67 79.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -86.31 10.12 15.8 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 53.76 30.12 10.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.791 2.036 . . . . 0.0 114.564 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.2 144.99 28.59 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.194 1.398 . . . . 0.0 112.165 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -76.92 -26.21 53.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.698 1.199 . . . . 0.0 112.764 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -128.99 151.66 49.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.433 1.493 . . . . 0.0 112.531 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.4 131.13 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.602 1.161 . . . . 0.0 110.264 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.82 149.62 36.34 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.57 1.948 . . . . 0.0 109.544 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -48.32 -40.55 35.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.713 2.942 . . . . 0.0 114.964 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -60.19 -38.86 84.55 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.284 1.034 . . . . 0.0 113.062 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -61.91 -42.23 98.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.669 0.788 . . . . 0.0 112.175 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' D' ' 62' ' ' MET . 84.6 mt -62.77 -46.08 89.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 111.936 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.68 -50.47 72.03 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.808 0.843 . . . . 0.0 111.82 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 84.3 mt -57.08 -50.6 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.421 -0.8 . . . . 0.0 111.871 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.11 64.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.161 0.984 . . . . 0.0 112.84 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 tt -68.65 -35.76 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 118.479 0.581 . . . . 0.0 112.533 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.362 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -66.06 -37.84 86.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.781 0.832 . . . . 0.0 112.304 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.01 115.81 18.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.021 0.928 . . . . 0.0 112.669 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.73 -39.39 84.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.238 -0.914 . . . . 0.0 113.449 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -67.31 -39.35 85.88 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.158 -0.964 . . . . 0.0 111.766 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.28 -36.38 83.92 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.432 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.14 -37.16 84.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.81 1.641 . . . . 0.0 112.739 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.53 -39.1 91.4 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.343 -0.848 . . . . 0.0 112.224 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.54 -53.79 8.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 113.622 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.98 119.18 34.97 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 111.444 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.31 144.65 32.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.364 0.983 . . . . 0.0 112.614 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -78.03 155.09 30.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.129 0.972 . . . . 0.0 112.319 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.92 130.31 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.322 1.049 . . . . 0.0 110.371 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 30.4 m -65.33 114.49 4.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 0.0 110.607 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -79.64 123.78 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.802 0.841 . . . . 0.0 109.172 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.5 88.14 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.719 0.808 . . . . 0.0 112.605 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -63.26 126.5 27.61 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.257 1.023 . . . . 0.0 111.031 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.04 122.95 30.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.582 0.61 . . . . 0.0 112.8 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.77 -138.41 2.18 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.694 1.14 . . . . 0.0 112.608 171.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.45 127.67 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.843 -0.798 . . . . 0.0 109.62 167.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -58.43 119.96 40.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.315 1.046 . . . . 0.0 110.893 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -63.77 152.06 82.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.935 2.423 . . . . 0.0 112.526 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -62.46 149.09 43.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.005 172.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.81 115.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.601 0.76 . . . . 0.0 109.361 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -76.32 156.45 33.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.01 0.924 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.84 143.14 52.03 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.89 -12.64 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.03 131.77 47.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.892 1.277 . . . . 0.0 111.723 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.17 -34.95 0.58 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -57.65 129.23 32.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.723 2.282 . . . . 0.0 112.562 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -67.95 113.64 5.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.069 0.947 . . . . 0.0 111.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.31 -26.02 23.62 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.345 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 41.5 m -70.46 106.9 3.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 109.961 171.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -140.79 154.4 46.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.391 1.077 . . . . 0.0 113.067 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 53.0 m -67.76 147.86 52.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.844 0.858 . . . . 0.0 111.58 167.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -57.94 -46.69 84.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.44 0.696 . . . . 0.0 112.188 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.39 130.27 34.72 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.098 0.959 . . . . 0.0 110.218 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.86 131.04 37.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.636 . . . . 0.0 111.068 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.48 135.0 48.28 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.251 0.62 . . . . 0.0 110.89 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -73.46 107.27 5.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.805 0.842 . . . . 0.0 111.479 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.55 167.69 54.26 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.718 1.152 . . . . 0.0 113.566 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 124.785 1.234 . . . . 0.0 112.341 173.779 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 CA-C-O 119.22 -0.766 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -59.48 133.2 50.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.585 2.857 . . . . 0.0 112.36 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 68.59 9.43 58.62 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.714 1.149 . . . . 0.0 115.961 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 96.4 mmm -101.4 152.5 38.0 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.263 1.425 . . . . 0.0 111.034 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -57.3 144.8 90.11 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.241 . . . . 0.0 111.842 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -63.16 127.99 91.72 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 121.674 -0.642 . . . . 0.0 110.822 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -62.49 158.11 42.82 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.191 2.594 . . . . 0.0 112.815 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.05 120.21 12.75 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.722 -0.611 . . . . 0.0 111.272 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.69 155.71 20.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.848 1.659 . . . . 0.0 111.397 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -27.32 62.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.374 1.07 . . . . 0.0 113.499 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.4 133.68 88.39 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.282 1.033 . . . . 0.0 112.108 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.46 149.94 89.13 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.216 2.611 . . . . 0.0 112.394 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.19 96.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 119.022 -0.513 . . . . 0.0 110.926 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -61.43 142.95 97.1 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.9 2.4 . . . . 0.0 111.779 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.27 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.098 0.559 . . . . 0.0 110.213 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.47 126.45 25.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.963 0.905 . . . . 0.0 111.032 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.57 130.12 50.52 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.005 0.812 . . . . 0.0 112.045 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -61.35 142.31 57.0 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 112.347 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.56 132.89 54.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.58 0.752 . . . . 0.0 110.863 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.46 134.25 56.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.664 0.786 . . . . 0.0 110.377 172.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 129.46 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.871 0.468 . . . . 0.0 110.71 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.42 91.82 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -62.34 119.3 8.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.971 0.908 . . . . 0.0 109.386 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 114.76 4.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.612 0.765 . . . . 0.0 110.563 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.85 123.26 18.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.729 0.812 . . . . 0.0 111.289 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -86.81 140.04 30.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.84 133.88 54.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.121 0.569 . . . . 0.0 110.82 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.13 156.29 22.03 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.681 1.193 . . . . 0.0 112.183 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -57.29 127.79 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.141 0.496 . . . . 0.0 111.432 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.57 -2.95 70.36 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.1 -44.68 53.06 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.772 1.786 . . . . 0.0 111.566 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.65 143.8 45.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.607 1.163 . . . . 0.0 111.642 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -64.14 132.71 51.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.688 0.795 . . . . 0.0 109.919 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -71.6 102.68 2.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.208 1.003 . . . . 0.0 110.485 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -125.38 71.33 1.2 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.975 1.71 . . . . 0.0 111.202 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -62.6 132.24 51.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.602 0.761 . . . . 0.0 111.598 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -137.63 -166.98 2.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.913 1.685 . . . . 0.0 110.371 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.031 0.933 . . . . 0.0 111.927 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.01 121.87 11.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.769 1.628 . . . . 0.0 111.062 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -135.19 -104.83 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.558 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -70.73 -10.88 60.43 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.773 -1.204 . . . . 0.0 113.358 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -57.67 -38.53 75.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.206 1.802 . . . . 0.0 113.918 162.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -59.78 -44.23 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.283 1.033 . . . . 0.0 110.394 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -105.35 29.11 6.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.531 1.532 . . . . 0.0 112.882 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.55 -34.8 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.35 -45.09 92.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.698 1.199 . . . . 0.0 112.274 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.79 -35.36 80.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.144 0.978 . . . . 0.0 112.248 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.46 -50.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.476 0.58 . . . . 0.0 110.59 171.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.11 -38.21 82.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.406 -0.809 . . . . 0.0 112.776 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -51.62 -34.94 39.79 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.219 1.408 . . . . 0.0 113.379 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.67 -14.24 60.72 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.9 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.798 1.639 . . . . 0.0 111.36 -170.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.81 73.11 79.19 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.559 1.944 . . . . 0.0 110.073 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.26 -23.92 64.84 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.756 2.971 . . . . 0.0 114.743 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -79.17 -3.48 45.79 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.997 1.719 . . . . 0.0 113.894 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 43.2 m -119.42 140.06 51.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.842 1.657 . . . . 0.0 111.007 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.11 -166.22 25.82 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.533 1.063 . . . . 0.0 113.968 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.98 137.06 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.963 -1.316 . . . . 0.0 110.237 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.33 147.12 41.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.025 0.93 . . . . 0.0 112.777 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.9 p -56.96 -34.62 68.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.009 0.923 . . . . 0.0 112.756 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -75.67 -44.09 44.18 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.404 1.082 . . . . 0.0 111.762 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.2 -37.42 72.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.871 0.868 . . . . 0.0 113.3 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 64.5 ttp -52.43 -50.77 61.91 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.268 -0.895 . . . . 0.0 111.712 167.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.7 95.52 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.872 1.225 . . . . 0.0 114.066 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.63 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.379 1.09 . . . . 0.0 110.878 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' MET . . . . . 0.401 ' SD ' HD22 ' C' ' 83' ' ' LEU . 92.6 mmm -60.81 -40.03 91.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.363 0.983 . . . . 0.0 112.443 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.64 -47.96 82.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.831 0.741 . . . . 0.0 111.781 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -56.27 -53.29 59.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.333 1.053 . . . . 0.0 111.996 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -53.17 -55.1 26.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.674 1.19 . . . . 0.0 112.218 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.46 -51.0 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.184 0.994 . . . . 0.0 110.83 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -60.61 -38.77 85.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.822 0.737 . . . . 0.0 112.378 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -64.83 -52.09 58.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.251 0.932 . . . . 0.0 113.257 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.02 -31.45 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.167 0.894 . . . . 0.0 113.103 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -47.6 -51.33 21.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.123 1.369 . . . . 0.0 111.781 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -59.51 -44.87 93.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.379 0.672 . . . . 0.0 112.017 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -67.01 -52.34 43.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.171 0.588 . . . . 0.0 111.523 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.35 -42.93 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.161 0.984 . . . . 0.0 111.278 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.34 91.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.78 0.832 . . . . 0.0 112.095 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.97 -51.03 59.86 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.786 0.708 . . . . 0.0 113.226 169.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -56.4 -40.72 75.11 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.002 -1.293 . . . . 0.0 112.633 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.89 -47.61 51.96 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.298 1.039 . . . . 0.0 112.62 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -77.55 -39.8 44.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.75 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -50.35 -50.39 51.34 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.745 1.157 . . . . 0.0 111.274 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.59 -44.02 97.78 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.732 1.213 . . . . 0.0 112.747 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.55 88.25 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.337 -0.852 . . . . 0.0 112.063 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -63.16 -38.25 90.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.8 1.24 . . . . 0.0 113.142 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -59.6 -34.11 72.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.662 1.119 . . . . 0.0 111.728 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -83.71 11.95 6.61 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.419 1.487 . . . . 0.0 113.257 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 59.46 28.57 17.98 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.696 2.398 . . . . 0.0 115.197 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.88 139.35 53.31 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.526 1.531 . . . . 0.0 112.815 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 35.6 p -86.97 -31.81 20.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.272 1.429 . . . . 0.0 113.591 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -87.48 147.69 25.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.655 1.582 . . . . 0.0 111.741 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 56.9 mt -104.78 120.92 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 0.0 108.353 168.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -100.38 161.89 13.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.068 0.947 . . . . 0.0 113.118 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 53.0 p -66.84 -23.68 66.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.429 1.092 . . . . 0.0 113.669 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.72 -42.83 21.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.644 1.178 . . . . 0.0 112.189 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -54.82 -28.7 51.47 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.991 1.317 . . . . 0.0 114.035 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.76 -32.83 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.79 0.836 . . . . 0.0 112.449 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -54.96 -33.98 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.432 1.093 . . . . 0.0 112.811 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 51.7 m -99.53 -46.65 5.39 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.639 1.176 . . . . 0.0 111.406 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.5 74.89 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.925 -1.109 . . . . 0.0 113.019 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.8 -36.79 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.646 -1.284 . . . . 0.0 111.135 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.53 -36.65 84.9 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.441 1.096 . . . . 0.0 113.055 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.35 -42.65 87.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.179 0.592 . . . . 0.0 112.007 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.66 -54.11 15.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -104.3 111.59 65.22 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.187 1.395 . . . . 0.0 110.832 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.05 152.88 76.19 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.339 2.693 . . . . 0.0 113.68 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.37 -140.53 45.19 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.846 1.212 . . . . 0.0 114.824 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.5 -14.04 61.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -52.35 -48.49 65.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.731 0.812 . . . . 0.0 110.999 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.79 72.88 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -46.31 -52.25 13.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.589 1.156 . . . . 0.0 110.826 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -68.34 -49.31 61.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.756 1.222 . . . . 0.0 113.004 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.13 -44.9 71.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.392 -0.817 . . . . 0.0 112.972 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 86.8 t -69.61 -47.08 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.588 1.155 . . . . 0.0 111.677 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 64.7 p -66.84 -26.74 67.06 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -76.75 -42.58 40.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.602 0.761 . . . . 0.0 111.831 165.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.48 -23.28 34.53 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.997 1.76 . . . . 0.0 116.079 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 73.0 p -56.31 -38.98 72.03 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.973 1.887 . . . . 0.0 112.418 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.79 -43.57 95.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.274 1.03 . . . . 0.0 111.338 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.56 91.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.061 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -52.18 -52.45 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 120.029 1.286 . . . . 0.0 110.703 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 46.7 m -54.75 -47.55 73.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.402 0.681 . . . . 0.0 112.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.79 -48.86 76.97 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.032 0.833 . . . . 0.0 112.337 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -66.48 -31.01 71.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.9 p -81.83 -32.17 31.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.7 1.136 . . . . 0.0 113.691 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 56.6 p -79.45 -30.3 42.12 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.469 1.031 . . . . 0.0 113.721 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.78 136.86 39.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.164 . . . . 0.0 112.564 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.253 1.263 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.931 -179.639 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.88 133.46 50.88 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.435 2.757 . . . . 0.0 113.379 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -81.05 -173.96 48.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.922 . . . . 0.0 113.244 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.5 mmm -59.55 -30.8 68.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.25 1.02 . . . . 0.0 113.433 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p -91.51 -1.85 57.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.007 1.723 . . . . 0.0 114.386 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.36 8.55 66.39 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.031 1.3 . . . . 0.0 115.769 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -89.6 24.33 2.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.354 1.461 . . . . 0.0 114.712 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.36 15.92 61.96 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.86 133.19 51.37 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.711 1.256 . . . . 0.0 112.857 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -73.7 150.76 41.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.295 1.038 . . . . 0.0 111.063 166.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.73 -138.28 37.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.987 0.804 . . . . 0.0 113.15 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.17 24.38 65.19 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 123.939 0.78 . . . . 0.0 114.256 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -53.01 126.58 21.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.614 1.965 . . . . 0.0 112.408 -174.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.28 132.99 50.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.821 0.849 . . . . 0.0 111.971 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -76.02 147.34 38.82 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.303 1.041 . . . . 0.0 111.952 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.18 134.59 52.02 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 111.495 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.79 136.81 53.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.768 0.827 . . . . 0.0 111.319 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.2 140.23 58.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.055 0.542 . . . . 0.0 110.975 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.67 115.42 6.48 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.39 0.676 . . . . 0.0 111.14 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 36.4 p -81.76 -32.14 31.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.805 1.242 . . . . 0.0 112.752 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.45 133.31 49.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.838 1.255 . . . . 0.0 112.984 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 89.0 p -137.52 171.79 13.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.537 1.935 . . . . 0.0 110.505 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 117.28 6.17 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.298 -0.876 . . . . 0.0 110.85 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -65.49 141.61 58.42 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.091 0.956 . . . . 0.0 112.111 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.3 119.98 12.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.948 0.899 . . . . 0.0 112.098 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.07 142.95 48.16 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.169 0.89 . . . . 0.0 111.888 171.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.02 128.62 37.03 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.669 0.788 . . . . 0.0 111.806 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -106.94 34.64 3.35 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.388 1.475 . . . . 0.0 112.021 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -123.24 174.47 3.47 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.276 2.23 . . . . 0.0 109.995 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -54.18 -36.12 84.69 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.154 2.569 . . . . 0.0 113.96 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -60.32 -22.92 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 125.2 1.4 . . . . 0.0 114.426 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.09 91.7 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.615 1.102 . . . . 0.0 114.125 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -58.59 -49.83 76.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.853 0.827 . . . . 0.0 110.928 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -58.14 -49.0 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.115 0.966 . . . . 0.0 111.105 174.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -54.77 -49.57 70.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.309 1.444 . . . . 0.0 112.812 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.73 -49.03 76.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.506 1.122 . . . . 0.0 111.991 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.02 -37.69 88.46 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.93 . . . . 0.0 112.859 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.23 -45.88 86.92 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.631 0.772 . . . . 0.0 112.233 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -66.84 -47.64 71.34 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.313 0.645 . . . . 0.0 112.123 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.9 -48.71 64.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.91 1.684 . . . . 0.0 112.493 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.16 -4.34 59.35 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.969 1.271 . . . . 0.0 115.977 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.52 38.81 28.98 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.199 1.8 . . . . 0.0 113.975 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -69.06 -23.88 64.1 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 97.0 p -148.69 168.7 22.18 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.644 1.578 . . . . 0.0 111.846 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -61.47 -46.06 91.62 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.845 0.858 . . . . 0.0 112.284 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -139.37 138.02 36.23 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.97 1.708 . . . . 0.0 110.848 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.37 115.75 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 0.0 109.665 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.6 179.91 52.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.02 1.295 . . . . 0.0 114.094 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.15 57.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.15 96.93 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 121.331 -0.856 . . . . 0.0 114.286 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.66 10.95 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.71 -33.51 76.64 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.375 2.05 . . . . 0.0 113.388 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -49.28 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.746 1.157 . . . . 0.0 111.176 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -64.21 -34.87 79.09 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.571 -0.706 . . . . 0.0 112.586 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.91 -44.3 81.12 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.382 -0.823 . . . . 0.0 112.278 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.14 78.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.624 1.102 . . . . 0.0 112.519 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.79 -21.44 19.35 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -91.53 -54.16 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.322 1.449 . . . . 0.0 111.281 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' D' ' 70' ' ' PHE . 39.4 mt -50.17 -45.54 53.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.953 1.701 . . . . 0.0 113.391 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -48.13 -53.44 16.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.408 1.083 . . . . 0.0 112.172 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 -41.35 80.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.039 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.95 -49.55 75.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.993 0.815 . . . . 0.0 111.48 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -57.56 -48.64 78.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.127 0.971 . . . . 0.0 111.53 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.18 62.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.143 1.377 . . . . 0.0 113.432 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.95 -34.34 67.93 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 -34.48 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 118.77 0.714 . . . . 0.0 110.833 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.29 -44.3 88.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.912 0.778 . . . . 0.0 111.68 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.96 -53.06 61.96 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.533 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.65 -36.75 79.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.694 0.797 . . . . 0.0 112.323 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -38.39 79.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.463 1.028 . . . . 0.0 112.657 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.6 -45.56 93.08 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.619 0.645 . . . . 0.0 112.581 168.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.55 -42.18 95.85 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.482 -1.011 . . . . 0.0 111.842 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.38 -45.31 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.48 1.037 . . . . 0.0 111.625 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.7 86.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.758 0.823 . . . . 0.0 112.094 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -57.33 -48.61 78.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.855 1.262 . . . . 0.0 112.678 173.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -58.52 -39.44 80.13 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.524 1.129 . . . . 0.0 113.259 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.57 4.67 31.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.565 1.146 . . . . 0.0 112.968 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 53.09 36.88 23.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.423 2.289 . . . . 0.0 114.177 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.09 149.67 22.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.72 1.608 . . . . 0.0 112.513 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 33.1 p -85.46 -28.86 24.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.214 1.406 . . . . 0.0 113.345 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -119.36 140.24 50.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.32 1.848 . . . . 0.0 111.153 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.29 121.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 109.129 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.51 162.8 20.61 Favored Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 124.315 1.046 . . . . 0.0 111.671 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.38 -35.73 85.28 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.971 2.447 . . . . 0.0 114.091 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -64.3 -43.74 93.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.582 1.083 . . . . 0.0 111.692 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.75 -41.94 98.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.683 0.793 . . . . 0.0 111.424 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -64.06 -44.75 91.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 0.0 112.636 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.83 -51.22 70.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.049 -1.032 . . . . 0.0 111.044 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.06 -41.83 48.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.916 1.286 . . . . 0.0 113.362 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.27 -45.99 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.843 0.747 . . . . 0.0 112.966 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -71.13 -19.46 62.43 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.16 -28.56 64.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.814 1.246 . . . . 0.0 113.492 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -129.63 123.07 30.36 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.598 1.09 . . . . 0.0 112.637 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -61.77 -47.33 85.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.118 0.967 . . . . 0.0 113.059 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -60.67 -53.46 57.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.868 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -49.74 -47.13 50.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.633 1.106 . . . . 0.0 111.753 171.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -61.32 -30.1 70.29 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.704 -1.248 . . . . 0.0 114.151 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.64 -49.66 7.83 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.396 1.078 . . . . 0.0 112.362 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.09 -44.2 87.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.609 2.364 . . . . 0.0 113.409 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tp -119.48 -65.37 1.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.215 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.04 -174.94 19.78 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mmt-85 -146.3 179.77 7.29 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.737 2.815 . . . . 0.0 109.981 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.45 145.33 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.841 0.856 . . . . 0.0 111.555 158.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -89.08 108.1 19.41 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 49.0 mm -84.12 113.66 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.877 . . . . 0.0 109.729 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.15 43.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.806 . . . . 0.0 111.842 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -93.32 146.81 23.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.456 1.102 . . . . 0.0 111.605 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.59 0.21 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.573 1.082 . . . . 0.0 113.595 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.05 -153.79 50.27 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.108 1.337 . . . . 0.0 113.755 -172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.78 125.0 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.018 1.327 . . . . 0.0 109.932 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.91 144.97 40.1 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 111.121 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -59.85 137.19 74.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.848 2.365 . . . . 0.0 111.958 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.45 137.34 57.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.217 0.607 . . . . 0.0 110.239 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 72.2 mt -71.01 117.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.21 0.604 . . . . 0.0 109.562 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -105.02 130.55 53.2 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 109.942 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.29 132.23 49.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.177 0.591 . . . . 0.0 111.449 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.0 103.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.95 123.16 22.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.593 0.757 . . . . 0.0 110.369 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.04 144.2 29.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.295 1.038 . . . . 0.0 111.258 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -59.57 140.16 92.53 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.175 2.583 . . . . 0.0 112.345 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.29 146.36 51.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.28 1.032 . . . . 0.0 112.012 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.03 136.37 53.73 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.617 0.767 . . . . 0.0 110.529 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p -119.94 161.4 20.94 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.97 119.71 10.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 171.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.7 p -68.74 157.08 37.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 113.051 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -57.35 129.0 39.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.238 0.615 . . . . 0.0 110.833 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -60.04 117.93 5.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.747 0.819 . . . . 0.0 112.462 -172.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.85 119.99 11.69 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.277 1.031 . . . . 0.0 110.621 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.07 148.21 44.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.72 0.808 . . . . 0.0 112.628 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.02 137.3 53.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.069 0.947 . . . . 0.0 111.612 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 149.39 3.18 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.717 1.151 . . . . 0.0 113.924 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.028 1.731 . . . . 0.0 111.783 -176.351 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 CA-C-O 118.824 -0.987 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.1 -6.8 11.2 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.071 3.18 . . . . 0.0 114.344 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 75.62 6.32 80.89 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.134 1.349 . . . . 0.0 115.331 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 97.5 mmm -68.7 149.01 98.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.606 1.162 . . . . 0.0 111.916 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -33.83 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.078 2.519 . . . . 0.0 113.129 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -68.88 149.26 97.92 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.004 0.922 . . . . 0.0 112.19 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.23 124.9 17.39 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.233 2.622 . . . . 0.0 112.295 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.82 131.89 45.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.248 0.619 . . . . 0.0 112.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.31 151.45 46.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.136 0.974 . . . . 0.0 111.512 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -64.75 113.64 3.92 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.206 0.603 . . . . 0.0 111.155 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.86 152.17 51.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.489 1.516 . . . . 0.0 111.917 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -61.26 153.28 66.38 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.178 2.585 . . . . 0.0 112.408 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.55 145.91 96.96 Favored Pre-proline 0 CA--C 1.553 1.075 0 O-C-N 121.778 -0.576 . . . . 0.0 111.777 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.73 140.68 96.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.013 2.475 . . . . 0.0 113.087 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.27 123.14 15.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.695 0.798 . . . . 0.0 110.983 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 54.33 20.92 2.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.675 1.99 . . . . 0.0 114.834 -171.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.4 -157.49 15.34 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.116 1.341 . . . . 0.0 113.576 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 22.1 t -67.56 126.62 29.9 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.7 . . . . 0.0 111.442 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.46 126.11 34.18 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.738 1.215 . . . . 0.0 111.313 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.22 -32.36 66.43 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.602 1.161 . . . . 0.0 113.309 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 -14.5 62.84 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.43 117.34 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.906 1.282 . . . . 0.0 110.229 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -124.99 103.6 8.11 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.971 1.308 . . . . 0.0 109.184 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 39.83 64.35 0.89 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.805 2.042 . . . . 0.0 113.33 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 137.53 31.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.647 0.779 . . . . 0.0 111.526 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.56 115.52 3.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.504 0.722 . . . . 0.0 111.015 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.05 132.52 50.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.927 0.891 . . . . 0.0 110.28 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.92 114.24 5.58 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.883 0.873 . . . . 0.0 110.02 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -73.67 143.09 46.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.978 0.511 . . . . 0.0 111.771 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.84 11.14 62.55 Favored Glycine 0 CA--C 1.541 1.68 0 N-CA-C 115.285 0.874 . . . . 0.0 115.285 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.59 128.04 35.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.009 1.324 . . . . 0.0 110.855 172.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.37 131.93 45.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.974 0.91 . . . . 0.0 110.737 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -61.51 125.05 22.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.918 0.887 . . . . 0.0 109.877 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.11 132.12 52.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.66 136.42 58.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.624 0.77 . . . . 0.0 110.637 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 12.6 t -70.22 120.93 16.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.511 0.325 . . . . 0.0 110.137 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -125.06 132.06 53.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.465 1.506 . . . . 0.0 110.296 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.1 106.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.389 2.675 . . . . 0.0 114.233 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -85.13 138.15 32.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.067 0.947 . . . . 0.0 109.62 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -146.74 143.06 28.42 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -162.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 47.72 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 135.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -51.55 -17.97 0.98 Allowed 'General case' 0 N--CA 1.48 1.057 0 O-C-N 119.817 -1.802 . . . . 0.0 114.741 163.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.96 -52.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.85 1.26 . . . . 0.0 111.028 170.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -83.34 -27.98 29.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.832 0.853 . . . . 0.0 113.045 -169.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 18.8 m -46.61 -43.56 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.812 1.187 . . . . 0.0 112.341 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -56.91 -52.83 63.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.889 1.276 . . . . 0.0 112.556 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.93 -50.84 69.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.956 0.902 . . . . 0.0 111.345 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 83.2 t -57.03 -46.4 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.84 0.856 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.57 -50.8 62.25 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.341 1.056 . . . . 0.0 112.085 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.41 -43.77 79.68 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.267 1.027 . . . . 0.0 112.299 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -66.15 -47.74 73.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.37 -30.04 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -121.55 90.36 47.92 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.201 1.4 . . . . 0.0 110.226 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.79 -26.26 72.74 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.626 2.884 . . . . 0.0 114.491 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.25 -12.64 61.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.218 1.807 . . . . 0.0 113.62 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -103.12 117.5 34.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 110.097 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.56 -169.68 15.64 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.855 1.217 . . . . 0.0 112.937 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.94 151.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -70.01 143.87 52.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.835 0.854 . . . . 0.0 112.461 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 34.8 p -58.37 -40.29 81.89 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.012 0.925 . . . . 0.0 112.196 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.82 -43.64 98.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.94 0.896 . . . . 0.0 111.702 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.49 81.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.185 0.594 . . . . 0.0 112.566 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.2 mmm -65.92 -41.83 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.965 -1.084 . . . . 0.0 112.98 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.41 -41.96 88.67 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.298 0.953 . . . . 0.0 113.041 170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -61.12 -49.78 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.791 1.637 . . . . 0.0 111.008 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mmm -56.03 -40.49 73.55 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.668 1.122 . . . . 0.0 112.933 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -64.65 -42.5 95.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.812 -1.18 . . . . 0.0 111.726 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -55.61 -46.85 77.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.603 0.761 . . . . 0.0 111.241 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -56.79 -52.7 64.01 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.677 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.46 -41.33 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.87 1.214 . . . . 0.0 112.384 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -66.05 -54.52 24.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.072 0.851 . . . . 0.0 112.057 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.7 -50.8 71.1 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 11.9 pt -62.58 -36.48 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.368 1.067 . . . . 0.0 112.489 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' PHE . . . . . 0.559 ' CD1' HD13 ' C' ' 55' ' ' LEU . 10.7 m-30 -66.94 -23.52 65.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.323 1.049 . . . . 0.0 112.33 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -81.22 -47.83 12.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.59 0.756 . . . . 0.0 110.944 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -54.98 -42.94 73.07 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 13.7 tt -59.63 -34.0 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.767 0.712 . . . . 0.0 112.552 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.43 88.21 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.301 0.955 . . . . 0.0 111.797 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.82 94.48 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.995 0.807 . . . . 0.0 113.371 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -70.95 -40.4 72.04 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.076 -1.25 . . . . 0.0 112.741 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.91 72.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.914 -1.116 . . . . 0.0 111.576 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -62.43 -47.4 84.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.363 1.065 . . . . 0.0 112.123 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -54.28 -46.84 72.82 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.0 -1.062 . . . . 0.0 112.403 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.88 -41.73 98.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 0.0 112.304 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.43 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.922 0.889 . . . . 0.0 112.257 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -60.8 -42.37 97.46 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.501 1.12 . . . . 0.0 112.594 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -57.62 -33.37 68.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.211 0.914 . . . . 0.0 112.302 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -90.01 7.84 35.54 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.473 1.509 . . . . 0.0 113.326 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.25 31.1 13.53 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.526 2.33 . . . . 0.0 114.876 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -91.39 143.25 26.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.93 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 40.2 p -90.11 -37.56 14.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.363 1.465 . . . . 0.0 113.213 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 72.9 p -106.22 -179.45 3.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.534 1.933 . . . . 0.0 111.515 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mt -125.22 125.25 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.998 1.319 . . . . 0.0 109.358 171.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -101.77 164.22 11.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.263 1.025 . . . . 0.0 113.084 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 45.8 p -57.33 -43.22 83.18 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.211 -0.931 . . . . 0.0 112.565 170.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.19 -37.03 84.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.209 1.004 . . . . 0.0 112.836 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.91 -39.43 90.58 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.577 0.751 . . . . 0.0 111.952 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.32 -43.12 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 169.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -54.82 -45.33 74.41 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.455 1.025 . . . . 0.0 112.587 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 42.2 p -70.48 -38.27 74.36 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.411 1.005 . . . . 0.0 112.174 171.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -24.63 63.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 117.59 -1.195 . . . . 0.0 114.164 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -46.62 -50.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 121.204 1.82 . . . . 0.0 111.612 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.45 -28.06 64.73 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.33 -39.33 54.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.538 1.135 . . . . 0.0 111.772 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -84.57 -20.31 31.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.016 1.726 . . . . 0.0 112.906 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 63.3 tp -144.08 100.8 4.91 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 126.412 1.885 . . . . 0.0 109.976 169.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.75 143.51 95.18 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.046 2.498 . . . . 0.0 112.714 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.01 89.62 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.433 0.54 . . . . 0.0 113.348 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -65.29 -39.11 92.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.739 -0.859 . . . . 0.0 112.286 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 46.2 tp -66.2 -43.72 85.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.663 0.785 . . . . 0.0 111.401 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.72 68.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.39 0.676 . . . . 0.0 111.84 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -57.47 -45.82 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.267 1.027 . . . . 0.0 112.448 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -56.64 -54.26 48.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 0.0 111.604 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.99 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.374 1.07 . . . . 0.0 113.135 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.2 -68.15 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.801 0.84 . . . . 0.0 110.942 171.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.5 m -71.36 -40.82 70.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -163.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -68.35 -37.29 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.026 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.91 95.6 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.638 0.637 . . . . 0.0 113.368 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.2 m -54.74 -53.62 52.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.508 1.123 . . . . 0.0 111.391 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -54.91 -47.51 74.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.929 0.892 . . . . 0.0 111.988 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.35 88.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 0.0 112.677 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.65 -48.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.646 1.112 . . . . 0.0 111.432 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 39.8 m -54.14 -44.12 71.13 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.78 1.173 . . . . 0.0 112.167 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.67 -48.52 81.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.161 0.984 . . . . 0.0 111.906 173.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -58.85 -44.75 91.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.485 1.114 . . . . 0.0 112.885 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -1.19 54.35 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 11.5 t -56.28 138.3 50.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.115 1.366 . . . . 0.0 113.59 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.14 149.06 47.96 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.273 1.029 . . . . 0.0 112.842 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.054 1.342 . . . . 0.0 112.45 177.433 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 CA-C-O 119.573 -0.571 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.95 141.34 89.09 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.942 3.094 . . . . 0.0 113.551 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -70.3 173.41 39.78 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.757 1.17 . . . . 0.0 113.964 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.7 mmm -62.61 143.43 57.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.604 0.762 . . . . 0.0 112.324 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p -79.54 170.12 17.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.982 1.313 . . . . 0.0 113.649 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.01 -177.39 45.23 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.702 1.144 . . . . 0.0 114.505 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 54.41 20.42 2.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.9 2.08 . . . . 0.0 115.252 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.9 171.62 41.6 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.167 1.365 . . . . 0.0 113.975 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.64 124.49 18.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.592 1.157 . . . . 0.0 111.221 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -71.63 129.97 40.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.888 0.875 . . . . 0.0 111.486 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.82 145.85 47.66 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.795 1.188 . . . . 0.0 114.009 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.42 -135.67 49.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.539 1.066 . . . . 0.0 112.939 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -76.9 115.36 16.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.656 0.782 . . . . 0.0 110.259 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.05 157.29 35.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.609 0.763 . . . . 0.0 112.629 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 103.38 2.57 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 123.63 18.18 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.29 147.34 52.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.704 0.802 . . . . 0.0 111.409 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.76 134.34 56.94 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.389 0.676 . . . . 0.0 111.573 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.83 137.36 58.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.728 0.811 . . . . 0.0 111.395 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 27.1 p -66.38 149.86 49.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.836 0.854 . . . . 0.0 111.995 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.65 142.22 58.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.157 0.583 . . . . 0.0 110.447 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t -60.03 127.35 31.46 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.9 0.48 . . . . 0.0 110.869 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -62.33 125.87 25.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.372 0.669 . . . . 0.0 111.308 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.11 126.83 29.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.757 0.823 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.33 122.52 15.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.402 0.681 . . . . 0.0 111.875 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.41 173.19 25.61 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.08 0.848 . . . . 0.0 112.969 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 64.1 tp -54.34 123.4 12.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.503 0.721 . . . . 0.0 110.812 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -77.84 145.43 36.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.341 0.657 . . . . 0.0 111.731 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.71 148.96 60.87 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.943 1.297 . . . . 0.0 110.657 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.44 -42.95 63.0 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.157 2.571 . . . . 0.0 113.707 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.89 -41.08 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.814 0.846 . . . . 0.0 111.257 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.12 97.13 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.583 1.087 . . . . 0.0 113.85 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.6 -45.06 95.68 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.233 -1.157 . . . . 0.0 111.42 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.05 -47.9 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.677 0.791 . . . . 0.0 111.336 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -47.56 -47.82 28.15 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 119.806 1.185 . . . . 0.0 112.336 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.15 -51.32 68.34 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.411 1.085 . . . . 0.0 112.504 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -54.69 -44.02 73.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 112.831 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.44 -44.84 89.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.189 0.995 . . . . 0.0 112.11 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -64.9 -48.96 72.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.966 0.906 . . . . 0.0 112.199 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -57.59 -43.82 84.9 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.273 1.429 . . . . 0.0 112.551 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.59 -13.56 65.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.267 1.413 . . . . 0.0 115.302 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.66 40.05 31.64 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.464 1.906 . . . . 0.0 113.288 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -70.6 -32.61 70.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.2 p -131.33 165.36 23.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.432 1.493 . . . . 0.0 111.737 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -56.08 -47.1 78.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.534 1.134 . . . . 0.0 112.907 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -139.58 154.15 47.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.958 1.703 . . . . 0.0 109.994 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 t -116.55 109.16 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.063 0.945 . . . . 0.0 108.877 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.61 162.01 41.08 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.653 1.121 . . . . 0.0 112.585 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -36.96 63.63 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.99 -24.41 74.46 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.287 0.946 . . . . 0.0 115.26 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -58.75 17.03 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.805 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.89 -38.52 92.61 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.478 2.119 . . . . 0.0 113.219 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.78 -53.95 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.033 0.933 . . . . 0.0 110.954 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -57.17 -50.09 73.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.777 0.831 . . . . 0.0 112.286 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.66 -45.59 85.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.316 1.046 . . . . 0.0 111.617 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.12 96.22 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.254 0.934 . . . . 0.0 112.97 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.89 75.19 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.257 -0.902 . . . . 0.0 112.656 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.43 -41.85 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.54 -0.725 . . . . 0.0 111.541 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.8 -52.75 38.05 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.355 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -59.53 -42.87 93.3 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.236 1.38 . . . . 0.0 113.108 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -53.98 -47.87 70.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.585 0.754 . . . . 0.0 112.626 171.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.92 -45.04 75.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.828 0.851 . . . . 0.0 112.392 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -54.94 -40.04 69.52 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.543 1.537 . . . . 0.0 112.285 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.7 -47.21 70.72 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.914 1.234 . . . . 0.0 112.269 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -63.42 -46.62 85.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.606 0.762 . . . . 0.0 112.403 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -51.52 -55.39 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.771 0.714 . . . . 0.0 110.369 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.49 -46.31 83.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.438 0.695 . . . . 0.0 112.154 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.42 -51.49 64.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.724 0.693 . . . . 0.0 111.913 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.3 -33.24 72.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.604 0.762 . . . . 0.0 112.765 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.67 90.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.62 1.1 . . . . 0.0 112.094 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.68 -46.09 89.68 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 122.084 -0.385 . . . . 0.0 112.655 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -61.33 -45.17 95.56 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.956 -0.732 . . . . 0.0 111.473 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.45 81.96 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.995 0.918 . . . . 0.0 112.723 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.25 86.72 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.607 -0.683 . . . . 0.0 112.375 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -59.08 -39.5 82.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -60.03 -31.68 70.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -89.99 3.84 51.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.06 0.944 . . . . 0.0 113.503 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 56.46 33.03 21.8 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.904 2.081 . . . . 0.0 113.711 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.21 147.7 26.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.623 1.569 . . . . 0.0 112.553 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.4 p -98.02 2.02 48.4 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.974 1.71 . . . . 0.0 113.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -126.27 120.09 29.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.676 1.591 . . . . 0.0 110.709 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.29 123.77 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.493 1.517 . . . . 0.0 109.056 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.17 167.21 9.38 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.074 1.75 . . . . 0.0 111.309 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -48.32 -40.31 35.66 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.4 -36.27 75.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.974 0.909 . . . . 0.0 113.213 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -65.56 -39.66 91.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.264 0.938 . . . . 0.0 112.429 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.01 -44.34 85.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.149 0.58 . . . . 0.0 111.229 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -57.19 -49.91 74.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.448 -0.783 . . . . 0.0 112.035 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 64.8 mt -56.56 -46.55 80.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.081 0.952 . . . . 0.0 111.766 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.4 76.91 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.44 -0.787 . . . . 0.0 112.893 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.06 -45.82 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.472 1.109 . . . . 0.0 110.985 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.79 -24.9 64.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.959 1.304 . . . . 0.0 114.512 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -88.78 -34.97 16.91 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.344 1.058 . . . . 0.0 112.181 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.42 117.41 7.9 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.13 0.877 . . . . 0.0 112.489 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.44 -37.12 74.76 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.181 0.993 . . . . 0.0 113.079 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -64.93 -43.87 91.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.432 1.014 . . . . 0.0 111.865 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.91 -32.77 69.81 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.857 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.59 -39.6 94.24 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.218 1.372 . . . . 0.0 112.061 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.22 -41.97 96.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 112.231 171.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 29.7 tp -75.23 -49.26 19.91 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.99 102.74 14.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.609 1.564 . . . . 0.0 110.295 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.34 152.18 49.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.446 0.546 . . . . 0.0 112.725 162.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.0 -35.74 79.42 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.588 -0.948 . . . . 0.0 112.617 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.81 131.95 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.052 1.341 . . . . 0.0 110.606 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 28.4 p -105.15 -23.2 12.95 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.091 1.356 . . . . 0.0 113.92 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.58 104.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 108.873 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.98 137.92 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.594 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -92.61 138.72 31.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.116 0.966 . . . . 0.0 111.608 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.47 -156.28 31.11 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.361 0.981 . . . . 0.0 113.922 -170.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.3 156.75 53.55 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.504 1.05 . . . . 0.0 113.578 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 39.7 t -67.97 128.8 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.718 -0.872 . . . . 0.0 110.346 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 98.2 mt -123.78 147.46 53.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.564 1.546 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -56.99 134.68 66.13 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.362 2.708 . . . . 0.0 112.917 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -73.08 -44.36 60.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.738 0.815 . . . . 0.0 111.932 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 34.3 mm -63.17 131.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.039 0.935 . . . . 0.0 110.234 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -94.38 142.91 26.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.28 1.032 . . . . 0.0 111.6 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.71 147.17 53.62 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.41 0.684 . . . . 0.0 112.277 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 22.3 t 60.83 119.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 127.119 2.168 . . . . 0.0 112.713 -165.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.6 122.35 14.49 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 0.0 111.053 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.37 138.74 81.16 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.182 0.593 . . . . 0.0 111.22 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -61.15 150.41 84.57 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.788 2.326 . . . . 0.0 111.61 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.14 108.24 2.6 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.75 -0.594 . . . . 0.0 110.423 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.79 151.26 45.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.655 1.182 . . . . 0.0 111.262 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -57.67 122.76 13.56 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.022 0.929 . . . . 0.0 110.731 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -62.68 133.35 54.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.406 0.682 . . . . 0.0 111.3 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -77.83 108.54 11.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.913 -0.492 . . . . 0.0 110.787 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.36 -0.26 57.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.539 1.135 . . . . 0.0 112.877 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -73.68 142.05 46.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.105 1.362 . . . . 0.0 111.692 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.25 127.3 32.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.57 0.748 . . . . 0.0 110.593 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.74 147.31 53.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.701 0.8 . . . . 0.0 112.681 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.15 114.49 5.31 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.326 1.05 . . . . 0.0 111.903 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.16 147.48 44.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.934 1.254 . . . . 0.0 113.429 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 124.74 1.216 . . . . 0.0 112.226 173.0 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 CA-C-O 119.205 -0.775 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.33 -32.01 16.98 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.679 2.92 . . . . 0.0 113.762 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -60.83 123.42 32.69 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.37 0.986 . . . . 0.0 112.803 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.5 141.43 82.85 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.553 0.741 . . . . 0.0 112.065 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.41 148.94 92.48 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.104 2.536 . . . . 0.0 112.071 172.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -65.33 124.7 87.77 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.603 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -61.96 130.14 29.89 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.758 2.305 . . . . 0.0 110.999 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.7 117.58 6.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.51 0.724 . . . . 0.0 112.233 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.3 135.72 57.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.307 1.043 . . . . 0.0 110.544 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -58.85 122.83 14.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.242 0.617 . . . . 0.0 111.152 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 139.77 84.75 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.06 0.544 . . . . 0.0 112.174 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -59.74 131.52 40.39 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.82 2.346 . . . . 0.0 111.317 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.18 132.07 94.97 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.947 -0.549 . . . . 0.0 110.999 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.1 129.53 26.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.958 2.439 . . . . 0.0 112.058 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.73 125.28 24.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.911 0.884 . . . . 0.0 110.401 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -72.34 113.22 9.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.79 -178.5 30.42 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.355 0.978 . . . . 0.0 113.528 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 57.3 p -65.77 -32.02 73.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.05 0.94 . . . . 0.0 112.913 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.13 125.36 23.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.473 1.509 . . . . 0.0 111.324 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.0 157.64 37.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.878 1.271 . . . . 0.0 112.582 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.75 -34.39 75.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.778 0.831 . . . . 0.0 112.565 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.31 113.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.156 1.382 . . . . 0.0 109.232 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -106.06 172.15 6.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.932 1.693 . . . . 0.0 110.745 171.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.81 113.94 2.77 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 117.91 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.696 0.798 . . . . 0.0 110.687 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -68.31 143.63 55.12 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 110.511 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.4 110.54 1.69 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.0 110.178 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.66 145.59 55.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.329 1.052 . . . . 0.0 111.323 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -63.82 129.44 40.1 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.548 0.339 . . . . 0.0 111.271 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 135.63 51.72 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.11 125.46 10.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.68 1.192 . . . . 0.0 111.084 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.73 117.51 4.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.391 1.076 . . . . 0.0 111.145 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.36 125.85 30.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.167 0.987 . . . . 0.0 110.35 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -114.12 153.12 30.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.293 1.837 . . . . 0.0 109.754 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -61.06 115.52 3.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.417 0.687 . . . . 0.0 110.353 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 15.4 t -70.61 130.43 41.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 0.0 111.482 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.44 142.24 52.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.637 0.775 . . . . 0.0 111.223 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.66 -8.76 59.42 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.99 100.59 0.22 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.825 1.65 . . . . 0.0 111.686 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -150.68 -160.8 1.22 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.705 1.602 . . . . 0.0 110.165 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' TYR . . . . . 0.447 ' HB2' HG21 ' D' ' 66' ' ' VAL . 52.3 m-85 -72.98 36.77 0.08 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.592 1.957 . . . . 0.0 112.469 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.8 p -124.97 -14.24 6.68 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.98 1.712 . . . . 0.0 115.249 -154.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.1 -55.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.221 0.919 . . . . 0.0 111.411 -169.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -56.21 -22.89 32.13 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 m -51.38 -32.86 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.996 1.319 . . . . 0.0 112.986 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -58.52 -54.4 47.5 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 111.292 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.66 -36.84 79.72 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.627 1.171 . . . . 0.0 112.835 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 81.5 t -55.47 -56.61 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.701 0.8 . . . . 0.0 110.605 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.71 -25.34 59.07 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -52.35 -37.66 56.66 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.991 1.268 . . . . 0.0 112.147 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.56 -47.03 23.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.761 0.825 . . . . 0.0 112.728 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.41 -47.38 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.024 0.93 . . . . 0.0 112.285 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -127.34 82.64 67.83 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.812 2.045 . . . . 0.0 110.4 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -57.67 -24.9 65.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.488 2.792 . . . . 0.0 115.533 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -86.3 -7.9 58.14 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.929 2.092 . . . . 0.0 114.097 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -126.19 122.66 36.25 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.48 1.036 . . . . 0.0 112.539 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.8 178.66 26.11 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.384 1.469 . . . . 0.0 113.704 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.56 134.26 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.662 1.585 . . . . 0.0 109.541 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 23.5 p -70.46 160.7 31.91 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -55.06 -42.89 73.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.174 0.99 . . . . 0.0 112.22 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.82 -44.09 91.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.932 1.293 . . . . 0.0 112.149 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.44 92.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 112.43 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.4 mtm -58.15 -44.94 88.14 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.203 -0.936 . . . . 0.0 111.676 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.93 -49.13 63.5 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.773 1.178 . . . . 0.0 114.651 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.65 -22.32 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.732 1.266 . . . . 0.0 113.833 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.55 -35.75 61.08 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.504 -1.373 . . . . 0.0 112.125 170.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -55.76 -40.3 72.39 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 78.7 p -79.03 -37.14 39.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.072 -1.017 . . . . 0.0 112.339 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -58.25 -40.03 80.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.339 0.972 . . . . 0.0 112.858 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' D' ' 37' ' ' TYR . 56.1 t -51.22 -54.39 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.504 1.121 . . . . 0.0 111.287 169.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.65 -44.38 93.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.716 0.807 . . . . 0.0 111.536 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -58.3 -49.8 75.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.032 0.833 . . . . 0.0 112.944 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.19 -51.24 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.542 1.137 . . . . 0.0 110.732 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.41 -52.43 59.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.807 0.843 . . . . 0.0 111.892 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -53.06 -48.89 67.34 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.442 1.097 . . . . 0.0 112.519 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.21 -50.41 65.98 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 44.1 mt -63.24 -48.28 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.092 0.86 . . . . 0.0 110.491 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.93 90.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.81 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.26 -51.0 58.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.464 1.03 . . . . 0.0 112.95 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -61.62 -45.7 92.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.55 1.175 . . . . 0.0 112.591 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.68 77.84 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.061 -1.025 . . . . 0.0 112.361 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -61.58 -47.79 83.87 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.357 1.063 . . . . 0.0 111.799 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -57.76 -36.06 71.61 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.841 1.256 . . . . 0.0 112.802 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.16 -41.78 85.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.122 0.874 . . . . 0.0 112.375 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.24 86.28 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.951 -1.093 . . . . 0.0 112.483 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -63.5 -41.94 98.51 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.508 1.123 . . . . 0.0 112.74 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -59.16 -38.45 79.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.99 8.32 3.28 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.252 1.421 . . . . 0.0 113.879 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 53.46 29.68 9.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.82 2.448 . . . . 0.0 115.23 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -81.56 158.82 24.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.153 0.981 . . . . 0.0 112.868 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 65.3 p -112.85 -10.29 13.58 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.978 1.711 . . . . 0.0 113.496 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 53.0 m -134.23 135.01 42.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.582 1.953 . . . . 0.0 109.461 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.46 112.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 108.822 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 55.2 p -96.87 170.42 9.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.216 1.406 . . . . 0.0 111.903 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 37.1 p -53.16 -37.2 61.67 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.929 0.891 . . . . 0.0 112.71 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.71 -44.99 69.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.722 1.209 . . . . 0.0 112.422 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.37 -42.3 91.31 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.612 0.642 . . . . 0.0 111.89 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 69.5 mt -58.17 -53.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.608 0.763 . . . . 0.0 110.356 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -50.7 -46.46 58.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.809 1.186 . . . . 0.0 112.405 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 98.8 m -61.74 -49.4 76.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.773 0.829 . . . . 0.0 112.115 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.04 81.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.992 0.917 . . . . 0.0 112.686 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -51.49 -51.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.617 1.167 . . . . 0.0 110.993 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.58 -44.25 97.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.921 0.888 . . . . 0.0 112.699 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.32 -36.26 83.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.211 1.004 . . . . 0.0 113.26 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.24 -30.42 48.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.0 1.32 . . . . 0.0 113.061 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 68.0 mt -120.88 63.79 11.53 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.755 1.622 . . . . 0.0 111.911 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.4 -39.34 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.915 2.41 . . . . 0.0 112.491 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.97 129.63 18.55 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.655 1.121 . . . . 0.0 113.081 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -59.88 -37.87 80.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.585 0.754 . . . . 0.0 112.399 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.0 tp -52.55 -52.85 52.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.346 1.058 . . . . 0.0 111.818 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.6 -47.51 81.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.749 0.82 . . . . 0.0 111.649 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.78 -55.11 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.448 1.099 . . . . 0.0 112.016 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -60.47 -46.54 89.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.645 1.178 . . . . 0.0 112.105 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.82 76.72 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.15 -39.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.034 -1.041 . . . . 0.0 112.267 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 67.4 m -59.47 -42.01 91.06 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.466 1.485 . . . . 0.0 112.47 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -61.8 -34.33 75.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.032 -1.043 . . . . 0.0 111.766 168.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.3 -44.24 84.51 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.798 1.189 . . . . 0.0 113.678 165.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -57.42 -46.58 83.38 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.687 1.743 . . . . 0.0 111.44 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.05 -42.84 95.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.266 0.627 . . . . 0.0 111.945 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.12 82.77 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.831 0.853 . . . . 0.0 112.425 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 94.4 t -57.96 -51.96 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.208 0.913 . . . . 0.0 111.57 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 69.2 p -74.09 -16.45 61.02 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -91.2 -49.2 6.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.668 1.587 . . . . 0.0 112.92 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -106.26 -50.96 3.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.392 1.077 . . . . 0.0 112.779 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -63.66 -51.26 65.91 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.032 0.833 . . . . 0.0 113.234 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 97.7 p -75.96 -11.41 59.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.47 143.61 54.95 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.994 0.917 . . . . 0.0 112.7 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.416 1.487 . . . . 0.0 112.509 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 CA-C-O 119.172 -0.794 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.5 140.87 71.29 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.977 3.118 . . . . 0.0 113.079 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -69.83 172.39 39.99 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.364 0.983 . . . . 0.0 114.009 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 97.0 mmm -69.21 157.67 36.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 112.16 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 17.8 t -84.97 123.03 30.05 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.711 0.805 . . . . 0.0 111.838 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.67 137.58 37.03 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.504 1.05 . . . . 0.0 113.097 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -50.98 141.5 13.58 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.475 1.51 . . . . 0.0 114.905 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.68 -175.17 30.8 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.794 1.188 . . . . 0.0 113.782 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.87 -59.49 5.36 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.309 1.444 . . . . 0.0 112.769 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -151.47 138.68 19.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.325 1.45 . . . . 0.0 110.801 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.16 -142.85 38.45 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.25 0.929 . . . . 0.0 113.863 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.66 153.37 9.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.657 1.122 . . . . 0.0 114.011 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.71 125.24 23.66 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.901 0.88 . . . . 0.0 111.671 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.1 130.13 42.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.673 0.789 . . . . 0.0 111.257 172.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -64.22 120.13 11.55 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.674 -0.641 . . . . 0.0 109.455 169.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.19 128.91 38.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.643 . . . . 0.0 111.333 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.7 143.28 54.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.501 0.72 . . . . 0.0 110.652 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.14 118.44 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.98 0.512 . . . . 0.0 110.677 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.66 133.12 55.78 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.695 0.798 . . . . 0.0 110.656 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 38.2 p -62.07 150.47 38.2 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.205 0.602 . . . . 0.0 110.936 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -58.23 121.56 11.04 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.654 -0.654 . . . . 0.0 109.765 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 22.2 t -58.82 126.8 29.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.268 0.627 . . . . 0.0 110.864 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -61.5 122.48 15.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.122 0.569 . . . . 0.0 110.904 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.16 134.66 57.26 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.453 0.701 . . . . 0.0 111.122 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.68 3.01 17.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 113.918 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.26 -160.91 50.68 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.771 1.177 . . . . 0.0 112.631 -166.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.51 -44.39 67.71 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.264 -0.55 . . . . 0.0 112.123 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 106.53 0.57 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.748 0.819 . . . . 0.0 111.896 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -154.67 130.69 5.51 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.584 1.154 . . . . 0.0 111.28 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.55 125.24 13.54 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.769 2.312 . . . . 0.0 113.91 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 t -58.49 -35.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.867 1.267 . . . . 0.0 112.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.1 -26.3 63.3 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.065 0.84 . . . . 0.0 114.281 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -81.64 -44.65 16.89 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.736 1.268 . . . . 0.0 111.42 168.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -50.27 -50.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.213 0.915 . . . . 0.0 111.1 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -64.59 -43.18 94.65 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.406 -0.809 . . . . 0.0 112.699 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -59.64 -41.77 91.26 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.803 0.729 . . . . 0.0 112.402 171.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.71 -41.2 92.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.269 1.028 . . . . 0.0 112.814 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.17 -44.46 83.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.13 0.877 . . . . 0.0 111.441 172.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -61.81 -54.41 42.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.659 0.784 . . . . 0.0 112.319 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.5 -50.73 59.34 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.923 1.689 . . . . 0.0 112.565 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.24 -0.05 64.98 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.332 1.444 . . . . 0.0 115.596 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 65.6 t30 52.17 41.66 30.26 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.291 1.836 . . . . 0.0 113.549 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -71.8 -28.01 63.31 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 113.424 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.9 t -141.0 153.08 45.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.785 1.234 . . . . 0.0 111.841 170.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -66.77 -29.16 69.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.246 1.019 . . . . 0.0 112.585 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -134.84 120.31 19.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.59 1.556 . . . . 0.0 110.516 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.78 122.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.173 1.389 . . . . 0.0 108.236 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.31 50.4 1.0 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.069 1.795 . . . . 0.0 115.628 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.1 -15.24 21.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.38 79.69 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.975 -1.078 . . . . 0.0 113.702 165.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.36 -59.23 11.67 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 118.642 1.221 . . . . 0.0 112.58 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.71 -31.34 60.38 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.244 1.963 . . . . 0.0 114.383 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.18 -48.79 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.739 1.154 . . . . 0.0 112.059 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -61.08 -38.37 86.01 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.101 -0.999 . . . . 0.0 111.99 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.37 -30.06 70.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.978 -1.076 . . . . 0.0 112.729 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.437 ' HB1' ' CE1' ' D' ' 40' ' ' TYR . . . -59.46 -45.15 92.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.696 1.135 . . . . 0.0 111.998 168.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.61 90.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.21 -49.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.906 -1.122 . . . . 0.0 112.015 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.6 -35.58 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.595 1.158 . . . . 0.0 112.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.3 -50.0 51.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -76.71 -38.25 54.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.572 0.749 . . . . 0.0 112.921 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.72 -45.17 86.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.317 0.508 . . . . 0.0 111.346 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -77.5 -28.42 52.11 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.66 -46.15 77.58 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.267 0.94 . . . . 0.0 112.545 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.76 -42.19 96.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.963 0.801 . . . . 0.0 112.61 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.09 -55.02 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.518 0.727 . . . . 0.0 110.259 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.84 -32.79 73.56 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.18 -52.36 62.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.695 1.198 . . . . 0.0 111.612 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.73 -36.1 83.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.692 -0.63 . . . . 0.0 112.017 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.13 90.91 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.619 -0.675 . . . . 0.0 111.939 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.05 -46.11 85.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.166 0.889 . . . . 0.0 113.681 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -60.95 -46.13 91.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.155 0.977 . . . . 0.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.44 82.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.607 -0.683 . . . . 0.0 112.305 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.97 88.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.284 1.034 . . . . 0.0 112.629 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -54.48 -50.63 67.3 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.755 1.222 . . . . 0.0 111.86 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -58.68 -38.76 78.91 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -87.72 6.33 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.591 1.156 . . . . 0.0 113.267 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 52.88 34.88 17.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.107 2.163 . . . . 0.0 114.275 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 148.99 21.81 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.506 1.522 . . . . 0.0 112.805 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.0 p -90.58 -28.71 18.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.311 1.445 . . . . 0.0 113.074 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -122.75 138.54 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.302 1.441 . . . . 0.0 111.765 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.72 130.19 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.892 1.277 . . . . 0.0 110.849 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.19 164.39 20.43 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 125.743 1.617 . . . . 0.0 111.481 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.01 -38.3 48.9 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.692 2.928 . . . . 0.0 114.923 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.47 -40.55 87.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.736 0.814 . . . . 0.0 113.036 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -62.21 -41.81 98.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.018 0.826 . . . . 0.0 111.812 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.23 -45.68 87.12 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.84 0.856 . . . . 0.0 111.476 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -58.13 -48.69 79.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.007 0.923 . . . . 0.0 112.024 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.27 -46.77 82.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.76 0.824 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.13 -52.17 59.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.89 0.768 . . . . 0.0 112.622 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 24.6 pt -71.16 -24.99 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -74.36 -43.38 56.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.273 1.429 . . . . 0.0 112.46 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -73.81 -21.34 60.18 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -120.57 115.0 22.56 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.113 0.965 . . . . 0.0 111.382 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.05 -37.33 64.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.666 1.186 . . . . 0.0 112.873 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -60.5 -30.52 69.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 112.757 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.39 -38.17 35.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.946 0.898 . . . . 0.0 111.497 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.07 -32.12 70.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.617 0.767 . . . . 0.0 112.87 172.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.27 -42.23 96.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.54 1.136 . . . . 0.0 113.2 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -51.97 66.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.766 0.826 . . . . 0.0 112.052 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.75 169.43 10.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 113.388 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.48 143.34 43.97 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.602 -0.686 . . . . 0.0 112.829 169.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.89 160.24 12.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.449 0.7 . . . . 0.0 111.054 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.99 117.47 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.34 0.656 . . . . 0.0 110.524 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 36.2 p -88.07 162.23 16.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.358 1.463 . . . . 0.0 112.147 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 tt -61.11 139.41 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 111.988 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.9 133.66 55.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.64 0.776 . . . . 0.0 112.523 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -139.64 159.9 41.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.66 1.584 . . . . 0.0 111.907 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.34 -153.77 15.18 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.59 0.614 . . . . 0.0 114.428 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.41 -168.63 25.81 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.873 1.225 . . . . 0.0 113.874 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.69 112.92 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.747 0.819 . . . . 0.0 109.298 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.24 141.34 73.86 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.551 0.74 . . . . 0.0 111.314 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.41 139.3 76.03 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.334 2.689 . . . . 0.0 112.305 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -100.8 98.81 9.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.19 0.996 . . . . 0.0 109.987 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 73.2 mt -72.75 119.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.751 0.82 . . . . 0.0 109.448 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -96.02 150.14 20.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.467 1.107 . . . . 0.0 111.108 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.45 141.49 57.64 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.792 0.437 . . . . 0.0 111.135 169.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.88 98.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 136.48 39.02 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.039 1.336 . . . . 0.0 110.148 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.12 150.31 97.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.422 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.09 128.82 31.8 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.982 2.455 . . . . 0.0 112.995 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.36 143.84 56.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.589 0.756 . . . . 0.0 110.556 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.32 114.31 3.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.28 0.632 . . . . 0.0 110.089 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.25 156.07 39.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.35 1.06 . . . . 0.0 111.967 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.81 113.96 4.16 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 170.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 30.0 p -67.2 143.63 56.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.694 0.798 . . . . 0.0 112.311 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.69 141.23 57.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.181 0.593 . . . . 0.0 110.852 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -74.59 97.33 3.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.274 0.559 . . . . 0.0 110.909 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -112.21 142.77 44.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.204 1.801 . . . . 0.0 110.563 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.72 56.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.425 0.69 . . . . 0.0 112.348 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.23 11.2 31.06 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.245 1.418 . . . . 0.0 113.334 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.95 9.88 63.85 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.263 1.411 . . . . 0.0 114.877 -169.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.252 1.213 0 C-N-CA 127.1 2.16 . . . . 0.0 111.385 179.326 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.92 -42.59 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.376 2.718 . . . . 0.0 112.424 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -83.87 -148.14 8.43 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.762 1.172 . . . . 0.0 112.386 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -71.14 128.17 90.71 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.715 -0.874 . . . . 0.0 110.958 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.04 145.33 73.21 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.247 2.631 . . . . 0.0 112.617 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -73.1 127.88 88.65 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.105 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -63.02 143.98 91.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.973 2.449 . . . . 0.0 112.468 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.95 92.79 3.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.598 0.759 . . . . 0.0 111.01 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.33 -39.97 62.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.44 1.096 . . . . 0.0 111.646 175.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 60.9 p -70.09 161.39 30.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.689 1.596 . . . . 0.0 112.923 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.55 131.5 45.32 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.186 0.994 . . . . 0.0 113.499 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -66.93 146.25 77.02 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.358 2.705 . . . . 0.0 112.462 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.64 95.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.751 -0.593 . . . . 0.0 111.202 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -62.85 147.76 94.24 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.966 2.444 . . . . 0.0 112.182 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.24 149.95 47.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.125 0.97 . . . . 0.0 112.09 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.61 135.96 57.83 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.069 0.548 . . . . 0.0 110.871 170.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.97 63.06 Favored Glycine 0 CA--C 1.54 1.614 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -173.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -67.91 129.36 39.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.405 1.603 . . . . 0.0 111.645 174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.63 147.56 33.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.431 1.092 . . . . 0.0 111.911 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 91.6 mttt 54.77 27.69 9.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.331 1.852 . . . . 0.0 114.502 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 140.21 58.65 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.154 0.982 . . . . 0.0 112.874 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.94 -46.53 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.014 0.926 . . . . 0.0 111.24 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 36.7 p -116.02 172.0 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.282 1.833 . . . . 0.0 111.961 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -80.18 148.48 30.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.019 0.927 . . . . 0.0 111.416 170.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.7 130.15 45.09 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.618 0.767 . . . . 0.0 111.83 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.549 1.14 . . . . 0.0 110.849 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.74 144.01 51.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.823 0.849 . . . . 0.0 111.945 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.89 143.36 31.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.303 1.441 . . . . 0.0 111.21 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 p30 -140.24 162.71 34.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.615 1.566 . . . . 0.0 112.512 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 -160.62 6.74 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.092 0.853 . . . . 0.0 113.232 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.08 48.87 1.03 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.74 1.216 . . . . 0.0 111.849 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.06 62.73 2.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.116 2.167 . . . . 0.0 111.353 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.81 112.04 1.88 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.445 0.698 . . . . 0.0 109.96 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.2 137.99 51.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.514 1.126 . . . . 0.0 111.155 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.49 138.17 58.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.365 0.666 . . . . 0.0 110.257 169.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 38.0 p -64.1 145.47 55.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.954 0.502 . . . . 0.0 111.199 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -68.79 120.79 15.28 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.566 -0.709 . . . . 0.0 110.949 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -96.08 92.01 6.23 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 0.0 109.929 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -110.6 5.08 20.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.869 1.268 . . . . 0.0 113.103 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 37.0 p -60.6 145.98 46.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.956 0.902 . . . . 0.0 112.302 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' C' ' 52' ' ' ALA 0.302 48.7 m-85 -68.16 134.35 50.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.79 1.281 . . . . 0.0 111.869 -177.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -179.7 -48.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 -155.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 pt -48.15 -38.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.835 1.654 . . . . 0.0 113.903 169.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' TYR . . . . . 0.437 ' CE1' ' HB1' ' C' ' 52' ' ' ALA . 80.2 m-85 -66.27 -46.93 75.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.755 0.822 . . . . 0.0 112.026 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.38 -46.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 118.677 0.671 . . . . 0.0 110.491 170.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -62.22 -38.38 88.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.66 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.59 -53.18 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.814 0.845 . . . . 0.0 111.64 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.35 -43.0 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.53 1.132 . . . . 0.0 111.982 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -52.85 -49.96 64.72 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.429 1.013 . . . . 0.0 111.697 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.98 -37.62 77.24 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.044 0.838 . . . . 0.0 113.013 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -75.8 -46.17 32.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.1 0.96 . . . . 0.0 113.38 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.39 -36.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.951 1.3 . . . . 0.0 111.831 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -120.79 68.08 15.45 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.294 1.838 . . . . 0.0 111.547 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.24 -38.82 3.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.152 2.568 . . . . 0.0 112.968 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.81 -42.9 7.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.772 1.229 . . . . 0.0 112.852 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -69.6 172.98 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.41 1.884 . . . . 0.0 112.822 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.72 -163.23 10.32 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 124.529 1.062 . . . . 0.0 113.938 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.13 152.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.305 1.442 . . . . 0.0 110.627 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 51.4 p -81.24 154.82 26.42 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.207 0.912 . . . . 0.0 112.842 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 47.9 p -56.69 -40.13 75.03 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.215 -0.928 . . . . 0.0 112.011 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.48 -50.22 74.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.955 1.302 . . . . 0.0 111.849 172.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.55 98.12 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.678 0.791 . . . . 0.0 112.989 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.9 -43.58 86.24 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.094 -1.003 . . . . 0.0 111.454 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.08 -48.64 66.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.503 1.049 . . . . 0.0 113.544 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.92 -47.23 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.138 0.975 . . . . 0.0 111.393 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.26 -39.58 83.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.451 1.023 . . . . 0.0 112.887 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -63.99 -46.44 84.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.173 -0.955 . . . . 0.0 111.183 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 57.7 m -55.4 -46.79 76.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.258 0.936 . . . . 0.0 112.373 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -53.94 -53.86 46.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.735 0.814 . . . . 0.0 111.179 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 82.7 t -57.11 -49.0 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.485 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -52.16 -50.77 61.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 120.186 1.357 . . . . 0.0 111.752 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.26 -51.43 66.22 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.59 -45.33 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.379 1.072 . . . . 0.0 111.342 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -55.03 -51.51 66.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.07 1.348 . . . . 0.0 112.369 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.98 -42.02 97.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.165 0.986 . . . . 0.0 112.003 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -60.68 -51.72 68.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.051 0.94 . . . . 0.0 112.305 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 pt -69.52 -26.36 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.88 67.67 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.349 0.977 . . . . 0.0 112.395 169.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.24 86.05 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.166 0.412 . . . . 0.0 112.394 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.5 -43.19 86.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.254 -1.144 . . . . 0.0 112.046 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.72 -42.69 75.69 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.878 1.217 . . . . 0.0 113.129 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 81.5 p -70.03 -44.23 69.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.945 0.793 . . . . 0.0 112.332 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -55.69 -42.16 74.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.653 1.115 . . . . 0.0 113.339 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -57.01 -35.03 68.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.683 1.193 . . . . 0.0 112.389 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.72 -45.58 64.65 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.316 -0.865 . . . . 0.0 112.052 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -59.04 -39.16 81.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.951 1.3 . . . . 0.0 113.616 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -56.55 -29.83 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.13 1.372 . . . . 0.0 112.813 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -99.2 13.86 31.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.812 1.645 . . . . 0.0 112.232 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.62 29.22 6.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.631 2.372 . . . . 0.0 114.464 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -73.36 139.82 46.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.52 1.128 . . . . 0.0 111.336 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 59.6 p -76.61 -32.81 58.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.719 1.208 . . . . 0.0 113.787 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -136.93 -167.94 2.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.505 1.922 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.29 113.09 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.83 1.252 . . . . 0.0 110.482 168.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 30.4 p -85.7 168.87 13.98 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.125 1.37 . . . . 0.0 113.647 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 34.9 p -50.06 -44.72 51.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.23 1.412 . . . . 0.0 113.497 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.04 -42.2 69.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.084 0.953 . . . . 0.0 112.007 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.74 -29.86 71.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.1 -48.84 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.091 -1.006 . . . . 0.0 110.956 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -38.49 83.19 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.331 -0.856 . . . . 0.0 111.406 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 32.6 m -58.43 -48.09 81.82 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.442 -0.786 . . . . 0.0 111.974 169.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.14 -44.65 83.59 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.945 -1.097 . . . . 0.0 112.243 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.41 -49.95 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.844 0.858 . . . . 0.0 111.959 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -72.02 -14.16 61.8 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.19 -29.33 21.83 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.328 1.051 . . . . 0.0 112.121 170.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.2 -47.4 24.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 112.784 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 79.8 mt -106.1 130.32 23.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.549 1.14 . . . . 0.0 112.166 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.56 159.78 22.21 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.639 2.892 . . . . 0.0 113.299 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.94 -139.17 41.01 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.961 1.267 . . . . 0.0 114.858 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -66.67 -26.39 67.02 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.32 -33.46 63.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.265 1.026 . . . . 0.0 112.25 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.75 4.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.314 1.046 . . . . 0.0 112.318 169.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.03 -45.36 90.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.611 1.164 . . . . 0.0 111.338 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -54.17 -55.37 28.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.009 0.924 . . . . 0.0 111.751 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.37 83.4 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -56.4 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.625 1.102 . . . . 0.0 110.757 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -56.44 -49.07 75.65 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.605 1.093 . . . . 0.0 112.905 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -61.87 -43.48 98.77 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.439 -0.788 . . . . 0.0 112.145 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.73 97.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.544 1.069 . . . . 0.0 113.736 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -58.09 -50.2 74.28 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.244 1.018 . . . . 0.0 110.919 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -59.26 -44.58 92.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.148 0.579 . . . . 0.0 112.166 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.31 75.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.051 0.941 . . . . 0.0 112.184 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.74 -54.93 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.946 0.794 . . . . 0.0 110.565 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 97.5 m -52.92 -51.46 61.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.74 0.816 . . . . 0.0 112.375 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -58.18 -43.74 87.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.467 1.107 . . . . 0.0 112.635 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -71.67 -34.68 69.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.387 0.675 . . . . 0.0 112.748 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.5 p -78.99 -32.56 45.25 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.497 1.044 . . . . 0.0 113.5 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 54.5 p -76.36 -14.85 60.06 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.37 135.81 38.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.051 1.34 . . . . 0.0 113.014 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.213 1.405 . . . . 0.0 112.969 -177.762 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.61 -25.46 50.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.626 3.551 . . . . 0.0 116.968 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -63.91 -18.61 62.33 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 124.386 0.993 . . . . 0.0 115.56 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 99.2 mmm -81.31 161.7 23.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.764 1.226 . . . . 0.0 112.765 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t -65.21 159.01 24.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.807 0.843 . . . . 0.0 112.909 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.77 -146.41 49.41 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.776 1.179 . . . . 0.0 113.318 -170.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.59 143.51 38.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.179 0.992 . . . . 0.0 112.692 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.88 -169.71 15.36 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.851 1.215 . . . . 0.0 114.212 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.06 127.87 34.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.673 1.189 . . . . 0.0 111.49 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -105.47 144.97 31.5 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.94 1.296 . . . . 0.0 111.677 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.25 148.09 51.17 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.094 0.854 . . . . 0.0 113.309 171.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.27 153.25 31.88 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.091 0.853 . . . . 0.0 113.063 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.87 125.1 11.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 111.705 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 128.44 35.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.735 0.814 . . . . 0.0 111.39 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -66.41 131.69 46.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.73 0.812 . . . . 0.0 111.295 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 136.42 55.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.497 0.719 . . . . 0.0 111.652 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.91 133.75 51.55 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.635 0.774 . . . . 0.0 111.293 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.43 139.45 57.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.474 0.71 . . . . 0.0 111.714 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.18 109.55 8.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.948 0.899 . . . . 0.0 111.268 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 41.6 m -61.57 123.43 17.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.526 1.131 . . . . 0.0 111.933 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 49.92 33.37 6.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.666 1.986 . . . . 0.0 114.834 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 16.1 t -59.88 122.62 14.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 112.747 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 47.0 p -92.76 143.95 25.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.938 1.695 . . . . 0.0 111.284 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.59 118.95 12.27 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.535 -0.728 . . . . 0.0 110.971 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.25 140.38 50.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.976 0.91 . . . . 0.0 112.319 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.46 -168.14 24.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.099 1.333 . . . . 0.0 113.788 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 88.4 mt -95.42 -2.05 49.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 113.887 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -102.37 152.52 21.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.195 1.398 . . . . 0.0 112.7 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -123.64 70.14 46.14 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.519 1.128 . . . . 0.0 111.225 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -61.39 156.56 45.63 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.392 2.061 . . . . 0.0 110.991 169.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.47 -32.33 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.379 -0.826 . . . . 0.0 112.651 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.59 -35.03 88.39 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.37 0.986 . . . . 0.0 115.039 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.08 -45.18 86.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.515 1.158 . . . . 0.0 110.228 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.18 -36.09 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.833 0.853 . . . . 0.0 111.749 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -56.97 -37.43 71.6 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.26 1.391 . . . . 0.0 112.556 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.44 -46.02 81.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.735 1.152 . . . . 0.0 112.496 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.78 -41.01 85.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.545 0.738 . . . . 0.0 111.966 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.75 -37.51 82.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.447 1.499 . . . . 0.0 112.737 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -60.41 -39.3 86.88 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.674 1.189 . . . . 0.0 112.338 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.41 -40.05 74.03 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.296 0.953 . . . . 0.0 111.943 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.23 7.61 29.32 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.825 1.679 . . . . 0.0 115.82 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 53.06 26.71 5.04 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.807 2.043 . . . . 0.0 115.018 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.49 -50.74 40.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 113.605 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -120.36 145.34 47.24 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.2 1.0 . . . . 0.0 111.65 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -71.26 -27.09 63.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.458 1.103 . . . . 0.0 112.485 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -139.67 130.69 26.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.936 1.694 . . . . 0.0 111.346 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.36 97.82 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.691 1.196 . . . . 0.0 109.277 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.31 151.62 34.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.686 1.136 . . . . 0.0 113.367 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.86 60.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.24 -9.21 86.83 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.05 31.54 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.533 1.667 . . . . 0.0 114.984 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.86 -35.86 81.04 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.62 2.88 . . . . 0.0 114.738 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.71 -44.82 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.018 0.927 . . . . 0.0 110.547 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -65.02 -49.29 70.76 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.51 -38.08 86.43 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.092 -1.005 . . . . 0.0 111.703 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.48 87.58 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.515 -0.74 . . . . 0.0 112.298 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.32 82.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.215 0.916 . . . . 0.0 112.103 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.3 -49.67 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.551 -0.718 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.86 -33.14 75.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -62.07 -29.37 70.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.98 -6.92 50.31 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.322 -1.486 . . . . 0.0 113.917 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.47 -43.76 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.457 1.103 . . . . 0.0 111.268 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 57.9 p -62.56 -19.53 63.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.701 0.801 . . . . 0.0 112.736 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.73 -40.53 40.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.958 1.303 . . . . 0.0 113.666 166.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.95 -45.35 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.667 1.121 . . . . 0.0 111.578 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.24 -41.25 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.118 0.967 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.41 -45.16 85.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.81 1.244 . . . . 0.0 113.17 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -61.26 -44.53 97.08 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.463 1.029 . . . . 0.0 112.034 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.16 -41.26 87.96 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.81 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.19 75.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.108 -0.995 . . . . 0.0 112.528 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.18 -44.14 93.29 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.355 0.978 . . . . 0.0 112.914 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.703 -0.881 . . . . 0.0 111.254 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.18 88.26 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.281 -0.887 . . . . 0.0 112.979 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.16 78.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.055 1.342 . . . . 0.0 112.145 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -54.0 -47.7 71.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.584 1.153 . . . . 0.0 112.508 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -57.97 -34.56 70.08 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.03 4.21 45.98 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.821 1.248 . . . . 0.0 113.444 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.14 32.04 19.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.824 2.05 . . . . 0.0 114.324 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.89 154.05 21.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.933 1.693 . . . . 0.0 113.018 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -115.36 15.68 16.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.474 1.91 . . . . 0.0 113.082 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -130.69 126.85 37.57 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.191 1.397 . . . . 0.0 110.4 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.09 124.27 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.921 0.888 . . . . 0.0 109.766 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.86 164.92 24.08 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.724 1.61 . . . . 0.0 110.879 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -50.16 -34.94 41.01 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.564 2.843 . . . . 0.0 114.915 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.51 -35.57 79.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.889 0.876 . . . . 0.0 113.362 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.63 -39.42 77.18 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.924 -1.11 . . . . 0.0 112.026 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.89 -39.84 91.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.455 0.702 . . . . 0.0 111.229 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.22 -51.74 66.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.336 1.054 . . . . 0.0 111.052 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.09 -39.87 79.69 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.188 0.904 . . . . 0.0 112.811 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.21 70.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.585 0.754 . . . . 0.0 112.493 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.08 -30.53 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -48.82 -35.86 15.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.276 1.83 . . . . 0.0 113.643 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.36 -12.29 61.48 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -130.71 130.34 43.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.009 1.323 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.05 -48.34 82.2 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.128 -0.983 . . . . 0.0 113.24 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.42 -45.99 88.41 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.481 -0.762 . . . . 0.0 112.044 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.8 -36.87 85.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.072 0.851 . . . . 0.0 112.438 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -60.92 -46.39 90.86 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.994 1.27 . . . . 0.0 111.753 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.41 -32.83 74.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 113.388 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.25 -47.89 54.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.488 1.515 . . . . 0.0 112.037 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 tt -68.29 105.3 2.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.772 0.796 . . . . 0.0 110.368 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.37 -156.39 7.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.745 1.64 . . . . 0.0 111.104 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -97.89 144.75 27.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.177 0.991 . . . . 0.0 110.742 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.8 119.65 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.578 0.751 . . . . 0.0 109.807 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 59.0 p -120.41 156.76 30.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.652 1.581 . . . . 0.0 111.288 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 85.8 mt -71.5 116.28 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.22 128.41 36.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.555 0.742 . . . . 0.0 111.886 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.08 5.44 42.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.598 1.159 . . . . 0.0 113.163 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.52 -149.11 8.81 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.152 1.358 . . . . 0.0 113.82 171.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.2 -150.36 40.65 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.652 1.12 . . . . 0.0 113.795 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.52 127.17 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.788 0.835 . . . . 0.0 109.903 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.14 156.1 37.38 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.144 1.377 . . . . 0.0 111.602 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 132.17 49.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.194 2.596 . . . . 0.0 112.519 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -72.46 122.33 21.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.897 -0.502 . . . . 0.0 110.433 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 99.0 mt -67.13 -41.35 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.515 1.126 . . . . 0.0 111.496 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -110.12 151.79 26.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.964 1.306 . . . . 0.0 112.017 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.6 144.3 57.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.216 0.606 . . . . 0.0 111.543 168.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.9 t -71.14 116.77 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.194 0.598 . . . . 0.0 110.125 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 63.7 tp -99.35 114.58 27.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 109.888 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.58 149.67 98.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.992 170.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.07 118.38 5.16 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.973 2.449 . . . . 0.0 112.344 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.55 132.4 48.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.69 0.796 . . . . 0.0 111.078 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.08 135.42 57.51 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 162.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 38.9 m -62.93 111.74 2.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.279 0.491 . . . . 0.0 110.129 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.31 98.39 6.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.538 0.735 . . . . 0.0 110.021 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -56.15 133.95 52.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.465 0.706 . . . . 0.0 110.126 170.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -61.43 111.1 1.65 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.995 0.518 . . . . 0.0 110.944 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -75.51 126.96 32.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.568 0.747 . . . . 0.0 111.396 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.12 122.9 13.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.148 0.979 . . . . 0.0 110.338 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.7 137.57 57.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.442 0.697 . . . . 0.0 112.491 -175.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.97 -19.85 60.53 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.26 1.024 . . . . 0.0 113.695 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.81 29.84 74.01 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.358 0.98 . . . . 0.0 113.64 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.817 2.047 . . . . 0.0 111.695 -177.309 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.85 133.92 53.84 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.921 3.081 . . . . 0.0 113.759 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -65.99 152.98 51.86 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.342 0.972 . . . . 0.0 113.301 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 99.4 mmm -60.03 144.13 87.09 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.988 -0.713 . . . . 0.0 111.769 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -57.29 134.81 66.36 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.149 2.566 . . . . 0.0 113.575 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.97 147.89 84.13 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.335 0.654 . . . . 0.0 111.633 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -57.74 134.91 65.97 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.858 2.372 . . . . 0.0 113.509 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.26 55.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.37 0.668 . . . . 0.0 111.964 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.06 114.75 11.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.02 0.928 . . . . 0.0 110.798 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.2 p -143.5 166.19 25.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.378 1.471 . . . . 0.0 112.76 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.04 139.63 93.03 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.359 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.19 123.1 13.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.128 2.552 . . . . 0.0 113.021 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.69 152.63 68.86 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.923 1.689 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -57.64 128.02 27.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.786 2.324 . . . . 0.0 111.832 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.81 -120.48 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.317 1.447 . . . . 0.0 110.496 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.19 160.2 14.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.743 1.617 . . . . 0.0 111.736 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.47 -171.4 42.07 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.399 1.476 . . . . 0.0 111.802 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 66.7 p -51.92 -31.54 28.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.973 1.309 . . . . 0.0 114.187 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -52.47 -26.34 12.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.907 1.683 . . . . 0.0 114.184 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -58.75 -25.93 63.49 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 119.608 1.094 . . . . 0.0 113.838 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.45 -10.76 59.74 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.647 1.179 . . . . 0.0 114.145 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.47 105.65 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.105 0.962 . . . . 0.0 110.024 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 126.23 29.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.968 0.907 . . . . 0.0 110.025 172.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.3 122.45 16.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.42 0.688 . . . . 0.0 110.852 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 136.14 57.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.712 0.805 . . . . 0.0 112.327 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -88.67 -10.13 49.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.988 0.915 . . . . 0.0 113.249 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.49 141.24 55.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.961 1.304 . . . . 0.0 111.084 168.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.78 129.61 41.83 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.015 0.926 . . . . 0.0 111.061 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.75 127.72 33.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.092 0.557 . . . . 0.0 112.392 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 -159.26 5.73 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.916 0.769 . . . . 0.0 113.314 168.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.92 -29.95 70.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.057 0.943 . . . . 0.0 113.245 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 60.87 152.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.347 2.659 . . . . 0.0 113.55 -167.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.97 146.1 37.69 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.689 0.796 . . . . 0.0 110.906 170.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.04 122.01 12.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 0.0 111.527 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.29 141.36 50.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 111.347 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -71.22 157.76 37.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.122 0.969 . . . . 0.0 112.546 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.9 126.38 27.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.791 . . . . 0.0 110.532 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.08 154.41 42.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.309 1.044 . . . . 0.0 112.808 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -86.63 72.17 10.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 110.073 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 53.1 m -62.8 -36.93 84.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.009 0.923 . . . . 0.0 111.404 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.43 -154.85 0.47 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.959 1.703 . . . . 0.0 108.291 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t 68.14 -35.97 0.3 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.965 1.711 . . . . 0.0 114.769 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 44.4 mm -35.37 -45.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 128.68 2.792 . . . . 0.0 113.357 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -103.07 -34.65 8.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.844 1.257 . . . . 0.0 112.844 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 51.3 t -47.17 -51.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 119.751 1.16 . . . . 0.0 111.719 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.01 -42.29 99.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.597 . . . . 0.0 112.519 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -55.07 -37.19 66.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.014 1.325 . . . . 0.0 113.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.23 -57.01 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.873 1.269 . . . . 0.0 111.2 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.58 -37.36 27.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.644 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -46.94 -43.31 18.95 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.844 1.202 . . . . 0.0 112.239 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.89 -50.92 8.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.065 . . . . 0.0 113.08 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.29 -43.71 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 118.837 0.744 . . . . 0.0 112.912 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -126.4 69.06 68.31 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.06 1.744 . . . . 0.0 110.449 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -58.14 -21.42 51.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.798 2.998 . . . . 0.0 114.015 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.19 -10.37 59.4 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.678 1.991 . . . . 0.0 113.991 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -111.45 120.34 41.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.064 1.346 . . . . 0.0 111.948 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.47 168.46 42.15 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.436 1.493 . . . . 0.0 113.923 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 56.9 mt -133.59 132.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.322 1.449 . . . . 0.0 108.694 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 31.0 p -73.94 156.33 37.73 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 51.2 p -55.66 -38.19 69.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.3 -0.875 . . . . 0.0 112.293 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.99 -44.66 84.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.66 1.184 . . . . 0.0 112.452 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.73 88.28 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.917 0.887 . . . . 0.0 111.906 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.3 mtm -59.36 -46.13 89.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.747 -0.595 . . . . 0.0 111.073 171.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.67 58.38 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.961 1.267 . . . . 0.0 114.81 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.04 -35.63 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.202 1.501 . . . . 0.0 111.977 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 78.1 mtm -62.83 -36.64 83.85 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.297 -0.877 . . . . 0.0 112.841 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.37 -46.05 91.8 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 110.527 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -53.89 -47.46 71.11 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.491 0.716 . . . . 0.0 111.973 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -52.03 -37.59 54.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.01 -51.15 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.559 1.527 . . . . 0.0 111.137 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.99 -45.1 95.1 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.179 0.592 . . . . 0.0 111.583 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -56.37 -47.84 78.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.1 -45.84 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.178 0.899 . . . . 0.0 110.02 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.49 -50.75 67.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.943 0.792 . . . . 0.0 111.948 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.56 -44.87 95.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.039 0.936 . . . . 0.0 112.72 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -60.19 -49.72 76.52 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.79 0.723 . . . . 0.0 111.866 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.25 -51.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.163 0.985 . . . . 0.0 110.785 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.46 72.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.111 0.964 . . . . 0.0 112.343 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.82 50.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.517 1.055 . . . . 0.0 113.685 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.28 -45.21 94.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.217 1.009 . . . . 0.0 112.38 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.62 80.7 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.948 0.795 . . . . 0.0 111.796 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 68.4 m -58.27 -52.43 65.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.556 0.742 . . . . 0.0 112.252 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -59.13 -37.9 78.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.971 0.908 . . . . 0.0 113.241 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.22 -42.97 87.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 112.096 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.98 88.5 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.801 0.728 . . . . 0.0 111.972 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -59.38 -45.4 91.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 112.532 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -56.89 -43.04 80.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.671 1.188 . . . . 0.0 112.359 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -79.56 6.7 9.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.446 1.099 . . . . 0.0 113.943 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 54.0 43.18 31.16 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.153 2.181 . . . . 0.0 114.114 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.09 152.02 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.087 1.355 . . . . 0.0 112.434 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 33.1 p -77.88 -45.39 24.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 111.706 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 28.2 m -61.56 117.05 5.25 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.996 1.318 . . . . 0.0 111.746 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -74.17 129.11 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.347 1.459 . . . . 0.0 108.959 163.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -96.41 159.7 14.8 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 38.6 p -57.4 -39.24 75.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.944 0.898 . . . . 0.0 112.387 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.31 -42.23 96.45 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.673 1.189 . . . . 0.0 112.391 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.506 -0.746 . . . . 0.0 111.839 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.56 -42.83 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.38 -0.825 . . . . 0.0 111.12 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.31 -39.15 82.16 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.806 -1.184 . . . . 0.0 112.236 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 81.6 m -64.82 -45.11 87.59 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.918 -1.114 . . . . 0.0 111.964 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.33 -44.14 75.62 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.824 1.193 . . . . 0.0 111.799 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.47 -55.0 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.402 1.081 . . . . 0.0 111.353 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -52.97 -47.27 68.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 120.081 1.31 . . . . 0.0 112.333 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.98 -51.58 67.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.746 1.218 . . . . 0.0 112.577 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.38 -31.15 23.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -170.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 42.5 mt -124.36 57.92 15.24 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 126.401 1.88 . . . . 0.0 111.097 -170.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.58 -26.88 61.56 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.299 2.666 . . . . 0.0 113.621 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.86 133.37 52.43 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.831 1.205 . . . . 0.0 113.209 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.61 -50.43 73.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.421 1.089 . . . . 0.0 112.844 -172.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 tt -58.47 -53.28 60.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.63 0.772 . . . . 0.0 110.154 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.71 63.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.067 0.849 . . . . 0.0 112.724 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.44 -51.83 57.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.54 1.136 . . . . 0.0 112.017 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -64.04 -43.03 96.79 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.366 0.666 . . . . 0.0 112.271 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.16 72.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 114.041 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.52 -43.08 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.495 1.498 . . . . 0.0 112.381 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -58.67 -52.04 67.37 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.712 1.142 . . . . 0.0 112.928 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.83 -31.64 72.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.66 0.784 . . . . 0.0 111.488 170.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.4 -41.2 79.6 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.925 1.25 . . . . 0.0 114.321 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 66.6 m -55.09 -43.64 74.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.313 1.557 . . . . 0.0 111.374 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -64.8 -42.52 94.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.947 0.899 . . . . 0.0 111.423 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.38 -46.39 80.1 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 112.313 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -52.59 -49.88 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.167 0.894 . . . . 0.0 110.823 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 34.7 m -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.133 0.879 . . . . 0.0 112.402 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.36 -20.23 64.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.416 1.087 . . . . 0.0 113.892 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -90.8 -45.6 8.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.862 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 77.6 p -63.68 -26.45 68.67 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.438 1.017 . . . . 0.0 113.414 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 85.8 p -70.55 -14.63 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.92 147.02 54.01 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.142 0.883 . . . . 0.0 112.59 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.957 1.303 . . . . 0.0 112.636 -178.889 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.45 -20.19 31.89 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.205 3.27 . . . . 0.0 114.824 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 81.37 162.92 30.0 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.546 1.069 . . . . 0.0 113.362 -171.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 52.7 ttm -62.09 126.79 28.56 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.121 0.969 . . . . 0.0 111.774 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p -77.43 -44.73 28.1 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.566 1.147 . . . . 0.0 112.573 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.69 173.33 21.97 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.687 1.137 . . . . 0.0 113.508 165.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.91 127.78 33.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.97 0.908 . . . . 0.0 111.432 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.28 130.99 51.81 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.536 1.065 . . . . 0.0 113.165 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.57 146.69 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.436 1.095 . . . . 0.0 112.36 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -74.63 -22.97 58.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.3 5.74 67.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.884 1.23 . . . . 0.0 115.264 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.8 -174.87 30.61 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.062 1.315 . . . . 0.0 114.183 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.1 144.48 57.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.656 1.182 . . . . 0.0 112.16 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.69 54.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.557 0.743 . . . . 0.0 111.567 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.99 141.47 54.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.782 0.833 . . . . 0.0 111.673 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.86 136.96 56.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.621 0.768 . . . . 0.0 112.241 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.77 143.65 55.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.078 0.951 . . . . 0.0 111.53 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.77 124.05 21.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.282 0.633 . . . . 0.0 110.927 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 135.89 55.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.836 0.854 . . . . 0.0 111.513 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -70.46 149.74 46.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.072 0.949 . . . . 0.0 112.134 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.97 141.52 52.98 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.529 0.732 . . . . 0.0 111.305 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 62.0 p -78.46 -20.48 50.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 113.546 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 60.7 p -67.28 160.8 26.34 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.354 1.461 . . . . 0.0 113.258 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -56.65 122.45 12.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.856 1.262 . . . . 0.0 112.093 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.15 142.25 43.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.013 0.925 . . . . 0.0 111.661 171.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.97 -178.16 48.18 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 123.639 0.637 . . . . 0.0 114.412 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 mt -78.72 161.57 26.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.011 1.324 . . . . 0.0 112.554 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -81.22 89.19 6.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 109.939 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.8 154.59 80.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.843 0.857 . . . . 0.0 111.169 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.23 147.54 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.026 2.484 . . . . 0.0 111.791 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 t 64.09 -25.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 126.615 1.966 . . . . 0.0 115.172 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 -41.37 70.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 120.768 1.622 . . . . 0.0 113.853 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.74 -39.85 94.33 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.164 -1.198 . . . . 0.0 112.435 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.05 -43.38 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.278 0.631 . . . . 0.0 110.243 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.28 -42.15 98.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.48 -47.62 83.47 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.324 -0.86 . . . . 0.0 111.958 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.15 -40.11 96.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.092 0.957 . . . . 0.0 112.695 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.73 -47.32 82.78 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.629 1.572 . . . . 0.0 111.114 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -66.08 -43.5 87.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.064 0.946 . . . . 0.0 113.311 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.77 -43.91 63.17 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.937 1.295 . . . . 0.0 111.832 172.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.58 0.16 14.76 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.591 1.567 . . . . 0.0 116.447 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 50.71 39.07 20.96 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.472 1.909 . . . . 0.0 113.207 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -53.07 -49.81 65.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.7 t -126.12 150.46 48.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.955 1.302 . . . . 0.0 111.502 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -81.18 -16.86 51.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.286 1.035 . . . . 0.0 113.077 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -136.52 124.4 22.69 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.628 1.571 . . . . 0.0 110.838 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.96 109.35 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.737 1.215 . . . . 0.0 109.964 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.8 156.35 53.23 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.817 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.78 64.37 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.42 83.9 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.023 1.297 . . . . 0.0 115.895 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.14 82.16 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.686 1.743 . . . . 0.0 115.399 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.19 -39.48 90.13 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.649 2.232 . . . . 0.0 112.922 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.83 -48.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.057 1.343 . . . . 0.0 110.688 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -62.53 -44.4 96.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.76 -53.97 44.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.801 0.84 . . . . 0.0 110.802 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.26 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -53.81 53.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.759 0.823 . . . . 0.0 111.785 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.53 -40.45 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.079 0.952 . . . . 0.0 112.694 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.22 -18.51 58.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.032 1.333 . . . . 0.0 113.739 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -100.47 -29.94 12.1 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.002 1.321 . . . . 0.0 112.927 173.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -55.74 -54.99 37.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.532 1.133 . . . . 0.0 112.943 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -38.02 66.56 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.643 -0.661 . . . . 0.0 112.346 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 38.0 p -64.61 -29.51 70.52 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.567 -0.708 . . . . 0.0 112.846 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.9 65.32 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.701 0.8 . . . . 0.0 112.791 167.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -78.51 -41.63 31.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.56 -0.712 . . . . 0.0 112.379 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -53.97 -50.7 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.226 0.61 . . . . 0.0 110.561 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.73 -33.32 70.71 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.86 -53.0 63.17 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.989 0.813 . . . . 0.0 111.199 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.689 0.796 . . . . 0.0 112.159 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.77 84.59 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.104 -0.997 . . . . 0.0 112.909 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.14 -42.33 93.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.053 0.835 . . . . 0.0 112.659 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.46 -44.41 82.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.023 0.911 . . . . 0.0 111.927 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.59 82.05 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.371 0.987 . . . . 0.0 112.018 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.96 79.56 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.204 1.002 . . . . 0.0 112.58 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.88 -48.59 69.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.32 -32.93 67.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -91.84 6.12 47.34 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.029 1.332 . . . . 0.0 112.629 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.26 32.8 16.86 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.307 2.243 . . . . 0.0 114.252 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -99.68 152.18 20.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.295 1.438 . . . . 0.0 113.041 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -102.02 -6.66 23.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.655 1.582 . . . . 0.0 113.881 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -128.11 129.95 47.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.666 1.587 . . . . 0.0 110.877 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.16 124.69 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.465 1.506 . . . . 0.0 109.721 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.6 pt -117.18 168.16 9.52 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 125.912 1.685 . . . . 0.0 111.34 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.67 -37.07 63.45 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.385 2.723 . . . . 0.0 115.294 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.72 -38.57 88.36 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.314 -0.866 . . . . 0.0 112.797 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -65.59 -39.64 91.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.4 -0.812 . . . . 0.0 112.034 172.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.49 -44.85 93.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.593 0.757 . . . . 0.0 112.045 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.28 -50.13 73.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.898 0.879 . . . . 0.0 111.692 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.7 mt -58.07 -45.33 87.29 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.712 0.805 . . . . 0.0 112.349 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.37 -51.86 61.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.161 0.984 . . . . 0.0 112.129 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.26 -39.97 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -55.28 -42.87 74.16 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.957 -1.089 . . . . 0.0 112.385 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -86.16 -8.08 58.1 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -129.19 116.92 19.92 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.653 1.115 . . . . 0.0 112.409 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -67.53 -35.4 79.01 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -64.92 -42.08 95.02 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.194 0.906 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -51.87 -48.5 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.156 168.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -67.6 -14.62 63.1 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -84.34 -40.65 17.65 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.502 1.046 . . . . 0.0 111.324 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.95 -53.28 11.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.983 1.313 . . . . 0.0 112.019 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.11 94.71 9.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.109 2.163 . . . . 0.0 107.957 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 43.94 0.59 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-O 119.24 -0.756 . . . . 0.0 114.463 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -124.58 7.33 8.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.087 1.355 . . . . 0.0 113.694 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.12 125.97 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.97 1.308 . . . . 0.0 108.85 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 27.3 m -61.92 125.83 25.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.701 0.801 . . . . 0.0 111.457 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 79.4 mt -79.27 118.24 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.771 0.829 . . . . 0.0 109.464 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.56 148.08 33.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.111 0.964 . . . . 0.0 112.659 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -77.56 160.24 28.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.86 . . . . 0.0 112.54 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.19 82.92 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.446 1.022 . . . . 0.0 115.135 -172.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.74 163.77 32.14 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.743 1.163 . . . . 0.0 113.634 169.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.53 147.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.919 0.887 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.79 151.33 96.88 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.048 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.84 128.97 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.878 2.386 . . . . 0.0 112.567 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.97 138.0 55.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.151 0.58 . . . . 0.0 110.423 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 65.9 mt -75.6 114.7 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -119.26 146.98 44.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 110.378 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.7 137.68 58.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.731 0.412 . . . . 0.0 110.697 167.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.1 t -71.1 107.18 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.32 111.23 12.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.522 0.729 . . . . 0.0 110.423 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.59 144.43 45.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.953 . . . . 0.0 111.02 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -59.14 148.64 84.79 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.786 2.324 . . . . 0.0 111.729 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.26 70.31 4.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.192 0.997 . . . . 0.0 111.341 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.7 135.76 56.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.179 1.392 . . . . 0.0 110.964 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 31.2 p -69.2 154.04 42.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.855 0.862 . . . . 0.0 112.137 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.7 128.93 39.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.331 1.052 . . . . 0.0 111.707 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 55.9 p -84.88 -9.07 58.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -122.49 142.77 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.236 1.414 . . . . 0.0 111.813 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -55.51 -38.94 69.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.724 1.21 . . . . 0.0 113.125 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.14 -30.35 66.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.579 1.151 . . . . 0.0 113.554 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.43 60.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.145 0.978 . . . . 0.0 112.532 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.98 123.93 15.13 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.316 1.046 . . . . 0.0 111.815 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.66 150.93 51.85 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.497 1.046 . . . . 0.0 113.552 173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.656 1.183 . . . . 0.0 112.179 173.684 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.888 0 CA-C-O 118.648 -1.085 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -65.62 168.27 15.28 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.887 3.058 . . . . 0.0 112.98 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.88 -2.16 51.11 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.93 1.252 . . . . 0.0 115.528 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 27.8 ptm -134.16 154.84 80.3 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 110.25 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.29 137.54 82.12 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.796 2.33 . . . . 0.0 112.515 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -67.43 157.82 84.33 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.791 0.836 . . . . 0.0 111.631 172.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -56.5 -32.4 89.38 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.899 2.4 . . . . 0.0 114.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.67 58.8 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -90.49 118.9 30.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.138 1.375 . . . . 0.0 110.441 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 35.3 p -67.8 149.93 49.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.065 0.946 . . . . 0.0 112.522 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 148.25 91.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.564 172.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.31 124.8 16.94 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.201 2.601 . . . . 0.0 113.089 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.25 138.71 94.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.407 0.683 . . . . 0.0 112.291 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.59 137.36 63.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.213 2.609 . . . . 0.0 112.223 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -112.22 153.12 27.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.749 1.619 . . . . 0.0 111.265 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -63.28 133.79 54.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.076 0.95 . . . . 0.0 111.687 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.69 -165.59 28.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.635 1.588 . . . . 0.0 112.582 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 18.9 t -72.33 129.94 39.58 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.394 0.677 . . . . 0.0 111.77 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.5 125.19 25.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.49 1.116 . . . . 0.0 111.22 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.57 136.58 56.55 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.046 0.939 . . . . 0.0 111.368 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.16 140.78 58.81 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.157 0.583 . . . . 0.0 111.536 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.99 114.7 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.233 0.613 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 29.1 p -75.52 144.65 41.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.181 0.993 . . . . 0.0 112.698 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.59 148.51 23.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.036 1.334 . . . . 0.0 110.528 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 112.16 1.78 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.657 0.783 . . . . 0.0 112.017 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -81.68 165.27 21.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.608 1.163 . . . . 0.0 111.797 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.58 123.09 16.35 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.66 -0.65 . . . . 0.0 109.578 163.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.6 122.15 12.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.847 1.259 . . . . 0.0 111.835 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.84 143.38 45.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.7 0.8 . . . . 0.0 112.051 170.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.97 9.52 59.97 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.5 126.26 26.71 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.845 1.322 . . . . 0.0 110.918 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -138.48 124.57 20.18 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.385 1.474 . . . . 0.0 110.516 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.11 -44.53 79.72 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.228 1.011 . . . . 0.0 112.244 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.12 108.38 4.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.415 1.086 . . . . 0.0 109.968 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.14 127.65 32.38 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.865 0.866 . . . . 0.0 110.639 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 52.3 p -67.82 156.71 36.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.789 0.835 . . . . 0.0 111.737 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -60.32 119.96 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.617 -0.677 . . . . 0.0 110.094 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.92 130.29 45.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.938 0.895 . . . . 0.0 110.543 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -60.4 123.84 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.335 1.054 . . . . 0.0 111.62 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -85.93 16.25 4.3 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.13 179.5 1.17 Allowed 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.261 -0.899 . . . . 0.0 112.378 165.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t 67.75 -29.49 0.15 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.491 1.916 . . . . 0.0 114.932 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.7 -26.25 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.59 1.956 . . . . 0.0 114.343 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -55.15 -34.21 63.59 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.199 -0.938 . . . . 0.0 112.154 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t -56.18 -48.23 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.916 0.886 . . . . 0.0 110.8 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.1 -42.68 88.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.824 0.85 . . . . 0.0 112.622 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.08 -45.93 86.31 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.382 -0.824 . . . . 0.0 112.33 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.69 -45.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.469 0.708 . . . . 0.0 110.814 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -53.46 -47.85 69.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.422 1.01 . . . . 0.0 112.73 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -53.35 -41.09 65.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 0.0 112.884 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -76.37 -41.23 48.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.378 1.071 . . . . 0.0 112.821 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.37 -55.36 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.207 1.403 . . . . 0.0 112.732 -168.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -149.52 71.04 9.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.574 1.15 . . . . 0.0 111.47 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.03 -20.28 67.47 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.368 2.712 . . . . 0.0 114.666 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.73 -25.62 68.28 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -119.74 126.12 50.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.9 1.28 . . . . 0.0 109.591 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.98 -172.22 25.93 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.06 0.838 . . . . 0.0 113.489 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -140.18 155.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.948 -1.325 . . . . 0.0 111.689 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 42.0 p -89.35 157.04 18.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.683 0.793 . . . . 0.0 113.039 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.969 . . . . 0.0 112.402 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.07 -48.52 81.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.24 1.016 . . . . 0.0 111.373 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.4 94.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 112.73 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.6 mtp -55.11 -46.22 75.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.023 0.829 . . . . 0.0 111.316 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.76 -46.44 67.36 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.313 0.959 . . . . 0.0 114.245 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.07 -45.5 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 118.086 0.943 . . . . 0.0 111.41 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 85.4 mtp -60.37 -36.23 77.58 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.084 -1.01 . . . . 0.0 113.205 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -60.06 -41.3 92.08 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.92 0.782 . . . . 0.0 110.966 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 50.8 m -60.27 -50.17 74.71 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.302 -0.873 . . . . 0.0 112.13 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -52.03 -47.04 65.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.661 0.784 . . . . 0.0 112.683 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.82 -27.34 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.47 -34.18 72.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.378 0.99 . . . . 0.0 111.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.25 -48.01 71.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.83 -42.01 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 119.493 1.042 . . . . 0.0 111.004 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -56.93 -42.74 80.57 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.392 0.996 . . . . 0.0 111.655 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.29 -41.76 98.78 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -62.64 -45.91 90.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.454 1.025 . . . . 0.0 112.726 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.67 -53.49 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.973 0.909 . . . . 0.0 110.538 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.0 87.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.752 0.821 . . . . 0.0 112.368 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.44 59.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.647 1.118 . . . . 0.0 113.69 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -64.11 -41.04 97.4 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.345 -1.091 . . . . 0.0 111.95 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.78 94.9 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.095 -1.003 . . . . 0.0 112.149 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.6 t -60.78 -46.96 88.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.73 1.212 . . . . 0.0 111.726 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -57.37 -46.01 83.81 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.146 -0.971 . . . . 0.0 112.285 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.78 -45.33 86.13 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.508 0.723 . . . . 0.0 111.863 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.84 80.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.811 0.732 . . . . 0.0 112.22 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -58.29 -49.68 76.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.354 0.979 . . . . 0.0 112.256 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -56.53 -38.37 71.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.88 0.764 . . . . 0.0 112.504 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.64 2.8 31.63 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.931 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.45 35.08 22.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.11 2.164 . . . . 0.0 114.343 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -104.33 145.44 30.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.374 1.87 . . . . 0.0 112.249 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 27.2 p -84.32 -51.88 6.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.152 1.381 . . . . 0.0 111.487 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 60.0 m -82.05 127.35 33.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.042 1.337 . . . . 0.0 111.618 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.09 133.89 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.682 1.193 . . . . 0.0 110.971 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 9.4 p -90.93 160.7 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -50.53 -45.77 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 112.666 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.76 -44.96 88.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.199 1.0 . . . . 0.0 111.63 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -59.14 -40.59 85.97 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.625 0.77 . . . . 0.0 112.272 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.73 -52.83 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.066 0.848 . . . . 0.0 110.969 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -57.65 -42.28 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.954 0.797 . . . . 0.0 112.575 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 92.3 m -64.26 -46.27 84.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.153 0.981 . . . . 0.0 111.247 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.4 81.31 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.139 1.336 . . . . 0.0 113.183 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.8 -51.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.873 0.869 . . . . 0.0 110.664 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.39 -27.69 67.3 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 77.1 mt -64.46 -37.79 88.77 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.451 1.023 . . . . 0.0 111.93 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 50.4 mt -79.37 -29.66 42.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.14 68.19 3.44 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.331 1.852 . . . . 0.0 111.39 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.62 -26.65 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.298 2.665 . . . . 0.0 114.716 -172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 138.54 47.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.618 1.104 . . . . 0.0 113.7 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -49.69 -55.09 15.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.826 1.25 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.06 -37.87 84.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.362 0.665 . . . . 0.0 112.472 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.94 80.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.46 0.704 . . . . 0.0 111.668 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -55.61 -49.24 73.32 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.198 0.999 . . . . 0.0 111.57 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -55.94 -57.36 12.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.37 76.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.469 1.108 . . . . 0.0 112.975 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.63 -32.27 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.499 -0.75 . . . . 0.0 112.688 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -67.98 -40.42 83.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.429 0.691 . . . . 0.0 112.237 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.4 -36.6 76.12 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.105 -0.997 . . . . 0.0 111.47 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -43.97 90.33 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.336 0.969 . . . . 0.0 113.965 168.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -58.03 -50.62 72.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.786 1.293 . . . . 0.0 110.98 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.05 -44.81 75.07 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.216 0.606 . . . . 0.0 111.789 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.91 65.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.798 0.839 . . . . 0.0 112.641 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.72 -34.68 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 119.709 1.14 . . . . 0.0 113.352 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 96.4 m -62.79 -37.37 86.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 119.082 0.855 . . . . 0.0 112.196 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.17 -43.6 91.21 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.996 -1.065 . . . . 0.0 111.853 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -58.88 -32.52 69.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -78.74 -7.67 57.99 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t -65.83 130.65 44.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.262 0.937 . . . . 0.0 112.122 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.77 140.85 30.12 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.262 1.025 . . . . 0.0 112.266 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.94 1.296 . . . . 0.0 112.343 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.932 0 CA-C-O 118.946 -0.919 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -56.67 131.43 45.57 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.068 3.179 . . . . 0.0 114.052 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -78.58 -171.99 40.26 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.564 1.078 . . . . 0.0 113.986 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.3 137.54 57.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.557 0.743 . . . . 0.0 111.734 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 34.8 p -71.06 149.02 46.95 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.986 0.914 . . . . 0.0 112.788 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.99 -149.17 19.77 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.197 0.903 . . . . 0.0 112.877 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.48 78.13 7.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.736 1.214 . . . . 0.0 110.69 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.43 10.18 74.61 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 125.155 1.36 . . . . 0.0 115.141 -169.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.24 120.44 32.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -122.51 109.14 13.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.638 1.575 . . . . 0.0 109.381 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.52 49.61 68.31 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.386 0.517 . . . . 0.0 112.266 -167.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.07 -173.08 48.9 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.697 1.141 . . . . 0.0 113.009 -163.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -71.35 120.44 16.93 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.31 -1.112 . . . . 0.0 110.282 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.92 132.81 50.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.434 0.694 . . . . 0.0 111.36 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -62.08 128.86 38.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.941 0.896 . . . . 0.0 110.859 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.41 120.32 12.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.356 0.662 . . . . 0.0 110.871 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.85 0.86 . . . . 0.0 111.232 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 122.63 16.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.25 0.62 . . . . 0.0 110.846 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.88 135.33 55.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.691 0.796 . . . . 0.0 111.274 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.3 p -67.82 161.78 25.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.033 0.933 . . . . 0.0 111.647 171.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.04 106.52 0.85 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.664 0.786 . . . . 0.0 110.731 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 65.8 p -82.76 -26.15 32.14 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.947 1.299 . . . . 0.0 113.35 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 28.3 t -59.78 119.57 7.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.148 0.979 . . . . 0.0 110.854 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -71.05 120.49 16.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.249 1.02 . . . . 0.0 110.987 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 144.18 56.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 112.483 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 179.39 29.29 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.979 1.276 . . . . 0.0 112.984 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.62 139.07 51.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.551 0.74 . . . . 0.0 112.041 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -89.98 139.44 30.6 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.784 0.834 . . . . 0.0 110.202 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -123.69 153.59 66.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.539 1.136 . . . . 0.0 111.155 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.79 -41.0 56.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.026 3.15 . . . . 0.0 114.416 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.27 -33.44 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.122 0.969 . . . . 0.0 113.275 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.73 89.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 113.36 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.85 -50.01 70.55 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.359 1.08 . . . . 0.0 111.921 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.37 -36.35 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 O-C-N 121.899 -0.501 . . . . 0.0 112.263 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -56.85 -53.25 60.01 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.831 1.252 . . . . 0.0 112.119 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -61.52 -42.12 98.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.593 1.157 . . . . 0.0 113.066 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.45 -47.84 78.29 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.871 0.76 . . . . 0.0 111.943 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 56.3 tp -62.06 -47.08 86.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.141 0.882 . . . . 0.0 112.054 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -54.74 -50.14 69.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.533 1.133 . . . . 0.0 112.652 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.79 -36.97 73.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.645 1.178 . . . . 0.0 112.693 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.36 76.49 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.581 1.086 . . . . 0.0 113.941 171.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.0 t30 54.88 35.61 24.76 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.194 1.798 . . . . 0.0 113.512 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.13 -25.91 61.91 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 61.0 p -127.7 161.95 27.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.005 1.722 . . . . 0.0 112.601 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.29 -46.31 87.33 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.11 0.964 . . . . 0.0 112.849 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -114.07 130.79 56.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.863 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.91 97.36 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.5 1.12 . . . . 0.0 109.706 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.22 147.05 43.68 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.247 0.927 . . . . 0.0 112.983 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.29 -58.95 2.96 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.753 0.821 . . . . 0.0 113.059 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.86 88.4 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.11 -59.61 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 119.483 1.642 . . . . 0.0 113.938 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.03 -33.64 98.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.539 2.159 . . . . 0.0 113.058 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.76 -42.67 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.21 1.368 . . . . 0.0 111.584 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -77.22 -38.87 50.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.869 -1.144 . . . . 0.0 113.602 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.91 -43.62 73.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.92 1.236 . . . . 0.0 110.581 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.92 91.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.943 0.897 . . . . 0.0 112.787 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.671 ' HA ' ' H ' ' D' ' 36' ' ' SER . . . -55.78 -42.94 76.28 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.293 1.406 . . . . 0.0 112.667 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -60.14 -53.39 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.574 0.625 . . . . 0.0 111.39 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.11 -21.59 65.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -48.85 -49.06 41.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.644 1.111 . . . . 0.0 112.062 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -64.03 -29.56 70.7 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -73.59 -51.42 16.95 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.983 0.913 . . . . 0.0 111.659 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 67.8 p -70.88 -21.42 62.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.972 -1.08 . . . . 0.0 113.372 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.55 94.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.244 1.018 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -38.63 91.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.242 0.928 . . . . 0.0 111.768 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mt -56.47 -52.66 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 118.809 0.731 . . . . 0.0 110.148 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.39 -30.04 70.81 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.21 -53.85 42.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.805 1.184 . . . . 0.0 111.165 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.62 -41.51 99.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.856 0.863 . . . . 0.0 111.995 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.38 87.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.317 1.047 . . . . 0.0 111.858 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.75 97.73 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.766 1.175 . . . . 0.0 112.935 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.18 -44.36 95.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.435 1.117 . . . . 0.0 111.253 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.226 -0.921 . . . . 0.0 112.462 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.22 82.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.402 1.081 . . . . 0.0 112.011 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.68 -50.33 63.49 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 0.0 112.21 171.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -58.16 -36.0 72.38 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -87.05 3.34 46.46 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.797 1.239 . . . . 0.0 113.441 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 92.3 mttt 55.64 32.91 20.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.844 2.058 . . . . 0.0 114.257 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.6 152.79 22.01 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.907 1.683 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 30.4 p -109.41 12.17 24.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.014 1.726 . . . . 0.0 112.905 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -133.54 126.65 31.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.472 -1.393 . . . . 0.0 111.268 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.6 127.52 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.027 0.931 . . . . 0.0 109.19 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.04 167.13 13.83 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.987 1.715 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -44.49 -42.71 14.16 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.241 3.294 . . . . 0.0 115.465 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.87 -40.69 93.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.749 0.82 . . . . 0.0 112.887 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -65.66 -41.56 92.38 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.621 0.768 . . . . 0.0 111.904 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.57 -43.9 95.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.41 0.684 . . . . 0.0 111.618 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -56.69 -50.29 72.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.426 1.09 . . . . 0.0 111.713 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.79 -46.85 81.29 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.736 0.698 . . . . 0.0 111.978 173.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.79 62.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.596 0.758 . . . . 0.0 112.593 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 pt -68.34 -30.84 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -65.78 -41.89 91.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.774 1.229 . . . . 0.0 112.388 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -79.57 -7.55 58.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -171.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -124.1 122.0 36.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.952 1.251 . . . . 0.0 111.361 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -53.33 -41.61 65.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.42 1.088 . . . . 0.0 112.516 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -64.08 -29.49 70.63 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.286 -0.883 . . . . 0.0 113.358 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.57 -43.83 30.52 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.607 -0.683 . . . . 0.0 111.306 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -53.93 -45.55 71.27 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.91 0.884 . . . . 0.0 112.261 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.39 -26.5 53.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.086 1.354 . . . . 0.0 113.915 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -91.12 -97.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.088 1.355 . . . . 0.0 110.276 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.13 112.63 7.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.852 1.205 . . . . 0.0 110.617 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.71 -29.73 3.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.991 1.281 . . . . 0.0 113.258 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -66.65 -46.52 75.49 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.088 0.955 . . . . 0.0 111.669 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.93 131.02 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.45 1.1 . . . . 0.0 110.07 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 41.9 m -71.64 109.47 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.548 0.739 . . . . 0.0 109.703 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.3 119.68 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.256 0.622 . . . . 0.0 109.723 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.54 69.42 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.634 0.774 . . . . 0.0 112.589 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -71.3 158.51 36.24 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.222 1.009 . . . . 0.0 112.591 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.81 1.32 61.92 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.332 0.968 . . . . 0.0 115.277 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.83 -179.0 19.31 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.484 1.142 . . . . 0.0 113.323 165.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.57 110.19 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.675 -0.897 . . . . 0.0 110.248 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.93 150.88 92.9 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.826 0.85 . . . . 0.0 111.132 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.47 135.14 67.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.118 2.545 . . . . 0.0 113.168 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.79 91.54 5.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.85 0.86 . . . . 0.0 111.288 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 43.2 pt -62.03 143.31 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.855 0.862 . . . . 0.0 112.939 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -93.26 -20.28 20.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.958 0.903 . . . . 0.0 112.56 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.63 159.02 19.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 0.0 111.967 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.59 122.22 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.594 -0.691 . . . . 0.0 110.016 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -71.76 106.39 4.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.138 0.575 . . . . 0.0 109.593 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.59 140.43 97.51 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.135 0.574 . . . . 0.0 110.98 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -59.29 144.84 99.26 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.607 2.205 . . . . 0.0 111.407 172.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.72 124.21 17.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.301 0.64 . . . . 0.0 110.062 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.45 119.69 7.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.976 0.91 . . . . 0.0 110.004 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -57.14 123.03 13.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.215 1.006 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.17 111.51 5.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 23.4 t -123.13 118.34 27.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.148 1.379 . . . . 0.0 109.73 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -84.57 128.65 34.71 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.689 0.795 . . . . 0.0 110.786 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -74.71 134.82 41.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.702 0.801 . . . . 0.0 111.728 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -99.4 146.49 26.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.024 1.33 . . . . 0.0 111.144 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.04 140.84 58.91 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.418 0.687 . . . . 0.0 111.821 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.87 128.19 34.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.047 0.939 . . . . 0.0 111.409 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.88 132.15 46.3 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.303 0.954 . . . . 0.0 112.835 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 125.532 1.533 . . . . 0.0 112.764 178.729 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.846 0 CA-C-O 119.901 -0.388 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.76 -1.13 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.235 3.29 . . . . 0.0 114.944 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.18 13.57 81.16 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.356 0.979 . . . . 0.0 114.968 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.8 mmm -89.97 158.16 44.86 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.469 1.508 . . . . 0.0 111.49 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.48 124.24 15.4 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.06 2.507 . . . . 0.0 112.074 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -80.21 125.68 80.89 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.85 0.86 . . . . 0.0 110.985 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.69 -35.65 98.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.121 2.547 . . . . 0.0 114.646 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.42 -11.13 59.92 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.65 120.11 26.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 110.78 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 49.3 p -74.3 -41.29 61.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.454 1.101 . . . . 0.0 112.886 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.45 144.51 97.63 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.233 1.013 . . . . 0.0 112.362 173.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -60.24 150.21 81.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.137 2.558 . . . . 0.0 112.36 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.3 149.99 93.6 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.015 0.526 . . . . 0.0 112.053 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.92 134.12 60.37 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.07 2.514 . . . . 0.0 113.554 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.55 106.7 14.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.976 0.91 . . . . 0.0 109.995 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -104.67 16.53 25.86 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.693 1.597 . . . . 0.0 113.43 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.2 12.74 69.37 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.005 1.288 . . . . 0.0 114.863 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 40.1 p -74.47 155.06 38.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.42 1.488 . . . . 0.0 112.949 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.66 134.57 47.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.885 0.874 . . . . 0.0 110.969 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.68 143.7 57.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.943 0.897 . . . . 0.0 111.427 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.05 138.89 58.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.261 0.624 . . . . 0.0 111.558 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.81 115.39 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.316 0.646 . . . . 0.0 109.543 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -73.92 157.76 35.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.592 1.157 . . . . 0.0 112.641 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.75 119.5 7.24 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.179 0.992 . . . . 0.0 111.125 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.54 119.78 9.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.505 0.722 . . . . 0.0 110.706 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -73.67 142.08 46.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.522 0.729 . . . . 0.0 111.502 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.92 142.32 58.35 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.633 0.773 . . . . 0.0 111.429 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.98 145.17 53.8 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.973 0.909 . . . . 0.0 111.111 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.02 124.29 22.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.92 0.39 . . . . 0.0 111.735 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.69 160.12 37.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.714 0.674 . . . . 0.0 112.32 166.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.63 109.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.808 0.843 . . . . 0.0 110.829 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.73 148.85 41.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.573 1.149 . . . . 0.0 110.279 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -62.14 102.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.413 0.685 . . . . 0.0 110.695 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.57 140.8 51.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.572 1.149 . . . . 0.0 109.371 171.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -67.53 107.32 2.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.204 0.602 . . . . 0.0 110.771 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 27.8 t -78.69 -49.54 12.96 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.565 0.746 . . . . 0.0 110.795 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -80.65 109.92 15.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.001 1.32 . . . . 0.0 110.437 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.47 133.13 51.28 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 110.025 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -137.25 132.34 33.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' SER . . . . . 0.671 ' H ' ' HA ' ' C' ' 53' ' ' ALA 0.371 5.0 m 78.88 142.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 131.417 3.887 . . . . 0.0 119.809 168.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 -9.15 42.17 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 119.126 3.01 . . . . 0.0 119.126 -137.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 38.3 t -163.19 -60.42 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -170.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -46.37 -51.46 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 127.109 2.164 . . . . 0.0 111.97 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.36 -41.39 10.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 p -51.31 -27.43 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 120.928 1.695 . . . . 0.0 114.627 -171.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -45.79 -34.68 3.84 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.746 1.618 . . . . 0.0 113.046 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -50.23 -33.93 21.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.497 -1.377 . . . . 0.0 114.086 171.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.5 -50.71 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.456 1.025 . . . . 0.0 110.454 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -51.87 66.76 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.876 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -51.0 -40.45 58.15 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -80.55 -50.29 10.21 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 113.179 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.44 -47.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.738 0.815 . . . . 0.0 111.937 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -131.24 84.9 55.53 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.598 1.559 . . . . 0.0 110.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.4 -31.26 76.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.571 2.847 . . . . 0.0 115.161 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -70.13 -19.51 63.22 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -94.59 133.16 38.53 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.855 1.262 . . . . 0.0 112.048 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.34 -172.49 13.22 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.731 1.158 . . . . 0.0 114.691 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -121.96 162.21 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.616 1.566 . . . . 0.0 110.284 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -89.45 163.58 15.2 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.958 168.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -55.84 -41.22 73.96 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.169 0.988 . . . . 0.0 111.845 168.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.43 -41.15 93.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.308 1.043 . . . . 0.0 112.176 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.32 92.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.763 0.825 . . . . 0.0 112.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 56.6 tpp -52.9 -48.26 67.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.005 168.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.55 -45.39 77.23 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.497 1.046 . . . . 0.0 114.729 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.72 -42.55 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.49 1.145 . . . . 0.0 112.011 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.73 -41.0 94.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.936 -1.102 . . . . 0.0 111.46 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -60.79 -47.3 86.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.848 0.859 . . . . 0.0 112.083 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 81.0 p -64.81 -39.63 93.91 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.572 1.533 . . . . 0.0 112.775 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -51.82 -55.83 17.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.93 1.292 . . . . 0.0 111.908 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.35 -31.2 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -60.94 -44.07 97.76 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.058 0.845 . . . . 0.0 112.04 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.49 -42.22 87.09 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.727 -0.608 . . . . 0.0 111.987 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.99 -43.28 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.34 -0.85 . . . . 0.0 111.466 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.36 -44.56 76.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.418 1.463 . . . . 0.0 112.501 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.717 0.69 . . . . 0.0 111.743 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -61.68 -43.76 98.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.775 0.83 . . . . 0.0 112.881 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -52.95 -52.8 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.555 1.142 . . . . 0.0 110.132 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.36 90.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.28 -50.85 61.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.892 0.758 . . . . 0.0 113.235 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -64.17 -41.45 97.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.604 -0.939 . . . . 0.0 112.156 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.15 94.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.419 1.009 . . . . 0.0 112.007 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -57.8 -53.77 54.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.291 1.036 . . . . 0.0 111.866 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -51.88 -54.75 25.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.169 0.987 . . . . 0.0 112.025 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.62 -44.51 89.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.297 1.039 . . . . 0.0 112.705 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.39 79.35 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.967 0.803 . . . . 0.0 112.138 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -63.14 -45.33 92.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.776 0.83 . . . . 0.0 112.594 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -60.62 -35.94 77.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.076 0.95 . . . . 0.0 112.45 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -86.18 15.49 5.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.613 1.565 . . . . 0.0 113.215 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 55.3 29.04 12.2 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.547 2.339 . . . . 0.0 115.075 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -81.77 152.92 26.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.489 1.116 . . . . 0.0 112.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 53.9 p -71.13 -35.6 71.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.834 1.253 . . . . 0.0 112.824 170.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 7.2 t -143.73 167.39 22.4 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.39 1.476 . . . . 0.0 112.806 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 84.1 mt -71.45 138.19 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.51 1.524 . . . . 0.0 110.457 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 16.7 p -112.51 166.16 11.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.511 1.125 . . . . 0.0 111.814 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 31.7 p -51.56 -41.66 61.29 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.403 1.081 . . . . 0.0 112.67 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.51 -45.76 89.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.3 1.04 . . . . 0.0 111.932 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.87 -40.68 96.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.323 0.51 . . . . 0.0 112.276 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.5 -51.78 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.685 0.794 . . . . 0.0 110.963 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -53.2 -48.63 67.95 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.68 1.127 . . . . 0.0 111.852 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 77.1 m -60.49 -46.28 90.67 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.187 0.903 . . . . 0.0 112.16 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.29 72.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.475 1.034 . . . . 0.0 112.753 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -60.31 -50.92 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.005 0.922 . . . . 0.0 110.583 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -58.42 -39.52 80.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.493 1.117 . . . . 0.0 113.748 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 72.4 mt -58.08 -44.2 87.42 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.721 0.691 . . . . 0.0 112.212 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.11 -37.76 64.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.226 1.01 . . . . 0.0 112.139 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.34 80.04 20.71 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 126.565 1.946 . . . . 0.0 111.059 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -77.09 178.47 7.6 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 124.395 3.397 . . . . 0.0 114.359 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.45 41.35 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.102 1.334 . . . . 0.0 114.113 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.73 -34.74 69.83 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.24 -1.153 . . . . 0.0 112.021 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 45.2 mt -64.0 -28.86 70.1 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.441 -0.787 . . . . 0.0 112.328 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.13 69.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.467 1.03 . . . . 0.0 111.957 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.09 -44.81 91.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.21 1.004 . . . . 0.0 110.919 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -60.42 -48.72 80.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.911 0.484 . . . . 0.0 112.032 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.45 66.35 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.78 -49.35 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 118.539 0.609 . . . . 0.0 111.628 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -61.82 -57.23 12.63 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -63.99 -44.17 93.49 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.381 -0.825 . . . . 0.0 111.428 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.54 -35.36 66.36 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.631 -0.668 . . . . 0.0 113.457 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -71.75 -45.03 62.99 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.571 1.185 . . . . 0.0 111.769 172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -53.68 -38.79 64.56 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.923 1.238 . . . . 0.0 112.967 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.5 -54.9 30.5 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.365 0.666 . . . . 0.0 112.238 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.72 -43.92 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.447 1.099 . . . . 0.0 111.283 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 44.0 m -52.26 -47.53 65.76 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.396 0.998 . . . . 0.0 112.201 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -65.92 -15.94 63.42 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -90.25 -41.28 11.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.089 0.955 . . . . 0.0 112.541 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -70.09 -25.53 63.56 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.139 -0.975 . . . . 0.0 113.098 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 59.6 p -82.59 -8.49 59.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 171.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.02 165.15 22.44 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.982 0.913 . . . . 0.0 113.324 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.347 1.459 . . . . 0.0 113.175 179.13 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.02 142.76 48.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.884 0.754 . . . . 0.0 112.862 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.28 68.79 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.281 1.041 . . . . 0.0 113.513 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.98 -24.98 76.15 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.445 1.021 . . . . 0.0 114.982 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.22 -55.82 37.96 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.355 1.578 . . . . 0.0 114.36 -174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.83 -34.41 95.65 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.357 2.038 . . . . 0.0 113.068 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.69 -51.02 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.155 0.888 . . . . 0.0 110.91 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -66.78 -42.28 86.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.589 0.756 . . . . 0.0 110.118 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 69.7 mt -63.32 -35.16 79.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.932 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.21 93.21 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.508 1.504 . . . . 0.0 112.077 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.39 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.92 0.488 . . . . 0.0 111.864 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -51.57 -53.86 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.512 1.125 . . . . 0.0 111.393 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 mt -53.11 -49.1 67.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.718 1.607 . . . . 0.0 112.104 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -48.04 -51.63 23.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.49 1.041 . . . . 0.0 111.985 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -69.45 -31.99 70.65 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.53 -23.3 57.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 1.5 p -119.22 5.12 11.24 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.598 1.544 . . . . 0.0 114.867 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.65 73.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.165 1.348 . . . . 0.0 112.718 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -70.1 -32.96 71.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.8 -54.14 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.012 0.925 . . . . 0.0 109.667 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.92 -46.48 81.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.51 1.524 . . . . 0.0 112.551 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -54.71 -56.78 15.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.586 0.754 . . . . 0.0 111.514 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.43 -38.07 71.4 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.0 99.45 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.334 -0.854 . . . . 0.0 111.802 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.97 94.99 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.506 -0.746 . . . . 0.0 113.596 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -58.8 -49.89 76.01 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.848 1.324 . . . . 0.0 110.603 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.78 80.96 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.63 0.772 . . . . 0.0 112.509 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.1 75.36 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.817 0.847 . . . . 0.0 112.606 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -56.82 -50.95 70.84 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.436 1.094 . . . . 0.0 112.289 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -55.51 -42.01 73.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.613 1.165 . . . . 0.0 113.075 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.79 10.68 17.62 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.625 1.17 . . . . 0.0 113.089 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 53.63 33.32 16.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.392 2.277 . . . . 0.0 114.777 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -89.29 146.51 24.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.23 1.412 . . . . 0.0 112.386 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.6 p -77.91 -30.63 50.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.881 1.272 . . . . 0.0 112.967 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -131.24 151.76 51.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.126 1.37 . . . . 0.0 112.603 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.7 mt -67.46 129.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 0.0 109.928 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 pt -122.71 167.1 15.16 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.429 1.892 . . . . 0.0 111.265 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -54.55 -34.5 82.73 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.344 2.696 . . . . 0.0 114.952 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.03 -36.75 75.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.988 0.915 . . . . 0.0 113.252 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -63.23 -38.69 92.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.551 -0.718 . . . . 0.0 111.982 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.21 -46.27 71.05 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.502 0.721 . . . . 0.0 111.761 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -50.65 -46.64 58.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.725 0.81 . . . . 0.0 111.746 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.83 -62.31 1.73 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.944 0.898 . . . . 0.0 112.173 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.99 69.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.755 1.222 . . . . 0.0 113.074 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -56.87 -61.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.857 0.863 . . . . 0.0 110.741 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.0 -32.69 74.11 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -86.79 -8.59 57.21 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -129.3 118.1 21.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 112.407 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.78 -26.81 67.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.822 -1.173 . . . . 0.0 114.067 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -70.98 -31.36 67.89 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 111.489 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.75 -36.94 67.81 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 111.493 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.54 -29.38 66.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.406 1.003 . . . . 0.0 112.771 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -77.11 -46.0 25.01 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.417 1.008 . . . . 0.0 112.417 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 mt -57.18 -45.1 83.98 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.083 0.953 . . . . 0.0 112.877 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 123.763 0.825 . . . . 0.0 111.992 178.045 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.25 96.06 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.12 140.37 97.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.33 0.652 . . . . 0.0 110.789 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -58.66 149.52 76.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.44 2.093 . . . . 0.0 111.15 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.15 109.26 1.06 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.783 -0.573 . . . . 0.0 109.929 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.31 131.45 46.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.921 0.889 . . . . 0.0 110.387 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -63.34 155.57 28.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.275 0.63 . . . . 0.0 110.813 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.84 121.05 10.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.296 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -58.46 136.7 57.56 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.406 0.682 . . . . 0.0 111.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.8 100.39 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.102 0.561 . . . . 0.0 111.309 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 N--CA 1.469 0.492 0 C-N-CA 124.546 1.138 . . . . 0.0 111.409 174.477 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.92 -41.47 74.58 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.14 -58.34 8.34 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 0.0 112.223 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 51.6 t -71.97 -35.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.962 -0.461 . . . . 0.0 111.372 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 tp -50.15 -57.54 7.49 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.679 169.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.77 -34.21 77.65 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -63.72 -50.16 70.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.509 0.724 . . . . 0.0 112.546 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.37 -44.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.921 0.889 . . . . 0.0 111.966 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.41 66.05 61.02 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.52 1.928 . . . . 0.0 111.445 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -55.99 -25.88 56.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.016 3.144 . . . . 0.0 114.18 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.3 -14.21 59.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.521 2.328 . . . . 0.0 114.2 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -121.17 126.21 49.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.527 1.131 . . . . 0.0 111.741 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.68 -164.75 40.54 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.071 0.843 . . . . 0.0 113.667 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.9 tt -143.79 149.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.99 -1.3 . . . . 0.0 111.73 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -80.69 156.07 26.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -56.65 -39.25 73.37 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.243 -0.91 . . . . 0.0 112.128 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.98 -55.82 29.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.189 1.396 . . . . 0.0 111.57 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.95 -42.08 97.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.469 0.708 . . . . 0.0 112.558 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 53.9 ttp -54.59 -53.55 53.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.846 0.859 . . . . 0.0 111.681 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.4 85.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.786 0.708 . . . . 0.0 113.069 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.84 -48.33 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.161 0.984 . . . . 0.0 111.113 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 65.1 mtt -57.5 -41.64 81.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.984 1.265 . . . . 0.0 112.615 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.86 -52.06 67.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.432 0.56 . . . . 0.0 110.727 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 72.8 m -54.92 -47.57 74.23 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.12 0.873 . . . . 0.0 112.794 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -54.54 -46.89 73.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 112.02 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -44.1 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.513 0.597 . . . . 0.0 111.739 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.06 -41.98 84.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.356 0.98 . . . . 0.0 111.933 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -60.0 -31.14 69.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 tp -90.9 -34.1 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 111.707 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.13 -42.05 89.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.61 1.164 . . . . 0.0 112.46 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -56.82 -44.38 81.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.371 1.068 . . . . 0.0 111.925 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -64.93 -44.87 88.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.053 0.941 . . . . 0.0 111.76 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.52 -49.4 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.707 1.203 . . . . 0.0 110.986 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.37 81.96 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 112.359 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.87 -46.11 90.86 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.268 0.937 . . . . 0.0 113.594 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.6 -41.89 87.75 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.379 -1.071 . . . . 0.0 112.856 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.47 94.36 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.156 0.889 . . . . 0.0 111.53 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -57.69 -49.76 75.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.418 1.087 . . . . 0.0 111.928 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.74 -49.86 67.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.471 1.109 . . . . 0.0 112.039 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.9 -48.22 78.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.685 0.794 . . . . 0.0 111.733 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -44.97 73.92 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.766 0.712 . . . . 0.0 112.473 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -57.6 -52.21 66.37 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.898 . . . . 0.0 112.387 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -62.43 -32.75 73.65 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -81.16 4.8 18.83 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.908 1.283 . . . . 0.0 113.627 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 56.86 31.9 20.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.968 2.107 . . . . 0.0 114.275 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -101.08 140.97 34.64 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.6 1.56 . . . . 0.0 112.074 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 61.0 p -79.68 -19.63 48.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.844 1.258 . . . . 0.0 113.086 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 63.7 p -114.73 148.91 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.87 2.068 . . . . 0.0 111.651 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.75 129.32 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.202 1.001 . . . . 0.0 110.014 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 6.1 p -83.37 162.42 21.06 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.016 0.912 . . . . 0.0 113.31 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -65.78 -10.29 36.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 0.0 114.295 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.44 -40.97 8.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.17 1.388 . . . . 0.0 112.187 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.53 -39.97 74.3 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.118 0.967 . . . . 0.0 112.663 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -57.81 -41.32 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -61.86 -49.5 75.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.229 0.922 . . . . 0.0 110.376 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 45.2 m -60.81 -46.86 88.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.397 1.079 . . . . 0.0 111.833 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.2 -46.93 65.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.445 1.098 . . . . 0.0 112.525 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.5 -51.23 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.605 0.762 . . . . 0.0 111.008 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -53.96 -45.78 71.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.114 0.966 . . . . 0.0 112.598 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.92 -36.77 72.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.875 1.27 . . . . 0.0 112.962 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.81 -22.41 25.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.551 1.14 . . . . 0.0 113.787 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 CA--C 1.548 0.886 0 C-N-CA 124.736 1.214 . . . . 0.0 112.108 -172.743 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.59 -179.22 27.29 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.947 0.784 . . . . 0.0 113.48 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.46 -50.04 23.7 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.578 -0.954 . . . . 0.0 111.997 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.76 -26.69 55.76 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.71 1.148 . . . . 0.0 115.458 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.78 -52.33 73.13 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.77 -37.1 89.0 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.59 2.194 . . . . 0.0 112.914 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.77 -40.97 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.755 0.822 . . . . 0.0 110.827 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.69 -45.12 87.98 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.373 -0.83 . . . . 0.0 112.547 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.01 -40.45 89.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.647 1.112 . . . . 0.0 111.827 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.38 90.45 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.346 -0.846 . . . . 0.0 111.334 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.88 -18.64 57.44 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.52 -59.43 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.322 -0.861 . . . . 0.0 110.733 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.67 -21.27 64.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.299 1.04 . . . . 0.0 112.869 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -37.7 -49.3 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.594 1.958 . . . . 0.0 112.917 159.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -61.18 -50.24 73.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.917 0.78 . . . . 0.0 112.5 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.34 -48.4 81.77 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.621 . . . . 0.0 111.348 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 71.8 m -60.98 -41.18 95.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.665 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.04 83.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.323 0.965 . . . . 0.0 112.086 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -56.5 -46.44 80.5 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.048 0.84 . . . . 0.0 112.561 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 86.5 mt -57.66 -57.76 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.698 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.01 -30.81 69.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.3 -55.22 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.909 1.231 . . . . 0.0 111.192 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.21 -36.68 84.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.647 -0.658 . . . . 0.0 112.102 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.57 96.83 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.477 -0.765 . . . . 0.0 112.433 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.38 -40.03 95.53 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.179 0.895 . . . . 0.0 113.175 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -64.2 -44.56 91.57 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.726 -0.867 . . . . 0.0 111.271 172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -42.98 87.84 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.287 0.949 . . . . 0.0 112.435 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.43 79.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.717 0.807 . . . . 0.0 112.281 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -55.86 -48.14 76.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.386 1.074 . . . . 0.0 112.164 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.77 -39.34 77.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.174 0.989 . . . . 0.0 113.519 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.79 2.97 27.6 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 57.22 32.54 21.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.502 1.921 . . . . 0.0 113.811 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.97 146.27 28.59 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.817 1.647 . . . . 0.0 112.332 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -100.48 9.58 42.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.696 1.598 . . . . 0.0 113.492 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.51 136.22 44.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.831 -1.168 . . . . 0.0 111.304 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.72 131.09 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.029 0.932 . . . . 0.0 109.732 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.87 165.93 14.12 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 125.936 1.694 . . . . 0.0 111.807 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -46.13 -44.47 19.4 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.26 3.306 . . . . 0.0 115.586 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.776 0.83 . . . . 0.0 112.702 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.38 -44.5 95.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.848 0.859 . . . . 0.0 112.16 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.24 -42.07 96.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.92 0.888 . . . . 0.0 111.804 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.865 0.866 . . . . 0.0 111.788 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.03 -46.94 72.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.662 1.185 . . . . 0.0 112.064 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.96 -47.54 64.73 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 94.1 mt -65.46 -55.46 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.35 0.66 . . . . 0.0 110.944 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -54.95 -37.84 66.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.603 1.161 . . . . 0.0 113.506 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.87 0.43 54.96 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -125.02 127.16 46.55 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.752 1.16 . . . . 0.0 112.943 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -57.11 -51.35 69.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.021 0.929 . . . . 0.0 112.918 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -66.24 -34.12 77.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 112.2 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.28 -41.04 73.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.293 0.637 . . . . 0.0 112.575 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -58.88 -40.06 83.24 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.463 1.483 . . . . 0.0 111.88 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.69 -3.18 1.38 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.32 1.448 . . . . 0.0 114.879 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -76.15 -73.32 0.28 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.76 1.164 . . . . 0.0 110.147 167.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 123.715 0.806 . . . . 0.0 112.873 -173.339 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.21 114.0 6.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.061 1.344 . . . . 0.0 110.929 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 37.3 tp -64.61 127.9 92.91 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.143 0.977 . . . . 0.0 110.531 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.35 119.72 7.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.747 2.298 . . . . 0.0 112.09 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.05 138.05 40.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.047 0.939 . . . . 0.0 111.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.68 140.19 58.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.851 0.861 . . . . 0.0 111.496 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -73.33 150.95 41.48 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.068 0.947 . . . . 0.0 112.089 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -90.92 139.14 31.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 111.824 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -81.09 124.78 29.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.43 0.692 . . . . 0.0 110.827 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -108.97 6.37 25.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.73 1.212 . . . . 0.0 113.058 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 124.848 1.259 . . . . 0.0 112.274 172.613 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.031 0.443 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -62.31 -29.95 70.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.541 0.736 . . . . 0.0 112.573 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.04 -50.04 72.23 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.337 0.971 . . . . 0.0 111.568 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -52.47 -52.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 119.524 1.056 . . . . 0.0 110.202 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.94 -52.59 64.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.89 0.876 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.38 -35.02 73.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.779 1.232 . . . . 0.0 114.001 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.5 -42.03 59.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.272 0.942 . . . . 0.0 112.812 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -87.09 -61.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.318 1.047 . . . . 0.0 112.231 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -137.23 91.43 14.57 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.683 1.593 . . . . 0.0 110.57 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -56.36 -29.24 76.26 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.814 3.009 . . . . 0.0 115.173 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -84.35 -1.78 56.02 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.479 1.912 . . . . 0.0 113.951 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -111.28 137.63 48.77 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.259 1.424 . . . . 0.0 111.848 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.84 14.18 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.954 1.74 . . . . 0.0 113.233 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.64 141.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 110.207 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -73.99 155.79 38.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.653 -0.655 . . . . 0.0 112.72 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p -57.32 -37.24 72.21 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.288 -0.882 . . . . 0.0 112.005 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.34 -47.48 85.71 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.948 1.299 . . . . 0.0 111.998 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.32 94.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.832 0.853 . . . . 0.0 112.933 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.76 -39.09 87.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.473 1.033 . . . . 0.0 111.896 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -44.46 76.9 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.247 0.927 . . . . 0.0 113.167 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -68.58 -35.1 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.315 1.058 . . . . 0.0 112.531 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 38.3 tpp -57.95 -41.14 82.21 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.65 -1.282 . . . . 0.0 111.284 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -65.83 -35.34 80.41 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.045 -1.034 . . . . 0.0 112.216 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 47.7 m -58.55 -39.4 80.14 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.27 -1.519 . . . . 0.0 112.19 167.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.94 -33.51 76.2 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.628 -1.295 . . . . 0.0 113.134 172.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . 0.463 ' HA ' ' CD2' ' D' ' 70' ' ' PHE . 47.0 t -57.96 -52.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.45 1.023 . . . . 0.0 110.935 165.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -64.92 -32.46 74.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.856 0.863 . . . . 0.0 113.249 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.1 -63.82 1.22 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.219 1.408 . . . . 0.0 113.505 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 81.2 mt -68.15 -51.8 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.155 0.982 . . . . 0.0 111.196 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' D' ' 66' ' ' VAL . 9.1 m-30 -66.85 -35.98 81.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.547 -0.721 . . . . 0.0 111.051 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.12 -47.64 84.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.171 0.988 . . . . 0.0 112.62 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.28 -46.69 85.57 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.133 -0.98 . . . . 0.0 112.113 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.01 -44.15 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 118.762 0.71 . . . . 0.0 111.368 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.48 84.55 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.302 0.956 . . . . 0.0 112.392 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.17 -47.15 91.12 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.429 1.014 . . . . 0.0 113.547 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -64.83 -45.17 87.3 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.478 -1.013 . . . . 0.0 112.607 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.25 83.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.215 173.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -60.17 -53.12 61.5 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.254 1.022 . . . . 0.0 111.639 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -57.37 -42.06 81.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.33 -0.857 . . . . 0.0 112.811 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.86 -46.0 90.68 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.692 1.197 . . . . 0.0 112.012 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.98 96.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.91 0.884 . . . . 0.0 112.427 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -60.91 -40.66 94.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.387 1.075 . . . . 0.0 112.839 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -57.6 -37.96 74.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.615 0.766 . . . . 0.0 112.135 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -86.43 15.7 5.2 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.204 1.402 . . . . 0.0 113.737 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 52.25 28.05 5.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.466 2.306 . . . . 0.0 115.121 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -71.76 156.71 39.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.429 1.091 . . . . 0.0 112.805 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 63.7 p -80.52 -29.44 37.22 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.713 1.205 . . . . 0.0 113.068 165.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 5.7 t -141.96 168.73 19.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.578 1.551 . . . . 0.0 113.048 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.18 107.05 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 19.2 p -88.75 169.28 11.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.332 1.053 . . . . 0.0 112.277 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 46.3 p -52.99 -36.95 60.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.209 -0.932 . . . . 0.0 112.946 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.43 -42.9 67.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.683 1.193 . . . . 0.0 112.267 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -61.8 -42.56 99.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.476 0.58 . . . . 0.0 111.736 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.94 -50.58 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.613 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -49.12 -53.69 19.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.829 1.195 . . . . 0.0 111.296 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 55.9 m -59.77 -43.26 94.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.616 -0.677 . . . . 0.0 111.968 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.68 75.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.461 1.028 . . . . 0.0 112.324 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -35.33 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.549 -1.345 . . . . 0.0 112.415 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.04 -21.47 64.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.777 1.171 . . . . 0.0 113.388 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.82 -43.14 22.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.357 1.063 . . . . 0.0 111.93 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.82 -25.99 66.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 127.033 2.133 . . . . 0.0 110.813 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.68 152.25 42.42 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.003 0.811 . . . . 0.0 112.731 171.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.24 -31.84 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.305 -1.115 . . . . 0.0 113.46 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.45 -22.35 77.71 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.659 1.123 . . . . 0.0 115.27 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.31 -54.2 58.26 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 119.653 1.727 . . . . 0.0 113.672 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -56.74 -31.4 87.87 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.022 1.815 . . . . 0.0 113.761 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.4 -46.78 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.821 1.191 . . . . 0.0 111.109 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -67.76 -38.75 83.84 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.18 -0.95 . . . . 0.0 113.096 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.66 -42.6 97.33 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.684 -1.26 . . . . 0.0 111.349 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.57 71.51 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.295 -0.878 . . . . 0.0 112.736 169.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.49 75.99 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 120.239 1.381 . . . . 0.0 113.498 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.99 -47.56 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.882 -1.136 . . . . 0.0 109.731 168.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.22 -39.43 86.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.689 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -52.85 -47.24 67.9 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.704 1.593 . . . . 0.0 112.595 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -57.91 -43.77 86.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.675 -0.64 . . . . 0.0 111.925 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.2 -34.4 70.83 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.969 -1.082 . . . . 0.0 112.877 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 88.7 m -53.65 -49.54 67.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.904 1.281 . . . . 0.0 110.071 164.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.38 82.91 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.196 0.907 . . . . 0.0 112.941 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.32 -43.26 91.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.751 1.16 . . . . 0.0 113.389 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.27 -43.62 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.781 -1.2 . . . . 0.0 110.137 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.06 -30.53 71.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.023 0.929 . . . . 0.0 113.331 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -63.59 -49.13 74.55 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.004 1.275 . . . . 0.0 111.384 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.06 -46.69 82.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.752 0.821 . . . . 0.0 111.253 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.95 78.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.969 0.908 . . . . 0.0 113.138 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -45.78 95.18 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.995 1.283 . . . . 0.0 112.765 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.89 -43.92 97.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.331 1.066 . . . . 0.0 111.423 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.47 75.99 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.573 -0.705 . . . . 0.0 112.845 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -45.63 82.43 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.158 -0.964 . . . . 0.0 112.336 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.25 -42.76 73.88 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.213 1.405 . . . . 0.0 112.982 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -57.16 -22.97 44.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -106.65 4.81 28.29 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.677 1.591 . . . . 0.0 112.838 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.18 31.73 14.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.965 2.106 . . . . 0.0 114.191 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.24 156.22 17.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.19 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.4 p -114.51 15.87 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.494 1.918 . . . . 0.0 112.961 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -133.61 129.43 36.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.098 1.359 . . . . 0.0 110.745 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -73.99 124.35 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 109.837 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 pt -126.0 169.94 10.56 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.788 1.635 . . . . 0.0 111.053 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.66 -34.34 83.23 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.191 2.594 . . . . 0.0 114.703 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.14 -24.57 67.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -81.79 -38.27 25.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.108 0.963 . . . . 0.0 111.865 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.73 0.696 . . . . 0.0 112.555 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -57.09 -57.75 11.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.166 -0.959 . . . . 0.0 111.159 166.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.01 -43.55 91.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.941 0.896 . . . . 0.0 112.72 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.43 45.11 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 15.5 mt -113.96 -63.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.884 1.274 . . . . 0.0 110.278 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.97 -27.87 69.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -99.94 0.78 41.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.763 1.225 . . . . 0.0 113.018 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.65 114.15 26.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.435 1.016 . . . . 0.0 110.417 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -49.61 -43.52 46.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.461 1.504 . . . . 0.0 113.093 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.788 0.835 . . . . 0.0 112.157 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.89 -17.63 61.5 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.21 -0.9 . . . . 0.0 112.484 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.39 -34.69 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.286 1.403 . . . . 0.0 112.591 165.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.54 -30.24 65.67 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.121 -0.987 . . . . 0.0 112.882 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 66.9 tp -92.7 -52.27 4.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 CA--C 1.548 0.899 0 C-N-CA 126.32 1.848 . . . . 0.0 110.534 -169.242 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 62.6 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -66.2 110.77 3.13 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.644 . . . . 0.0 109.366 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.07 123.33 83.66 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.563 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.68 138.73 71.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.763 2.309 . . . . 0.0 111.676 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.62 113.93 2.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.516 0.726 . . . . 0.0 109.466 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.7 117.64 15.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.627 0.771 . . . . 0.0 110.502 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 86.8 m -107.25 108.22 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.756 1.222 . . . . 0.0 108.354 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -65.93 127.33 31.64 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.149 0.58 . . . . 0.0 110.858 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 18.4 p -71.27 138.18 49.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.861 0.865 . . . . 0.0 113.063 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.42 -29.35 47.09 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.977 0.911 . . . . 0.0 112.333 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.009 1.323 . . . . 0.0 111.43 171.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -67.32 -41.85 84.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.189 -0.945 . . . . 0.0 112.165 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -54.7 -37.75 66.19 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.063 0.847 . . . . 0.0 112.43 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.03 -48.79 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.464 0.706 . . . . 0.0 111.896 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 34.4 tp -50.67 -42.95 57.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.634 1.106 . . . . 0.0 112.72 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.51 -24.78 22.07 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -72.2 -32.0 66.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.314 1.045 . . . . 0.0 112.662 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.83 -41.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.7 1.2 . . . . 0.0 113.536 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -135.45 70.73 67.03 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.47 1.508 . . . . 0.0 110.692 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -58.06 -23.09 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.611 2.874 . . . . 0.0 113.974 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -77.46 -6.51 53.75 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.656 1.982 . . . . 0.0 113.963 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 98.8 m -115.37 129.77 56.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.271 1.428 . . . . 0.0 111.34 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.09 175.15 41.2 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.974 1.273 . . . . 0.0 113.423 172.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.83 140.65 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.167 -1.196 . . . . 0.0 110.923 171.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 34.4 p -73.2 154.5 40.24 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 38.6 p -54.68 -44.02 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.025 0.93 . . . . 0.0 112.291 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.82 -46.9 87.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.792 1.237 . . . . 0.0 112.155 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.28 89.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.354 0.661 . . . . 0.0 112.263 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 74.8 mtm -60.78 -40.89 94.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.08 -1.012 . . . . 0.0 112.449 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.18 -42.17 97.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.665 1.126 . . . . 0.0 113.899 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.01 -51.84 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.25 1.02 . . . . 0.0 110.073 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 46.3 mtp -61.29 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -50.66 -50.62 54.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.501 1.5 . . . . 0.0 112.339 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -59.37 -55.8 30.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.634 0.774 . . . . 0.0 111.519 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -61.71 -43.89 97.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.61 -51.18 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.391 0.996 . . . . 0.0 110.908 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -62.02 -40.92 97.33 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.739 0.7 . . . . 0.0 111.569 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -56.54 -28.89 61.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.8 mt -49.75 -57.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.36 1.437 . . . . 0.0 109.917 172.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.8 -52.91 38.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 0.0 111.335 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -54.73 -35.49 63.75 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.79 -53.19 5.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.352 1.061 . . . . 0.0 112.1 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.76 -58.58 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 120.263 1.392 . . . . 0.0 111.386 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.41 62.93 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.481 -0.762 . . . . 0.0 112.106 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.0 -47.91 88.71 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 118.9 0.773 . . . . 0.0 113.164 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.16 -39.86 93.55 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.197 -1.179 . . . . 0.0 112.214 172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.57 78.79 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.045 -1.034 . . . . 0.0 112.222 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -60.63 -50.6 72.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.063 0.945 . . . . 0.0 111.271 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -51.09 -48.99 61.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.11 0.868 . . . . 0.0 111.946 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.01 -48.67 75.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.577 0.751 . . . . 0.0 111.773 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.73 73.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.741 0.816 . . . . 0.0 112.916 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -58.48 -52.18 66.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.432 1.015 . . . . 0.0 111.467 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -60.95 -35.07 75.78 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -82.57 5.41 21.01 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.817 1.247 . . . . 0.0 113.769 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 56.19 34.3 23.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.998 2.119 . . . . 0.0 114.328 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -101.13 142.71 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.725 1.61 . . . . 0.0 112.626 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 48.4 p -83.73 -22.27 32.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.467 1.507 . . . . 0.0 113.498 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 40.1 m -126.22 128.98 48.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.508 1.523 . . . . 0.0 111.41 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.92 130.62 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.17 1.388 . . . . 0.0 110.737 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.1 p -84.33 160.19 20.74 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 41.3 p -55.34 -38.8 69.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.068 -1.02 . . . . 0.0 112.433 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.32 -43.59 90.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.686 1.194 . . . . 0.0 112.287 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -62.11 -41.86 98.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.498 0.719 . . . . 0.0 112.305 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.64 -54.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.517 0.599 . . . . 0.0 109.864 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -55.31 -42.1 73.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.246 0.93 . . . . 0.0 112.818 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 89.4 m -62.34 -50.31 72.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.397 1.079 . . . . 0.0 111.707 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.28 84.32 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.561 1.073 . . . . 0.0 112.691 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.49 -56.05 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.504 1.122 . . . . 0.0 110.264 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -57.44 -41.91 81.39 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.789 1.177 . . . . 0.0 113.405 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.54 -45.37 91.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 112.418 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -89.54 -23.36 22.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.552 1.032 0 C-N-CA 127.139 2.176 . . . . 0.0 110.813 176.144 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.82 -165.18 10.28 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.502 1.525 . . . . 0.0 111.022 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.99 -30.21 24.06 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.44 -36.25 88.45 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.468 1.033 . . . . 0.0 115.361 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.74 -55.81 21.26 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.475 1.137 . . . . 0.0 113.943 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.04 -33.69 49.82 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 112.876 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.26 -37.71 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 120.569 1.531 . . . . 0.0 113.027 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -53.71 -53.58 50.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.972 0.805 . . . . 0.0 111.017 168.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.76 -50.9 69.17 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.401 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.66 61.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.904 1.229 . . . . 0.0 113.289 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.22 -46.03 65.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.133 0.973 . . . . 0.0 112.211 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.27 -56.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.4 1.08 . . . . 0.0 111.784 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.43 -46.63 82.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.336 1.455 . . . . 0.0 113.029 -172.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -58.27 -46.43 86.03 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.513 1.051 . . . . 0.0 110.762 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -62.64 -51.93 65.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.391 0.676 . . . . 0.0 112.555 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.2 -42.04 89.96 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.235 -0.915 . . . . 0.0 111.995 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -53.64 -51.8 61.95 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.095 . . . . 0.0 110.776 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.81 95.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.756 0.822 . . . . 0.0 113.167 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -60.68 -47.73 84.93 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.467 1.03 . . . . 0.0 112.864 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.1 -50.58 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.45 0.7 . . . . 0.0 109.951 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.63 -37.84 79.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.186 0.994 . . . . 0.0 113.207 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.93 -55.4 29.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.55 1.068 . . . . 0.0 111.615 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.51 -47.15 82.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.687 1.195 . . . . 0.0 111.707 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.47 92.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 0.0 112.453 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.98 98.04 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.321 -0.862 . . . . 0.0 113.202 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.35 -44.67 96.79 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.803 1.301 . . . . 0.0 110.937 172.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.29 89.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.411 -0.805 . . . . 0.0 112.668 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.35 89.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.173 -0.954 . . . . 0.0 112.547 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -57.59 -47.06 83.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.044 0.937 . . . . 0.0 112.024 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.22 -41.67 79.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -86.31 10.12 15.8 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 53.76 30.12 10.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.791 2.036 . . . . 0.0 114.564 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.2 144.99 28.59 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.194 1.398 . . . . 0.0 112.165 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -76.92 -26.21 53.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.698 1.199 . . . . 0.0 112.764 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -128.99 151.66 49.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.433 1.493 . . . . 0.0 112.531 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.4 131.13 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.602 1.161 . . . . 0.0 110.264 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.82 149.62 36.34 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.57 1.948 . . . . 0.0 109.544 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -48.32 -40.55 35.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.713 2.942 . . . . 0.0 114.964 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -60.19 -38.86 84.55 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.284 1.034 . . . . 0.0 113.062 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -61.91 -42.23 98.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.669 0.788 . . . . 0.0 112.175 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' D' ' 62' ' ' MET . 84.6 mt -62.77 -46.08 89.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 111.936 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.68 -50.47 72.03 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.808 0.843 . . . . 0.0 111.82 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 84.3 mt -57.08 -50.6 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.421 -0.8 . . . . 0.0 111.871 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.11 64.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.161 0.984 . . . . 0.0 112.84 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 tt -68.65 -35.76 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 118.479 0.581 . . . . 0.0 112.533 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.362 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -66.06 -37.84 86.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.781 0.832 . . . . 0.0 112.304 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.01 115.81 18.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.021 0.928 . . . . 0.0 112.669 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.73 -39.39 84.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.238 -0.914 . . . . 0.0 113.449 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -67.31 -39.35 85.88 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.158 -0.964 . . . . 0.0 111.766 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.28 -36.38 83.92 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.432 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.14 -37.16 84.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.81 1.641 . . . . 0.0 112.739 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.53 -39.1 91.4 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.343 -0.848 . . . . 0.0 112.224 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.54 -53.79 8.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 113.622 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.542 0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 111.444 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.03 131.77 47.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.892 1.277 . . . . 0.0 111.723 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.17 -34.95 0.58 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -57.65 129.23 32.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.723 2.282 . . . . 0.0 112.562 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -67.95 113.64 5.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.069 0.947 . . . . 0.0 111.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.31 -26.02 23.62 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.345 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 41.5 m -70.46 106.9 3.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 109.961 171.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -140.79 154.4 46.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.391 1.077 . . . . 0.0 113.067 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 53.0 m -67.76 147.86 52.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.844 0.858 . . . . 0.0 111.58 167.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -57.94 -46.69 84.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.44 0.696 . . . . 0.0 112.188 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 . . . . . 0 N--CA 1.467 0.413 0 C-N-CA 124.098 0.959 . . . . 0.0 110.218 167.804 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.35 -45.09 92.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.698 1.199 . . . . 0.0 112.274 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.79 -35.36 80.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.144 0.978 . . . . 0.0 112.248 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.46 -50.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.476 0.58 . . . . 0.0 110.59 171.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.11 -38.21 82.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.406 -0.809 . . . . 0.0 112.776 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -51.62 -34.94 39.79 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.219 1.408 . . . . 0.0 113.379 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.67 -14.24 60.72 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.9 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.798 1.639 . . . . 0.0 111.36 -170.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.81 73.11 79.19 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.559 1.944 . . . . 0.0 110.073 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.26 -23.92 64.84 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.756 2.971 . . . . 0.0 114.743 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -79.17 -3.48 45.79 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.997 1.719 . . . . 0.0 113.894 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 43.2 m -119.42 140.06 51.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.842 1.657 . . . . 0.0 111.007 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.11 -166.22 25.82 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.533 1.063 . . . . 0.0 113.968 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.98 137.06 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.963 -1.316 . . . . 0.0 110.237 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.33 147.12 41.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.025 0.93 . . . . 0.0 112.777 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.9 p -56.96 -34.62 68.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.009 0.923 . . . . 0.0 112.756 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -75.67 -44.09 44.18 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.404 1.082 . . . . 0.0 111.762 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.2 -37.42 72.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.871 0.868 . . . . 0.0 113.3 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 64.5 ttp -52.43 -50.77 61.91 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.268 -0.895 . . . . 0.0 111.712 167.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.7 95.52 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.872 1.225 . . . . 0.0 114.066 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.63 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.379 1.09 . . . . 0.0 110.878 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . 0.401 ' SD ' HD22 ' C' ' 83' ' ' LEU . 92.6 mmm -60.81 -40.03 91.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.363 0.983 . . . . 0.0 112.443 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.64 -47.96 82.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.831 0.741 . . . . 0.0 111.781 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -56.27 -53.29 59.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.333 1.053 . . . . 0.0 111.996 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -53.17 -55.1 26.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.674 1.19 . . . . 0.0 112.218 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.46 -51.0 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.184 0.994 . . . . 0.0 110.83 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -60.61 -38.77 85.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.822 0.737 . . . . 0.0 112.378 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -64.83 -52.09 58.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.251 0.932 . . . . 0.0 113.257 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.02 -31.45 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.167 0.894 . . . . 0.0 113.103 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -47.6 -51.33 21.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.123 1.369 . . . . 0.0 111.781 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -59.51 -44.87 93.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.379 0.672 . . . . 0.0 112.017 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -67.01 -52.34 43.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.171 0.588 . . . . 0.0 111.523 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.35 -42.93 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.161 0.984 . . . . 0.0 111.278 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.34 91.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.78 0.832 . . . . 0.0 112.095 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.97 -51.03 59.86 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.786 0.708 . . . . 0.0 113.226 169.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -56.4 -40.72 75.11 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.002 -1.293 . . . . 0.0 112.633 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.89 -47.61 51.96 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.298 1.039 . . . . 0.0 112.62 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -77.55 -39.8 44.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.75 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -50.35 -50.39 51.34 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.745 1.157 . . . . 0.0 111.274 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.59 -44.02 97.78 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.732 1.213 . . . . 0.0 112.747 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.55 88.25 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.337 -0.852 . . . . 0.0 112.063 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -63.16 -38.25 90.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.8 1.24 . . . . 0.0 113.142 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -59.6 -34.11 72.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.662 1.119 . . . . 0.0 111.728 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -83.71 11.95 6.61 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.419 1.487 . . . . 0.0 113.257 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 59.46 28.57 17.98 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.696 2.398 . . . . 0.0 115.197 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.88 139.35 53.31 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.526 1.531 . . . . 0.0 112.815 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 35.6 p -86.97 -31.81 20.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.272 1.429 . . . . 0.0 113.591 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -87.48 147.69 25.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.655 1.582 . . . . 0.0 111.741 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 56.9 mt -104.78 120.92 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 0.0 108.353 168.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -100.38 161.89 13.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.068 0.947 . . . . 0.0 113.118 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 53.0 p -66.84 -23.68 66.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.429 1.092 . . . . 0.0 113.669 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.72 -42.83 21.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.644 1.178 . . . . 0.0 112.189 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -54.82 -28.7 51.47 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.991 1.317 . . . . 0.0 114.035 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.76 -32.83 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.79 0.836 . . . . 0.0 112.449 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -54.96 -33.98 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.432 1.093 . . . . 0.0 112.811 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 51.7 m -99.53 -46.65 5.39 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.639 1.176 . . . . 0.0 111.406 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.5 74.89 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.925 -1.109 . . . . 0.0 113.019 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.8 -36.79 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.646 -1.284 . . . . 0.0 111.135 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.53 -36.65 84.9 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.441 1.096 . . . . 0.0 113.055 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.35 -42.65 87.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.179 0.592 . . . . 0.0 112.007 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.66 -54.11 15.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 CA--C 1.549 0.941 0 C-N-CA 125.187 1.395 . . . . 0.0 110.832 -170.392 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.6 179.91 52.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.02 1.295 . . . . 0.0 114.094 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.15 57.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.15 96.93 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 121.331 -0.856 . . . . 0.0 114.286 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.66 10.95 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.71 -33.51 76.64 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.375 2.05 . . . . 0.0 113.388 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -49.28 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.746 1.157 . . . . 0.0 111.176 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -64.21 -34.87 79.09 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.571 -0.706 . . . . 0.0 112.586 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.91 -44.3 81.12 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.382 -0.823 . . . . 0.0 112.278 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.14 78.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.624 1.102 . . . . 0.0 112.519 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.79 -21.44 19.35 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -91.53 -54.16 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.322 1.449 . . . . 0.0 111.281 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' D' ' 70' ' ' PHE . 39.4 mt -50.17 -45.54 53.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.953 1.701 . . . . 0.0 113.391 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -48.13 -53.44 16.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.408 1.083 . . . . 0.0 112.172 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 -41.35 80.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.039 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.95 -49.55 75.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.993 0.815 . . . . 0.0 111.48 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -57.56 -48.64 78.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.127 0.971 . . . . 0.0 111.53 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.18 62.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.143 1.377 . . . . 0.0 113.432 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.95 -34.34 67.93 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 -34.48 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 118.77 0.714 . . . . 0.0 110.833 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.29 -44.3 88.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.912 0.778 . . . . 0.0 111.68 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.96 -53.06 61.96 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.533 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.65 -36.75 79.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.694 0.797 . . . . 0.0 112.323 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -38.39 79.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.463 1.028 . . . . 0.0 112.657 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.6 -45.56 93.08 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.619 0.645 . . . . 0.0 112.581 168.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.55 -42.18 95.85 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.482 -1.011 . . . . 0.0 111.842 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.38 -45.31 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.48 1.037 . . . . 0.0 111.625 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.7 86.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.758 0.823 . . . . 0.0 112.094 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -57.33 -48.61 78.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.855 1.262 . . . . 0.0 112.678 173.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -58.52 -39.44 80.13 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.524 1.129 . . . . 0.0 113.259 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.57 4.67 31.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.565 1.146 . . . . 0.0 112.968 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 53.09 36.88 23.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.423 2.289 . . . . 0.0 114.177 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.09 149.67 22.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.72 1.608 . . . . 0.0 112.513 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 33.1 p -85.46 -28.86 24.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.214 1.406 . . . . 0.0 113.345 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -119.36 140.24 50.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.32 1.848 . . . . 0.0 111.153 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.29 121.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 109.129 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.51 162.8 20.61 Favored Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 124.315 1.046 . . . . 0.0 111.671 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.38 -35.73 85.28 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.971 2.447 . . . . 0.0 114.091 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -64.3 -43.74 93.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.582 1.083 . . . . 0.0 111.692 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.75 -41.94 98.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.683 0.793 . . . . 0.0 111.424 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -64.06 -44.75 91.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 0.0 112.636 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.83 -51.22 70.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.049 -1.032 . . . . 0.0 111.044 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.06 -41.83 48.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.916 1.286 . . . . 0.0 113.362 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.27 -45.99 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.843 0.747 . . . . 0.0 112.966 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -71.13 -19.46 62.43 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.16 -28.56 64.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.814 1.246 . . . . 0.0 113.492 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -129.63 123.07 30.36 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.598 1.09 . . . . 0.0 112.637 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -61.77 -47.33 85.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.118 0.967 . . . . 0.0 113.059 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -60.67 -53.46 57.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.868 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -49.74 -47.13 50.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.633 1.106 . . . . 0.0 111.753 171.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -61.32 -30.1 70.29 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.704 -1.248 . . . . 0.0 114.151 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.64 -49.66 7.83 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.396 1.078 . . . . 0.0 112.362 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.09 -44.2 87.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.609 2.364 . . . . 0.0 113.409 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tp . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.215 -173.073 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.95 123.16 22.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.593 0.757 . . . . 0.0 110.369 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.04 144.2 29.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.295 1.038 . . . . 0.0 111.258 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -59.57 140.16 92.53 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.175 2.583 . . . . 0.0 112.345 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.29 146.36 51.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.28 1.032 . . . . 0.0 112.012 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.03 136.37 53.73 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.617 0.767 . . . . 0.0 110.529 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p -119.94 161.4 20.94 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.97 119.71 10.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 171.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.7 p -68.74 157.08 37.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 113.051 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -57.35 129.0 39.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.238 0.615 . . . . 0.0 110.833 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.3 t60 . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 123.747 0.819 . . . . 0.0 112.462 -172.21 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -56.91 -52.83 63.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.889 1.276 . . . . 0.0 112.556 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.93 -50.84 69.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.956 0.902 . . . . 0.0 111.345 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 83.2 t -57.03 -46.4 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.84 0.856 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.57 -50.8 62.25 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.341 1.056 . . . . 0.0 112.085 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.41 -43.77 79.68 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.267 1.027 . . . . 0.0 112.299 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -66.15 -47.74 73.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.37 -30.04 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -121.55 90.36 47.92 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.201 1.4 . . . . 0.0 110.226 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.79 -26.26 72.74 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.626 2.884 . . . . 0.0 114.491 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.25 -12.64 61.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.218 1.807 . . . . 0.0 113.62 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -103.12 117.5 34.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 110.097 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.56 -169.68 15.64 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.855 1.217 . . . . 0.0 112.937 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.94 151.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -70.01 143.87 52.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.835 0.854 . . . . 0.0 112.461 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 34.8 p -58.37 -40.29 81.89 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.012 0.925 . . . . 0.0 112.196 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.82 -43.64 98.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.94 0.896 . . . . 0.0 111.702 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.49 81.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.185 0.594 . . . . 0.0 112.566 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.2 mmm -65.92 -41.83 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.965 -1.084 . . . . 0.0 112.98 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.41 -41.96 88.67 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.298 0.953 . . . . 0.0 113.041 170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -61.12 -49.78 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.791 1.637 . . . . 0.0 111.008 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mmm -56.03 -40.49 73.55 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.668 1.122 . . . . 0.0 112.933 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -64.65 -42.5 95.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.812 -1.18 . . . . 0.0 111.726 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -55.61 -46.85 77.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.603 0.761 . . . . 0.0 111.241 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -56.79 -52.7 64.01 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.677 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.46 -41.33 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.87 1.214 . . . . 0.0 112.384 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -66.05 -54.52 24.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.072 0.851 . . . . 0.0 112.057 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.7 -50.8 71.1 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 11.9 pt -62.58 -36.48 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.368 1.067 . . . . 0.0 112.489 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . 0.559 ' CD1' HD13 ' C' ' 55' ' ' LEU . 10.7 m-30 -66.94 -23.52 65.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.323 1.049 . . . . 0.0 112.33 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -81.22 -47.83 12.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.59 0.756 . . . . 0.0 110.944 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -54.98 -42.94 73.07 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 13.7 tt -59.63 -34.0 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.767 0.712 . . . . 0.0 112.552 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.43 88.21 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.301 0.955 . . . . 0.0 111.797 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.82 94.48 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.995 0.807 . . . . 0.0 113.371 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -70.95 -40.4 72.04 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.076 -1.25 . . . . 0.0 112.741 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.91 72.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.914 -1.116 . . . . 0.0 111.576 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -62.43 -47.4 84.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.363 1.065 . . . . 0.0 112.123 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -54.28 -46.84 72.82 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.0 -1.062 . . . . 0.0 112.403 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.88 -41.73 98.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 0.0 112.304 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.43 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.922 0.889 . . . . 0.0 112.257 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -60.8 -42.37 97.46 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.501 1.12 . . . . 0.0 112.594 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -57.62 -33.37 68.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.211 0.914 . . . . 0.0 112.302 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -90.01 7.84 35.54 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.473 1.509 . . . . 0.0 113.326 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.25 31.1 13.53 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.526 2.33 . . . . 0.0 114.876 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -91.39 143.25 26.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.93 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 40.2 p -90.11 -37.56 14.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.363 1.465 . . . . 0.0 113.213 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 72.9 p -106.22 -179.45 3.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.534 1.933 . . . . 0.0 111.515 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mt -125.22 125.25 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.998 1.319 . . . . 0.0 109.358 171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -101.77 164.22 11.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.263 1.025 . . . . 0.0 113.084 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 45.8 p -57.33 -43.22 83.18 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.211 -0.931 . . . . 0.0 112.565 170.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.19 -37.03 84.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.209 1.004 . . . . 0.0 112.836 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.91 -39.43 90.58 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.577 0.751 . . . . 0.0 111.952 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.32 -43.12 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 169.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -54.82 -45.33 74.41 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.455 1.025 . . . . 0.0 112.587 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 42.2 p -70.48 -38.27 74.36 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.411 1.005 . . . . 0.0 112.174 171.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -24.63 63.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 117.59 -1.195 . . . . 0.0 114.164 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -46.62 -50.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 121.204 1.82 . . . . 0.0 111.612 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.45 -28.06 64.73 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.33 -39.33 54.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.538 1.135 . . . . 0.0 111.772 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -84.57 -20.31 31.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.016 1.726 . . . . 0.0 112.906 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 63.3 tp . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 126.412 1.885 . . . . 0.0 109.976 169.467 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.61 162.01 41.08 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.653 1.121 . . . . 0.0 112.585 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -36.96 63.63 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.99 -24.41 74.46 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.287 0.946 . . . . 0.0 115.26 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -58.75 17.03 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.805 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.89 -38.52 92.61 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.478 2.119 . . . . 0.0 113.219 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.78 -53.95 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.033 0.933 . . . . 0.0 110.954 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -57.17 -50.09 73.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.777 0.831 . . . . 0.0 112.286 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.66 -45.59 85.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.316 1.046 . . . . 0.0 111.617 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.12 96.22 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.254 0.934 . . . . 0.0 112.97 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.89 75.19 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.257 -0.902 . . . . 0.0 112.656 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.43 -41.85 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.54 -0.725 . . . . 0.0 111.541 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.8 -52.75 38.05 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.355 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -59.53 -42.87 93.3 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.236 1.38 . . . . 0.0 113.108 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -53.98 -47.87 70.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.585 0.754 . . . . 0.0 112.626 171.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.92 -45.04 75.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.828 0.851 . . . . 0.0 112.392 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -54.94 -40.04 69.52 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.543 1.537 . . . . 0.0 112.285 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.7 -47.21 70.72 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.914 1.234 . . . . 0.0 112.269 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -63.42 -46.62 85.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.606 0.762 . . . . 0.0 112.403 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -51.52 -55.39 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.771 0.714 . . . . 0.0 110.369 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.49 -46.31 83.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.438 0.695 . . . . 0.0 112.154 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.42 -51.49 64.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.724 0.693 . . . . 0.0 111.913 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.3 -33.24 72.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.604 0.762 . . . . 0.0 112.765 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.67 90.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.62 1.1 . . . . 0.0 112.094 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.68 -46.09 89.68 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 122.084 -0.385 . . . . 0.0 112.655 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -61.33 -45.17 95.56 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.956 -0.732 . . . . 0.0 111.473 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.45 81.96 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.995 0.918 . . . . 0.0 112.723 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.25 86.72 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.607 -0.683 . . . . 0.0 112.375 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -59.08 -39.5 82.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -60.03 -31.68 70.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -89.99 3.84 51.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.06 0.944 . . . . 0.0 113.503 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 56.46 33.03 21.8 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.904 2.081 . . . . 0.0 113.711 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.21 147.7 26.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.623 1.569 . . . . 0.0 112.553 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.4 p -98.02 2.02 48.4 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.974 1.71 . . . . 0.0 113.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -126.27 120.09 29.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.676 1.591 . . . . 0.0 110.709 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.29 123.77 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.493 1.517 . . . . 0.0 109.056 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.17 167.21 9.38 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.074 1.75 . . . . 0.0 111.309 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -48.32 -40.31 35.66 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.4 -36.27 75.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.974 0.909 . . . . 0.0 113.213 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -65.56 -39.66 91.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.264 0.938 . . . . 0.0 112.429 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.01 -44.34 85.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.149 0.58 . . . . 0.0 111.229 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -57.19 -49.91 74.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.448 -0.783 . . . . 0.0 112.035 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 64.8 mt -56.56 -46.55 80.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.081 0.952 . . . . 0.0 111.766 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.4 76.91 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.44 -0.787 . . . . 0.0 112.893 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.06 -45.82 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.472 1.109 . . . . 0.0 110.985 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.79 -24.9 64.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.959 1.304 . . . . 0.0 114.512 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -88.78 -34.97 16.91 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.344 1.058 . . . . 0.0 112.181 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.42 117.41 7.9 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.13 0.877 . . . . 0.0 112.489 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.44 -37.12 74.76 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.181 0.993 . . . . 0.0 113.079 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -64.93 -43.87 91.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.432 1.014 . . . . 0.0 111.865 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.91 -32.77 69.81 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.857 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.59 -39.6 94.24 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.218 1.372 . . . . 0.0 112.061 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.22 -41.97 96.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 112.231 171.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 29.7 tp -75.23 -49.26 19.91 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 125.609 1.564 . . . . 0.0 110.295 -175.469 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.844 0.831 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.6 122.35 14.49 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 0.0 111.053 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.37 138.74 81.16 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.182 0.593 . . . . 0.0 111.22 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -61.15 150.41 84.57 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.788 2.326 . . . . 0.0 111.61 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.14 108.24 2.6 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.75 -0.594 . . . . 0.0 110.423 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.79 151.26 45.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.655 1.182 . . . . 0.0 111.262 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -57.67 122.76 13.56 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.022 0.929 . . . . 0.0 110.731 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -62.68 133.35 54.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.406 0.682 . . . . 0.0 111.3 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -77.83 108.54 11.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.913 -0.492 . . . . 0.0 110.787 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.36 -0.26 57.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.539 1.135 . . . . 0.0 112.877 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 125.105 1.362 . . . . 0.0 111.692 175.669 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -58.52 -54.4 47.5 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 111.292 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.66 -36.84 79.72 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.627 1.171 . . . . 0.0 112.835 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 81.5 t -55.47 -56.61 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.701 0.8 . . . . 0.0 110.605 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.71 -25.34 59.07 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -52.35 -37.66 56.66 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.991 1.268 . . . . 0.0 112.147 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.56 -47.03 23.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.761 0.825 . . . . 0.0 112.728 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.41 -47.38 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.024 0.93 . . . . 0.0 112.285 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -127.34 82.64 67.83 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.812 2.045 . . . . 0.0 110.4 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -57.67 -24.9 65.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.488 2.792 . . . . 0.0 115.533 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -86.3 -7.9 58.14 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.929 2.092 . . . . 0.0 114.097 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -126.19 122.66 36.25 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.48 1.036 . . . . 0.0 112.539 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.8 178.66 26.11 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.384 1.469 . . . . 0.0 113.704 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.56 134.26 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.662 1.585 . . . . 0.0 109.541 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 23.5 p -70.46 160.7 31.91 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -55.06 -42.89 73.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.174 0.99 . . . . 0.0 112.22 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.82 -44.09 91.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.932 1.293 . . . . 0.0 112.149 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.44 92.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 112.43 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.4 mtm -58.15 -44.94 88.14 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.203 -0.936 . . . . 0.0 111.676 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.93 -49.13 63.5 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.773 1.178 . . . . 0.0 114.651 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.65 -22.32 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.732 1.266 . . . . 0.0 113.833 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.55 -35.75 61.08 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.504 -1.373 . . . . 0.0 112.125 170.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -55.76 -40.3 72.39 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 78.7 p -79.03 -37.14 39.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.072 -1.017 . . . . 0.0 112.339 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -58.25 -40.03 80.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.339 0.972 . . . . 0.0 112.858 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.22 -54.39 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.504 1.121 . . . . 0.0 111.287 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.65 -44.38 93.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.716 0.807 . . . . 0.0 111.536 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -58.3 -49.8 75.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.032 0.833 . . . . 0.0 112.944 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.19 -51.24 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.542 1.137 . . . . 0.0 110.732 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.41 -52.43 59.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.807 0.843 . . . . 0.0 111.892 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -53.06 -48.89 67.34 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.442 1.097 . . . . 0.0 112.519 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.21 -50.41 65.98 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 44.1 mt -63.24 -48.28 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.092 0.86 . . . . 0.0 110.491 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.93 90.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.81 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.26 -51.0 58.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.464 1.03 . . . . 0.0 112.95 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -61.62 -45.7 92.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.55 1.175 . . . . 0.0 112.591 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.68 77.84 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.061 -1.025 . . . . 0.0 112.361 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -61.58 -47.79 83.87 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.357 1.063 . . . . 0.0 111.799 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -57.76 -36.06 71.61 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.841 1.256 . . . . 0.0 112.802 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.16 -41.78 85.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.122 0.874 . . . . 0.0 112.375 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.24 86.28 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.951 -1.093 . . . . 0.0 112.483 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -63.5 -41.94 98.51 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.508 1.123 . . . . 0.0 112.74 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -59.16 -38.45 79.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.99 8.32 3.28 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.252 1.421 . . . . 0.0 113.879 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 53.46 29.68 9.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.82 2.448 . . . . 0.0 115.23 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -81.56 158.82 24.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.153 0.981 . . . . 0.0 112.868 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 65.3 p -112.85 -10.29 13.58 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.978 1.711 . . . . 0.0 113.496 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 53.0 m -134.23 135.01 42.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.582 1.953 . . . . 0.0 109.461 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.46 112.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 108.822 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 55.2 p -96.87 170.42 9.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.216 1.406 . . . . 0.0 111.903 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 37.1 p -53.16 -37.2 61.67 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.929 0.891 . . . . 0.0 112.71 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.71 -44.99 69.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.722 1.209 . . . . 0.0 112.422 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.37 -42.3 91.31 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.612 0.642 . . . . 0.0 111.89 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 69.5 mt -58.17 -53.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.608 0.763 . . . . 0.0 110.356 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -50.7 -46.46 58.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.809 1.186 . . . . 0.0 112.405 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 98.8 m -61.74 -49.4 76.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.773 0.829 . . . . 0.0 112.115 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.04 81.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.992 0.917 . . . . 0.0 112.686 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -51.49 -51.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.617 1.167 . . . . 0.0 110.993 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.58 -44.25 97.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.921 0.888 . . . . 0.0 112.699 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.32 -36.26 83.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.211 1.004 . . . . 0.0 113.26 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.24 -30.42 48.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.0 1.32 . . . . 0.0 113.061 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 125.755 1.622 . . . . 0.0 111.911 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.31 50.4 1.0 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.069 1.795 . . . . 0.0 115.628 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.1 -15.24 21.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.38 79.69 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.975 -1.078 . . . . 0.0 113.702 165.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.36 -59.23 11.67 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 118.642 1.221 . . . . 0.0 112.58 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.71 -31.34 60.38 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.244 1.963 . . . . 0.0 114.383 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.18 -48.79 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.739 1.154 . . . . 0.0 112.059 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -61.08 -38.37 86.01 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.101 -0.999 . . . . 0.0 111.99 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.37 -30.06 70.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.978 -1.076 . . . . 0.0 112.729 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.46 -45.15 92.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.696 1.135 . . . . 0.0 111.998 168.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.61 90.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.21 -49.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.906 -1.122 . . . . 0.0 112.015 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.6 -35.58 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.595 1.158 . . . . 0.0 112.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.3 -50.0 51.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -76.71 -38.25 54.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.572 0.749 . . . . 0.0 112.921 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.72 -45.17 86.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.317 0.508 . . . . 0.0 111.346 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -77.5 -28.42 52.11 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.66 -46.15 77.58 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.267 0.94 . . . . 0.0 112.545 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.76 -42.19 96.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.963 0.801 . . . . 0.0 112.61 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.09 -55.02 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.518 0.727 . . . . 0.0 110.259 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.84 -32.79 73.56 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.18 -52.36 62.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.695 1.198 . . . . 0.0 111.612 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.73 -36.1 83.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.692 -0.63 . . . . 0.0 112.017 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.13 90.91 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.619 -0.675 . . . . 0.0 111.939 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.05 -46.11 85.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.166 0.889 . . . . 0.0 113.681 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -60.95 -46.13 91.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.155 0.977 . . . . 0.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.44 82.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.607 -0.683 . . . . 0.0 112.305 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.97 88.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.284 1.034 . . . . 0.0 112.629 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -54.48 -50.63 67.3 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.755 1.222 . . . . 0.0 111.86 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -58.68 -38.76 78.91 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -87.72 6.33 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.591 1.156 . . . . 0.0 113.267 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 52.88 34.88 17.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.107 2.163 . . . . 0.0 114.275 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 148.99 21.81 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.506 1.522 . . . . 0.0 112.805 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.0 p -90.58 -28.71 18.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.311 1.445 . . . . 0.0 113.074 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -122.75 138.54 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.302 1.441 . . . . 0.0 111.765 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.72 130.19 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.892 1.277 . . . . 0.0 110.849 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.19 164.39 20.43 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 125.743 1.617 . . . . 0.0 111.481 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.01 -38.3 48.9 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.692 2.928 . . . . 0.0 114.923 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.47 -40.55 87.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.736 0.814 . . . . 0.0 113.036 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -62.21 -41.81 98.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.018 0.826 . . . . 0.0 111.812 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.23 -45.68 87.12 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.84 0.856 . . . . 0.0 111.476 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -58.13 -48.69 79.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.007 0.923 . . . . 0.0 112.024 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.27 -46.77 82.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.76 0.824 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.13 -52.17 59.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.89 0.768 . . . . 0.0 112.622 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 24.6 pt -71.16 -24.99 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -74.36 -43.38 56.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.273 1.429 . . . . 0.0 112.46 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -73.81 -21.34 60.18 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -120.57 115.0 22.56 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.113 0.965 . . . . 0.0 111.382 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.05 -37.33 64.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.666 1.186 . . . . 0.0 112.873 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -60.5 -30.52 69.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 112.757 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.39 -38.17 35.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.946 0.898 . . . . 0.0 111.497 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.07 -32.12 70.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.617 0.767 . . . . 0.0 112.87 172.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.27 -42.23 96.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.54 1.136 . . . . 0.0 113.2 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -51.97 66.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.766 0.826 . . . . 0.0 112.052 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 113.388 -172.846 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.3 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 136.48 39.02 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.039 1.336 . . . . 0.0 110.148 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.12 150.31 97.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.422 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.09 128.82 31.8 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.982 2.455 . . . . 0.0 112.995 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.36 143.84 56.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.589 0.756 . . . . 0.0 110.556 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.32 114.31 3.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.28 0.632 . . . . 0.0 110.089 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.25 156.07 39.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.35 1.06 . . . . 0.0 111.967 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.81 113.96 4.16 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 170.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 30.0 p -67.2 143.63 56.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.694 0.798 . . . . 0.0 112.311 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.69 141.23 57.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.181 0.593 . . . . 0.0 110.852 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.274 0.559 . . . . 0.0 110.909 -178.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -62.22 -38.38 88.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.66 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.59 -53.18 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.814 0.845 . . . . 0.0 111.64 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.35 -43.0 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.53 1.132 . . . . 0.0 111.982 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -52.85 -49.96 64.72 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.429 1.013 . . . . 0.0 111.697 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.98 -37.62 77.24 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.044 0.838 . . . . 0.0 113.013 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -75.8 -46.17 32.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.1 0.96 . . . . 0.0 113.38 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.39 -36.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.951 1.3 . . . . 0.0 111.831 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -120.79 68.08 15.45 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.294 1.838 . . . . 0.0 111.547 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.24 -38.82 3.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.152 2.568 . . . . 0.0 112.968 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.81 -42.9 7.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.772 1.229 . . . . 0.0 112.852 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -69.6 172.98 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.41 1.884 . . . . 0.0 112.822 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.72 -163.23 10.32 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 124.529 1.062 . . . . 0.0 113.938 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.13 152.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.305 1.442 . . . . 0.0 110.627 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 51.4 p -81.24 154.82 26.42 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.207 0.912 . . . . 0.0 112.842 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 47.9 p -56.69 -40.13 75.03 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.215 -0.928 . . . . 0.0 112.011 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.48 -50.22 74.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.955 1.302 . . . . 0.0 111.849 172.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.55 98.12 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.678 0.791 . . . . 0.0 112.989 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.9 -43.58 86.24 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.094 -1.003 . . . . 0.0 111.454 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.08 -48.64 66.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.503 1.049 . . . . 0.0 113.544 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.92 -47.23 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.138 0.975 . . . . 0.0 111.393 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.26 -39.58 83.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.451 1.023 . . . . 0.0 112.887 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -63.99 -46.44 84.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.173 -0.955 . . . . 0.0 111.183 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 57.7 m -55.4 -46.79 76.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.258 0.936 . . . . 0.0 112.373 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -53.94 -53.86 46.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.735 0.814 . . . . 0.0 111.179 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 82.7 t -57.11 -49.0 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.485 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -52.16 -50.77 61.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 120.186 1.357 . . . . 0.0 111.752 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.26 -51.43 66.22 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.59 -45.33 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.379 1.072 . . . . 0.0 111.342 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -55.03 -51.51 66.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.07 1.348 . . . . 0.0 112.369 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.98 -42.02 97.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.165 0.986 . . . . 0.0 112.003 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -60.68 -51.72 68.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.051 0.94 . . . . 0.0 112.305 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 pt -69.52 -26.36 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.88 67.67 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.349 0.977 . . . . 0.0 112.395 169.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.24 86.05 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.166 0.412 . . . . 0.0 112.394 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.5 -43.19 86.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.254 -1.144 . . . . 0.0 112.046 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.72 -42.69 75.69 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.878 1.217 . . . . 0.0 113.129 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 81.5 p -70.03 -44.23 69.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.945 0.793 . . . . 0.0 112.332 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -55.69 -42.16 74.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.653 1.115 . . . . 0.0 113.339 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -57.01 -35.03 68.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.683 1.193 . . . . 0.0 112.389 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.72 -45.58 64.65 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.316 -0.865 . . . . 0.0 112.052 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -59.04 -39.16 81.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.951 1.3 . . . . 0.0 113.616 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -56.55 -29.83 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.13 1.372 . . . . 0.0 112.813 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -99.2 13.86 31.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.812 1.645 . . . . 0.0 112.232 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.62 29.22 6.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.631 2.372 . . . . 0.0 114.464 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -73.36 139.82 46.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.52 1.128 . . . . 0.0 111.336 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 59.6 p -76.61 -32.81 58.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.719 1.208 . . . . 0.0 113.787 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -136.93 -167.94 2.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.505 1.922 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.29 113.09 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.83 1.252 . . . . 0.0 110.482 168.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 30.4 p -85.7 168.87 13.98 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.125 1.37 . . . . 0.0 113.647 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 34.9 p -50.06 -44.72 51.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.23 1.412 . . . . 0.0 113.497 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.04 -42.2 69.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.084 0.953 . . . . 0.0 112.007 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.74 -29.86 71.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.1 -48.84 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.091 -1.006 . . . . 0.0 110.956 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -38.49 83.19 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.331 -0.856 . . . . 0.0 111.406 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 32.6 m -58.43 -48.09 81.82 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.442 -0.786 . . . . 0.0 111.974 169.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.14 -44.65 83.59 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.945 -1.097 . . . . 0.0 112.243 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.41 -49.95 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.844 0.858 . . . . 0.0 111.959 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -72.02 -14.16 61.8 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.19 -29.33 21.83 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.328 1.051 . . . . 0.0 112.121 170.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.2 -47.4 24.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 112.784 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 CA--C 1.545 0.778 0 C-N-CA 124.549 1.14 . . . . 0.0 112.166 -176.828 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.31 151.62 34.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.686 1.136 . . . . 0.0 113.367 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.86 60.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.24 -9.21 86.83 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.05 31.54 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.533 1.667 . . . . 0.0 114.984 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.86 -35.86 81.04 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.62 2.88 . . . . 0.0 114.738 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.71 -44.82 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.018 0.927 . . . . 0.0 110.547 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -65.02 -49.29 70.76 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.51 -38.08 86.43 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.092 -1.005 . . . . 0.0 111.703 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.48 87.58 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.515 -0.74 . . . . 0.0 112.298 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.32 82.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.215 0.916 . . . . 0.0 112.103 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.3 -49.67 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.551 -0.718 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.86 -33.14 75.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -62.07 -29.37 70.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.98 -6.92 50.31 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.322 -1.486 . . . . 0.0 113.917 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.47 -43.76 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.457 1.103 . . . . 0.0 111.268 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 57.9 p -62.56 -19.53 63.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.701 0.801 . . . . 0.0 112.736 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.73 -40.53 40.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.958 1.303 . . . . 0.0 113.666 166.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.95 -45.35 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.667 1.121 . . . . 0.0 111.578 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.24 -41.25 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.118 0.967 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.41 -45.16 85.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.81 1.244 . . . . 0.0 113.17 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -61.26 -44.53 97.08 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.463 1.029 . . . . 0.0 112.034 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.16 -41.26 87.96 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.81 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.19 75.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.108 -0.995 . . . . 0.0 112.528 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.18 -44.14 93.29 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.355 0.978 . . . . 0.0 112.914 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.703 -0.881 . . . . 0.0 111.254 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.18 88.26 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.281 -0.887 . . . . 0.0 112.979 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.16 78.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.055 1.342 . . . . 0.0 112.145 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -54.0 -47.7 71.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.584 1.153 . . . . 0.0 112.508 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -57.97 -34.56 70.08 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.03 4.21 45.98 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.821 1.248 . . . . 0.0 113.444 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.14 32.04 19.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.824 2.05 . . . . 0.0 114.324 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.89 154.05 21.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.933 1.693 . . . . 0.0 113.018 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -115.36 15.68 16.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.474 1.91 . . . . 0.0 113.082 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -130.69 126.85 37.57 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.191 1.397 . . . . 0.0 110.4 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.09 124.27 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.921 0.888 . . . . 0.0 109.766 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.86 164.92 24.08 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.724 1.61 . . . . 0.0 110.879 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -50.16 -34.94 41.01 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.564 2.843 . . . . 0.0 114.915 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.51 -35.57 79.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.889 0.876 . . . . 0.0 113.362 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.63 -39.42 77.18 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.924 -1.11 . . . . 0.0 112.026 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.89 -39.84 91.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.455 0.702 . . . . 0.0 111.229 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.22 -51.74 66.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.336 1.054 . . . . 0.0 111.052 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.09 -39.87 79.69 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.188 0.904 . . . . 0.0 112.811 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.21 70.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.585 0.754 . . . . 0.0 112.493 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.08 -30.53 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -48.82 -35.86 15.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.276 1.83 . . . . 0.0 113.643 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.36 -12.29 61.48 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -130.71 130.34 43.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.009 1.323 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.05 -48.34 82.2 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.128 -0.983 . . . . 0.0 113.24 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.42 -45.99 88.41 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.481 -0.762 . . . . 0.0 112.044 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.8 -36.87 85.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.072 0.851 . . . . 0.0 112.438 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -60.92 -46.39 90.86 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.994 1.27 . . . . 0.0 111.753 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.41 -32.83 74.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 113.388 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.25 -47.89 54.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.488 1.515 . . . . 0.0 112.037 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.772 0.796 . . . . 0.0 110.368 175.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 63.7 tp -99.35 114.58 27.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 109.888 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.58 149.67 98.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.992 170.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.07 118.38 5.16 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.973 2.449 . . . . 0.0 112.344 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.55 132.4 48.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.69 0.796 . . . . 0.0 111.078 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.08 135.42 57.51 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 162.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 38.9 m -62.93 111.74 2.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.279 0.491 . . . . 0.0 110.129 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.31 98.39 6.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.538 0.735 . . . . 0.0 110.021 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -56.15 133.95 52.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.465 0.706 . . . . 0.0 110.126 170.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -61.43 111.1 1.65 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.995 0.518 . . . . 0.0 110.944 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.236 0.384 0 C-N-CA 123.568 0.747 . . . . 0.0 111.396 -174.745 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.01 -42.29 99.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.597 . . . . 0.0 112.519 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -55.07 -37.19 66.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.014 1.325 . . . . 0.0 113.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.23 -57.01 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.873 1.269 . . . . 0.0 111.2 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.58 -37.36 27.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.644 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -46.94 -43.31 18.95 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.844 1.202 . . . . 0.0 112.239 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.89 -50.92 8.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.065 . . . . 0.0 113.08 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.29 -43.71 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 118.837 0.744 . . . . 0.0 112.912 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -126.4 69.06 68.31 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.06 1.744 . . . . 0.0 110.449 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -58.14 -21.42 51.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.798 2.998 . . . . 0.0 114.015 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.19 -10.37 59.4 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.678 1.991 . . . . 0.0 113.991 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -111.45 120.34 41.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.064 1.346 . . . . 0.0 111.948 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.47 168.46 42.15 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.436 1.493 . . . . 0.0 113.923 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 56.9 mt -133.59 132.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.322 1.449 . . . . 0.0 108.694 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 31.0 p -73.94 156.33 37.73 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 51.2 p -55.66 -38.19 69.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.3 -0.875 . . . . 0.0 112.293 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.99 -44.66 84.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.66 1.184 . . . . 0.0 112.452 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.73 88.28 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.917 0.887 . . . . 0.0 111.906 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.3 mtm -59.36 -46.13 89.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.747 -0.595 . . . . 0.0 111.073 171.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.67 58.38 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.961 1.267 . . . . 0.0 114.81 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.04 -35.63 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.202 1.501 . . . . 0.0 111.977 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 78.1 mtm -62.83 -36.64 83.85 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.297 -0.877 . . . . 0.0 112.841 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.37 -46.05 91.8 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 110.527 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -53.89 -47.46 71.11 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.491 0.716 . . . . 0.0 111.973 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -52.03 -37.59 54.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.01 -51.15 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.559 1.527 . . . . 0.0 111.137 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.99 -45.1 95.1 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.179 0.592 . . . . 0.0 111.583 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -56.37 -47.84 78.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.1 -45.84 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.178 0.899 . . . . 0.0 110.02 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.49 -50.75 67.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.943 0.792 . . . . 0.0 111.948 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.56 -44.87 95.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.039 0.936 . . . . 0.0 112.72 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -60.19 -49.72 76.52 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.79 0.723 . . . . 0.0 111.866 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.25 -51.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.163 0.985 . . . . 0.0 110.785 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.46 72.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.111 0.964 . . . . 0.0 112.343 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.82 50.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.517 1.055 . . . . 0.0 113.685 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.28 -45.21 94.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.217 1.009 . . . . 0.0 112.38 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.62 80.7 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.948 0.795 . . . . 0.0 111.796 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 68.4 m -58.27 -52.43 65.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.556 0.742 . . . . 0.0 112.252 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -59.13 -37.9 78.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.971 0.908 . . . . 0.0 113.241 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.22 -42.97 87.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 112.096 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.98 88.5 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.801 0.728 . . . . 0.0 111.972 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -59.38 -45.4 91.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 112.532 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -56.89 -43.04 80.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.671 1.188 . . . . 0.0 112.359 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -79.56 6.7 9.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.446 1.099 . . . . 0.0 113.943 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 54.0 43.18 31.16 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.153 2.181 . . . . 0.0 114.114 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.09 152.02 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.087 1.355 . . . . 0.0 112.434 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 33.1 p -77.88 -45.39 24.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 111.706 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 28.2 m -61.56 117.05 5.25 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.996 1.318 . . . . 0.0 111.746 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -74.17 129.11 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.347 1.459 . . . . 0.0 108.959 163.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -96.41 159.7 14.8 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 38.6 p -57.4 -39.24 75.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.944 0.898 . . . . 0.0 112.387 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.31 -42.23 96.45 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.673 1.189 . . . . 0.0 112.391 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.506 -0.746 . . . . 0.0 111.839 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.56 -42.83 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.38 -0.825 . . . . 0.0 111.12 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.31 -39.15 82.16 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.806 -1.184 . . . . 0.0 112.236 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 81.6 m -64.82 -45.11 87.59 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.918 -1.114 . . . . 0.0 111.964 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.33 -44.14 75.62 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.824 1.193 . . . . 0.0 111.799 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.47 -55.0 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.402 1.081 . . . . 0.0 111.353 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -52.97 -47.27 68.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 120.081 1.31 . . . . 0.0 112.333 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.98 -51.58 67.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.746 1.218 . . . . 0.0 112.577 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.38 -31.15 23.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -170.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 126.401 1.88 . . . . 0.0 111.097 -170.623 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.8 156.35 53.23 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.817 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.78 64.37 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.42 83.9 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.023 1.297 . . . . 0.0 115.895 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.14 82.16 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.686 1.743 . . . . 0.0 115.399 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.19 -39.48 90.13 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.649 2.232 . . . . 0.0 112.922 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.83 -48.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.057 1.343 . . . . 0.0 110.688 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -62.53 -44.4 96.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.76 -53.97 44.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.801 0.84 . . . . 0.0 110.802 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.26 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -53.81 53.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.759 0.823 . . . . 0.0 111.785 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.53 -40.45 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.079 0.952 . . . . 0.0 112.694 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.22 -18.51 58.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.032 1.333 . . . . 0.0 113.739 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -100.47 -29.94 12.1 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.002 1.321 . . . . 0.0 112.927 173.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -55.74 -54.99 37.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.532 1.133 . . . . 0.0 112.943 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -38.02 66.56 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.643 -0.661 . . . . 0.0 112.346 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 38.0 p -64.61 -29.51 70.52 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.567 -0.708 . . . . 0.0 112.846 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.9 65.32 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.701 0.8 . . . . 0.0 112.791 167.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -78.51 -41.63 31.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.56 -0.712 . . . . 0.0 112.379 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -53.97 -50.7 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.226 0.61 . . . . 0.0 110.561 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.73 -33.32 70.71 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.86 -53.0 63.17 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.989 0.813 . . . . 0.0 111.199 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.689 0.796 . . . . 0.0 112.159 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.77 84.59 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.104 -0.997 . . . . 0.0 112.909 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.14 -42.33 93.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.053 0.835 . . . . 0.0 112.659 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.46 -44.41 82.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.023 0.911 . . . . 0.0 111.927 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.59 82.05 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.371 0.987 . . . . 0.0 112.018 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.96 79.56 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.204 1.002 . . . . 0.0 112.58 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.88 -48.59 69.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.32 -32.93 67.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -91.84 6.12 47.34 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.029 1.332 . . . . 0.0 112.629 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.26 32.8 16.86 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.307 2.243 . . . . 0.0 114.252 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -99.68 152.18 20.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.295 1.438 . . . . 0.0 113.041 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -102.02 -6.66 23.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.655 1.582 . . . . 0.0 113.881 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -128.11 129.95 47.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.666 1.587 . . . . 0.0 110.877 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.16 124.69 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.465 1.506 . . . . 0.0 109.721 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.6 pt -117.18 168.16 9.52 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 125.912 1.685 . . . . 0.0 111.34 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.67 -37.07 63.45 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.385 2.723 . . . . 0.0 115.294 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.72 -38.57 88.36 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.314 -0.866 . . . . 0.0 112.797 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -65.59 -39.64 91.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.4 -0.812 . . . . 0.0 112.034 172.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.49 -44.85 93.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.593 0.757 . . . . 0.0 112.045 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.28 -50.13 73.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.898 0.879 . . . . 0.0 111.692 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.7 mt -58.07 -45.33 87.29 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.712 0.805 . . . . 0.0 112.349 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.37 -51.86 61.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.161 0.984 . . . . 0.0 112.129 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.26 -39.97 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -55.28 -42.87 74.16 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.957 -1.089 . . . . 0.0 112.385 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -86.16 -8.08 58.1 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -129.19 116.92 19.92 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.653 1.115 . . . . 0.0 112.409 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -67.53 -35.4 79.01 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -64.92 -42.08 95.02 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.194 0.906 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -51.87 -48.5 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.156 168.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -67.6 -14.62 63.1 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -84.34 -40.65 17.65 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.502 1.046 . . . . 0.0 111.324 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.95 -53.28 11.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.983 1.313 . . . . 0.0 112.019 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 127.109 2.163 . . . . 0.0 107.957 174.081 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.1 t . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.32 111.23 12.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.522 0.729 . . . . 0.0 110.423 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.59 144.43 45.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.953 . . . . 0.0 111.02 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -59.14 148.64 84.79 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.786 2.324 . . . . 0.0 111.729 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.26 70.31 4.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.192 0.997 . . . . 0.0 111.341 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.7 135.76 56.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.179 1.392 . . . . 0.0 110.964 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 31.2 p -69.2 154.04 42.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.855 0.862 . . . . 0.0 112.137 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.7 128.93 39.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.331 1.052 . . . . 0.0 111.707 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 55.9 p -84.88 -9.07 58.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -122.49 142.77 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.236 1.414 . . . . 0.0 111.813 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.6 t60 . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 124.724 1.21 . . . . 0.0 113.125 178.412 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 119.73 -0.176 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.1 -42.68 88.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.824 0.85 . . . . 0.0 112.622 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.08 -45.93 86.31 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.382 -0.824 . . . . 0.0 112.33 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.69 -45.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.469 0.708 . . . . 0.0 110.814 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -53.46 -47.85 69.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.422 1.01 . . . . 0.0 112.73 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -53.35 -41.09 65.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 0.0 112.884 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -76.37 -41.23 48.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.378 1.071 . . . . 0.0 112.821 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.37 -55.36 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.207 1.403 . . . . 0.0 112.732 -168.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -149.52 71.04 9.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.574 1.15 . . . . 0.0 111.47 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.03 -20.28 67.47 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.368 2.712 . . . . 0.0 114.666 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.73 -25.62 68.28 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -119.74 126.12 50.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.9 1.28 . . . . 0.0 109.591 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.98 -172.22 25.93 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.06 0.838 . . . . 0.0 113.489 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -140.18 155.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.948 -1.325 . . . . 0.0 111.689 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 42.0 p -89.35 157.04 18.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.683 0.793 . . . . 0.0 113.039 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.969 . . . . 0.0 112.402 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.07 -48.52 81.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.24 1.016 . . . . 0.0 111.373 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.4 94.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 112.73 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.6 mtp -55.11 -46.22 75.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.023 0.829 . . . . 0.0 111.316 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.76 -46.44 67.36 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.313 0.959 . . . . 0.0 114.245 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.07 -45.5 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 118.086 0.943 . . . . 0.0 111.41 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 85.4 mtp -60.37 -36.23 77.58 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.084 -1.01 . . . . 0.0 113.205 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -60.06 -41.3 92.08 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.92 0.782 . . . . 0.0 110.966 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 50.8 m -60.27 -50.17 74.71 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.302 -0.873 . . . . 0.0 112.13 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -52.03 -47.04 65.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.661 0.784 . . . . 0.0 112.683 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.82 -27.34 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.47 -34.18 72.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.378 0.99 . . . . 0.0 111.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.25 -48.01 71.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.83 -42.01 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 119.493 1.042 . . . . 0.0 111.004 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -56.93 -42.74 80.57 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.392 0.996 . . . . 0.0 111.655 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.29 -41.76 98.78 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -62.64 -45.91 90.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.454 1.025 . . . . 0.0 112.726 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.67 -53.49 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.973 0.909 . . . . 0.0 110.538 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.0 87.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.752 0.821 . . . . 0.0 112.368 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.44 59.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.647 1.118 . . . . 0.0 113.69 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -64.11 -41.04 97.4 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.345 -1.091 . . . . 0.0 111.95 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.78 94.9 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.095 -1.003 . . . . 0.0 112.149 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.6 t -60.78 -46.96 88.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.73 1.212 . . . . 0.0 111.726 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -57.37 -46.01 83.81 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.146 -0.971 . . . . 0.0 112.285 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.78 -45.33 86.13 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.508 0.723 . . . . 0.0 111.863 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.84 80.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.811 0.732 . . . . 0.0 112.22 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -58.29 -49.68 76.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.354 0.979 . . . . 0.0 112.256 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -56.53 -38.37 71.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.88 0.764 . . . . 0.0 112.504 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.64 2.8 31.63 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.931 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.45 35.08 22.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.11 2.164 . . . . 0.0 114.343 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -104.33 145.44 30.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.374 1.87 . . . . 0.0 112.249 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 27.2 p -84.32 -51.88 6.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.152 1.381 . . . . 0.0 111.487 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 60.0 m -82.05 127.35 33.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.042 1.337 . . . . 0.0 111.618 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.09 133.89 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.682 1.193 . . . . 0.0 110.971 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 9.4 p -90.93 160.7 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -50.53 -45.77 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 112.666 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.76 -44.96 88.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.199 1.0 . . . . 0.0 111.63 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -59.14 -40.59 85.97 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.625 0.77 . . . . 0.0 112.272 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.73 -52.83 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.066 0.848 . . . . 0.0 110.969 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -57.65 -42.28 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.954 0.797 . . . . 0.0 112.575 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 92.3 m -64.26 -46.27 84.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.153 0.981 . . . . 0.0 111.247 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.4 81.31 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.139 1.336 . . . . 0.0 113.183 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.8 -51.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.873 0.869 . . . . 0.0 110.664 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.39 -27.69 67.3 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 77.1 mt -64.46 -37.79 88.77 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.451 1.023 . . . . 0.0 111.93 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 50.4 mt -79.37 -29.66 42.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.551 1.01 0 C-N-CA 126.331 1.852 . . . . 0.0 111.39 179.329 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.464 0.649 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.22 147.05 43.68 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.247 0.927 . . . . 0.0 112.983 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.29 -58.95 2.96 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.753 0.821 . . . . 0.0 113.059 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.86 88.4 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.11 -59.61 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 119.483 1.642 . . . . 0.0 113.938 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.03 -33.64 98.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.539 2.159 . . . . 0.0 113.058 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.76 -42.67 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.21 1.368 . . . . 0.0 111.584 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -77.22 -38.87 50.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.869 -1.144 . . . . 0.0 113.602 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.91 -43.62 73.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.92 1.236 . . . . 0.0 110.581 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.92 91.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.943 0.897 . . . . 0.0 112.787 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.78 -42.94 76.28 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.293 1.406 . . . . 0.0 112.667 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -60.14 -53.39 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.574 0.625 . . . . 0.0 111.39 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.11 -21.59 65.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -48.85 -49.06 41.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.644 1.111 . . . . 0.0 112.062 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -64.03 -29.56 70.7 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -73.59 -51.42 16.95 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.983 0.913 . . . . 0.0 111.659 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 67.8 p -70.88 -21.42 62.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.972 -1.08 . . . . 0.0 113.372 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.55 94.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.244 1.018 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -38.63 91.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.242 0.928 . . . . 0.0 111.768 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mt -56.47 -52.66 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 118.809 0.731 . . . . 0.0 110.148 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.39 -30.04 70.81 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.21 -53.85 42.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.805 1.184 . . . . 0.0 111.165 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.62 -41.51 99.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.856 0.863 . . . . 0.0 111.995 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.38 87.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.317 1.047 . . . . 0.0 111.858 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.75 97.73 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.766 1.175 . . . . 0.0 112.935 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.18 -44.36 95.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.435 1.117 . . . . 0.0 111.253 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.226 -0.921 . . . . 0.0 112.462 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.22 82.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.402 1.081 . . . . 0.0 112.011 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.68 -50.33 63.49 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 0.0 112.21 171.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -58.16 -36.0 72.38 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -87.05 3.34 46.46 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.797 1.239 . . . . 0.0 113.441 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 92.3 mttt 55.64 32.91 20.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.844 2.058 . . . . 0.0 114.257 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.6 152.79 22.01 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.907 1.683 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 30.4 p -109.41 12.17 24.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.014 1.726 . . . . 0.0 112.905 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -133.54 126.65 31.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.472 -1.393 . . . . 0.0 111.268 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.6 127.52 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.027 0.931 . . . . 0.0 109.19 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.04 167.13 13.83 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.987 1.715 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -44.49 -42.71 14.16 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.241 3.294 . . . . 0.0 115.465 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.87 -40.69 93.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.749 0.82 . . . . 0.0 112.887 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -65.66 -41.56 92.38 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.621 0.768 . . . . 0.0 111.904 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.57 -43.9 95.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.41 0.684 . . . . 0.0 111.618 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -56.69 -50.29 72.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.426 1.09 . . . . 0.0 111.713 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.79 -46.85 81.29 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.736 0.698 . . . . 0.0 111.978 173.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.79 62.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.596 0.758 . . . . 0.0 112.593 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 pt -68.34 -30.84 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -65.78 -41.89 91.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.774 1.229 . . . . 0.0 112.388 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -79.57 -7.55 58.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -171.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -124.1 122.0 36.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.952 1.251 . . . . 0.0 111.361 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -53.33 -41.61 65.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.42 1.088 . . . . 0.0 112.516 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -64.08 -29.49 70.63 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.286 -0.883 . . . . 0.0 113.358 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.57 -43.83 30.52 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.607 -0.683 . . . . 0.0 111.306 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -53.93 -45.55 71.27 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.91 0.884 . . . . 0.0 112.261 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.39 -26.5 53.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.086 1.354 . . . . 0.0 113.915 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -91.12 -97.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.088 1.355 . . . . 0.0 110.276 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 CA--C 1.541 0.614 0 CA-C-N 119.852 1.205 . . . . 0.0 110.617 175.322 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -71.76 106.39 4.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.138 0.575 . . . . 0.0 109.593 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.59 140.43 97.51 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.135 0.574 . . . . 0.0 110.98 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -59.29 144.84 99.26 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.607 2.205 . . . . 0.0 111.407 172.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.72 124.21 17.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.301 0.64 . . . . 0.0 110.062 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.45 119.69 7.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.976 0.91 . . . . 0.0 110.004 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -57.14 123.03 13.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.215 1.006 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.17 111.51 5.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 23.4 t -123.13 118.34 27.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.148 1.379 . . . . 0.0 109.73 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -84.57 128.65 34.71 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.689 0.795 . . . . 0.0 110.786 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 123.702 0.801 . . . . 0.0 111.728 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -45.79 -34.68 3.84 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.746 1.618 . . . . 0.0 113.046 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -50.23 -33.93 21.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.497 -1.377 . . . . 0.0 114.086 171.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.5 -50.71 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.456 1.025 . . . . 0.0 110.454 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -51.87 66.76 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.876 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -51.0 -40.45 58.15 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -80.55 -50.29 10.21 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 113.179 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.44 -47.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.738 0.815 . . . . 0.0 111.937 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -131.24 84.9 55.53 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.598 1.559 . . . . 0.0 110.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.4 -31.26 76.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.571 2.847 . . . . 0.0 115.161 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -70.13 -19.51 63.22 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -94.59 133.16 38.53 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.855 1.262 . . . . 0.0 112.048 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.34 -172.49 13.22 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.731 1.158 . . . . 0.0 114.691 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -121.96 162.21 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.616 1.566 . . . . 0.0 110.284 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -89.45 163.58 15.2 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.958 168.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -55.84 -41.22 73.96 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.169 0.988 . . . . 0.0 111.845 168.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.43 -41.15 93.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.308 1.043 . . . . 0.0 112.176 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.32 92.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.763 0.825 . . . . 0.0 112.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 56.6 tpp -52.9 -48.26 67.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.005 168.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.55 -45.39 77.23 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.497 1.046 . . . . 0.0 114.729 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.72 -42.55 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.49 1.145 . . . . 0.0 112.011 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.73 -41.0 94.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.936 -1.102 . . . . 0.0 111.46 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -60.79 -47.3 86.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.848 0.859 . . . . 0.0 112.083 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 81.0 p -64.81 -39.63 93.91 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.572 1.533 . . . . 0.0 112.775 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -51.82 -55.83 17.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.93 1.292 . . . . 0.0 111.908 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.35 -31.2 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -60.94 -44.07 97.76 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.058 0.845 . . . . 0.0 112.04 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.49 -42.22 87.09 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.727 -0.608 . . . . 0.0 111.987 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.99 -43.28 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.34 -0.85 . . . . 0.0 111.466 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.36 -44.56 76.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.418 1.463 . . . . 0.0 112.501 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.717 0.69 . . . . 0.0 111.743 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -61.68 -43.76 98.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.775 0.83 . . . . 0.0 112.881 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -52.95 -52.8 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.555 1.142 . . . . 0.0 110.132 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.36 90.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.28 -50.85 61.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.892 0.758 . . . . 0.0 113.235 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -64.17 -41.45 97.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.604 -0.939 . . . . 0.0 112.156 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.15 94.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.419 1.009 . . . . 0.0 112.007 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -57.8 -53.77 54.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.291 1.036 . . . . 0.0 111.866 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -51.88 -54.75 25.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.169 0.987 . . . . 0.0 112.025 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.62 -44.51 89.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.297 1.039 . . . . 0.0 112.705 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.39 79.35 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.967 0.803 . . . . 0.0 112.138 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -63.14 -45.33 92.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.776 0.83 . . . . 0.0 112.594 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -60.62 -35.94 77.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.076 0.95 . . . . 0.0 112.45 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -86.18 15.49 5.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.613 1.565 . . . . 0.0 113.215 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 55.3 29.04 12.2 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.547 2.339 . . . . 0.0 115.075 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -81.77 152.92 26.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.489 1.116 . . . . 0.0 112.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 53.9 p -71.13 -35.6 71.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.834 1.253 . . . . 0.0 112.824 170.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 7.2 t -143.73 167.39 22.4 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.39 1.476 . . . . 0.0 112.806 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 84.1 mt -71.45 138.19 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.51 1.524 . . . . 0.0 110.457 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 16.7 p -112.51 166.16 11.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.511 1.125 . . . . 0.0 111.814 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 31.7 p -51.56 -41.66 61.29 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.403 1.081 . . . . 0.0 112.67 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.51 -45.76 89.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.3 1.04 . . . . 0.0 111.932 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.87 -40.68 96.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.323 0.51 . . . . 0.0 112.276 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.5 -51.78 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.685 0.794 . . . . 0.0 110.963 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -53.2 -48.63 67.95 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.68 1.127 . . . . 0.0 111.852 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 77.1 m -60.49 -46.28 90.67 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.187 0.903 . . . . 0.0 112.16 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.29 72.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.475 1.034 . . . . 0.0 112.753 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -60.31 -50.92 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.005 0.922 . . . . 0.0 110.583 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -58.42 -39.52 80.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.493 1.117 . . . . 0.0 113.748 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 72.4 mt -58.08 -44.2 87.42 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.721 0.691 . . . . 0.0 112.212 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.11 -37.76 64.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.226 1.01 . . . . 0.0 112.139 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 mt . . . . . 0 CA--C 1.553 1.091 0 C-N-CA 126.565 1.946 . . . . 0.0 111.059 -171.681 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.739 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.19 135.56 47.59 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.146 3.231 . . . . 0.0 113.491 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -74.32 156.87 50.47 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.875 1.226 . . . . 0.0 113.693 171.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 99.8 mmm -68.68 138.38 54.91 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.74 0.816 . . . . 0.0 111.867 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 40.1 p -80.96 143.45 32.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.427 1.091 . . . . 0.0 113.412 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.41 151.61 52.33 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.353 0.978 . . . . 0.0 112.964 170.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.49 136.18 57.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.039 0.936 . . . . 0.0 111.686 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.52 -28.1 73.54 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.221 0.915 . . . . 0.0 114.712 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.82 137.07 58.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.968 1.307 . . . . 0.0 112.244 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -92.75 168.19 11.37 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.805 1.242 . . . . 0.0 112.139 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.16 -152.76 48.89 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.181 0.896 . . . . 0.0 113.43 -172.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.43 5.3 35.32 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 124.759 1.171 . . . . 0.0 115.95 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -77.12 150.12 35.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.427 1.491 . . . . 0.0 111.776 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.18 132.18 46.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.147 0.579 . . . . 0.0 110.978 169.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.62 138.54 55.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.575 0.75 . . . . 0.0 111.354 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.01 133.92 51.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.525 0.73 . . . . 0.0 111.86 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.16 145.8 54.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.936 0.894 . . . . 0.0 111.489 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.97 137.59 58.27 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.347 0.659 . . . . 0.0 111.706 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 135.39 57.27 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.745 0.818 . . . . 0.0 111.779 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 33.4 p -73.12 156.99 38.1 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.369 1.067 . . . . 0.0 112.265 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -60.81 146.2 47.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 51.8 p -74.41 -37.37 63.38 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.576 1.15 . . . . 0.0 112.923 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 19.9 t -58.18 129.31 41.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 112.134 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.82 144.48 49.11 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.645 1.178 . . . . 0.0 112.102 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.02 118.22 10.91 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.67 0.788 . . . . 0.0 112.173 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.8 165.01 54.04 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.651 1.119 . . . . 0.0 113.66 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -78.59 151.99 32.08 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.923 0.889 . . . . 0.0 111.488 171.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -79.5 117.72 20.71 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.764 -0.585 . . . . 0.0 110.098 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.61 147.58 34.25 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 124.504 1.122 . . . . 0.0 110.403 170.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.23 -27.2 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.438 2.092 . . . . 0.0 114.32 -167.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.94 -32.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 O-C-N 120.629 -1.295 . . . . 0.0 113.244 -170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.87 -30.32 74.87 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.348 0.975 . . . . 0.0 114.046 170.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 16.4 tpp85 -79.41 -37.87 36.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.33 1.052 . . . . 0.0 111.714 170.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.84 -39.97 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.529 1.059 . . . . 0.0 111.265 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -50.57 -48.2 57.63 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 119.321 0.964 . . . . 0.0 112.394 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -66.7 -38.65 87.16 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.037 0.935 . . . . 0.0 112.953 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.24 -42.53 91.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.66 1.118 . . . . 0.0 111.992 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 95.7 mt -59.9 -44.63 94.13 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.438 0.695 . . . . 0.0 111.707 172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -61.13 -45.85 92.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.103 0.961 . . . . 0.0 112.764 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -58.73 -42.21 88.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.209 1.403 . . . . 0.0 112.444 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.98 -20.91 54.84 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 124.837 1.208 . . . . 0.0 114.464 170.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.9 t30 53.83 39.69 30.65 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.094 2.158 . . . . 0.0 113.51 176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -62.88 -36.67 84.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.863 0.865 . . . . 0.0 112.527 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 59.7 p -151.84 178.75 9.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.726 1.211 . . . . 0.0 112.682 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -61.58 -39.09 89.93 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.552 1.141 . . . . 0.0 113.651 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -139.67 146.84 40.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.541 1.536 . . . . 0.0 110.982 174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 92.9 t -102.77 118.87 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.02 142.76 48.0 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.884 0.754 . . . . 0.0 112.862 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.43 -38.28 68.79 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 118.281 1.041 . . . . 0.0 113.513 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.98 -24.98 76.15 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.445 1.021 . . . . 0.0 114.982 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.22 -55.82 37.96 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.355 1.578 . . . . 0.0 114.36 -174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -59.83 -34.41 95.65 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.357 2.038 . . . . 0.0 113.068 175.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.69 -51.02 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 119.155 0.888 . . . . 0.0 110.91 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -66.78 -42.28 86.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.589 0.756 . . . . 0.0 110.118 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 69.7 mt -63.32 -35.16 79.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.445 -0.788 . . . . 0.0 112.932 173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.52 -44.21 93.21 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 120.508 1.504 . . . . 0.0 112.077 171.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.69 -50.39 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 122.92 0.488 . . . . 0.0 111.864 172.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -51.57 -53.86 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.512 1.125 . . . . 0.0 111.393 173.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 mt -53.11 -49.1 67.19 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.718 1.607 . . . . 0.0 112.104 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -48.04 -51.63 23.4 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.49 1.041 . . . . 0.0 111.985 176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -69.45 -31.99 70.65 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -58.53 -23.3 57.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 1.5 p -119.22 5.12 11.24 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.598 1.544 . . . . 0.0 114.867 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.65 73.65 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 120.165 1.348 . . . . 0.0 112.718 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -70.1 -32.96 71.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.8 -54.14 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.012 0.925 . . . . 0.0 109.667 172.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.92 -46.48 81.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.51 1.524 . . . . 0.0 112.551 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -54.71 -56.78 15.59 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.586 0.754 . . . . 0.0 111.514 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -71.43 -38.07 71.4 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.0 99.45 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.334 -0.854 . . . . 0.0 111.802 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.8 -37.97 94.99 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.506 -0.746 . . . . 0.0 113.596 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -58.8 -49.89 76.01 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.848 1.324 . . . . 0.0 110.603 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.01 -42.78 80.96 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.63 0.772 . . . . 0.0 112.509 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.1 75.36 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.817 0.847 . . . . 0.0 112.606 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -56.82 -50.95 70.84 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.436 1.094 . . . . 0.0 112.289 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -55.51 -42.01 73.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.613 1.165 . . . . 0.0 113.075 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -87.79 10.68 17.62 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.625 1.17 . . . . 0.0 113.089 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 53.63 33.32 16.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.392 2.277 . . . . 0.0 114.777 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -89.29 146.51 24.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.23 1.412 . . . . 0.0 112.386 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.6 p -77.91 -30.63 50.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.881 1.272 . . . . 0.0 112.967 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -131.24 151.76 51.17 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.126 1.37 . . . . 0.0 112.603 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.7 mt -67.46 129.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.015 . . . . 0.0 109.928 167.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 pt -122.71 167.1 15.16 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 126.429 1.892 . . . . 0.0 111.265 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -54.55 -34.5 82.73 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.344 2.696 . . . . 0.0 114.952 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.03 -36.75 75.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.988 0.915 . . . . 0.0 113.252 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -63.23 -38.69 92.17 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.551 -0.718 . . . . 0.0 111.982 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 96.2 mt -68.21 -46.27 71.05 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.502 0.721 . . . . 0.0 111.761 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -50.65 -46.64 58.52 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.725 0.81 . . . . 0.0 111.746 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 99.1 mt -63.83 -62.31 1.73 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.944 0.898 . . . . 0.0 112.173 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.99 69.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.755 1.222 . . . . 0.0 113.074 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -56.87 -61.06 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.857 0.863 . . . . 0.0 110.741 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.0 -32.69 74.11 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -172.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -86.79 -8.59 57.21 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -129.3 118.1 21.74 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 112.407 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -65.78 -26.81 67.87 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.822 -1.173 . . . . 0.0 114.067 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -70.98 -31.36 67.89 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.623 -1.298 . . . . 0.0 111.489 174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.75 -36.94 67.81 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.404 -0.81 . . . . 0.0 111.493 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -58.54 -29.38 66.3 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.406 1.003 . . . . 0.0 112.771 168.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -77.11 -46.0 25.01 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 119.417 1.008 . . . . 0.0 112.417 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 54.8 mt -57.18 -45.1 83.98 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.083 0.953 . . . . 0.0 112.877 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 43.0 tp -83.6 122.19 28.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.763 0.825 . . . . 0.0 111.992 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.35 -127.81 44.45 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 123.686 0.66 . . . . 0.0 114.407 167.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -62.91 123.95 19.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.357 1.063 . . . . 0.0 111.953 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.89 123.75 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.351 1.061 . . . . 0.0 109.937 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.393 0.677 . . . . 0.0 111.806 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -68.44 124.3 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 121.582 -0.699 . . . . 0.0 109.65 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.14 -42.32 72.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.65 0.78 . . . . 0.0 113.065 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -78.06 158.36 29.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.115 0.966 . . . . 0.0 112.57 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.76 8.56 77.48 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.057 0.837 . . . . 0.0 114.855 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.77 141.9 48.19 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.871 1.224 . . . . 0.0 113.065 172.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 52.4 t -68.47 123.71 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.047 0.939 . . . . 0.0 110.982 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.48 144.36 42.99 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.242 1.017 . . . . 0.0 111.347 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.75 -34.98 17.24 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.113 2.542 . . . . 0.0 113.354 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -71.14 133.49 46.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.87 0.868 . . . . 0.0 110.525 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.33 117.76 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.799 0.839 . . . . 0.0 109.71 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -80.79 148.07 30.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.935 0.894 . . . . 0.0 111.244 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.17 132.09 51.63 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.864 -0.522 . . . . 0.0 111.272 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.0 120.34 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.25 96.06 3.27 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.12 140.37 97.65 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.33 0.652 . . . . 0.0 110.789 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -58.66 149.52 76.01 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.44 2.093 . . . . 0.0 111.15 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -61.15 109.26 1.06 Allowed 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.783 -0.573 . . . . 0.0 109.929 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.31 131.45 46.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.921 0.889 . . . . 0.0 110.387 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -63.34 155.57 28.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.275 0.63 . . . . 0.0 110.813 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.84 121.05 10.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.317 -0.865 . . . . 0.0 110.296 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -58.46 136.7 57.56 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.406 0.682 . . . . 0.0 111.151 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -68.8 100.39 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.102 0.561 . . . . 0.0 111.309 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -62.62 152.66 34.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.546 1.138 . . . . 0.0 111.409 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -52.97 116.44 2.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.08 0.952 . . . . 0.0 111.037 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.91 140.52 57.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.738 0.815 . . . . 0.0 111.861 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -69.48 112.34 5.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.703 0.801 . . . . 0.0 111.047 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.32 178.64 37.71 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.862 1.22 . . . . 0.0 114.422 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--O 1.252 1.211 0 C-N-CA 125.485 1.514 . . . . 0.0 111.951 174.684 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.888 0 CA-C-O 119.877 -0.401 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -60.85 -23.98 78.1 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.838 3.692 . . . . 0.0 114.904 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -63.77 -20.1 63.77 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.327 0.965 . . . . 0.0 115.234 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.3 mmm -79.56 141.76 56.84 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 118.559 1.18 . . . . 0.0 112.108 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.24 144.04 94.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.103 2.536 . . . . 0.0 112.175 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -72.45 124.26 90.57 Favored Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 121.581 -0.699 . . . . 0.0 110.211 170.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -63.5 147.02 93.43 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.026 2.484 . . . . 0.0 112.169 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.79 115.43 5.29 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.388 0.675 . . . . 0.0 111.633 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -86.66 143.96 27.36 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.942 1.297 . . . . 0.0 111.315 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 54.5 p -66.81 156.78 34.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.815 0.846 . . . . 0.0 112.207 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.2 131.45 84.12 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.718 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -55.17 128.55 30.98 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.067 2.512 . . . . 0.0 113.342 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.12 131.05 94.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 123.243 0.617 . . . . 0.0 111.257 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -62.6 137.69 65.65 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.054 2.503 . . . . 0.0 112.016 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.68 131.75 51.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.584 0.753 . . . . 0.0 110.726 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.4 134.17 54.03 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.575 0.75 . . . . 0.0 110.883 174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.71 140.11 48.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.668 0.652 . . . . 0.0 112.253 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 69.4 p -60.63 152.51 26.22 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.453 0.701 . . . . 0.0 112.354 173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -66.67 103.81 1.17 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.556 0.742 . . . . 0.0 110.173 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.69 130.48 44.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 110.429 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.34 124.1 21.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.124 0.57 . . . . 0.0 110.989 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.4 t -79.42 108.24 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 56.1 p -76.79 166.34 23.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 0.0 112.687 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.03 108.44 2.22 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 124.14 19.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.59 0.756 . . . . 0.0 110.927 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -73.28 142.13 47.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.172 0.589 . . . . 0.0 110.351 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -72.92 105.3 4.36 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.606 -0.684 . . . . 0.0 111.163 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -101.35 -1.36 33.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.627 1.571 . . . . 0.0 113.158 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -75.09 139.24 42.66 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.305 1.042 . . . . 0.0 111.578 167.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.33 16.19 62.29 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -63.66 138.17 58.39 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.628 1.214 . . . . 0.0 113.151 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -96.87 -26.79 14.96 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.867 1.267 . . . . 0.0 113.273 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -99.27 88.36 3.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.722 1.609 . . . . 0.0 110.598 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -137.76 154.65 49.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.848 1.659 . . . . 0.0 112.238 176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.28 -16.48 17.69 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.652 1.181 . . . . 0.0 113.692 170.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 9.9 t -63.76 122.27 16.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.563 0.745 . . . . 0.0 111.104 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.41 150.56 46.18 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.113 0.965 . . . . 0.0 110.142 169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -48.3 118.54 2.49 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.588 0.755 . . . . 0.0 110.192 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -62.54 110.73 1.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.215 1.006 . . . . 0.0 110.727 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 15.3 t -154.92 -179.74 8.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.333 1.853 . . . . 0.0 109.662 -172.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -62.14 -17.81 59.02 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -42.2 -33.31 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.639 1.976 . . . . 0.0 114.185 173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -41.69 -54.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.234 1.814 . . . . 0.0 111.705 169.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -90.56 -25.15 20.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.46 -58.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.096 0.959 . . . . 0.0 110.412 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -69.92 -41.47 74.58 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.14 -58.34 8.34 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 0.0 112.223 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 51.6 t -71.97 -35.87 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.962 -0.461 . . . . 0.0 111.372 -176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 46.8 tp -50.15 -57.54 7.49 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.679 169.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.77 -34.21 77.65 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -63.72 -50.16 70.22 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.509 0.724 . . . . 0.0 112.546 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.37 -44.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.921 0.889 . . . . 0.0 111.966 -173.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -126.41 66.05 61.02 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 126.52 1.928 . . . . 0.0 111.445 -174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -55.99 -25.88 56.01 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 124.016 3.144 . . . . 0.0 114.18 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.3 -14.21 59.79 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.521 2.328 . . . . 0.0 114.2 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -121.17 126.21 49.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.527 1.131 . . . . 0.0 111.741 -169.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.68 -164.75 40.54 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.071 0.843 . . . . 0.0 113.667 172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.9 tt -143.79 149.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 120.99 -1.3 . . . . 0.0 111.73 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -80.69 156.07 26.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -56.65 -39.25 73.37 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.243 -0.91 . . . . 0.0 112.128 172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.98 -55.82 29.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.189 1.396 . . . . 0.0 111.57 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.95 -42.08 97.55 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.469 0.708 . . . . 0.0 112.558 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 53.9 ttp -54.59 -53.55 53.09 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.846 0.859 . . . . 0.0 111.681 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.44 -43.4 85.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 123.786 0.708 . . . . 0.0 113.069 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.84 -48.33 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.161 0.984 . . . . 0.0 111.113 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 65.1 mtt -57.5 -41.64 81.13 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.984 1.265 . . . . 0.0 112.615 175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.86 -52.06 67.35 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.432 0.56 . . . . 0.0 110.727 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 72.8 m -54.92 -47.57 74.23 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.12 0.873 . . . . 0.0 112.794 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -54.54 -46.89 73.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.225 1.01 . . . . 0.0 112.02 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -44.1 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.513 0.597 . . . . 0.0 111.739 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.06 -41.98 84.5 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.356 0.98 . . . . 0.0 111.933 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -60.0 -31.14 69.64 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 tp -90.9 -34.1 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.83 0.852 . . . . 0.0 111.707 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -59.13 -42.05 89.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.61 1.164 . . . . 0.0 112.46 174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -56.82 -44.38 81.96 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.371 1.068 . . . . 0.0 111.925 171.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -64.93 -44.87 88.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.053 0.941 . . . . 0.0 111.76 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 58.3 mt -55.52 -49.4 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.707 1.203 . . . . 0.0 110.986 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.43 -47.37 81.96 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.831 0.852 . . . . 0.0 112.359 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.87 -46.11 90.86 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.268 0.937 . . . . 0.0 113.594 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -66.6 -41.89 87.75 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.379 -1.071 . . . . 0.0 112.856 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.47 94.36 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.156 0.889 . . . . 0.0 111.53 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -57.69 -49.76 75.45 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.418 1.087 . . . . 0.0 111.928 171.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.74 -49.86 67.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.471 1.109 . . . . 0.0 112.039 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.9 -48.22 78.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.685 0.794 . . . . 0.0 111.733 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.71 -44.97 73.92 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.766 0.712 . . . . 0.0 112.473 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -57.6 -52.21 66.37 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.898 . . . . 0.0 112.387 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -62.43 -32.75 73.65 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -81.16 4.8 18.83 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.908 1.283 . . . . 0.0 113.627 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 56.86 31.9 20.46 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.968 2.107 . . . . 0.0 114.275 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -101.08 140.97 34.64 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.6 1.56 . . . . 0.0 112.074 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 61.0 p -79.68 -19.63 48.52 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.844 1.258 . . . . 0.0 113.086 168.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 63.7 p -114.73 148.91 37.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.87 2.068 . . . . 0.0 111.651 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 52.2 mt -85.75 129.32 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.202 1.001 . . . . 0.0 110.014 170.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 6.1 p -83.37 162.42 21.06 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.016 0.912 . . . . 0.0 113.31 177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -65.78 -10.29 36.04 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.91 1.284 . . . . 0.0 114.295 170.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.44 -40.97 8.43 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.17 1.388 . . . . 0.0 112.187 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -56.53 -39.97 74.3 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.118 0.967 . . . . 0.0 112.663 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 21.7 pt -57.81 -41.32 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -61.86 -49.5 75.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.229 0.922 . . . . 0.0 110.376 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 45.2 m -60.81 -46.86 88.89 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.397 1.079 . . . . 0.0 111.833 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.2 -46.93 65.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.445 1.098 . . . . 0.0 112.525 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.5 -51.23 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.605 0.762 . . . . 0.0 111.008 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -53.96 -45.78 71.42 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.114 0.966 . . . . 0.0 112.598 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 81.9 mt -57.92 -36.77 72.95 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.875 1.27 . . . . 0.0 112.962 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 84.4 mt -86.81 -22.41 25.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.551 1.14 . . . . 0.0 113.787 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 24.5 mt -115.69 78.56 6.97 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.736 1.214 . . . . 0.0 112.108 -172.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -61.87 157.35 43.71 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 122.818 2.345 . . . . 0.0 113.412 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 59.84 -137.8 49.34 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.862 1.22 . . . . 0.0 114.53 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.76 -21.2 66.71 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.65 -41.39 85.96 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.435 -0.791 . . . . 0.0 112.061 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.82 73.39 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.118 0.872 . . . . 0.0 113.244 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -56.6 -44.14 80.84 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.45 1.023 . . . . 0.0 110.963 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -66.04 -71.07 0.21 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.701 0.8 . . . . 0.0 112.251 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -29.28 69.16 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -166.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.44 -57.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.327 1.051 . . . . 0.0 111.459 -175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 10.8 t -66.26 -58.56 5.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.075 1.307 . . . . 0.0 111.645 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.47 -30.11 69.74 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.242 -0.911 . . . . 0.0 112.3 172.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.5 -48.8 59.54 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 124.119 0.866 . . . . 0.0 113.917 168.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.2 m -66.91 -39.51 87.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.343 1.057 . . . . 0.0 111.854 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.21 -40.96 87.44 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.291 0.95 . . . . 0.0 112.199 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.66 -23.48 67.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 99.6 t -48.47 -41.59 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 120.147 1.34 . . . . 0.0 111.865 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 38.0 m -52.37 -39.46 60.8 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.77 1.228 . . . . 0.0 112.946 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.0 -47.82 76.12 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.091 -1.006 . . . . 0.0 111.059 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -61.92 -32.24 72.62 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 60.3 p -81.35 -39.3 25.3 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.418 1.008 . . . . 0.0 112.827 176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 42.4 m -69.39 -51.64 34.64 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.43 142.24 33.14 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.97 0.908 . . . . 0.0 112.224 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 82.2 tttt . . . . . 0 C--O 1.253 1.26 0 C-N-CA 124.176 0.991 . . . . 0.0 112.044 177.434 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 CA-C-O 119.478 -0.623 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.37 149.33 91.16 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.989 3.126 . . . . 0.0 113.076 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -61.24 137.34 47.76 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.777 0.703 . . . . 0.0 112.307 169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.6 mmm -59.82 137.64 58.0 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.47 0.708 . . . . 0.0 111.738 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p -91.14 160.54 15.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.964 1.306 . . . . 0.0 112.815 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.99 -123.99 27.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.683 0.658 . . . . 0.0 112.385 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.96 144.16 57.47 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.92 0.86 . . . . 0.0 112.159 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.86 3.9 75.32 Favored Glycine 0 CA--C 1.541 1.692 0 C-N-CA 124.753 1.168 . . . . 0.0 115.643 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -74.82 117.42 16.64 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.055 1.427 . . . . 0.0 110.969 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -64.67 124.93 23.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.09 0.556 . . . . 0.0 110.697 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.1 11.64 52.31 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 124.33 0.967 . . . . 0.0 115.179 -171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.0 154.93 53.17 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.052 1.31 . . . . 0.0 114.14 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.51 118.78 6.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.258 1.023 . . . . 0.0 110.587 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.05 136.49 57.34 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.359 0.664 . . . . 0.0 110.949 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -58.8 129.94 44.52 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.31 0.644 . . . . 0.0 111.278 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.02 56.43 1.98 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.155 1.382 . . . . 0.0 112.066 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -54.28 133.48 44.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.168 1.387 . . . . 0.0 111.082 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.02 136.4 57.94 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.036 0.534 . . . . 0.0 111.092 172.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.74 102.0 2.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.499 0.719 . . . . 0.0 109.988 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 39.3 p -69.75 148.78 48.74 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.298 1.039 . . . . 0.0 112.009 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.98 139.45 55.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.387 0.675 . . . . 0.0 111.248 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 61.5 p -71.18 -25.64 62.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.361 1.064 . . . . 0.0 113.423 177.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -55.52 125.97 23.24 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.951 1.3 . . . . 0.0 112.038 174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.09 142.06 36.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.494 1.117 . . . . 0.0 111.545 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.93 -27.61 66.77 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.317 0.647 . . . . 0.0 112.653 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.03 -141.5 47.41 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.87 1.224 . . . . 0.0 112.993 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.42 97.81 8.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.53 0.732 . . . . 0.0 111.059 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -103.15 141.62 35.55 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.184 1.394 . . . . 0.0 110.182 168.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.0 74.87 80.17 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.152 0.981 . . . . 0.0 112.157 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -65.99 165.46 23.82 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.649 2.233 . . . . 0.0 111.784 165.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 11.9 t -67.0 -21.35 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 120.271 -1.518 . . . . 0.0 113.047 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.76 -43.68 91.86 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.207 0.912 . . . . 0.0 112.92 161.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -71.09 -37.85 72.41 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.518 -0.989 . . . . 0.0 112.259 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 37.0 t -55.94 -44.89 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 119.495 1.043 . . . . 0.0 110.529 168.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -63.03 -38.3 90.62 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.671 -1.268 . . . . 0.0 112.411 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.02 -41.52 99.57 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.156 0.982 . . . . 0.0 113.066 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 94.3 mt -62.73 -43.34 99.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.859 0.864 . . . . 0.0 111.575 172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.55 -42.08 98.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.518 1.527 . . . . 0.0 112.509 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -54.33 -55.77 25.11 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.066 1.346 . . . . 0.0 111.153 172.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.89 -37.0 84.97 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.01 0.924 . . . . 0.0 113.062 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.99 8.42 23.22 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.053 2.263 . . . . 0.0 116.493 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 61.9 24.86 14.86 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.489 1.916 . . . . 0.0 115.387 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.6 -32.34 18.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.391 1.076 . . . . 0.0 112.894 172.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.0 t -124.57 137.87 54.36 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.039 1.336 . . . . 0.0 110.757 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -80.17 -40.11 27.95 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.167 -0.958 . . . . 0.0 112.349 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -137.23 165.25 26.57 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.518 1.527 . . . . 0.0 111.505 173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.41 105.88 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.453 1.501 . . . . 0.0 108.491 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.59 -179.22 27.29 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 123.947 0.784 . . . . 0.0 113.48 171.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.46 -50.04 23.7 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.578 -0.954 . . . . 0.0 111.997 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.76 -26.69 55.76 Favored Glycine 0 N--CA 1.473 1.124 0 C-N-CA 124.71 1.148 . . . . 0.0 115.458 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.78 -52.33 73.13 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.77 -37.1 89.0 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.59 2.194 . . . . 0.0 112.914 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.77 -40.97 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.755 0.822 . . . . 0.0 110.827 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -64.69 -45.12 87.98 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.373 -0.83 . . . . 0.0 112.547 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 tp -60.01 -40.45 89.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.647 1.112 . . . . 0.0 111.827 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.91 -45.38 90.45 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.346 -0.846 . . . . 0.0 111.334 167.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.88 -18.64 57.44 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.52 -59.43 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.322 -0.861 . . . . 0.0 110.733 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mp -68.67 -21.27 64.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.299 1.04 . . . . 0.0 112.869 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -37.7 -49.3 1.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.594 1.958 . . . . 0.0 112.917 159.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -61.18 -50.24 73.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.917 0.78 . . . . 0.0 112.5 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.7 mt -59.34 -48.4 81.77 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.621 . . . . 0.0 111.348 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 71.8 m -60.98 -41.18 95.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.8 -0.619 . . . . 0.0 112.665 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.04 83.15 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.323 0.965 . . . . 0.0 112.086 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -56.5 -46.44 80.5 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.048 0.84 . . . . 0.0 112.561 174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 86.5 mt -57.66 -57.76 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.506 0.723 . . . . 0.0 110.698 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.01 -30.81 69.28 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.3 -55.22 34.28 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.909 1.231 . . . . 0.0 111.192 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.21 -36.68 84.93 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.647 -0.658 . . . . 0.0 112.102 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -42.57 96.83 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.477 -0.765 . . . . 0.0 112.433 173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.38 -40.03 95.53 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.179 0.895 . . . . 0.0 113.175 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -64.2 -44.56 91.57 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.726 -0.867 . . . . 0.0 111.271 172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -42.98 87.84 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 119.287 0.949 . . . . 0.0 112.435 173.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.43 79.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.717 0.807 . . . . 0.0 112.281 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -55.86 -48.14 76.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.386 1.074 . . . . 0.0 112.164 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -57.77 -39.34 77.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.174 0.989 . . . . 0.0 113.519 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.79 2.97 27.6 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 90.7 mttt 57.22 32.54 21.89 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.502 1.921 . . . . 0.0 113.811 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.97 146.27 28.59 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.817 1.647 . . . . 0.0 112.332 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -100.48 9.58 42.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.696 1.598 . . . . 0.0 113.492 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.51 136.22 44.91 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.831 -1.168 . . . . 0.0 111.304 167.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 66.3 mt -67.72 131.09 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.029 0.932 . . . . 0.0 109.732 166.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.87 165.93 14.12 Favored Pre-proline 0 N--CA 1.482 1.126 0 C-N-CA 125.936 1.694 . . . . 0.0 111.807 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -46.13 -44.47 19.4 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.26 3.306 . . . . 0.0 115.586 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.776 0.83 . . . . 0.0 112.702 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -60.38 -44.5 95.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.848 0.859 . . . . 0.0 112.16 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.24 -42.07 96.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.92 0.888 . . . . 0.0 111.804 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.865 0.866 . . . . 0.0 111.788 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.03 -46.94 72.0 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.662 1.185 . . . . 0.0 112.064 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -51.96 -47.54 64.73 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.106 0.963 . . . . 0.0 112.817 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 94.1 mt -65.46 -55.46 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.35 0.66 . . . . 0.0 110.944 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -54.95 -37.84 66.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.603 1.161 . . . . 0.0 113.506 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -86.87 0.43 54.96 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -125.02 127.16 46.55 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.752 1.16 . . . . 0.0 112.943 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -57.11 -51.35 69.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.021 0.929 . . . . 0.0 112.918 -177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -66.24 -34.12 77.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.87 0.868 . . . . 0.0 112.2 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.28 -41.04 73.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.293 0.637 . . . . 0.0 112.575 169.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -58.88 -40.06 83.24 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.463 1.483 . . . . 0.0 111.88 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -62.69 -3.18 1.38 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.32 1.448 . . . . 0.0 114.879 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 38.1 mt -76.15 -73.32 0.28 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.76 1.164 . . . . 0.0 110.147 167.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 85.5 mt -78.35 -20.39 51.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.715 0.806 . . . . 0.0 112.873 -173.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.24 -21.75 54.26 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 124.418 1.009 . . . . 0.0 114.66 168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -87.99 2.42 51.79 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 66.4 t -77.42 109.21 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.487 -0.758 . . . . 0.0 109.169 168.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 54.4 m -79.64 114.0 18.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.354 0.662 . . . . 0.0 109.734 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -79.39 118.48 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.775 0.83 . . . . 0.0 109.032 178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 139.19 58.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.599 0.76 . . . . 0.0 111.686 175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -64.71 117.4 7.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.484 0.714 . . . . 0.0 111.393 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.11 131.83 39.35 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.93 0.776 . . . . 0.0 112.145 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.17 171.46 39.49 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 124.204 0.907 . . . . 0.0 113.506 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 81.9 t -61.79 123.23 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.704 0.802 . . . . 0.0 110.241 173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 88.6 mt -88.72 157.26 49.47 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.598 1.159 . . . . 0.0 111.714 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -57.71 125.07 17.56 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.102 2.535 . . . . 0.0 112.852 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -75.7 140.32 42.4 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.463 0.705 . . . . 0.0 110.765 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.29 124.39 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.006 0.923 . . . . 0.0 110.237 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -97.79 154.89 17.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.859 1.264 . . . . 0.0 111.257 175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.54 113.2 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.29 0.636 . . . . 0.0 111.879 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.66 -18.52 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 124.099 0.96 . . . . 0.0 113.132 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 67.0 tp -68.21 114.0 6.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.061 1.344 . . . . 0.0 110.929 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 37.3 tp -64.61 127.9 92.91 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.143 0.977 . . . . 0.0 110.531 172.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -60.35 119.72 7.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.747 2.298 . . . . 0.0 112.09 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.05 138.05 40.59 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.047 0.939 . . . . 0.0 111.27 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.68 140.19 58.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.851 0.861 . . . . 0.0 111.496 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -73.33 150.95 41.48 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.068 0.947 . . . . 0.0 112.089 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -90.92 139.14 31.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.044 0.938 . . . . 0.0 111.824 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 47.9 t -81.09 124.78 29.5 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.43 0.692 . . . . 0.0 110.827 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -108.97 6.37 25.15 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.73 1.212 . . . . 0.0 113.058 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -66.91 -31.5 72.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.848 1.259 . . . . 0.0 112.274 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -95.56 156.77 16.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.905 1.682 . . . . 0.0 111.791 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.68 -36.74 83.24 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.095 0.958 . . . . 0.0 113.363 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -66.76 124.34 22.65 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.79 1.236 . . . . 0.0 111.769 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -92.66 24.88 21.46 Favored Glycine 0 CA--C 1.539 1.549 0 C-N-CA 125.448 1.499 . . . . 0.0 115.437 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 125.761 1.624 . . . . 0.0 112.418 -176.636 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 CA-C-O 118.753 -1.026 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -65.84 166.9 18.92 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.152 3.235 . . . . 0.0 113.86 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 64.91 -155.81 48.04 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.833 1.206 . . . . 0.0 113.866 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 99.8 mmm -104.97 140.17 20.81 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.572 1.149 . . . . 0.0 111.457 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -61.86 139.12 78.12 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.877 2.385 . . . . 0.0 111.533 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -69.67 135.46 88.13 Favored Pre-proline 0 CA--C 1.545 0.761 0 O-C-N 121.561 -0.712 . . . . 0.0 111.216 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.58 117.92 4.94 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.098 2.532 . . . . 0.0 111.57 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.7 123.84 26.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.641 0.776 . . . . 0.0 111.13 176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.44 135.24 55.89 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.36 0.664 . . . . 0.0 110.492 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 51.3 p -63.53 151.36 41.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.247 0.619 . . . . 0.0 111.645 169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.73 132.7 89.04 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 118.787 -0.625 . . . . 0.0 110.734 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -58.65 139.01 88.96 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.736 2.29 . . . . 0.0 111.248 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 133.88 83.0 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 119.006 -0.521 . . . . 0.0 111.122 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -59.95 152.1 67.02 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.857 2.371 . . . . 0.0 111.538 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.44 105.61 1.21 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 110.479 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -78.57 144.88 35.15 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.182 0.993 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.57 14.46 62.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.126 0.87 . . . . 0.0 114.888 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 15.9 t -68.98 132.74 47.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.828 1.314 . . . . 0.0 111.705 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.93 145.66 54.34 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.199 1.0 . . . . 0.0 110.652 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.94 117.88 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.468 0.707 . . . . 0.0 110.443 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 141.82 58.01 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.379 0.672 . . . . 0.0 111.67 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.93 109.32 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 36.4 m -71.42 102.8 2.73 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.744 0.818 . . . . 0.0 110.194 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.8 144.43 56.31 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.254 1.022 . . . . 0.0 111.29 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.6 120.63 10.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.397 0.679 . . . . 0.0 111.303 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -88.62 144.13 26.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.158 0.983 . . . . 0.0 111.521 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -67.19 136.33 54.87 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.388 0.675 . . . . 0.0 111.026 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -74.18 -26.27 60.19 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.898 0.879 . . . . 0.0 112.555 173.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -60.25 129.1 40.0 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.249 1.02 . . . . 0.0 112.009 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.71 -179.79 28.92 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.021 0.82 . . . . 0.0 113.756 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.49 141.32 43.1 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.779 0.831 . . . . 0.0 111.179 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -57.22 125.18 21.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.092 0.957 . . . . 0.0 110.32 173.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -75.85 95.51 3.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.584 0.754 . . . . 0.0 110.654 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.62 136.59 57.15 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.352 1.061 . . . . 0.0 109.959 168.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -67.29 126.42 29.2 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.056 0.542 . . . . 0.0 110.353 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 47.7 p -65.76 151.16 47.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.607 0.763 . . . . 0.0 111.404 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -64.73 119.14 10.03 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.583 -0.698 . . . . 0.0 110.419 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -87.77 150.43 23.58 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.729 1.212 . . . . 0.0 111.064 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -83.12 146.23 28.78 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.502 0.721 . . . . 0.0 110.629 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 2.5 p -150.95 161.09 43.38 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -153.61 -179.1 7.48 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 121.079 -1.013 . . . . 0.0 113.709 -122.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 96.9 p -71.9 -27.7 63.02 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 121.15 1.795 . . . . 0.0 114.092 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.56 -45.47 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 121.348 -0.845 . . . . 0.0 109.867 160.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -98.96 34.16 2.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.801 2.04 . . . . 0.0 114.378 -169.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.7 -48.43 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.069 -1.645 . . . . 0.0 110.711 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -62.31 -29.95 70.81 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.541 0.736 . . . . 0.0 112.573 175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -63.04 -50.04 72.23 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.337 0.971 . . . . 0.0 111.568 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -52.47 -52.2 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 119.524 1.056 . . . . 0.0 110.202 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.94 -52.59 64.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.89 0.876 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.38 -35.02 73.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.779 1.232 . . . . 0.0 114.001 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -74.5 -42.03 59.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.272 0.942 . . . . 0.0 112.812 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -87.09 -61.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.318 1.047 . . . . 0.0 112.231 -172.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -137.23 91.43 14.57 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 125.683 1.593 . . . . 0.0 110.57 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -56.36 -29.24 76.26 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.814 3.009 . . . . 0.0 115.173 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -84.35 -1.78 56.02 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.479 1.912 . . . . 0.0 113.951 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -111.28 137.63 48.77 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.259 1.424 . . . . 0.0 111.848 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.87 -159.84 14.18 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.954 1.74 . . . . 0.0 113.233 175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.64 141.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 110.207 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 53.3 p -73.99 155.79 38.23 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.653 -0.655 . . . . 0.0 112.72 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 50.7 p -57.32 -37.24 72.21 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.288 -0.882 . . . . 0.0 112.005 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.34 -47.48 85.71 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.948 1.299 . . . . 0.0 111.998 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.32 94.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.832 0.853 . . . . 0.0 112.933 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.6 mtp -60.76 -39.09 87.45 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.473 1.033 . . . . 0.0 111.896 168.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -44.46 76.9 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.247 0.927 . . . . 0.0 113.167 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -68.58 -35.1 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.315 1.058 . . . . 0.0 112.531 173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 38.3 tpp -57.95 -41.14 82.21 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.65 -1.282 . . . . 0.0 111.284 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -65.83 -35.34 80.41 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.045 -1.034 . . . . 0.0 112.216 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 47.7 m -58.55 -39.4 80.14 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.27 -1.519 . . . . 0.0 112.19 167.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -64.94 -33.51 76.2 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.628 -1.295 . . . . 0.0 113.134 172.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . 0.463 ' HA ' ' CD2' ' D' ' 70' ' ' PHE . 47.0 t -57.96 -52.31 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.45 1.023 . . . . 0.0 110.935 165.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -64.92 -32.46 74.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.856 0.863 . . . . 0.0 113.249 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -106.1 -63.82 1.22 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.219 1.408 . . . . 0.0 113.505 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 81.2 mt -68.15 -51.8 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.155 0.982 . . . . 0.0 111.196 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . 0.463 ' CD2' ' HA ' ' D' ' 66' ' ' VAL . 9.1 m-30 -66.85 -35.98 81.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.547 -0.721 . . . . 0.0 111.051 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.12 -47.64 84.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.171 0.988 . . . . 0.0 112.62 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -58.28 -46.69 85.57 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 121.133 -0.98 . . . . 0.0 112.113 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 35.4 mm -60.01 -44.15 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 118.762 0.71 . . . . 0.0 111.368 174.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.48 84.55 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.302 0.956 . . . . 0.0 112.392 173.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.17 -47.15 91.12 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.429 1.014 . . . . 0.0 113.547 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -64.83 -45.17 87.3 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.478 -1.013 . . . . 0.0 112.607 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.25 83.48 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.16 0.984 . . . . 0.0 112.215 173.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.1 t -60.17 -53.12 61.5 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.254 1.022 . . . . 0.0 111.639 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -57.37 -42.06 81.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.33 -0.857 . . . . 0.0 112.811 175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.86 -46.0 90.68 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.692 1.197 . . . . 0.0 112.012 173.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.98 96.28 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.91 0.884 . . . . 0.0 112.427 173.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -60.91 -40.66 94.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.387 1.075 . . . . 0.0 112.839 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -57.6 -37.96 74.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.615 0.766 . . . . 0.0 112.135 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -86.43 15.7 5.2 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.204 1.402 . . . . 0.0 113.737 172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 52.25 28.05 5.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.466 2.306 . . . . 0.0 115.121 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -71.76 156.71 39.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.429 1.091 . . . . 0.0 112.805 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 63.7 p -80.52 -29.44 37.22 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.713 1.205 . . . . 0.0 113.068 165.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 5.7 t -141.96 168.73 19.06 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.578 1.551 . . . . 0.0 113.048 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.18 107.05 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 167.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 19.2 p -88.75 169.28 11.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.332 1.053 . . . . 0.0 112.277 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 46.3 p -52.99 -36.95 60.97 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.209 -0.932 . . . . 0.0 112.946 167.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.43 -42.9 67.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.683 1.193 . . . . 0.0 112.267 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -61.8 -42.56 99.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 118.476 0.58 . . . . 0.0 111.736 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.94 -50.58 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.613 171.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -49.12 -53.69 19.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.829 1.195 . . . . 0.0 111.296 176.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 55.9 m -59.77 -43.26 94.44 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.616 -0.677 . . . . 0.0 111.968 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.68 75.33 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.461 1.028 . . . . 0.0 112.324 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.8 -35.33 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.549 -1.345 . . . . 0.0 112.415 176.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.04 -21.47 64.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 119.777 1.171 . . . . 0.0 113.388 173.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 83.6 mt -79.82 -43.14 22.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.357 1.063 . . . . 0.0 111.93 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.82 -25.99 66.71 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 83.6 mt -121.18 90.95 47.81 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.033 2.133 . . . . 0.0 110.813 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -66.79 -27.63 44.08 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.717 2.945 . . . . 0.0 115.327 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.72 129.25 44.28 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.294 0.949 . . . . 0.0 113.57 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -61.64 -38.0 86.08 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.147 -1.207 . . . . 0.0 113.298 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.76 -39.1 93.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.646 0.778 . . . . 0.0 111.84 173.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.37 77.77 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.729 0.812 . . . . 0.0 111.721 175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.17 -45.5 75.73 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.072 -1.018 . . . . 0.0 112.096 171.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -57.11 -48.77 77.81 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.252 0.621 . . . . 0.0 112.149 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.24 -36.62 71.18 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 174.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 78.7 t -65.42 -43.58 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.093 -1.005 . . . . 0.0 112.076 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.3 m -61.48 -39.43 90.92 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.386 0.994 . . . . 0.0 112.597 173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.83 -34.77 76.55 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.063 -1.023 . . . . 0.0 111.727 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.7 -37.91 70.38 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.189 1.376 . . . . 0.0 114.324 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 8.1 m -60.56 -35.02 75.04 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.601 1.201 . . . . 0.0 112.047 171.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -71.53 -44.34 64.79 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.461 -0.774 . . . . 0.0 111.247 169.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.97 74.67 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.41 1.084 . . . . 0.0 112.981 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.02 -39.29 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.751 1.16 . . . . 0.0 112.767 175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 85.6 m -60.42 -43.55 96.64 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.701 0.682 . . . . 0.0 111.612 170.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -58.88 -44.61 91.18 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.315 0.961 . . . . 0.0 112.074 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -57.99 -40.14 79.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.554 0.742 . . . . 0.0 112.536 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.5 p -80.74 -33.88 34.8 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 54.4 p -78.5 -19.52 52.84 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.35 139.96 18.22 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.19 1.396 . . . . 0.0 113.609 175.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.1 tttt . . . . . 0 C--O 1.255 1.347 0 C-N-CA 125.627 1.571 . . . . 0.0 112.806 -179.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.66 148.05 46.54 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 124.376 3.384 . . . . 0.0 114.731 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 79.27 -9.9 38.22 Favored Glycine 0 CA--C 1.541 1.657 0 C-N-CA 125.216 1.389 . . . . 0.0 115.828 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.6 mmm -88.58 147.08 24.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.013 1.407 . . . . 0.0 111.185 171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 12.7 t -76.21 118.01 18.5 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.448 0.699 . . . . 0.0 112.348 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.43 153.58 51.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.078 1.323 . . . . 0.0 114.039 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.41 132.27 50.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.33 1.052 . . . . 0.0 111.907 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.32 155.87 50.92 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.63 1.109 . . . . 0.0 113.68 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.1 -39.63 90.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.151 0.981 . . . . 0.0 112.437 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -67.41 117.84 9.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.489 1.115 . . . . 0.0 110.772 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.33 -162.05 15.71 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.464 1.03 . . . . 0.0 114.224 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.99 -153.32 3.56 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.436 1.017 . . . . 0.0 113.642 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -56.23 122.2 11.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.768 1.227 . . . . 0.0 111.022 172.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 133.32 50.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.381 0.672 . . . . 0.0 110.835 172.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -72.73 101.03 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 0.0 110.833 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.44 143.71 56.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.586 0.754 . . . . 0.0 110.774 167.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.46 117.28 5.07 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 0.0 110.048 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.92 140.9 56.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.567 0.747 . . . . 0.0 111.243 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.14 110.42 1.21 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 110.839 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 40.3 p -72.27 153.47 41.52 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.544 1.137 . . . . 0.0 111.224 174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -66.02 113.83 4.74 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.673 -0.642 . . . . 0.0 110.299 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 51.0 p -72.61 -34.69 67.53 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.618 1.167 . . . . 0.0 112.807 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.4 131.31 50.6 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.253 1.021 . . . . 0.0 111.668 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -60.91 133.34 56.0 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.934 1.294 . . . . 0.0 112.097 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.82 57.0 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.955 0.902 . . . . 0.0 112.737 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 -167.16 36.16 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.314 0.959 . . . . 0.0 113.604 -178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -57.75 139.42 53.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.396 1.078 . . . . 0.0 112.631 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -106.81 137.5 44.73 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.115 1.366 . . . . 0.0 110.542 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -128.12 157.74 73.19 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.024 1.33 . . . . 0.0 112.005 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -54.37 -34.96 82.9 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.795 2.997 . . . . 0.0 114.61 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.0 m -54.64 -30.89 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.66 -24.93 60.44 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.544 1.545 . . . . 0.0 114.747 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -96.77 -42.8 7.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.57 1.548 . . . . 0.0 111.557 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -55.38 -42.66 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.019 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.07 -37.13 78.96 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 120.693 1.588 . . . . 0.0 112.953 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.08 -45.89 75.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.46 1.104 . . . . 0.0 111.597 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.32 -40.76 82.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.051 0.941 . . . . 0.0 112.374 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.06 -42.63 98.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.838 0.855 . . . . 0.0 112.266 172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -61.86 -51.61 67.5 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.049 -1.032 . . . . 0.0 111.411 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -55.07 -42.4 72.71 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.921 1.288 . . . . 0.0 112.669 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.48 6.13 8.98 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.116 1.817 . . . . 0.0 116.179 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 57.88 30.33 18.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.601 1.961 . . . . 0.0 114.728 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -68.13 -49.45 61.01 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.257 -0.902 . . . . 0.0 111.028 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 90.8 p -145.24 159.19 43.39 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 163.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -52.09 -45.29 64.76 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.206 1.802 . . . . 0.0 113.03 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -137.14 131.52 32.71 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.62 1.568 . . . . 0.0 110.222 172.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.42 121.91 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.983 1.313 . . . . 0.0 109.547 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.68 152.25 42.42 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.003 0.811 . . . . 0.0 112.731 171.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.24 -31.84 65.95 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.305 -1.115 . . . . 0.0 113.46 176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.45 -22.35 77.71 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.659 1.123 . . . . 0.0 115.27 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.31 -54.2 58.26 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-N 119.653 1.727 . . . . 0.0 113.672 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -56.74 -31.4 87.87 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.022 1.815 . . . . 0.0 113.761 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.4 -46.78 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.821 1.191 . . . . 0.0 111.109 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -67.76 -38.75 83.84 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.18 -0.95 . . . . 0.0 113.096 175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.66 -42.6 97.33 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.684 -1.26 . . . . 0.0 111.349 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.57 71.51 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.295 -0.878 . . . . 0.0 112.736 169.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.51 -34.49 75.99 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 120.239 1.381 . . . . 0.0 113.498 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.99 -47.56 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.882 -1.136 . . . . 0.0 109.731 168.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.22 -39.43 86.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 117.985 -1.007 . . . . 0.0 112.689 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -52.85 -47.24 67.9 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.704 1.593 . . . . 0.0 112.595 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -57.91 -43.77 86.39 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.675 -0.64 . . . . 0.0 111.925 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.2 -34.4 70.83 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.969 -1.082 . . . . 0.0 112.877 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 88.7 m -53.65 -49.54 67.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.904 1.281 . . . . 0.0 110.071 164.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.32 -39.38 82.91 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.196 0.907 . . . . 0.0 112.941 174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -65.32 -43.26 91.56 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.751 1.16 . . . . 0.0 113.389 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 89.4 mt -59.27 -43.62 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 120.781 -1.2 . . . . 0.0 110.137 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.06 -30.53 71.07 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.023 0.929 . . . . 0.0 113.331 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -63.59 -49.13 74.55 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.004 1.275 . . . . 0.0 111.384 170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -57.06 -46.69 82.28 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.752 0.821 . . . . 0.0 111.253 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.95 78.91 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.969 0.908 . . . . 0.0 113.138 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -45.78 95.18 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.995 1.283 . . . . 0.0 112.765 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -61.89 -43.92 97.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.331 1.066 . . . . 0.0 111.423 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -40.47 75.99 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 121.573 -0.705 . . . . 0.0 112.845 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.61 -45.63 82.43 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.158 -0.964 . . . . 0.0 112.336 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -55.25 -42.76 73.88 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.213 1.405 . . . . 0.0 112.982 173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -57.16 -22.97 44.25 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -106.65 4.81 28.29 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.677 1.591 . . . . 0.0 112.838 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.18 31.73 14.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.965 2.106 . . . . 0.0 114.191 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -101.24 156.22 17.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.382 1.473 . . . . 0.0 113.19 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 36.4 p -114.51 15.87 17.75 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.494 1.918 . . . . 0.0 112.961 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -133.61 129.43 36.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.098 1.359 . . . . 0.0 110.745 171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 79.9 mt -73.99 124.35 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.827 1.251 . . . . 0.0 109.837 169.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 pt -126.0 169.94 10.56 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.788 1.635 . . . . 0.0 111.053 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -54.66 -34.34 83.23 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.191 2.594 . . . . 0.0 114.703 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.14 -24.57 67.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -81.79 -38.27 25.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.108 0.963 . . . . 0.0 111.865 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.73 0.696 . . . . 0.0 112.555 171.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -57.09 -57.75 11.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.166 -0.959 . . . . 0.0 111.159 166.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 97.6 mt -59.01 -43.55 91.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.941 0.896 . . . . 0.0 112.72 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.26 -37.43 45.11 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 15.5 mt -113.96 -63.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.884 1.274 . . . . 0.0 110.278 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -62.97 -27.87 69.7 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -99.94 0.78 41.85 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.763 1.225 . . . . 0.0 113.018 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.65 114.15 26.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.435 1.016 . . . . 0.0 110.417 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -49.61 -43.52 46.63 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.461 1.504 . . . . 0.0 113.093 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -62.16 -48.58 79.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.788 0.835 . . . . 0.0 112.157 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.89 -17.63 61.5 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 118.21 -0.9 . . . . 0.0 112.484 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.39 -34.69 54.83 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.286 1.403 . . . . 0.0 112.591 165.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -71.54 -30.24 65.67 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 121.121 -0.987 . . . . 0.0 112.882 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 66.9 tp -92.7 -52.27 4.71 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 33.0 mt -114.5 -161.02 0.75 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.32 1.848 . . . . 0.0 110.534 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.39 -122.79 29.29 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.187 -0.945 . . . . 0.0 112.225 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -109.41 118.58 37.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.609 1.163 . . . . 0.0 109.065 162.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.68 127.04 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.572 0.749 . . . . 0.0 110.085 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 26.8 m -65.76 110.06 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.64 0.776 . . . . 0.0 110.838 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 71.1 mt -81.08 116.68 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.32 5.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.333 0.653 . . . . 0.0 111.001 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -71.56 142.47 50.06 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.813 0.845 . . . . 0.0 111.445 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.52 105.17 0.9 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.338 0.97 . . . . 0.0 113.398 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.0 142.75 43.79 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.713 1.149 . . . . 0.0 112.505 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.75 106.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.971 0.908 . . . . 0.0 110.061 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -73.09 147.61 88.33 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.192 0.997 . . . . 0.0 111.001 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -61.35 117.0 3.77 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.636 2.224 . . . . 0.0 110.737 171.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -73.54 130.61 40.44 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.752 -0.592 . . . . 0.0 111.097 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 80.2 mt -77.98 124.45 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -67.0 113.22 4.83 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.043 -0.411 . . . . 0.0 109.966 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.09 128.08 34.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.276 0.63 . . . . 0.0 110.81 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.68 116.31 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -66.2 110.77 3.13 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.309 0.644 . . . . 0.0 109.366 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 88.7 mt -65.07 123.33 83.66 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.732 -0.651 . . . . 0.0 109.563 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -62.68 138.73 71.26 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.763 2.309 . . . . 0.0 111.676 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.62 113.93 2.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.516 0.726 . . . . 0.0 109.466 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -73.7 117.64 15.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.627 0.771 . . . . 0.0 110.502 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 86.8 m -107.25 108.22 19.53 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.756 1.222 . . . . 0.0 108.354 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -65.93 127.33 31.64 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.149 0.58 . . . . 0.0 110.858 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 18.4 p -71.27 138.18 49.18 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.861 0.865 . . . . 0.0 113.063 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -78.42 -29.35 47.09 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.977 0.911 . . . . 0.0 112.333 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -64.97 130.98 45.37 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.009 1.323 . . . . 0.0 111.43 171.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.21 148.89 48.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.239 1.016 . . . . 0.0 113.057 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.16 143.66 48.16 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.084 0.953 . . . . 0.0 112.724 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 122.32 15.94 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.621 1.168 . . . . 0.0 112.182 -176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.85 135.39 30.41 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.469 1.033 . . . . 0.0 112.902 172.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.908 1.283 . . . . 0.0 112.172 176.162 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 CA-C-O 118.74 -1.033 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -59.64 139.26 88.09 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.093 3.195 . . . . 0.0 113.088 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -64.58 147.9 51.05 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.981 0.801 . . . . 0.0 112.487 168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -60.08 145.49 84.95 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.708 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -55.61 139.88 83.26 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.241 2.627 . . . . 0.0 113.393 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -56.38 130.95 76.11 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.244 1.018 . . . . 0.0 111.799 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -66.77 156.39 66.15 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.066 2.511 . . . . 0.0 112.341 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.2 56.79 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.476 1.111 . . . . 0.0 113.9 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -71.74 -20.12 61.94 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.407 1.483 . . . . 0.0 114.2 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -72.26 144.2 48.49 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.173 0.989 . . . . 0.0 112.183 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.91 146.34 98.25 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 123.564 0.745 . . . . 0.0 112.675 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.01 -16.49 32.29 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.549 2.833 . . . . 0.0 114.054 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.23 140.41 78.65 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.592 1.157 . . . . 0.0 113.084 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -63.77 145.98 91.47 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.651 2.901 . . . . 0.0 113.166 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.29 148.1 45.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.599 1.16 . . . . 0.0 111.748 174.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.56 143.91 54.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.307 1.043 . . . . 0.0 112.424 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.64 -20.23 79.5 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.518 1.056 . . . . 0.0 114.75 175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -70.99 158.36 36.64 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.373 1.469 . . . . 0.0 113.818 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.52 143.69 55.54 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.477 1.111 . . . . 0.0 111.589 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.95 137.65 58.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.795 0.838 . . . . 0.0 111.42 173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.91 144.17 56.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.314 0.645 . . . . 0.0 111.643 173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.47 117.71 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.262 0.625 . . . . 0.0 109.459 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 26.0 p -72.7 139.95 47.56 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.904 0.882 . . . . 0.0 112.178 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -80.81 138.8 36.25 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.051 0.941 . . . . 0.0 110.908 175.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.98 131.94 47.95 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.022 0.529 . . . . 0.0 110.684 170.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -65.47 120.99 13.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.247 0.619 . . . . 0.0 110.943 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -64.31 131.28 46.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.046 0.938 . . . . 0.0 110.971 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -61.73 133.7 55.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.265 1.026 . . . . 0.0 111.562 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.37 145.49 52.88 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.169 1.388 . . . . 0.0 112.899 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.29 -133.28 3.82 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.542 1.067 . . . . 0.0 111.81 172.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.48 -40.34 82.44 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.615 0.766 . . . . 0.0 111.355 166.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -121.14 160.1 24.45 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.777 2.031 . . . . 0.0 111.256 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.13 156.72 16.54 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.505 1.522 . . . . 0.0 112.143 173.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -80.96 72.07 7.96 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.208 1.403 . . . . 0.0 111.637 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.25 -38.74 84.41 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.483 1.513 . . . . 0.0 113.027 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 8.4 t -121.63 162.19 21.12 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.352 1.461 . . . . 0.0 111.913 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -66.21 150.79 48.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.537 1.535 . . . . 0.0 113.163 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -111.13 12.71 21.9 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.09 1.756 . . . . 0.0 112.983 171.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -76.38 -23.65 54.11 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.178 1.391 . . . . 0.0 112.891 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 16.2 p -71.55 148.02 47.1 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.952 1.701 . . . . 0.0 113.933 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -70.97 -28.39 64.42 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.3 1.04 . . . . 0.0 113.502 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 77.5 p -43.44 -39.46 3.29 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.842 2.057 . . . . 0.0 114.767 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.62 -26.05 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.991 1.717 . . . . 0.0 114.281 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -51.8 -37.09 50.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.454 1.101 . . . . 0.0 112.874 171.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -59.54 -40.85 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 120.902 -1.124 . . . . 0.0 111.254 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -67.32 -41.85 84.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.189 -0.945 . . . . 0.0 112.165 172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -54.7 -37.75 66.19 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 119.063 0.847 . . . . 0.0 112.43 172.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.03 -48.79 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.464 0.706 . . . . 0.0 111.896 170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 34.4 tp -50.67 -42.95 57.21 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.634 1.106 . . . . 0.0 112.72 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -54.51 -24.78 22.07 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -72.2 -32.0 66.39 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.314 1.045 . . . . 0.0 112.662 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.83 -41.84 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.7 1.2 . . . . 0.0 113.536 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -135.45 70.73 67.03 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 125.47 1.508 . . . . 0.0 110.692 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -58.06 -23.09 58.96 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.611 2.874 . . . . 0.0 113.974 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -77.46 -6.51 53.75 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.656 1.982 . . . . 0.0 113.963 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 98.8 m -115.37 129.77 56.69 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.271 1.428 . . . . 0.0 111.34 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.09 175.15 41.2 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.974 1.273 . . . . 0.0 113.423 172.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 18.4 tt -144.83 140.65 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.167 -1.196 . . . . 0.0 110.923 171.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 34.4 p -73.2 154.5 40.24 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 38.6 p -54.68 -44.02 72.98 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.025 0.93 . . . . 0.0 112.291 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -61.82 -46.9 87.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.792 1.237 . . . . 0.0 112.155 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.58 -46.28 89.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.354 0.661 . . . . 0.0 112.263 175.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 74.8 mtm -60.78 -40.89 94.26 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.08 -1.012 . . . . 0.0 112.449 173.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.18 -42.17 97.04 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.665 1.126 . . . . 0.0 113.899 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.01 -51.84 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.25 1.02 . . . . 0.0 110.073 170.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 46.3 mtp -61.29 -35.02 76.18 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -50.66 -50.62 54.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.501 1.5 . . . . 0.0 112.339 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -59.37 -55.8 30.19 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.634 0.774 . . . . 0.0 111.519 174.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -61.71 -43.89 97.98 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.61 -51.18 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.391 0.996 . . . . 0.0 110.908 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -62.02 -40.92 97.33 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 118.739 0.7 . . . . 0.0 111.569 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -56.54 -28.89 61.17 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.8 mt -49.75 -57.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 120.36 1.437 . . . . 0.0 109.917 172.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -66.8 -52.91 38.42 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 0.0 111.335 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -54.73 -35.49 63.75 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.79 -53.19 5.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.352 1.061 . . . . 0.0 112.1 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.76 -58.58 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-N 120.263 1.392 . . . . 0.0 111.386 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.41 62.93 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.481 -0.762 . . . . 0.0 112.106 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.0 -47.91 88.71 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 118.9 0.773 . . . . 0.0 113.164 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -65.16 -39.86 93.55 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.197 -1.179 . . . . 0.0 112.214 172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.57 78.79 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.045 -1.034 . . . . 0.0 112.222 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.3 t -60.63 -50.6 72.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.063 0.945 . . . . 0.0 111.271 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -51.09 -48.99 61.55 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 119.11 0.868 . . . . 0.0 111.946 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 96.6 mt -56.01 -48.67 75.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.577 0.751 . . . . 0.0 111.773 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.73 73.75 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.741 0.816 . . . . 0.0 112.916 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -58.48 -52.18 66.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 119.432 1.015 . . . . 0.0 111.467 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -60.95 -35.07 75.78 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -82.57 5.41 21.01 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.817 1.247 . . . . 0.0 113.769 174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.0 mttt 56.19 34.3 23.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.998 2.119 . . . . 0.0 114.328 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -101.13 142.71 32.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.725 1.61 . . . . 0.0 112.626 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 48.4 p -83.73 -22.27 32.02 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.467 1.507 . . . . 0.0 113.498 172.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 40.1 m -126.22 128.98 48.06 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.508 1.523 . . . . 0.0 111.41 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.92 130.62 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 125.17 1.388 . . . . 0.0 110.737 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.1 p -84.33 160.19 20.74 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 41.3 p -55.34 -38.8 69.23 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.068 -1.02 . . . . 0.0 112.433 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.32 -43.59 90.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.686 1.194 . . . . 0.0 112.287 174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -62.11 -41.86 98.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.498 0.719 . . . . 0.0 112.305 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.64 -54.71 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.517 0.599 . . . . 0.0 109.864 167.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -55.31 -42.1 73.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.246 0.93 . . . . 0.0 112.818 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 89.4 m -62.34 -50.31 72.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.397 1.079 . . . . 0.0 111.707 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.28 84.32 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.561 1.073 . . . . 0.0 112.691 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 77.4 t -55.49 -56.05 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.504 1.122 . . . . 0.0 110.264 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -57.44 -41.91 81.39 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.789 1.177 . . . . 0.0 113.405 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 76.0 mt -59.54 -45.37 91.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.484 1.114 . . . . 0.0 112.418 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -89.54 -23.36 22.04 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.07 80.15 73.22 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 127.139 2.176 . . . . 0.0 110.813 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -62.55 -25.11 75.5 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.887 2.391 . . . . 0.0 115.368 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -72.03 135.49 22.92 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.061 1.791 . . . . 0.0 114.796 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -56.13 -49.66 73.29 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.174 1.39 . . . . 0.0 113.149 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.9 tp -55.57 -47.51 76.29 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.974 0.91 . . . . 0.0 111.925 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.74 -47.7 58.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.29 0.636 . . . . 0.0 112.406 -175.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -60.93 -42.49 98.28 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.239 0.927 . . . . 0.0 111.76 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -57.0 -47.77 80.05 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.407 1.083 . . . . 0.0 111.905 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.58 -47.73 72.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.833 0.742 . . . . 0.0 112.474 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 44.3 t -60.63 -52.91 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 72.0 m -56.61 -44.45 81.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -60.21 -48.86 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.233 0.924 . . . . 0.0 111.624 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.9 -46.19 69.07 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.73 0.681 . . . . 0.0 112.841 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 92.6 m -60.66 -57.63 11.87 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.08 0.952 . . . . 0.0 111.515 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -55.66 -42.51 75.17 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.964 1.306 . . . . 0.0 113.118 -177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.09 -52.44 64.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.63 0.772 . . . . 0.0 111.481 172.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.35 -31.88 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 31.0 m -56.68 -27.15 58.23 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 120.318 1.417 . . . . 0.0 112.851 171.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -83.17 -5.21 59.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 172.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 m-30 -111.42 -30.43 7.4 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 113.015 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.1 p -56.18 -21.92 25.88 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 50.7 p -67.19 -19.76 65.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.697 1.599 . . . . 0.0 114.535 172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.18 179.35 7.69 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.978 1.311 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.975 1.71 . . . . 0.0 112.031 -177.79 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.044 0 CA-C-O 118.668 -1.073 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -59.13 129.45 31.75 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.398 2.732 . . . . 0.0 113.19 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 72.39 4.5 60.66 Favored Glycine 0 CA--C 1.539 1.594 0 N-CA-C 116.204 1.241 . . . . 0.0 116.204 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 13.9 tpt -85.85 115.98 23.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.513 1.657 . . . . 0.0 110.551 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p -85.62 163.12 18.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.532 1.133 . . . . 0.0 113.36 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.67 169.81 41.92 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.354 0.978 . . . . 0.0 113.915 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.22 -40.61 36.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.596 1.158 . . . . 0.0 112.01 177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.54 -178.05 19.6 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.637 1.113 . . . . 0.0 113.514 164.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.88 135.44 55.82 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.43 1.092 . . . . 0.0 111.861 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -72.25 138.91 47.8 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.845 0.858 . . . . 0.0 111.406 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.2 146.2 20.51 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.047 0.832 . . . . 0.0 112.19 -167.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.78 -23.86 2.44 Favored Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.272 1.415 . . . . 0.0 115.445 -172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.09 134.61 48.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.885 1.274 . . . . 0.0 111.378 170.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.49 134.62 46.66 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.039 0.935 . . . . 0.0 111.853 174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -79.14 127.58 32.2 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.547 0.739 . . . . 0.0 110.963 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.89 128.66 37.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.552 0.741 . . . . 0.0 111.594 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.06 143.24 47.52 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.913 0.885 . . . . 0.0 110.895 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.98 126.86 29.05 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.33 0.652 . . . . 0.0 111.5 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.02 136.82 55.87 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.82 0.848 . . . . 0.0 111.197 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 39.0 p -70.09 150.89 46.09 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.724 0.81 . . . . 0.0 111.596 171.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -65.04 137.06 57.46 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.631 -0.668 . . . . 0.0 111.179 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 21.0 t -63.1 136.94 58.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.509 0.724 . . . . 0.0 111.535 176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.0 t -66.63 116.56 7.7 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.139 0.576 . . . . 0.0 110.502 175.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.87 131.24 48.11 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.892 0.877 . . . . 0.0 111.025 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.16 131.6 51.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.593 0.757 . . . . 0.0 111.987 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 122.42 29.7 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.028 0.823 . . . . 0.0 112.153 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.57 148.48 30.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.706 0.802 . . . . 0.0 112.455 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -89.19 143.99 26.43 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.019 0.928 . . . . 0.0 110.139 163.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -121.85 70.83 29.05 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.82 0.848 . . . . 0.0 112.889 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.95 -43.51 57.49 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.829 2.352 . . . . 0.0 112.844 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.34 -47.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.666 1.186 . . . . 0.0 111.098 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.77 80.4 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.319 0.962 . . . . 0.0 113.79 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -65.68 -38.23 88.7 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.088 -1.242 . . . . 0.0 112.434 173.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.05 -40.85 88.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 118.815 0.734 . . . . 0.0 111.566 170.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -56.24 -52.1 65.7 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.653 1.115 . . . . 0.0 111.295 171.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -55.33 -49.49 72.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.505 1.122 . . . . 0.0 112.359 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -50.31 -52.82 33.45 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.589 1.155 . . . . 0.0 111.832 172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 82.7 mt -65.85 -41.02 92.23 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.655 0.782 . . . . 0.0 112.712 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -61.61 -52.28 65.02 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.398 1.479 . . . . 0.0 111.81 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.58 -41.26 80.76 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.961 1.305 . . . . 0.0 112.58 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.64 -8.72 57.27 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 124.677 1.132 . . . . 0.0 115.825 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 53.23 31.82 12.3 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.674 1.99 . . . . 0.0 113.884 -175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -67.57 -31.86 72.22 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.2 t -131.05 164.38 25.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.538 1.135 . . . . 0.0 112.716 170.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -74.28 -39.0 63.25 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.239 1.015 . . . . 0.0 111.677 175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -133.25 119.7 20.14 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.793 1.237 . . . . 0.0 110.429 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.12 119.46 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.617 1.567 . . . . 0.0 109.159 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.82 -165.18 10.28 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.502 1.525 . . . . 0.0 111.022 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.99 -30.21 24.06 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.44 -36.25 88.45 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.468 1.033 . . . . 0.0 115.361 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.74 -55.81 21.26 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 118.475 1.137 . . . . 0.0 113.943 -176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.04 -33.69 49.82 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 112.876 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.26 -37.71 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 120.569 1.531 . . . . 0.0 113.027 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -53.71 -53.58 50.01 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.972 0.805 . . . . 0.0 111.017 168.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 31.7 mt -55.76 -50.9 69.17 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.401 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.66 61.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.904 1.229 . . . . 0.0 113.289 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.22 -46.03 65.51 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.133 0.973 . . . . 0.0 112.211 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 92.0 t -71.27 -56.92 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.4 1.08 . . . . 0.0 111.784 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.43 -46.63 82.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.336 1.455 . . . . 0.0 113.029 -172.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -58.27 -46.43 86.03 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.513 1.051 . . . . 0.0 110.762 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -62.64 -51.93 65.35 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.391 0.676 . . . . 0.0 112.555 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.2 -42.04 89.96 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.235 -0.915 . . . . 0.0 111.995 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -53.64 -51.8 61.95 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.439 1.095 . . . . 0.0 110.776 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -43.81 95.05 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.756 0.822 . . . . 0.0 113.167 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -60.68 -47.73 84.93 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.467 1.03 . . . . 0.0 112.864 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.1 -50.58 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.45 0.7 . . . . 0.0 109.951 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 75.7 mt -59.63 -37.84 79.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.186 0.994 . . . . 0.0 113.207 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -61.93 -55.4 29.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.55 1.068 . . . . 0.0 111.615 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.51 -47.15 82.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.687 1.195 . . . . 0.0 111.707 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.47 92.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 0.0 112.453 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.44 -39.98 98.04 Favored Glycine 0 CA--C 1.532 1.118 0 O-C-N 121.321 -0.862 . . . . 0.0 113.202 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -61.35 -44.67 96.79 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.803 1.301 . . . . 0.0 110.937 172.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.29 89.81 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.411 -0.805 . . . . 0.0 112.668 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.35 89.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.173 -0.954 . . . . 0.0 112.547 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -57.59 -47.06 83.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.044 0.937 . . . . 0.0 112.024 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -57.22 -41.67 79.89 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -86.31 10.12 15.8 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 53.76 30.12 10.7 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.791 2.036 . . . . 0.0 114.564 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -84.2 144.99 28.59 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.194 1.398 . . . . 0.0 112.165 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.0 p -76.92 -26.21 53.81 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.698 1.199 . . . . 0.0 112.764 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -128.99 151.66 49.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.433 1.493 . . . . 0.0 112.531 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 65.8 mt -63.4 131.13 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.602 1.161 . . . . 0.0 110.264 169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.82 149.62 36.34 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.57 1.948 . . . . 0.0 109.544 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -48.32 -40.55 35.75 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.713 2.942 . . . . 0.0 114.964 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -60.19 -38.86 84.55 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.284 1.034 . . . . 0.0 113.062 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -61.91 -42.23 98.84 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.669 0.788 . . . . 0.0 112.175 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' D' ' 62' ' ' MET . 84.6 mt -62.77 -46.08 89.7 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.403 0.681 . . . . 0.0 111.936 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -56.68 -50.47 72.03 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.808 0.843 . . . . 0.0 111.82 173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 84.3 mt -57.08 -50.6 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.421 -0.8 . . . . 0.0 111.871 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.11 64.93 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.161 0.984 . . . . 0.0 112.84 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 tt -68.65 -35.76 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 118.479 0.581 . . . . 0.0 112.533 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.362 174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -66.06 -37.84 86.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.781 0.832 . . . . 0.0 112.304 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -78.01 115.81 18.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.021 0.928 . . . . 0.0 112.669 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -67.73 -39.39 84.29 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.238 -0.914 . . . . 0.0 113.449 -174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -67.31 -39.35 85.88 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.158 -0.964 . . . . 0.0 111.766 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 68.3 mt -64.28 -36.38 83.92 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.432 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -62.14 -37.16 84.11 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.81 1.641 . . . . 0.0 112.739 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.53 -39.1 91.4 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.343 -0.848 . . . . 0.0 112.224 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.54 -53.79 8.77 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 113.622 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.98 119.18 34.97 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.323 1.849 . . . . 0.0 111.444 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.31 144.65 32.17 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.364 0.983 . . . . 0.0 112.614 169.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -78.03 155.09 30.88 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.129 0.972 . . . . 0.0 112.319 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.92 130.31 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.322 1.049 . . . . 0.0 110.371 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 30.4 m -65.33 114.49 4.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.731 0.812 . . . . 0.0 110.607 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 62.9 mt -79.64 123.78 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.802 0.841 . . . . 0.0 109.172 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.65 -41.5 88.14 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.719 0.808 . . . . 0.0 112.605 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -63.26 126.5 27.61 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.257 1.023 . . . . 0.0 111.031 170.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.04 122.95 30.11 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.582 0.61 . . . . 0.0 112.8 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.77 -138.41 2.18 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.694 1.14 . . . . 0.0 112.608 171.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.45 127.67 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.843 -0.798 . . . . 0.0 109.62 167.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 25.1 tp -58.43 119.96 40.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.315 1.046 . . . . 0.0 110.893 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -63.77 152.06 82.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.935 2.423 . . . . 0.0 112.526 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -62.46 149.09 43.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.005 172.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.81 115.36 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.601 0.76 . . . . 0.0 109.361 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -76.32 156.45 33.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.01 0.924 . . . . 0.0 111.785 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.84 143.14 52.03 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.163 0.585 . . . . 0.0 112.139 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.89 -12.64 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 87.3 mt -66.03 131.77 47.0 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.892 1.277 . . . . 0.0 111.723 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.17 -34.95 0.58 Allowed Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -57.65 129.23 32.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.723 2.282 . . . . 0.0 112.562 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -67.95 113.64 5.83 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.069 0.947 . . . . 0.0 111.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -87.31 -26.02 23.62 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.658 1.183 . . . . 0.0 113.345 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 41.5 m -70.46 106.9 3.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 109.961 171.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -140.79 154.4 46.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.391 1.077 . . . . 0.0 113.067 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 53.0 m -67.76 147.86 52.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.844 0.858 . . . . 0.0 111.58 167.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -57.94 -46.69 84.66 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.44 0.696 . . . . 0.0 112.188 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -87.39 130.27 34.72 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.098 0.959 . . . . 0.0 110.218 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.86 131.04 37.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.289 0.636 . . . . 0.0 111.068 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.48 135.0 48.28 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.251 0.62 . . . . 0.0 110.89 172.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -73.46 107.27 5.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.805 0.842 . . . . 0.0 111.479 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.55 167.69 54.26 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.718 1.152 . . . . 0.0 113.566 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.253 1.269 0 C-N-CA 124.785 1.234 . . . . 0.0 112.341 173.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 CA-C-O 119.22 -0.766 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -59.48 133.2 50.46 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.585 2.857 . . . . 0.0 112.36 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 68.59 9.43 58.62 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.714 1.149 . . . . 0.0 115.961 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 96.4 mmm -101.4 152.5 38.0 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.263 1.425 . . . . 0.0 111.034 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -57.3 144.8 90.11 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.662 2.241 . . . . 0.0 111.842 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -63.16 127.99 91.72 Favored Pre-proline 0 CA--C 1.55 0.949 0 O-C-N 121.674 -0.642 . . . . 0.0 110.822 175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -62.49 158.11 42.82 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.191 2.594 . . . . 0.0 112.815 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.05 120.21 12.75 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.722 -0.611 . . . . 0.0 111.272 174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -108.69 155.71 20.4 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.848 1.659 . . . . 0.0 111.397 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -27.32 62.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.374 1.07 . . . . 0.0 113.499 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.4 133.68 88.39 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 124.282 1.033 . . . . 0.0 112.108 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.46 149.94 89.13 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.216 2.611 . . . . 0.0 112.394 177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 136.19 96.61 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-O 119.022 -0.513 . . . . 0.0 110.926 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -61.43 142.95 97.1 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.9 2.4 . . . . 0.0 111.779 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.27 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.098 0.559 . . . . 0.0 110.213 169.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.47 126.45 25.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.963 0.905 . . . . 0.0 111.032 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.57 130.12 50.52 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.005 0.812 . . . . 0.0 112.045 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -61.35 142.31 57.0 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.685 0.794 . . . . 0.0 112.347 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.56 132.89 54.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.58 0.752 . . . . 0.0 110.863 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -60.46 134.25 56.89 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.664 0.786 . . . . 0.0 110.377 172.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 129.46 40.91 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.871 0.468 . . . . 0.0 110.71 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.42 91.82 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -62.34 119.3 8.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.971 0.908 . . . . 0.0 109.386 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 114.76 4.0 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.612 0.765 . . . . 0.0 110.563 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.85 123.26 18.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.729 0.812 . . . . 0.0 111.289 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -86.81 140.04 30.1 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.036 0.934 . . . . 0.0 110.888 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.84 133.88 54.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.121 0.569 . . . . 0.0 110.82 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -62.13 156.29 22.03 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.681 1.193 . . . . 0.0 112.183 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -57.29 127.79 33.76 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.141 0.496 . . . . 0.0 111.432 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.57 -2.95 70.36 Favored Glycine 0 CA--C 1.54 1.642 0 N-CA-C 116.19 1.236 . . . . 0.0 116.19 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.1 -44.68 53.06 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.772 1.786 . . . . 0.0 111.566 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.65 143.8 45.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.607 1.163 . . . . 0.0 111.642 171.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -64.14 132.71 51.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.688 0.795 . . . . 0.0 109.919 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -71.6 102.68 2.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.208 1.003 . . . . 0.0 110.485 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -125.38 71.33 1.2 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.975 1.71 . . . . 0.0 111.202 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 5.0 m -62.6 132.24 51.73 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.602 0.761 . . . . 0.0 111.598 173.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 87.7 mmt-85 -137.63 -166.98 2.04 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.913 1.685 . . . . 0.0 110.371 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.031 0.933 . . . . 0.0 111.927 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -58.01 121.87 11.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.769 1.628 . . . . 0.0 111.062 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -135.19 -104.83 0.22 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.172 0.989 . . . . 0.0 111.558 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -70.73 -10.88 60.43 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.773 -1.204 . . . . 0.0 113.358 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 14.4 p -57.67 -38.53 75.29 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.206 1.802 . . . . 0.0 113.918 162.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 92.8 mt -59.78 -44.23 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.283 1.033 . . . . 0.0 110.394 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -105.35 29.11 6.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.531 1.532 . . . . 0.0 112.882 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.55 -34.8 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.463 1.105 . . . . 0.0 113.259 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.35 -45.09 92.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.698 1.199 . . . . 0.0 112.274 171.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.79 -35.36 80.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.144 0.978 . . . . 0.0 112.248 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.46 -50.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 118.476 0.58 . . . . 0.0 110.59 171.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 tp -60.11 -38.21 82.31 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.406 -0.809 . . . . 0.0 112.776 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -51.62 -34.94 39.79 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.219 1.408 . . . . 0.0 113.379 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -74.67 -14.24 60.72 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.9 -59.98 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.798 1.639 . . . . 0.0 111.36 -170.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.81 73.11 79.19 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 126.559 1.944 . . . . 0.0 110.073 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.26 -23.92 64.84 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.756 2.971 . . . . 0.0 114.743 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -79.17 -3.48 45.79 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.997 1.719 . . . . 0.0 113.894 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 43.2 m -119.42 140.06 51.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.842 1.657 . . . . 0.0 111.007 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.11 -166.22 25.82 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.533 1.063 . . . . 0.0 113.968 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 54.6 mt -132.98 137.06 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.963 -1.316 . . . . 0.0 110.237 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.33 147.12 41.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.025 0.93 . . . . 0.0 112.777 170.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 42.9 p -56.96 -34.62 68.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.009 0.923 . . . . 0.0 112.756 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -75.67 -44.09 44.18 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.404 1.082 . . . . 0.0 111.762 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.2 -37.42 72.17 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.871 0.868 . . . . 0.0 113.3 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 64.5 ttp -52.43 -50.77 61.91 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.268 -0.895 . . . . 0.0 111.712 167.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.7 95.52 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.872 1.225 . . . . 0.0 114.066 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 48.8 mm -59.63 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.379 1.09 . . . . 0.0 110.878 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . 0.401 ' SD ' HD22 ' C' ' 83' ' ' LEU . 92.6 mmm -60.81 -40.03 91.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.363 0.983 . . . . 0.0 112.443 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -58.64 -47.96 82.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.831 0.741 . . . . 0.0 111.781 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 10.3 t -56.27 -53.29 59.04 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.333 1.053 . . . . 0.0 111.996 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -53.17 -55.1 26.84 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.674 1.19 . . . . 0.0 112.218 176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.46 -51.0 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.184 0.994 . . . . 0.0 110.83 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -60.61 -38.77 85.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.822 0.737 . . . . 0.0 112.378 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -64.83 -52.09 58.6 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.251 0.932 . . . . 0.0 113.257 174.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.02 -31.45 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.167 0.894 . . . . 0.0 113.103 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -47.6 -51.33 21.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.123 1.369 . . . . 0.0 111.781 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -59.51 -44.87 93.02 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.379 0.672 . . . . 0.0 112.017 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -67.01 -52.34 43.78 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.171 0.588 . . . . 0.0 111.523 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.35 -42.93 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.161 0.984 . . . . 0.0 111.278 -177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.34 91.46 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.78 0.832 . . . . 0.0 112.095 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.97 -51.03 59.86 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.786 0.708 . . . . 0.0 113.226 169.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -56.4 -40.72 75.11 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.002 -1.293 . . . . 0.0 112.633 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.89 -47.61 51.96 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.298 1.039 . . . . 0.0 112.62 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p -77.55 -39.8 44.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.75 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -50.35 -50.39 51.34 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.745 1.157 . . . . 0.0 111.274 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 97.5 mt -61.59 -44.02 97.78 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.732 1.213 . . . . 0.0 112.747 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.22 -44.55 88.25 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 121.337 -0.852 . . . . 0.0 112.063 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -63.16 -38.25 90.42 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.8 1.24 . . . . 0.0 113.142 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -59.6 -34.11 72.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.662 1.119 . . . . 0.0 111.728 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -83.71 11.95 6.61 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.419 1.487 . . . . 0.0 113.257 171.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 91.9 mttt 59.46 28.57 17.98 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.696 2.398 . . . . 0.0 115.197 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.88 139.35 53.31 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.526 1.531 . . . . 0.0 112.815 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 35.6 p -86.97 -31.81 20.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.272 1.429 . . . . 0.0 113.591 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -87.48 147.69 25.27 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.655 1.582 . . . . 0.0 111.741 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 56.9 mt -104.78 120.92 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 0.0 108.353 168.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 7.0 p -100.38 161.89 13.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.068 0.947 . . . . 0.0 113.118 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 53.0 p -66.84 -23.68 66.06 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.429 1.092 . . . . 0.0 113.669 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -80.72 -42.83 21.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.644 1.178 . . . . 0.0 112.189 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -54.82 -28.7 51.47 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.991 1.317 . . . . 0.0 114.035 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.76 -32.83 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.79 0.836 . . . . 0.0 112.449 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -54.96 -33.98 62.85 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.432 1.093 . . . . 0.0 112.811 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 51.7 m -99.53 -46.65 5.39 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.639 1.176 . . . . 0.0 111.406 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.5 74.89 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.925 -1.109 . . . . 0.0 113.019 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.8 -36.79 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.646 -1.284 . . . . 0.0 111.135 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.53 -36.65 84.9 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.441 1.096 . . . . 0.0 113.055 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.35 -42.65 87.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.179 0.592 . . . . 0.0 112.007 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.66 -54.11 15.42 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 87.4 mt -104.3 111.59 65.22 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 125.187 1.395 . . . . 0.0 110.832 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.05 152.88 76.19 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.339 2.693 . . . . 0.0 113.68 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.37 -140.53 45.19 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.846 1.212 . . . . 0.0 114.824 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.5 -14.04 61.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -52.35 -48.49 65.49 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.731 0.812 . . . . 0.0 110.999 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.06 -45.79 72.88 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -46.31 -52.25 13.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.589 1.156 . . . . 0.0 110.826 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -68.34 -49.31 61.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.756 1.222 . . . . 0.0 113.004 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.13 -44.9 71.75 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.392 -0.817 . . . . 0.0 112.972 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 86.8 t -69.61 -47.08 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.588 1.155 . . . . 0.0 111.677 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 64.7 p -66.84 -26.74 67.06 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -76.75 -42.58 40.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.602 0.761 . . . . 0.0 111.831 165.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.48 -23.28 34.53 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.997 1.76 . . . . 0.0 116.079 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 73.0 p -56.31 -38.98 72.03 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.973 1.887 . . . . 0.0 112.418 172.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -63.79 -43.57 95.94 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.274 1.03 . . . . 0.0 111.338 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.56 91.4 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.061 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -52.18 -52.45 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 120.029 1.286 . . . . 0.0 110.703 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 46.7 m -54.75 -47.55 73.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.402 0.681 . . . . 0.0 112.172 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.79 -48.86 76.97 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.032 0.833 . . . . 0.0 112.337 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -66.48 -31.01 71.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.9 p -81.83 -32.17 31.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.7 1.136 . . . . 0.0 113.691 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 56.6 p -79.45 -30.3 42.12 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.469 1.031 . . . . 0.0 113.721 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.78 136.86 39.34 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.611 1.164 . . . . 0.0 112.564 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.253 1.263 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.931 -179.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -59.88 133.46 50.88 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.435 2.757 . . . . 0.0 113.379 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -81.05 -173.96 48.25 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.922 . . . . 0.0 113.244 170.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.5 mmm -59.55 -30.8 68.87 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.25 1.02 . . . . 0.0 113.433 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 79.8 p -91.51 -1.85 57.39 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.007 1.723 . . . . 0.0 114.386 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.36 8.55 66.39 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.031 1.3 . . . . 0.0 115.769 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -89.6 24.33 2.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.354 1.461 . . . . 0.0 114.712 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.36 15.92 61.96 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 116.188 1.235 . . . . 0.0 116.188 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.86 133.19 51.37 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.711 1.256 . . . . 0.0 112.857 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -73.7 150.76 41.01 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.295 1.038 . . . . 0.0 111.063 166.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.73 -138.28 37.59 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.987 0.804 . . . . 0.0 113.15 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.17 24.38 65.19 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 123.939 0.78 . . . . 0.0 114.256 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -53.01 126.58 21.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.614 1.965 . . . . 0.0 112.408 -174.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.28 132.99 50.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.821 0.849 . . . . 0.0 111.971 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -76.02 147.34 38.82 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.303 1.041 . . . . 0.0 111.952 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.18 134.59 52.02 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.495 0.718 . . . . 0.0 111.495 172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.79 136.81 53.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.768 0.827 . . . . 0.0 111.319 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.2 140.23 58.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.055 0.542 . . . . 0.0 110.975 169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -66.67 115.42 6.48 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.39 0.676 . . . . 0.0 111.14 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 36.4 p -81.76 -32.14 31.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.805 1.242 . . . . 0.0 112.752 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.45 133.31 49.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.838 1.255 . . . . 0.0 112.984 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 89.0 p -137.52 171.79 13.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.537 1.935 . . . . 0.0 110.505 167.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.0 t -62.91 117.28 6.17 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.298 -0.876 . . . . 0.0 110.85 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -65.49 141.61 58.42 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.091 0.956 . . . . 0.0 112.111 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.3 119.98 12.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.948 0.899 . . . . 0.0 112.098 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.07 142.95 48.16 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.169 0.89 . . . . 0.0 111.888 171.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.02 128.62 37.03 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.669 0.788 . . . . 0.0 111.806 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -106.94 34.64 3.35 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.388 1.475 . . . . 0.0 112.021 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -123.24 174.47 3.47 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.276 2.23 . . . . 0.0 109.995 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -54.18 -36.12 84.69 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.154 2.569 . . . . 0.0 113.96 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 m -60.32 -22.92 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 125.2 1.4 . . . . 0.0 114.426 172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.09 91.7 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.615 1.102 . . . . 0.0 114.125 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -58.59 -49.83 76.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.853 0.827 . . . . 0.0 110.928 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -58.14 -49.0 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.115 0.966 . . . . 0.0 111.105 174.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -54.77 -49.57 70.56 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.309 1.444 . . . . 0.0 112.812 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.73 -49.03 76.42 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.506 1.122 . . . . 0.0 111.991 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.02 -37.69 88.46 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.93 . . . . 0.0 112.859 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 71.8 mt -58.23 -45.88 86.92 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.631 0.772 . . . . 0.0 112.233 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 74.3 mtt180 -66.84 -47.64 71.34 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.313 0.645 . . . . 0.0 112.123 176.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -51.9 -48.71 64.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.91 1.684 . . . . 0.0 112.493 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.16 -4.34 59.35 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 124.969 1.271 . . . . 0.0 115.977 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 64.1 t30 53.52 38.81 28.98 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.199 1.8 . . . . 0.0 113.975 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -69.06 -23.88 64.1 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 97.0 p -148.69 168.7 22.18 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.644 1.578 . . . . 0.0 111.846 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -61.47 -46.06 91.62 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.845 0.858 . . . . 0.0 112.284 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -139.37 138.02 36.23 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.97 1.708 . . . . 0.0 110.848 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.37 115.75 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 0.0 109.665 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.6 179.91 52.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.02 1.295 . . . . 0.0 114.094 172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.91 -28.15 57.94 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.6 -44.15 96.93 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 121.331 -0.856 . . . . 0.0 114.286 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.51 -58.66 10.95 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -62.71 -33.51 76.64 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.375 2.05 . . . . 0.0 113.388 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.59 -49.28 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.746 1.157 . . . . 0.0 111.176 174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -64.21 -34.87 79.09 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.571 -0.706 . . . . 0.0 112.586 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.91 -44.3 81.12 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.382 -0.823 . . . . 0.0 112.278 169.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.06 -41.14 78.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.624 1.102 . . . . 0.0 112.519 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.79 -21.44 19.35 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -91.53 -54.16 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.322 1.449 . . . . 0.0 111.281 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.559 HD13 ' CD1' ' D' ' 70' ' ' PHE . 39.4 mt -50.17 -45.54 53.42 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.953 1.701 . . . . 0.0 113.391 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -48.13 -53.44 16.69 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.408 1.083 . . . . 0.0 112.172 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 -41.35 80.98 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.039 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -56.95 -49.55 75.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 118.993 0.815 . . . . 0.0 111.48 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 86.1 m -57.56 -48.64 78.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.127 0.971 . . . . 0.0 111.53 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.26 -48.18 62.25 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.143 1.377 . . . . 0.0 113.432 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -56.95 -34.34 67.93 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 6.9 mm -70.05 -34.48 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 118.77 0.714 . . . . 0.0 110.833 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.29 -44.3 88.42 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.912 0.778 . . . . 0.0 111.68 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.96 -53.06 61.96 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.533 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -60.65 -36.75 79.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.694 0.797 . . . . 0.0 112.323 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -38.39 79.93 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.463 1.028 . . . . 0.0 112.657 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.6 -45.56 93.08 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.619 0.645 . . . . 0.0 112.581 168.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.55 -42.18 95.85 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.482 -1.011 . . . . 0.0 111.842 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.38 -45.31 84.6 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.48 1.037 . . . . 0.0 111.625 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.7 86.86 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.758 0.823 . . . . 0.0 112.094 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -57.33 -48.61 78.54 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.855 1.262 . . . . 0.0 112.678 173.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -58.52 -39.44 80.13 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.524 1.129 . . . . 0.0 113.259 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.57 4.67 31.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.565 1.146 . . . . 0.0 112.968 174.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 53.09 36.88 23.42 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 127.423 2.289 . . . . 0.0 114.177 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -98.09 149.67 22.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.72 1.608 . . . . 0.0 112.513 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 33.1 p -85.46 -28.86 24.75 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.214 1.406 . . . . 0.0 113.345 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -119.36 140.24 50.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.32 1.848 . . . . 0.0 111.153 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 72.8 mt -74.29 121.52 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 109.129 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 pt -98.51 162.8 20.61 Favored Pre-proline 0 N--CA 1.48 1.075 0 C-N-CA 124.315 1.046 . . . . 0.0 111.671 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.38 -35.73 85.28 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.971 2.447 . . . . 0.0 114.091 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 43.2 m170 -64.3 -43.74 93.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.582 1.083 . . . . 0.0 111.692 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.75 -41.94 98.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.683 0.793 . . . . 0.0 111.424 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -64.06 -44.75 91.47 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.173 0.989 . . . . 0.0 112.636 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.1 mt -60.83 -51.22 70.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.049 -1.032 . . . . 0.0 111.044 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -50.06 -41.83 48.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.916 1.286 . . . . 0.0 113.362 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.27 -45.99 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.843 0.747 . . . . 0.0 112.966 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 -71.13 -19.46 62.43 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -58.16 -28.56 64.85 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.814 1.246 . . . . 0.0 113.492 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -129.63 123.07 30.36 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.598 1.09 . . . . 0.0 112.637 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -61.77 -47.33 85.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.118 0.967 . . . . 0.0 113.059 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -60.67 -53.46 57.21 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 118.748 -0.644 . . . . 0.0 110.868 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mp -49.74 -47.13 50.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.633 1.106 . . . . 0.0 111.753 171.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -61.32 -30.1 70.29 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.704 -1.248 . . . . 0.0 114.151 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.64 -49.66 7.83 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.396 1.078 . . . . 0.0 112.362 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.09 -44.2 87.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.609 2.364 . . . . 0.0 113.409 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 3.2 tp -119.48 -65.37 1.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.971 1.708 . . . . 0.0 110.215 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.04 -174.94 19.78 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mmt-85 -146.3 179.77 7.29 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 128.737 2.815 . . . . 0.0 109.981 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 13.4 p -54.45 145.33 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.841 0.856 . . . . 0.0 111.555 158.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 61.8 m -89.08 108.1 19.41 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.484 -0.76 . . . . 0.0 109.629 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 49.0 mm -84.12 113.66 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.877 . . . . 0.0 109.729 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.15 43.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.806 . . . . 0.0 111.842 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -93.32 146.81 23.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.456 1.102 . . . . 0.0 111.605 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.85 -90.59 0.21 Allowed Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.573 1.082 . . . . 0.0 113.595 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.05 -153.79 50.27 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.108 1.337 . . . . 0.0 113.755 -172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.78 125.0 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.018 1.327 . . . . 0.0 109.932 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.91 144.97 40.1 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 111.121 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -59.85 137.19 74.92 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.848 2.365 . . . . 0.0 111.958 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -65.45 137.34 57.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.217 0.607 . . . . 0.0 110.239 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 72.2 mt -71.01 117.24 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.21 0.604 . . . . 0.0 109.562 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -105.02 130.55 53.2 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 109.942 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.29 132.23 49.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.177 0.591 . . . . 0.0 111.449 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.0 103.13 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.5 mt -72.95 123.16 22.91 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.593 0.757 . . . . 0.0 110.369 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 83.1 mt -91.04 144.2 29.64 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.295 1.038 . . . . 0.0 111.258 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -59.57 140.16 92.53 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.175 2.583 . . . . 0.0 112.345 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.29 146.36 51.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.28 1.032 . . . . 0.0 112.012 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.03 136.37 53.73 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.617 0.767 . . . . 0.0 110.529 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p -119.94 161.4 20.94 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.627 1.571 . . . . 0.0 111.792 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.97 119.71 10.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.584 -0.697 . . . . 0.0 110.401 171.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.7 p -68.74 157.08 37.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.268 1.027 . . . . 0.0 113.051 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -57.35 129.0 39.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.238 0.615 . . . . 0.0 110.833 173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -60.04 117.93 5.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.747 0.819 . . . . 0.0 112.462 -172.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.85 119.99 11.69 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.277 1.031 . . . . 0.0 110.621 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.07 148.21 44.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.72 0.808 . . . . 0.0 112.628 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.02 137.3 53.53 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.069 0.947 . . . . 0.0 111.612 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.93 149.39 3.18 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.717 1.151 . . . . 0.0 113.924 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.028 1.731 . . . . 0.0 111.783 -176.351 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 CA-C-O 118.824 -0.987 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.1 -6.8 11.2 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.071 3.18 . . . . 0.0 114.344 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 75.62 6.32 80.89 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.134 1.349 . . . . 0.0 115.331 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 97.5 mmm -68.7 149.01 98.07 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.606 1.162 . . . . 0.0 111.916 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -33.83 17.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.078 2.519 . . . . 0.0 113.129 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -68.88 149.26 97.92 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.004 0.922 . . . . 0.0 112.19 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.23 124.9 17.39 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.233 2.622 . . . . 0.0 112.295 173.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.82 131.89 45.2 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.248 0.619 . . . . 0.0 112.053 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.31 151.45 46.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.136 0.974 . . . . 0.0 111.512 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -64.75 113.64 3.92 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.206 0.603 . . . . 0.0 111.155 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.86 152.17 51.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.489 1.516 . . . . 0.0 111.917 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -61.26 153.28 66.38 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.178 2.585 . . . . 0.0 112.408 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.55 145.91 96.96 Favored Pre-proline 0 CA--C 1.553 1.075 0 O-C-N 121.778 -0.576 . . . . 0.0 111.777 171.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.73 140.68 96.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.013 2.475 . . . . 0.0 113.087 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -59.27 123.14 15.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.695 0.798 . . . . 0.0 110.983 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 54.33 20.92 2.9 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.675 1.99 . . . . 0.0 114.834 -171.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.4 -157.49 15.34 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.116 1.341 . . . . 0.0 113.576 173.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 22.1 t -67.56 126.62 29.9 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.011 -0.7 . . . . 0.0 111.442 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.46 126.11 34.18 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.738 1.215 . . . . 0.0 111.313 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.22 -32.36 66.43 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.602 1.161 . . . . 0.0 113.309 177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 -14.5 62.84 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.43 117.34 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.906 1.282 . . . . 0.0 110.229 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 90.0 m -124.99 103.6 8.11 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.971 1.308 . . . . 0.0 109.184 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 39.83 64.35 0.89 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.805 2.042 . . . . 0.0 113.33 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.71 137.53 31.01 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.647 0.779 . . . . 0.0 111.526 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.56 115.52 3.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.504 0.722 . . . . 0.0 111.015 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.05 132.52 50.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.927 0.891 . . . . 0.0 110.28 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.92 114.24 5.58 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.883 0.873 . . . . 0.0 110.02 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -73.67 143.09 46.38 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.978 0.511 . . . . 0.0 111.771 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.84 11.14 62.55 Favored Glycine 0 CA--C 1.541 1.68 0 N-CA-C 115.285 0.874 . . . . 0.0 115.285 -171.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.59 128.04 35.2 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.009 1.324 . . . . 0.0 110.855 172.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.37 131.93 45.58 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.974 0.91 . . . . 0.0 110.737 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -61.51 125.05 22.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.918 0.887 . . . . 0.0 109.877 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.11 132.12 52.96 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.66 136.42 58.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.624 0.77 . . . . 0.0 110.637 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 12.6 t -70.22 120.93 16.63 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.511 0.325 . . . . 0.0 110.137 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -125.06 132.06 53.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.465 1.506 . . . . 0.0 110.296 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 53.1 106.5 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.389 2.675 . . . . 0.0 114.233 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -85.13 138.15 32.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.067 0.947 . . . . 0.0 109.62 167.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 63.4 m -146.74 143.06 28.42 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -162.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 47.72 142.78 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 135.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -51.55 -17.97 0.98 Allowed 'General case' 0 N--CA 1.48 1.057 0 O-C-N 119.817 -1.802 . . . . 0.0 114.741 163.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.96 -52.01 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.85 1.26 . . . . 0.0 111.028 170.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -83.34 -27.98 29.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.832 0.853 . . . . 0.0 113.045 -169.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 18.8 m -46.61 -43.56 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.812 1.187 . . . . 0.0 112.341 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -56.91 -52.83 63.63 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.889 1.276 . . . . 0.0 112.556 177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.93 -50.84 69.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.956 0.902 . . . . 0.0 111.345 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 83.2 t -57.03 -46.4 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.84 0.856 . . . . 0.0 111.248 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 tp -52.57 -50.8 62.25 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.341 1.056 . . . . 0.0 112.085 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.41 -43.77 79.68 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.267 1.027 . . . . 0.0 112.299 174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -66.15 -47.74 73.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 19.6 m -78.37 -30.04 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -121.55 90.36 47.92 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.201 1.4 . . . . 0.0 110.226 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -57.79 -26.26 72.74 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.626 2.884 . . . . 0.0 114.491 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -71.25 -12.64 61.57 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.218 1.807 . . . . 0.0 113.62 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -103.12 117.5 34.69 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.253 1.421 . . . . 0.0 110.097 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.56 -169.68 15.64 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.855 1.217 . . . . 0.0 112.937 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 tt -133.94 151.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 -176.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 24.0 t -70.01 143.87 52.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.835 0.854 . . . . 0.0 112.461 170.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 34.8 p -58.37 -40.29 81.89 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.012 0.925 . . . . 0.0 112.196 169.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.82 -43.64 98.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.94 0.896 . . . . 0.0 111.702 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.49 81.2 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.185 0.594 . . . . 0.0 112.566 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.2 mmm -65.92 -41.83 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.965 -1.084 . . . . 0.0 112.98 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.41 -41.96 88.67 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 119.298 0.953 . . . . 0.0 113.041 170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -61.12 -49.78 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.791 1.637 . . . . 0.0 111.008 171.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 86.8 mmm -56.03 -40.49 73.55 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.668 1.122 . . . . 0.0 112.933 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -64.65 -42.5 95.38 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.812 -1.18 . . . . 0.0 111.726 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -55.61 -46.85 77.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.603 0.761 . . . . 0.0 111.241 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -56.79 -52.7 64.01 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 118.274 -0.87 . . . . 0.0 111.677 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.46 -41.33 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.87 1.214 . . . . 0.0 112.384 177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -66.05 -54.52 24.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 119.072 0.851 . . . . 0.0 112.057 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.7 -50.8 71.1 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 11.9 pt -62.58 -36.48 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.368 1.067 . . . . 0.0 112.489 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . 0.559 ' CD1' HD13 ' C' ' 55' ' ' LEU . 10.7 m-30 -66.94 -23.52 65.97 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.323 1.049 . . . . 0.0 112.33 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -81.22 -47.83 12.87 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.59 0.756 . . . . 0.0 110.944 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -54.98 -42.94 73.07 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 13.7 tt -59.63 -34.0 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 118.767 0.712 . . . . 0.0 112.552 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.43 88.21 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.301 0.955 . . . . 0.0 111.797 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.82 94.48 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 123.995 0.807 . . . . 0.0 113.371 169.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -70.95 -40.4 72.04 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.076 -1.25 . . . . 0.0 112.741 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.91 72.32 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.914 -1.116 . . . . 0.0 111.576 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 7.1 t -62.43 -47.4 84.22 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.363 1.065 . . . . 0.0 112.123 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -54.28 -46.84 72.82 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.0 -1.062 . . . . 0.0 112.403 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 89.6 mt -61.88 -41.73 98.23 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 0.0 112.304 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.53 86.43 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.922 0.889 . . . . 0.0 112.257 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -60.8 -42.37 97.46 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.501 1.12 . . . . 0.0 112.594 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -57.62 -33.37 68.17 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.211 0.914 . . . . 0.0 112.302 172.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -90.01 7.84 35.54 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.473 1.509 . . . . 0.0 113.326 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.25 31.1 13.53 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.526 2.33 . . . . 0.0 114.876 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -91.39 143.25 26.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.93 177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 40.2 p -90.11 -37.56 14.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.363 1.465 . . . . 0.0 113.213 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 72.9 p -106.22 -179.45 3.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.534 1.933 . . . . 0.0 111.515 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mt -125.22 125.25 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.998 1.319 . . . . 0.0 109.358 171.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 18.5 p -101.77 164.22 11.85 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.263 1.025 . . . . 0.0 113.084 173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 45.8 p -57.33 -43.22 83.18 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.211 -0.931 . . . . 0.0 112.565 170.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.19 -37.03 84.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.209 1.004 . . . . 0.0 112.836 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -65.91 -39.43 90.58 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.577 0.751 . . . . 0.0 111.952 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.32 -43.12 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 169.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -54.82 -45.33 74.41 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.455 1.025 . . . . 0.0 112.587 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 42.2 p -70.48 -38.27 74.36 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.411 1.005 . . . . 0.0 112.174 171.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.32 -24.63 63.48 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 117.59 -1.195 . . . . 0.0 114.164 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -46.62 -50.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 121.204 1.82 . . . . 0.0 111.612 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.45 -28.06 64.73 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -76.33 -39.33 54.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.538 1.135 . . . . 0.0 111.772 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 67.3 mt -84.57 -20.31 31.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.016 1.726 . . . . 0.0 112.906 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 63.3 tp -144.08 100.8 4.91 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 126.412 1.885 . . . . 0.0 109.976 169.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -57.75 143.51 95.18 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 123.046 2.498 . . . . 0.0 112.714 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.31 -39.01 89.62 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.433 0.54 . . . . 0.0 113.348 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -65.29 -39.11 92.11 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.739 -0.859 . . . . 0.0 112.286 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 46.2 tp -66.2 -43.72 85.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.663 0.785 . . . . 0.0 111.401 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.25 -51.72 68.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.39 0.676 . . . . 0.0 111.84 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -57.47 -45.82 84.38 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.267 1.027 . . . . 0.0 112.448 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -56.64 -54.26 48.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 0.0 111.604 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -54.87 -40.99 70.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.374 1.07 . . . . 0.0 113.135 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -64.2 -68.15 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.801 0.84 . . . . 0.0 110.942 171.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.5 m -71.36 -40.82 70.39 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -163.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -68.35 -37.29 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.839 -1.163 . . . . 0.0 111.026 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.79 -44.91 95.6 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.638 0.637 . . . . 0.0 113.368 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 47.2 m -54.74 -53.62 52.59 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.508 1.123 . . . . 0.0 111.391 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -54.91 -47.51 74.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.929 0.892 . . . . 0.0 111.988 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.36 -45.35 88.36 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 0.0 112.677 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.65 -48.97 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.646 1.112 . . . . 0.0 111.432 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 39.8 m -54.14 -44.12 71.13 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.78 1.173 . . . . 0.0 112.167 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -60.67 -48.52 81.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.161 0.984 . . . . 0.0 111.906 173.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -58.85 -44.75 91.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.485 1.114 . . . . 0.0 112.885 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 61.1 p -84.05 -1.19 54.35 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 11.5 t -56.28 138.3 50.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.115 1.366 . . . . 0.0 113.59 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.14 149.06 47.96 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.273 1.029 . . . . 0.0 112.842 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.054 1.342 . . . . 0.0 112.45 177.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 CA-C-O 119.573 -0.571 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.95 141.34 89.09 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.942 3.094 . . . . 0.0 113.551 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -70.3 173.41 39.78 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 124.757 1.17 . . . . 0.0 113.964 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.7 mmm -62.61 143.43 57.31 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.604 0.762 . . . . 0.0 112.324 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p -79.54 170.12 17.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.982 1.313 . . . . 0.0 113.649 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.01 -177.39 45.23 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.702 1.144 . . . . 0.0 114.505 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 54.41 20.42 2.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 126.9 2.08 . . . . 0.0 115.252 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.9 171.62 41.6 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.167 1.365 . . . . 0.0 113.975 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.64 124.49 18.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.592 1.157 . . . . 0.0 111.221 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -71.63 129.97 40.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.888 0.875 . . . . 0.0 111.486 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.82 145.85 47.66 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.795 1.188 . . . . 0.0 114.009 177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.42 -135.67 49.71 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.539 1.066 . . . . 0.0 112.939 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -76.9 115.36 16.61 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.656 0.782 . . . . 0.0 110.259 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.05 157.29 35.53 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.609 0.763 . . . . 0.0 112.629 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 103.38 2.57 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.01 123.63 18.18 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.29 147.34 52.32 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.704 0.802 . . . . 0.0 111.409 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.76 134.34 56.94 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.389 0.676 . . . . 0.0 111.573 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.83 137.36 58.25 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.728 0.811 . . . . 0.0 111.395 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 27.1 p -66.38 149.86 49.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.836 0.854 . . . . 0.0 111.995 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.65 142.22 58.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.157 0.583 . . . . 0.0 110.447 169.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t -60.03 127.35 31.46 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.9 0.48 . . . . 0.0 110.869 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -62.33 125.87 25.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.372 0.669 . . . . 0.0 111.308 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -59.11 126.83 29.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.757 0.823 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.33 122.52 15.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.402 0.681 . . . . 0.0 111.875 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.41 173.19 25.61 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.08 0.848 . . . . 0.0 112.969 169.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 64.1 tp -54.34 123.4 12.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.503 0.721 . . . . 0.0 110.812 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -77.84 145.43 36.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.341 0.657 . . . . 0.0 111.731 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -124.71 148.96 60.87 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.943 1.297 . . . . 0.0 110.657 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -55.44 -42.95 63.0 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.157 2.571 . . . . 0.0 113.707 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.89 -41.08 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.814 0.846 . . . . 0.0 111.257 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.78 -40.12 97.13 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.583 1.087 . . . . 0.0 113.85 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -61.6 -45.06 95.68 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.233 -1.157 . . . . 0.0 111.42 172.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.05 -47.9 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.677 0.791 . . . . 0.0 111.336 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -47.56 -47.82 28.15 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 119.806 1.185 . . . . 0.0 112.336 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.15 -51.32 68.34 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.411 1.085 . . . . 0.0 112.504 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -54.69 -44.02 73.03 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 112.831 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.44 -44.84 89.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.189 0.995 . . . . 0.0 112.11 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -64.9 -48.96 72.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.966 0.906 . . . . 0.0 112.199 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -57.59 -43.82 84.9 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.273 1.429 . . . . 0.0 112.551 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.59 -13.56 65.87 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.267 1.413 . . . . 0.0 115.302 172.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.4 t30 54.66 40.05 31.64 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.464 1.906 . . . . 0.0 113.288 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 -70.6 -32.61 70.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 71.2 p -131.33 165.36 23.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.432 1.493 . . . . 0.0 111.737 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -56.08 -47.1 78.63 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.534 1.134 . . . . 0.0 112.907 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -139.58 154.15 47.55 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.958 1.703 . . . . 0.0 109.994 169.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 t -116.55 109.16 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.063 0.945 . . . . 0.0 108.877 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.61 162.01 41.08 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.653 1.121 . . . . 0.0 112.585 170.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.05 -36.96 63.63 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.99 -24.41 74.46 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.287 0.946 . . . . 0.0 115.26 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.71 -58.75 17.03 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.805 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -54.89 -38.52 92.61 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.478 2.119 . . . . 0.0 113.219 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.78 -53.95 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.033 0.933 . . . . 0.0 110.954 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -57.17 -50.09 73.91 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.777 0.831 . . . . 0.0 112.286 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.66 -45.59 85.35 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.316 1.046 . . . . 0.0 111.617 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.21 -43.12 96.22 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.254 0.934 . . . . 0.0 112.97 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.32 -49.89 75.19 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.257 -0.902 . . . . 0.0 112.656 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.43 -41.85 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 121.54 -0.725 . . . . 0.0 111.541 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 tp -50.8 -52.75 38.05 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.355 171.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -59.53 -42.87 93.3 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.236 1.38 . . . . 0.0 113.108 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -53.98 -47.87 70.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.585 0.754 . . . . 0.0 112.626 171.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.92 -45.04 75.48 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.828 0.851 . . . . 0.0 112.392 176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -54.94 -40.04 69.52 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.543 1.537 . . . . 0.0 112.285 175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.7 -47.21 70.72 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.914 1.234 . . . . 0.0 112.269 173.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -63.42 -46.62 85.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.606 0.762 . . . . 0.0 112.403 174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -51.52 -55.39 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 118.771 0.714 . . . . 0.0 110.369 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.49 -46.31 83.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.438 0.695 . . . . 0.0 112.154 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.42 -51.49 64.74 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.724 0.693 . . . . 0.0 111.913 174.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.3 -33.24 72.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.604 0.762 . . . . 0.0 112.765 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.67 90.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.62 1.1 . . . . 0.0 112.094 176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.68 -46.09 89.68 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 122.084 -0.385 . . . . 0.0 112.655 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -61.33 -45.17 95.56 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.956 -0.732 . . . . 0.0 111.473 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -42.45 81.96 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.995 0.918 . . . . 0.0 112.723 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.25 86.72 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.607 -0.683 . . . . 0.0 112.375 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -59.08 -39.5 82.36 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -60.03 -31.68 70.19 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 174.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -89.99 3.84 51.95 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.06 0.944 . . . . 0.0 113.503 170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.5 mttt 56.46 33.03 21.8 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.904 2.081 . . . . 0.0 113.711 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -103.21 147.7 26.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.623 1.569 . . . . 0.0 112.553 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.4 p -98.02 2.02 48.4 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.974 1.71 . . . . 0.0 113.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 61.3 ttp180 -126.27 120.09 29.09 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.676 1.591 . . . . 0.0 110.709 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.29 123.77 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.493 1.517 . . . . 0.0 109.056 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 30.7 pt -111.17 167.21 9.38 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 126.074 1.75 . . . . 0.0 111.309 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -48.32 -40.31 35.66 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.565 2.843 . . . . 0.0 114.906 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.4 -36.27 75.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.974 0.909 . . . . 0.0 113.213 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -65.56 -39.66 91.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.264 0.938 . . . . 0.0 112.429 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.01 -44.34 85.05 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.149 0.58 . . . . 0.0 111.229 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -57.19 -49.91 74.51 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.448 -0.783 . . . . 0.0 112.035 172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 64.8 mt -56.56 -46.55 80.66 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.081 0.952 . . . . 0.0 111.766 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.36 -48.4 76.91 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.44 -0.787 . . . . 0.0 112.893 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.06 -45.82 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.472 1.109 . . . . 0.0 110.985 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.79 -24.9 64.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.959 1.304 . . . . 0.0 114.512 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -88.78 -34.97 16.91 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.344 1.058 . . . . 0.0 112.181 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -65.42 117.41 7.9 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.13 0.877 . . . . 0.0 112.489 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.44 -37.12 74.76 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.181 0.993 . . . . 0.0 113.079 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -64.93 -43.87 91.34 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.432 1.014 . . . . 0.0 111.865 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -70.91 -32.77 69.81 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.142 -0.932 . . . . 0.0 112.857 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.59 -39.6 94.24 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.218 1.372 . . . . 0.0 112.061 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -64.22 -41.97 96.79 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.611 0.765 . . . . 0.0 112.231 171.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 29.7 tp -75.23 -49.26 19.91 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 9.9 mp -97.99 102.74 14.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.609 1.564 . . . . 0.0 110.295 -175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.34 152.18 49.72 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 123.446 0.546 . . . . 0.0 112.725 162.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.0 -35.74 79.42 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 121.588 -0.948 . . . . 0.0 112.617 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 58.2 t -75.81 131.95 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.052 1.341 . . . . 0.0 110.606 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 28.4 p -105.15 -23.2 12.95 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.091 1.356 . . . . 0.0 113.92 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.58 104.44 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.687 1.195 . . . . 0.0 108.873 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.98 137.92 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.42 0.688 . . . . 0.0 111.594 173.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -92.61 138.72 31.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.116 0.966 . . . . 0.0 111.608 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.47 -156.28 31.11 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.361 0.981 . . . . 0.0 113.922 -170.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -69.3 156.75 53.55 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 124.504 1.05 . . . . 0.0 113.578 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 39.7 t -67.97 128.8 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 121.718 -0.872 . . . . 0.0 110.346 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 98.2 mt -123.78 147.46 53.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.564 1.546 . . . . 0.0 110.844 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -56.99 134.68 66.13 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.362 2.708 . . . . 0.0 112.917 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -73.08 -44.36 60.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.738 0.815 . . . . 0.0 111.932 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 34.3 mm -63.17 131.8 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.039 0.935 . . . . 0.0 110.234 172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -94.38 142.91 26.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.28 1.032 . . . . 0.0 111.6 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.71 147.17 53.62 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.41 0.684 . . . . 0.0 112.277 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 22.3 t 60.83 119.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 127.119 2.168 . . . . 0.0 112.713 -165.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.6 122.35 14.49 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.972 0.909 . . . . 0.0 111.053 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.37 138.74 81.16 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.182 0.593 . . . . 0.0 111.22 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -61.15 150.41 84.57 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.788 2.326 . . . . 0.0 111.61 170.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.14 108.24 2.6 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.75 -0.594 . . . . 0.0 110.423 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.79 151.26 45.96 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.655 1.182 . . . . 0.0 111.262 175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -57.67 122.76 13.56 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.022 0.929 . . . . 0.0 110.731 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -62.68 133.35 54.71 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.406 0.682 . . . . 0.0 111.3 177.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 21.2 t -77.83 108.54 11.14 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 121.913 -0.492 . . . . 0.0 110.787 177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -91.36 -0.26 57.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.539 1.135 . . . . 0.0 112.877 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -73.68 142.05 46.42 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.105 1.362 . . . . 0.0 111.692 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.25 127.3 32.42 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.57 0.748 . . . . 0.0 110.593 172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.74 147.31 53.35 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.701 0.8 . . . . 0.0 112.681 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.15 114.49 5.31 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.326 1.05 . . . . 0.0 111.903 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -70.16 147.48 44.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.934 1.254 . . . . 0.0 113.429 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 86.2 tttt . . . . . 0 C--O 1.252 1.234 0 C-N-CA 124.74 1.216 . . . . 0.0 112.226 173.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 CA-C-O 119.205 -0.775 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.33 -32.01 16.98 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.679 2.92 . . . . 0.0 113.762 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -60.83 123.42 32.69 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.37 0.986 . . . . 0.0 112.803 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.9 mmm -72.5 141.43 82.85 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 123.553 0.741 . . . . 0.0 112.065 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.41 148.94 92.48 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.104 2.536 . . . . 0.0 112.071 172.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -65.33 124.7 87.77 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.603 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -61.96 130.14 29.89 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.758 2.305 . . . . 0.0 110.999 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.7 117.58 6.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.51 0.724 . . . . 0.0 112.233 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.3 135.72 57.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.307 1.043 . . . . 0.0 110.544 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 16.4 t -58.85 122.83 14.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.242 0.617 . . . . 0.0 111.152 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 139.77 84.75 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 123.06 0.544 . . . . 0.0 112.174 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -59.74 131.52 40.39 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.82 2.346 . . . . 0.0 111.317 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.18 132.07 94.97 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.947 -0.549 . . . . 0.0 110.999 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -63.1 129.53 26.04 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.958 2.439 . . . . 0.0 112.058 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.73 125.28 24.27 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.911 0.884 . . . . 0.0 110.401 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -72.34 113.22 9.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.79 -178.5 30.42 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.355 0.978 . . . . 0.0 113.528 171.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 57.3 p -65.77 -32.02 73.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.05 0.94 . . . . 0.0 112.913 170.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -59.13 125.36 23.31 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.473 1.509 . . . . 0.0 111.324 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -70.0 157.64 37.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.878 1.271 . . . . 0.0 112.582 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.75 -34.39 75.76 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.778 0.831 . . . . 0.0 112.565 172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.31 113.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.156 1.382 . . . . 0.0 109.232 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 54.2 p -106.06 172.15 6.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.932 1.693 . . . . 0.0 110.745 171.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.81 113.94 2.77 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.222 -0.924 . . . . 0.0 110.505 173.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 117.91 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.696 0.798 . . . . 0.0 110.687 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -68.31 143.63 55.12 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 110.511 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.4 110.54 1.69 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.216 0.606 . . . . 0.0 110.178 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.66 145.59 55.96 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.329 1.052 . . . . 0.0 111.323 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -63.82 129.44 40.1 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 122.548 0.339 . . . . 0.0 111.271 172.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.44 135.63 51.72 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -49.11 125.46 10.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.68 1.192 . . . . 0.0 111.084 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.73 117.51 4.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.391 1.076 . . . . 0.0 111.145 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.36 125.85 30.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.167 0.987 . . . . 0.0 110.35 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -114.12 153.12 30.06 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.293 1.837 . . . . 0.0 109.754 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 64.1 ttm-85 -61.06 115.52 3.82 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.417 0.687 . . . . 0.0 110.353 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 15.4 t -70.61 130.43 41.79 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.514 0.726 . . . . 0.0 111.482 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -70.44 142.24 52.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.637 0.775 . . . . 0.0 111.223 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.66 -8.76 59.42 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.99 100.59 0.22 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.825 1.65 . . . . 0.0 111.686 172.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 11.5 t -150.68 -160.8 1.22 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.705 1.602 . . . . 0.0 110.165 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . 0.447 ' HB2' HG21 ' D' ' 66' ' ' VAL . 52.3 m-85 -72.98 36.77 0.08 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.592 1.957 . . . . 0.0 112.469 172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.8 p -124.97 -14.24 6.68 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.98 1.712 . . . . 0.0 115.249 -154.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.1 -55.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.221 0.919 . . . . 0.0 111.411 -169.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -56.21 -22.89 32.13 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 m -51.38 -32.86 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.996 1.319 . . . . 0.0 112.986 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -58.52 -54.4 47.5 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.103 0.961 . . . . 0.0 111.292 169.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.66 -36.84 79.72 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.627 1.171 . . . . 0.0 112.835 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 81.5 t -55.47 -56.61 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.701 0.8 . . . . 0.0 110.605 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.71 -25.34 59.07 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -52.35 -37.66 56.66 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.991 1.268 . . . . 0.0 112.147 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.56 -47.03 23.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.761 0.825 . . . . 0.0 112.728 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.41 -47.38 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.024 0.93 . . . . 0.0 112.285 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -127.34 82.64 67.83 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.812 2.045 . . . . 0.0 110.4 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -57.67 -24.9 65.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.488 2.792 . . . . 0.0 115.533 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -86.3 -7.9 58.14 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.929 2.092 . . . . 0.0 114.097 178.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -126.19 122.66 36.25 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.48 1.036 . . . . 0.0 112.539 -173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.8 178.66 26.11 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.384 1.469 . . . . 0.0 113.704 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.56 134.26 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.662 1.585 . . . . 0.0 109.541 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 23.5 p -70.46 160.7 31.91 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 36.4 p -55.06 -42.89 73.31 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.174 0.99 . . . . 0.0 112.22 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.82 -44.09 91.01 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.932 1.293 . . . . 0.0 112.149 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.44 92.64 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.242 1.017 . . . . 0.0 112.43 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.4 mtm -58.15 -44.94 88.14 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.203 -0.936 . . . . 0.0 111.676 169.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.93 -49.13 63.5 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.773 1.178 . . . . 0.0 114.651 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.65 -22.32 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.732 1.266 . . . . 0.0 113.833 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 94.6 mmm -53.55 -35.75 61.08 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 120.504 -1.373 . . . . 0.0 112.125 170.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -55.76 -40.3 72.39 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 78.7 p -79.03 -37.14 39.83 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.072 -1.017 . . . . 0.0 112.339 175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -58.25 -40.03 80.69 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.339 0.972 . . . . 0.0 112.858 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' D' ' 37' ' ' TYR . 56.1 t -51.22 -54.39 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.504 1.121 . . . . 0.0 111.287 169.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.65 -44.38 93.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.716 0.807 . . . . 0.0 111.536 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -58.3 -49.8 75.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.032 0.833 . . . . 0.0 112.944 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 67.6 mt -58.19 -51.24 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.542 1.137 . . . . 0.0 110.732 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.41 -52.43 59.38 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.807 0.843 . . . . 0.0 111.892 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -53.06 -48.89 67.34 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.442 1.097 . . . . 0.0 112.519 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -65.21 -50.41 65.98 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 44.1 mt -63.24 -48.28 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.092 0.86 . . . . 0.0 110.491 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.93 90.66 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.661 0.784 . . . . 0.0 111.81 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.26 -51.0 58.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.464 1.03 . . . . 0.0 112.95 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -61.62 -45.7 92.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.55 1.175 . . . . 0.0 112.591 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.68 77.84 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.061 -1.025 . . . . 0.0 112.361 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -61.58 -47.79 83.87 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.357 1.063 . . . . 0.0 111.799 173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -57.76 -36.06 71.61 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.841 1.256 . . . . 0.0 112.802 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.16 -41.78 85.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.122 0.874 . . . . 0.0 112.375 171.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.24 86.28 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.951 -1.093 . . . . 0.0 112.483 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 43.6 m170 -63.5 -41.94 98.51 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.508 1.123 . . . . 0.0 112.74 171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -59.16 -38.45 79.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.784 0.834 . . . . 0.0 111.73 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.99 8.32 3.28 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.252 1.421 . . . . 0.0 113.879 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 53.46 29.68 9.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.82 2.448 . . . . 0.0 115.23 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -81.56 158.82 24.27 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.153 0.981 . . . . 0.0 112.868 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 65.3 p -112.85 -10.29 13.58 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 125.978 1.711 . . . . 0.0 113.496 169.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 53.0 m -134.23 135.01 42.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.582 1.953 . . . . 0.0 109.461 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.3 mt -92.46 112.86 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.763 0.825 . . . . 0.0 108.822 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 55.2 p -96.87 170.42 9.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.216 1.406 . . . . 0.0 111.903 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 37.1 p -53.16 -37.2 61.67 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.929 0.891 . . . . 0.0 112.71 166.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.71 -44.99 69.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.722 1.209 . . . . 0.0 112.422 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.37 -42.3 91.31 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.612 0.642 . . . . 0.0 111.89 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 69.5 mt -58.17 -53.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.608 0.763 . . . . 0.0 110.356 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -50.7 -46.46 58.83 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.809 1.186 . . . . 0.0 112.405 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 98.8 m -61.74 -49.4 76.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.773 0.829 . . . . 0.0 112.115 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.04 81.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.992 0.917 . . . . 0.0 112.686 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -51.49 -51.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.617 1.167 . . . . 0.0 110.993 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.58 -44.25 97.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.921 0.888 . . . . 0.0 112.699 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.32 -36.26 83.5 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.211 1.004 . . . . 0.0 113.26 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.24 -30.42 48.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.0 1.32 . . . . 0.0 113.061 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 68.0 mt -120.88 63.79 11.53 Favored Pre-proline 0 CA--C 1.554 1.097 0 C-N-CA 125.755 1.622 . . . . 0.0 111.911 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.4 -39.34 12.86 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.915 2.41 . . . . 0.0 112.491 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.97 129.63 18.55 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.655 1.121 . . . . 0.0 113.081 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -59.88 -37.87 80.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.585 0.754 . . . . 0.0 112.399 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.0 tp -52.55 -52.85 52.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.346 1.058 . . . . 0.0 111.818 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.6 -47.51 81.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.749 0.82 . . . . 0.0 111.649 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.78 -55.11 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.448 1.099 . . . . 0.0 112.016 175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -60.47 -46.54 89.72 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.645 1.178 . . . . 0.0 112.105 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.82 76.72 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.15 -39.95 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 121.034 -1.041 . . . . 0.0 112.267 171.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 67.4 m -59.47 -42.01 91.06 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.466 1.485 . . . . 0.0 112.47 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -61.8 -34.33 75.71 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.032 -1.043 . . . . 0.0 111.766 168.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.3 -44.24 84.51 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.798 1.189 . . . . 0.0 113.678 165.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 6.0 m -57.42 -46.58 83.38 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.687 1.743 . . . . 0.0 111.44 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.05 -42.84 95.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.266 0.627 . . . . 0.0 111.945 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.71 -40.12 82.77 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.831 0.853 . . . . 0.0 112.425 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 94.4 t -57.96 -51.96 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.208 0.913 . . . . 0.0 111.57 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 69.2 p -74.09 -16.45 61.02 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -91.2 -49.2 6.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.668 1.587 . . . . 0.0 112.92 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -106.26 -50.96 3.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.392 1.077 . . . . 0.0 112.779 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -63.66 -51.26 65.91 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.032 0.833 . . . . 0.0 113.234 -174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 97.7 p -75.96 -11.41 59.95 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.47 143.61 54.95 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.994 0.917 . . . . 0.0 112.7 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.416 1.487 . . . . 0.0 112.509 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 CA-C-O 119.172 -0.794 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.5 140.87 71.29 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.977 3.118 . . . . 0.0 113.079 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -69.83 172.39 39.99 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.364 0.983 . . . . 0.0 114.009 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 97.0 mmm -69.21 157.67 36.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 0.0 112.16 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 17.8 t -84.97 123.03 30.05 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.711 0.805 . . . . 0.0 111.838 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.67 137.58 37.03 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.504 1.05 . . . . 0.0 113.097 175.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -50.98 141.5 13.58 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.475 1.51 . . . . 0.0 114.905 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.68 -175.17 30.8 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.794 1.188 . . . . 0.0 113.782 168.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -58.87 -59.49 5.36 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.309 1.444 . . . . 0.0 112.769 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -151.47 138.68 19.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.325 1.45 . . . . 0.0 110.801 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.16 -142.85 38.45 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.25 0.929 . . . . 0.0 113.863 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.66 153.37 9.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.657 1.122 . . . . 0.0 114.011 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.71 125.24 23.66 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.901 0.88 . . . . 0.0 111.671 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.1 130.13 42.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.673 0.789 . . . . 0.0 111.257 172.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -64.22 120.13 11.55 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.674 -0.641 . . . . 0.0 109.455 169.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.19 128.91 38.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.309 0.643 . . . . 0.0 111.333 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.7 143.28 54.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.501 0.72 . . . . 0.0 110.652 171.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.14 118.44 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.98 0.512 . . . . 0.0 110.677 175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.66 133.12 55.78 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.695 0.798 . . . . 0.0 110.656 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 38.2 p -62.07 150.47 38.2 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.205 0.602 . . . . 0.0 110.936 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -58.23 121.56 11.04 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.654 -0.654 . . . . 0.0 109.765 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 22.2 t -58.82 126.8 29.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.268 0.627 . . . . 0.0 110.864 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -61.5 122.48 15.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.122 0.569 . . . . 0.0 110.904 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.16 134.66 57.26 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.453 0.701 . . . . 0.0 111.122 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.68 3.01 17.61 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.534 1.134 . . . . 0.0 113.918 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.26 -160.91 50.68 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.771 1.177 . . . . 0.0 112.631 -166.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.51 -44.39 67.71 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.264 -0.55 . . . . 0.0 112.123 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -60.68 106.53 0.57 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.748 0.819 . . . . 0.0 111.896 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -154.67 130.69 5.51 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.584 1.154 . . . . 0.0 111.28 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.55 125.24 13.54 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.769 2.312 . . . . 0.0 113.91 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 t -58.49 -35.22 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.867 1.267 . . . . 0.0 112.168 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.1 -26.3 63.3 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.065 0.84 . . . . 0.0 114.281 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -81.64 -44.65 16.89 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.736 1.268 . . . . 0.0 111.42 168.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -50.27 -50.14 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 CA-C-N 119.213 0.915 . . . . 0.0 111.1 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -64.59 -43.18 94.65 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.406 -0.809 . . . . 0.0 112.699 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -59.64 -41.77 91.26 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.803 0.729 . . . . 0.0 112.402 171.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.71 -41.2 92.58 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.269 1.028 . . . . 0.0 112.814 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 78.1 mt -57.17 -44.46 83.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.13 0.877 . . . . 0.0 111.441 172.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -61.81 -54.41 42.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.659 0.784 . . . . 0.0 112.319 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.5 -50.73 59.34 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.923 1.689 . . . . 0.0 112.565 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.24 -0.05 64.98 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.332 1.444 . . . . 0.0 115.596 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 65.6 t30 52.17 41.66 30.26 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.291 1.836 . . . . 0.0 113.549 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -71.8 -28.01 63.31 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.082 0.953 . . . . 0.0 113.424 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 22.9 t -141.0 153.08 45.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.785 1.234 . . . . 0.0 111.841 170.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -66.77 -29.16 69.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.246 1.019 . . . . 0.0 112.585 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 -134.84 120.31 19.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.59 1.556 . . . . 0.0 110.516 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.78 122.87 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.173 1.389 . . . . 0.0 108.236 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.31 50.4 1.0 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.069 1.795 . . . . 0.0 115.628 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.1 -15.24 21.67 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.38 79.69 Favored Glycine 0 CA--C 1.536 1.347 0 O-C-N 120.975 -1.078 . . . . 0.0 113.702 165.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.36 -59.23 11.67 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 118.642 1.221 . . . . 0.0 112.58 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -53.71 -31.34 60.38 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.244 1.963 . . . . 0.0 114.383 174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.18 -48.79 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.739 1.154 . . . . 0.0 112.059 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -61.08 -38.37 86.01 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.101 -0.999 . . . . 0.0 111.99 170.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.37 -30.06 70.37 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.978 -1.076 . . . . 0.0 112.729 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.437 ' HB1' ' CE1' ' D' ' 40' ' ' TYR . . . -59.46 -45.15 92.42 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.696 1.135 . . . . 0.0 111.998 168.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.45 -38.61 90.46 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.21 -49.47 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 120.906 -1.122 . . . . 0.0 112.015 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 25.4 mt -53.6 -35.58 61.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.595 1.158 . . . . 0.0 112.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.3 -50.0 51.93 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.898 0.879 . . . . 0.0 111.911 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -76.71 -38.25 54.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.572 0.749 . . . . 0.0 112.921 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 81.1 mt -57.72 -45.17 86.11 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.317 0.508 . . . . 0.0 111.346 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 69.8 p -77.5 -28.42 52.11 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.66 -46.15 77.58 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.267 0.94 . . . . 0.0 112.545 170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -60.76 -42.19 96.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.963 0.801 . . . . 0.0 112.61 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.09 -55.02 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.518 0.727 . . . . 0.0 110.259 171.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 79.9 mt -67.84 -32.79 73.56 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.18 -52.36 62.67 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.695 1.198 . . . . 0.0 111.612 172.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 93.7 mt -64.73 -36.1 83.19 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.692 -0.63 . . . . 0.0 112.017 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.13 90.91 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.619 -0.675 . . . . 0.0 111.939 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -56.05 -46.11 85.62 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.166 0.889 . . . . 0.0 113.681 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -60.95 -46.13 91.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.155 0.977 . . . . 0.0 111.205 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.98 -45.44 82.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.607 -0.683 . . . . 0.0 112.305 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.34 -46.97 88.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.284 1.034 . . . . 0.0 112.629 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -54.48 -50.63 67.3 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.755 1.222 . . . . 0.0 111.86 172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -58.68 -38.76 78.91 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -87.72 6.33 35.5 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.591 1.156 . . . . 0.0 113.267 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 52.88 34.88 17.59 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.107 2.163 . . . . 0.0 114.275 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.85 148.99 21.81 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.506 1.522 . . . . 0.0 112.805 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 38.0 p -90.58 -28.71 18.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.311 1.445 . . . . 0.0 113.074 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -122.75 138.54 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.302 1.441 . . . . 0.0 111.765 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.72 130.19 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.892 1.277 . . . . 0.0 110.849 170.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.19 164.39 20.43 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 125.743 1.617 . . . . 0.0 111.481 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -50.01 -38.3 48.9 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.692 2.928 . . . . 0.0 114.923 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -59.47 -40.55 87.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.736 0.814 . . . . 0.0 113.036 176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -62.21 -41.81 98.72 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 119.018 0.826 . . . . 0.0 111.812 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 80.6 mt -64.23 -45.68 87.12 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.84 0.856 . . . . 0.0 111.476 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -58.13 -48.69 79.45 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.007 0.923 . . . . 0.0 112.024 173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 73.3 mt -57.27 -46.77 82.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.76 0.824 . . . . 0.0 111.981 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.13 -52.17 59.56 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.89 0.768 . . . . 0.0 112.622 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 24.6 pt -71.16 -24.99 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -74.36 -43.38 56.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.273 1.429 . . . . 0.0 112.46 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -73.81 -21.34 60.18 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -120.57 115.0 22.56 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.113 0.965 . . . . 0.0 111.382 175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -54.05 -37.33 64.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.666 1.186 . . . . 0.0 112.873 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -60.5 -30.52 69.76 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.152 -0.968 . . . . 0.0 112.757 178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.39 -38.17 35.53 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.946 0.898 . . . . 0.0 111.497 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -60.07 -32.12 70.65 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.617 0.767 . . . . 0.0 112.87 172.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -64.27 -42.23 96.54 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.54 1.136 . . . . 0.0 113.2 172.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.33 -51.97 66.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.766 0.826 . . . . 0.0 112.052 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.75 169.43 10.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.105 1.362 . . . . 0.0 113.388 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.48 143.34 43.97 Favored Glycine 0 CA--C 1.537 1.408 0 O-C-N 121.602 -0.686 . . . . 0.0 112.829 169.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.89 160.24 12.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.449 0.7 . . . . 0.0 111.054 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.99 117.47 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.34 0.656 . . . . 0.0 110.524 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 36.2 p -88.07 162.23 16.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.358 1.463 . . . . 0.0 112.147 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 19.1 tt -61.11 139.41 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.358 0.663 . . . . 0.0 111.988 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.9 133.66 55.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.64 0.776 . . . . 0.0 112.523 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -139.64 159.9 41.11 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.66 1.584 . . . . 0.0 111.907 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 176.34 -153.77 15.18 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 123.59 0.614 . . . . 0.0 114.428 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.41 -168.63 25.81 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.873 1.225 . . . . 0.0 113.874 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -85.69 112.92 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.747 0.819 . . . . 0.0 109.298 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.24 141.34 73.86 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.551 0.74 . . . . 0.0 111.314 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.41 139.3 76.03 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.334 2.689 . . . . 0.0 112.305 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -100.8 98.81 9.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.19 0.996 . . . . 0.0 109.987 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 73.2 mt -72.75 119.99 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.751 0.82 . . . . 0.0 109.448 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -96.02 150.14 20.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.467 1.107 . . . . 0.0 111.108 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.45 141.49 57.64 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.792 0.437 . . . . 0.0 111.135 169.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.88 98.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -99.12 136.48 39.02 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.039 1.336 . . . . 0.0 110.148 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.12 150.31 97.99 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.422 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.09 128.82 31.8 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.982 2.455 . . . . 0.0 112.995 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.36 143.84 56.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.589 0.756 . . . . 0.0 110.556 170.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.32 114.31 3.41 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.28 0.632 . . . . 0.0 110.089 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 33.7 p -70.25 156.07 39.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.35 1.06 . . . . 0.0 111.967 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.81 113.96 4.16 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.436 -0.79 . . . . 0.0 109.821 170.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 30.0 p -67.2 143.63 56.43 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.694 0.798 . . . . 0.0 112.311 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.69 141.23 57.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.181 0.593 . . . . 0.0 110.852 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -74.59 97.33 3.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.274 0.559 . . . . 0.0 110.909 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -112.21 142.77 44.28 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.204 1.801 . . . . 0.0 110.563 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.86 140.72 56.55 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.425 0.69 . . . . 0.0 112.348 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -94.23 11.2 31.06 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.245 1.418 . . . . 0.0 113.334 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.95 9.88 63.85 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.263 1.411 . . . . 0.0 114.877 -169.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.252 1.213 0 C-N-CA 127.1 2.16 . . . . 0.0 111.385 179.326 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 CA-C-O 119.558 -0.579 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.92 -42.59 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.376 2.718 . . . . 0.0 112.424 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -83.87 -148.14 8.43 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.762 1.172 . . . . 0.0 112.386 166.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -71.14 128.17 90.71 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.715 -0.874 . . . . 0.0 110.958 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.04 145.33 73.21 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.247 2.631 . . . . 0.0 112.617 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -73.1 127.88 88.65 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.105 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -63.02 143.98 91.99 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.973 2.449 . . . . 0.0 112.468 177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.95 92.79 3.71 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.598 0.759 . . . . 0.0 111.01 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.33 -39.97 62.48 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.44 1.096 . . . . 0.0 111.646 175.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 60.9 p -70.09 161.39 30.24 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.689 1.596 . . . . 0.0 112.923 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.55 131.5 45.32 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.186 0.994 . . . . 0.0 113.499 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -66.93 146.25 77.02 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.358 2.705 . . . . 0.0 112.462 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.64 95.71 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.751 -0.593 . . . . 0.0 111.202 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -62.85 147.76 94.24 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.966 2.444 . . . . 0.0 112.182 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.24 149.95 47.97 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.125 0.97 . . . . 0.0 112.09 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.61 135.96 57.83 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.069 0.548 . . . . 0.0 110.871 170.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.22 8.97 63.06 Favored Glycine 0 CA--C 1.54 1.614 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 -173.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -67.91 129.36 39.68 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.405 1.603 . . . . 0.0 111.645 174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.63 147.56 33.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.431 1.092 . . . . 0.0 111.911 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 91.6 mttt 54.77 27.69 9.2 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.331 1.852 . . . . 0.0 114.502 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.33 140.21 58.65 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.154 0.982 . . . . 0.0 112.874 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 65.2 t -74.94 -46.53 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.014 0.926 . . . . 0.0 111.24 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 36.7 p -116.02 172.0 7.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.282 1.833 . . . . 0.0 111.961 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -80.18 148.48 30.87 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.019 0.927 . . . . 0.0 111.416 170.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.7 130.15 45.09 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.618 0.767 . . . . 0.0 111.83 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -99.75 137.51 38.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.549 1.14 . . . . 0.0 110.849 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.74 144.01 51.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.823 0.849 . . . . 0.0 111.945 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -101.89 143.36 31.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.303 1.441 . . . . 0.0 111.21 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 25.2 p30 -140.24 162.71 34.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.615 1.566 . . . . 0.0 112.512 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.84 -160.62 6.74 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.092 0.853 . . . . 0.0 113.232 166.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -80.08 48.87 1.03 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.74 1.216 . . . . 0.0 111.849 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.06 62.73 2.22 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.116 2.167 . . . . 0.0 111.353 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -60.81 112.04 1.88 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.445 0.698 . . . . 0.0 109.96 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.2 137.99 51.38 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.514 1.126 . . . . 0.0 111.155 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.49 138.17 58.41 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.365 0.666 . . . . 0.0 110.257 169.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 38.0 p -64.1 145.47 55.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.954 0.502 . . . . 0.0 111.199 168.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -68.79 120.79 15.28 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.566 -0.709 . . . . 0.0 110.949 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -96.08 92.01 6.23 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 0.0 109.929 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -110.6 5.08 20.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.869 1.268 . . . . 0.0 113.103 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 37.0 p -60.6 145.98 46.95 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.956 0.902 . . . . 0.0 112.302 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' C' ' 52' ' ' ALA 0.302 48.7 m-85 -68.16 134.35 50.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.79 1.281 . . . . 0.0 111.869 -177.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 25.3 t -179.7 -48.06 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.345 1.858 . . . . 0.0 107.932 -155.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 pt -48.15 -38.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.835 1.654 . . . . 0.0 113.903 169.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . 0.437 ' CE1' ' HB1' ' C' ' 52' ' ' ALA . 80.2 m-85 -66.27 -46.93 75.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.755 0.822 . . . . 0.0 112.026 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.38 -46.8 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 118.677 0.671 . . . . 0.0 110.491 170.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -62.22 -38.38 88.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.66 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.59 -53.18 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.814 0.845 . . . . 0.0 111.64 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 78.6 t -56.35 -43.0 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.53 1.132 . . . . 0.0 111.982 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt -52.85 -49.96 64.72 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.429 1.013 . . . . 0.0 111.697 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.98 -37.62 77.24 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.044 0.838 . . . . 0.0 113.013 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -75.8 -46.17 32.07 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.1 0.96 . . . . 0.0 113.38 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.39 -36.85 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.951 1.3 . . . . 0.0 111.831 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -120.79 68.08 15.45 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.294 1.838 . . . . 0.0 111.547 -177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.24 -38.82 3.38 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.152 2.568 . . . . 0.0 112.968 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.81 -42.9 7.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.772 1.229 . . . . 0.0 112.852 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -69.6 172.98 6.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.41 1.884 . . . . 0.0 112.822 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.72 -163.23 10.32 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 124.529 1.062 . . . . 0.0 113.938 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.13 152.09 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.305 1.442 . . . . 0.0 110.627 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 51.4 p -81.24 154.82 26.42 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 119.207 0.912 . . . . 0.0 112.842 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 47.9 p -56.69 -40.13 75.03 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.215 -0.928 . . . . 0.0 112.011 172.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.48 -50.22 74.5 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.955 1.302 . . . . 0.0 111.849 172.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.96 -41.55 98.12 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.678 0.791 . . . . 0.0 112.989 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.9 -43.58 86.24 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.094 -1.003 . . . . 0.0 111.454 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.08 -48.64 66.68 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.503 1.049 . . . . 0.0 113.544 171.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 36.0 mm -57.92 -47.23 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.138 0.975 . . . . 0.0 111.393 173.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 93.3 mmm -59.26 -39.58 83.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.451 1.023 . . . . 0.0 112.887 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -63.99 -46.44 84.55 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.173 -0.955 . . . . 0.0 111.183 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 57.7 m -55.4 -46.79 76.57 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.258 0.936 . . . . 0.0 112.373 171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -53.94 -53.86 46.85 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.735 0.814 . . . . 0.0 111.179 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 82.7 t -57.11 -49.0 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.485 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -52.16 -50.77 61.15 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 120.186 1.357 . . . . 0.0 111.752 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -63.26 -51.43 66.22 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.59 -45.33 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.379 1.072 . . . . 0.0 111.342 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -55.03 -51.51 66.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.07 1.348 . . . . 0.0 112.369 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.98 -42.02 97.53 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.165 0.986 . . . . 0.0 112.003 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -60.68 -51.72 68.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.051 0.94 . . . . 0.0 112.305 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 27.4 pt -69.52 -26.36 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.88 67.67 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.349 0.977 . . . . 0.0 112.395 169.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.24 86.05 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 123.166 0.412 . . . . 0.0 112.394 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -66.5 -43.19 86.02 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.254 -1.144 . . . . 0.0 112.046 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.72 -42.69 75.69 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.878 1.217 . . . . 0.0 113.129 176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 81.5 p -70.03 -44.23 69.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.945 0.793 . . . . 0.0 112.332 172.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -55.69 -42.16 74.78 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.653 1.115 . . . . 0.0 113.339 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 70.8 mt -57.01 -35.03 68.77 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.683 1.193 . . . . 0.0 112.389 174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.72 -45.58 64.65 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.316 -0.865 . . . . 0.0 112.052 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -59.04 -39.16 81.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.951 1.3 . . . . 0.0 113.616 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 21.3 m-30 -56.55 -29.83 62.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.13 1.372 . . . . 0.0 112.813 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -99.2 13.86 31.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.812 1.645 . . . . 0.0 112.232 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 52.62 29.22 6.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.631 2.372 . . . . 0.0 114.464 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -73.36 139.82 46.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.52 1.128 . . . . 0.0 111.336 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 59.6 p -76.61 -32.81 58.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.719 1.208 . . . . 0.0 113.787 -176.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -136.93 -167.94 2.18 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.505 1.922 . . . . 0.0 110.767 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.29 113.09 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.83 1.252 . . . . 0.0 110.482 168.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 30.4 p -85.7 168.87 13.98 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.125 1.37 . . . . 0.0 113.647 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 34.9 p -50.06 -44.72 51.8 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.23 1.412 . . . . 0.0 113.497 171.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.04 -42.2 69.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.084 0.953 . . . . 0.0 112.007 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.74 -29.86 71.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.1 -48.84 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.091 -1.006 . . . . 0.0 110.956 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -38.49 83.19 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.331 -0.856 . . . . 0.0 111.406 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 32.6 m -58.43 -48.09 81.82 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.442 -0.786 . . . . 0.0 111.974 169.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.14 -44.65 83.59 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.945 -1.097 . . . . 0.0 112.243 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 74.1 t -53.41 -49.95 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.844 0.858 . . . . 0.0 111.959 174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -72.02 -14.16 61.8 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 89.7 mt -87.19 -29.33 21.83 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.328 1.051 . . . . 0.0 112.121 170.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 87.8 mt -76.2 -47.4 24.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.766 1.226 . . . . 0.0 112.784 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 79.8 mt -106.1 130.32 23.17 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.549 1.14 . . . . 0.0 112.166 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.56 159.78 22.21 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.639 2.892 . . . . 0.0 113.299 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.94 -139.17 41.01 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.961 1.267 . . . . 0.0 114.858 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -66.67 -26.39 67.02 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.0 mt -55.32 -33.46 63.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.265 1.026 . . . . 0.0 112.25 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.62 -59.75 4.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.314 1.046 . . . . 0.0 112.318 169.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.03 -45.36 90.9 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.611 1.164 . . . . 0.0 111.338 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -54.17 -55.37 28.51 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.009 0.924 . . . . 0.0 111.751 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.37 83.4 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -60.41 -56.4 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.625 1.102 . . . . 0.0 110.757 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -56.44 -49.07 75.65 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.605 1.093 . . . . 0.0 112.905 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -61.87 -43.48 98.77 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.439 -0.788 . . . . 0.0 112.145 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.12 -44.73 97.05 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.544 1.069 . . . . 0.0 113.736 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -58.09 -50.2 74.28 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.244 1.018 . . . . 0.0 110.919 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -59.26 -44.58 92.41 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.148 0.579 . . . . 0.0 112.166 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.91 -49.31 75.97 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.051 0.941 . . . . 0.0 112.184 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.74 -54.93 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.946 0.794 . . . . 0.0 110.565 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 97.5 m -52.92 -51.46 61.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.74 0.816 . . . . 0.0 112.375 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -58.18 -43.74 87.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.467 1.107 . . . . 0.0 112.635 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 15.2 m-30 -71.67 -34.68 69.9 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.387 0.675 . . . . 0.0 112.748 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.5 p -78.99 -32.56 45.25 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.497 1.044 . . . . 0.0 113.5 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 54.5 p -76.36 -14.85 60.06 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.37 135.81 38.46 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.051 1.34 . . . . 0.0 113.014 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.213 1.405 . . . . 0.0 112.969 -177.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 CA-C-O 118.652 -1.082 . . . . 0.0 112.845 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -55.61 -25.46 50.26 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.626 3.551 . . . . 0.0 116.968 -171.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -63.91 -18.61 62.33 Favored Glycine 0 CA--C 1.542 1.742 0 C-N-CA 124.386 0.993 . . . . 0.0 115.56 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 99.2 mmm -81.31 161.7 23.76 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.764 1.226 . . . . 0.0 112.765 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t -65.21 159.01 24.62 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.807 0.843 . . . . 0.0 112.909 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.77 -146.41 49.41 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.776 1.179 . . . . 0.0 113.318 -170.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.59 143.51 38.24 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.179 0.992 . . . . 0.0 112.692 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.88 -169.71 15.36 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 124.851 1.215 . . . . 0.0 114.212 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.06 127.87 34.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.673 1.189 . . . . 0.0 111.49 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -105.47 144.97 31.5 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.94 1.296 . . . . 0.0 111.677 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.25 148.09 51.17 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.094 0.854 . . . . 0.0 113.309 171.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.27 153.25 31.88 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.091 0.853 . . . . 0.0 113.063 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -49.87 125.1 11.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 111.705 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.71 128.44 35.83 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.735 0.814 . . . . 0.0 111.39 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -66.41 131.69 46.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.73 0.812 . . . . 0.0 111.295 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 136.42 55.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.497 0.719 . . . . 0.0 111.652 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.91 133.75 51.55 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.635 0.774 . . . . 0.0 111.293 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.43 139.45 57.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.474 0.71 . . . . 0.0 111.714 175.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -75.18 109.55 8.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.948 0.899 . . . . 0.0 111.268 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 41.6 m -61.57 123.43 17.85 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.526 1.131 . . . . 0.0 111.933 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 49.92 33.37 6.53 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 126.666 1.986 . . . . 0.0 114.834 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 16.1 t -59.88 122.62 14.71 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.531 0.732 . . . . 0.0 112.747 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 47.0 p -92.76 143.95 25.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.938 1.695 . . . . 0.0 111.284 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -68.59 118.95 12.27 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.535 -0.728 . . . . 0.0 110.971 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.25 140.38 50.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.976 0.91 . . . . 0.0 112.319 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.46 -168.14 24.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.099 1.333 . . . . 0.0 113.788 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 88.4 mt -95.42 -2.05 49.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.74 1.216 . . . . 0.0 113.887 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -102.37 152.52 21.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.195 1.398 . . . . 0.0 112.7 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -123.64 70.14 46.14 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 124.519 1.128 . . . . 0.0 111.225 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -61.39 156.56 45.63 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.392 2.061 . . . . 0.0 110.991 169.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.47 -32.33 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 O-C-N 121.379 -0.826 . . . . 0.0 112.651 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.59 -35.03 88.39 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.37 0.986 . . . . 0.0 115.039 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -65.08 -45.18 86.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.515 1.158 . . . . 0.0 110.228 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 37.0 t -64.18 -36.09 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.833 0.853 . . . . 0.0 111.749 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -56.97 -37.43 71.6 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.26 1.391 . . . . 0.0 112.556 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.44 -46.02 81.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.735 1.152 . . . . 0.0 112.496 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 87.3 mt -58.78 -41.01 85.64 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.545 0.738 . . . . 0.0 111.966 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.75 -37.51 82.23 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.447 1.499 . . . . 0.0 112.737 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -60.41 -39.3 86.88 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.674 1.189 . . . . 0.0 112.338 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.41 -40.05 74.03 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 119.296 0.953 . . . . 0.0 111.943 169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.23 7.61 29.32 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 125.825 1.679 . . . . 0.0 115.82 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 53.06 26.71 5.04 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.807 2.043 . . . . 0.0 115.018 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.49 -50.74 40.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 113.605 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.2 t -120.36 145.34 47.24 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.2 1.0 . . . . 0.0 111.65 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -71.26 -27.09 63.2 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.458 1.103 . . . . 0.0 112.485 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -139.67 130.69 26.35 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.936 1.694 . . . . 0.0 111.346 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 66.9 t -119.36 97.82 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.691 1.196 . . . . 0.0 109.277 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.31 151.62 34.98 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.686 1.136 . . . . 0.0 113.367 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.86 60.04 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.24 -9.21 86.83 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.218 1.247 . . . . 0.0 116.218 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.21 -37.05 31.54 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.533 1.667 . . . . 0.0 114.984 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.86 -35.86 81.04 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 123.62 2.88 . . . . 0.0 114.738 172.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.71 -44.82 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.018 0.927 . . . . 0.0 110.547 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -65.02 -49.29 70.76 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 77.4 mt -66.51 -38.08 86.43 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.092 -1.005 . . . . 0.0 111.703 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.21 -45.48 87.58 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.515 -0.74 . . . . 0.0 112.298 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.32 82.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.215 0.916 . . . . 0.0 112.103 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.3 -49.67 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 121.551 -0.718 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.86 -33.14 75.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -62.07 -29.37 70.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.084 1.354 . . . . 0.0 112.773 169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -73.98 -6.92 50.31 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 120.322 -1.486 . . . . 0.0 113.917 171.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 mt -86.47 -43.76 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.457 1.103 . . . . 0.0 111.268 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 57.9 p -62.56 -19.53 63.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.701 0.801 . . . . 0.0 112.736 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.73 -40.53 40.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.958 1.303 . . . . 0.0 113.666 166.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -66.95 -45.35 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.667 1.121 . . . . 0.0 111.578 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 43.3 mt -57.24 -41.25 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.118 0.967 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 46.9 tp -65.41 -45.16 85.06 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.81 1.244 . . . . 0.0 113.17 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -61.26 -44.53 97.08 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.463 1.029 . . . . 0.0 112.034 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.16 -41.26 87.96 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.81 171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.33 -33.19 75.27 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.108 -0.995 . . . . 0.0 112.528 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.18 -44.14 93.29 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.355 0.978 . . . . 0.0 112.914 167.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -63.72 -43.86 95.3 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.703 -0.881 . . . . 0.0 111.254 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.18 88.26 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 121.281 -0.887 . . . . 0.0 112.979 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -49.16 78.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.055 1.342 . . . . 0.0 112.145 172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -54.0 -47.7 71.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.584 1.153 . . . . 0.0 112.508 171.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -57.97 -34.56 70.08 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -88.03 4.21 45.98 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.821 1.248 . . . . 0.0 113.444 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.14 32.04 19.4 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.824 2.05 . . . . 0.0 114.324 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -106.89 154.05 21.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.933 1.693 . . . . 0.0 113.018 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -115.36 15.68 16.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.474 1.91 . . . . 0.0 113.082 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -130.69 126.85 37.57 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.191 1.397 . . . . 0.0 110.4 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.09 124.27 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.921 0.888 . . . . 0.0 109.766 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.86 164.92 24.08 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.724 1.61 . . . . 0.0 110.879 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -50.16 -34.94 41.01 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.564 2.843 . . . . 0.0 114.915 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -62.51 -35.57 79.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.889 0.876 . . . . 0.0 113.362 175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -69.63 -39.42 77.18 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.924 -1.11 . . . . 0.0 112.026 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.89 -39.84 91.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.455 0.702 . . . . 0.0 111.229 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.22 -51.74 66.97 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.336 1.054 . . . . 0.0 111.052 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.09 -39.87 79.69 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.188 0.904 . . . . 0.0 112.811 174.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -51.21 70.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.585 0.754 . . . . 0.0 112.493 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 pt -73.08 -30.53 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -48.82 -35.86 15.48 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 126.276 1.83 . . . . 0.0 113.643 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -70.36 -12.29 61.48 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -130.71 130.34 43.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.009 1.323 . . . . 0.0 112.367 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.05 -48.34 82.2 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.128 -0.983 . . . . 0.0 113.24 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -63.42 -45.99 88.41 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.481 -0.762 . . . . 0.0 112.044 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 83.2 mt -64.8 -36.87 85.71 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.072 0.851 . . . . 0.0 112.438 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -60.92 -46.39 90.86 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.994 1.27 . . . . 0.0 111.753 172.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.41 -32.83 74.61 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.724 1.21 . . . . 0.0 113.388 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 16.6 tp -50.25 -47.89 54.9 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.488 1.515 . . . . 0.0 112.037 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 tt -68.29 105.3 2.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.772 0.796 . . . . 0.0 110.368 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.37 -156.39 7.39 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.745 1.64 . . . . 0.0 111.104 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -97.89 144.75 27.13 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.177 0.991 . . . . 0.0 110.742 171.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.8 119.65 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.578 0.751 . . . . 0.0 109.807 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 59.0 p -120.41 156.76 30.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.652 1.581 . . . . 0.0 111.288 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 85.8 mt -71.5 116.28 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.22 128.41 36.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.555 0.742 . . . . 0.0 111.886 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -101.08 5.44 42.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.598 1.159 . . . . 0.0 113.163 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.52 -149.11 8.81 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.152 1.358 . . . . 0.0 113.82 171.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . 60.2 -150.36 40.65 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.652 1.12 . . . . 0.0 113.795 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 48.6 t -89.52 127.17 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.788 0.835 . . . . 0.0 109.903 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.14 156.1 37.38 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.144 1.377 . . . . 0.0 111.602 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.33 132.17 49.3 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.194 2.596 . . . . 0.0 112.519 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -72.46 122.33 21.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.897 -0.502 . . . . 0.0 110.433 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 99.0 mt -67.13 -41.35 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.515 1.126 . . . . 0.0 111.496 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -110.12 151.79 26.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.964 1.306 . . . . 0.0 112.017 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.6 144.3 57.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.216 0.606 . . . . 0.0 111.543 168.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.9 t -71.14 116.77 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.194 0.598 . . . . 0.0 110.125 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 63.7 tp -99.35 114.58 27.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.862 1.265 . . . . 0.0 109.888 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 87.6 mt -67.58 149.67 98.21 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.992 170.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.07 118.38 5.16 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.973 2.449 . . . . 0.0 112.344 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.55 132.4 48.12 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.69 0.796 . . . . 0.0 111.078 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.08 135.42 57.51 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 162.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 38.9 m -62.93 111.74 2.28 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.279 0.491 . . . . 0.0 110.129 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.31 98.39 6.66 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.538 0.735 . . . . 0.0 110.021 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 22.7 t -56.15 133.95 52.58 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.465 0.706 . . . . 0.0 110.126 170.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -61.43 111.1 1.65 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.995 0.518 . . . . 0.0 110.944 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -75.51 126.96 32.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.568 0.747 . . . . 0.0 111.396 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.12 122.9 13.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.148 0.979 . . . . 0.0 110.338 174.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.7 137.57 57.89 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.442 0.697 . . . . 0.0 112.491 -175.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.97 -19.85 60.53 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.26 1.024 . . . . 0.0 113.695 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.81 29.84 74.01 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.358 0.98 . . . . 0.0 113.64 -169.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.817 2.047 . . . . 0.0 111.695 -177.309 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 CA-C-O 118.758 -1.023 . . . . 0.0 111.437 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.85 133.92 53.84 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.921 3.081 . . . . 0.0 113.759 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . -65.99 152.98 51.86 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.342 0.972 . . . . 0.0 113.301 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 99.4 mmm -60.03 144.13 87.09 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.988 -0.713 . . . . 0.0 111.769 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -57.29 134.81 66.36 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.149 2.566 . . . . 0.0 113.575 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.97 147.89 84.13 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.335 0.654 . . . . 0.0 111.633 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -57.74 134.91 65.97 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.858 2.372 . . . . 0.0 113.509 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.26 55.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.37 0.668 . . . . 0.0 111.964 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -73.06 114.75 11.58 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.02 0.928 . . . . 0.0 110.798 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 89.2 p -143.5 166.19 25.47 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.378 1.471 . . . . 0.0 112.76 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.04 139.63 93.03 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.359 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -56.19 123.1 13.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.128 2.552 . . . . 0.0 113.021 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.69 152.63 68.86 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.923 1.689 . . . . 0.0 110.928 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -57.64 128.02 27.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.786 2.324 . . . . 0.0 111.832 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.81 -120.48 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.317 1.447 . . . . 0.0 110.496 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.19 160.2 14.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.743 1.617 . . . . 0.0 111.736 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.47 -171.4 42.07 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.399 1.476 . . . . 0.0 111.802 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 66.7 p -51.92 -31.54 28.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.973 1.309 . . . . 0.0 114.187 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -52.47 -26.34 12.59 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.907 1.683 . . . . 0.0 114.184 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -58.75 -25.93 63.49 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 119.608 1.094 . . . . 0.0 113.838 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.45 -10.76 59.74 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.647 1.179 . . . . 0.0 114.145 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.47 105.65 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.105 0.962 . . . . 0.0 110.024 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 44.9 m -69.7 126.23 29.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.968 0.907 . . . . 0.0 110.025 172.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.3 122.45 16.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.42 0.688 . . . . 0.0 110.852 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 136.14 57.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.712 0.805 . . . . 0.0 112.327 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -88.67 -10.13 49.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.988 0.915 . . . . 0.0 113.249 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.49 141.24 55.2 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.961 1.304 . . . . 0.0 111.084 168.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.78 129.61 41.83 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.015 0.926 . . . . 0.0 111.061 175.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -71.75 127.72 33.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.092 0.557 . . . . 0.0 112.392 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 -159.26 5.73 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.916 0.769 . . . . 0.0 113.314 168.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.92 -29.95 70.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.057 0.943 . . . . 0.0 113.245 175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 60.87 152.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.347 2.659 . . . . 0.0 113.55 -167.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -76.97 146.1 37.69 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.689 0.796 . . . . 0.0 110.906 170.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.04 122.01 12.02 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.876 1.27 . . . . 0.0 111.527 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.29 141.36 50.51 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.351 1.06 . . . . 0.0 111.347 175.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -71.22 157.76 37.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.122 0.969 . . . . 0.0 112.546 173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.9 126.38 27.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.791 . . . . 0.0 110.532 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -69.08 154.41 42.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.309 1.044 . . . . 0.0 112.808 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -86.63 72.17 10.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.306 1.042 . . . . 0.0 110.073 173.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 53.1 m -62.8 -36.93 84.75 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.009 0.923 . . . . 0.0 111.404 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.43 -154.85 0.47 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.959 1.703 . . . . 0.0 108.291 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.5 t 68.14 -35.97 0.3 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.965 1.711 . . . . 0.0 114.769 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 44.4 mm -35.37 -45.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 128.68 2.792 . . . . 0.0 113.357 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -103.07 -34.65 8.81 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.844 1.257 . . . . 0.0 112.844 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 51.3 t -47.17 -51.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 119.751 1.16 . . . . 0.0 111.719 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -63.01 -42.29 99.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.597 . . . . 0.0 112.519 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -55.07 -37.19 66.43 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.014 1.325 . . . . 0.0 113.29 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.23 -57.01 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 124.873 1.269 . . . . 0.0 111.2 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.58 -37.36 27.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 117.874 -1.06 . . . . 0.0 112.644 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -46.94 -43.31 18.95 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 119.844 1.202 . . . . 0.0 112.239 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -82.89 -50.92 8.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.065 . . . . 0.0 113.08 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 64.9 t -78.29 -43.71 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 118.837 0.744 . . . . 0.0 112.912 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -126.4 69.06 68.31 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.06 1.744 . . . . 0.0 110.449 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -58.14 -21.42 51.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.798 2.998 . . . . 0.0 114.015 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -75.19 -10.37 59.4 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.678 1.991 . . . . 0.0 113.991 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 97.6 m -111.45 120.34 41.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.064 1.346 . . . . 0.0 111.948 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.47 168.46 42.15 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.436 1.493 . . . . 0.0 113.923 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 56.9 mt -133.59 132.82 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.322 1.449 . . . . 0.0 108.694 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 31.0 p -73.94 156.33 37.73 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 51.2 p -55.66 -38.19 69.27 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.3 -0.875 . . . . 0.0 112.293 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.99 -44.66 84.21 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.66 1.184 . . . . 0.0 112.452 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.77 -46.73 88.28 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.917 0.887 . . . . 0.0 111.906 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 76.3 mtm -59.36 -46.13 89.49 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.747 -0.595 . . . . 0.0 111.073 171.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.14 -48.67 58.38 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.961 1.267 . . . . 0.0 114.81 174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 8.4 tp -72.04 -35.63 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.202 1.501 . . . . 0.0 111.977 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 78.1 mtm -62.83 -36.64 83.85 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.297 -0.877 . . . . 0.0 112.841 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -61.37 -46.05 91.8 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.267 -0.896 . . . . 0.0 110.527 170.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -53.89 -47.46 71.11 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.491 0.716 . . . . 0.0 111.973 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -52.03 -37.59 54.0 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 86.4 t -58.01 -51.15 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.559 1.527 . . . . 0.0 111.137 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -61.99 -45.1 95.1 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.179 0.592 . . . . 0.0 111.583 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -56.37 -47.84 78.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.1 -45.84 97.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.178 0.899 . . . . 0.0 110.02 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.49 -50.75 67.03 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.943 0.792 . . . . 0.0 111.948 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -60.56 -44.87 95.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.039 0.936 . . . . 0.0 112.72 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -60.19 -49.72 76.52 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 118.79 0.723 . . . . 0.0 111.866 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 62.7 mt -56.25 -51.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.163 0.985 . . . . 0.0 110.785 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.79 -48.46 72.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.111 0.964 . . . . 0.0 112.343 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.49 -52.82 50.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.517 1.055 . . . . 0.0 113.685 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -62.28 -45.21 94.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.217 1.009 . . . . 0.0 112.38 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.62 80.7 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.948 0.795 . . . . 0.0 111.796 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 68.4 m -58.27 -52.43 65.6 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.556 0.742 . . . . 0.0 112.252 172.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 84.0 mtm-85 -59.13 -37.9 78.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.971 0.908 . . . . 0.0 113.241 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 64.9 mt -66.22 -42.97 87.96 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.139 0.976 . . . . 0.0 112.096 174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.98 88.5 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.801 0.728 . . . . 0.0 111.972 171.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -59.38 -45.4 91.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 112.532 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -56.89 -43.04 80.89 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.671 1.188 . . . . 0.0 112.359 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -79.56 6.7 9.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.446 1.099 . . . . 0.0 113.943 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 54.0 43.18 31.16 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.153 2.181 . . . . 0.0 114.114 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 88.3 mmt-85 -129.09 152.02 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.087 1.355 . . . . 0.0 112.434 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 33.1 p -77.88 -45.39 24.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 111.706 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 28.2 m -61.56 117.05 5.25 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.996 1.318 . . . . 0.0 111.746 172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 94.9 mt -74.17 129.11 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.347 1.459 . . . . 0.0 108.959 163.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -96.41 159.7 14.8 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 38.6 p -57.4 -39.24 75.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.944 0.898 . . . . 0.0 112.387 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.31 -42.23 96.45 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.673 1.189 . . . . 0.0 112.391 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -62.14 -41.65 98.48 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.506 -0.746 . . . . 0.0 111.839 172.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 89.1 mt -61.56 -42.83 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.38 -0.825 . . . . 0.0 111.12 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.31 -39.15 82.16 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.806 -1.184 . . . . 0.0 112.236 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 81.6 m -64.82 -45.11 87.59 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.918 -1.114 . . . . 0.0 111.964 171.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.33 -44.14 75.62 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.824 1.193 . . . . 0.0 111.799 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.47 -55.0 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.402 1.081 . . . . 0.0 111.353 170.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -52.97 -47.27 68.27 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 120.081 1.31 . . . . 0.0 112.333 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.98 -51.58 67.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.746 1.218 . . . . 0.0 112.577 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.38 -31.15 23.09 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -170.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 42.5 mt -124.36 57.92 15.24 Favored Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 126.401 1.88 . . . . 0.0 111.097 -170.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.58 -26.88 61.56 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.299 2.666 . . . . 0.0 113.621 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.86 133.37 52.43 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.831 1.205 . . . . 0.0 113.209 175.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -57.61 -50.43 73.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.421 1.089 . . . . 0.0 112.844 -172.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 5.8 tt -58.47 -53.28 60.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.63 0.772 . . . . 0.0 110.154 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.71 63.77 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.067 0.849 . . . . 0.0 112.724 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.44 -51.83 57.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.54 1.136 . . . . 0.0 112.017 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -64.04 -43.03 96.79 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.366 0.666 . . . . 0.0 112.271 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.91 -31.16 72.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.694 1.198 . . . . 0.0 114.041 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.52 -43.08 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 CA-C-N 120.495 1.498 . . . . 0.0 112.381 169.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 75.0 m -58.67 -52.04 67.37 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 119.712 1.142 . . . . 0.0 112.928 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -66.83 -31.64 72.4 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.66 0.784 . . . . 0.0 111.488 170.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -55.4 -41.2 79.6 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.925 1.25 . . . . 0.0 114.321 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 66.6 m -55.09 -43.64 74.18 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.313 1.557 . . . . 0.0 111.374 172.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -64.8 -42.52 94.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.947 0.899 . . . . 0.0 111.423 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.38 -46.39 80.1 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.815 0.846 . . . . 0.0 112.313 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -52.59 -49.88 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.167 0.894 . . . . 0.0 110.823 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 34.7 m -56.16 -45.07 79.82 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.133 0.879 . . . . 0.0 112.402 174.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.36 -20.23 64.19 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.416 1.087 . . . . 0.0 113.892 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -90.8 -45.6 8.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.862 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 77.6 p -63.68 -26.45 68.67 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.438 1.017 . . . . 0.0 113.414 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 85.8 p -70.55 -14.63 62.58 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.92 147.02 54.01 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.142 0.883 . . . . 0.0 112.59 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.957 1.303 . . . . 0.0 112.636 -178.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 CA-C-O 119.003 -0.887 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.45 -20.19 31.89 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 124.205 3.27 . . . . 0.0 114.824 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . 81.37 162.92 30.0 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.546 1.069 . . . . 0.0 113.362 -171.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 52.7 ttm -62.09 126.79 28.56 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.121 0.969 . . . . 0.0 111.774 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 35.8 p -77.43 -44.73 28.1 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.566 1.147 . . . . 0.0 112.573 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.69 173.33 21.97 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.687 1.137 . . . . 0.0 113.508 165.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.91 127.78 33.78 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.97 0.908 . . . . 0.0 111.432 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.28 130.99 51.81 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.536 1.065 . . . . 0.0 113.165 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.57 146.69 53.65 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.436 1.095 . . . . 0.0 112.36 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -74.63 -22.97 58.64 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.3 5.74 67.7 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 124.884 1.23 . . . . 0.0 115.264 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.8 -174.87 30.61 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 125.062 1.315 . . . . 0.0 114.183 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.1 144.48 57.21 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.656 1.182 . . . . 0.0 112.16 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.34 135.69 54.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.557 0.743 . . . . 0.0 111.567 172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.99 141.47 54.9 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.782 0.833 . . . . 0.0 111.673 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.86 136.96 56.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.621 0.768 . . . . 0.0 112.241 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.77 143.65 55.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.078 0.951 . . . . 0.0 111.53 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.77 124.05 21.84 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.282 0.633 . . . . 0.0 110.927 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.99 135.89 55.31 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.836 0.854 . . . . 0.0 111.513 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -70.46 149.74 46.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.072 0.949 . . . . 0.0 112.134 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.97 141.52 52.98 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.529 0.732 . . . . 0.0 111.305 175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 62.0 p -78.46 -20.48 50.85 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.367 1.067 . . . . 0.0 113.546 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 60.7 p -67.28 160.8 26.34 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.354 1.461 . . . . 0.0 113.258 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -56.65 122.45 12.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.856 1.262 . . . . 0.0 112.093 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.15 142.25 43.57 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.013 0.925 . . . . 0.0 111.661 171.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.97 -178.16 48.18 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 123.639 0.637 . . . . 0.0 114.412 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 58.4 mt -78.72 161.57 26.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.011 1.324 . . . . 0.0 112.554 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -81.22 89.19 6.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 109.939 165.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -77.8 154.59 80.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 123.843 0.857 . . . . 0.0 111.169 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.23 147.54 15.77 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.026 2.484 . . . . 0.0 111.791 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 28.3 t 64.09 -25.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 126.615 1.966 . . . . 0.0 115.172 -171.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.27 -41.37 70.63 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 120.768 1.622 . . . . 0.0 113.853 173.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.74 -39.85 94.33 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.164 -1.198 . . . . 0.0 112.435 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.05 -43.38 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.278 0.631 . . . . 0.0 110.243 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -61.28 -42.15 98.16 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.48 -47.62 83.47 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.324 -0.86 . . . . 0.0 111.958 171.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.15 -40.11 96.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.092 0.957 . . . . 0.0 112.695 175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.73 -47.32 82.78 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.629 1.572 . . . . 0.0 111.114 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -66.08 -43.5 87.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.064 0.946 . . . . 0.0 113.311 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -51.77 -43.91 63.17 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.937 1.295 . . . . 0.0 111.832 172.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.58 0.16 14.76 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.591 1.567 . . . . 0.0 116.447 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 50.71 39.07 20.96 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.472 1.909 . . . . 0.0 113.207 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -53.07 -49.81 65.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 27.7 t -126.12 150.46 48.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.955 1.302 . . . . 0.0 111.502 175.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -81.18 -16.86 51.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.286 1.035 . . . . 0.0 113.077 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -136.52 124.4 22.69 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.628 1.571 . . . . 0.0 110.838 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.96 109.35 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.737 1.215 . . . . 0.0 109.964 -176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.8 156.35 53.23 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.817 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.65 -33.78 64.37 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.03 -9.42 83.9 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.023 1.297 . . . . 0.0 115.895 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.14 82.16 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.686 1.743 . . . . 0.0 115.399 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.19 -39.48 90.13 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.649 2.232 . . . . 0.0 112.922 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.83 -48.26 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.057 1.343 . . . . 0.0 110.688 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -62.53 -44.4 96.44 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 52.3 tp -53.76 -53.97 44.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.801 0.84 . . . . 0.0 110.802 170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.26 79.99 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.42 -53.81 53.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.759 0.823 . . . . 0.0 111.785 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.53 -40.45 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.079 0.952 . . . . 0.0 112.694 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.22 -18.51 58.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.032 1.333 . . . . 0.0 113.739 172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -100.47 -29.94 12.1 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.002 1.321 . . . . 0.0 112.927 173.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-30 -55.74 -54.99 37.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.532 1.133 . . . . 0.0 112.943 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -38.02 66.56 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.643 -0.661 . . . . 0.0 112.346 -177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 38.0 p -64.61 -29.51 70.52 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.567 -0.708 . . . . 0.0 112.846 -173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.19 -47.9 65.32 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.701 0.8 . . . . 0.0 112.791 167.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -78.51 -41.63 31.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.56 -0.712 . . . . 0.0 112.379 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt -53.97 -50.7 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.226 0.61 . . . . 0.0 110.561 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.73 -33.32 70.71 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.86 -53.0 63.17 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.989 0.813 . . . . 0.0 111.199 170.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.26 -42.17 80.0 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.689 0.796 . . . . 0.0 112.159 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.77 84.59 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.104 -0.997 . . . . 0.0 112.909 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.14 -42.33 93.17 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.053 0.835 . . . . 0.0 112.659 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -66.46 -44.41 82.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.023 0.911 . . . . 0.0 111.927 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.59 82.05 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.371 0.987 . . . . 0.0 112.018 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.96 79.56 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.204 1.002 . . . . 0.0 112.58 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -53.88 -48.59 69.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.547 1.539 . . . . 0.0 112.514 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.32 -32.93 67.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -91.84 6.12 47.34 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.029 1.332 . . . . 0.0 112.629 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 54.26 32.8 16.86 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 127.307 2.243 . . . . 0.0 114.252 -175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -99.68 152.18 20.36 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.295 1.438 . . . . 0.0 113.041 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -102.02 -6.66 23.13 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.655 1.582 . . . . 0.0 113.881 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 48.2 mmm-85 -128.11 129.95 47.38 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.666 1.587 . . . . 0.0 110.877 176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.16 124.69 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.465 1.506 . . . . 0.0 109.721 168.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.6 pt -117.18 168.16 9.52 Favored Pre-proline 0 N--CA 1.48 1.071 0 C-N-CA 125.912 1.685 . . . . 0.0 111.34 174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.67 -37.07 63.45 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.385 2.723 . . . . 0.0 115.294 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -61.72 -38.57 88.36 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.314 -0.866 . . . . 0.0 112.797 174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -65.59 -39.64 91.8 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.4 -0.812 . . . . 0.0 112.034 172.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.49 -44.85 93.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.593 0.757 . . . . 0.0 112.045 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -57.28 -50.13 73.88 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.898 0.879 . . . . 0.0 111.692 172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 77.7 mt -58.07 -45.33 87.29 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.712 0.805 . . . . 0.0 112.349 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.37 -51.86 61.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.161 0.984 . . . . 0.0 112.129 177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 pt -70.26 -39.97 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -55.28 -42.87 74.16 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.957 -1.089 . . . . 0.0 112.385 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -86.16 -8.08 58.1 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -129.19 116.92 19.92 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.653 1.115 . . . . 0.0 112.409 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -67.53 -35.4 79.01 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -64.92 -42.08 95.02 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.194 0.906 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -51.87 -48.5 64.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.325 -0.845 . . . . 0.0 111.156 168.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -67.6 -14.62 63.1 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -84.34 -40.65 17.65 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 119.502 1.046 . . . . 0.0 111.324 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.95 -53.28 11.66 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.983 1.313 . . . . 0.0 112.019 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.11 94.71 9.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.109 2.163 . . . . 0.0 107.957 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 43.94 0.59 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-O 119.24 -0.756 . . . . 0.0 114.463 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -124.58 7.33 8.25 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.087 1.355 . . . . 0.0 113.694 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.12 125.97 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.97 1.308 . . . . 0.0 108.85 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 27.3 m -61.92 125.83 25.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.701 0.801 . . . . 0.0 111.457 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 79.4 mt -79.27 118.24 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.771 0.829 . . . . 0.0 109.464 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.56 148.08 33.5 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.111 0.964 . . . . 0.0 112.659 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -77.56 160.24 28.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.851 0.86 . . . . 0.0 112.54 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.19 82.92 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.446 1.022 . . . . 0.0 115.135 -172.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -63.74 163.77 32.14 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 124.743 1.163 . . . . 0.0 113.634 169.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.53 147.65 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.919 0.887 . . . . 0.0 113.045 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.79 151.33 96.88 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.048 168.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.84 128.97 31.11 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.878 2.386 . . . . 0.0 112.567 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.97 138.0 55.58 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.151 0.58 . . . . 0.0 110.423 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 65.9 mt -75.6 114.7 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -119.26 146.98 44.78 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.657 1.583 . . . . 0.0 110.378 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.7 137.68 58.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.731 0.412 . . . . 0.0 110.697 167.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 64.1 t -71.1 107.18 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.32 111.23 12.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.522 0.729 . . . . 0.0 110.423 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 79.3 mt -83.59 144.43 45.78 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.953 . . . . 0.0 111.02 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -59.14 148.64 84.79 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.786 2.324 . . . . 0.0 111.729 170.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.26 70.31 4.6 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.192 0.997 . . . . 0.0 111.341 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.7 135.76 56.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.179 1.392 . . . . 0.0 110.964 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 31.2 p -69.2 154.04 42.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.855 0.862 . . . . 0.0 112.137 174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.7 128.93 39.39 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.331 1.052 . . . . 0.0 111.707 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 55.9 p -84.88 -9.07 58.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -122.49 142.77 50.22 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.236 1.414 . . . . 0.0 111.813 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -55.51 -38.94 69.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.724 1.21 . . . . 0.0 113.125 178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.14 -30.35 66.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.579 1.151 . . . . 0.0 113.554 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.24 -38.43 60.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.145 0.978 . . . . 0.0 112.532 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.98 123.93 15.13 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.316 1.046 . . . . 0.0 111.815 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -67.66 150.93 51.85 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.497 1.046 . . . . 0.0 113.552 173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.253 1.253 0 C-N-CA 124.656 1.183 . . . . 0.0 112.179 173.684 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.888 0 CA-C-O 118.648 -1.085 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -65.62 168.27 15.28 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.887 3.058 . . . . 0.0 112.98 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.88 -2.16 51.11 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 124.93 1.252 . . . . 0.0 115.528 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 27.8 ptm -134.16 154.84 80.3 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.908 2.083 . . . . 0.0 110.25 169.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -57.29 137.54 82.12 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.796 2.33 . . . . 0.0 112.515 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -67.43 157.82 84.33 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.791 0.836 . . . . 0.0 111.631 172.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -56.5 -32.4 89.38 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.899 2.4 . . . . 0.0 114.759 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.67 58.8 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -90.49 118.9 30.32 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.138 1.375 . . . . 0.0 110.441 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 35.3 p -67.8 149.93 49.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.065 0.946 . . . . 0.0 112.522 174.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 148.25 91.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.564 172.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.31 124.8 16.94 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.201 2.601 . . . . 0.0 113.089 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.25 138.71 94.56 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 123.407 0.683 . . . . 0.0 112.291 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.59 137.36 63.75 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.213 2.609 . . . . 0.0 112.223 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -112.22 153.12 27.58 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.749 1.619 . . . . 0.0 111.265 176.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -63.28 133.79 54.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.076 0.95 . . . . 0.0 111.687 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.69 -165.59 28.79 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 125.635 1.588 . . . . 0.0 112.582 -177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 18.9 t -72.33 129.94 39.58 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.394 0.677 . . . . 0.0 111.77 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.5 125.19 25.72 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.49 1.116 . . . . 0.0 111.22 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.57 136.58 56.55 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.046 0.939 . . . . 0.0 111.368 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.16 140.78 58.81 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.157 0.583 . . . . 0.0 111.536 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.99 114.7 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.233 0.613 . . . . 0.0 109.473 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 29.1 p -75.52 144.65 41.85 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.181 0.993 . . . . 0.0 112.698 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.59 148.51 23.21 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.036 1.334 . . . . 0.0 110.528 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.04 112.16 1.78 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.657 0.783 . . . . 0.0 112.017 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -81.68 165.27 21.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.608 1.163 . . . . 0.0 111.797 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.58 123.09 16.35 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.66 -0.65 . . . . 0.0 109.578 163.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.6 122.15 12.74 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.847 1.259 . . . . 0.0 111.835 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -73.84 143.38 45.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.7 0.8 . . . . 0.0 112.051 170.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.97 9.52 59.97 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 115.354 0.902 . . . . 0.0 115.354 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.5 126.26 26.71 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.845 1.322 . . . . 0.0 110.918 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -138.48 124.57 20.18 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.385 1.474 . . . . 0.0 110.516 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.11 -44.53 79.72 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.228 1.011 . . . . 0.0 112.244 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.12 108.38 4.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.415 1.086 . . . . 0.0 109.968 169.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.14 127.65 32.38 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.865 0.866 . . . . 0.0 110.639 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 52.3 p -67.82 156.71 36.46 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.789 0.835 . . . . 0.0 111.737 169.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -60.32 119.96 8.94 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.617 -0.677 . . . . 0.0 110.094 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -57.92 130.29 45.86 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.938 0.895 . . . . 0.0 110.543 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -60.4 123.84 18.51 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.335 1.054 . . . . 0.0 111.62 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -85.93 16.25 4.3 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.13 179.5 1.17 Allowed 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.261 -0.899 . . . . 0.0 112.378 165.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t 67.75 -29.49 0.15 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.491 1.916 . . . . 0.0 114.932 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 tt -54.7 -26.25 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.59 1.956 . . . . 0.0 114.343 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -55.15 -34.21 63.59 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.199 -0.938 . . . . 0.0 112.154 174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t -56.18 -48.23 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.916 0.886 . . . . 0.0 110.8 171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.1 -42.68 88.92 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.824 0.85 . . . . 0.0 112.622 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -58.08 -45.93 86.31 Favored 'General case' 0 N--CA 1.48 1.063 0 O-C-N 121.382 -0.824 . . . . 0.0 112.33 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.69 -45.92 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.469 0.708 . . . . 0.0 110.814 172.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -53.46 -47.85 69.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.422 1.01 . . . . 0.0 112.73 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -53.35 -41.09 65.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 0.0 112.884 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -76.37 -41.23 48.81 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.378 1.071 . . . . 0.0 112.821 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.37 -55.36 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.207 1.403 . . . . 0.0 112.732 -168.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -149.52 71.04 9.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.574 1.15 . . . . 0.0 111.47 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.03 -20.28 67.47 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.368 2.712 . . . . 0.0 114.666 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.73 -25.62 68.28 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -119.74 126.12 50.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.9 1.28 . . . . 0.0 109.591 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.98 -172.22 25.93 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.06 0.838 . . . . 0.0 113.489 173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 tt -140.18 155.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.948 -1.325 . . . . 0.0 111.689 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 42.0 p -89.35 157.04 18.33 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.683 0.793 . . . . 0.0 113.039 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p -59.58 -39.36 83.85 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.969 . . . . 0.0 112.402 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -60.07 -48.52 81.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.24 1.016 . . . . 0.0 111.373 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.4 94.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.876 0.87 . . . . 0.0 112.73 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 93.6 mtp -55.11 -46.22 75.53 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.023 0.829 . . . . 0.0 111.316 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.76 -46.44 67.36 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 124.313 0.959 . . . . 0.0 114.245 172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.07 -45.5 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 118.086 0.943 . . . . 0.0 111.41 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 85.4 mtp -60.37 -36.23 77.58 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.084 -1.01 . . . . 0.0 113.205 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -60.06 -41.3 92.08 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 118.92 0.782 . . . . 0.0 110.966 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 50.8 m -60.27 -50.17 74.71 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.302 -0.873 . . . . 0.0 112.13 168.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -52.03 -47.04 65.23 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.661 0.784 . . . . 0.0 112.683 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.82 -27.34 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -59.47 -34.18 72.23 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.378 0.99 . . . . 0.0 111.167 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.25 -48.01 71.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 tt -64.83 -42.01 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 119.493 1.042 . . . . 0.0 111.004 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -56.93 -42.74 80.57 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.392 0.996 . . . . 0.0 111.655 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.29 -41.76 98.78 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -62.64 -45.91 90.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.454 1.025 . . . . 0.0 112.726 172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -59.67 -53.49 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.973 0.909 . . . . 0.0 110.538 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.29 -43.0 87.84 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.752 0.821 . . . . 0.0 112.368 176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.44 59.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.647 1.118 . . . . 0.0 113.69 174.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -64.11 -41.04 97.4 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.345 -1.091 . . . . 0.0 111.95 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.63 -39.78 94.9 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.095 -1.003 . . . . 0.0 112.149 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 18.6 t -60.78 -46.96 88.45 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.73 1.212 . . . . 0.0 111.726 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -57.37 -46.01 83.81 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.146 -0.971 . . . . 0.0 112.285 173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.78 -45.33 86.13 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.508 0.723 . . . . 0.0 111.863 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.49 -43.84 80.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.811 0.732 . . . . 0.0 112.22 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -58.29 -49.68 76.29 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.354 0.979 . . . . 0.0 112.256 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -56.53 -38.37 71.74 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.88 0.764 . . . . 0.0 112.504 173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -82.64 2.8 31.63 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.128 1.371 . . . . 0.0 113.931 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 93.6 mttt 54.45 35.08 22.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.11 2.164 . . . . 0.0 114.343 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -104.33 145.44 30.24 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.374 1.87 . . . . 0.0 112.249 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 27.2 p -84.32 -51.88 6.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.152 1.381 . . . . 0.0 111.487 170.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 60.0 m -82.05 127.35 33.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.042 1.337 . . . . 0.0 111.618 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.09 133.89 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.682 1.193 . . . . 0.0 110.971 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 9.4 p -90.93 160.7 15.53 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 49.4 m -50.53 -45.77 56.98 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.19 1.396 . . . . 0.0 112.666 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.76 -44.96 88.37 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.199 1.0 . . . . 0.0 111.63 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -59.14 -40.59 85.97 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.625 0.77 . . . . 0.0 112.272 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.73 -52.83 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 119.066 0.848 . . . . 0.0 110.969 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -57.65 -42.28 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.954 0.797 . . . . 0.0 112.575 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 92.3 m -64.26 -46.27 84.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.153 0.981 . . . . 0.0 111.247 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.4 81.31 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.139 1.336 . . . . 0.0 113.183 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.8 -51.55 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.873 0.869 . . . . 0.0 110.664 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -67.39 -27.69 67.3 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 77.1 mt -64.46 -37.79 88.77 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.451 1.023 . . . . 0.0 111.93 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 50.4 mt -79.37 -29.66 42.24 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 93.3 mt -116.14 68.19 3.44 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 126.331 1.852 . . . . 0.0 111.39 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.62 -26.65 11.52 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.298 2.665 . . . . 0.0 114.716 -172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.13 138.54 47.76 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.618 1.104 . . . . 0.0 113.7 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -49.69 -55.09 15.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.826 1.25 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.06 -37.87 84.19 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.362 0.665 . . . . 0.0 112.472 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.67 -46.94 80.29 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.46 0.704 . . . . 0.0 111.668 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -55.61 -49.24 73.32 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.198 0.999 . . . . 0.0 111.57 172.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -55.94 -57.36 12.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.722 0.809 . . . . 0.0 111.46 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.37 76.11 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.469 1.108 . . . . 0.0 112.975 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.63 -32.27 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.499 -0.75 . . . . 0.0 112.688 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 48.7 m -67.98 -40.42 83.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.429 0.691 . . . . 0.0 112.237 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -59.4 -36.6 76.12 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.105 -0.997 . . . . 0.0 111.47 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.46 -43.97 90.33 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.336 0.969 . . . . 0.0 113.965 168.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -58.03 -50.62 72.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.786 1.293 . . . . 0.0 110.98 171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.05 -44.81 75.07 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.216 0.606 . . . . 0.0 111.789 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.91 65.02 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.798 0.839 . . . . 0.0 112.641 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -65.72 -34.68 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 119.709 1.14 . . . . 0.0 113.352 177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 96.4 m -62.79 -37.37 86.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 119.082 0.855 . . . . 0.0 112.196 171.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.17 -43.6 91.21 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.996 -1.065 . . . . 0.0 111.853 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -58.88 -32.52 69.57 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -78.74 -7.67 57.99 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t -65.83 130.65 44.0 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.262 0.937 . . . . 0.0 112.122 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -85.77 140.85 30.12 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.262 1.025 . . . . 0.0 112.266 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--O 1.252 1.237 0 C-N-CA 124.94 1.296 . . . . 0.0 112.343 177.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.932 0 CA-C-O 118.946 -0.919 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' -2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -56.67 131.43 45.57 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.068 3.179 . . . . 0.0 114.052 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' -1' ' ' GLY . . . . . . . . . . . . . . . -78.58 -171.99 40.26 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.564 1.078 . . . . 0.0 113.986 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 0' ' ' MET . . . . . . . . . . . . . 98.0 mmm -66.3 137.54 57.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.557 0.743 . . . . 0.0 111.734 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 34.8 p -71.06 149.02 46.95 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.986 0.914 . . . . 0.0 112.788 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.99 -149.17 19.77 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.197 0.903 . . . . 0.0 112.877 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.48 78.13 7.22 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.736 1.214 . . . . 0.0 110.69 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.43 10.18 74.61 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 125.155 1.36 . . . . 0.0 115.141 -169.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.24 120.44 32.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.493 1.517 . . . . 0.0 110.464 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -122.51 109.14 13.97 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.638 1.575 . . . . 0.0 109.381 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.52 49.61 68.31 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.386 0.517 . . . . 0.0 112.266 -167.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.07 -173.08 48.9 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.697 1.141 . . . . 0.0 113.009 -163.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -71.35 120.44 16.93 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.31 -1.112 . . . . 0.0 110.282 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.92 132.81 50.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.434 0.694 . . . . 0.0 111.36 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -62.08 128.86 38.14 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.941 0.896 . . . . 0.0 110.859 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.41 120.32 12.04 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.356 0.662 . . . . 0.0 110.871 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.8 139.68 58.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.85 0.86 . . . . 0.0 111.232 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.66 122.63 16.82 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.25 0.62 . . . . 0.0 110.846 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -64.88 135.33 55.6 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.691 0.796 . . . . 0.0 111.274 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 46.3 p -67.82 161.78 25.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.033 0.933 . . . . 0.0 111.647 171.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -63.04 106.52 0.85 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.664 0.786 . . . . 0.0 110.731 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 65.8 p -82.76 -26.15 32.14 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.947 1.299 . . . . 0.0 113.35 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' SER . . . . . . . . . . . . . 28.3 t -59.78 119.57 7.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.148 0.979 . . . . 0.0 110.854 170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -71.05 120.49 16.69 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.249 1.02 . . . . 0.0 110.987 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 144.18 56.51 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.577 0.751 . . . . 0.0 112.483 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.97 179.39 29.29 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.979 1.276 . . . . 0.0 112.984 -176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.62 139.07 51.28 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.551 0.74 . . . . 0.0 112.041 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -89.98 139.44 30.6 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.784 0.834 . . . . 0.0 110.202 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -123.69 153.59 66.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.539 1.136 . . . . 0.0 111.155 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.79 -41.0 56.44 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 124.026 3.15 . . . . 0.0 114.416 174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -61.27 -33.44 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.122 0.969 . . . . 0.0 113.275 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.73 89.09 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.59 1.091 . . . . 0.0 113.36 177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.85 -50.01 70.55 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.359 1.08 . . . . 0.0 111.921 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.37 -36.35 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 O-C-N 121.899 -0.501 . . . . 0.0 112.263 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -56.85 -53.25 60.01 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.831 1.252 . . . . 0.0 112.119 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -61.52 -42.12 98.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.593 1.157 . . . . 0.0 113.066 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.45 -47.84 78.29 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.871 0.76 . . . . 0.0 111.943 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 56.3 tp -62.06 -47.08 86.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.141 0.882 . . . . 0.0 112.054 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -54.74 -50.14 69.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.533 1.133 . . . . 0.0 112.652 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.79 -36.97 73.27 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.645 1.178 . . . . 0.0 112.693 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.55 -33.36 76.49 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.581 1.086 . . . . 0.0 113.941 171.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 57.0 t30 54.88 35.61 24.76 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.194 1.798 . . . . 0.0 113.512 175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.13 -25.91 61.91 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -173.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 61.0 p -127.7 161.95 27.71 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.005 1.722 . . . . 0.0 112.601 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -63.29 -46.31 87.33 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.11 0.964 . . . . 0.0 112.849 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -114.07 130.79 56.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.863 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.91 97.36 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.5 1.12 . . . . 0.0 109.706 -175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.22 147.05 43.68 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.247 0.927 . . . . 0.0 112.983 171.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.29 -58.95 2.96 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.753 0.821 . . . . 0.0 113.059 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.31 -33.86 88.4 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 115.831 1.092 . . . . 0.0 115.831 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.11 -59.61 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 119.483 1.642 . . . . 0.0 113.938 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.03 -33.64 98.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.539 2.159 . . . . 0.0 113.058 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.76 -42.67 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 120.21 1.368 . . . . 0.0 111.584 174.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -77.22 -38.87 50.39 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.869 -1.144 . . . . 0.0 113.602 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 94.3 mt -54.91 -43.62 73.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.92 1.236 . . . . 0.0 110.581 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.51 -38.92 91.8 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.943 0.897 . . . . 0.0 112.787 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.671 ' HA ' ' H ' ' D' ' 36' ' ' SER . . . -55.78 -42.94 76.28 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.293 1.406 . . . . 0.0 112.667 172.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 t -60.14 -53.39 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 118.574 0.625 . . . . 0.0 111.39 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 40.6 mt -67.11 -21.59 65.84 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -48.85 -49.06 41.16 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.644 1.111 . . . . 0.0 112.062 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -64.03 -29.56 70.7 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -73.59 -51.42 16.95 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.983 0.913 . . . . 0.0 111.659 171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' THR . . . . . . . . . . . . . 67.8 p -70.88 -21.42 62.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.972 -1.08 . . . . 0.0 113.372 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.55 94.63 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.244 1.018 . . . . 0.0 111.877 164.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -38.63 91.62 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.242 0.928 . . . . 0.0 111.768 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mt -56.47 -52.66 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 118.809 0.731 . . . . 0.0 110.148 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.39 -30.04 70.81 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.21 -53.85 42.81 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.805 1.184 . . . . 0.0 111.165 171.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.62 -41.51 99.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.856 0.863 . . . . 0.0 111.995 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.4 -37.38 87.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.317 1.047 . . . . 0.0 111.858 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.78 -41.75 97.73 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.766 1.175 . . . . 0.0 112.935 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.18 -44.36 95.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.435 1.117 . . . . 0.0 111.253 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.46 88.24 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.226 -0.921 . . . . 0.0 112.462 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.25 -48.22 82.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.402 1.081 . . . . 0.0 112.011 174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.68 -50.33 63.49 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.797 1.239 . . . . 0.0 112.21 171.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -58.16 -36.0 72.38 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -87.05 3.34 46.46 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.797 1.239 . . . . 0.0 113.441 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' LYS . . . . . . . . . . . . . 92.3 mttt 55.64 32.91 20.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.844 2.058 . . . . 0.0 114.257 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.6 152.79 22.01 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.907 1.683 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 30.4 p -109.41 12.17 24.75 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.014 1.726 . . . . 0.0 112.905 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -133.54 126.65 31.49 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.472 -1.393 . . . . 0.0 111.268 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.6 127.52 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.027 0.931 . . . . 0.0 109.19 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.04 167.13 13.83 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.987 1.715 . . . . 0.0 111.281 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -44.49 -42.71 14.16 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.241 3.294 . . . . 0.0 115.465 175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.87 -40.69 93.92 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.749 0.82 . . . . 0.0 112.887 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -65.66 -41.56 92.38 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.621 0.768 . . . . 0.0 111.904 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.57 -43.9 95.65 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.41 0.684 . . . . 0.0 111.618 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -56.69 -50.29 72.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.426 1.09 . . . . 0.0 111.713 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 78.3 mt -56.79 -46.85 81.29 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.736 0.698 . . . . 0.0 111.978 173.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.79 62.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.596 0.758 . . . . 0.0 112.593 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ILE . . . . . . . . . . . . . 21.8 pt -68.34 -30.84 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -65.78 -41.89 91.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.774 1.229 . . . . 0.0 112.388 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -79.57 -7.55 58.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 -171.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -124.1 122.0 36.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.952 1.251 . . . . 0.0 111.361 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -53.33 -41.61 65.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.42 1.088 . . . . 0.0 112.516 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -64.08 -29.49 70.63 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.286 -0.883 . . . . 0.0 113.358 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.57 -43.83 30.52 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.607 -0.683 . . . . 0.0 111.306 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -53.93 -45.55 71.27 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.91 0.884 . . . . 0.0 112.261 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.39 -26.5 53.32 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.086 1.354 . . . . 0.0 113.915 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -91.12 -97.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.088 1.355 . . . . 0.0 110.276 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' LEU . . . . . . . . . . . . . 23.6 tp -71.13 112.63 7.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.852 1.205 . . . . 0.0 110.617 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.71 -29.73 3.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.991 1.281 . . . . 0.0 113.258 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -66.65 -46.52 75.49 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.088 0.955 . . . . 0.0 111.669 174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' VAL . . . . . . . . . . . . . 58.7 t -79.93 131.02 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.45 1.1 . . . . 0.0 110.07 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' THR . . . . . . . . . . . . . 41.9 m -71.64 109.47 5.58 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.548 0.739 . . . . 0.0 109.703 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.3 119.68 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.256 0.622 . . . . 0.0 109.723 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.07 -38.54 69.42 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.634 0.774 . . . . 0.0 112.589 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -71.3 158.51 36.24 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.222 1.009 . . . . 0.0 112.591 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.81 1.32 61.92 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.332 0.968 . . . . 0.0 115.277 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.83 -179.0 19.31 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 118.484 1.142 . . . . 0.0 113.323 165.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.57 110.19 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.675 -0.897 . . . . 0.0 110.248 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -71.93 150.88 92.9 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.826 0.85 . . . . 0.0 111.132 171.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.47 135.14 67.81 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.118 2.545 . . . . 0.0 113.168 176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.79 91.54 5.34 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.85 0.86 . . . . 0.0 111.288 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ILE . . . . . . . . . . . . . 43.2 pt -62.03 143.31 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.855 0.862 . . . . 0.0 112.939 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -93.26 -20.28 20.58 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.958 0.903 . . . . 0.0 112.56 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.63 159.02 19.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 0.0 111.967 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.59 122.22 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.594 -0.691 . . . . 0.0 110.016 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -71.76 106.39 4.12 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.138 0.575 . . . . 0.0 109.593 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.59 140.43 97.51 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.135 0.574 . . . . 0.0 110.98 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -59.29 144.84 99.26 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.607 2.205 . . . . 0.0 111.407 172.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.72 124.21 17.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.301 0.64 . . . . 0.0 110.062 173.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.45 119.69 7.95 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.976 0.91 . . . . 0.0 110.004 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' THR . . . . . . . . . . . . . 27.2 m -57.14 123.03 13.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.215 1.006 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.17 111.51 5.16 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 0.0 110.688 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 23.4 t -123.13 118.34 27.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.148 1.379 . . . . 0.0 109.73 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -84.57 128.65 34.71 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.689 0.795 . . . . 0.0 110.786 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -74.71 134.82 41.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.702 0.801 . . . . 0.0 111.728 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -99.4 146.49 26.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.024 1.33 . . . . 0.0 111.144 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.04 140.84 58.91 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.418 0.687 . . . . 0.0 111.821 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.87 128.19 34.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.047 0.939 . . . . 0.0 111.409 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' GLY . . . . . . . . . . . . . . . -61.88 132.15 46.3 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.303 0.954 . . . . 0.0 112.835 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.253 1.259 0 C-N-CA 125.532 1.533 . . . . 0.0 112.764 178.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.846 0 CA-C-O 119.901 -0.388 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' -2' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.76 -1.13 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.235 3.29 . . . . 0.0 114.944 -172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.18 13.57 81.16 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.356 0.979 . . . . 0.0 114.968 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 0' ' ' MET . . . . . . . . . . . . . 98.8 mmm -89.97 158.16 44.86 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.469 1.508 . . . . 0.0 111.49 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.48 124.24 15.4 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.06 2.507 . . . . 0.0 112.074 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -80.21 125.68 80.89 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.85 0.86 . . . . 0.0 110.985 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -57.69 -35.65 98.73 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.121 2.547 . . . . 0.0 114.646 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.42 -11.13 59.92 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.65 120.11 26.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.574 1.15 . . . . 0.0 110.78 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' SER . . . . . . . . . . . . . 49.3 p -74.3 -41.29 61.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.454 1.101 . . . . 0.0 112.886 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.45 144.51 97.63 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.233 1.013 . . . . 0.0 112.362 173.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -60.24 150.21 81.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.137 2.558 . . . . 0.0 112.36 173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.3 149.99 93.6 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 123.015 0.526 . . . . 0.0 112.053 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.92 134.12 60.37 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.07 2.514 . . . . 0.0 113.554 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.55 106.7 14.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.976 0.91 . . . . 0.0 109.995 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -104.67 16.53 25.86 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.693 1.597 . . . . 0.0 113.43 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.2 12.74 69.37 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.005 1.288 . . . . 0.0 114.863 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' SER . . . . . . . . . . . . . 40.1 p -74.47 155.06 38.41 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.42 1.488 . . . . 0.0 112.949 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -70.66 134.57 47.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.885 0.874 . . . . 0.0 110.969 174.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -65.68 143.7 57.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.943 0.897 . . . . 0.0 111.427 174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.05 138.89 58.67 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.261 0.624 . . . . 0.0 111.558 173.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.81 115.39 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.316 0.646 . . . . 0.0 109.543 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' THR . . . . . . . . . . . . . 41.0 p -73.92 157.76 35.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.592 1.157 . . . . 0.0 112.641 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.75 119.5 7.24 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.179 0.992 . . . . 0.0 111.125 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.54 119.78 9.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.505 0.722 . . . . 0.0 110.706 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -73.67 142.08 46.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.522 0.729 . . . . 0.0 111.502 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.92 142.32 58.35 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.633 0.773 . . . . 0.0 111.429 175.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.98 145.17 53.8 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.973 0.909 . . . . 0.0 111.111 172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -68.02 124.29 22.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.92 0.39 . . . . 0.0 111.735 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.69 160.12 37.78 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.714 0.674 . . . . 0.0 112.32 166.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.63 109.59 0.65 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.808 0.843 . . . . 0.0 110.829 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.73 148.85 41.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.573 1.149 . . . . 0.0 110.279 171.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -62.14 102.96 0.33 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.413 0.685 . . . . 0.0 110.695 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.57 140.8 51.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.572 1.149 . . . . 0.0 109.371 171.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -67.53 107.32 2.45 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.204 0.602 . . . . 0.0 110.771 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' SER . . . . . . . . . . . . . 27.8 t -78.69 -49.54 12.96 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.565 0.746 . . . . 0.0 110.795 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttm-85 -80.65 109.92 15.65 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.001 1.32 . . . . 0.0 110.437 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.47 133.13 51.28 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 110.025 170.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -137.25 132.34 33.65 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . 0.671 ' H ' ' HA ' ' C' ' 53' ' ' ALA 0.371 5.0 m 78.88 142.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 131.417 3.887 . . . . 0.0 119.809 168.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.58 -9.15 42.17 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 119.126 3.01 . . . . 0.0 119.126 -137.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 38.3 t -163.19 -60.42 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -170.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -46.37 -51.46 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 127.109 2.164 . . . . 0.0 111.97 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -92.36 -41.39 10.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 5.6 p -51.31 -27.43 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 120.928 1.695 . . . . 0.0 114.627 -171.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -45.79 -34.68 3.84 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.746 1.618 . . . . 0.0 113.046 167.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -50.23 -33.93 21.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 120.497 -1.377 . . . . 0.0 114.086 171.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.5 -50.71 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.456 1.025 . . . . 0.0 110.454 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.58 -51.87 66.76 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 118.757 -0.64 . . . . 0.0 110.876 174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -51.0 -40.45 58.15 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -80.55 -50.29 10.21 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.218 1.007 . . . . 0.0 113.179 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.44 -47.84 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.738 0.815 . . . . 0.0 111.937 -173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -131.24 84.9 55.53 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.598 1.559 . . . . 0.0 110.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.4 -31.26 76.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.571 2.847 . . . . 0.0 115.161 -175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -70.13 -19.51 63.22 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -94.59 133.16 38.53 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.855 1.262 . . . . 0.0 112.048 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -128.34 -172.49 13.22 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.731 1.158 . . . . 0.0 114.691 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ILE . . . . . . . . . . . . . 22.6 pt -121.96 162.21 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.616 1.566 . . . . 0.0 110.284 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -89.45 163.58 15.2 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.283 -0.886 . . . . 0.0 112.958 168.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -55.84 -41.22 73.96 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.169 0.988 . . . . 0.0 111.845 168.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -65.43 -41.15 93.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.308 1.043 . . . . 0.0 112.176 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.5 -45.32 92.06 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.763 0.825 . . . . 0.0 112.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' MET . . . . . . . . . . . . . 56.6 tpp -52.9 -48.26 67.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.358 0.663 . . . . 0.0 111.005 168.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.55 -45.39 77.23 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.497 1.046 . . . . 0.0 114.729 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.72 -42.55 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.49 1.145 . . . . 0.0 112.011 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.73 -41.0 94.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.936 -1.102 . . . . 0.0 111.46 172.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -60.79 -47.3 86.97 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.848 0.859 . . . . 0.0 112.083 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' SER . . . . . . . . . . . . . 81.0 p -64.81 -39.63 93.91 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.572 1.533 . . . . 0.0 112.775 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -51.82 -55.83 17.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.93 1.292 . . . . 0.0 111.908 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' VAL . . . . . . . . . . . . . 29.6 m -72.35 -31.2 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -60.94 -44.07 97.76 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 119.058 0.845 . . . . 0.0 112.04 173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -58.49 -42.22 87.09 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.727 -0.608 . . . . 0.0 111.987 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.99 -43.28 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 121.34 -0.85 . . . . 0.0 111.466 174.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -55.36 -44.56 76.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 120.418 1.463 . . . . 0.0 112.501 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.717 0.69 . . . . 0.0 111.743 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -61.68 -43.76 98.24 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.775 0.83 . . . . 0.0 112.881 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ILE . . . . . . . . . . . . . 69.7 mt -52.95 -52.8 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.555 1.142 . . . . 0.0 110.132 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.36 90.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.28 -50.85 61.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.892 0.758 . . . . 0.0 113.235 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -64.17 -41.45 97.12 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.604 -0.939 . . . . 0.0 112.156 176.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.15 94.47 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.419 1.009 . . . . 0.0 112.007 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' SER . . . . . . . . . . . . . 17.9 t -57.8 -53.77 54.48 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.291 1.036 . . . . 0.0 111.866 172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -51.88 -54.75 25.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.169 0.987 . . . . 0.0 112.025 174.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.62 -44.51 89.99 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.297 1.039 . . . . 0.0 112.705 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.39 79.35 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.967 0.803 . . . . 0.0 112.138 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -63.14 -45.33 92.43 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.776 0.83 . . . . 0.0 112.594 175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -60.62 -35.94 77.39 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.076 0.95 . . . . 0.0 112.45 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -86.18 15.49 5.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.613 1.565 . . . . 0.0 113.215 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 55.3 29.04 12.2 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 127.547 2.339 . . . . 0.0 115.075 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -81.77 152.92 26.75 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.489 1.116 . . . . 0.0 112.887 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' SER . . . . . . . . . . . . . 53.9 p -71.13 -35.6 71.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.834 1.253 . . . . 0.0 112.824 170.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' THR . . . . . . . . . . . . . 7.2 t -143.73 167.39 22.4 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.39 1.476 . . . . 0.0 112.806 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 84.1 mt -71.45 138.19 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 125.51 1.524 . . . . 0.0 110.457 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' THR . . . . . . . . . . . . . 16.7 p -112.51 166.16 11.58 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.511 1.125 . . . . 0.0 111.814 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 31.7 p -51.56 -41.66 61.29 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.403 1.081 . . . . 0.0 112.67 167.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -63.51 -45.76 89.16 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.3 1.04 . . . . 0.0 111.932 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -61.87 -40.68 96.22 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.323 0.51 . . . . 0.0 112.276 174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' ILE . . . . . . . . . . . . . 91.4 mt -59.5 -51.78 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.685 0.794 . . . . 0.0 110.963 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -53.2 -48.63 67.95 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.68 1.127 . . . . 0.0 111.852 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 77.1 m -60.49 -46.28 90.67 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.187 0.903 . . . . 0.0 112.16 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.29 72.43 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.475 1.034 . . . . 0.0 112.753 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' VAL . . . . . . . . . . . . . 61.3 t -60.31 -50.92 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.005 0.922 . . . . 0.0 110.583 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -58.42 -39.52 80.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.493 1.117 . . . . 0.0 113.748 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' LEU . . . . . . . . . . . . . 72.4 mt -58.08 -44.2 87.42 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.721 0.691 . . . . 0.0 112.212 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.11 -37.76 64.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.226 1.01 . . . . 0.0 112.139 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.34 80.04 20.71 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 126.565 1.946 . . . . 0.0 111.059 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -77.09 178.47 7.6 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 124.395 3.397 . . . . 0.0 114.359 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.62 -133.45 41.35 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.102 1.334 . . . . 0.0 114.113 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -57.73 -34.74 69.83 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.24 -1.153 . . . . 0.0 112.021 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 45.2 mt -64.0 -28.86 70.1 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.441 -0.787 . . . . 0.0 112.328 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.77 -40.13 69.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.467 1.03 . . . . 0.0 111.957 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -59.09 -44.81 91.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.21 1.004 . . . . 0.0 110.919 172.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -60.42 -48.72 80.55 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.911 0.484 . . . . 0.0 112.032 169.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.62 -48.45 66.35 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.78 -49.35 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 118.539 0.609 . . . . 0.0 111.628 176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -61.82 -57.23 12.63 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -63.99 -44.17 93.49 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.381 -0.825 . . . . 0.0 111.428 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.54 -35.36 66.36 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.631 -0.668 . . . . 0.0 113.457 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -71.75 -45.03 62.99 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.571 1.185 . . . . 0.0 111.769 172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -53.68 -38.79 64.56 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 119.923 1.238 . . . . 0.0 112.967 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.5 -54.9 30.5 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.365 0.666 . . . . 0.0 112.238 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.72 -43.92 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.447 1.099 . . . . 0.0 111.283 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' THR . . . . . . . . . . . . . 44.0 m -52.26 -47.53 65.76 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.396 0.998 . . . . 0.0 112.201 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -65.92 -15.94 63.42 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -90.25 -41.28 11.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.089 0.955 . . . . 0.0 112.541 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -70.09 -25.53 63.56 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.139 -0.975 . . . . 0.0 113.098 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' SER . . . . . . . . . . . . . 59.6 p -82.59 -8.49 59.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 171.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.02 165.15 22.44 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.982 0.913 . . . . 0.0 113.324 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.347 1.459 . . . . 0.0 113.175 179.13 . . . . . . . . 0 0 . 1 stop_ save_